
<html lang="en"     class="pb-page"  data-request-id="0ec68bc1-7519-4a2f-88e3-a26e37b334df"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2013.56.issue-8;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm3015926;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Target- and Mechanism-Based Therapeutics for Neurodegenerative Diseases: Strength in Numbers" /></meta><meta name="dc.Creator" content="Paul C.  Trippier" /></meta><meta name="dc.Creator" content="Kristin  Jansen Labby" /></meta><meta name="dc.Creator" content="Dustin D.  Hawker" /></meta><meta name="dc.Creator" content="Jan J.  Mataka" /></meta><meta name="dc.Creator" content="Richard B.  Silverman" /></meta><meta name="dc.Description" content="The development of new therapeutics for the treatment of neurodegenerative pathophysiologies currently stands at a crossroads. This presents an opportunity to transition future drug discovery effor..." /></meta><meta name="Description" content="The development of new therapeutics for the treatment of neurodegenerative pathophysiologies currently stands at a crossroads. This presents an opportunity to transition future drug discovery effor..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 27, 2013" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm3015926" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm3015926" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm3015926" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm3015926" /></link>
        
    
    

<title>Target- and Mechanism-Based Therapeutics for Neurodegenerative Diseases: Strength in Numbers | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm3015926" /></meta><meta property="og:title" content="Target- and Mechanism-Based Therapeutics for Neurodegenerative Diseases: Strength in Numbers" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/large/jm-2012-015926_0038.jpeg" /></meta><meta property="og:description" content="The development of new therapeutics for the treatment of neurodegenerative pathophysiologies currently stands at a crossroads. This presents an opportunity to transition future drug discovery efforts to target disease modification, an area in which much still remains unknown. In this Perspective we examine recent progress in the areas of neurodegenerative drug discovery, focusing on some of the most common targets and mechanisms: N-methyl-d-aspartic acid (NMDA) receptors, voltage gated calcium channels (VGCCs), neuronal nitric oxide synthase (nNOS), oxidative stress from reactive oxygen species, and protein aggregation. These represent the key players identified in neurodegeneration and are part of a complex, intertwined signaling cascade. The synergistic delivery of two or more compounds directed against these targets, along with the design of small molecules with multiple modes of action, should be explored in pursuit of more effective clinical treatments for neurodegenerative diseases." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm3015926"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm3015926">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm3015926&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm3015926&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm3015926&amp;href=/doi/10.1021/jm3015926" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 3121-3147</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm301848w" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Target- and Mechanism-Based Therapeutics for Neurodegenerative Diseases: Strength in Numbers</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+C.++Trippier">Paul C. Trippier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kristin++Jansen+Labby">Kristin Jansen Labby</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dustin+D.++Hawker">Dustin D. Hawker</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jan+J.++Mataka">Jan J. Mataka</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard+B.++Silverman">Richard B. Silverman</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Molecular Biosciences, Chemistry of Life Processes Institute, Center for Molecular Innovation and Drug Discovery, Northwestern University, Evanston, Illinois, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 1-847-491-5653. Fax: 1-847-491-7713. E-mail: <a href="/cdn-cgi/l/email-protection#1253757f737c52717a777f3c7c7d60667a6577616677607c3c777667"><span class="__cf_email__" data-cfemail="3170565c505f715259545c1f5f5e4345594654424554435f1f545544">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm3015926&amp;href=/doi/10.1021%2Fjm3015926" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 3121–3147</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 4, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>29 October 2012</li><li><span class="item_label"><b>Published</b> online</span>27 March 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 April 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm3015926" title="DOI URL">https://doi.org/10.1021/jm3015926</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3121%26pageCount%3D27%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPaul%2BC.%2BTrippier%252C%2BKristin%2BJansen%2BLabby%252C%2BDustin%2BD.%2BHawker%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D8%26contentID%3Djm3015926%26title%3DTarget-%2Band%2BMechanism-Based%2BTherapeutics%2Bfor%2BNeurodegenerative%2BDiseases%253A%2BStrength%2Bin%2BNumbers%26numPages%3D27%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3147%26publicationDate%3DApril%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm3015926"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">6144</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">89</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm3015926" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Target- and Mechanism-Based Therapeutics for Neurodegenerative Diseases: Strength in Numbers&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;C. Trippier&quot;},{&quot;first_name&quot;:&quot;Kristin&quot;,&quot;last_name&quot;:&quot;Jansen Labby&quot;},{&quot;first_name&quot;:&quot;Dustin&quot;,&quot;last_name&quot;:&quot;D. Hawker&quot;},{&quot;first_name&quot;:&quot;Jan&quot;,&quot;last_name&quot;:&quot;J. Mataka&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;B. Silverman&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;3121-3147&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm3015926&quot;},&quot;abstract&quot;:&quot;The development of new therapeutics for the treatment of neurodegenerative pathophysiologies currently stands at a crossroads. This presents an opportunity to transition future drug discovery efforts to target disease modification, an area in which much still remains unknown. In this Perspective we examine recent progress in the areas of neurodegenerative drug discovery, focusing on some of the most common targets and mechanisms: N-methyl-d-aspartic acid (NMDA) receptors, voltage gated calcium channels (VGCCs), neuronal nitric oxide synthase (nNOS), oxidative stress from reactive oxygen species, and protein aggregation. These represent the key players identified in neurodegeneration and are part of a complex, intertwined signaling cascade. The synergistic delivery of two or more compounds directed against these targets, along with the design of small molecules with multiple modes of action, should be explored in pursuit of more effective clinical treatments for neurodegenerative diseases.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3015926&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3015926" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3015926&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3015926" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3015926&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3015926" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm3015926&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3015926&amp;href=/doi/10.1021/jm3015926" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm3015926" /></input><a href="/doi/pdf/10.1021/jm3015926" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm3015926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm3015926%26sid%3Dliteratum%253Aachs%26pmid%3D23458846%26genre%3Darticle%26aulast%3DTrippier%26date%3D2013%26atitle%3DTarget-%2Band%2BMechanism-Based%2BTherapeutics%2Bfor%2BNeurodegenerative%2BDiseases%253A%2BStrength%2Bin%2BNumbers%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D8%26spage%3D3121%26epage%3D3147%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290729" title="Nervous system diseases">Nervous system diseases</a>,</li><li><a href="/action/doSearch?ConceptID=292016" title="Therapeutics">Therapeutics</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jmcmar.2013.56.issue-8/production/jmcmar.2013.56.issue-8.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0038.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/large/jm-2012-015926_0038.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3015926&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The development of new therapeutics for the treatment of neurodegenerative pathophysiologies currently stands at a crossroads. This presents an opportunity to transition future drug discovery efforts to target disease modification, an area in which much still remains unknown. In this Perspective we examine recent progress in the areas of neurodegenerative drug discovery, focusing on some of the most common targets and mechanisms: <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartic acid (NMDA) receptors, voltage gated calcium channels (VGCCs), neuronal nitric oxide synthase (nNOS), oxidative stress from reactive oxygen species, and protein aggregation. These represent the key players identified in neurodegeneration and are part of a complex, intertwined signaling cascade. The synergistic delivery of two or more compounds directed against these targets, along with the design of small molecules with multiple modes of action, should be explored in pursuit of more effective clinical treatments for neurodegenerative diseases.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74177" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74177" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Neurodegenerative disease is an encompassing term for a set of over 600 diseases in which the nervous system progressively and irreversibly deteriorates. The single greatest risk factor for the development of neurodegenerative disease is advancing age, with associated mitochondrial DNA mutation and oxidative stress damage,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> illustrated by the fact that the majority of these diseases are late-onset. Alzheimer’s disease (AD), the most prevalent of the neurodegenerative diseases, affects approximately 15 million people worldwide. Estimates expect the number of sufferers to triple in the U.S.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and Europe<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> by 2050, figures that are repeated for most other forms of neurodegeneration, including Parkinson’s disease (PD) and Huntington’s disease (HD).</div><div class="NLM_p">The most common forms of neurodegenerative diseases are AD, PD, HD, and amyotrophic lateral sclerosis (ALS) (or in Europe, motor neurone disease, MND).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Specific aspects of these diseases, including protein aggregation, genetic mutations, and pathophysiology, are discussed in this Perspective. Extensive literature exists detailing each of the pathways highlighted, as well as for the many other neurodegenerative diseases. The interested reader is directed to those excellent reviews and references cited within this manuscript.</div><div class="NLM_p">A commonality of the neurodegenerative diseases is that they are not diseases attributed to a single gene or even multiple genes; they are far more complicated, involving a myriad of known and unknown signaling cascades, misfolded proteins, protofibril formation, ubiquitin–proteasome dysfunction, oxidative and nitrosative stress, mitrochondrial injury, and many more events.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Our current understanding of neuroscience has enabled the identification of some key genes involved, but since many cases are seemingly sporadic, we know that mechanisms of neurodegeneration are more than just genetic.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> While they vary in symptoms, neurodegenerative diseases have many pathologic overlaps (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). In this Perspective, we focus on the major components of this shared pathway: <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartic acid (NMDA) receptors, voltage gated calcium channels (VGCCs), neuronal nitric oxide synthase (nNOS), oxidative stress from reactive oxygen species (ROS), and protein aggregation.</div><div class="NLM_p">NMDA receptors are ligand-gated, voltage-dependent ion channels that respond to the neurotransmitters glutamate and NMDA. NMDA receptor activation leads to Ca<sup>2+</sup> influx into postsynaptic cells, which continues signal potentiation by activating signaling cascades. Overstimulation of NMDA receptors has been implicated in neurodegeneration, in addition to other disease states, and therefore NMDA receptors have been greatly investigated as a drug target (<a class="ref internalNav" href="#sec2" aria-label="section 2">section 2</a>). Ca<sup>2+</sup> influx is also regulated by VGCCs. As discussed in <a class="ref internalNav" href="#sec3" aria-label="section 3">section 3</a>, one specific channel, Ca<sub>v</sub>1.3, has been identified to play a role in the progression of PD, and therefore, selective antagonism of Ca<sub>v</sub>1.3 is hypothesized to be potentially neuroprotective in early or presymptomatic stages of PD. Among many other responses, increased intracellular Ca<sup>2+</sup> concentration activates nNOS. Overactivation of nNOS produces high intracellular levels of nitrite and superoxide, which react to form ROS including peroxynitrite. This oxidative stress within the cell causes damage to DNA and lipids and causes protein modifications. Overactivation of nNOS has also been implicated in neurodegeneration, and therefore, inhibitors of nNOS are sought-after as potential therapeutics (<a class="ref internalNav" href="#sec4" aria-label="section 4">section 4</a>). Additionally antioxidant therapeutics are designed to directly prevent cellular damage from oxidative species (<a class="ref internalNav" href="#sec5" aria-label="section 5">section 5</a>). Lastly, protein aggregation is a hallmark of AD and PD, and while it may result from modifications by ROS, other mechanisms, such as mutations, are thought to be involved in protein aggregates observed in AD and PD. Progress toward developing antiaggregation therapeutics is examined in <a class="ref internalNav" href="#sec6" aria-label="section 6">section 6</a>.</div><div class="NLM_p">A separate, but crucially important, pathophysiological pathway that contributes to neurodegeneration is inflammation and immune response.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> Many of the most relevant immunological molecules are produced within the brain, and this leads to the observation that systemic immune responses affect brain function and contribute to neurodegeneration.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> This pathway of inflammation and immune response is intricately connected with several, if not all, of the individual targets discussed in this Perspective. Space does not permit an all-encompassing review of this subject, and the reader is directed to the excellent review articles referenced herein. Expanding research continues to link this key pathophysiological pathway to the individual targets discussed in this Perspective, as briefly highlighted below.</div><div class="NLM_p">Highly regulated by the immune system, the kynurenine pathway is an enzymatic cascade that converts tryptophan to serotonin but also to several other neuroactive compounds. Misregulation of this pathway results in increased or decreased production of these metabolites and contributes to a neurodegenerative effect.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Kynurenic acid is a competitive antagonist for the NMDA, kainite, and AMPA receptors and forms the structural scaffold for drug discovery efforts mentioned in <a class="ref internalNav" href="#sec2" aria-label="section 2">section 2</a>. Independent of the antagonistic effect of kynurenic acid is the observation that it is an effective free radical scavenger and can therefore display antioxidant properties similar to those of compounds discussed in <a class="ref internalNav" href="#sec5" aria-label="section 5">section 5</a>.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Further connections from inflammation and immune response to antioxidants and nNOS inhibitors exist via a family of proteins known as toll-like receptors (TLRs). Evidence is increasing for the role of TLRs in sterile inflammation observed in neurodegenerative diseases, such as PD and AD.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> These receptors play an important role in innate immunity because they recognize conserved motifs found in microorganisms. They are expressed in large numbers in various cells within the central nervous system (CNS) and serve to activate microglia. Microglia, the immune cells of the brain, are activated by distress signals from nearby cells. A side effect of this activation is the release of toxic factors, such as nitric oxide (<a class="ref internalNav" href="#sec4" aria-label="section 4">section 4</a>) and ROS (<a class="ref internalNav" href="#sec5" aria-label="section 5">section 5</a>), resulting in increased neuronal damage. TLRs are also being explored as targets for the treatment of neurodegenerative diseases.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Furthermore, polyphenols, discussed in <a class="ref internalNav" href="#sec5" aria-label="section 5">section 5</a> and acting predominantly as antioxidants, also have activity crossover to the inflammation and inflammatory response; these compounds are known to modulate neuroinflammation by inhibiting the expression of inflammatory genes and the level of intracellular antioxidants.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Neuroinflammation commonly occurs as a result of oxidative and excitotoxic damage to neurons, and because of mitochondrial dysfunction, it is linked to protein aggregation.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> It is therefore envisioned that drugs that combat neuroinflammation might also combat neurodegenerative disease progression.</div><div class="NLM_p">However, while anti-inflammatory agents may be required to treat neurodegenerative diseases, they may not be sufficient on their own but may be effective as part of a combination therapy.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Such a combination might include targeting proinflammatory factors, such as tumor necrosis factor α and Fas ligand. One compound, revlimid, has been reported to modestly reduce these proinflammatory cytokines and to show some neuroprotection in an ALS mouse model.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Use of revlimid in a combinatorial approach with selected antiaggregation agents discussed in <a class="ref internalNav" href="#sec6" aria-label="section 6">section 6</a> or potentially any of the agents in this Perspective may increase the neuroprotective effects from “modest” results with a single therapeutic compound to “significant” results with a combination of two or more compounds.</div><div class="NLM_p">The thesis that AD, PD, HD, and ALS, although distinct disorders, share a common mechanism that progresses neuron death along a “neurodegenerative spectrum” has been advanced by numerous researchers.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/large/jm-2012-015926_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Common targets and mechanisms associated with many neurodegenerative diseases that are highlighted in this Perspective.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/large/jm-2012-015926_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3015926&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recent advances have increased our understanding of the processes underlying neurodegeneration.<a onclick="showRef(event, 'ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23">(20-23)</a> Drug candidates that target single or dual processes have been advanced to the clinic, but they only provide relief of symptoms, not of the underlying causes (which still remain unknown). Modulation of multiple targets along the same biological pathway could potentially lead to disease modification rather than just control of symptoms. The widely accepted definition of a disease modifying drug is “an agent that alters the underlying pathophysiology of the disease in question and demonstrates meaningful reduction in the rate of decline or progression to a defined milestone”.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In a complex pathway with many drug targets, such as those contributing to neurodegenerative diseases, a drug with a single-target mechanism of action cannot always correct that pathway. The synergistic delivery of a “cocktail” of two or more drugs may deliver enhanced potency in the treatment of neurodegenerative diseases by potentially leading to disease modification.</div><div class="NLM_p">Polypharmacy, the synergistic combination of two or more drugs acting on different targets, has been successful in treating other diseases such as hyperlipidemia (high blood cholesterol). The combination of simvastatin (a 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor) and ezetimibe (an inhibitor of dietary cholesterol uptake) is marketed as Vytorin.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> This combination therapy works by preventing the body from making its own cholesterol while also inhibiting the absorption of cholesterol from dietary intake. A drug that inhibits only one source of cholesterol is less effective at lowering overall levels, as cholesterol is still produced by the second source. This disease-modifying therapy reduces overall cholesterol levels by targeting both sources. Other disease-modifying synergistic drug combinations have been utilized for the treatment of cancer,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> hepatitis C virus,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and HIV/AIDS,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> supporting the potential strategy of treating other complex diseases in a similar manner.</div><div class="NLM_p">Alternatively, a single therapeutic agent could be designed to interact at two different targets. An example of a dual-acting drug that is disease-modifying is duloxetine (Cymbalta), used in the treatment of depression. This compound inhibits both serotonin and norepinephrine reuptake in the CNS.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Inhibition of the reuptake of both neurotransmitters increases overall levels of the two compounds, known to play an important role in mood. A deficit in either neurotransmitter can cause depression; therefore, increasing levels of both provides a disease-modifying therapy to counteract this deficit.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> An example relevant to the disease pathway outlined in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> is the polycyclic caged amine compound NGP1-01 (<b>18</b>) (<a class="ref internalNav" href="#sec2" aria-label="section 2">section 2</a>), which blocks both the NMDA receptor and L-type calcium channel with resulting neuroprotective effects. Blocking only one of these targets allows the continued influx of Ca<sup>2+</sup> ions from the other. As excess Ca<sup>2+</sup> ion concentration is implicated in excitotoxicity, this would be analogous to trying to stop a bucket leaking from two holes by only stoppering one. Preventing an increase in overall Ca<sup>2+</sup> ion concentration, and thereby excitotoxicity, could be considered disease-modifying over simply reducing the concentration.</div><div class="NLM_p">Additionally, a multifaceted strategy would further probe the pathophysiological pathway(s) of neurodegeneration and confirm the intricate connectivity that has been proposed between therapeutic targets. Therapeutics developed for one type of neurodegenerative disease, when delivered in combination, may transfer their therapeutic potential to a different disease state, thereby exploiting and expanding the neurodegenerative therapeutic arsenal. Such combination therapy would also have advantages in drug delivery and dosing. Delivery of a significant dose of an inhibitor of Ca<sub>v</sub>1.3-type calcium channels is hindered by concerns of selectivity over other Ca<sub>v</sub> channels and resultant off-target toxicity. Dosing a lower concentration of such an inhibitor in conjunction with a modulator of another target on the pathophysiological pathway would allow for the inhibition of two targets that alone may provide no therapeutic response. This approach would provide the opportunity to use drugs that are active but only have low efficacy because of selectivity problems. As a result, the potential to tune inhibitory responses rather than outright blockage would allow for the use of small molecules previously discarded as nonefficacious.</div><div class="NLM_p last">This Perspective examines the state-of-the-art small molecule therapeutics available for each of the neurodegenerative disease targets depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. A combination of these molecules or the design of new compounds bearing active moieties that target two or more of the pathophysiological hallmarks of neurodegenerative diseases might be expected to bring about a new era in neuroscience drug discovery while efforts continue toward further elucidation of the underlying causes of neurodegeneration.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2 Alteration of NMDA Receptor Function</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31353" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31353" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">NMDA receptors, named after their selective agonist, <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate, are ionotropic receptors that mediate glutamatergic neurotransmission. These receptors, as well as α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, kainate cation channel receptors, and metabotropic receptors, respond to glutamate, the major excitatory transmitter in the brain.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> The NMDA receptors have long been studied as potential therapeutic targets because of the numerous CNS functions in which they have been implicated, both in normal physiological function and in disease states.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> However, the numerous roles they play in normal neurological function have led to disappointing clinical outcomes in the development of new drugs as a result of adverse side effects.<a onclick="showRef(event, 'ref32 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref34">(32, 34)</a> Another complicating factor for the lack of successful therapeutic intervention through modification of NMDA receptor function lies in the permeability of Ca<sup>2+</sup> through the channel; excessive ion influx results in excitotoxicity that can lead to neuronal cell death.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a></div><div class="NLM_p">The NMDA receptor has a relatively complex tetrameric subunit organization, and the subunit combination varies in different regions of the brain. This subunit heterogeneity presents additional challenges in drug design, since each subunit has distinct functional and pharmacological properties. Seven NMDA receptor subunits have been identified: a GluN1 subunit, four different GluN2 subunits (GluN2A–D), and two GluN3 subunits (GluN3A,B). The intact receptor consists of two GluN1 subunits and two GluN2 subunits. Glutamate binds to the GluN2 subunit, but for the receptor to be functional, glycine must simultaneously bind to the GluN1 subunit as a coagonist.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> However, studies involving the CA1 region of rat hippocampus tissue slices have shown that synaptic NMDA receptors, which are important in long-term potentiation and NMDA-induced neurotoxicity, utilize <span class="smallcaps smallerCapital">d</span>-serine as coagonist, whereas extrasynaptic NMDA receptors have a preferential affinity for glycine.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The intracellular portion of the transmembrane domains connect to a postsynaptic signaling complex known as the postsynaptic density, which contains PSD-95, enzymes such as nNOS and kinases, and other signaling and scaffolding proteins (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a> Excitotoxicity, including the excessive stimulation of NMDA receptors, has long been hypothesized to play a role in the etiology of neurodegenerative disorders such as PD<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and HD<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a> and may contribute, at least in part, to neuronal loss in AD<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> and other dementias, ALS,<a onclick="showRef(event, 'ref36 ref45 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref36 ref45 ref46 ref47">(36, 45-47)</a> and possibly multiple sclerosis and prion disease.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/large/jm-2012-015926_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. NMDA receptor showing agonist and antagonist binding site domains.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/large/jm-2012-015926_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3015926&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Earlier work on NMDA receptor antagonists has focused on designing compounds targeting four regions of the receptor: the glutamate and the glycine agonist binding domain (ABD) sites, the channel pore, and the N-terminal domain (NTD) region between GluN1 and GluN2B.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Among the earliest glutamate competitive antagonists to be developed was phosphonic acid (<i>R</i>)-AP5 (<b>1</b>), which showed strong selectivity for NMDA receptors over kainate and AMPA receptors.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50, 51)</a> The introduction of rigidity with a piperazine ring provided another phosphonic glutamate site antagonist (<b>2</b>), which relieved parkinsonian symptoms and improved locomotion in animal models of PD when coadministered with L-DOPA, although it was not effective when given alone.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> A drawback of the phosphonic acid class of antagonists is that their polarity makes passage through the blood–brain barrier (BBB) and intestinal membranes difficult.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Another problem with these competitive antagonists is that they generally demonstrate poor subunit selectivity.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The differences in potency between NMDA and glutamate between the different GluN2 subtypes are less than 4-fold, and an analysis of key residues in the binding pocket shows the presence of a highly conserved binding site.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Glycine site competitive antagonist 7-chlorokynurenate (<b>3</b>) did prevent NMDA-induced striatal lesions in an animal model as well as in vitro, but the compound targeted kainite receptors as well as NMDA receptors. In addition, the protection afforded by the compound could not be surmounted by coadministration of glycine but instead by increasing the dose of NMDA, calling into question its actual mechanism of action.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Since glycine acts at all NMDA subtypes, there may be an issue of tolerability of compounds targeting the glycine binding site, in addition to the higher doses of either glutamate or glycine antagonists that would be needed to surmount the competition with the endogenous ligands for their respective binding sites.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> However, since glycine antagonists act at the GluN1 subunit, they may be associated with fewer side effects, although in the case of 7-chlorokynurenate (<b>3</b>), there has been the added issue of poor BBB penetration.<a onclick="showRef(event, 'ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref53 ref54">(53, 54)</a> A series of 3-amino-1-hydroxypyrrolidin-2-one (HA-966, <b>4</b>) analogues were synthesized to overcome the limitations of poor solubility and BBB penetration.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0006.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0007.gif" alt="" id="fx2" /></img><div class="NLM_p">NMDA channel pore blockers, in particular amantadine (<b>5</b>) and its derivative memantine (<b>6</b>), have been developed for therapeutic use in inhibiting excitotoxicity. One of the earlier NMDA pore blockers to be advanced was dizocilpine (<b>7</b>), a high-affinity, uncompetitive antagonist.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Coadministration of dizocilpine with L-DOPA completely prevented the progressive reduction in the duration of the L-DOPA response occurring with chronic L-DOPA therapy in parkinsonian rats.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> However, use of dizocilpine has been associated with severe side effects, such as coma,<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> and in one study actually exacerbated the symptoms of MPTP-induced parkinsonism when administered to a monkey.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0008.gif" alt="" id="fx3" /></img><div class="NLM_p">Amantadine (<b>5</b>) is an FDA approved drug that has been widely used in the treatment of PD. The predominant inhibitory mechanism of action of amantadine results from increasing the rate of channel closed states when the drug is bound in the channel of NMDA receptors.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> In a retrospective study of PD patients attending a single clinic, improved survival was associated with amantadine use.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Amantadine, as well as the NMDA channel pore blocker dextromethorphan (<b>8</b>), also improved L-DOPA-associated motor response complications when given as an adjuvant to L-DOPA therapy.<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62, 63)</a> However, a systematic Cochrane review of randomized controlled trials for amantadine concluded that because of a lack of evidence, it was not possible to determine whether amantadine is a safe and effective treatment for L-DOPA-induced dyskinesias in PD patients. The report also noted that in one study, 8 out of 18 participants had side effects, including confusion and worsening of hallucinations.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> In an unrelated study, NMDA channel blocker remacemide (<b>9</b>), as adjunct therapy with L-DOPA, was not found to significantly improve motor fluctuation symptoms, although the compound was found to be safe and tolerable.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0009.gif" alt="" id="fx4" /></img><div class="NLM_p">Memantine (<b>6</b>), another NMDA antagonist, is classified as an uncompetitive, open-channel blocker. The drug was patented by Eli Lilly & Co. in 1968 and was marketed by the German pharmaceutical company Merz to treat PD. The drug has a relatively fast off-rate from channel binding, which contributes to the drug’s low affinity for the channel pore and, as a result, its clinical efficacy and tolerability. As a result, after several clinical trials, memantine was approved by the European Union in 2002 and the FDA in 2003 for the treatment of moderate to severe Alzheimer’s disease.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> One analysis concluded that the safety profile of memantine makes it particularly suitable for its use in elderly patients, since it is associated with a low overall rate of adverse events and a low potential for drug–drug interactions (because of a low extent of metabolism and protein binding, particularly to cytochrome P450 enzymes).<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> A recent review adds that for the treatment of moderate to severe AD, memantine should be offered either as a monotherapy or in conjunction with an acetylcholinesterase inhibitor but that the use of memantine as a first-line therapy for mild to moderate AD is not supported by current data. Further, insufficient data exist to make a recommendation for its use in PD dementia.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> A paradoxical feature of the action of memantine is that a higher concentration of memantine is needed to alleviate mild dementia than to counteract the damage associated with moderate-to-severe dementia. This apparent incongruity has been explained by the on-rate for channel blockage by memantine being increased by increasing the drug’s concentration, which leads to a greater proportion of channels being blocked.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> To increase the neuroprotective efficacy of memantine, a second-generation derivative has been designed to incorporate a nitric oxide moiety, which should bind to the sulfhydryl group of a cysteine residue in the channel pore that has been found to down-regulate NMDA receptor activity.<a onclick="showRef(event, 'ref58 ref69'); return false;" href="javascript:void(0);" class="ref ref58 ref69">(58, 69)</a></div><div class="NLM_p">Much work remains for the design of therapeutic agents that can modulate NMDA receptors without adversely affecting normal cellular processes regulated by these channels. One more recent approach toward accomplishing this goal would be to design ligands that are subunit-specific and serve as noncompetitive antagonists.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The first subunit-selective NMDA receptor antagonist was ifenprodil (<b>10</b>), which inhibits Glu2B-containing receptors with a 200- to 400-fold selectivity over receptors containing Glu2A, Glu2C, and Glu2D subunits and with an IC<sub>50</sub> of 0.34 μM for the GluN1/Glu2B receptor.<a onclick="showRef(event, 'ref31 ref70'); return false;" href="javascript:void(0);" class="ref ref31 ref70">(31, 70)</a> The difficulty in designing noncompetitive antagonists for the Glu2B subunit, which may be therapeutically relevant for a number of disorders, is that they also act at other receptors and channels, leading to side effects, causing a subefficacious lowering of the dose.<a onclick="showRef(event, 'ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref71 ref72">(71, 72)</a> To improve selectivity, ifenprodil analogue <b>11</b><a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> and traxoprodil (CP-101,606, <b>12</b>)<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> were designed. Analogue <b>11</b> was found to be more effective than <b>10</b> in preventing toxicity to cortical neurons that mimic ischemic brain damage when exposed to glutamate (IC<sub>50</sub> of 0.4 versus 3.5 μM, respectively).<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Compounds <b>10</b>–<b>12</b> have antiparkinsonian activity in animal models. In a study of the use of <b>12</b> in counteracting dyskinesia and parkinsonism, it was found to reduce the maximum severity of L-DOPA-induced dyskinesia by approximately 30%, although many of the subjects in the study experienced dissociation, abnormal thinking, and amnesia. Compound <b>12</b> did not reduce parkinsonism in the study; however, the antidyskinetic effects were maximal at a lower dose, and the adverse effects were found to be dose-responsive.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0010.gif" alt="" id="fx5" /></img><div class="NLM_p">Among the recently identified voltage-independent negative allosteric modulators of NMDA receptors is <b>13</b>, one of the quinazoline-4-one derivatives advanced by Traynelis and co-workers.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Compound <b>13</b> had approximately 50-fold selectivity for recombinant GluN2C/D-containing receptors over GluN2A/B-containing receptors, low micromolar potency, and a novel mechanism that requires binding of glutamate to the GluN2 subunit but not glycine binding to the GluN1 subunit. The GluN2C/D over GluNA/B subunit selectivity of <b>13</b> was determined from ABD residues adjacent to the transmembrane helices.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Differing subunit selectivity profiles for negative allosteric modulation were also seen in a recent series of naphthalene and phenanthrene derivatives.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> 9-Iodophenanthrene-3-carboxylic acid (UBP512, <b>14</b>) inhibited only GluN1/GluN2C and GluN1/GluN2D receptors, while 6-bromocoumarin-3-carboxylic acid (UBP608, <b>15</b>) inhibited GluN1/GluN2A receptors (23-fold) over GluN1/GluN2D, with IC<sub>50</sub> values in the micromolar range. Consistent with their characterization as allosteric modulators, these compounds were found to be voltage-independent and not competitive with glutamate and glycine agonists. The site of action for <b>14</b> and related compounds is thought to be at the dimer interface between the ABDs, and the NTD was not found to be necessary for inhibitory activity.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Another negative allosteric antagonist, dihydropyrazoloquinoline <b>16</b>, inhibited GluN2C- and GluN2D-containing NMDA receptors over recombinant GluN2A- and GluN2B-containing receptors, with at least 50-fold difference in IC<sub>50</sub> values. The selectivity was attributed to residues in the membrane-proximal lower lobe of the GluN2 ABD.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0011.gif" alt="" id="fx6" /></img><div class="NLM_p">Bettini and co-workers reported several sulfonamide derivatives from high-throughput screening that were selective antagonists at GluN1/GluN2A over GluN1/GluN2B.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Addition of 1 mM glycine, but not 1 mM <span class="smallcaps smallerCapital">l</span>-glutamate, overcame the inhibitory effects of the two most promising compounds. It was subsequently determined that one of the compounds, <b>17</b>, binds to a novel allosteric site at the dimer interface between the GluN1 and GluN2 ABDs, thereby reducing glycine potency (IC<sub>50</sub> = 0.1–0.32 μM).</div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0012.gif" alt="" id="fx7" /></img><div class="NLM_p">To exploit the subunit selectivity of these newer pharmacological tools for therapeutic advantage, it will be necessary to map the relative contribution of each subunit to its function both in normal cellular processes and in disease states. Recently, it was found that the NMDA receptor subtype specificity of three crucial channel properties (Mg<sup>2+</sup> blockage, relative Ca<sup>2+</sup> permeability, and single-channel conductance) were all determined primarily at a single GluN2 subunit residue in the transmembrane region.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> However, because of the challenges involved in obtaining highly selective antagonists, there is still relatively little known about the function and therapeutic potential of the different subunits of the NMDA receptors.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> One confounding issue in this regard is the subunit composition of the NMDA receptor, since two different GluN2 subunits may be present rather than only the binary combination of GluN1 and one type of GluN2 (or GluN3) subunit, in different regions of the brain.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> By use of recombinant heterotrimeric GluN1/GluN2A/GluN2B and GluN1/GluN2A/GluN2C receptors with Zn<sup>2+</sup> and ifenprodil antagonism, it was found that each ligand produced only partial inhibition and that maximal inhibition was only achieved with both copies of each GluN2 subunit in the receptor.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> This finding suggested a potential limitation in using ifenprodil and its derivatives, since both GluN1/GluN2B and heterotrimeric GluN1/GluN2A/GluN2B receptors will be inhibited, possibly affecting subunit-specific control of normal neurological processes.</div><div class="NLM_p">Other considerations may enter into the design of NMDA therapeutic antagonists, such as whether the agents will preferentially target synaptic or extrasynaptic NMDA receptors and the GluN2 subunit composition at those receptor sites. Work on the mechanism of action of memantine has shown that it preferentially targets extrasynaptic over synaptic NMDA receptors in a hippocampal autaptic neuronal preparation. In this study, the synaptic and extrasynaptic NMDA receptors in mature neurons differed in subunit composition, with the GluN2A receptors predominating at the synaptic receptors and the GluN2B subunits at the extrasynaptic receptors.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> When cultured primary striatal or cortical neurons from rat were transfected with the gene coding for mutant huntingtin, a protein with polyglutamine repeat residues implicated in the pathogenesis of HD, and treated with D-APV, memantine, or ifenprodil, there was a significant decrease in the number of neurons expressing aggregated mutant-protein macroinclusions.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> Further studies using a transgenic YAC128 mouse HD model showed that at high concentration of memantine both synaptic and extrasynaptic NMDA-mediated currents were blocked, worsening neurodegeneration. At low concentration of memantine the extrasynaptic receptors were predominately blocked, leading to a neuroprotective effect (reduction of striatal volume loss and motor learning deficits at 12 months post-treatment) from the largely unaffected synaptic activity.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> Milnerwood et al. reported a similar reversal in intracellular signaling and motor learning deficits when the extrasynaptic NMDA receptors of YAC128 HD mice were pharmacologically blocked with a low dose of memantine, thus providing further evidence for a new therapeutic approach to combating HD.<a onclick="showRef(event, 'ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref86 ref87">(86, 87)</a></div><div class="NLM_p">In view of the complex interplay of factors affecting NMDA receptor function, an integrative approach involving the modulation of receptor-associated pathways in the disease state may constitute a viable therapeutic strategy for neurodegenerative disorders. Since an excessive influx of Ca<sup>2+</sup> ion into neurons is an important factor in the excitotoxic process, blockade of NMDA receptors could potentially be offset by the presence of L-type voltage-gated calcium channels.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Thus, design of therapeutic agents that can jointly antagonize both targets may be a desirable goal, and at least one such compound (<b>18</b>) has been developed.<a onclick="showRef(event, 'ref89 ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref89 ref90 ref91">(89-91)</a> Dimebon (latrepirdine) (<b>19</b>), an antihistamine compound used clinically in Russia for many years, has demonstrated efficacy in phase II clinical trials for AD and HD,<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> although a phase III trial for use in mild-to-moderate AD gave disappointing results.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Dimebon was found to inhibit both NMDA receptors (IC<sub>50</sub> = 10 μM) and L-type calcium channels (IC<sub>50</sub> = 50 μM) in cultured neurons, possibly accounting, at least in part, for its mechanism of action.<a onclick="showRef(event, 'ref92 ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref92 ref94 ref95">(92, 94, 95)</a> Blockage of NMDA-induced currents was different from that of memantine, suggesting a different site of action for dimebon at the NMDA receptor.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0013.gif" alt="" id="fx8" /></img><div class="NLM_p">Influx of calcium via NMDA receptors can induce necrotic or apoptotic cell death, depending on the degree of glutamate stimulation, with the cellular fate influenced by the effect of the resultant intracellular calcium concentration on the mitochondria.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> A therapeutic approach targeting the apoptotic pathway had mixed results when compounds shown to be effective both in vitro and in animal models for several neurodegenerative disorders were tested in human clinical trials.<a onclick="showRef(event, 'ref97 ref98 ref99'); return false;" href="javascript:void(0);" class="ref ref97 ref98 ref99">(97-99)</a></div><div class="NLM_p">Another strategy for counteracting neuronal excitotoxicity might involve coadministration of an NMDA antagonist with an inhibitor of glutamate release. One potential candidate, riluzole (<b>20</b>), has been approved for use in treating the symptoms of ALS, although with limited success.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> In addition to its role as an inhibitor for glutamate release, riluzole also protects neurons against NMDA-induced toxicity.<a onclick="showRef(event, 'ref100 ref101 ref102'); return false;" href="javascript:void(0);" class="ref ref100 ref101 ref102">(100-102)</a> A clinical trial for use of riluzole in early PD showed that it was well tolerated in patients but with no significant difference relative to the placebo group.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Similarly, a 3-year randomized controlled study showed no neuroprotective or beneficial symptomatic effect of riluzole in HD.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> An alternative to inhibiting glutamate release might be to use an agonist, such as ceftriaxone (<b>21</b>), for stimulation of glutamate uptake transporters. Ceftriaxone, a third-generation cephalosporin antibiotic, was found to be a potent modulator of glutamate transport through NF-κB-mediated excitatory amino acid transporter-2 (EAAT2) in primary human fetal astrocytes<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> and was in a clinical trial for ALS.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0014.gif" alt="" id="fx9" /></img><div class="NLM_p last">Another important facet of an integrative therapeutic strategy to combat neurodegenerative diseases is the role that metabotropic glutamate receptors (mGluR) may play in the neural excitotoxicity process. An advantage of additionally targeting the mGlu receptors is that they can modulate the activity of voltage-gated calcium channels while not affecting fast excitatory synaptic transmission.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Pharmacological blockade of mGlu<sub>5</sub> receptors has led to reduced neuronal death in animal models of PD and ALS, and negative allosteric modulators for this receptor, as well as selective mGlu<sub>3</sub> receptor agonists, have been in clinical development.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> A recent perspective provides an excellent overview of this subject.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">3 Voltage-Gated Calcium Channels</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17084" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17084" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the central nervous system, calcium’s conductance properties are principally mediated by two types of receptors: ligand<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> and voltage-gated channels.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> While NMDA receptors are involved in the total calcium load in neurons, smaller, but still significant, calcium contributions are mediated primarily through voltage-gated calcium channels.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Voltage-gated calcium channels (VGCCs) are expressed on the plasma membrane and open in response to depolarizing stimuli (events that lower the resting potential of neurons). In most physiological environments, VGCCs shuttle calcium from the extracellular space into the intracellular space. The accessory subunit and conducting pore (α<sub>1</sub>-subunit) that constitutes VGCCs is the portion of the channel that conducts calcium, gives rise to the biochemical and biophysical properties in identified channels, and is the major site of pharmacological action. To date, 10 types of α<sub>1</sub>-subunits have been identified, normally classified into five subtypes: L-type (Ca<sub>v</sub>1.1, 1.2, 1.3, 1.4), P/Q-type (Ca<sub>v</sub>2.1), N-type (Ca<sub>v</sub>2.2), R-type (Ca<sub>v</sub>2.3), and T-type (Ca<sub>v</sub>3.1, 3.2, 3.3).<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a></div><div class="NLM_p">Ca<sub>v</sub>1.1, Ca<sub>v</sub>1.2, Ca<sub>v</sub>1.3, and Ca<sub>v</sub>1.4 α<sub>1</sub>-subunits, constituting the family of L-type calcium channels (LTCCs), are central players in neuronal calcium dynamics in both physiological and pathophysiological states. α<sub>1</sub>-Subunits constituting Ca<sub>v</sub>1.1 and Ca<sub>v</sub>1.4 LTCCs are predominantly expressed outside the central nervous system, in skeletal muscle and the retina, respectively.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Functional Ca<sub>v</sub>1.2 and Ca<sub>v</sub>1.3 LTCCs are found in cardiovascular<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> and nervous tissue, respectively,<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> and play central roles as pharmacological targets in antiarrhythmia and antihypertension therapeutics. 1,4-Dihydropyridines (DHPs), phenylalkylamines (PAAs), and benzodiazepines (BZAs) are among the most common LTCC channel antagonists.<a onclick="showRef(event, 'ref115 ref116'); return false;" href="javascript:void(0);" class="ref ref115 ref116">(115, 116)</a></div><div class="NLM_p">Ca<sub>v</sub>1.3 LTCCs have been identified as playing a role in the progression of Parkinson’s disease by allowing uncompensated calcium loading in dopaminergic (DA) neurons in the substantia nigra pars compacta (SNc), which subsequently places a heavy and unsustainable metabolic burden on these neurons. It has been shown that by antagonism of these channels nonselectively with isradipine (<b>22</b>), a potent LTCC inhibitor, SNc DA neurons exhibit less metabolic stress and are protected in multiple PD animal models.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> Selective antagonism of Ca<sub>v</sub>1.3 LTCC is therefore hypothesized to be potentially neuroprotective in early or presymptomatic stages of PD.</div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0015.gif" alt="" id="fx10" /></img><div class="NLM_p">While promising, isradipine is nonselective. It is also a potent Ca<sub>v</sub>1.2 LTCC inhibitor. Therefore, long-term use of isradipine as a treatment for PD might result in hypotension or peripheral edema. Even if this does not result directly from isradipine use, it is known that during the course of PD, hypotension is common, thereby exacerbating this undesirable side effect.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Moreover, the nonselective nature of DHP inhibition of both neuronal types of LTCCs, Ca<sub>v</sub>1.2 and Ca<sub>v</sub>1.3, makes dosing regimens of isradipine, or other nonselective DHPs that might be disease-modifying in PD or other neurodegenerative diseases, an impossibility because the efficacious dose may have a serious effect on the therapeutic index of this strategy.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> None of the Ca<sub>v</sub>1 antagonists in the clinic preferentially select for Ca<sub>v</sub>1.3 channels.<a onclick="showRef(event, 'ref114 ref120'); return false;" href="javascript:void(0);" class="ref ref114 ref120">(114, 120)</a> Thus, the search for more isoform-selective Ca<sub>v</sub>1.3 LTCC antagonists has garnered recent attention.</div><div class="NLM_p">Chang et al. described<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> a comprehensive structure–activity-relationship (SAR) study of modifications to the structurally simple, active DHP nifedipine<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> (<b>23</b>). A collection of 124 chemically diverse 4-substituted 1,4-dihydropyridines was generated; however, little selectivity of Ca<sub>v</sub>1.3 over Ca<sub>v</sub>1.2 was obtained. The most selective compounds generated (<b>24</b> and <b>25</b>) possessed Ca<sub>v</sub>1.3 selectivities of only 2.2- and 2.4-fold, respectively, and both demonstrated only micromolar potencies. Observations from the SAR study showed an activity pattern for 4-substituted 1,4-dihydropyridines of substituted phenyl > thienyl > furyl > pyridyl > napthyl > alkyl (cyclic alkyl), with substitution of the phenyl ring at the 2-position being the most potent and at the 4-position the least potent. Complete loss of activity was observed when the pyridyl nitrogen was methylated or replaced with oxygen. These data implied that the generation of a high Ca<sub>v</sub>1.3 selective DHP may be unlikely, and attention was focused on the generation of new scaffolds.</div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0016.gif" alt="" id="fx11" /></img><div class="NLM_p">Compounds that show Ca<sub>v</sub>1.3 LTCC inhibition, however selective, must maintain good pharmacokinetic properties and structure components with good potential for passing through the BBB. A high-throughput screen was initialized by the Silverman laboratory to identify novel Ca<sub>v</sub>1.3 selective LTCC inhibitors by use of a calcium-sensing fluorescent imaging plate reader (FLIPR) assay. Over 60 000 molecules from a variety of commercial and government libraries were screened for activity with no hits resulting. In parallel with this screen Xia et al. described a series of symmetric pyrimidine-2,4,6-triones (PYT) investigated for applications in antiaggregation ALS models, possessing good pharmacokinetic properties and BBB penetration.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> About 200 of these compounds and other scaffolds from the Silverman lab that were active in antiaggregation assays were tested, and the first PYT Ca<sub>v</sub>1.3-selective antagonists were realized, although most of the compounds screened showed Ca<sub>v</sub>1.2 selectivity. The lead compound was modified, providing the first highly selective Ca<sub>v</sub>1.3 antagonist (<b>26</b>).<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0017.gif" alt="" id="fx12" /></img></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">4 Neuronal Nitric Oxide Synthase Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55836" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55836" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As shown in the Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> cellular cascade, activation of the NMDA receptor leads to calcium influx, which activates many downstream proteins, including nNOS.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> The signaling molecule, nitric oxide (NO), is a free radical that is produced by nitric oxide synthases (NOSs) from substrate <span class="smallcaps smallerCapital">l</span>-arginine, molecular oxygen, and NADPH. There are three isoforms of NOS: neuronal NOS (nNOS), which produces NO as a neurotransmitter; endothelial NOS (eNOS), which produces NO to signal the relaxation of smooth muscle cells in blood vessels; inducible NOS (iNOS), which produces a burst of NO in response to invading pathogens. The prominent role of NO in the nervous system leads to the possibility of improper regulation of NO and therefore various disease pathologies. High levels of NO have been implicated in neurodegenerative diseases including ALS and PD.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> NO itself is a reactive molecule that leads to the formation of other oxidative species such as superoxide and peroxynitrite. Also, nitrated protein aggregates, which are highly toxic to neurons, are found in patients with neurodegenerative diseases. S-Nitrosylation of proteins is a common feature of Lewy bodies and intraneuronal protein aggregates found in PD.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> Increased nitrosative stress may also compromise the ubiquitin degradation system, which, when impaired, cannot properly degrade proteins, leading to aggregation.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> Parkin, an E3 ubiquitin ligase implicated in PD, has been shown to be S-nitrosylated, which impairs its function and leads to increased protein aggregation.<a onclick="showRef(event, 'ref128 ref129 ref130'); return false;" href="javascript:void(0);" class="ref ref128 ref129 ref130">(128-130)</a> S-Nitrosylation of Hsp90 compromises its protection abilities as a chaperone and leads to increased aggregation.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> NO stress can also compromise mitochondrial function. Electrons leak from the electron transport chain (ETC) to react with NO, forming peroxynitrite (ONOO<sup>–</sup>), which damages lipids, proteins, and DNA.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> S-Nitrosylation of prosurvival and proapoptotic proteins, p21, Ras, and Bcl-2 alters their activity.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> Two of the isoforms of NOS, nNOS and eNOS, are constitutively expressed and activated by an increase in intracellular calcium concentration. Calcium binds to calmodulin, a small protein, and this complex binds and activates these NOSs.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a></div><div class="NLM_p">NOS inhibitors as potential therapeutics have been sought since the discovery of NO’s signaling role in the late 1980s. Since crystal structure information was not yet available, early inhibitors began as arginine analogues, shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> (<b>27</b>–<b>33</b>).<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a>These inhibitors, however, lacked selectivity. Selectivity has proven to be difficult to achieve over the past 20 years because of the high homology of the isoforms, especially in the active site. <i>N</i>-Nitro-<span class="smallcaps smallerCapital">l</span>-arginine (L-NNA, <b>27</b>) does show some selectivity, about 250-fold for nNOS over iNOS, but essentially no selectivity for nNOS over eNOS.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Because of the important role of eNOS in vascular regulation, this poor selectivity over eNOS leads to hypertension in animals.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> L-NNA (<b>27</b>), L-NMA (<b>28</b>), and L-NAME (<b>29</b>) are commonly used in both in vitro and in vivo pharmacology experiments because of their stability, commercial availability, low toxicity, and solubility. Thiocitrulline and methylated thiocitrulline analogues have also been explored, but selectivity over eNOS has been difficult to achieve.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structures, Potencies, and Selectivities of Arginine Analogues<a class="ref internalNav" href="#tbl1-fn1" aria-label="e">e</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0004.gif" alt="" id="fx13" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last"><i>K</i><sub>i bovine eNOS</sub>/<i>K</i><sub>i rat nNOS.</sub></p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last"><i>K</i><sub>i murine iNOS</sub>/<i>K</i><sub>i rat nNOS</sub>.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Bovine nNOS, not rat nNOS.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">L-NAME presumably is hydrolyzed to L-NMA intracellularly or in vivo.</p></div><div class="footnote" id="tbl1-fn1"><sup>Table e</sup><p class="last">Data reported from Erdal et al. and references within ref <a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">134</a>.</p></div></div><div></div></div><div class="NLM_p">Using L-NNA as a starting point, Silverman and co-workers developed several series of nNOS-selective dipeptides (see Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). This approach takes advantage of the potency of the arginine analogue scaffolds but also provides compounds that can potentially extend out of the heme binding pocket in an attempt to interrogate the isozymes for selective contacts away from the active site. Residue differences between isoforms include the following: S585 in nNOS is N370 in iNOS but is S356 in eNOS; D597 nNOS is N368 in eNOS.</div><div class="NLM_p">Early dipeptide esters (<b>34</b>) achieved impressive selectivity over iNOS,<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> while more optimization led to <b>35</b>, which is highly selective over eNOS (1500-fold).<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Modifications of the peptide scaffold included acetylation, benzyloxycarbonylation, amide methylation or conversion to peptoids, in an attempt to protect against metabolic degradation but led to drops in selectivity.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> Exploration of conformationally rigid analogues of <b>34</b> led to highly potent, selective dipeptide amides <b>36</b>,<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a><b>37</b>,<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> and <b>38</b>,<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> but these compounds have limited BBB permeability because of their tricationic structures.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Dipeptide Ester and Amide nNOS Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0005.gif" alt="" id="fx14" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last"><i>K</i><sub>i bovine eNOS</sub>/<i>K</i><sub>i rat nNOS</sub>.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last"><i>K</i><sub>i murine iNOS</sub>/<i>K</i><sub>i rat nNOS</sub>.</p></div></div><div></div></div><div class="NLM_p">As crystal structures of NOS became available,<a onclick="showRef(event, 'ref143 ref144'); return false;" href="javascript:void(0);" class="ref ref143 ref144">(143, 144)</a> nNOS inhibitors moved away from the arginine mimetic scaffold. The Silverman group switched their strategy to de novo design using a pharmacophoric approach they developed termed “fragment hopping”.<a onclick="showRef(event, 'ref145 ref146'); return false;" href="javascript:void(0);" class="ref ref145 ref146">(145, 146)</a> This led to a potent, nNOS selective aminopyridine scaffold (±<b>39</b>). Optimization led to potent, selective nNOS inhibitors (±<b>40</b>), and replacement of a nitrogen atom with an oxygen atom increased bioavailability (<b>41</b>).<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Furthermore, (±)-<b>40</b> was shown to prevent hypoxia-ischemia-induced death in a rabbit model of cerebral palsy.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> Upon maternal administration, (±)-<b>40</b> and an analogue were able to distribute readily to the fetal brain, inhibit NOS activity, and decrease NO concentration in vivo, to be nontoxic, without detrimental cardiovascular effects, and to show a remarkable protection of fetal rabbit kits from the HI induced phenotype of cerebral palsy. The rabbit kits from saline-treated dams had a large incidence of fetal/neonatal deaths (16/34, 47%) but <i>no deaths</i> (0/49) were observed from animals treated with (±)-<b>40</b> and its analogue. Of the kits from saline-treated dams that came to term (18/34), severe neurobehavioral abnormalities occurred in 12/18 (67%) compared to only 7/49 (14%) in those from dams treated with the inhibitors. Furthermore, the inhibitor-treated animals exhibited a remarkably larger number (83%) of normal kits; only 9% (3/34) of the kits from saline-treated dams were born normal.</div><div class="NLM_p">Crystal structures of single enantiomers <b>41</b> and <b>42</b> revealed a surprising difference in binding mode.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> Previous crystal structures show aminopyridines bind NOS with the aminopyridine head over the heme, but the (<i>R</i>,<i>R</i>) stereochemistry of <b>42</b> induces a flipped binding mode with the fluorophenyl tail binding over the heme. Moreover, this flipped binding mode is more potent; the <i>K</i><sub>i</sub> of <b>42</b> is 7.2 nM, which is lower than the <i>K</i><sub>i</sub> of <b>41</b> (116 nM) for nNOS.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> Bioavailability of these inhibitors is poor as a result of the multiple cationic charges. A successful attempt to increase bioavailability and take advantage of the two binding pockets for the aminopyridine head led to <b>43</b>,<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> which displayed decreased nNOS selectivity. Compound <b>43</b> is a lead compound for designing future selective inhibitors of nNOS with increased bioavailability and a synthetically simple structure.</div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0018.gif" alt="" id="fx15" /></img><div class="NLM_p">The aminopyridine moiety is a bioisostere of the guanidinium group of arginine. 2-Amino-4-methylpyridine (<b>44</b>) was found to be potent both in vitro and in vivo but is nonselective.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> Simple substituted 2-aminopyridines were studied as NOS inhibitors but were found to be mostly selective for iNOS.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a>6-Phenyl-2-aminopyridines were explored by Pfizer in the early 2000s as nNOS selective inhibitors. Compound <b>45</b> had an IC<sub>50</sub> of 140 nM for human nNOS but only modest selectivity over eNOS (6 fold).<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> Compound <b>46</b> has an IC<sub>50</sub> of 70 nM for human nNOS with 50- and 10-fold selectivity over eNOS and iNOS, respectively. The compound possessed a good pharmacokinetic profile and was well tolerated and effective in vivo.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0019.gif" alt="" id="fx16" /></img><div class="NLM_p">L-NIO (<b>47</b>) is an arginine analogue known to be a nonselective inactivator of NOS.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> Compound <b>48</b>,<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> is an nNOS selective reversible inhibitor, unlike its homologue <b>49</b>,<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> which is iNOS selective and is an irreversible inhibitor. Compound <b>48</b> is selective for nNOS over eNOS (155-fold) and potent (IC<sub>50</sub> human nNOS = 40 nM) but is not effective in vivo in rats.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> nNOS selective carbamidines <b>50</b> and <b>51</b> were reported by Amoroso and co-workers;<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> computer modeling was used to rationalize that the selectivity of these bulky inhibitors is the result of the larger heme binding pocket of nNOS compared to that of eNOS and iNOS.</div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0020.gif" alt="" id="fx17" /></img><div class="NLM_p">Another successful guanidine-mimetic moiety is the thiophene amidine (thienylcarbamidine) (<b>52</b>). Developed by AstraZeneca, <b>52</b> is a selective nNOS inhibitor with an IC<sub>50</sub> of 0.035, 5.0, and 3.5 μM for human nNOS, iNOS, and eNOS, respectively.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> It has been shown to effectively cross the BBB in animal studies and to be neuroprotective in ischemia models.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> Crystal structures reveal that the amidine nitrogens hydrogen-bond to nNOS Glu592, much like arginine, while the thiophene sulfur lies 3.4 Å above the heme iron but does not coordinate as a sixth ligand.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> NeurAxon has further explored the thienylcarbamidine functionality with <b>53</b> and <b>54</b>; these nNOS selective inhibitors are being developed for the treatment of migraine pain. Compound <b>53</b> is a dual-acting inhibitor of nNOS (IC<sub>50</sub> of 0.44 μM) and agonist of the μ-opioid receptor (<i>K</i><sub>i</sub> of 5.4 nM), which is involved in pain.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> Compound <b>54</b> is a potent, selective nNOS inhibitor without any cardiovascular effects and with a good side effect profile.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0021.gif" alt="" id="fx18" /></img><div class="NLM_p last">A variety of other scaffolds have been explored as NOS inhibitors, but they are beyond the scope of this Perspective. They are described in detail in other excellent, recent review articles.<a onclick="showRef(event, 'ref134 ref164 ref165'); return false;" href="javascript:void(0);" class="ref ref134 ref164 ref165">(134, 164, 165)</a> The compounds described above have all been active site inhibitors. Inhibitors that disrupt dimerization<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> and inhibitors that displace tetrahydrobiopterin<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> also have been explored as NOS inhibitors.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">5 Antioxidants as Therapeutics for Neurodegenerative Disorders</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67408" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67408" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Misregulation of nNOS production can lead to oxidative stress, a hallmark of neurodegeneration. In addition to unregulated production of nitric oxide (NO) by nNOS, other reactive oxygen species (ROS) exist and have also been implicated in neurodegeneration. A large number of ROS are free radicals or radical-generating derivatives of oxygen such as superoxide (O<sub>2</sub><sup>•–</sup>), hydroxyl radical (<sup>•</sup>OH), and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>). Cellular damage in the nervous system by free radical species has been implicated in AD,<a onclick="showRef(event, 'ref168 ref169 ref170 ref171 ref172 ref173'); return false;" href="javascript:void(0);" class="ref ref168 ref169 ref170 ref171 ref172 ref173">(168-173)</a> PD,<a onclick="showRef(event, 'ref174 ref175 ref176 ref177'); return false;" href="javascript:void(0);" class="ref ref174 ref175 ref176 ref177">(174-177)</a> HD,<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a> and ALS.<a onclick="showRef(event, 'ref179 ref180'); return false;" href="javascript:void(0);" class="ref ref179 ref180">(179, 180)</a> Antioxidants are molecules that react with ROS to deactivate them and are of interest as potential therapeutics. Here, we present a summary of the major classes of antioxidants and their known or potential efficacy as treatments of neurodegenerative disease.</div><div class="NLM_p">Compounds that can directly react with free radical species are referred to as direct antioxidants. These compounds do not generally rely on endogenous cellular mechanisms to wield their primary effect. The major classes of direct antioxidants include phenols, low-molecular-weight enzyme mimetics, and polyenes. Because of their ability to quench free radical species, direct antioxidants can halt the procession of potentially damaging radical chain reactions.</div><div class="NLM_p">Free radical scavenging phenols, which rely on the facile ability of phenols to be oxidized to their corresponding quinones, can be divided into two categories: monophenolic and polyphenolic compounds. Monophenols vitamin E (α-tocopherol, <b>55</b>) and estrogens (<b>56</b>) have been repeatedly investigated for potential efficacy in treating a number of neurodegenerative diseases. Vitamin E has been shown to offer modest cognitive benefits in some AD patients;<a onclick="showRef(event, 'ref181 ref182 ref183'); return false;" href="javascript:void(0);" class="ref ref181 ref182 ref183">(181-183)</a> however, other studies have shown no preventative benefit of vitamin E for AD development.<a onclick="showRef(event, 'ref182 ref183 ref184 ref185 ref186'); return false;" href="javascript:void(0);" class="ref ref182 ref183 ref184 ref185 ref186">(182-186)</a> While no significant effects have been observed in PD,<a onclick="showRef(event, 'ref187 ref188 ref189 ref190'); return false;" href="javascript:void(0);" class="ref ref187 ref188 ref189 ref190">(187-190)</a> or HD,<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a> vitamin E was found to delay onset as well as slow the progression of ALS.<a onclick="showRef(event, 'ref192 ref193'); return false;" href="javascript:void(0);" class="ref ref192 ref193">(192, 193)</a> The use of estrogen replacement therapy (ERT) is also believed to play a preventative rather than therapeutic role in AD,<a onclick="showRef(event, 'ref194 ref195 ref196 ref197 ref198'); return false;" href="javascript:void(0);" class="ref ref194 ref195 ref196 ref197 ref198">(194-198)</a> and it is likewise the case for PD,<a onclick="showRef(event, 'ref199 ref200 ref201'); return false;" href="javascript:void(0);" class="ref ref199 ref200 ref201">(199-201)</a> which may be related to the increased disease prevalence observed in men over women.<a onclick="showRef(event, 'ref202 ref203'); return false;" href="javascript:void(0);" class="ref ref202 ref203">(202, 203)</a> Polyphenols, which include well-known compounds resveratrol (<b>57</b>) and curcumin (<b>58</b>), as well as a large family of flavonoids such as quercitin (<b>59</b>) and epicatechin (<b>60</b>), have already been extensively reviewed for their potential therapeutic properties.<a onclick="showRef(event, 'ref204 ref205 ref206 ref207'); return false;" href="javascript:void(0);" class="ref ref204 ref205 ref206 ref207">(204-207)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0022.gif" alt="" id="fx19" /></img><div class="NLM_p">Under normal conditions, cellular antioxidant defense mechanisms are present to combat both metabolic and exogenous sources of ROS. These mechanisms include both small molecules and enzymes. The primary small molecule utilized is glutathione (GSH), a tripeptide possessing a sulfhydryl moiety capable of donating electrons to oxidized molecules, followed by regeneration via NADPH.<a onclick="showRef(event, 'ref208 ref209'); return false;" href="javascript:void(0);" class="ref ref208 ref209">(208, 209)</a> As for antioxidant enzymes, superoxide dismutase (SOD) converts O<sub>2</sub><sup>•–</sup> into H<sub>2</sub>O<sub>2</sub>, which can then be rapidly reduced by catalase or glutathione peroxidase (GPx) to H<sub>2</sub>O and O<sub>2</sub>.<a onclick="showRef(event, 'ref177 ref210 ref211'); return false;" href="javascript:void(0);" class="ref ref177 ref210 ref211">(177, 210, 211)</a> The metabolism of O<sub>2</sub><sup>•–</sup> and H<sub>2</sub>O<sub>2</sub> is critical because O<sub>2</sub><sup>•–</sup> can react with NO to form peroxynitrite (ONOO<sup>–</sup>), and H<sub>2</sub>O<sub>2</sub> can react with Fe<sup>2+</sup>to generate <sup>•</sup>OH radicals, which are highly reactive species that are capable of lipid, protein, and DNA damage.<a onclick="showRef(event, 'ref209 ref212'); return false;" href="javascript:void(0);" class="ref ref209 ref212">(209, 212)</a> A study of potential low-molecular-weight mimics of SOD and GPx has identified a small number of potential therapeutics. The small, organoselenium compound ebselen (<b>61</b>) has exhibited notable activity as a GPx mimetic and ONOO<sup>–</sup> scavenger in vitro<a onclick="showRef(event, 'ref213 ref214'); return false;" href="javascript:void(0);" class="ref ref213 ref214">(213, 214)</a> and has shown significant beneficial effects in a primate model of PD.<a onclick="showRef(event, 'ref215'); return false;" href="javascript:void(0);" class="ref ref215">(215)</a> Ebselen’s catalytic ability can be initiated with or without the presence of ROS. In the presence of oxidative species, oxidation to the selenoxide (Se═O) followed by reduction via a thiol electron donor generates a reactive selenenic acid (Se–OH) that readily loses water and converts back to ebselen. Without the presence of ROS, oxidation of a free thiol forms a selenyl sulfide (Se–SR) leading to the production of a disulfide (RS–SR) and a selenol intermediate (Se–H). The selenol can be readily oxidized by ROS to form selenenic acid, which leads to regeneration of ebselen.<a onclick="showRef(event, 'ref216'); return false;" href="javascript:void(0);" class="ref ref216">(216)</a> The organoselenium compound <b>62</b>, similar to ebselen, has shown even higher in vitro GPx-like activity and may also possess therapeutic potential for PD or other neurodegenerative disorders.<a onclick="showRef(event, 'ref217 ref218'); return false;" href="javascript:void(0);" class="ref ref217 ref218">(217, 218)</a> Organoselenium compound <b>62</b> is currently in clinical trials for cardiovascular indications.</div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0023.gif" alt="" id="fx20" /></img><div class="NLM_p">In addition to the therapeutic potential found in GPx mimetics, Mn-containing complexes have been found to be effective SOD mimetics. Metalloporphyrins <b>63</b> and <b>64</b> have been found to exhibit high SOD activity, catalase activity, as well as inhibition of lipid peroxidation.<a onclick="showRef(event, 'ref219 ref220'); return false;" href="javascript:void(0);" class="ref ref219 ref220">(219, 220)</a> The antioxidant activity of <b>63</b>, <b>64</b>, and similar metalloporphyrins has been extensively studied in a variety of models for oxidative neuronal damage.<a onclick="showRef(event, 'ref221'); return false;" href="javascript:void(0);" class="ref ref221">(221)</a> Salen manganese complexes <b>65</b> and <b>66</b> are also SOD and catalase mimetics. These complexes have been shown to confer neuroprotection in both in vitro and in vivo models for PD.<a onclick="showRef(event, 'ref222 ref223'); return false;" href="javascript:void(0);" class="ref ref222 ref223">(222, 223)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0024.gif" alt="" id="fx21" /></img><div class="NLM_p">Polyene antioxidants primarily comprise carotenoids such as β-carotene (<b>67</b>), lycopene, retinol, and lutein and are typically of plant origin. These carotenoids are capable of scavenging singlet molecular oxygen (<sup>1</sup>O<sub>2</sub>) and peroxyl radicals forming stabilized radicals that can further react with ROS to halt radical chain reaction processes.<a onclick="showRef(event, 'ref224'); return false;" href="javascript:void(0);" class="ref ref224">(224)</a> The rate constants for singlet oxygen quenching by carotenoids are on the order of 10<sup>9</sup> M<sup>–1</sup> s<sup>–1</sup>, which is near diffusion control.<a onclick="showRef(event, 'ref225'); return false;" href="javascript:void(0);" class="ref ref225">(225)</a> Peroxyl radical scavenging is also efficient, especially under hypoxic conditions, and is important for the prevention of lipid peroxidation.<a onclick="showRef(event, 'ref226'); return false;" href="javascript:void(0);" class="ref ref226">(226)</a> Carotenoids are an important part of the diet of animals because many carotenoids are metabolized to retinol (vitamin A), which cannot be synthesized endogenously. Retinoic acid (RA), an irreversibly oxidized form of retinol, is an important signaling molecule involved in embryonic growth and development. There have been a number of studies that suggest the therapeutic potential of RA for AD prevention,<a onclick="showRef(event, 'ref227 ref228'); return false;" href="javascript:void(0);" class="ref ref227 ref228">(227, 228)</a> but there has been no evidence to suggest a direct antioxidant effect of carotenoids being involved in neurodegenerative prevention. A more recent study, however, has shown that all-trans RA (ATRA, <b>68</b>) treatment invokes a decrease in brain Aβ deposition in an AD mouse model by inhibition of amyloid precursor protein processing.<a onclick="showRef(event, 'ref229'); return false;" href="javascript:void(0);" class="ref ref229">(229)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0025.gif" alt="" id="fx22" /></img><div class="NLM_p">Indirect antioxidants are compounds that do not directly react with ROS but are involved in cellular management of oxidative species. Many of these compounds are essential cofactors required for cellular oxidative metabolism; however, a number of synthetic compounds have been identified that fall under this classification. These compounds act by easing the secondary metabolic burden of free radicals and therefore diminishing oxidative damage.</div><div class="NLM_p">Quinones are a class of compounds, often derived from aromatic compounds, containing two carbonyl groups in an unsaturated six-membered carbon ring. The general label of vitamin K is applied to a number of related quinone compounds with a polyprenylated naphthoquinone ring structure. The primary role of vitamin K is to act as a necessary enzyme cofactor for a number of processes that include blood coagulation<a onclick="showRef(event, 'ref230'); return false;" href="javascript:void(0);" class="ref ref230">(230)</a> and bone metabolism.<a onclick="showRef(event, 'ref231'); return false;" href="javascript:void(0);" class="ref ref231">(231)</a> There is growing evidence, however, that vitamin K has important functions in the brain, and that a deficiency may contribute to the pathogenesis of AD.<a onclick="showRef(event, 'ref232'); return false;" href="javascript:void(0);" class="ref ref232">(232)</a> Ubiquinone (<b>69</b>), also known as coenzyme Q<sub>10</sub>, serves as an important cofactor, primarily in the electron transport chain during aerobic cellular respiration. Ubiquinone has been found to exert a protective effect against PD and HD<a onclick="showRef(event, 'ref233 ref234'); return false;" href="javascript:void(0);" class="ref ref233 ref234">(233, 234)</a> in addition to reducing intracellular Aβ deposition<a onclick="showRef(event, 'ref235'); return false;" href="javascript:void(0);" class="ref ref235">(235)</a> and plaque pathology in AD mouse models.<a onclick="showRef(event, 'ref236'); return false;" href="javascript:void(0);" class="ref ref236">(236)</a></div><div class="NLM_p">The mitochondrial-targeted ubiquinone analogues <b>70</b> and <b>71</b> have shown encouraging results for the treatment of age-related neurodegenerative disease.<a onclick="showRef(event, 'ref237'); return false;" href="javascript:void(0);" class="ref ref237">(237)</a> Targeted delivery of these analogues is made possible by the cationic triphenylphosphonium group, which takes advantage of the potential gradient of the inner-mitochondrial membrane. Both have gone to clinical trials.<a onclick="showRef(event, 'ref238'); return false;" href="javascript:void(0);" class="ref ref238">(238)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0026.gif" alt="" id="fx23" /></img><div class="NLM_p">Spin trapping compounds are labeled as such because of their ability to form adducts with free radicals via their nitrone functionality. Initially utilized in analytical chemistry, spin traps have exhibited biological activity in a number of ROS implicated disease states.<a onclick="showRef(event, 'ref239 ref240'); return false;" href="javascript:void(0);" class="ref ref239 ref240">(239, 240)</a> Although spin traps are capable of directly quenching ROS, recent evidence suggests that they induce a number of endogenous antioxidants and enzymes involved in the attenuation of oxidative cellular damage.<a onclick="showRef(event, 'ref241'); return false;" href="javascript:void(0);" class="ref ref241">(241)</a>α-Phenyl-<i>N</i>-<i>tert</i>-butylnitrone (PBN, <b>72</b>) has exhibited efficacy for the treatment of neurodegenerative diseases by affecting signal transduction pathways related to neuroinflammatory processes.<a onclick="showRef(event, 'ref242 ref243'); return false;" href="javascript:void(0);" class="ref ref242 ref243">(242, 243)</a> On the other hand, cerovive (<b>73</b>) was tested in stroke patients in clinical trials and failed to show efficacy, likely because of its poor pharmacokinetic properties.<a onclick="showRef(event, 'ref244'); return false;" href="javascript:void(0);" class="ref ref244">(244)</a> The more lipophilic nitrones <b>74</b> and <b>75</b> have much higher radical scavenging potential over PBN and cerovive and have both exhibited neuroprotective efficacy in mouse models of PD.<a onclick="showRef(event, 'ref245 ref246'); return false;" href="javascript:void(0);" class="ref ref245 ref246">(245, 246)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0027.gif" alt="" id="fx24" /></img><div class="NLM_p">This final category of antioxidants is composed of a large and mixed group of compounds that are employed by the cell in the transport of reducing equivalents. Prominent examples include ascorbate (<b>76</b>), which has exhibited antioxidant activity in several in vitro studies,<a onclick="showRef(event, 'ref247'); return false;" href="javascript:void(0);" class="ref ref247">(247)</a> and the previously mentioned GSH (<b>77</b>). A number of thiol precursors of GSH belong to this category as well. These include the dipeptide CysGly, which is used to generate GSH in neurons,<a onclick="showRef(event, 'ref248'); return false;" href="javascript:void(0);" class="ref ref248">(248)</a> as well as cysteine precursors <i>N</i>-acetylcysteine (<b>78</b>) and procysteine (<b>79</b>).<a onclick="showRef(event, 'ref249 ref250'); return false;" href="javascript:void(0);" class="ref ref249 ref250">(249, 250)</a> Despite no known efficacy of these compounds for the treatment or prevention of neurodegenerative disease, brain levels of GSH are depleted by up to 30% in the elderly, suggesting a strong link to age-related disease.</div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0028.gif" alt="" id="fx25" /></img><div class="NLM_p">The nuclear factor E2-related factor 2 (Nrf2) signaled gene expression in response to cellular stress must be considered when discussing potential therapeutic effects of antioxidants. Nrf2 is a transcription factor responsible for the activation of a number of genes whose products are important in the reduction of cellular oxidative stress. These genes, which include glutathione-<i>S</i>-transferase (GST), coenzyme Q<sub>10</sub>, NAD(P)H:quinone oxidoreductase, superoxide dismutase 1 (SOD1), and many others, contain a common promoter called the antioxidant response element (ARE). Under normal conditions, Nrf2 is bound to repressor protein Keap1 (Kelch ECH associating protein 1) and retained in the cytoplasm. In the Nrf2-Keap1-ARE expression pathway, Keap1 acts as a sensor for oxidative stress through oxidation of or electrophilic addition to its many cysteine residues.<a onclick="showRef(event, 'ref251'); return false;" href="javascript:void(0);" class="ref ref251">(251)</a> Alteration of the cysteine residues of Keap1 disturbs Nrf2 binding, which allows Nrf2 to translocate into the nucleus. Once in the nucleus, Nrf2 heterodimerizes with members of the small Maf (sMaf) family of transcription factors, binds to the ARE, and ultimately leads to gene expression (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). An ever-growing number of molecules able to induce Nrf2 signaling have been identified, including many previously mentioned antioxidants. These molecules, and the varying chemical characteristics that provide their activity, have previously been reviewed in great detail.<a onclick="showRef(event, 'ref252 ref253'); return false;" href="javascript:void(0);" class="ref ref252 ref253">(252, 253)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/large/jm-2012-015926_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Mechanism of ARE-promoted gene expression by Nrf2. Disruption of the Keap1-Nrf2 complex allows for Nrf2 migration to the nucleus, where it joins with other transcription factors that bind to ARE regions of genes and initiate their transcription.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/large/jm-2012-015926_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3015926&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The Nrf2 system has previously been the subject of reviews in regard to its potential as a therapeutic target.<a onclick="showRef(event, 'ref254 ref255'); return false;" href="javascript:void(0);" class="ref ref254 ref255">(254, 255)</a> Activation of Nrf2 has been observed to prevent apoptosis of motor neurons that were cocultured with the ALS model G93A-SOD1 mutant astrocytes. This prevention of apoptotic signaling is believed to be caused by glutathione-mediated NO detoxification.<a onclick="showRef(event, 'ref256'); return false;" href="javascript:void(0);" class="ref ref256">(256)</a> Down-regulation of Nrf2 activated genes has also been observed in microarray analysis of mutant SOD transfected motor neuron-like Nsc34 cells.<a onclick="showRef(event, 'ref257'); return false;" href="javascript:void(0);" class="ref ref257">(257)</a> It has also been shown that dietary sulforophane (<b>80</b>), a known Nrf2 signaling activator, protects against degeneration of dopaminergic neurons in a <i>Drosophila</i> PD model.<a onclick="showRef(event, 'ref258'); return false;" href="javascript:void(0);" class="ref ref258">(258)</a> A study to assess the localization of Nrf2 in hippocampal neurons of AD indicated a loss of nuclear Nrf2 when compared to age-matched control individuals; however, cytoplasmic levels were the same between AD and control cases. This suggests impairment in nuclear trafficking and may limit Nrf2 activation as a potential AD treatment.<a onclick="showRef(event, 'ref259'); return false;" href="javascript:void(0);" class="ref ref259">(259)</a> In an N171-82Q transgenic mouse model of HD, up-regulation of the Nrf2/ARE pathway by synthetic terpenoids <b>81</b> and <b>82</b> was found to rescue behavioral deficits, extend survival, and attenuate brain and peripheral pathology.<a onclick="showRef(event, 'ref260'); return false;" href="javascript:void(0);" class="ref ref260">(260)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0029.gif" alt="" id="fx26" /></img></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">6 Antiaggregation Agents</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14058" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14058" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">One consequence of high levels of ROS is the damage and aggregation of proteins. Neurodegenerative diseases have been termed “protein aggregation diseases” because protein aggregation is another hallmark of these diseases. Aggregation consists of the formation of identical monomers of proteins self-associated into large oligomeric structures of reduced solubility that directly contribute to the onset and progression of the disease in question. Commonly implicated proteins (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) include tau and amyloid-β in AD, α-synuclein in PD, huntingtin in HD, SOD1 in ALS, and others covering a range of diseases.<a onclick="showRef(event, 'ref261'); return false;" href="javascript:void(0);" class="ref ref261">(261)</a> The aggregation process leads to formation of fibrils with defined morphologies or amorphous deposits or both. Here, we present an overview of therapeutic targets and a selection of molecules displaying antiaggregation properties. In this section we will concentrate on the most frequently studied protein targets for the development of antiaggregation inhibitors as listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. Additional targets are known, and inhibitors are being actively developed; however, space precludes a detailed examination of all potential targets. Comprehensive introductions to the subjects of pathogenicity and potential targets,<a onclick="showRef(event, 'ref262'); return false;" href="javascript:void(0);" class="ref ref262">(262)</a> and strategies for the design of antiaggregation inhibitors<a onclick="showRef(event, 'ref263'); return false;" href="javascript:void(0);" class="ref ref263">(263)</a> that have been published previously, are excellent sources of in-depth coverage of the subject matter.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Proteins Implicated in Misfolding Aggregation Diseases and Respective Targets for Aggregation Inhibitor Compound Design, As Discussed Herein</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">disease</th><th class="colsep0 rowsep0" align="center">aggregating protein</th><th class="colsep0 rowsep0" align="center">direct targets</th><th class="colsep0 rowsep0" align="center">indirect targets</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Alzheimer’s</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">BACE-1</td><td class="colsep0 rowsep0" align="left">HMG-CoA reductase inhibitors</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">amyloid-β</td><td class="colsep0 rowsep0" align="left">α-secretase</td><td class="colsep0 rowsep0" align="left">protein kinases (GSK3, CDK5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">γ-secretase</td><td class="colsep0 rowsep0" align="left">autophagy activators</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">metal chelators</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep1" align="left"> </td><td class="colsep0 rowsep1" align="left">tau</td><td class="colsep0 rowsep1" align="left">physiological tau</td><td class="colsep0 rowsep1" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Parkinson’s</td><td class="colsep0 rowsep0" align="left">α-synuclein</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">HMG-CoA reductase inhibitors</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">protein kinases (LRRK2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">autophagy activators</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep1" align="left"> </td><td class="colsep0 rowsep1" align="left"> </td><td class="colsep0 rowsep1" align="left"> </td><td class="colsep0 rowsep1" align="left">heat shock protein</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Huntington’s</td><td class="colsep0 rowsep0" align="left">huntingtin</td><td class="colsep0 rowsep0" align="left">polyQ aggregates</td><td class="colsep0 rowsep0" align="left">HMG-CoA reductase inhibitors</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">autophagy activators</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep1" align="left"> </td><td class="colsep0 rowsep1" align="left"> </td><td class="colsep0 rowsep1" align="left"> </td><td class="colsep0 rowsep1" align="left">heat shock protein</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">amyotrophic lateral sclerosis</td><td class="colsep0 rowsep0" align="left">SOD1 and many others implicated</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">protein kinases (GSK3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">autophagy activators</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">heat shock protein</td></tr></tbody></table></div></div><div class="NLM_p">Inhibiting the accrual of misfolded forms of the proteins comprising aggregates is one commonly exploited approach for targeting many neurodegenerative diseases. Kinase inhibitors offer the advantage of allowing inhibition of the transformative process responsible for misfolding over inhibition of the production of the naturally occurring protein, which may be crucial to normal cellular function. Dual inhibition of glycogen synthase kinase 3 (GSK-3)<a onclick="showRef(event, 'ref264'); return false;" href="javascript:void(0);" class="ref ref264">(264)</a> and cyclin-dependent kinase 5<a onclick="showRef(event, 'ref265'); return false;" href="javascript:void(0);" class="ref ref265">(265)</a> is a promising strategy for tau-related diseases such as AD, when hyperphosphorylation of tau protein leads to malfunction and aggregation.<a onclick="showRef(event, 'ref266'); return false;" href="javascript:void(0);" class="ref ref266">(266)</a> One such example of a dual-acting inhibitor for both kinases is the natural product hymenialdisine <b>83</b>, which has been the basis of intense SAR and analogue development to generate potential therapeutic candidates.<a onclick="showRef(event, 'ref267'); return false;" href="javascript:void(0);" class="ref ref267">(267)</a> Similarly, GSK-3 has been implicated in the pathogenesis of a number of neurodegenerative diseases, such as ALS<a onclick="showRef(event, 'ref268'); return false;" href="javascript:void(0);" class="ref ref268">(268)</a> and spinal muscular atrophy (SMA).<a onclick="showRef(event, 'ref269'); return false;" href="javascript:void(0);" class="ref ref269">(269)</a> GSK-3 inhibitor VII (<b>84</b>) has been shown to significantly delay the onset of symptoms and extend the life span of a G93A-SOD1 mouse model of ALS.<a onclick="showRef(event, 'ref270'); return false;" href="javascript:void(0);" class="ref ref270">(270)</a> BIP-135 (<b>85</b>) was found to prolong the median survival of the Δ7 SMA KO mouse model of SMA and elevate survival motor neuron levels in SMA patient-derived fibroblast cells.<a onclick="showRef(event, 'ref269'); return false;" href="javascript:void(0);" class="ref ref269">(269)</a> Leucine-rich repeat kinase 2 (LRRK2) may regulate the propensity of α-synuclein to aggregate and, as a result, has garnered much attention as a target for a therapeutic intervention in PD.<a onclick="showRef(event, 'ref271'); return false;" href="javascript:void(0);" class="ref ref271">(271)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0030.gif" alt="" id="fx27" /></img><div class="NLM_p">Inhibition of tau aggregation has become an important strategy in targeting pathological tau. The use of small molecules to inhibit self-assembly of tau into oligomeric and/or polymeric species, including the well-defined fibrils comprising neurofibrillary tangles, has met with mixed success. Several compounds demonstrate activity in vitro; however, most also suffer from toxicity and/or limited CNS uptake issues.<a onclick="showRef(event, 'ref272'); return false;" href="javascript:void(0);" class="ref ref272">(272)</a> A testament to the difficulty in designing tau inhibitors is the fact that one of the most promising structures is still one of the originally reported compounds having tau aggregation inhibition activity: methylene blue (<b>86</b>).<a onclick="showRef(event, 'ref273'); return false;" href="javascript:void(0);" class="ref ref273">(273)</a> While methylene blue itself only possesses weak inhibitory activity, the compound provided a lead scaffold for derivatization. The dimethyl derivative, tolonium chloride, was found to exhibit 30-fold greater activity with a <i>K</i><sub>i</sub> of 69 nM, acting at almost equimolar concentrations with tau. Crucially, the compound did not inhibit the required tau–tubulin binding interaction. Interestingly the inhibitory activity was also observed in hyperphosphorylated tau, bringing into question the need to inhibit kinases to elicit a subsequent inhibition of tau aggregation. Recent advances have identified aminothienopyridazines (ATPZs) as a novel class of tau fibrilization inhibitors with efficacy in in vitro models and favorable druglike properties. Compound <b>87</b> represents the current lead structure, demonstrating good brain penetration, oral bioavailability, and nonspecific brain tissue binding. The compound is set to undergo long-term in vivo testing.<a onclick="showRef(event, 'ref274'); return false;" href="javascript:void(0);" class="ref ref274">(274)</a> Refinement of in vitro models of tauopathy will also have a large impact on drug design targeting tau aggregation. A recently disclosed model using inducible hippocampal brain slices provides a more robust assay environment for further advances.<a onclick="showRef(event, 'ref275'); return false;" href="javascript:void(0);" class="ref ref275">(275)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0031.gif" alt="" id="fx28" /></img><div class="NLM_p">Accumulation of oligomeric β-amyloid peptides (Aβ) is characteristic of AD and is the primary agent in the pathogenesis of the disease. Aβ is generated from the amyloid precursor protein (APP) via two proteolytic enzymes, β-secretase and γ-secretase, responsible for the regulation of the first step in amyloidogenic APP metabolism and generation of Aβ, respectively. α-Secretase conducts an alternative proteolytic cleavage that prevents Aβ production and accumulation. Development of β-secretase (BACE-1) inhibitors has been hindered because of poor BBB permeability.<a onclick="showRef(event, 'ref276'); return false;" href="javascript:void(0);" class="ref ref276">(276)</a> Recent efforts have moved away from peptide-based compounds to more lipophilic structures such as difluoride <b>88</b>, which demonstrated a 70% reduction of Aβ in beagle dog CSF up to 9 h after dosing.<a onclick="showRef(event, 'ref277'); return false;" href="javascript:void(0);" class="ref ref277">(277)</a> Progression to phase I trials followed, showing for the first time a good correlation with preclinical and clinical efficacy. However, rat toxicology data indicated renal toxicity from an off-target interaction that has yet to be identified. The compound succeeded in demonstrating BACE to be a “druggable” target. Potent compounds inhibiting γ-secretase have been developed; however, inherent toxicity problems still remain as a challenge.<a onclick="showRef(event, 'ref278'); return false;" href="javascript:void(0);" class="ref ref278">(278)</a> Avegacestat (<b>89</b>), a potent and selective γ-secretase inhibitor, succeeded in reducing brain levels of Aβ40 in wild-type rats by 59 ± 12% with a 30 mg/kg dose.<a onclick="showRef(event, 'ref279'); return false;" href="javascript:void(0);" class="ref ref279">(279)</a> However, the compound has now been dropped from clinical studies by BMS. Modulation of α-secretase is an increasingly attractive target in AD therapy; activation is controlled by the protein phosphorylation signal transduction pathway of protein kinase C (PKC).<a onclick="showRef(event, 'ref280'); return false;" href="javascript:void(0);" class="ref ref280">(280)</a> The known PKC activator bryostatin (<b>90</b>) promotes sAPP-α-secretase at subnanomolar levels;<a onclick="showRef(event, 'ref281'); return false;" href="javascript:void(0);" class="ref ref281">(281)</a> analogue construction to refine pharmacological properties has garnered a great deal of attention in the literature.<a onclick="showRef(event, 'ref282'); return false;" href="javascript:void(0);" class="ref ref282">(282)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0032.gif" alt="" id="fx29" /></img><div class="NLM_p">Twenty-five percent of the cholesterol present in humans is synthesized in the brain, where it performs many vital functions, such as myelin formation, structural composition of glial and neuronal membranes, and in neurotransmission. A link between cholesterol levels and the production of APP in Alzheimer’s patients has been suggested by the use of statins, cholesterol-lowering drugs that inhibit 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, demonstrating a decreased prevalence of AD.<a onclick="showRef(event, 'ref283'); return false;" href="javascript:void(0);" class="ref ref283">(283)</a> In particular, simvastatin showed a marked decrease of both cholesterol and Aβ in guinea pig CSF; however, translation to human patients only showed a small decrease, which may be attributed to the higher concentration of Aβ in plaque formed within the brain and therefore not available to transfer to CSF.<a onclick="showRef(event, 'ref284'); return false;" href="javascript:void(0);" class="ref ref284">(284)</a> Interest in the link between cholesterol regulation and neurodegenerative diseases has grown considerably in recent years with implications ranging from AD<a onclick="showRef(event, 'ref285'); return false;" href="javascript:void(0);" class="ref ref285">(285)</a> to PD,<a onclick="showRef(event, 'ref286'); return false;" href="javascript:void(0);" class="ref ref286">(286)</a> HD,<a onclick="showRef(event, 'ref287'); return false;" href="javascript:void(0);" class="ref ref287">(287)</a> and the prion diseases.<a onclick="showRef(event, 'ref288'); return false;" href="javascript:void(0);" class="ref ref288">(288)</a> Attempts to identify new HMG-CoA reductase inhibitors and analogues of statins continue.<a onclick="showRef(event, 'ref289'); return false;" href="javascript:void(0);" class="ref ref289">(289)</a></div><div class="NLM_p">There is increasing evidence that heat shock proteins (HSPs), molecular chaperones that control protein misfolding and aggregation, could counteract the pathological mechanisms that take place during AD, PD, and HD.<a onclick="showRef(event, 'ref290'); return false;" href="javascript:void(0);" class="ref ref290">(290)</a> The HSPs can interfere with the misfolded disease-linked proteins, thereby preventing interactions that can lead to formation of toxic oligomers. Moreover, HSPs are expected to interfere with detrimental processes that occur during these diseases, such as oxidative stress, and act in support of the ubiquitin–proteasome degradation process. These factors combine to make HSP activators an important target in combating neurodegenerative disease.<a onclick="showRef(event, 'ref291'); return false;" href="javascript:void(0);" class="ref ref291">(291)</a> Central to the hypothesis of targeting protein misfolding is heat shock transcription factor 1 (HSF1), the main activator of chaperone protein gene expression; activating HSF1 increases the amount of chaperone expression and, in turn, the rate of clearance of misfolded proteins.<a onclick="showRef(event, 'ref292'); return false;" href="javascript:void(0);" class="ref ref292">(292)</a> The chaperone protein Hsp90 is responsible for protein folding regulation in many cells and, in addition, is known to bind to HSF1 and impede activation; therefore, Hsp90 inhibitors have therapeutic potential in many neurodegenerative diseases.<a onclick="showRef(event, 'ref293'); return false;" href="javascript:void(0);" class="ref ref293">(293)</a>A representative example of a Hsp90 inhibitor, celastrol (<b>91</b>), which is isolated from a Chinese medicinal herb, is a potent inhibitor of Hsp90 acting by activation of HSF1;<a onclick="showRef(event, 'ref294'); return false;" href="javascript:void(0);" class="ref ref294">(294)</a> however, the exact mode of action is poorly understood and is the subject of much investigation to aid in the development of this compound as a potential therapeutic.<a onclick="showRef(event, 'ref295'); return false;" href="javascript:void(0);" class="ref ref295">(295)</a> Arimoclomol (<b>92</b>), a co-inducer of heat shock proteins, increases median survival in a G93A-SOD1 mouse model of ALS by 22%, illustrating the therapeutic potential of the HSP target in ALS.<a onclick="showRef(event, 'ref296'); return false;" href="javascript:void(0);" class="ref ref296">(296)</a> In addition, the closely related protein Hsp70 is rapidly gaining interest as a target for many diseases, including those contributing to neurodegeneration.<a onclick="showRef(event, 'ref297'); return false;" href="javascript:void(0);" class="ref ref297">(297)</a> In addition to HSP inhibitors, several other classes of compounds have been found to elicit an activation effect in autophagy and hence increase the rate of fibril clearance.<a onclick="showRef(event, 'ref298'); return false;" href="javascript:void(0);" class="ref ref298">(298)</a> Among the most widely investigated of these compounds are rapamycin (<b>93</b>), which displays neuroprotective effects in many neurodegenerative diseases,<a onclick="showRef(event, 'ref299'); return false;" href="javascript:void(0);" class="ref ref299">(299)</a> and the disaccharide trehalose (<b>94</b>), which has been shown to reverse aggregation caused by proteasome inhibition.<a onclick="showRef(event, 'ref300'); return false;" href="javascript:void(0);" class="ref ref300">(300)</a> HSPs act as protein folding machinery and work in conjunction with the ubiquitin–proteasome system (UPS),<a onclick="showRef(event, 'ref301'); return false;" href="javascript:void(0);" class="ref ref301">(301)</a> failure of which is thought to contribute to the pathogenesis of PD.<a onclick="showRef(event, 'ref302'); return false;" href="javascript:void(0);" class="ref ref302">(302)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0033.gif" alt="" id="fx30" /></img><div class="NLM_p">A myriad of additional approaches for therapeutic design and intervention in neurodegenerative disease have been proposed, and a comprehensive discussion is beyond the scope of this Perspective; however, several newly emerging areas will be discussed briefly. The use of chemical chaperones, small molecules having the ability to stabilize unfolded monomer conformations and/or to destabilize misfolded oligomers, has been widely explored.<a onclick="showRef(event, 'ref303 ref304'); return false;" href="javascript:void(0);" class="ref ref303 ref304">(303, 304)</a> An alternative approach involves the use of metal chelators, compounds that sequester physiological metal ions and, in so doing, block protein aggregation. Aβ, for example, shows ready binding to metals such as Zn<sup>2+</sup> and Cu<sup>2+</sup>, which induce nucleation and the formation of aggregate plaques. In addition, the interaction between redox active Cu<sup>2+</sup> and Aβ can produce neurotoxic reactive oxygen species.<a onclick="showRef(event, 'ref305'); return false;" href="javascript:void(0);" class="ref ref305">(305)</a> Recent developments have led to the synthesis of platiniferous chelators such as <b>95</b>, containing a Pt(bipyridine)Cl<sub>2</sub> group as the Aβ binding portion.<a onclick="showRef(event, 'ref306'); return false;" href="javascript:void(0);" class="ref ref306">(306)</a> Compounds of this type show almost complete reversal of Aβ aggregation in turbidimetry experiments conducted using Aβ40. Additional compounds, many of them peptidyl in structure, acting as β-sheet blockers have been investigated.<a onclick="showRef(event, 'ref307'); return false;" href="javascript:void(0);" class="ref ref307">(307)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0034.gif" alt="" id="fx31" /></img><div class="NLM_p">Direct inhibition of the oligomerization pathway has been shown to be possible with a number of small molecule inhibitors that disrupt soluble oligomers and interfere with larger structures; however, this approach does not take into account the accumulation of potentially toxic monomers. Such compounds include <i>N-</i>phenylanthranilic acid analogues (<b>96</b>), displaying activity against the Aβ peptide with an IC<sub>50</sub> of 1 μM,<a onclick="showRef(event, 'ref308'); return false;" href="javascript:void(0);" class="ref ref308">(308)</a> and benzothiazole <b>97</b>, with activity to prevent polyQ aggregates (the cause of Huntington’s disease) in vitro with an IC<sub>50</sub> of 1.2 μM.<a onclick="showRef(event, 'ref309'); return false;" href="javascript:void(0);" class="ref ref309">(309)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0035.gif" alt="" id="fx32" /></img><div class="NLM_p last">Despite a rich choice of targets of action, the use of antiaggregation agents in the treatment of neurodegenerative diseases has been limited. Poor BBB penetration, off-target toxicity, distribution in target tissue, and poor kinase selectivity have limited the potential of this broad class of compounds. Developments continue to counteract these limitations, and further optimization has the potential to create an efficacious and clinically useful therapeutic. One such strategy is the development of compounds that interact at multiple targets across the antiaggregation target spectrum.</div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">7 Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48202" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48202" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Modulation of one or more of the distinct physiological processes depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> has been shown to be pathological in neurodegenerative diseases. Small molecule therapeutics have been developed to target each step of the process: voltage-gated calcium channels, NMDA receptors, neuronal nitric oxide synthase, oxidative stress from reactive oxygen species, and protein aggregation. In addition to their potential as therapeutics, small molecules targeting proteins involved in neurodegenerative pathways can provide insight into their roles and connections. Determining how targets interact with each other could reveal previously unknown pathways. However, after more than 100 years of intense research, all current therapies for neurodegeneration are still directed toward symptomatic relief, not disease-modifying effects.</div><div class="NLM_p">In the development of small molecules to combat neurodegenerative diseases, a combination therapy approach such as those taken to treat cancer, to fight microorganisms, and to remedy hypertension should be considered. A multitarget therapeutic approach will combat the disease from many pathways, greatly enhancing the probability of disease modification. For example, inhibiting nNOS from producing species that generate ROS and inhibiting protein aggregation provide a dual mode of action by simultaneously reducing the underlying cause of protein misfolding and aggregation (oxidative stress damage) and combating the aggregation caused by ROS that survive to cause protein damage. Second, the potential synergy that may result from a drug combination may allow for the use of therapeutics at lower levels, allowing for the deployment of therapeutics that have small therapeutic windows, off-target effects, poor potency, or high toxicity, thereby expanding the arsenal of drugs available to fight these crippling, fatal diseases.</div><div class="NLM_p">Successful dual-acting compounds are beginning to be reported; however, such compounds remain scarce in the literature and represent a minute proportion of the overall effort in drug discovery for neurodegeneration.<a onclick="showRef(event, 'ref310'); return false;" href="javascript:void(0);" class="ref ref310">(310)</a> Examples designed to target two of the pathways depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> include compound <b>18</b>, a dual NMDA and LTCC inhibitor discussed in <a class="ref internalNav" href="#sec2" aria-label="section 2">section 2</a>. Benzofuran-based compound <b>98</b> and analogues demonstrate activity in three pertinent targets for AD; they serve as acetylcholine esterase inhibitors, Aβ aggregation inhibitors, and inhibitors of Aβ<sub>25–35</sub> peptide-induced ROS formation. The potential of these compounds to be disease modifying lies not just with their targets but also with their ability to combat one of the underlying generators of ROS in AD rather than simply inactivating individual species.<a onclick="showRef(event, 'ref311'); return false;" href="javascript:void(0);" class="ref ref311">(311)</a> Imidazole <b>99</b> represents the most active compound of a library of analogues screened for nNOS inhibition activity. The compounds were designed as dual-target compounds; in addition to acting as nNOS inhibitors, the compounds are active antioxidants that scavenge free radicals and/or reduce lipid peroxidation.<a onclick="showRef(event, 'ref312'); return false;" href="javascript:void(0);" class="ref ref312">(312)</a> While these compounds were designed as a possible therapeutic for cerebral ischemia, they would appear to be ideal compounds for screening in neurodegenerative disease drug discovery.</div><div class="NLM_p">A final example is the combination of two therapeutic constructs by a linker chain. Huprine–tacrine heterodimers (<b>100</b>) simultaneously block the active and peripheral sites of acetylcholinesterase, resulting in high potency (approximately 1 nM). Additionally, the heterodimers interact at two targets in the pathway of Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, acting as both self-aggregation inhibitors of Aβ (ranging from 39% to 67% inhibition) and BACE-1 inhibitors (5–7 μM). Interestingly, while both of these targets are AD specific, the compounds inhibit the aggregation of a prion peptide that plays a key role in the aggregation of the prion protein.<a onclick="showRef(event, 'ref313'); return false;" href="javascript:void(0);" class="ref ref313">(313)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0036.gif" alt="" id="fx33" /></img><div class="NLM_p">A multitarget approach would provide drug combinations and first-in-class molecular scaffolds to allow for the further probing and elucidation of the precise molecular networks and signaling cascades that underlie the nature of neurodegeneration. Given the fact that at present there is not yet a single therapy, let alone a combination of therapies, that significantly alters the progression of neurodegeneration, an understanding of the root causes for neurodegeneration, and the knowledge of the important pathways that should be altered to accomplish this, would be welcomed.</div><div class="NLM_p last">This Perspective, based on the commonalities within neurodegeneration (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), describes druggable targets of action and the compounds developed to interact with them. In so doing, we have covered many targets that are specific to one particular disease (e.g., BACE1 inhibitors for AD). It is our intent to bring to the attention of the reader possible target combinations and molecular scaffolds that, when combined, may advance the discovery of the ultimate goal in neuroscience drug discovery: a disease modifying therapeutic.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm3015926" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84074" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84074" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard B. Silverman</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Northwestern University,
2145 Sheridan Road, Evanston, Illinois 60208-3113, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Molecular Biosciences,
Chemistry of Life Processes Institute, Center for Molecular Innovation
and Drug Discovery, Northwestern University, Evanston, Illinois, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3273555f535c72515a575f1c5c5d40465a4557414657405c1c575647"><span class="__cf_email__" data-cfemail="7637111b171836151e131b58181904021e0113050213041858131203">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul C. Trippier</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Northwestern University,
2145 Sheridan Road, Evanston, Illinois 60208-3113, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristin Jansen Labby</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Northwestern University,
2145 Sheridan Road, Evanston, Illinois 60208-3113, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dustin D. Hawker</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Northwestern University,
2145 Sheridan Road, Evanston, Illinois 60208-3113, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jan J. Mataka</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Northwestern University,
2145 Sheridan Road, Evanston, Illinois 60208-3113, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41851" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41851" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Paul C. Trippier</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3015926&amp;id=BIO-d36e2205-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Paul C. Trippier</b> is Assistant Professor of Medicinal Chemistry in the School of Pharmacy at Texas Tech University Health Sciences Center, TX, and a member of the Center for Chemical Biology, Department of Chemistry and Biochemistry at Texas Tech University. Paul completed his doctorate with Professor Mark G. Moloney at The University of Oxford, U.K., working on the total synthesis and biological evaluation of bioactive natural products. He carried out postdoctoral work at the Welsh School of Pharmacy, Cardiff, U.K., with Professor Chris McGuigan, working on the design and synthesis of antiviral and anticancer compounds. In 2010 he moved to the laboratory of Professor Richard B. Silverman at Northwestern University, IL, working on the synthesis of compounds possessing neuroprotective activity and determination of their intracellular targets of action.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Kristin Jansen Labby</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3015926&amp;id=BIO-d36e2210-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Kristin Jansen Labby</b> recently completed her doctorate in Organic Chemistry in the laboratory of Richard B. Silverman at Northwestern University, IL. Her dissertation examined substrate analogues of neuronal nitric oxide synthase. She was a 2011–2012 National Science Foundation GK-12 fellow at Northwestern University. Kristin earned her Bachelors degree from the University of Wisconsin-Madison, WI, in 2007, working under the direction of Hans J. Reich in the Department of Chemistry as well as with Andrew F. Bent in the Department of Plant Pathology. She is currently a Postdoctoral Fellow in the Life Sciences Institute at the University of Michigan in the laboratory of Sylvie Garneau-Tsodikova, studying aminoglycoside modifying enzymes and their roles in antibiotic resistance in tuberculosis and other mycobacterium.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Dustin D. Hawker</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3015926&amp;id=BIO-d36e2215-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Dustin D. Hawker</b> obtained his B.S. degree in Biochemistry from California Polytechnic State University, San Luis Obispo, CA, in 2007. In 2006 he was a Summer Undergraduate Research Fellow at California Institute of Technology in the laboratory of Harry B. Gray. He is currently a Ph.D. candidate in the laboratory of Richard B. Silverman at Northwestern University, IL, where his dissertation research is focused on the synthesis of novel substrates and inactivators of GABA aminotransferase.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Jan J. Mataka</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3015926&amp;id=BIO-d36e2220-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jan J. Mataka</b> completed his doctoral work in 2002 under the direction of Professor David Crich at the University of Illinois at Chicago on the stereoselective formation of glycosyl sulfoxides, as well as the development of novel organic bases. Since then, he has been an instructor of chemistry at Northeastern Illinois University, teaching courses in general, organic, and more recently toxicological chemistry and  pharmacology, in addition to teaching in the Urban Health Program at the University of Illinois at Chicago. Jan is a member of the National Academy of Clinical Biochemistry and currently is a Visiting Scholar in the laboratory of Richard B. Silverman at Northwestern University, IL, having worked on the development of inhibitors for neuronal nitric oxide synthase as a therapeutic target for Parkinson’s disease.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Richard B. Silverman</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3015926&amp;id=BIO-d36e2225-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Richard B. Silverman</b> received his Ph.D. in organic chemistry from Harvard, MA, in 1974, did postdoctoral work in enzymology for 2 years at Brandeis University, MA, then joined the chemistry faculty at Northwestern University, IL. Since 2004, he has been the John Evans Professor of Chemistry. He is the inventor of Lyrica, marketed by Pfizer for epilepsy, neuropathic pain, and fibromyalgia. Recent awards include the 2009 Perkin Medal, ACS Medicinal Chemistry Hall of Fame (2009), E. B. Hershberg Award from the ACS (2011), Fellow of the ACS (2011), Sato Memorial International Award of the Japan Pharmaceutical Society (2012), Roland T. Lakey Award from Wayne State (2013), and the BMS-Smissman Award from the ACS (2013). He has published over 300 articles, holds 48 domestic and foreign patents, and has written four books.</p></figure></div><div class="ack" id="ACK-d36e2230-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34311" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34311" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to the National Institutes of Health (Grants GM049725 and DA030604) and the Department of Defense (Grant W81XWH-10-1-0536) for financial support of our work in neurodegenerative and neurological diseases. We thank Garry Cooper for assistance in writing the section on voltage-gated calcium channels.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i21" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i21"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i22" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i22"> Abbreviations Used</h2><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinson’s disease</p></td></tr><tr><td class="NLM_term">HD</td><td class="NLM_def"><p class="first last">Huntington’s disease</p></td></tr><tr><td class="NLM_term">ALS</td><td class="NLM_def"><p class="first last">amyotrophic lateral sclerosis</p></td></tr><tr><td class="NLM_term">Ca<sub>v</sub></td><td class="NLM_def"><p class="first last">voltage gated calcium channel</p></td></tr><tr><td class="NLM_term">NMDA</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartic acid</p></td></tr><tr><td class="NLM_term">nNOS</td><td class="NLM_def"><p class="first last">neuronal nitric oxide synthase</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">AMPA</td><td class="NLM_def"><p class="first last">α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">ABD</td><td class="NLM_def"><p class="first last">agonist binding domain</p></td></tr><tr><td class="NLM_term">NTD</td><td class="NLM_def"><p class="first last">N-terminal domain</p></td></tr><tr><td class="NLM_term">L-DOPA</td><td class="NLM_def"><p class="first last"><span class="smallcaps smallerCapital">l</span>-3,4-dihydroxyphenylalanine</p></td></tr><tr><td class="NLM_term">mGluR</td><td class="NLM_def"><p class="first last">metabotropic glutamate receptor</p></td></tr><tr><td class="NLM_term">VGCC</td><td class="NLM_def"><p class="first last">voltage gated calcium channel</p></td></tr><tr><td class="NLM_term">DHP</td><td class="NLM_def"><p class="first last">1,4-dihydroxypyridine</p></td></tr><tr><td class="NLM_term">PAA</td><td class="NLM_def"><p class="first last">phenylalkylamine</p></td></tr><tr><td class="NLM_term">BZA</td><td class="NLM_def"><p class="first last">benzodiazepine</p></td></tr><tr><td class="NLM_term">DA</td><td class="NLM_def"><p class="first last">dopamine</p></td></tr><tr><td class="NLM_term">SNc</td><td class="NLM_def"><p class="first last">substantia nigra pars compacta</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">FLIPR</td><td class="NLM_def"><p class="first last">fluorescent imaging plate reader</p></td></tr><tr><td class="NLM_term">PYT</td><td class="NLM_def"><p class="first last">pyrimidine-2,4,6-trione</p></td></tr><tr><td class="NLM_term">NO</td><td class="NLM_def"><p class="first last">nitric oxide</p></td></tr><tr><td class="NLM_term">NADPH</td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide phosphate</p></td></tr><tr><td class="NLM_term">eNOS</td><td class="NLM_def"><p class="first last">endothelial nitric oxide synthase</p></td></tr><tr><td class="NLM_term">iNOS</td><td class="NLM_def"><p class="first last">inducible nitric oxide synthase</p></td></tr><tr><td class="NLM_term">nNOS</td><td class="NLM_def"><p class="first last">neuronal nitric oxide synthase</p></td></tr><tr><td class="NLM_term">HSP90</td><td class="NLM_def"><p class="first last">heat shock protein 90</p></td></tr><tr><td class="NLM_term">ETC</td><td class="NLM_def"><p class="first last">electron transport chain</p></td></tr><tr><td class="NLM_term">ONOO<sup>–</sup></td><td class="NLM_def"><p class="first last">peroxynitrite</p></td></tr><tr><td class="NLM_term">L-NNA</td><td class="NLM_def"><p class="first last"><i>N</i>-nitro-<span class="smallcaps smallerCapital">l</span>-arginine</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr><tr><td class="NLM_term">SOD</td><td class="NLM_def"><p class="first last">superoxide dismutase</p></td></tr><tr><td class="NLM_term">GPx</td><td class="NLM_def"><p class="first last">glutathione peroxidase</p></td></tr><tr><td class="NLM_term">RA</td><td class="NLM_def"><p class="first last">retinoic acid</p></td></tr><tr><td class="NLM_term">GSK-3</td><td class="NLM_def"><p class="first last">glycogen synthase kinase 3</p></td></tr><tr><td class="NLM_term">SMA</td><td class="NLM_def"><p class="first last">spinal muscular atrophy</p></td></tr><tr><td class="NLM_term">LRRK2</td><td class="NLM_def"><p class="first last">leucine rich repeat kinase 2</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">β-amyloid</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">BACE-1</td><td class="NLM_def"><p class="first last">β-secretase</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">PKC</td><td class="NLM_def"><p class="first last">protein kinase C</p></td></tr><tr><td class="NLM_term">HMG-CoA</td><td class="NLM_def"><p class="first last">3-hydroxy-3-methylglutaryl-coenzyme A</p></td></tr><tr><td class="NLM_term">HSP</td><td class="NLM_def"><p class="first last">heat shock protein</p></td></tr><tr><td class="NLM_term">HSF1</td><td class="NLM_def"><p class="first last">heat shock factor protein 1</p></td></tr><tr><td class="NLM_term">ETC</td><td class="NLM_def"><p class="first last">electron transport chain</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88262" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88262" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 313 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Lin, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, M. F.</span><span> </span><span class="NLM_article-title">Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">443</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnature05292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=17051205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyktbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=443&publication_year=2006&pages=787-795&author=M.+T.+Linauthor=M.+F.+Beal&title=Mitochondrial+dysfunction+and+oxidative+stress+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases</span></div><div class="casAuthors">Lin, Michael T.; Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">443</span>
        (<span class="NLM_cas:issue">7113</span>),
    <span class="NLM_cas:pages">787-795</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Many lines of evidence suggest that mitochondria have a central role in aging-related neurodegenerative diseases.  Mitochondria are crit. regulators of cell death, a key feature of neurodegeneration.  Mutations in mitochondrial DNA and oxidative stress both contribute to aging, which is the greatest risk factor for neurodegenerative diseases.  In all major examples of these diseases there is strong evidence that mitochondrial dysfunction occurs early and acts causally in disease pathogenesis.  Moreover, an impressive no. of disease-specific proteins interact with mitochondria.  Thus, therapies targeting basic mitochondrial processes, such as energy metab. or free-radical generation, or specific interactions of disease-related proteins with mitochondria, hold great promise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ_a_kJVRRZbVg90H21EOLACvtfcHk0liSf2k0CYLe5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyktbbO&md5=f1f1e0773f62373232ff10156e630cae</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnature05292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05292%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DM.%2BT.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DMitochondrial%2520dysfunction%2520and%2520oxidative%2520stress%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNature%26date%3D2006%26volume%3D443%26spage%3D787%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Hebert, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherr, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienias, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D. A.</span><span> </span><span class="NLM_article-title">Alzheimer disease in the US population: prevalence estimates using the 2000 census</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1119</span><span class="NLM_x">–</span> <span class="NLM_lpage">1122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1001%2Farchneur.60.8.1119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12925369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD3szovVSlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2003&pages=1119-1122&author=L.+E.+Hebertauthor=P.+A.+Scherrauthor=J.+L.+Bieniasauthor=D.+A.+Bennettauthor=D.+A.+Evans&title=Alzheimer+disease+in+the+US+population%3A+prevalence+estimates+using+the+2000+census"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer disease in the US population: prevalence estimates using the 2000 census</span></div><div class="casAuthors">Hebert Liesi E; Scherr Paul A; Bienias Julia L; Bennett David A; Evans Denis A</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1119-22</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">CONTEXT:  Current and future estimates of Alzheimer disease (AD) are essential for public health planning.  OBJECTIVE:  To provide prevalence estimates of AD for the US population from 2000 through 2050.  DESIGN:  Alzheimer disease incidence estimates from a population-based, biracial, urban study, using a stratified random sampling design, were converted to prevalence estimates and applied to US Census Bureau estimates of US population growth.  SETTING:  A geographically defined community of 3 adjacent neighborhoods in Chicago, Ill, applied to the US population.  PARTICIPANTS:  Alzheimer disease incidence was measured in 3838 persons free of AD at baseline; 835 persons were evaluated for disease incidence.  Main Outcome Measure Current and future estimates of prevalence of clinically diagnosed AD in the US population.  RESULTS:  In 2000, there were 4.5 million persons with AD in the US population.  By 2050, this number will increase by almost 3-fold, to 13.2 million.  Owing to the rapid growth of the oldest age groups of the US population, the number who are 85 years and older will more than quadruple to 8.0 million.  The number who are 75 to 84 years old will double to 4.8 million, while the number who are 65 to 74 years old will remain fairly constant at 0.3 to 0.5 million.  CONCLUSION:  The number of persons with AD in the US population will continue to increase unless new discoveries facilitate prevention of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSC6alhM6KljM25P7XSLhESfW6udTcc2eYLSoCEbCZP2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3szovVSlsw%253D%253D&md5=c891d749b9d9205514169c1ab401abba</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1001%2Farchneur.60.8.1119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.60.8.1119%26sid%3Dliteratum%253Aachs%26aulast%3DHebert%26aufirst%3DL.%2BE.%26aulast%3DScherr%26aufirst%3DP.%2BA.%26aulast%3DBienias%26aufirst%3DJ.%2BL.%26aulast%3DBennett%26aufirst%3DD.%2BA.%26aulast%3DEvans%26aufirst%3DD.%2BA.%26atitle%3DAlzheimer%2520disease%2520in%2520the%2520US%2520population%253A%2520prevalence%2520estimates%2520using%2520the%25202000%2520census%26jtitle%3DArch.%2520Neurol.%26date%3D2003%26volume%3D60%26spage%3D1119%26epage%3D1122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Wancata, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musalek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexandrowicz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krautgartner, M.</span><span> </span><span class="NLM_article-title">Number of dementia sufferers in Europe between the years 2000 and 2050</span> <span class="citation_source-journal">Eur. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">313</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.eurpsy.2003.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=14611926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD3srjtlKguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=306-313&author=J.+Wancataauthor=M.+Musalekauthor=R.+Alexandrowiczauthor=M.+Krautgartner&title=Number+of+dementia+sufferers+in+Europe+between+the+years+2000+and+2050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Number of dementia sufferers in Europe between the years 2000 and 2050</span></div><div class="casAuthors">Wancata Johannes; Musalek M; Alexandrowicz R; Krautgartner M</div><div class="citationInfo"><span class="NLM_cas:title">European psychiatry : the journal of the Association of European Psychiatrists</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">306-13</span>
        ISSN:<span class="NLM_cas:issn">0924-9338</span>.
    </div><div class="casAbstract">Several authors have pointed out that in the next few decades dementia will affect a considerably increasing number of the elderly.  To our knowledge there exist no calculations of the number of demented persons for the whole European region.  We made calculations on the number of dementia cases for the period 2000-2050 based on the population projections of the United Nations.  For this purpose, we used the results of several meta-analyses of epidemiological studies.  The number of prevalent dementia cases in the year 2000 was 7.1 million.  Within the next 50 years, this number will rise to about 16.2 million dementia sufferers.  The number of new dementia cases per year will increase from about 1.9 million in the year 2000 to about 4.1 million in the year 2050.  Contrarily, the working-age population will considerably decrease during the next 50 years.  In the year 2000, 7.1 million dementia cases faced 493 million persons in working-age.  This equals a ratio of 69.4 persons in working-age per one demented person.  Until the year 2050, this ratio will decrease to only 21.1.  Thus, the financial and emotional burden placed by dementia on the working-age population will markedly rise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_G_cqutvGMBKDYG3bNImrfW6udTcc2eabS2XDIhJa57ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srjtlKguw%253D%253D&md5=e38980ebf6fcdc8c503f9da7bdb383ab</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.eurpsy.2003.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.eurpsy.2003.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DWancata%26aufirst%3DJ.%26aulast%3DMusalek%26aufirst%3DM.%26aulast%3DAlexandrowicz%26aufirst%3DR.%26aulast%3DKrautgartner%26aufirst%3DM.%26atitle%3DNumber%2520of%2520dementia%2520sufferers%2520in%2520Europe%2520between%2520the%2520years%25202000%2520and%25202050%26jtitle%3DEur.%2520Psychiatry%26date%3D2003%26volume%3D18%26spage%3D306%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Forman, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M. Y.</span><span> </span><span class="NLM_article-title">Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1055</span><span class="NLM_x">–</span> <span class="NLM_lpage">1063</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnm1113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=15459709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvFyntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=1055-1063&author=M.+S.+Formanauthor=J.+Q.+Trojanowskiauthor=V.+M.+Y.+Lee&title=Neurodegenerative+diseases%3A+a+decade+of+discoveries+paves+the+way+for+therapeutic+breakthroughs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs</span></div><div class="casAuthors">Forman, Mark S.; Trojanowski, John Q.; Lee, Virginia M-Y.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1055-1063</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  A wide variety of neurodegenerative diseases are characterized by the accumulation of intracellular or extracellular protein aggregates.  More recently, the genetic identification of mutations in familial counterparts to the sporadic disorders, leading to the development of in vitro and in vivo model systems, has provided insights into disease pathogenesis.  The effect of many of these mutations is the abnormal processing of misfolded proteins that overwhelms the quality-control systems of the cell, resulting in the deposition of protein aggregates in the nucleus, cytosol and/or extracellular space.  Further understanding of mechanisms regulating protein processing and aggregation, as well as of the toxic effects of misfolded neurodegenerative disease proteins, will facilitate development of rationally designed therapies to treat and prevent these disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoedYkRDtkl5bVg90H21EOLACvtfcHk0ljxI2QigB1rwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvFyntbY%253D&md5=f5b1711b04c37db9b27ba3f2b47f3d39</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnm1113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1113%26sid%3Dliteratum%253Aachs%26aulast%3DForman%26aufirst%3DM.%2BS.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%2BY.%26atitle%3DNeurodegenerative%2520diseases%253A%2520a%2520decade%2520of%2520discoveries%2520paves%2520the%2520way%2520for%2520therapeutic%2520breakthroughs%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D1055%26epage%3D1063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Bossy-Wetzel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzenbacher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, S. A.</span><span> </span><span class="NLM_article-title">Molecular pathways to neurodegeneration</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">S2</span><span class="NLM_x">–</span> <span class="NLM_lpage">S9</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=S2-S9&issue=Suppl.&author=E.+Bossy-Wetzelauthor=R.+Schwarzenbacherauthor=S.+A.+Lipton&title=Molecular+pathways+to+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBossy-Wetzel%26aufirst%3DE.%26aulast%3DSchwarzenbacher%26aufirst%3DR.%26aulast%3DLipton%26aufirst%3DS.%2BA.%26atitle%3DMolecular%2520pathways%2520to%2520neurodegeneration%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26issue%3DSuppl%26spage%3DS2%26epage%3DS9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Pardo, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Duijn, C. M.</span><span> </span><span class="NLM_article-title">In search of genes involved in neurodegenerative disorders</span> <span class="citation_source-journal">Mutat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">592</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.mrfmmm.2005.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=16009383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1OmsL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=592&publication_year=2005&pages=89-101&author=L.+M.+Pardoauthor=C.+M.+van+Duijn&title=In+search+of+genes+involved+in+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">In search of genes involved in neurodegenerative disorders</span></div><div class="casAuthors">Pardo, Luba M.; van Duijn, Cornelia M.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">592</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">89-101</span>CODEN:
                <span class="NLM_cas:coden">MUREAV</span>;
        ISSN:<span class="NLM_cas:issn">0027-5107</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Dissecting the genetics of Alzheimer's disease (AD) and Parkinson's disease (PD) has contributed significantly to our understanding of the pathogenesis of neurodegeneration in these two complex disorders.  For AD, three highly penetrant genes amyloid precursor protein (APP, PSEN1, and PSEN2), and one susceptibility gene APOE have been identified.  For PD, seven genes (SNCA, Parkin, UCHL1, NR4A2, DJ1, PINK1 and LRRK2) have been found.  These genes explain only a small proportion of AD and PD patients and are mostly assocd. with an early onset presentation of the disease.  APOE remains the only common gene, which increases the risk of both rare early and late onset AD.  The ongoing challenge is to unravel the genetics of the most frequent forms of these complex disorders.  In the present paper, we briefly review the state of the art in the genetics of AD and PD.  We also discuss the prospects of finding new genes assocd. with common forms of these diseases in light of two hypotheses concerning the genetic variation of complex diseases: common disease/common variants and common disease/rare variants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTP1o6fjj6mrVg90H21EOLACvtfcHk0ljxI2QigB1rwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1OmsL3P&md5=f83d28b845ce20f5c107f8d19cb4867b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.mrfmmm.2005.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mrfmmm.2005.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DPardo%26aufirst%3DL.%2BM.%26aulast%3Dvan%2BDuijn%26aufirst%3DC.%2BM.%26atitle%3DIn%2520search%2520of%2520genes%2520involved%2520in%2520neurodegenerative%2520disorders%26jtitle%3DMutat.%2520Res.%26date%3D2005%26volume%3D592%26spage%3D89%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Amor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puentes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Valk, P.</span><span> </span><span class="NLM_article-title">Inflammation in neurodegenerative diseases</span> <span class="citation_source-journal">Immunology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1111%2Fj.1365-2567.2009.03225.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20561356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1ert7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2010&pages=154-169&author=S.+Amorauthor=F.+Puentesauthor=D.+Bakerauthor=P.+van+der+Valk&title=Inflammation+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation in neurodegenerative diseases</span></div><div class="casAuthors">Amor, Sandra; Puentes, Fabiola; Baker, David; van der Valk, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">154-169</span>CODEN:
                <span class="NLM_cas:coden">IMMUAM</span>;
        ISSN:<span class="NLM_cas:issn">0019-2805</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Neurodegeneration, the slow and progressive dysfunction and loss of neurons and axons in the central nervous system, is the primary pathol. feature of acute and chronic neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease, neurotropic viral infections, stroke, paraneoplastic disorders, traumatic brain injury and multiple sclerosis.  Despite different triggering events, a common feature is chronic immune activation, in particular of microglia, the resident macrophages of the central nervous system.  Apart from the pathogenic role of immune responses, emerging evidence indicates that immune responses are also crit. for neuroregeneration.  Here, we review the impact of innate and adaptive immune responses on the central nervous system in autoimmune, viral and other neurodegenerative disorders, and discuss their contribution to either damage or repair.  We also discuss potential therapies aimed at the immune responses within the central nervous system.  A better understanding of the interaction between the immune and nervous systems will be crucial to either target pathogenic responses, or augment the beneficial effects of immune responses as a strategy to intervene in chronic neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAfLAZyEDLZrVg90H21EOLACvtfcHk0li2ScV8fA3C0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1ert7w%253D&md5=25a55887688ccba95e7e1fe1488ad324</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2567.2009.03225.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2567.2009.03225.x%26sid%3Dliteratum%253Aachs%26aulast%3DAmor%26aufirst%3DS.%26aulast%3DPuentes%26aufirst%3DF.%26aulast%3DBaker%26aufirst%3DD.%26aulast%3Dvan%2Bder%2BValk%26aufirst%3DP.%26atitle%3DInflammation%2520in%2520neurodegenerative%2520diseases%26jtitle%3DImmunology%26date%3D2010%26volume%3D129%26spage%3D154%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Glass, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saijo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchetto, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gage, F. H.</span><span> </span><span class="NLM_article-title">Mechanisms underlying inflammation in neurodegeneration</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">918</span><span class="NLM_x">–</span> <span class="NLM_lpage">934</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.cell.2010.02.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20303880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSgu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2010&pages=918-934&author=C.+K.+Glassauthor=K.+Saijoauthor=B.+Winnerauthor=M.+C.+Marchettoauthor=F.+H.+Gage&title=Mechanisms+underlying+inflammation+in+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms underlying inflammation in neurodegeneration</span></div><div class="casAuthors">Glass, Christopher K.; Saijo, Kaoru; Winner, Beate; Marchetto, Maria Carolina; Gage, Fred H.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">918-934</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Inflammation is assocd. with many neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis.  In this Review, the authors discuss inducers, sensors, transducers, and effectors of neuroinflammation that contribute to neuronal dysfunction and death.  Although inducers of inflammation may be generated in a disease-specific manner, there is evidence for a remarkable convergence in the mechanisms responsible for the sensing, transduction, and amplification of inflammatory processes that result in the prodn. of neurotoxic mediators.  A major unanswered question is whether pharmacol. inhibition of inflammation pathways will be able to safely reverse or slow the course of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXo1ncn5lVrbVg90H21EOLACvtfcHk0li2ScV8fA3C0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSgu7Y%253D&md5=67b2963df2ff70d6ab744f6a1bbb1b87</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.02.016%26sid%3Dliteratum%253Aachs%26aulast%3DGlass%26aufirst%3DC.%2BK.%26aulast%3DSaijo%26aufirst%3DK.%26aulast%3DWinner%26aufirst%3DB.%26aulast%3DMarchetto%26aufirst%3DM.%2BC.%26aulast%3DGage%26aufirst%3DF.%2BH.%26atitle%3DMechanisms%2520underlying%2520inflammation%2520in%2520neurodegeneration%26jtitle%3DCell%26date%3D2010%26volume%3D140%26spage%3D918%26epage%3D934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Czirr, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyss-Coray, T.</span><span> </span><span class="NLM_article-title">The immunology of neurodegeneration</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">1156</span><span class="NLM_x">–</span> <span class="NLM_lpage">1163</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2012&pages=1156-1163&author=E.+Czirrauthor=T.+Wyss-Coray&title=The+immunology+of+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCzirr%26aufirst%3DE.%26aulast%3DWyss-Coray%26aufirst%3DT.%26atitle%3DThe%2520immunology%2520of%2520neurodegeneration%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2012%26volume%3D122%26spage%3D1156%26epage%3D1163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Schwarcz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchowski, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. Q.</span><span> </span><span class="NLM_article-title">Kynurenines in the mammalian brain: when physiology meets pathology</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnrn3257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=22678511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38Xot1CmsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=465-477&author=R.+Schwarczauthor=J.+P.+Brunoauthor=P.+J.+Muchowskiauthor=H.+Q.+Wu&title=Kynurenines+in+the+mammalian+brain%3A+when+physiology+meets+pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Kynurenines in the mammalian brain: when physiology meets pathology</span></div><div class="casAuthors">Schwarcz, Robert; Bruno, John P.; Muchowski, Paul J.; Wu, Hui-Qiu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">465-477</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The essential amino acid tryptophan is not only a precursor of serotonin but is also degraded to several other neuroactive compds., including kynurenic acid, 3-hydroxykynurenine and quinolinic acid.  The synthesis of these metabolites is regulated by an enzymic cascade, known as the kynurenine pathway, that is tightly controlled by the immune system.  Dysregulation of this pathway, resulting in hyper- or hypofunction of active metabolites, is assocd. with neurodegenerative and other neurol. disorders, as well as with psychiatric diseases such as depression and schizophrenia.  With recently developed pharmacol. agents, it is now possible to restore metabolic equil. and envisage novel therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr7vLdWHblurVg90H21EOLACvtfcHk0li2ScV8fA3C0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xot1CmsL4%253D&md5=b30a985543d32947138d98e6de82b9ea</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrn3257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3257%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarcz%26aufirst%3DR.%26aulast%3DBruno%26aufirst%3DJ.%2BP.%26aulast%3DMuchowski%26aufirst%3DP.%2BJ.%26aulast%3DWu%26aufirst%3DH.%2BQ.%26atitle%3DKynurenines%2520in%2520the%2520mammalian%2520brain%253A%2520when%2520physiology%2520meets%2520pathology%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2012%26volume%3D13%26spage%3D465%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Lugo-Huitron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanco-Ayala, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugalde-Muniz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrillo-Mora, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedraza-Chaverri, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva-Adaya, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldonado, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinzon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortiz-Islas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pineda, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres-Ramos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santamaria, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Cruz, V. P.</span><span> </span><span class="NLM_article-title">On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress</span> <span class="citation_source-journal">Neurotoxicol. Teratol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">538</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.ntt.2011.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=21763768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ejsbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2011&pages=538-547&author=R.+Lugo-Huitronauthor=T.+Blanco-Ayalaauthor=P.+Ugalde-Munizauthor=P.+Carrillo-Moraauthor=J.+Pedraza-Chaverriauthor=D.+Silva-Adayaauthor=P.+D.+Maldonadoauthor=I.+Torresauthor=E.+Pinzonauthor=E.+Ortiz-Islasauthor=T.+Lopezauthor=E.+Garciaauthor=B.+Pinedaauthor=M.+Torres-Ramosauthor=A.+Santamariaauthor=V.+P.+La+Cruz&title=On+the+antioxidant+properties+of+kynurenic+acid%3A+free+radical+scavenging+activity+and+inhibition+of+oxidative+stress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">On the antioxidant properties of kynurenic acid: Free radical scavenging activity and inhibition of oxidative stress</span></div><div class="casAuthors">Lugo-Huitron, R.; Blanco-Ayala, T.; Ugalde-Muniz, P.; Carrillo-Mora, P.; Pedraza-Chaverri, J.; Silva-Adaya, D.; Maldonado, P. D.; Torres, I.; Pinzon, E.; Ortiz-Islas, E.; Lopez, T.; Garcia, E.; Pineda, B.; Torres-Ramos, M.; Santamaria, A.; Perez-De La Cruz, V.</div><div class="citationInfo"><span class="NLM_cas:title">Neurotoxicology and Teratology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">538-547</span>CODEN:
                <span class="NLM_cas:coden">NETEEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-0362</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Kynurenic acid (KYNA) is an endogenous metabolite of the kynurenine pathway for tryptophan degrdn. and an antagonist of both N-methyl-D-aspartate (NMDA) and alpha-7 nicotinic acetylcholine (α7nACh) receptors.  KYNA has also been shown to scavenge hydroxyl radicals ([rad]OH) under controlled conditions of free radical prodn.  In this work we evaluated the ability of KYNA to scavenge superoxide anion (O2·-) and peroxynitrite (ONOO-).  The scavenging ability of KYNA (expressed as IC50 values) was as follows: [rad]OH = O2·- > ONOO-.  In parallel, the antiperoxidative and scavenging capacities of KYNA (0-150 μM) were tested in cerebellum and forebrain homogenates exposed to 5 μM FeSO4 and 2.5 mM 3-nitropropionic acid (3-NPA).  Both FeSO4 and 3-NPA increased lipid peroxidn. (LP) and ROS formation in a significant manner in these prepns., whereas KYNA significantly reduced these markers.  Reactive oxygen species (ROS) formation were detd. in the presence of FeSO4 and/or KYNA (0-100 μM), both at intra and extracellular levels.  An increase in ROS formation was induced by FeSO4 in forebrain and cerebellum in a time-dependent manner, and KYNA reduced this effect in a concn.-dependent manner.  To further know whether the effect of KYNA on oxidative stress is independent of NMDA and nicotinic receptors, we also tested KYNA (0-100 μM) in a biol. prepn. free of these receptors, defolliculated Xenopus laevis oocytes, incubated with FeSO4 for 1 h.  A 3-fold increase in LP and a 2-fold increase in ROS formation were seen after exposure to FeSO4, whereas KYNA attenuated these effects in a concn.-dependent manner.  In addn., the in vivo formation of ·OH evoked by an acute infusion of FeSO4 (100 μM) in the rat striatum was estd. by microdialysis and challenged by a topic infusion of KYNA (1 μM).  FeSO4 increased the striatal ·OH prodn., while KYNA mitigated this effect.  Altogether, these data strongly suggest that KYNA, in addn. to be a well-known antagonist acting on nicotinic and NMDA receptors, can be considered as a potential endogenous antioxidant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod9wpN_jkui7Vg90H21EOLACvtfcHk0ljMfp0ZiFGgdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ejsbfJ&md5=c779fed276225e3f596499f36e7dcf88</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.ntt.2011.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ntt.2011.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DLugo-Huitron%26aufirst%3DR.%26aulast%3DBlanco-Ayala%26aufirst%3DT.%26aulast%3DUgalde-Muniz%26aufirst%3DP.%26aulast%3DCarrillo-Mora%26aufirst%3DP.%26aulast%3DPedraza-Chaverri%26aufirst%3DJ.%26aulast%3DSilva-Adaya%26aufirst%3DD.%26aulast%3DMaldonado%26aufirst%3DP.%2BD.%26aulast%3DTorres%26aufirst%3DI.%26aulast%3DPinzon%26aufirst%3DE.%26aulast%3DOrtiz-Islas%26aufirst%3DE.%26aulast%3DLopez%26aufirst%3DT.%26aulast%3DGarcia%26aufirst%3DE.%26aulast%3DPineda%26aufirst%3DB.%26aulast%3DTorres-Ramos%26aufirst%3DM.%26aulast%3DSantamaria%26aufirst%3DA.%26aulast%3DLa%2BCruz%26aufirst%3DV.%2BP.%26atitle%3DOn%2520the%2520antioxidant%2520properties%2520of%2520kynurenic%2520acid%253A%2520free%2520radical%2520scavenging%2520activity%2520and%2520inhibition%2520of%2520oxidative%2520stress%26jtitle%3DNeurotoxicol.%2520Teratol.%26date%3D2011%26volume%3D33%26spage%3D538%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Hanisch, U. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kipnis, J.</span><span> </span><span class="NLM_article-title">Toll-like receptors: roles in neuroprotection?</span> <span class="citation_source-journal">Trends Neurosci</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">176</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=176-182&author=U.+K.+Hanischauthor=T.+V.+Johnsonauthor=J.+Kipnis&title=Toll-like+receptors%3A+roles+in+neuroprotection%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanisch%26aufirst%3DU.%2BK.%26aulast%3DJohnson%26aufirst%3DT.%2BV.%26aulast%3DKipnis%26aufirst%3DJ.%26atitle%3DToll-like%2520receptors%253A%2520roles%2520in%2520neuroprotection%253F%26jtitle%3DTrends%2520Neurosci%26date%3D2008%26volume%3D31%26spage%3D176%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Drouin-Ouellet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cicchetti, F.</span><span> </span><span class="NLM_article-title">Inflammation and neurodegeneration: the story “retolled”</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">551</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=542-551&author=J.+Drouin-Ouelletauthor=F.+Cicchetti&title=Inflammation+and+neurodegeneration%3A+the+story+%E2%80%9Cretolled%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDrouin-Ouellet%26aufirst%3DJ.%26aulast%3DCicchetti%26aufirst%3DF.%26atitle%3DInflammation%2520and%2520neurodegeneration%253A%2520the%2520story%2520%25E2%2580%259Cretolled%25E2%2580%259D%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2012%26volume%3D33%26spage%3D542%26epage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Aquilano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotilio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciriolo, M. R.</span><span> </span><span class="NLM_article-title">Role of nitric oxide synthases in Parkinson’s disease: a review on the antioxidant and anti-inflammatory activity of polyphenols</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">2416</span><span class="NLM_x">–</span> <span class="NLM_lpage">2426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1007%2Fs11064-008-9697-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=18415676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOktL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=2416-2426&author=K.+Aquilanoauthor=S.+Baldelliauthor=G.+Rotilioauthor=M.+R.+Ciriolo&title=Role+of+nitric+oxide+synthases+in+Parkinson%E2%80%99s+disease%3A+a+review+on+the+antioxidant+and+anti-inflammatory+activity+of+polyphenols"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Nitric Oxide Synthases in Parkinson's Disease: A Review on the Antioxidant and Anti-inflammatory Activity of Polyphenols</span></div><div class="casAuthors">Aquilano, Katia; Baldelli, Sara; Rotilio, Giuseppe; Ciriolo, Maria Rosa</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2416-2426</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Natural polyphenols can exert protective action on a no. of pathol. conditions including neurodegenerative disorders.  The neuroprotective effects of many polyphenols rely on their ability to permeate brain barrier and here directly scavenge pathol. concn. of reactive oxygen and nitrogen species and chelate transition metal ions.  Importantly, polyphenols modulate neuroinflammation by inhibiting the expression of inflammatory genes and the level of intracellular antioxidants.  Parkinson's disease (PD) is a neurodegenerative disorder characterized by several abnormalities including inflammation, mitochondrial dysfunction, iron accumulation and oxidative stress.  There is considerable evidence showing that cellular oxidative damage occurring in PD might result also from the actions of altered prodn. of nitric oxide (NO).  Indeed, high levels of neuronal and inducible NO synthase (NOS) were found in substantia nigra of patients and animal models of PD.  Here, we evaluate the involvement of NOS/NO in PD and explore the neuroprotective activity of natural polyphenol compds. in terms of anti-inflammatory and antioxidant action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJnRn1WmEk1rVg90H21EOLACvtfcHk0ljMfp0ZiFGgdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOktL3M&md5=4fed473750b90729d98e936339b6f4f4</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs11064-008-9697-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-008-9697-6%26sid%3Dliteratum%253Aachs%26aulast%3DAquilano%26aufirst%3DK.%26aulast%3DBaldelli%26aufirst%3DS.%26aulast%3DRotilio%26aufirst%3DG.%26aulast%3DCiriolo%26aufirst%3DM.%2BR.%26atitle%3DRole%2520of%2520nitric%2520oxide%2520synthases%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520a%2520review%2520on%2520the%2520antioxidant%2520and%2520anti-inflammatory%2520activity%2520of%2520polyphenols%26jtitle%3DNeurochem.%2520Res.%26date%3D2008%26volume%3D33%26spage%3D2416%26epage%3D2426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Frank-Cannon, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alto, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAlpine, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tansey, M. G.</span><span> </span><span class="NLM_article-title">Does neuroinflammation fan the flame in neurodegenerative diseases?</span> <span class="citation_source-journal">Mol. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1186%2F1750-1326-4-47" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=19917131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD1Mjos1yhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=47&author=T.+C.+Frank-Cannonauthor=L.+T.+Altoauthor=F.+E.+McAlpineauthor=M.+G.+Tansey&title=Does+neuroinflammation+fan+the+flame+in+neurodegenerative+diseases%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Does neuroinflammation fan the flame in neurodegenerative diseases?</span></div><div class="casAuthors">Frank-Cannon Tamy C; Alto Laura T; McAlpine Fiona E; Tansey Malu G</div><div class="citationInfo"><span class="NLM_cas:title">Molecular neurodegeneration</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">47</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract"> While peripheral immune access to the central nervous system (CNS) is restricted and tightly controlled, the CNS is capable of dynamic immune and inflammatory responses to a variety of insults.  Infections, trauma, stroke, toxins and other stimuli are capable of producing an immediate and short lived activation of the innate immune system within the CNS.  This acute neuroinflammatory response includes activation of the resident immune cells (microglia) resulting in a phagocytic phenotype and the release of inflammatory mediators such as cytokines and chemokines.  While an acute insult may trigger oxidative and nitrosative stress, it is typically short-lived and unlikely to be detrimental to long-term neuronal survival.  In contrast, chronic neuroinflammation is a long-standing and often self-perpetuating neuroinflammatory response that persists long after an initial injury or insult.  Chronic neuroinflammation includes not only long-standing activation of microglia and subsequent sustained release of inflammatory mediators, but also the resulting increased oxidative and nitrosative stress.  The sustained release of inflammatory mediators works to perpetuate the inflammatory cycle, activating additional microglia, promoting their proliferation, and resulting in further release of inflammatory factors.  Neurodegenerative CNS disorders, including multiple sclerosis (MS), Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), tauopathies, and age-related macular degeneration (ARMD), are associated with chronic neuroinflammation and elevated levels of several cytokines.  Here we review the hallmarks of acute and chronic inflammatory responses in the CNS, the reasons why microglial activation represents a convergence point for diverse stimuli that may promote or compromise neuronal survival, and the epidemiologic, pharmacologic and genetic evidence implicating neuroinflammation in the pathophysiology of several neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRzJ8CUclv_tsjl5L8hwNX0fW6udTcc2eYVbjl14kddU7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mjos1yhug%253D%253D&md5=83ecc85e481c4b3bf40477b8bd557fc1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-4-47&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-4-47%26sid%3Dliteratum%253Aachs%26aulast%3DFrank-Cannon%26aufirst%3DT.%2BC.%26aulast%3DAlto%26aufirst%3DL.%2BT.%26aulast%3DMcAlpine%26aufirst%3DF.%2BE.%26aulast%3DTansey%26aufirst%3DM.%2BG.%26atitle%3DDoes%2520neuroinflammation%2520fan%2520the%2520flame%2520in%2520neurodegenerative%2520diseases%253F%26jtitle%3DMol.%2520Neurodegener.%26date%3D2009%26volume%3D4%26spage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Mosley, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gendelman, H. E.</span><span> </span><span class="NLM_article-title">Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">222</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.expneurol.2009.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20044993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFGns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=222&publication_year=2010&pages=1-5&author=R.+L.+Mosleyauthor=H.+E.+Gendelman&title=Control+of+neuroinflammation+as+a+therapeutic+strategy+for+amyotrophic+lateral+sclerosis+and+other+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders</span></div><div class="casAuthors">Mosley, R. Lee; Gendelman, Howard E.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">222</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-5</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative diseases, Alzheimer's and Parkinson's diseases, and amyotrophic lateral sclerosis (ALS) are progressive and devastating disorders of the nervous system without cure.  Although a no. of distinct, but not mutually exclusive, mechanisms can affect disease pathogenesis, neuroinflammation stands in common.  Neuroinflammatory responses occur as a consequence of oxidative and excitotoxic neuronal damage, mitochondrial dysfunction, and protein aggregation.  Thus, it is believed drugs that modulate inflammation may combat disease progression.  Such strategies include those commented on in the report by Arie Neymotin et al. demonstrating lenalidomide's anti-inflammatory and neuroprotective responses in the G93A mutant superoxide dismutase-1 mouse model of ALS (Neymotin et al., ).  While anti-inflammatory interventions may be required, they may not be sufficient to pos. affect clin. outcomes.  The targeting of combinations of pathogenic events including clearance of disaggregated proteins together with neuroprotective and immune modulatory strategies may all be required to facilitate pos. therapeutic outcomes.  This may include the targeting of both innate and adaptive neurotoxic immune responses.  This commentary is designed to summarize the promises and perils in achieving immunoregulation for brain homeostatic responses and inevitable therapeutic gain.  Promising new ways to optimize immunization schemes and measure their clin. efficacy are discussed with a particular focus on ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcqlUFyjBZKrVg90H21EOLACvtfcHk0liSOheP0DX8kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFGns7o%253D&md5=410f09144b389dabc2516e6652d590ec</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2009.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2009.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DMosley%26aufirst%3DR.%2BL.%26aulast%3DGendelman%26aufirst%3DH.%2BE.%26atitle%3DControl%2520of%2520neuroinflammation%2520as%2520a%2520therapeutic%2520strategy%2520for%2520amyotrophic%2520lateral%2520sclerosis%2520and%2520other%2520neurodegenerative%2520disorders%26jtitle%3DExp.%2520Neurol.%26date%3D2010%26volume%3D222%26spage%3D1%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Neymotin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calingasan, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wille, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiaei, M.</span><span> </span><span class="NLM_article-title">Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">220</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.expneurol.2009.08.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=19733563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GmtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=220&publication_year=2009&pages=191-197&author=A.+Neymotinauthor=S.+Petriauthor=N.+Y.+Calingasanauthor=E.+Willeauthor=P.+Schaferauthor=C.+Stewartauthor=K.+Hensleyauthor=M.+F.+Bealauthor=M.+Kiaei&title=Lenalidomide+%28Revlimid%29+administration+at+symptom+onset+is+neuroprotective+in+a+mouse+model+of+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis</span></div><div class="casAuthors">Neymotin, Arie; Petri, Susanne; Calingasan, Noel Y.; Wille, Elizabeth; Schafer, Peter; Stewart, Charles; Hensley, Kenneth; Beal, M. Flint; Kiaei, Mahmoud</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">220</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">191-197</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease which is currently untreatable.  Inflammation plays a major role in the pathogenesis of motor neuron death in ALS.  Pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α) and Fas ligand (FasL) are amongst the most important mediators of neuro-inflammation.  We have previously demonstrated that elevation of these pro-inflammatory cytokines occurs in both ALS transgenic mice and in human ALS postmortem spinal cord tissues.  Lenalidomide is a potent immunomodulatory agent, with the ability to down-regulate pro-inflammatory cytokines and up-regulate anti-inflammatory cytokines.  We previously reported the neuroprotective effects of lenalidomide, when treatment was started 2 mo prior to onset of disease in the G93A SOD1 transgenic mouse model of ALS.  Since in ALS patients, treatment can only begin after the appearance of symptoms, we sought to det. the efficacy of lenalidomide administration starting at symptom onset in the G93A SOD1 mice.  We found that lenalidomide treatment extended the survival interval from the age of onset by 18.3 days (∼ 45%).  Addnl., lenalidomide treatment improved rotarod performance, reduced wt. loss, and attenuated neuronal cell death in the lumbar spinal cord.  Qual. histol. anal. showed that lenalidomide treatment modestly reduced the expression of the proinflammatory cytokines Fas Ligand, IL-1β, TNF-α and CD40 ligand.  RNA protection Assay (RPA) on a pre-selected panel of cytokines showed that proinflammatory cytokines were reduced and anti-inflammatory cytokines were up-regulated.  These data encourage further clin. evaluation of lenalidomide as therapeutic strategy to block or slow disease progression in human ALS patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFpqmn6J_A6rVg90H21EOLACvtfcHk0liSOheP0DX8kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GmtL3F&md5=ca86c5e88da2a26fb2e119731c1075ab</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2009.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2009.08.028%26sid%3Dliteratum%253Aachs%26aulast%3DNeymotin%26aufirst%3DA.%26aulast%3DPetri%26aufirst%3DS.%26aulast%3DCalingasan%26aufirst%3DN.%2BY.%26aulast%3DWille%26aufirst%3DE.%26aulast%3DSchafer%26aufirst%3DP.%26aulast%3DStewart%26aufirst%3DC.%26aulast%3DHensley%26aufirst%3DK.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26aulast%3DKiaei%26aufirst%3DM.%26atitle%3DLenalidomide%2520%2528Revlimid%2529%2520administration%2520at%2520symptom%2520onset%2520is%2520neuroprotective%2520in%2520a%2520mouse%2520model%2520of%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DExp.%2520Neurol.%26date%3D2009%26volume%3D220%26spage%3D191%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Greenfield, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaux, D. J.</span><span> </span><span class="NLM_article-title">Parkinson’s disease, Alzheimer’s disease and motor neurone disease: identifying a common mechanism</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">485</span><span class="NLM_x">–</span> <span class="NLM_lpage">492</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2002&pages=485-492&author=S.+Greenfieldauthor=D.+J.+Vaux&title=Parkinson%E2%80%99s+disease%2C+Alzheimer%E2%80%99s+disease+and+motor+neurone+disease%3A+identifying+a+common+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGreenfield%26aufirst%3DS.%26aulast%3DVaux%26aufirst%3DD.%2BJ.%26atitle%3DParkinson%25E2%2580%2599s%2520disease%252C%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520motor%2520neurone%2520disease%253A%2520identifying%2520a%2520common%2520mechanism%26jtitle%3DNeuroscience%26date%3D2002%26volume%3D113%26spage%3D485%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Calne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcgeer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, P.</span><span> </span><span class="NLM_article-title">Alzheimers-disease, Parkinsons-disease, and Motoneuron disease—abiotropic interaction between aging and environment</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1067</span><span class="NLM_x">–</span> <span class="NLM_lpage">1070</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1986&pages=1067-1070&author=D.+B.+Calneauthor=E.+Mcgeerauthor=A.+Eisenauthor=P.+Spencer&title=Alzheimers-disease%2C+Parkinsons-disease%2C+and+Motoneuron+disease%E2%80%94abiotropic+interaction+between+aging+and+environment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCalne%26aufirst%3DD.%2BB.%26aulast%3DMcgeer%26aufirst%3DE.%26aulast%3DEisen%26aufirst%3DA.%26aulast%3DSpencer%26aufirst%3DP.%26atitle%3DAlzheimers-disease%252C%2520Parkinsons-disease%252C%2520and%2520Motoneuron%2520disease%25E2%2580%2594abiotropic%2520interaction%2520between%2520aging%2520and%2520environment%26jtitle%3DLancet%26date%3D1986%26volume%3D2%26spage%3D1067%26epage%3D1070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Cooper-Knock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferraiuolo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heath, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattray, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, P. J.</span><span> </span><span class="NLM_article-title">Gene expression profiling in human neurodegenerative disease</span> <span class="citation_source-journal">Nat. Rev. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">518</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnrneurol.2012.156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlWhsL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=518-530&author=J.+Cooper-Knockauthor=J.+Kirbyauthor=L.+Ferraiuoloauthor=P.+R.+Heathauthor=M.+Rattrayauthor=P.+J.+Shaw&title=Gene+expression+profiling+in+human+neurodegenerative+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Gene expression profiling in human neurodegenerative disease</span></div><div class="casAuthors">Cooper-Knock, Johnathan; Kirby, Janine; Ferraiuolo, Laura; Heath, Paul R.; Rattray, Magnus; Shaw, Pamela J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">518-530</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Transcriptome study in neurodegenerative disease has advanced considerably in the past 5 years.  Increasing scientific rigour and improved anal. tools have led to more-reproducible data.  Many transcriptome anal. platforms assay the expression of the entire genome, enabling a complete biol. context to be captured.  Gene expression profiling (GEP) is, therefore, uniquely placed to discover pathways of disease pathogenesis, potential therapeutic targets, and biomarkers.  This Review summarizes microarray human GEP studies in the common neurodegenerative diseases amyotrophic lateral sclerosis (ALS), Parkinson disease (PD) and Alzheimer disease (AD).  Several interesting reports have compared pathol. gene expression in different patient groups, disease stages and anatomical areas.  In all three diseases, GEP has revealed dysregulation of genes related to neuroinflammation.  In ALS and PD, gene expression related to RNA splicing and protein turnover is disrupted, and several studies in ALS support involvement of the cytoskeleton.  GEP studies have implicated the ubiquitin-proteasome system in PD pathogenesis, and have provided evidence of mitochondrial dysfunction in PD and AD.  Lastly, in AD, a possible role for dysregulation of intracellular signalling pathways, including calcium signalling, has been highlighted.  This Review also provides a discussion of methodol. considerations in microarray sample prepn. and data anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCZ1bkpRySvLVg90H21EOLACvtfcHk0ljn1BJwa3QBog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlWhsL7E&md5=e7d16cb140ebfa305e749941a0bf37e8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2012.156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2012.156%26sid%3Dliteratum%253Aachs%26aulast%3DCooper-Knock%26aufirst%3DJ.%26aulast%3DKirby%26aufirst%3DJ.%26aulast%3DFerraiuolo%26aufirst%3DL.%26aulast%3DHeath%26aufirst%3DP.%2BR.%26aulast%3DRattray%26aufirst%3DM.%26aulast%3DShaw%26aufirst%3DP.%2BJ.%26atitle%3DGene%2520expression%2520profiling%2520in%2520human%2520neurodegenerative%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2012%26volume%3D8%26spage%3D518%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Cramer, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirrito, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlo, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinn, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casali, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Restivo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goebel, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landreth, G. E.</span><span> </span><span class="NLM_article-title">ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">1503</span><span class="NLM_x">–</span> <span class="NLM_lpage">1506</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2012&pages=1503-1506&author=P.+E.+Cramerauthor=J.+R.+Cirritoauthor=D.+W.+Wessonauthor=C.+Y.+Leeauthor=J.+C.+Karloauthor=A.+E.+Zinnauthor=B.+T.+Casaliauthor=J.+L.+Restivoauthor=W.+D.+Goebelauthor=M.+J.+Jamesauthor=K.+R.+Brundenauthor=D.+A.+Wilsonauthor=G.+E.+Landreth&title=ApoE-directed+therapeutics+rapidly+clear+beta-amyloid+and+reverse+deficits+in+AD+mouse+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCramer%26aufirst%3DP.%2BE.%26aulast%3DCirrito%26aufirst%3DJ.%2BR.%26aulast%3DWesson%26aufirst%3DD.%2BW.%26aulast%3DLee%26aufirst%3DC.%2BY.%26aulast%3DKarlo%26aufirst%3DJ.%2BC.%26aulast%3DZinn%26aufirst%3DA.%2BE.%26aulast%3DCasali%26aufirst%3DB.%2BT.%26aulast%3DRestivo%26aufirst%3DJ.%2BL.%26aulast%3DGoebel%26aufirst%3DW.%2BD.%26aulast%3DJames%26aufirst%3DM.%2BJ.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DWilson%26aufirst%3DD.%2BA.%26aulast%3DLandreth%26aufirst%3DG.%2BE.%26atitle%3DApoE-directed%2520therapeutics%2520rapidly%2520clear%2520beta-amyloid%2520and%2520reverse%2520deficits%2520in%2520AD%2520mouse%2520models%26jtitle%3DScience%26date%3D2012%26volume%3D335%26spage%3D1503%26epage%3D1506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Graff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennig, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieland, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fass, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samiei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haggarty, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delalle, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, L. H.</span><span> </span><span class="NLM_article-title">An epigenetic blockade of cognitive functions in the neurodegenerating brain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">483</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnature10849" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=22388814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BC383ptlCjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2012&pages=222-226&author=J.+Graffauthor=D.+Reiauthor=J.+S.+Guanauthor=W.+Y.+Wangauthor=J.+Seoauthor=K.+M.+Hennigauthor=T.+J.+Nielandauthor=D.+M.+Fassauthor=P.+F.+Kaoauthor=M.+Kahnauthor=S.+C.+Suauthor=A.+Samieiauthor=N.+Josephauthor=S.+J.+Haggartyauthor=I.+Delalleauthor=L.+H.+Tsai&title=An+epigenetic+blockade+of+cognitive+functions+in+the+neurodegenerating+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">An epigenetic blockade of cognitive functions in the neurodegenerating brain</span></div><div class="casAuthors">Graff Johannes; Rei Damien; Guan Ji-Song; Wang Wen-Yuan; Seo Jinsoo; Hennig Krista M; Nieland Thomas J F; Fass Daniel M; Kao Patricia F; Kahn Martin; Su Susan C; Samiei Alireza; Joseph Nadine; Haggarty Stephen J; Delalle Ivana; Tsai Li-Huei</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">483</span>
        (<span class="NLM_cas:issue">7388</span>),
    <span class="NLM_cas:pages">222-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cognitive decline is a debilitating feature of most neurodegenerative diseases of the central nervous system, including Alzheimer's disease.  The causes leading to such impairment are only poorly understood and effective treatments are slow to emerge.  Here we show that cognitive capacities in the neurodegenerating brain are constrained by an epigenetic blockade of gene transcription that is potentially reversible.  This blockade is mediated by histone deacetylase 2, which is increased by Alzheimer's-disease-related neurotoxic insults in vitro, in two mouse models of neurodegeneration and in patients with Alzheimer's disease.  Histone deacetylase 2 associates with and reduces the histone acetylation of genes important for learning and memory, which show a concomitant decrease in expression.  Importantly, reversing the build-up of histone deacetylase 2 by short-hairpin-RNA-mediated knockdown unlocks the repression of these genes, reinstates structural and synaptic plasticity, and abolishes neurodegeneration-associated memory impairments.  These findings advocate for the development of selective inhibitors of histone deacetylase 2 and suggest that cognitive capacities following neurodegeneration are not entirely lost, but merely impaired by this epigenetic blockade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_TBTrhihJh3WEEzDrymxmfW6udTcc2eaF6HYXTjOt0Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383ptlCjtw%253D%253D&md5=6e567f82c587972acbdf75fbb06d2954</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnature10849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10849%26sid%3Dliteratum%253Aachs%26aulast%3DGraff%26aufirst%3DJ.%26aulast%3DRei%26aufirst%3DD.%26aulast%3DGuan%26aufirst%3DJ.%2BS.%26aulast%3DWang%26aufirst%3DW.%2BY.%26aulast%3DSeo%26aufirst%3DJ.%26aulast%3DHennig%26aufirst%3DK.%2BM.%26aulast%3DNieland%26aufirst%3DT.%2BJ.%26aulast%3DFass%26aufirst%3DD.%2BM.%26aulast%3DKao%26aufirst%3DP.%2BF.%26aulast%3DKahn%26aufirst%3DM.%26aulast%3DSu%26aufirst%3DS.%2BC.%26aulast%3DSamiei%26aufirst%3DA.%26aulast%3DJoseph%26aufirst%3DN.%26aulast%3DHaggarty%26aufirst%3DS.%2BJ.%26aulast%3DDelalle%26aufirst%3DI.%26aulast%3DTsai%26aufirst%3DL.%2BH.%26atitle%3DAn%2520epigenetic%2520blockade%2520of%2520cognitive%2520functions%2520in%2520the%2520neurodegenerating%2520brain%26jtitle%3DNature%26date%3D2012%26volume%3D483%26spage%3D222%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Jellinger, K. A.</span><span> </span><span class="NLM_article-title">Recent advances in our understanding of neurodegeneration</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">1111</span><span class="NLM_x">–</span> <span class="NLM_lpage">1162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2009&pages=1111-1162&author=K.+A.+Jellinger&title=Recent+advances+in+our+understanding+of+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJellinger%26aufirst%3DK.%2BA.%26atitle%3DRecent%2520advances%2520in%2520our%2520understanding%2520of%2520neurodegeneration%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2009%26volume%3D116%26spage%3D1111%26epage%3D1162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Salloway, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintzer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, J. L.</span><span> </span><span class="NLM_article-title">Disease-modifying therapies in Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.jalz.2007.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=18631951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlSmtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=65-79&author=S.+Sallowayauthor=J.+Mintzerauthor=M.+F.+Weinerauthor=J.+L.+Cummings&title=Disease-modifying+therapies+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Disease-modifying therapies in Alzheimer's disease</span></div><div class="casAuthors">Salloway, Stephen; Mintzer, Jacobo; Weiner, Myron F.; Cummings, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & Dementia</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">65-79</span>CODEN:
                <span class="NLM_cas:coden">ADLEBN</span>;
        ISSN:<span class="NLM_cas:issn">1552-5260</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a chronic, progressive, neurodegenerative disorder that places a substantial burden on patients, their families, and society.  The disease affects approx. 5 million individuals in the United States, with an annual cost of care greater than $100 billion.  During the past dozen years, several agents have been approved that enhance cognition and global function of AD patients, and recent advances in understanding AD pathogenesis has led to the development of numerous compds. that might modify the disease process.  A wide array of antiamyloid and neuroprotective therapeutic approaches are under investigation on the basis of the hypothesis that amyloid beta (Aβ) protein plays a pivotal role in disease onset and progression and that secondary consequences of Aβ generation and deposition, including tau hyperphosphorylation and neurofibrillary tangle formation, oxidn., inflammation, and excitotoxicity, contribute to the disease process.  Interventions in these processes with agents that reduce amyloid prodn., limit aggregation, or increase removal might block the cascade of events comprising AD pathogenesis.  Reducing tau hyperphosphorylation, limiting oxidn. and excitotoxicity, and controlling inflammation might be beneficial disease-modifying strategies.  Potentially neuroprotective and restorative treatments such as neurotrophins, neurotrophic factor enhancers, and stem cell-related approaches are also under investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDVz15jwhEbrVg90H21EOLACvtfcHk0lhHq-CCwOpB9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlSmtb0%253D&md5=626e36a2b80a383e57173f52e7722a86</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2007.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2007.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DMintzer%26aufirst%3DJ.%26aulast%3DWeiner%26aufirst%3DM.%2BF.%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26atitle%3DDisease-modifying%2520therapies%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2008%26volume%3D4%26spage%3D65%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Zimmermann, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, C. T.</span><span> </span><span class="NLM_article-title">Multi-target therapeutics: when the whole is greater than the sum of the parts</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.drudis.2006.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=17198971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252Fgt1ygtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=34-42&author=G.+R.+Zimmermannauthor=J.+Leharauthor=C.+T.+Keith&title=Multi-target+therapeutics%3A+when+the+whole+is+greater+than+the+sum+of+the+parts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target therapeutics: when the whole is greater than the sum of the parts</span></div><div class="casAuthors">Zimmermann Grant R; Lehar Joseph; Keith Curtis T</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">34-42</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">Drugs designed to act against individual molecular targets cannot usually combat multigenic diseases such as cancer, or diseases that affect multiple tissues or cell types such as diabetes and immunoinflammatory disorders.  Combination drugs that impact multiple targets simultaneously are better at controlling complex disease systems, are less prone to drug resistance and are the standard of care in many important therapeutic areas.  The combination drugs currently employed are primarily of rational design, but the increased efficacy they provide justifies in vitro discovery efforts for identifying novel multi-target mechanisms.  In this review, we discuss the biological rationale for combination therapeutics, review some existing combination drugs and present a systematic approach to identify interactions between molecular pathways that could be leveraged for therapeutic benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTI14vYK2Q1LENHe_gFldTbfW6udTcc2eaKVU_-LCqaeLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252Fgt1ygtQ%253D%253D&md5=66715499ce21c2855dc6c477aa87f161</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2006.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2006.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DG.%2BR.%26aulast%3DLehar%26aufirst%3DJ.%26aulast%3DKeith%26aufirst%3DC.%2BT.%26atitle%3DMulti-target%2520therapeutics%253A%2520when%2520the%2520whole%2520is%2520greater%2520than%2520the%2520sum%2520of%2520the%2520parts%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D34%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">De Raedt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yecies, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malone, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maertens, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebleu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalluri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haigis, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macleod, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cichowski, K.</span><span> </span><span class="NLM_article-title">Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">400</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=400-413&author=T.+De+Raedtauthor=Z.+Waltonauthor=J.+L.+Yeciesauthor=D.+Liauthor=Y.+Chenauthor=C.+F.+Maloneauthor=O.+Maertensauthor=S.+M.+Jeongauthor=R.+T.+Bronsonauthor=V.+Lebleuauthor=R.+Kalluriauthor=E.+Normantauthor=M.+C.+Haigisauthor=B.+D.+Manningauthor=K.+K.+Wongauthor=K.+F.+Macleodauthor=K.+Cichowski&title=Exploiting+cancer+cell+vulnerabilities+to+develop+a+combination+therapy+for+ras-driven+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BRaedt%26aufirst%3DT.%26aulast%3DWalton%26aufirst%3DZ.%26aulast%3DYecies%26aufirst%3DJ.%2BL.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DMalone%26aufirst%3DC.%2BF.%26aulast%3DMaertens%26aufirst%3DO.%26aulast%3DJeong%26aufirst%3DS.%2BM.%26aulast%3DBronson%26aufirst%3DR.%2BT.%26aulast%3DLebleu%26aufirst%3DV.%26aulast%3DKalluri%26aufirst%3DR.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DHaigis%26aufirst%3DM.%2BC.%26aulast%3DManning%26aufirst%3DB.%2BD.%26aulast%3DWong%26aufirst%3DK.%2BK.%26aulast%3DMacleod%26aufirst%3DK.%2BF.%26aulast%3DCichowski%26aufirst%3DK.%26atitle%3DExploiting%2520cancer%2520cell%2520vulnerabilities%2520to%2520develop%2520a%2520combination%2520therapy%2520for%2520ras-driven%2520tumors%26jtitle%3DCancer%2520Cell%26date%3D2011%26volume%3D20%26spage%3D400%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">McHutchison, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manns, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poynard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsay, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trepo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dienstag, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garaud, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, J. K.</span><span> </span><span class="NLM_article-title">Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">1061</span><span class="NLM_x">–</span> <span class="NLM_lpage">1069</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2002&pages=1061-1069&author=J.+G.+McHutchisonauthor=M.+Mannsauthor=K.+Patelauthor=T.+Poynardauthor=K.+L.+Lindsayauthor=C.+Trepoauthor=J.+Dienstagauthor=W.+M.+Leeauthor=C.+Makauthor=J.+J.+Garaudauthor=J.+K.+Albrecht&title=Adherence+to+combination+therapy+enhances+sustained+response+in+genotype-1-infected+patients+with+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26aulast%3DManns%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DPoynard%26aufirst%3DT.%26aulast%3DLindsay%26aufirst%3DK.%2BL.%26aulast%3DTrepo%26aufirst%3DC.%26aulast%3DDienstag%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DW.%2BM.%26aulast%3DMak%26aufirst%3DC.%26aulast%3DGaraud%26aufirst%3DJ.%2BJ.%26aulast%3DAlbrecht%26aufirst%3DJ.%2BK.%26atitle%3DAdherence%2520to%2520combination%2520therapy%2520enhances%2520sustained%2520response%2520in%2520genotype-1-infected%2520patients%2520with%2520chronic%2520hepatitis%2520C%26jtitle%3DGastroenterology%26date%3D2002%26volume%3D123%26spage%3D1061%26epage%3D1069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Ho, D. D.</span><span> </span><span class="NLM_article-title">Time to hit HIV, early and hard</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">450</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1056%2FNEJM199508173330710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=7616996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADyaK2Mzkt1Wquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=1995&pages=450-451&author=D.+D.+Ho&title=Time+to+hit+HIV%2C+early+and+hard"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Time to hit HIV, early and hard</span></div><div class="casAuthors">Ho D D</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">450-1</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQN6PDxc8sWzYMcDoIzZtNkfW6udTcc2eaHbg4CkfSnzLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2Mzkt1Wquw%253D%253D&md5=d3b7657886ea7b7deb3eafc0dcdd5170</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1056%2FNEJM199508173330710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199508173330710%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DD.%2BD.%26atitle%3DTime%2520to%2520hit%2520HIV%252C%2520early%2520and%2520hard%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1995%26volume%3D333%26spage%3D450%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Kihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, M.</span><span> </span><span class="NLM_article-title">Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=7815331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK2MXjtFSqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1995&pages=177-183&author=T.+Kiharaauthor=M.+Ikeda&title=Effects+of+duloxetine%2C+a+new+serotonin+and+norepinephrine+uptake+inhibitor%2C+on+extracellular+monoamine+levels+in+rat+frontal+cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex</span></div><div class="casAuthors">Kihara, Tsuyoshi; Ikeda, Masato</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">177-83</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The effects of duloxetine (LY248686), a new inhibitor of serotonin (5-hydroxytryptamine; 5-HT) and norepinephrine (NE) uptake on extracellular levels of NE, 5-HT and dopamine (DA), were studied in the rat frontal cortex and nucleus accumbens, using in vivo microdialysis.  The oral administration of duloxetine (3. 125-12.5 mg/kg) produced a dose-dependent increase in the output of both NE and 5-HT from the frontal cortex, this increase being maintained throughout the 4-h observation period.  Chronic administration of duloxetine (6.25 mg/kg, p.o.) for 14 days failed to alter basal NE and 5-HT levels in the frontal cortex, but augmented the duloxetine-induced increase in output of NE and 5-HT.  Amitriptyline and maprotiline, administered p.o. at doses of 6.25 to 25 mg/kg, increased NE output, but the effect was weaker than that of duloxetine, and neither amitriptyline nor maprotiline changed 5-HT output from the frontal cortex.  Duloxetine, amitriptyline, and maprotiline brought about increases in DA levels in the rat frontal cortex, the increase in DA levels induced by duloxetine being approx. two or three times more potent than that induced by amitriptyline and maprotiline.  In the nucleus accumbens, duloxetine also produced a dose-dependent increase in DA output more potent than that produced by amitriptyline and maprotiline.  These results show that duloxetine causes a potent and sustained increase in the output of both NE and 5-HT in the rat frontal cortex, related to its inhibition of NE and 5-HT uptake; these results also show that duloxetine increases DA output in the frontal cortex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1L0O8hPzv07Vg90H21EOLACvtfcHk0liGxMwSHJk7eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjtFSqtrs%253D&md5=e9fcc91cf637f65c08ad17a55ecc453f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKihara%26aufirst%3DT.%26aulast%3DIkeda%26aufirst%3DM.%26atitle%3DEffects%2520of%2520duloxetine%252C%2520a%2520new%2520serotonin%2520and%2520norepinephrine%2520uptake%2520inhibitor%252C%2520on%2520extracellular%2520monoamine%2520levels%2520in%2520rat%2520frontal%2520cortex%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1995%26volume%3D272%26spage%3D177%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Delgado, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, F. A.</span><span> </span><span class="NLM_article-title">Role of norepinephrine in depression</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=10703757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvFGhs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2000&pages=5-12&issue=Suppl.+1&author=P.+L.+Delgadoauthor=F.+A.+Moreno&title=Role+of+norepinephrine+in+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Role of norepinephrine in depression</span></div><div class="casAuthors">Delgado, Pedro L.; Moreno, Francisco A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">5-12</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press, Inc.</span>)
        </div><div class="casAbstract">A review is given with 72 refs. on the role of norepinephrine (NE) and serotonin (5-HT) in depression and the therapeutic effects of antidepressant drugs from the perspective of human neurotransmitter depletion studies.  The data reviewed suggest that both noradrenergic and serotonergic systems are involved in antidepressant action, but the specific impairment that underlies depression is unclear and is likely to vary among patients.  Results from neurotransmitter depletion studies in depressed patients who have responded to treatment suggest that, while interactions between NE and 5-HT are likely, neither of these 2 neurotransmitter systems is the final common pathway for the therapeutic effect of antidepressant drugs.  NE-selective antidepressant drugs appear to be primarily dependent on the availability of NE for their effects.  Likewise, 5-HT-selective antidepressants appear to be primarily dependent on the availability of 5-HT for their effects.  Antidepressants that cause effects on both noradrenergic and serotonergic systems-such as mirtazapine-may be dependent on the availability of both neurotransmitters for their effects.  Neither 5-HT nor NE depletion induced clin. depression in healthy subjects or worsened depression in unmedicated symptomatic patients with major depression.  This finding suggests that the cause of depression is more complex than just an alteration in the levels of 5-HT and/or NE.  For some patients, depression may be more directly caused by dysfunction in brain areas or neuronal systems modulated by monoamine systems.  The authors propose that antidepressant drugs may enhance neurotransmission in normal noradrenergic or serotonergic neurons and, through a time-dependent but as yet undiscovered process, restore function to brain areas modulated by monoamine neurons.  Future research should focus on understanding the adaptive changes that follow enhancement of synaptic levels of monoamines in neuronal circuits of the frontal cortex, amygdala, and hippocampus.  Research investigating the neurobiol. of depression may be more informed if the focus is shifted to investigating areas of the brain modulated by monoamine systems rather than the monoamine systems themselves.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3g2phmY5oxLVg90H21EOLACvtfcHk0liGxMwSHJk7eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvFGhs78%253D&md5=26a84c53d447981467d59d618cfa4f16</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDelgado%26aufirst%3DP.%2BL.%26aulast%3DMoreno%26aufirst%3DF.%2BA.%26atitle%3DRole%2520of%2520norepinephrine%2520in%2520depression%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2000%26volume%3D61%26issue%3DSuppl.%25201%26spage%3D5%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Traynelis, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wollmuth, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBain, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span> </span><span class="NLM_article-title">Glutamate receptor ion channels: structure, regulation, and function</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1124%2Fpr.109.002451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20716669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=405-496&author=S.+F.+Traynelisauthor=L.+P.+Wollmuthauthor=C.+J.+McBainauthor=F.+S.+Mennitiauthor=K.+M.+Vanceauthor=K.+K.+Ogdenauthor=K.+B.+Hansenauthor=H.+Yuanauthor=S.+J.+Myersauthor=R.+Dingledine&title=Glutamate+receptor+ion+channels%3A+structure%2C+regulation%2C+and+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate receptor ion channels: structure, regulation, and function</span></div><div class="casAuthors">Traynelis, Stephen F.; Wollmuth, Lonnie P.; McBain, Chris J.; Menniti, Frank S.; Vance, Katie M.; Ogden, Kevin K.; Hansen, Kasper B.; Yuan, Hongjie; Myers, Scott J.; Dingledine, Ray</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">405-496</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The mammalian ionotropic glutamate receptor family encodes 18 gene products that coassemble to form ligand-gated ion channels contg. an agonist recognition site, a transmembrane ion permeation pathway, and gating elements that couple agonist-induced conformational changes to the opening or closing of the permeation pore.  Glutamate receptors mediate fast excitatory synaptic transmission in the central nervous system and are localized on neuronal and non-neuronal cells.  These receptors regulate a broad spectrum of processes in the brain, spinal cord, retina, and peripheral nervous system.  Glutamate receptors are postulated to play important roles in numerous neurol. diseases and have attracted intense scrutiny.  The description of glutamate receptor structure, including its transmembrane elements, reveals a complex assembly of multiple semiautonomous extracellular domains linked to a pore-forming element with striking resemblance to an inverted potassium channel.  In this review we discuss International Union of Basic and Clin. Pharmacol. glutamate receptor nomenclature, structure, assembly, accessory subunits, interacting proteins, gene expression and translation, post-translational modifications, agonist and antagonist pharmacol., allosteric modulation, mechanisms of gating and permeation, roles in normal physiol. function, as well as the potential therapeutic use of pharmacol. agents acting at glutamate receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov0rj4nMr5ObVg90H21EOLACvtfcHk0liGxMwSHJk7eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbJ&md5=5d0a7945b5ad99113adf9f6312bafe13</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1124%2Fpr.109.002451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.109.002451%26sid%3Dliteratum%253Aachs%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DWollmuth%26aufirst%3DL.%2BP.%26aulast%3DMcBain%26aufirst%3DC.%2BJ.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DMyers%26aufirst%3DS.%2BJ.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DGlutamate%2520receptor%2520ion%2520channels%253A%2520structure%252C%2520regulation%252C%2520and%2520function%26jtitle%3DPharmacol.%2520Rev.%26date%3D2010%26volume%3D62%26spage%3D405%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Lipton, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, P. A.</span><span> </span><span class="NLM_article-title">Excitatory amino-acids as a final common pathway for neurologic disorders</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1056%2FNEJM199403033300907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=7905600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK2cXltVGhtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=1994&pages=613-622&author=S.+A.+Liptonauthor=P.+A.+Rosenberg&title=Excitatory+amino-acids+as+a+final+common+pathway+for+neurologic+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Excitatory amino acids as a final common pathway for neurologic disorders</span></div><div class="casAuthors">Lipton, Stuart A.; Rosenberg, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">613-22</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">A review with 89 refs. on types of excitatory amino acid receptors, intracellular calcium and neurotoxicity, pathogenesis of excitotoxicity, and pharmacotherapy for excitatory amino acid-induced neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRu6Iwoj1WVLVg90H21EOLACvtfcHk0lhNnHZr-fkkzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXltVGhtbk%253D&md5=d1d6678f75416d8d35c2ee090f61f950</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1056%2FNEJM199403033300907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199403033300907%26sid%3Dliteratum%253Aachs%26aulast%3DLipton%26aufirst%3DS.%2BA.%26aulast%3DRosenberg%26aufirst%3DP.%2BA.%26atitle%3DExcitatory%2520amino-acids%2520as%2520a%2520final%2520common%2520pathway%2520for%2520neurologic%2520disorders%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1994%26volume%3D330%26spage%3D613%26epage%3D622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Lynch, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guttmann, R. P.</span><span> </span><span class="NLM_article-title">Excitotoxicity: perspectives based on <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor subtypes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">300</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1124%2Fjpet.300.3.717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11861773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD38XitVemsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=2002&pages=717-723&author=D.+R.+Lynchauthor=R.+P.+Guttmann&title=Excitotoxicity%3A+perspectives+based+on+N-methyl-d-aspartate+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Excitotoxicity: perspectives based on N-methyl-D-aspartate receptor subtypes</span></div><div class="casAuthors">Lynch, David R.; Guttmann, Rodney P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">300</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">717-723</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Since excitotoxicity has been implicated in a variety of neuropathol. conditions, understanding the pathways involved in this type of cell death is of crit. importance to the future clin. treatment of many diseases.  The N-methyl-D-aspartate (NMDA) receptor has become a primary focus of excitotoxic research because early studies demonstrated that antagonism of this receptor subtype was neuroprotective.  However, initial pharmacol. agents were not clin. useful due to the adverse effects of complete NMDA receptor blockade.  Understanding the biochem. properties of the multitude of NMDA receptor subtypes offers the possibility of developing more effective and clin. useful drugs.  With the discovery of the basis of heterogeneity of NMDA receptors through mol. biol. approaches, many new potential therapeutic targets have been uncovered, and several model systems have been developed for the study of NMDA receptor-mediated cell death.  This review discusses these models and the current understanding of the relationship between NMDA receptor subtypes and excitotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkmgoUtyFzvLVg90H21EOLACvtfcHk0lhNnHZr-fkkzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitVemsb8%253D&md5=ef53bded6e3807e2fc45ea58119eea65</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fjpet.300.3.717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.300.3.717%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DD.%2BR.%26aulast%3DGuttmann%26aufirst%3DR.%2BP.%26atitle%3DExcitotoxicity%253A%2520perspectives%2520based%2520on%2520N-methyl-d-aspartate%2520receptor%2520subtypes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D300%26spage%3D717%26epage%3D723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Waxman, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, D. R.</span><span> </span><span class="NLM_article-title"><i>N</i>-Methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease</span> <span class="citation_source-journal">Neuroscientist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=37-49&author=E.+A.+Waxmanauthor=D.+R.+Lynch&title=N-Methyl-d-aspartate+receptor+subtypes%3A+multiple+roles+in+excitotoxicity+and+neurological+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWaxman%26aufirst%3DE.%2BA.%26aulast%3DLynch%26aufirst%3DD.%2BR.%26atitle%3DN-Methyl-d-aspartate%2520receptor%2520subtypes%253A%2520multiple%2520roles%2520in%2520excitotoxicity%2520and%2520neurological%2520disease%26jtitle%3DNeuroscientist%26date%3D2005%26volume%3D11%26spage%3D37%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Hartley, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurth, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjerkness, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, D. W.</span><span> </span><span class="NLM_article-title">Glutamate receptor-induced <sup>45</sup>Ca<sup>2+</sup> accumulation in cortical cell culture correlates with subsequent neuronal degeneration</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1993</span><span class="NLM_x">–</span> <span class="NLM_lpage">2000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=7683048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK3sXkt1Squro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1993&pages=1993-2000&author=D.+M.+Hartleyauthor=M.+C.+Kurthauthor=L.+Bjerknessauthor=J.+H.+Weissauthor=D.+W.+Choi&title=Glutamate+receptor-induced+45Ca2%2B+accumulation+in+cortical+cell+culture+correlates+with+subsequent+neuronal+degeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate receptor-induced calcium-45 accumulation in cortical cell culture correlates with subsequent neuronal degeneration</span></div><div class="casAuthors">Hartley, Dean M.; Kurth, Matthias C.; Bjerkness, Lisa; Weiss, John H.; Choi, Dennis W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1993-2000</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    </div><div class="casAbstract">Murine neuronal and glial cell cultures exposed briefly to glutamate accumulated large amts. of 45Ca2+ from the extracellular medium during the exposure.  Most of the accumulation likely reflected influx into neurons, as little accumulation was obsd. in similarly treated glial cultures.  When the concn. of glutamate was varied between 10 and 1000 μM, or exposure duration was varied between 0 and 10 min, the amt. of 45Ca2+ accumulation correlated closely with the amt. of neuronal death 24 h later.  Both 45Ca2+ accumulation and cell death could be attenuated in a dose-dependent manner by the competitive NMDA antagonist D-aminophosphonovalerate or the noncompetitive antagonist dextrophan, with IC50 values of approx. 100 and 15 μM, resp.  In contrast, neither 45Ca2+ accumulation nor cell death was blocked by the α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)/kainate antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) in the presence of high glycine.  With brief exposure, high concns., of AMPA, kainate, or K+ produced much less death or 45Ca2 accumulation than produced by glutamate esp. if 10 μM MK-801 was included in the exposure medium to block NMDA receptor activation. .  Kainate- or AMPA-induced 45Ca2+ accumulation or neuronal cell death was blocked with CNQX.  However, high K+-triggered 45Ca2+ accumulation was only partially blocked with CNQX plus MK-801, consistent with mediation by voltage-gated Ca2+ channels.  In addn. to measuring the accumulation of 45Ca2+ occurring during agonist exposure, accumulations were also examd. during the 30 min immediately following completion of a 3-5 min exposure to 500 μM NMDA.  This late 45Ca2+ accumulation was approx. 1/2 that accumulated during the initial exposure period.  Delayed addn. of MK-801 blocked this late accumulation and produced a corresponding partial redn. in cell death.  These results support the hypothesis that excess net Ca2+ influx through NMDA receptor-gated channels is a key step in triggering the neuronal death induced by brief, intense glutamate exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr56x4lalLNrVg90H21EOLACvtfcHk0lhNnHZr-fkkzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkt1Squro%253D&md5=572babae9913a86de41d9d32d6974d99</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHartley%26aufirst%3DD.%2BM.%26aulast%3DKurth%26aufirst%3DM.%2BC.%26aulast%3DBjerkness%26aufirst%3DL.%26aulast%3DWeiss%26aufirst%3DJ.%2BH.%26aulast%3DChoi%26aufirst%3DD.%2BW.%26atitle%3DGlutamate%2520receptor-induced%252045Ca2%252B%2520accumulation%2520in%2520cortical%2520cell%2520culture%2520correlates%2520with%2520subsequent%2520neuronal%2520degeneration%26jtitle%3DJ.%2520Neurosci.%26date%3D1993%26volume%3D13%26spage%3D1993%26epage%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Rothstein, J. D.</span><span> </span><span class="NLM_article-title">Excitotoxicity hypothesis</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">19S</span><span class="NLM_x">–</span> <span class="NLM_lpage">26S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1996&pages=19S-26S&author=J.+D.+Rothstein&title=Excitotoxicity+hypothesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRothstein%26aufirst%3DJ.%2BD.%26atitle%3DExcitotoxicity%2520hypothesis%26jtitle%3DNeurology%26date%3D1996%26volume%3D47%26spage%3D19S%26epage%3D26S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Hedegaard, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bräuner-Osborne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span> </span><span class="NLM_article-title">Molecular pharmacology of human NMDA receptors</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">609</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.neuint.2011.11.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=22197913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlSktrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=601-609&author=M.+K.+Hedegaardauthor=K.+B.+Hansenauthor=K.+T.+Andersenauthor=H.+Br%C3%A4uner-Osborneauthor=S.+F.+Traynelis&title=Molecular+pharmacology+of+human+NMDA+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular pharmacology of human NMDA receptors</span></div><div class="casAuthors">Hedegaard, Maiken; Hansen, Kasper B.; Andersen, Karen T.; Brauner-Osborne, Hans; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">601-609</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">N-methyl-D-aspartate (NMDA) receptors are ionotropic glutamate receptors that mediate excitatory neurotransmission.  NMDA receptors are also important drug targets that are implicated in a no. of pathophysiol. conditions.  To facilitate the transition from lead compds. in pre-clin. animal models to drug candidates for human use, it is important to establish whether NMDA receptor ligands have similar properties at rodent and human NMDA receptors.  Here, we compare amino acid sequences for human and rat NMDA receptor subunits and discuss inter-species variation in the context of our current knowledge of the relationship between NMDA receptor structure and function.  We summarize studies on the biophys. properties of human NMDA receptors and compare these properties to those of rat orthologs.  Finally, we provide a comprehensive pharmacol. characterization that allows side-by-side comparison of agonists, un-competitive antagonists, GluN2B-selective non-competitive antagonists, and GluN2C/D-selective modulators at recombinant human and rat NMDA receptors.  The evaluation of biophys. properties and pharmacol. probes acting at different sites on the receptor suggest that the binding sites and conformational changes leading to channel gating in response to agonist binding are highly conserved between human and rat NMDA receptors.  In summary, the results of this study suggest that no major detectable differences exist in the pharmacol. and functional properties of human and rat NMDA receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS0vde2fdkdbVg90H21EOLACvtfcHk0lgkPjGCwMRdkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlSktrfE&md5=97fbf713df306543c9bf801d4ad3b39f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2011.11.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2011.11.016%26sid%3Dliteratum%253Aachs%26aulast%3DHedegaard%26aufirst%3DM.%2BK.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DAndersen%26aufirst%3DK.%2BT.%26aulast%3DBr%25C3%25A4uner-Osborne%26aufirst%3DH.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DMolecular%2520pharmacology%2520of%2520human%2520NMDA%2520receptors%26jtitle%3DNeurochem.%2520Int.%26date%3D2012%26volume%3D61%26spage%3D601%26epage%3D609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Papouin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladepeche, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labasque, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groc, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollegioni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mothet, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliet, S. H.</span><span> </span><span class="NLM_article-title">Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">150</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2012&pages=633-646&author=T.+Papouinauthor=L.+Ladepecheauthor=J.+Ruelauthor=S.+Sacchiauthor=M.+Labasqueauthor=M.+Haniniauthor=L.+Grocauthor=L.+Pollegioniauthor=J.+P.+Mothetauthor=S.+H.+Oliet&title=Synaptic+and+extrasynaptic+NMDA+receptors+are+gated+by+different+endogenous+coagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPapouin%26aufirst%3DT.%26aulast%3DLadepeche%26aufirst%3DL.%26aulast%3DRuel%26aufirst%3DJ.%26aulast%3DSacchi%26aufirst%3DS.%26aulast%3DLabasque%26aufirst%3DM.%26aulast%3DHanini%26aufirst%3DM.%26aulast%3DGroc%26aufirst%3DL.%26aulast%3DPollegioni%26aufirst%3DL.%26aulast%3DMothet%26aufirst%3DJ.%2BP.%26aulast%3DOliet%26aufirst%3DS.%2BH.%26atitle%3DSynaptic%2520and%2520extrasynaptic%2520NMDA%2520receptors%2520are%2520gated%2520by%2520different%2520endogenous%2520coagonists%26jtitle%3DCell%26date%3D2012%26volume%3D150%26spage%3D633%26epage%3D646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Kemp, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKernan, R. M.</span><span> </span><span class="NLM_article-title">NMDA receptor pathways as drug targets</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1042</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnn936" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12403981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1entLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2002&pages=1039-1042&author=J.+A.+Kempauthor=R.+M.+McKernan&title=NMDA+receptor+pathways+as+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor pathways as drug targets</span></div><div class="casAuthors">Kemp, John. A.; McKernan, Ruth M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">Suppl.</span>),
    <span class="NLM_cas:pages">1039-1042</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the mid 1980s, there has been a great deal of enthusiasm within both academia and industry about the therapeutic potential of drugs targeting the NMDA subtype of glutamate receptors.  That early promise is just beginning to translate into approvable drugs.  Here we review the reasons for this slow progress and critically assess the future prospects for drugs that act on NMDA receptor pathways, including potential treatments for some major disorders such as stroke and Alzheimer's disease, for which effective therapies are still lacking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2kTkiwztgKrVg90H21EOLACvtfcHk0lgkPjGCwMRdkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1entLY%253D&md5=29b82e717cf4eebafb777ff0bafb9601</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnn936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn936%26sid%3Dliteratum%253Aachs%26aulast%3DKemp%26aufirst%3DJ.%2BA.%26aulast%3DMcKernan%26aufirst%3DR.%2BM.%26atitle%3DNMDA%2520receptor%2520pathways%2520as%2520drug%2520targets%26jtitle%3DNat.%2520Neurosci.%26date%3D2002%26volume%3D5%26spage%3D1039%26epage%3D1042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Paoletti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neyton, J.</span><span> </span><span class="NLM_article-title">NMDA receptor subunits: function and pharmacology</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.coph.2006.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=17088105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntlGitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=39-47&author=P.+Paolettiauthor=J.+Neyton&title=NMDA+receptor+subunits%3A+function+and+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor subunits: function and pharmacology</span></div><div class="casAuthors">Paoletti, Pierre; Neyton, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-47</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  N-methyl-D-aspartate receptors (NMDARs) are glutamate-gated ion channels widely expressed in the central nervous system that play key roles in excitatory synaptic transmission.  Because of their involvement in numerous neurol. disorders, NMDARs are also targets of therapeutic interest.  NMDARs occur as multiple subtypes which differ in their subunit compn. and in their biophys. and pharmacol. properties.  In particular, NMDARs contain a diversity of sites at which endogenous ligands or pharmacol. agents can act to modulate receptor activity in a subunit-selective manner, and recent structural and functional data have started to reveal the mol. determinants for this subunit selectivity.  These include the binding sites for glutamate, the ion-channel pore and the recently identified allosteric sites on the N-terminal domain.  Other potential sites yet unexplored by medicinal chem. programs are also considered, in particular at the interface between subunits.  Given the growing body of evidence that diverse brain disorders implicate different NMDAR subtypes, such as NR2B in pain or NR3A in white matter injury, there is a growing interest in exploiting the pharmacol. heterogeneity of NMDARs for the development of novel NMDAR subtype-selective compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ5E8KNWeeb7Vg90H21EOLACvtfcHk0lgkPjGCwMRdkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntlGitQ%253D%253D&md5=18296410fb9b50af0b2a7ceae124faf4</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2006.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2006.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DPaoletti%26aufirst%3DP.%26aulast%3DNeyton%26aufirst%3DJ.%26atitle%3DNMDA%2520receptor%2520subunits%253A%2520function%2520and%2520pharmacology%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2007%26volume%3D7%26spage%3D39%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Beal, M. F.</span><span> </span><span class="NLM_article-title">Aging, energy, and oxidative stress in neurodegenerative diseases</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1002%2Fana.410380304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=7668820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK2MXosl2ls7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=357-366&author=M.+F.+Beal&title=Aging%2C+energy%2C+and+oxidative+stress+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Aging, energy, and oxidative stress in neurodegenerative diseases</span></div><div class="casAuthors">Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">357-66</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Little, Brown</span>)
        </div><div class="casAbstract">A review with 117 refs.  The etiol. of neurodegenerative diseases remains enigmatic; however, evidence for defects in energy metab., excitotoxicity, and for oxidative damage is increasingly compelling.  It is likely that there is a complex interplay between these mechanisms.  A defect in energy metab. may lead to neuronal depolarization, activation of N-methyl-D-aspartate excitatory amino acid receptors, and increases in intracellular calcium, which are buffered by mitochondria.  Mitochondria are the major intracellular source of free radicals, and increased mitochondrial calcium concns. enhance free radical generation.  Mitochondrial DNA is particularly susceptible to oxidative stress, and there is evidence of age-dependent damage and deterioration of respiratory enzyme activities with normal aging.  This may contribute to the delayed onset and age dependence of neurodegenerative diseases.  There is evidence for increased oxidative damage to macromols. in amyotrophic lateral sclerosis, Huntington's disease, Parkinson's disease, and Alzheimer's disease.  Potential therapeutic approaches include glutamate release inhibitors, excitatory amino acid antagonists, strategies to improve mitochondrial function, free radical scavengers, and trophic factors.  All of these approaches appear promising in exptl. studies and are now being applied to human studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCU8YQWvvyfbVg90H21EOLACvtfcHk0lgrA3P3ZBLmLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXosl2ls7c%253D&md5=cefb4160c5bd42e0ad069265ec644299</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fana.410380304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410380304%26sid%3Dliteratum%253Aachs%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DAging%252C%2520energy%252C%2520and%2520oxidative%2520stress%2520in%2520neurodegenerative%2520diseases%26jtitle%3DAnn.%2520Neurol.%26date%3D1995%26volume%3D38%26spage%3D357%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Coyle, J.</span><span> </span><span class="NLM_article-title">An animal model for Huntington’s disease</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=38864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaE1MXktFOlurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1979&pages=251-276&author=J.+Coyle&title=An+animal+model+for+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">An animal model for Huntington's disease</span></div><div class="casAuthors">Coyle, Joseph T.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">251-76</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    </div><div class="casAbstract">A review with 74 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokeFb203gEcrVg90H21EOLACvtfcHk0lgrA3P3ZBLmLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXktFOlurY%253D&md5=a14751f2b7448c2a8a712e58693db575</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoyle%26aufirst%3DJ.%26atitle%3DAn%2520animal%2520model%2520for%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DBiol.%2520Psychiatry%26date%3D1979%26volume%3D14%26spage%3D251%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Fan, M. M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, L. A.</span><span> </span><span class="NLM_article-title"><i>N</i>-Methyl-<span class="smallcaps smallerCapital">d</span>-aspartate (NMDA) receptor function and excitotoxicity in Huntington’s disease</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">272</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.pneurobio.2006.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=17188796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFGqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=272-293&author=M.+M.+Y.+Fanauthor=L.+A.+Raymond&title=N-Methyl-d-aspartate+%28NMDA%29+receptor+function+and+excitotoxicity+in+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">N-Methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease</span></div><div class="casAuthors">Fan, Mannie M. Y.; Raymond, Lynn A.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">272-293</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Many lines of evidence support a role for neuronal damage arising as a result of excessive activation of glutamate receptors by excitatory amino acids in the pathogenesis of Huntington disease.  The N-methyl-D-aspartate subclass of inotropic glutamate receptors (NMDARs) is more selective and effective than the other subclasses in mediating this damage.  As well, neurons expressing high levels of NMDARs are lost early from the striatum of individuals affected with Huntington's disease (HD), and injection of NMDAR agonists into the striatum of rodents or non-human primates recapitulates the pattern of neuronal damage obsd. in HD.  Altered NMDAR function has been reported in corticostriatal synapses in one mouse model of HD, and NMDAR-mediated current and/or toxicity have been found to be potentiated in striatal neurons from several HD mouse models as well as heterologous cells expressing the mutant huntington protein.  Changes in NMDAR activity have been correlated with altered calcium homeostasis, mitochondrial membrane depolarization and caspase activation.  NMDAR stimulation is also closely linked to mitochondrial activity, as treatment with mitochondrial toxins has been demonstrated to produce striatal damage that can be reversed by the addn. of NMDAR antagonists.  Recent efforts have focused on the elucidation of mol. pathways linking huntington to NMDARs, as well as the mechanisms which underlie the enhancement of NMDAR activity by mutant huntington.  Here, we review the literature to date and recent findings concerning the role of NMDARs in HD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWmSAU9WE51bVg90H21EOLACvtfcHk0lgrA3P3ZBLmLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFGqtLw%253D&md5=d6ed0834cf6cf86a2134887e459e6991</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2006.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2006.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DM.%2BM.%2BY.%26aulast%3DRaymond%26aufirst%3DL.%2BA.%26atitle%3DN-Methyl-d-aspartate%2520%2528NMDA%2529%2520receptor%2520function%2520and%2520excitotoxicity%2520in%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DProg.%2520Neurobiol.%26date%3D2007%26volume%3D81%26spage%3D272%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Good, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olanow, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perl, D. P.</span><span> </span><span class="NLM_article-title">Evidence of neuronal oxidative damage in Alzheimer’s disease</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=8686745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADyaK283nsFGntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=1996&pages=21-28&author=P.+F.+Goodauthor=P.+Wernerauthor=A.+Hsuauthor=C.+W.+Olanowauthor=D.+P.+Perl&title=Evidence+of+neuronal+oxidative+damage+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence of neuronal oxidative damage in Alzheimer's disease</span></div><div class="casAuthors">Good P F; Werner P; Hsu A; Olanow C W; Perl D P</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of pathology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-8</span>
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    </div><div class="casAbstract">Oxidative stress has been proposed as a pathogenetic mechanism in Alzheimer's disease.  One mechanism of oxidative damage is the nitration of tyrosine residues in proteins, mediated by peroxynitrite breakdown.  Peroxynitrite, a reaction product of nitric oxide and superoxide radicals, has been implicated in N-methyl-D-aspartate receptor-mediated excitotoxic damage.  Reported evidence of oxidative stress in Alzheimer's disease includes increased iron, alterations in protective enzymes, and markers of oxidative damage to proteins and lipids.  In this report, we demonstrate the presence of nitrotyrosine in neurofibrillary tangles of Alzheimer's disease.  Nitrotyrosine was not detected in controls lacking neurofibrillary tangles.  Immunolabeling was demonstrated to be specific nitrotyrosine in a series of control experiments.  These observations link oxidative stress with a key pathological lesion of Alzheimer's disease, the neurofibrillary tangle, and demonstrate a pathogenetic mechanism in common with the other major neurodegenerative diseases of aging, Parkinson's disease and amyotrophic lateral sclerosis.  These findings further implicate nitric oxide expression and excitotoxicity in the pathogenesis of cell death in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSwmVjLDGBOySm0e6ZOaemfW6udTcc2eYbNnPSGk1farntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK283nsFGntw%253D%253D&md5=2ba6b91dae67e7b0e1c66fcc74052acd</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGood%26aufirst%3DP.%2BF.%26aulast%3DWerner%26aufirst%3DP.%26aulast%3DHsu%26aufirst%3DA.%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26aulast%3DPerl%26aufirst%3DD.%2BP.%26atitle%3DEvidence%2520of%2520neuronal%2520oxidative%2520damage%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D1996%26volume%3D149%26spage%3D21%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Plaitakis, A.</span><span> </span><span class="NLM_article-title">Glutamate dysfunction and selective motor neuron degeneration inamyotrophic lateral sclerosis: a hypothesis</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1002%2Fana.410280103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=1973889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK3MXktVGqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1990&pages=3-8&author=A.+Plaitakis&title=Glutamate+dysfunction+and+selective+motor+neuron+degeneration+inamyotrophic+lateral+sclerosis%3A+a+hypothesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis:  a hypothesis</span></div><div class="casAuthors">Plaitakis, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">A review with 48 refs.  Recent studies have provided evidence for a generalized defect in glutamate metab. in patients with amyotrophic lateral sclerosis, assocd. with widespread alterations in the central nervous system levels of this excitatory amino acid putative transmitter.  Present data support the hypothesis that altered presynaptic glutamatergic mechanisms may be responsible for a neuroexcitotoxic cell loss in this disorder.  High local concns. of glycine, released from glycinergic terminals, may disrupt adaptive process contributing to abnormal potentiation of excitatory transmission mediated by glutamate receptors and resultant selective degeneration of motor neurons.  These considerations offer new therapeutic strategies for amyotrophic lateral sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpat2FGrhK0CrVg90H21EOLACvtfcHk0lgwJ4fj2F2BzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXktVGqtrY%253D&md5=36ed932b1059beeb64aebf44d979280e</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2Fana.410280103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410280103%26sid%3Dliteratum%253Aachs%26aulast%3DPlaitakis%26aufirst%3DA.%26atitle%3DGlutamate%2520dysfunction%2520and%2520selective%2520motor%2520neuron%2520degeneration%2520inamyotrophic%2520lateral%2520sclerosis%253A%2520a%2520hypothesis%26jtitle%3DAnn.%2520Neurol.%26date%3D1990%26volume%3D28%26spage%3D3%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Rothstein, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuncl, R. W.</span><span> </span><span class="NLM_article-title">Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">1464</span><span class="NLM_x">–</span> <span class="NLM_lpage">1468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1056%2FNEJM199205283262204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=1349424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADyaK383ksVejug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=1992&pages=1464-1468&author=J.+D.+Rothsteinauthor=L.+J.+Martinauthor=R.+W.+Kuncl&title=Decreased+glutamate+transport+by+the+brain+and+spinal+cord+in+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis</span></div><div class="casAuthors">Rothstein J D; Martin L J; Kuncl R W</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1464-8</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND:  Amyotrophic lateral sclerosis (ALS) is a chronic degenerative neurologic disorder characterized by the death of motor neurons in the cerebral cortex and spinal cord.  Recent studies have suggested that the metabolism of glutamate, a potentially neurotoxic amino acid, is abnormal in patients with ALS.  We hypothesized that the high-affinity glutamate transporter is the site of the defect.  METHODS:  We measured high-affinity, sodium-dependent glutamate transport in synaptosomes from neural tissue obtained from 13 patients with ALS, 17 patients with no neurologic disease, and 27 patients with other neuro-degenerative diseases (Alzheimer's disease in 15 patients and Huntington's disease in 12 patients).  The groups were comparable with respect to age and the interval between death and autopsy.  Synaptosomes were prepared from spinal cord, motor cortex, sensory cortex, visual cortex, striatum, and hippocampus.  We also measured sodium-dependent transport of gamma-aminobutyric acid and phenylalanine in the synaptosomal preparations.  RESULTS:  In patients with ALS, there was a marked decrease in the maximal velocity of transport for high-affinity glutamate uptake in synaptosomes from spinal cord (-59 percent, P less than 0.001), motor cortex (-70 percent, P less than 0.001), and somatosensory cortex (-39 percent, P less than 0.05), but not in those from visual cortex, striatum, or hippocampus.  The affinity of the transporter for glutamate was not altered.  No abnormalities in glutamate transport were found in synaptosomes from patients with other chronic neurodegenerative disorders.  The transport of gamma-aminobutyric acid and phenylalanine was normal in patients with ALS.  CONCLUSIONS:  ALS is associated with a defect in high-affinity glutamate transport that has disease, region, and chemical specificity.  Defects in the clearance of extracellular glutamate because of a faulty transporter could lead to neurotoxic levels of extracellular glutamate and thus be pathogenic in ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSb-TqizNGf3TQLBVDQn4bCfW6udTcc2eYbNnPSGk1farntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK383ksVejug%253D%253D&md5=ef942d464aa496ae655355af27de2e3a</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1056%2FNEJM199205283262204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199205283262204%26sid%3Dliteratum%253Aachs%26aulast%3DRothstein%26aufirst%3DJ.%2BD.%26aulast%3DMartin%26aufirst%3DL.%2BJ.%26aulast%3DKuncl%26aufirst%3DR.%2BW.%26atitle%3DDecreased%2520glutamate%2520transport%2520by%2520the%2520brain%2520and%2520spinal%2520cord%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1992%26volume%3D326%26spage%3D1464%26epage%3D1468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Rothstein, J.</span><span> </span><span class="NLM_article-title">Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Clin. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">348</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADyaK2s7ntlemsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1996&pages=348-359&author=J.+Rothstein&title=Excitotoxicity+and+neurodegeneration+in+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis</span></div><div class="casAuthors">Rothstein J D</div><div class="citationInfo"><span class="NLM_cas:title">Clinical neuroscience (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1995-1996</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">348-59</span>
        ISSN:<span class="NLM_cas:issn">1065-6766</span>.
    </div><div class="casAbstract">The pathogenesis of sporadic amyotrophic lateral sclerosis (ALS) is unknown, but several observations suggest that glutamate could participate in selective motor neuron degeneration.  Extracellular levels of glutamate are elevated in ALS.  Synaptic concentrations of glutamate are regulated by high-affinity glutamate transport, and defects in glutamate transport have also been observed in ALS tissue.  Three sodium-dependent glutamate transporters have now been identified: a neuronal transporter EAAC1, and two astroglial transporters GLT-1 and GLAST.  The defect in glutamate transport in ALS appears to be relatively specific for the GLT-1 subtype.  The role of chronic excess glutamate and glutamate transporter loss has been investigated in experimental paradigms, where it was found that excitotoxicity could account for selective motor neuron degeneration.  These culture paradigms have demonstrated that motor neurons are sensitive to glutamate toxicity via non-NMDA receptors and that various agents (e.g., antioxidants, glutamate release inhibitors, non-NMDA receptor antagonists) can be neuroprotective.  These experimental studies will provide a basis for understanding the primary and secondary role of glutamate in motor neuron death and will provide important insight into possible therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR-2zF9ydsEnb9KldV63DuefW6udTcc2eYbNnPSGk1farntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s7ntlemsg%253D%253D&md5=10245b0efe8fde472a6430d573d46a13</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRothstein%26aufirst%3DJ.%26atitle%3DExcitotoxicity%2520and%2520neurodegeneration%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DClin.%2520Neurosci.%26date%3D1996%26volume%3D3%26spage%3D348%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Kalia, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalia, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter, M. W.</span><span> </span><span class="NLM_article-title">NMDA receptors in clinical neurology: excitatory times ahead</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS1474-4422%2808%2970165-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=18635022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVSku7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=742-755&author=L.+V.+Kaliaauthor=S.+K.+Kaliaauthor=M.+W.+Salter&title=NMDA+receptors+in+clinical+neurology%3A+excitatory+times+ahead"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptors in clinical neurology: excitatory times ahead</span></div><div class="casAuthors">Kalia, Lorraine V.; Kalia, Suneil K.; Salter, Michael W.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">742-755</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Since the N-methyl-D-aspartate receptor (NMDAR) subunits were cloned less than two decades ago, a substantial amt. of research has been invested into understanding their physiol. function in the healthy CNS.  Research has also been directed at their pathol. roles in various neurol. diseases, including disorders resulting from acute excitotoxic insults (eg, ischemic stroke, traumatic brain injury), diseases due to chronic neurodegeneration (eg, Alzheimer's, Parkinson's, and Huntington's diseases and amyotrophic lateral sclerosis), disorders arising from sensitization of neurons (eg, epilepsy, neuropathic pain), and neurodevelopmental disorders assocd. with NMDAR hypofunction (eg, schizophrenia).  Selective NMDAR antagonists have not produced pos. results in clin. trials.  However, there are other NMDAR-targeted therapies used in current practice that are effective for treating some neurol. disorders.  In this Review, we describe the evidence for the use of these therapies and provide an overview of drugs being investigated in clin. trials.  We also discuss new NMDAR-targeted strategies in clin. neurol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosefSpb6NE_LVg90H21EOLACvtfcHk0lj_ZXdY3AUHQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVSku7rM&md5=add37ea63d62466ae78b939673339859</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2808%2970165-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252808%252970165-0%26sid%3Dliteratum%253Aachs%26aulast%3DKalia%26aufirst%3DL.%2BV.%26aulast%3DKalia%26aufirst%3DS.%2BK.%26aulast%3DSalter%26aufirst%3DM.%2BW.%26atitle%3DNMDA%2520receptors%2520in%2520clinical%2520neurology%253A%2520excitatory%2520times%2520ahead%26jtitle%3DLancet%2520Neurol.%26date%3D2008%26volume%3D7%26spage%3D742%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Monaghan, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irvine, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jane, D. E.</span><span> </span><span class="NLM_article-title">Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">581</span><span class="NLM_x">–</span> <span class="NLM_lpage">592</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.neuint.2012.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=22269804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVOrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=581-592&author=D.+T.+Monaghanauthor=M.+W.+Irvineauthor=B.+M.+Costaauthor=G.+Fangauthor=D.+E.+Jane&title=Pharmacological+modulation+of+NMDA+receptor+activity+and+the+advent+of+negative+and+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators</span></div><div class="casAuthors">Monaghan, Daniel T.; Irvine, Mark W.; Costa, Blaise Mathias; Fang, Guangyu; Jane, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">581-592</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The NMDA receptor (NMDAR) family of l-glutamate receptors are well known to have diverse roles in CNS function as well as in various neuropathol. and psychiatric conditions.  Until recently, the types of agents available to pharmacol. regulate NMDAR function have been quite limited in terms of mechanism of action and subtype selectivity.  This has changed significantly in the past two years.  The purpose of this review is to summarize the many drug classes now available for modulating NMDAR activity.  Previously, this included competitive antagonists at the l-glutamate and glycine binding sites, high and low affinity channel blockers, and GluN2B-selective N-terminal domain binding site antagonists.  More recently, we and others have identified new classes of NMDAR agents that are either pos. or neg. allosteric modulators (PAMs and NAMs, resp.).  These compds. include the pan potentiator UBP646, the GluN2A-selective potentiator/GluN2C and GluN2D inhibitor UBP512, the GluN2D-selective potentiator UBP551, the GluN2C/GluN2D-selective potentiator CIQ as well as the new NMDAR-NAMs such as the pan-inhibitor UBP618, the GluN2C/GluN2D-selective inhibitor QZN46 and the GluN2A inhibitors UBP608 and TCN201.  These new agents do not bind within the l-glutamate or glycine binding sites, the ion channel pore or the N-terminal regulatory domain.  Collectively, these new allosteric modulators appear to be acting at multiple novel sites on the NMDAR complex.  Importantly, these agents display improved subtype-selectivity and as NMDAR PAMs and NAMs, they represent a new generation of potential NMDAR therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbjX9esQoLw7Vg90H21EOLACvtfcHk0lj_ZXdY3AUHQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVOrsLk%253D&md5=451c3bb058975f210b9936e67079392f</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2012.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2012.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DMonaghan%26aufirst%3DD.%2BT.%26aulast%3DIrvine%26aufirst%3DM.%2BW.%26aulast%3DCosta%26aufirst%3DB.%2BM.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DJane%26aufirst%3DD.%2BE.%26atitle%3DPharmacological%2520modulation%2520of%2520NMDA%2520receptor%2520activity%2520and%2520the%2520advent%2520of%2520negative%2520and%2520positive%2520allosteric%2520modulators%26jtitle%3DNeurochem.%2520Int.%26date%3D2012%26volume%3D61%26spage%3D581%26epage%3D592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Evans, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, J.</span><span> </span><span class="NLM_article-title">The effects of a series of omega-phosphonic alpha-carboxylic amino acids on electrically evoked and excitant amino acid-induced responses in isolated spinal cord preparations</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1111%2Fj.1476-5381.1982.tb08758.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=7042024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaL38XktVShu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1982&pages=65-75&author=R.+Evansauthor=A.+Francisauthor=A.+Jonesauthor=D.+Smithauthor=J.+Watkins&title=The+effects+of+a+series+of+omega-phosphonic+alpha-carboxylic+amino+acids+on+electrically+evoked+and+excitant+amino+acid-induced+responses+in+isolated+spinal+cord+preparations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of a series of ω-phosphonic α-carboxylic amino acids on electrically evoked and excitant amino acid-induced responses in isolated spinal cord preparations</span></div><div class="casAuthors">Evans, R. H.; Francis, A. A.; Jones, A. W.; Smith, D. A. S.; Watkins, J. C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-75</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">The depressant actions on evoked elec. activity and the excitant amino acid antagonist properties of a range of ω-phosphonic α-carboxylic amino acids ranging from 2-amino-3-phosphonopropionic acid  [5652-28-8] to 2-amino-8-phosphonooctanoic acid  [98517-63-6] were examd. in frog and rat isolated spinal cord prepns.  The results are discussed in relation to structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDFJha1E6AJ7Vg90H21EOLACvtfcHk0lj_ZXdY3AUHQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XktVShu70%253D&md5=71d6e95f4ca1fbc352e5347e265c661e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1982.tb08758.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1982.tb08758.x%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DR.%26aulast%3DFrancis%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DWatkins%26aufirst%3DJ.%26atitle%3DThe%2520effects%2520of%2520a%2520series%2520of%2520omega-phosphonic%2520alpha-carboxylic%2520amino%2520acids%2520on%2520electrically%2520evoked%2520and%2520excitant%2520amino%2520acid-induced%2520responses%2520in%2520isolated%2520spinal%2520cord%2520preparations%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1982%26volume%3D75%26spage%3D65%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Ogden, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span> </span><span class="NLM_article-title">New advances in NMDA receptor pharmacology</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">726</span><span class="NLM_x">–</span> <span class="NLM_lpage">733</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=726-733&author=K.+K.+Ogdenauthor=S.+F.+Traynelis&title=New+advances+in+NMDA+receptor+pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DNew%2520advances%2520in%2520NMDA%2520receptor%2520pharmacology%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2011%26volume%3D32%26spage%3D726%26epage%3D733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Löschmann, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jähnig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wachtel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, C.</span><span> </span><span class="NLM_article-title">Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-dopa in models of Parkinson’s disease</span> <span class="citation_source-journal">J. Neural Transm.: Parkinson’s Dis. Dementia Sect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1007%2FBF02259538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=1835581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADyaK38%252FmvVegsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1991&pages=203-213&author=P.+A.+L%C3%B6schmannauthor=K.+Langeauthor=M.+Kunowauthor=K.+J.+Rettigauthor=P.+J%C3%A4hnigauthor=T.+Honoreauthor=L.+Turskiauthor=H.+Wachtelauthor=P.+Jennerauthor=C.+Marsden&title=Synergism+of+the+AMPA-antagonist+NBQX+and+the+NMDA-antagonist+CPP+with+L-dopa+in+models+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-dopa in models of Parkinson's disease</span></div><div class="casAuthors">Loschmann P A; Lange K W; Kunow M; Rettig K J; Jahnig P; Honore T; Turski L; Wachtel H; Jenner P; Marsden C D</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neural transmission. Parkinson's disease and dementia section</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-13</span>
        ISSN:<span class="NLM_cas:issn">0936-3076</span>.
    </div><div class="casAbstract">Degeneration of dopaminergic nigrostriatal neurons in Parkinson's disease results in an overactivity of excitatory glutamatergic projections from the subthalamic nucleus to the output nuclei of the basal ganglia resulting in rigidity and akinesia.  In theory pharmacological blockade of these overactive systems should improve parkinsonian symptomatology.  The selective AMPA-antagonist NBQX and the competitive NMDA-antagonist CPP are not effective in animal models of Parkinson's disease when given alone but ameliorate parkinsonian symptomatology and stimulate locomotor activity when co-administered with a threshold dose of L-Dopa.  These synergistic effects are seen in the MPTP-treated (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) common marmoset and the rat with unilateral 6-hydroxydopamine (6-OHDA) lesions of the substantia nigra.  Therefore competitive NMDA and non-NMDA antagonists may offer a new therapeutic strategy for the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRgJ6XegtVkhP6BottYdIAWfW6udTcc2eZBo27ZM_BY3Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38%252FmvVegsw%253D%253D&md5=3fa0154e1867b5f84b48897fb2409be1</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2FBF02259538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02259538%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6schmann%26aufirst%3DP.%2BA.%26aulast%3DLange%26aufirst%3DK.%26aulast%3DKunow%26aufirst%3DM.%26aulast%3DRettig%26aufirst%3DK.%2BJ.%26aulast%3DJ%25C3%25A4hnig%26aufirst%3DP.%26aulast%3DHonore%26aufirst%3DT.%26aulast%3DTurski%26aufirst%3DL.%26aulast%3DWachtel%26aufirst%3DH.%26aulast%3DJenner%26aufirst%3DP.%26aulast%3DMarsden%26aufirst%3DC.%26atitle%3DSynergism%2520of%2520the%2520AMPA-antagonist%2520NBQX%2520and%2520the%2520NMDA-antagonist%2520CPP%2520with%2520L-dopa%2520in%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neural%2520Transm.%253A%2520Parkinson%25E2%2580%2599s%2520Dis.%2520Dementia%2520Sect.%26date%3D1991%26volume%3D3%26spage%3D203%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Veender, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J. C.</span><span> </span><span class="NLM_article-title">NMDA receptors: the first decade</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1994&pages=341-354&author=J.+R.+Veenderauthor=S.+N.+Nairauthor=J.+C.+Lehmann&title=NMDA+receptors%3A+the+first+decade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVeender%26aufirst%3DJ.%2BR.%26aulast%3DNair%26aufirst%3DS.%2BN.%26aulast%3DLehmann%26aufirst%3DJ.%2BC.%26atitle%3DNMDA%2520receptors%253A%2520the%2520first%2520decade%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D1994%26volume%3D3%26spage%3D341%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Bräuner-Osborne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egebjerg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krogsgaard-Larsen, P.</span><span> </span><span class="NLM_article-title">Ligands for glutamate receptors: design and therapeutic prospects</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2609</span><span class="NLM_x">–</span> <span class="NLM_lpage">2645</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000007r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2609-2645&author=H.+Br%C3%A4uner-Osborneauthor=J.+Egebjergauthor=E.+O.+Nielsenauthor=U.+Madsenauthor=P.+Krogsgaard-Larsen&title=Ligands+for+glutamate+receptors%3A+design+and+therapeutic+prospects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm000007r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000007r%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25A4uner-Osborne%26aufirst%3DH.%26aulast%3DEgebjerg%26aufirst%3DJ.%26aulast%3DNielsen%26aufirst%3DE.%2BO.%26aulast%3DMadsen%26aufirst%3DU.%26aulast%3DKrogsgaard-Larsen%26aufirst%3DP.%26atitle%3DLigands%2520for%2520glutamate%2520receptors%253A%2520design%2520and%2520therapeutic%2520prospects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2609%26epage%3D2645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Lehmann, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, P. L.</span><span> </span><span class="NLM_article-title">7-Chlorokynurenate prevents NMDA-induced and kainate-induced striatal lesions</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">620</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2F0006-8993%2893%2990263-M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=7691379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK3sXltlWnsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=620&publication_year=1993&pages=1-6&author=J.+C.+Lehmannauthor=P.+L.+Wood&title=7-Chlorokynurenate+prevents+NMDA-induced+and+kainate-induced+striatal+lesions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">7-Chlorokynurenate prevents NMDA-induced and kainate-induced striatal lesions</span></div><div class="casAuthors">Lehmann, John C.; Procureur, Dominique; Wood, Paul L.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">620</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">NMDA-induced lesions of striatal cholinergic interneurons were attenuated by 7-chlorokynurenate (7-ClKyn), an antagonist of the glycine site of the NMDA receptor complex.  However, it was not possible to demonstrate clearly that the mechanism of action of 7-ClKyn was in fact antagonism of the glycine site.  Thus, the agonists at the glycine site, D-serine and 1-aminocyclopropane-1-carboxylic acid, failed to reverse the protection afforded by 7-ClKyn.  Finally, 7-ClKyn also protected against lesions produced by kainate.  The selectivity of 7-ClKyn under intracerebral administration is apparently insufficient for detg. the role of the glycine site in NMDA-receptor mediated excitotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmvBEiGApML7Vg90H21EOLACvtfcHk0liQXCcton10fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltlWnsL0%253D&md5=cc73ae0162f9ae3221dcecea2a6eef80</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2893%2990263-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252893%252990263-M%26sid%3Dliteratum%253Aachs%26aulast%3DLehmann%26aufirst%3DJ.%2BC.%26aulast%3DWood%26aufirst%3DP.%2BL.%26atitle%3D7-Chlorokynurenate%2520prevents%2520NMDA-induced%2520and%2520kainate-induced%2520striatal%2520lesions%26jtitle%3DBrain%2520Res.%26date%3D1993%26volume%3D620%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Wong, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priestley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodruff, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iversen, L. L.</span><span> </span><span class="NLM_article-title">The anticonvulsant MK-801 is a potent <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate antagonist</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">7104</span><span class="NLM_x">–</span> <span class="NLM_lpage">7108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1986&pages=7104-7108&author=E.+Wongauthor=J.+A.+Kempauthor=T.+Priestleyauthor=A.+R.+Knightauthor=G.+N.+Woodruffauthor=L.+L.+Iversen&title=The+anticonvulsant+MK-801+is+a+potent+N-methyl-d-aspartate+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DE.%26aulast%3DKemp%26aufirst%3DJ.%2BA.%26aulast%3DPriestley%26aufirst%3DT.%26aulast%3DKnight%26aufirst%3DA.%2BR.%26aulast%3DWoodruff%26aufirst%3DG.%2BN.%26aulast%3DIversen%26aufirst%3DL.%2BL.%26atitle%3DThe%2520anticonvulsant%2520MK-801%2520is%2520a%2520potent%2520N-methyl-d-aspartate%2520antagonist%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1986%26volume%3D83%26spage%3D7104%26epage%3D7108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Marin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engber, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonastre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolosa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, T.</span><span> </span><span class="NLM_article-title">MK-801 prevents levodopa-induced motor response alterations in parkinsonian rats</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">736</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2F0006-8993%2896%2900693-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=8930325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK28XmtV2jsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=736&publication_year=1996&pages=202-205&author=C.+Marinauthor=S.+Papaauthor=T.+M.+Engberauthor=M.+Bonastreauthor=E.+Tolosaauthor=T.+Chase&title=MK-801+prevents+levodopa-induced+motor+response+alterations+in+parkinsonian+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">MK-801 prevents levodopa-induced motor response alterations in parkinsonian rats</span></div><div class="casAuthors">Marin, Concepcio; Papa, Stella; Engber, Thomas M.; Bonastre, Merce; Tolosa, Eduardo; Chase, T. N.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">736</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">202-205</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The systemic administration of the N-methyl-D-aspartate (NMDA) receptor antagonist, MK801 ((+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine), has previously been found to reverse the motor response alterations that develop during long-term levodopa treatment of parkinsonian rats.  To det. whether co-administration of MK801 with levodopa might prevent the initial appearance of these response changes, rats, rendered parkinsonian by a 6-hydroxydopamine lesion of the medial forebrain bundle, received either levodopa alone or levodopa with the NMDA receptor antagonist.  After four weeks of treatment with levodopa alone, the duration of the turning response declined by 37 (P<0.05) and the no. of ineffectual levodopa injections had more than doubled (P<0.05).  MK801 co-treatment completely blocked the shortening in response duration and prevented the frequency of ineffectual levodopa injection from exceeding baseline levels in animals receiving levodopa alone.  The total magnitude of the turning response to levodopa was not affected.  These results suggest that NMDA receptor blockade may act prophylactically to prevent the appearance of motor response alterations in levodopa-treated parkinsonian rodents that resemble those occurring in levodopa-treated patients with Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbcHFV0esxAbVg90H21EOLACvtfcHk0ljuKwsF0Qx14Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmtV2jsrw%253D&md5=07f0dfd622fd5733648fc6264f27f8ee</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2896%2900693-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252896%252900693-2%26sid%3Dliteratum%253Aachs%26aulast%3DMarin%26aufirst%3DC.%26aulast%3DPapa%26aufirst%3DS.%26aulast%3DEngber%26aufirst%3DT.%2BM.%26aulast%3DBonastre%26aufirst%3DM.%26aulast%3DTolosa%26aufirst%3DE.%26aulast%3DChase%26aufirst%3DT.%26atitle%3DMK-801%2520prevents%2520levodopa-induced%2520motor%2520response%2520alterations%2520in%2520parkinsonian%2520rats%26jtitle%3DBrain%2520Res.%26date%3D1996%26volume%3D736%26spage%3D202%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Chen, H. S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, S. A.</span><span> </span><span class="NLM_article-title">The chemical biology of clinically tolerated NMDA receptor antagonists</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">1611</span><span class="NLM_x">–</span> <span class="NLM_lpage">1626</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1111%2Fj.1471-4159.2006.03991.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=16805772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnt1Ons7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2006&pages=1611-1626&author=H.+S.+V.+Chenauthor=S.+A.+Lipton&title=The+chemical+biology+of+clinically+tolerated+NMDA+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The chemical biology of clinically tolerated NMDA receptor antagonists</span></div><div class="casAuthors">Chen, Huei-Sheng Vincent; Lipton, Stuart A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1611-1626</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Most neuroprotective drugs have failed in clin. trials because of side-effects, causing normal brain function to become compromised.  A case in point concerns antagonists of the N-methyl-D-aspartate type of glutamate receptor (NMDAR).  Glutamate receptors are essential to the normal function of the central nervous system.  However, their excessive activation by excitatory amino acids, such as glutamate itself, is thought to contribute to neuronal damage in many neurol. disorders ranging from acute hypoxic-ischemic brain injury to chronic neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis.  The dual role of NMDARs in particular for normal and abnormal functioning of the nervous system imposes important constraints on possible therapeutic strategies aimed at ameliorating neurol. diseases.  Blockade of excessive NMDAR activity must therefore be achieved without interference with its normal function.  In general, NMDAR antagonists can be categorized pharmacol. according to the site of action on the receptor-channel complex.  These include drugs acting at the agonist (NMDA) or co-agonist (glycine) sites, channel pore, and modulatory sites, such as the S-nitrosylation site where nitric oxide (NO) reacts with crit. cysteine thiol groups.  Because glutamate is thought to be the major excitatory transmitter in the brain, generalized inhibition of a glutamate receptor subtype like the NMDAR causes side-effects that clearly limit the potential for clin. applications.  Both competitive NMDA and glycine antagonists, even although effective in preventing glutamate-mediated neurotoxicity, will cause generalized inhibition of NMDAR activities and thus have failed in many clin. trials.  Open-channel block with the property of uncompetitive antagonism is the most appealing strategy for therapeutic intervention during excessive NMDAR activation as this action of blockade requires prior activation of the receptor.  This property, in theory, leads to a higher degree of channel blockade in the presence of excessive levels of glutamate and little blockade at relatively lower levels, for example, during physiol. neurotransmission.  Utilizing this mol. strategy of action, we review here the logical process that we applied over the past decade to help develop memantine as the first clin. tolerated yet effective agent against NMDAR-mediated neurotoxicity.  Phase 3 (final) clin. trials have shown that memantine is effective in treating moderate-to-severe Alzheimer's disease while being well tolerated.  Memantine is also currently in trials for addnl. neurol. disorders, including other forms of dementia, glaucoma, and severe neuropathic pain.  Addnl., taking advantage of memantine's preferential binding to open channels and the fact that excessive NMDAR activity can be down-regulated by S-nitrosylation, we have recently developed combinatorial drugs called NitroMemantines.  These drugs use memantine as a homing signal to target NO to hyperactivated NMDARs in order to avoid systemic side-effects of NO such as hypotension (low blood pressure).  These second-generation memantine derivs. are designed as pathol. activated therapeutics, and in preliminary studies appear to have even greater neuroprotective properties than memantine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCWEVOUjqGi7Vg90H21EOLACvtfcHk0ljuKwsF0Qx14Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnt1Ons7o%253D&md5=2ba27dcb5100dd829611db45bc9cd0f7</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.03991.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.03991.x%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%2BS.%2BV.%26aulast%3DLipton%26aufirst%3DS.%2BA.%26atitle%3DThe%2520chemical%2520biology%2520of%2520clinically%2520tolerated%2520NMDA%2520receptor%2520antagonists%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D97%26spage%3D1611%26epage%3D1626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Crossman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peggs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luquin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambrook, M.</span><span> </span><span class="NLM_article-title">Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkey</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1271</span><span class="NLM_x">–</span> <span class="NLM_lpage">1273</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1989&pages=1271-1273&author=A.+Crossmanauthor=D.+Peggsauthor=S.+Boyceauthor=M.+Luquinauthor=M.+Sambrook&title=Effect+of+the+NMDA+antagonist+MK-801+on+MPTP-induced+parkinsonism+in+the+monkey"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrossman%26aufirst%3DA.%26aulast%3DPeggs%26aufirst%3DD.%26aulast%3DBoyce%26aufirst%3DS.%26aulast%3DLuquin%26aufirst%3DM.%26aulast%3DSambrook%26aufirst%3DM.%26atitle%3DEffect%2520of%2520the%2520NMDA%2520antagonist%2520MK-801%2520on%2520MPTP-induced%2520parkinsonism%2520in%2520the%2520monkey%26jtitle%3DNeuropharmacology%26date%3D1989%26volume%3D28%26spage%3D1271%26epage%3D1273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Blanpied, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. W.</span><span> </span><span class="NLM_article-title">Amantadine inhibits NMDA receptors by accelerating channel closure during channel block</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">3312</span><span class="NLM_x">–</span> <span class="NLM_lpage">3322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1523%2FJNEUROSCI.4262-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=15800186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlSmsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=3312-3322&author=T.+A.+Blanpiedauthor=R.+J.+Clarkeauthor=J.+W.+Johnson&title=Amantadine+inhibits+NMDA+receptors+by+accelerating+channel+closure+during+channel+block"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Amantadine inhibits NMDA receptors by accelerating channel closure during channel block</span></div><div class="casAuthors">Blanpied, Thomas A.; Clarke, Richard J.; Johnson, Jon W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3312-3322</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The channel of NMDA receptors is blocked by a wide variety of drugs.  NMDA receptor channel blockers include drugs of abuse that induce psychotic behavior, such as phencyclidine, and drugs with wide therapeutic utility, such as amantadine and memantine.  We describe here the mol. mechanism of amantadine inhibition.  In contrast to most other described channel-blocking mols., amantadine causes the channel gate of NMDA receptors to close more quickly.  Our results confirm that amantadine binding inhibits current flow through NMDA receptor channels but show that its main inhibitory action at pharmaceutically relevant concns. results from stabilization of closed states of the channel.  The surprising variation in the clin. utility of NMDA channel blockers may in part derive from their diverse effects on channel gating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSq2CI2BASrrVg90H21EOLACvtfcHk0ljuKwsF0Qx14Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlSmsbY%253D&md5=25c2c601163f84bd8fe56ff1dbe0be87</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4262-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4262-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DBlanpied%26aufirst%3DT.%2BA.%26aulast%3DClarke%26aufirst%3DR.%2BJ.%26aulast%3DJohnson%26aufirst%3DJ.%2BW.%26atitle%3DAmantadine%2520inhibits%2520NMDA%2520receptors%2520by%2520accelerating%2520channel%2520closure%2520during%2520channel%2520block%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D3312%26epage%3D3322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Uitti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajput, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlskog, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offord, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajput, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basran, P.</span><span> </span><span class="NLM_article-title">Amantadine treatment is an independent predictor of improved survival in Parkinson’s disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1551</span><span class="NLM_x">–</span> <span class="NLM_lpage">1556</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1996&pages=1551-1556&author=R.+Uittiauthor=A.+Rajputauthor=J.+Ahlskogauthor=K.+Offordauthor=D.+Schroederauthor=M.+Hoauthor=M.+Prasadauthor=A.+Rajputauthor=P.+Basran&title=Amantadine+treatment+is+an+independent+predictor+of+improved+survival+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUitti%26aufirst%3DR.%26aulast%3DRajput%26aufirst%3DA.%26aulast%3DAhlskog%26aufirst%3DJ.%26aulast%3DOfford%26aufirst%3DK.%26aulast%3DSchroeder%26aufirst%3DD.%26aulast%3DHo%26aufirst%3DM.%26aulast%3DPrasad%26aufirst%3DM.%26aulast%3DRajput%26aufirst%3DA.%26aulast%3DBasran%26aufirst%3DP.%26atitle%3DAmantadine%2520treatment%2520is%2520an%2520independent%2520predictor%2520of%2520improved%2520survival%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D1996%26volume%3D46%26spage%3D1551%26epage%3D1556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Metman, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotto, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natte, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Munckhof, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, T.</span><span> </span><span class="NLM_article-title">Dextromethorphan improves levodopa-induced dyskinesias in Parkinson’s disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1998&pages=203-206&author=V.+L.+Metmanauthor=D.+P.+Dottoauthor=R.+Natteauthor=P.+Van+den+Munckhofauthor=T.+Chase&title=Dextromethorphan+improves+levodopa-induced+dyskinesias+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMetman%26aufirst%3DV.%2BL.%26aulast%3DDotto%26aufirst%3DD.%2BP.%26aulast%3DNatte%26aufirst%3DR.%26aulast%3DVan%2Bden%2BMunckhof%26aufirst%3DP.%26aulast%3DChase%26aufirst%3DT.%26atitle%3DDextromethorphan%2520improves%2520levodopa-induced%2520dyskinesias%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D1998%26volume%3D51%26spage%3D203%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Metman, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Dotto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LePoole, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konitsiotis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, T. N.</span><span> </span><span class="NLM_article-title">Amantadine for levodopa-induced dyskinesias: a 1-year follow-up study</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1383</span><span class="NLM_x">–</span> <span class="NLM_lpage">1386</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1001%2Farchneur.56.11.1383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=10555659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD3c%252Fit1Grtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1999&pages=1383-1386&author=L.+V.+Metmanauthor=P.+Del+Dottoauthor=K.+LePooleauthor=S.+Konitsiotisauthor=J.+Fangauthor=T.+N.+Chase&title=Amantadine+for+levodopa-induced+dyskinesias%3A+a+1-year+follow-up+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Amantadine for levodopa-induced dyskinesias: a 1-year follow-up study</span></div><div class="casAuthors">Metman L V; Del Dotto P; LePoole K; Konitsiotis S; Fang J; Chase T N</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1383-6</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">BACKGROUND:  In a recent acute study, amantadine was found to have antidyskinetic effect against levodopa-induced motor complications in patients with Parkinson disease.  The longevity of this effect was not addressed but is of interest in light of the controversy in the literature regarding the duration of amantadine's well-established antiparkinsonian action.  OBJECTIVE:  To determine the duration of the antidyskinetic effect of amantadine in advanced Parkinson disease.  DESIGN:  One year after completion of an acute, double-blind, placebo-controlled, crossover study, patients returned for re-evaluation of motor symptoms and dyskinesias using a nonrandomized, double-blind, placebo-controlled follow-up paradigm.  SETTING:  National Institutes of Health Clinical Center.  PATIENTS:  Seventeen of the original 18 patients with advanced Parkinson disease complicated by dyskinesias and motor fluctuations participated in this study; 1 was lost to follow-up.  Thirteen of the 17 individuals had remained on amantadine therapy for the entire year.  INTERVENTIONS:  Ten days prior to the follow-up assessment, amantadine was replaced with identical capsules containing either amantadine or placebo.  MAIN OUTCOME MEASURES:  Parkinsonian symptoms and dyskinesia severity were scored using standard rating scales, while subjects received steady-state intravenous levodopa infusions at the same rate as 1 year earlier.  RESULTS:  One year after initiation of amantadine cotherapy, its antidyskinetic effect was similar in magnitude (56% reduction in dyskinesia compared with 60% 1 year earlier).  Motor complications occurring with the patients' regular oral levodopa regimen also remained improved according to the Unified Parkinson's Disease Rating Scale (UPDRS-IV).  CONCLUSION:  The beneficial effects of amantadine on motor response complications are maintained for at least 1 year after treatment initiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgPRDOnNPw9wpJitSxOdIlfW6udTcc2eb286iY6UYHuLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c%252Fit1Grtw%253D%253D&md5=1de1d65f8e90f9e5fdc70b2c8c2020e2</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1001%2Farchneur.56.11.1383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.56.11.1383%26sid%3Dliteratum%253Aachs%26aulast%3DMetman%26aufirst%3DL.%2BV.%26aulast%3DDel%2BDotto%26aufirst%3DP.%26aulast%3DLePoole%26aufirst%3DK.%26aulast%3DKonitsiotis%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DChase%26aufirst%3DT.%2BN.%26atitle%3DAmantadine%2520for%2520levodopa-induced%2520dyskinesias%253A%2520a%25201-year%2520follow-up%2520study%26jtitle%3DArch.%2520Neurol.%26date%3D1999%26volume%3D56%26spage%3D1383%26epage%3D1386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Crosby, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deane, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, C.</span><span> </span><span class="NLM_article-title">Amantadine for dyskinesia in Parkinson’s disease</span> <span class="citation_source-journal">Cochrane Database Syst. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=1-14&author=N.+Crosbyauthor=K.+Deaneauthor=C.+Clarke&title=Amantadine+for+dyskinesia+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrosby%26aufirst%3DN.%26aulast%3DDeane%26aufirst%3DK.%26aulast%3DClarke%26aufirst%3DC.%26atitle%3DAmantadine%2520for%2520dyskinesia%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2003%26volume%3D2%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Shoulson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwid, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenamyre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siderowf, A.</span><span> </span><span class="NLM_article-title">A randomized, controlled trial of remacemide for motor fluctuations in Parkinson’s disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2001&pages=455-462&author=I.+Shoulsonauthor=J.+Penneyauthor=M.+McDermottauthor=S.+Schwidauthor=E.+Kaysonauthor=T.+Chaseauthor=S.+Fahnauthor=J.+Greenamyreauthor=A.+Langauthor=A.+Siderowf&title=A+randomized%2C+controlled+trial+of+remacemide+for+motor+fluctuations+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShoulson%26aufirst%3DI.%26aulast%3DPenney%26aufirst%3DJ.%26aulast%3DMcDermott%26aufirst%3DM.%26aulast%3DSchwid%26aufirst%3DS.%26aulast%3DKayson%26aufirst%3DE.%26aulast%3DChase%26aufirst%3DT.%26aulast%3DFahn%26aufirst%3DS.%26aulast%3DGreenamyre%26aufirst%3DJ.%26aulast%3DLang%26aufirst%3DA.%26aulast%3DSiderowf%26aufirst%3DA.%26atitle%3DA%2520randomized%252C%2520controlled%2520trial%2520of%2520remacemide%2520for%2520motor%2520fluctuations%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D2001%26volume%3D56%26spage%3D455%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Lipton, S. A.</span><span> </span><span class="NLM_article-title">Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">160</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnrd1958" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=16424917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslaquro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=160-170&author=S.+A.+Lipton&title=Paradigm+shift+in+neuroprotection+by+NMDA+receptor+blockade%3A+memantine+and+beyond"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond</span></div><div class="casAuthors">Lipton, Stuart A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">160-170</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Neuroprotective drugs tested in clin. trials, particularly those that block N-methyl-D-aspartate-sensitive glutamate receptors (NMDARs), have failed miserably in large part because of intolerable side effects.  However, one such drug, memantine, was recently approved by the European Union and the US FDA for the treatment of dementia following our group's discovery of its clin. tolerated mechanism of action.  Here, we review the mol. basis for memantine efficacy in neurol. diseases that are mediated, at least in part, by overactivation of NMDARs, producing excessive Ca2+ influx through the receptor's assocd. ion channel and consequent free-radical formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDq-DUijWIWbVg90H21EOLACvtfcHk0lgkn2IqrI5vTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslaquro%253D&md5=14bc9411b6a2b539aaef36aed789eaf8</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fnrd1958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1958%26sid%3Dliteratum%253Aachs%26aulast%3DLipton%26aufirst%3DS.%2BA.%26atitle%3DParadigm%2520shift%2520in%2520neuroprotection%2520by%2520NMDA%2520receptor%2520blockade%253A%2520memantine%2520and%2520beyond%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D160%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Ferris, S. H.</span><span> </span><span class="NLM_article-title">Evaluation of memantine for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2305</span><span class="NLM_x">–</span> <span class="NLM_lpage">2313</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1517%2F14656566.4.12.2305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=14640929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlemu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=2305-2313&author=S.+H.+Ferris&title=Evaluation+of+memantine+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of memantine for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Ferris, Steven H.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2305-2313</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Increasing evidence suggests that disturbances in glutamatergic activity play an important role in Alzheimer's disease (AD).  Excessive glutamate-mediated activation of NMDA receptors, for example, may contribute to the neuronal death that characterizes AD.  On the other hand, physiol. activation of the NMDA receptor appears necessary for normal cognitive function.  Therefore, compds. that finely modulate NMDA receptor activity hold promise as treatments for AD.  Memantine is a low-moderate affinity, uncompetitive NMDA-receptor antagonist that appears to block pathol., but not physiol., activation of the NMDA receptor.  Consequently, therapeutic doses of the drug are well-tolerated and do not seem to interfere with the acquisition or processing of cognitive information.  Memantine has been shown to improve symptoms and reduce the rate of clin. deterioration among patients with moderate-to-severe AD and was approved in the US for this indication in Oct. 2003.  This review provides a brief rationale for the development of memantine as a therapy for AD, as well as an overview of the pharmacol., clin. efficacy, safety and tolerability of this novel therapeutic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNYUSq0TIr0bVg90H21EOLACvtfcHk0lgkn2IqrI5vTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlemu78%253D&md5=495fec335eb670f61900aa37b0b7707d</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1517%2F14656566.4.12.2305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.4.12.2305%26sid%3Dliteratum%253Aachs%26aulast%3DFerris%26aufirst%3DS.%2BH.%26atitle%3DEvaluation%2520of%2520memantine%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2003%26volume%3D4%26spage%3D2305%26epage%3D2313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Herrmann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanctoot, K.</span><span> </span><span class="NLM_article-title">Memantine in dementia: a review of the current evidence</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">800</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1517%2F14656566.2011.558006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=21385152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivFWitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=787-800&author=N.+Herrmannauthor=A.+Liauthor=K.+Lanctoot&title=Memantine+in+dementia%3A+a+review+of+the+current+evidence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Memantine in dementia: a review of the current evidence</span></div><div class="casAuthors">Herrmann, Nathan; Li, Abby; Lanctoot, Krista</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">787-800</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  As the world's population ages, the incidence of Alzheimer's disease (AD) is projected to double every 20 years.  Understanding the pathogenesis of AD and developing effective treatments is a public health imperative.  Memantine is a low- to moderate-affinity, non-competitive NMDA receptor antagonist that is currently approved for the treatment of moderate to severe AD.  We discuss the current evidence, emphasizing more recent studies examg. the effects of memantine in AD.  We also look at the gaps in the current knowledge; the studies that will be required to fill these gaps are also discussed.  The present paper reviews: the pharmacol. of memantine; evidence for its use in moderate to severe AD, as well as in mild to moderate AD; adverse events related to memantine use; its effects specifically on behaviors including aggression and agitation; the pharmacoeconomics of memantine; and the use of memantine in other dementias.  Memantine has shown modest benefits in cognition, function, global and behavioral measures, and has shown little potential for drug-drug interactions.  For the treatment of moderate to severe AD, memantine should be offered as a therapeutic option, either on its own, or in combination with a cholinesterase inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryDfWm9U4acLVg90H21EOLACvtfcHk0lgkn2IqrI5vTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivFWitrc%253D&md5=e333d89fd45b6c8fad73d7998e186a63</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1517%2F14656566.2011.558006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2011.558006%26sid%3Dliteratum%253Aachs%26aulast%3DHerrmann%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DLanctoot%26aufirst%3DK.%26atitle%3DMemantine%2520in%2520dementia%253A%2520a%2520review%2520of%2520the%2520current%2520evidence%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2011%26volume%3D12%26spage%3D787%26epage%3D800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Lipton, S. A.</span><span> </span><span class="NLM_article-title">Pathologically activated therapeutics for neuroprotection</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">803</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnrn2229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=17882256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKht77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=803-808&author=S.+A.+Lipton&title=Pathologically+activated+therapeutics+for+neuroprotection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Pathologically activated therapeutics for neuroprotection</span></div><div class="casAuthors">Lipton, Stuart A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">803-808</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Many drugs that have been developed to treat neurodegenerative diseases fail to gain approval for clin. use because they are not well tolerated in humans.  In this article, I describe a series of strategies for the development of neuroprotective therapeutics that are both effective and well tolerated.  These strategies are based on the principle that drugs should be activated by the pathol. state that they are intended to inhibit.  This approach has already met with success, and has led to the development of the potentially neuroprotective drug memantine, an N-methyl-D-aspartate (NMDA)-type and glutamate receptor antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-chT-qiedELVg90H21EOLACvtfcHk0lgkn2IqrI5vTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKht77N&md5=07391644bbd0a7ab6f8cf6f2803fd97f</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1038%2Fnrn2229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2229%26sid%3Dliteratum%253Aachs%26aulast%3DLipton%26aufirst%3DS.%2BA.%26atitle%3DPathologically%2520activated%2520therapeutics%2520for%2520neuroprotection%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2007%26volume%3D8%26spage%3D803%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Williams, K.</span><span> </span><span class="NLM_article-title">Ifenprodil discriminates subtypes of the <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">851</span><span class="NLM_x">–</span> <span class="NLM_lpage">859</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=7901753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK2cXitlCnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1993&pages=851-859&author=K.+Williams&title=Ifenprodil+discriminates+subtypes+of+the+N-methyl-d-aspartate+receptor%3A+selectivity+and+mechanisms+at+recombinant+heteromeric+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: Selectivity and mechanisms at recombinant heteromeric receptors</span></div><div class="casAuthors">Williams, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">851-9</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">The effects of the atypical N-methyl-D-aspartate (NMDA) receptor antagonist ifenprodil were studied by voltage-clamp recording of Xenopus oocytes expressing heteromeric NMDA receptors from cloned NR1 and NR2 subunit RNAs.  In oocytes voltage-clamped at -70 mV, ifenprodil inhibited NMDA-induced currents at NR1A/NR2B receptors with high affinity (IC50 = 0.34 μM).  The affinity of NR1A/NR2A receptors for ifenprodil (IC50 = 146 μM) was 400-fold lower than that of NR1A/NR2B receptors.  The rate of onset of inhibition by low concns. of ifenprodil acting at NR1A/NR2B receptors was considerably slower than the onset of inhibition seen with high concns. of ifenprodil acting at NR1A/NR2A receptors.  The onset and recovery of blockade by ifenprodil at NR1A/NR2B receptors were not activity dependent.  The inhibitory effects of low concns. of ifenprodil at NR1A/NR2B receptors were not voltage dependent.  In contrast, the inhibitory effects of high concns. of ifenprodil at NR1A/NR2A receptors were partially voltage dependent, and a greater inhibition of NMDA-induced currents was seen at hyperpolarized membrane potentials than at depolarized membrane potentials.  The reversal potential of NMDA currents was not altered in the presence of ifenprodil.  Ifenprodil may act as a weak open-channel blocker of NR1A/NR2A receptors.  The degree of inhibition seen with 100 μM ifenprodil at NR1A/NR2A receptors was not altered by changes in the concn. of extracellular glycine.  However, the inhibitory effect of 1 μM ifenprodil at NR1A/NR2B receptors was reduced by increasing the concn. of glycine.  Thus, part of the mechanism of action of ifenprodil at NR1A/NR2B receptors may involve noncompetitive antagonism of the effects of glycine.  Apparently, the mechanism of action of ifenprodil, as well as the potency of this antagonist, is different at NR1A/NR2B and NR1A/NR2A receptors expressed in Xenopus oocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoffD1y7apqXrVg90H21EOLACvtfcHk0ljKc2kJRgOgng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlCnsw%253D%253D&md5=27f84915114a10b17c5f5c02740d84f8</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DK.%26atitle%3DIfenprodil%2520discriminates%2520subtypes%2520of%2520the%2520N-methyl-d-aspartate%2520receptor%253A%2520selectivity%2520and%2520mechanisms%2520at%2520recombinant%2520heteromeric%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D1993%26volume%3D44%26spage%3D851%26epage%3D859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Tahirovic, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geballe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruszecka-Kowalik, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyuboslavsky, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">French, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irier, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easterling, K.</span><span> </span><span class="NLM_article-title">Enantiomeric propanolamines as selective <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate 2B receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5506</span><span class="NLM_x">–</span> <span class="NLM_lpage">5521</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8002153" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5506-5521&author=Y.+A.+Tahirovicauthor=M.+Geballeauthor=E.+Gruszecka-Kowalikauthor=S.+J.+Myersauthor=P.+Lyuboslavskyauthor=P.+Leauthor=A.+Frenchauthor=H.+Irierauthor=W.+Choiauthor=K.+Easterling&title=Enantiomeric+propanolamines+as+selective+N-methyl-d-aspartate+2B+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm8002153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8002153%26sid%3Dliteratum%253Aachs%26aulast%3DTahirovic%26aufirst%3DY.%2BA.%26aulast%3DGeballe%26aufirst%3DM.%26aulast%3DGruszecka-Kowalik%26aufirst%3DE.%26aulast%3DMyers%26aufirst%3DS.%2BJ.%26aulast%3DLyuboslavsky%26aufirst%3DP.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DFrench%26aufirst%3DA.%26aulast%3DIrier%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DW.%26aulast%3DEasterling%26aufirst%3DK.%26atitle%3DEnantiomeric%2520propanolamines%2520as%2520selective%2520N-methyl-d-aspartate%25202B%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5506%26epage%3D5521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Mosley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santangelo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahirovic, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurtkaya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullasseril, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyuboslavsky, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P.</span><span> </span><span class="NLM_article-title">Synthesis, structural activity-relationships, and biological evaluation of novel amide-based allosteric binding site antagonists in NR1A/NR2B <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6463</span><span class="NLM_x">–</span> <span class="NLM_lpage">6480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=6463-6480&author=C.+A.+Mosleyauthor=S.+J.+Myersauthor=E.+E.+Murrayauthor=R.+Santangeloauthor=Y.+A.+Tahirovicauthor=N.+Kurtkayaauthor=P.+Mullasserilauthor=H.+Yuanauthor=P.+Lyuboslavskyauthor=P.+Le&title=Synthesis%2C+structural+activity-relationships%2C+and+biological+evaluation+of+novel+amide-based+allosteric+binding+site+antagonists+in+NR1A%2FNR2B+N-methyl-d-aspartate+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMosley%26aufirst%3DC.%2BA.%26aulast%3DMyers%26aufirst%3DS.%2BJ.%26aulast%3DMurray%26aufirst%3DE.%2BE.%26aulast%3DSantangelo%26aufirst%3DR.%26aulast%3DTahirovic%26aufirst%3DY.%2BA.%26aulast%3DKurtkaya%26aufirst%3DN.%26aulast%3DMullasseril%26aufirst%3DP.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DLyuboslavsky%26aufirst%3DP.%26aulast%3DLe%26aufirst%3DP.%26atitle%3DSynthesis%252C%2520structural%2520activity-relationships%252C%2520and%2520biological%2520evaluation%2520of%2520novel%2520amide-based%2520allosteric%2520binding%2520site%2520antagonists%2520in%2520NR1A%252FNR2B%2520N-methyl-d-aspartate%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D6463%26epage%3D6480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Fischer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trube, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malherbe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kew, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohacsi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, J.</span><span> </span><span class="NLM_article-title">Ro 25-6981, a highly potent and selective blocker of <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptors containing the NR2B subunit. Characterization in vitro</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">1285</span><span class="NLM_x">–</span> <span class="NLM_lpage">1292</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=9400004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1cXis1Giuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=1285-1292&author=G.+Fischerauthor=V.+Mutelauthor=G.+Trubeauthor=P.+Malherbeauthor=J.+Kewauthor=E.+Mohacsiauthor=M.+Heitzauthor=J.+Kemp&title=Ro+25-6981%2C+a+highly+potent+and+selective+blocker+of+N-methyl-d-aspartate+receptors+containing+the+NR2B+subunit.+Characterization+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro</span></div><div class="casAuthors">Fischer, G.; Mutel, V.; Trube, G.; Malherbe, P.; Kew, J. N. C.; Mohacsi, E.; Heitz, M. P.; Kemp, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1285-1292</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The interaction of Ro 25-6981 with N-methyl-D-aspartate (NMDA) receptors was characterized by a variety of different tests in vitro.  Ro 25-6981 inhibited 3H-MK-801 binding to rat forebrain membranes in a biphasic manner with IC50 values of 0.003 μM and 149 μM for high- (about 60%) and low-affinity sites, resp.  NMDA receptor subtypes expressed in Xenopus oocytes were blocked with IC50 values of 0.009 μM and 52 μM for the subunit combinations NR1C & NR2B and NR1C & NR2A, resp., which indicated a >5000-fold selectivity.  Like ifenprodil, Ro 25-6981 blocked NMDA receptor subtypes in an activity-dependent manner.  Ro 25-6981 protected cultured cortical neurons against glutamate toxicity (16 h exposure to 300 μM glutamate) and combined oxygen and glucose deprivation (60 min followed by 20 h recovery) with IC50 values of 0.4 μM and 0.04 μM, resp.  Ro 25-6981 was more potent than ifenprodil in all of these tests.  It showed no protection against kainate toxicity (exposure to 500 μM for 20 h) and only weak activity in blocking Na+ and Ca2+ channels, activated by exposure of cortical neurons to veratridine (10 μM) and potassium (50 mM), resp.  These findings demonstrate that Ro 25-6981 is a highly selective, activity-dependent blocker of NMDA receptors that contain the NR2B subunit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIOB0rLJv_oLVg90H21EOLACvtfcHk0ljKc2kJRgOgng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXis1Giuw%253D%253D&md5=42ab1bd4fa72ee96b25007a92ebce37a</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DMutel%26aufirst%3DV.%26aulast%3DTrube%26aufirst%3DG.%26aulast%3DMalherbe%26aufirst%3DP.%26aulast%3DKew%26aufirst%3DJ.%26aulast%3DMohacsi%26aufirst%3DE.%26aulast%3DHeitz%26aufirst%3DM.%26aulast%3DKemp%26aufirst%3DJ.%26atitle%3DRo%252025-6981%252C%2520a%2520highly%2520potent%2520and%2520selective%2520blocker%2520of%2520N-methyl-d-aspartate%2520receptors%2520containing%2520the%2520NR2B%2520subunit.%2520Characterization%2520in%2520vitro%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D1285%26epage%3D1292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Taniguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinjo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagahisa, A.</span><span> </span><span class="NLM_article-title">Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">812</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fsj.bjp.0701445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=9384494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK2sXnt1Sqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=1997&pages=809-812&author=K.+Taniguchiauthor=K.+Shinjoauthor=M.+Mizutaniauthor=K.+Shimadaauthor=T.+Ishikawaauthor=F.+S.+Mennitiauthor=A.+Nagahisa&title=Antinociceptive+activity+of+CP-101%2C606%2C+an+NMDA+receptor+NR2B+subunit+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist</span></div><div class="casAuthors">Taniguchi, Kana; Shinjo, Katsuhiro; Mizutani, Mayumi; Shimada, Kaoru; Ishikawa, Oshihisa; Menniti, Frank S.; Nagahisa, Atsushi</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">809-812</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">1. The analgesic activity of CP-101,606, an NR2B subunit-selective N-methyl-D-aspartate (NMDA) receptor antagonist, was examd. in carrageenan-induced hyperalgesia, capsaicin- and 4β-phorbol-12-myristate-13-acetate (PMA)-induced nociceptive tests in the rat.  2. CP-101,606 30 mg kg-1, s.c., at 0.5 and 2.5 h after carrageenan challenge suppressed mech. hyperalgesia without any apparent alternations in motor coordination or behavior in the rat.  3. CP-101,606 also inhibited capsaicin- and PMA-induced nociceptive responses (licking behavior) with ED50 values of 7.5 and 5.7 mg kg-1, s.c., resp.  4. These results suggest that inhibition of the NR2B subunit of the NMDA receptor is effective in vivo at modulating nociception and hyperalgesia responses without causing the behavioral side effects often obsd. with currently available NMDA receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN7dqi1JClaLVg90H21EOLACvtfcHk0lg1DFThbYvkwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnt1Sqtbc%253D&md5=9727650ebb93e9b63fa173ebd19305b3</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0701445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0701445%26sid%3Dliteratum%253Aachs%26aulast%3DTaniguchi%26aufirst%3DK.%26aulast%3DShinjo%26aufirst%3DK.%26aulast%3DMizutani%26aufirst%3DM.%26aulast%3DShimada%26aufirst%3DK.%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DNagahisa%26aufirst%3DA.%26atitle%3DAntinociceptive%2520activity%2520of%2520CP-101%252C606%252C%2520an%2520NMDA%2520receptor%2520NR2B%2520subunit%2520antagonist%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D122%26spage%3D809%26epage%3D812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Nutt, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzler, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirchhoff, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogarth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamerson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landen, J. W.</span><span> </span><span class="NLM_article-title">Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and parkinsonism</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1860</span><span class="NLM_x">–</span> <span class="NLM_lpage">1866</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1002%2Fmds.22169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=18759356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD1cjht1KnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=1860-1866&author=J.+G.+Nuttauthor=S.+A.+Gunzlerauthor=T.+Kirchhoffauthor=P.+Hogarthauthor=J.+L.+Weaverauthor=M.+Kramsauthor=B.+Jamersonauthor=F.+S.+Mennitiauthor=J.+W.+Landen&title=Effects+of+a+NR2B+selective+NMDA+glutamate+antagonist%2C+CP-101%2C606%2C+on+dyskinesia+and+parkinsonism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and Parkinsonism</span></div><div class="casAuthors">Nutt John G; Gunzler Steven A; Kirchhoff Trish; Hogarth Penelope; Weaver Jerry L; Krams Michael; Jamerson Brenda; Menniti Frank S; Landen Jaren W</div><div class="citationInfo"><span class="NLM_cas:title">Movement disorders : official journal of the Movement Disorder Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1860-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glutamate antagonists decrease dyskinesia and augment the antiparkinsonian effects of levodopa in animal models of Parkinson's disease (PD).  In a randomized, double-blind, placebo-controlled clinical trial, we investigated the acute effects of placebo and two doses of a NR2B subunit selective NMDA glutamate antagonist, CP-101,606, on the response to 2-hour levodopa infusions in 12 PD subjects with motor fluctuations and dyskinesia.  Both doses of CP-101,606 reduced the maximum severity of levodopa-induced dyskinesia approximately 30% but neither dose improved Parkinsonism.  CP-101,606 was associated with a dose-related dissociation and amnesia.  These results support the hypothesis that glutamate antagonists may be useful antidyskinetic agents.  However, future studies will have to determine if the benefits of dyskinesia suppression can be achieved without adverse cognitive effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRsgHo5QLhgm7YtC3U5jeOifW6udTcc2eYaZo-kUhdZ87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjht1KnsA%253D%253D&md5=69a5fd96cd5ee1922ef79c530157d756</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1002%2Fmds.22169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.22169%26sid%3Dliteratum%253Aachs%26aulast%3DNutt%26aufirst%3DJ.%2BG.%26aulast%3DGunzler%26aufirst%3DS.%2BA.%26aulast%3DKirchhoff%26aufirst%3DT.%26aulast%3DHogarth%26aufirst%3DP.%26aulast%3DWeaver%26aufirst%3DJ.%2BL.%26aulast%3DKrams%26aufirst%3DM.%26aulast%3DJamerson%26aufirst%3DB.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DLanden%26aufirst%3DJ.%2BW.%26atitle%3DEffects%2520of%2520a%2520NR2B%2520selective%2520NMDA%2520glutamate%2520antagonist%252C%2520CP-101%252C606%252C%2520on%2520dyskinesia%2520and%2520parkinsonism%26jtitle%3DMov.%2520Disord.%26date%3D2008%26volume%3D23%26spage%3D1860%26epage%3D1866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Mosley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acker, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullasseril, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vellano, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bräuner-Osborne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span> </span><span class="NLM_article-title">Quinazolin-4-one derivatives: a novel class of noncompetitive NR2C/D subunit-selective <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_fpage">5476</span><span class="NLM_x">–</span> <span class="NLM_lpage">5490</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=5476-5490&author=C.+A.+Mosleyauthor=T.+M.+Ackerauthor=K.+B.+Hansenauthor=P.+Mullasserilauthor=K.+T.+Andersenauthor=P.+Leauthor=K.+M.+Vellanoauthor=H.+Br%C3%A4uner-Osborneauthor=D.+C.+Liottaauthor=S.+F.+Traynelis&title=Quinazolin-4-one+derivatives%3A+a+novel+class+of+noncompetitive+NR2C%2FD+subunit-selective+N-methyl-d-aspartate+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMosley%26aufirst%3DC.%2BA.%26aulast%3DAcker%26aufirst%3DT.%2BM.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DMullasseril%26aufirst%3DP.%26aulast%3DAndersen%26aufirst%3DK.%2BT.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DVellano%26aufirst%3DK.%2BM.%26aulast%3DBr%25C3%25A4uner-Osborne%26aufirst%3DH.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DQuinazolin-4-one%2520derivatives%253A%2520a%2520novel%2520class%2520of%2520noncompetitive%2520NR2C%252FD%2520subunit-selective%2520N-methyl-d-aspartate%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26spage%3D5476%26epage%3D5490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span> </span><span class="NLM_article-title">Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">3650</span><span class="NLM_x">–</span> <span class="NLM_lpage">3661</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1523%2FJNEUROSCI.5565-10.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=21389220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslGqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=3650-3661&author=K.+B.+Hansenauthor=S.+F.+Traynelis&title=Structural+and+mechanistic+determinants+of+a+novel+site+for+noncompetitive+inhibition+of+GluN2D-containing+NMDA+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors</span></div><div class="casAuthors">Hansen, Kasper B.; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3650-3661</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">NMDA receptors are ionotropic glutamate receptors that mediate excitatory synaptic transmission and have been implicated in several neurol. diseases.  We have evaluated the mechanism of action of a class of novel subunit-selective NMDA receptor antagonists, typified by (E)-4-(6-methoxy-2-(3-nitrostyryl)-4-oxoquinazolin-3(4H)-yl)-benzoic acid (QNZ46).  We found that QNZ46 inhibits NMDA receptor function in a noncompetitive and voltage-independent manner by an unconventional mechanism that requires binding of glutamate to the GluN2 subunit, but not glycine binding to the GluN1 subunit.  This dependency of antagonist assocn. on glutamate binding to GluN2 renders these compds. nominally use-dependent, since inhibition will rely on synaptic release of glutamate.  Evaluation of the structural determinants responsible for the subunit-selectivity of QNZ46 revealed that these compds. act at a new site that has not previously been described.  Residues residing in the part of the agonist binding domain immediately adjacent to the transmembrane helixes appear to control selectivity of QNZ46 for GluN2C- and GluN2D-contg. receptors.  These residues are well-positioned to sense glutamate binding to GluN2 and thus to mediate glutamate-dependent actions.  This new class of noncompetitive antagonists could provide an opportunity for the development of pharmacol. tools and therapeutic agents that target NMDA receptors at a new site and modulate function by a novel mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6tfEgKAb7trVg90H21EOLACvtfcHk0lg1DFThbYvkwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslGqt7w%253D&md5=ac8e6c3cd76ba67768f765926a66381c</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5565-10.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5565-10.2011%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DStructural%2520and%2520mechanistic%2520determinants%2520of%2520a%2520novel%2520site%2520for%2520noncompetitive%2520inhibition%2520of%2520GluN2D-containing%2520NMDA%2520receptors%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D3650%26epage%3D3661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Costa, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irvine, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaves, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayo-Martin, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skifter, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jane, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monaghan, D. T.</span><span> </span><span class="NLM_article-title">A novel family of negative and positive allosteric modulators of NMDA receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">614</span><span class="NLM_x">–</span> <span class="NLM_lpage">621</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1124%2Fjpet.110.174144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20858708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFOmsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2010&pages=614-621&author=B.+M.+Costaauthor=M.+W.+Irvineauthor=G.+Fangauthor=R.+J.+Eavesauthor=M.+B.+Mayo-Martinauthor=D.+A.+Skifterauthor=D.+E.+Janeauthor=D.+T.+Monaghan&title=A+novel+family+of+negative+and+positive+allosteric+modulators+of+NMDA+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">A novel family of negative and positive allosteric modulators of NMDA receptors</span></div><div class="casAuthors">Costa, Blaise Mathias; Irvine, Mark W.; Fang, Guangyu; Eaves, Richard J.; Mayo-Martin, Marie Belen; Skifter, Donald A.; Jane, David E.; Monaghan, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">614-621</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The N-methyl-D-aspartate (NMDA) receptor family regulates various central nervous system functions, such as synaptic plasticity.  However, hypo- or hyperactivation of NMDA receptors is critically involved in many neurol. and psychiatric conditions, such as pain, stroke, epilepsy, neurodegeneration, schizophrenia, and depression.  Consequently, subtype-selective pos. and neg. modulators of NMDA receptor function have many potential therapeutic applications not addressed by currently available compds.  We have identified allosteric modulators with several novel patterns of NMDA receptor subtype selectivity that have a novel mechanism of action.  In a series of carboxylated naphthalene and phenanthrene derivs., compds. were identified that selectively potentiate responses at GluN1/GluN2A [e.g., 9-iodophenanthrene-3-carboxylic acid (UBP512)]; GluN1/GluN2A and GluN1/GluN2B [9-cyclopropylphenanthrene-3-carboxylic acid (UBP710)]; GluN1/GluN2D [3,5-dihydroxynaphthalene-2-carboxylic acid (UBP551)]; or GluN1/GluN2C and GluN1/GluN2D receptors [6-, 7-, 8-, and 9-nitro isomers of naphth[1,2-c][1,2,5]oxadiazole-5-sulfonic acid (NSC339614)] and have no effect or inhibit responses at the other NMDA receptors.  Selective inhibition was also obsd.; UBP512 inhibits only GluN1/GluN2C and GluN1/GluN2D receptors, whereas 6-bromo-2-oxo-2H-chromene-3-carboxylic acid (UBP608) inhibits GluN1/GluN2A receptors with a 23-fold selectivity compared with GluN1/GluN2D receptors.  The actions of these compds. were not competitive with the agonists L-glutamate or glycine and were not voltage-dependent.  Whereas the N-terminal regulatory domain was not necessary for activity of either potentiators or inhibitors, segment 2 of the agonist ligand-binding domain was important for potentiating activity, whereas subtype-specific inhibitory activity was dependent upon segment 1.  In terms of chem. structure, activity profile, and mechanism of action, these modulators represent a new class of pharmacol. agents for the study of NMDA receptor subtype function and provide novel lead compds. for a variety of neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ9F9N6PVoh7Vg90H21EOLACvtfcHk0lhJN4itJ4QKcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFOmsrnI&md5=cefc65523d06856f6dd704274ecb6f22</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.174144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.174144%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DB.%2BM.%26aulast%3DIrvine%26aufirst%3DM.%2BW.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DEaves%26aufirst%3DR.%2BJ.%26aulast%3DMayo-Martin%26aufirst%3DM.%2BB.%26aulast%3DSkifter%26aufirst%3DD.%2BA.%26aulast%3DJane%26aufirst%3DD.%2BE.%26aulast%3DMonaghan%26aufirst%3DD.%2BT.%26atitle%3DA%2520novel%2520family%2520of%2520negative%2520and%2520positive%2520allosteric%2520modulators%2520of%2520NMDA%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D335%26spage%3D614%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Acker, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullasseril, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span> </span><span class="NLM_article-title">Mechanism for noncompetitive inhibition by novel GluN2C/D <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor subunit-selective modulators</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">782</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2011&pages=782-795&author=T.+M.+Ackerauthor=H.+Yuanauthor=K.+B.+Hansenauthor=K.+M.+Vanceauthor=K.+K.+Ogdenauthor=H.+S.+Jensenauthor=P.+B.+Burgerauthor=P.+Mullasserilauthor=J.+P.+Snyderauthor=D.+C.+Liotta&title=Mechanism+for+noncompetitive+inhibition+by+novel+GluN2C%2FD+N-methyl-d-aspartate+receptor+subunit-selective+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAcker%26aufirst%3DT.%2BM.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DJensen%26aufirst%3DH.%2BS.%26aulast%3DBurger%26aufirst%3DP.%2BB.%26aulast%3DMullasseril%26aufirst%3DP.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26atitle%3DMechanism%2520for%2520noncompetitive%2520inhibition%2520by%2520novel%2520GluN2C%252FD%2520N-methyl-d-aspartate%2520receptor%2520subunit-selective%2520modulators%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D80%26spage%3D782%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Bettini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffante, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carignani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelli, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreetta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senar-Sancho, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiral, L.</span><span> </span><span class="NLM_article-title">Identification and characterization of novel NMDA receptor antagonists selective for NR2A-over NR2B-containing receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">636</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1124%2Fjpet.110.172544" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20810618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFOmsrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2010&pages=636-644&author=E.+Bettiniauthor=A.+Savaauthor=C.+Griffanteauthor=C.+Carignaniauthor=A.+Busonauthor=A.+M.+Capelliauthor=M.+Negriauthor=F.+Andreettaauthor=S.+A.+Senar-Sanchoauthor=L.+Guiral&title=Identification+and+characterization+of+novel+NMDA+receptor+antagonists+selective+for+NR2A-over+NR2B-containing+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors</span></div><div class="casAuthors">Bettini, Ezio; Sava, Anna; Griffante, Cristiana; Carignani, Corrado; Buson, Alberto; Capelli, Anna Maria; Negri, Michele; Andreetta, Filippo; Senar-Sancho, Sergio A.; Guiral, Lorena; Cardullo, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">636-644</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">NR1/NR2A is a subtype of N-methyl-D-aspartate receptors (NMDARs), which are glutamate and glycine-gated Ca2+-permeable channels highly expressed in the central nervous system.  A high-throughput screening (HTS) campaign using human osteosarcoma (U-2 OS) cells transiently transduced with NR1/NR2A NMDAR subunits, tested in a specifically designed fluorometric imaging plate reader (FLIPR)/Ca2+ assay, identified sulfonamide deriv. series, exemplified by 3-chloro-4-fluoro-N-[(4-{[2-(phenylcarbonyl)hydrazino]carbonyl}phenyl)methyl]benzenesulfonamide (compd. 1) and thiodiazole deriv. N-(cyclohexylmethyl)-2-({5-[(phenylmethyl)amino]-1,3,4-thiadiazol-2-yl}thio)acetamide (compd. 13) as novel NR1/NR2A receptor antagonists.  Compds. 1 and 13 displayed submicromolar and micromolar potency at NR1/NR2A receptor, resp., although they did not show activity at NR2B-contg. receptor up to 50 μM concn.  Addn. of 1 mM glycine, but not 1 mM L-glutamate, was able to surmount compd. 1 and 13 inhibitory effects in FLIPR NR1/NR2A assay.  However, compds. 1 and 13 displaced a glutamate site antagonist [3H]D,L-(E)-2-amino-4-propyl-5-phosphono-3-pentenoic acid ([3H]CGP 39653) to a greater extent than the glycine site antagonist [3H]3-[(E)-2-carboxy-2-phenylethenyl]-4,6-dichloro-1H-indole-2-carboxylic acid ([3H]MDL 105,519), in rat brain cortex binding assay.  Results of FLIPR cell-based, electrophysiol., and biochem. binding assays suggest that compds. 1 and 13 are the prototypes of novel classes of NMDAR ligands, which to the best of our knowledge are the first selective antagonists at NR1/NR2A over NR1/NR2B receptor, and might constitute useful tools able to elucidate the relative role of the NR2A subunit in physiol. and pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFB-QKFiC9sLVg90H21EOLACvtfcHk0lhJN4itJ4QKcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFOmsrnK&md5=0bffd70be964ba27d17b9fbd877eaef0</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.172544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.172544%26sid%3Dliteratum%253Aachs%26aulast%3DBettini%26aufirst%3DE.%26aulast%3DSava%26aufirst%3DA.%26aulast%3DGriffante%26aufirst%3DC.%26aulast%3DCarignani%26aufirst%3DC.%26aulast%3DBuson%26aufirst%3DA.%26aulast%3DCapelli%26aufirst%3DA.%2BM.%26aulast%3DNegri%26aufirst%3DM.%26aulast%3DAndreetta%26aufirst%3DF.%26aulast%3DSenar-Sancho%26aufirst%3DS.%2BA.%26aulast%3DGuiral%26aufirst%3DL.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520novel%2520NMDA%2520receptor%2520antagonists%2520selective%2520for%2520NR2A-over%2520NR2B-containing%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D335%26spage%3D636%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Retchless, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. W.</span><span> </span><span class="NLM_article-title">A single GluN2 subunit residue controls NMDA receptor channel properties via intersubunit interaction</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">406</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnn.3025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=22246434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1Kktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=406-413&author=B.+S.+Retchlessauthor=W.+Gaoauthor=J.+W.+Johnson&title=A+single+GluN2+subunit+residue+controls+NMDA+receptor+channel+properties+via+intersubunit+interaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">A single GluN2 subunit residue controls NMDA receptor channel properties via intersubunit interaction</span></div><div class="casAuthors">Retchless, Beth Siegler; Gao, Wei; Johnson, Jon W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">406-413</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">NMDA receptors (NMDARs) are glutamate-gated ion channels that are present at most excitatory mammalian synapses.  The four GluN2 subunits (GluN2A-D) contribute to four diheteromeric NMDAR subtypes that have divergent physiol. and pathol. roles.  Channel properties that are fundamental to NMDAR function vary among subtypes.  We investigated the amino acid residues responsible for variations in channel properties by creating and examg. NMDARs contg. mutant GluN2 subunits.  We found that the NMDAR subtype specificity of three crucial channel properties, Mg2+ block, selective permeability to Ca2+ and single-channel conductance, were all controlled primarily by the residue at a single GluN2 site in the M3 transmembrane region.  Mutant cycle anal. guided by mol. modeling revealed that a GluN2-GluN1 subunit interaction mediates the site's effects.  We conclude that a single GluN2 subunit residue couples with the pore-forming loop of the GluN1 subunit to create naturally occurring variations in NMDAR properties that are crit. to synaptic plasticity and learning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzoTtIKoNyPbVg90H21EOLACvtfcHk0lghoqe3KDKvbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1Kktw%253D%253D&md5=dec3943ae92b083656d1d9fa1dc9f58b</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1038%2Fnn.3025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3025%26sid%3Dliteratum%253Aachs%26aulast%3DRetchless%26aufirst%3DB.%2BS.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DJohnson%26aufirst%3DJ.%2BW.%26atitle%3DA%2520single%2520GluN2%2520subunit%2520residue%2520controls%2520NMDA%2520receptor%2520channel%2520properties%2520via%2520intersubunit%2520interaction%26jtitle%3DNat.%2520Neurosci.%26date%3D2012%26volume%3D15%26spage%3D406%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Neyton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paoletti, P.</span><span> </span><span class="NLM_article-title">Relating NMDA receptor function to receptor subunit composition: limitations of the pharmacological approach</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1331</span><span class="NLM_x">–</span> <span class="NLM_lpage">1333</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1523%2FJNEUROSCI.5242-05.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=16452656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFaitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=1331-1333&author=J.+Neytonauthor=P.+Paoletti&title=Relating+NMDA+receptor+function+to+receptor+subunit+composition%3A+limitations+of+the+pharmacological+approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Relating NMDA receptor function to receptor subunit composition: Limitations of the pharmacological approach</span></div><div class="casAuthors">Neyton, Jacques; Paoletti, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1331-1333</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A review.  Data showing that NVP-AAM077 displays much less subunit selectivity than originally described is presented.  Then, in a more general perspective, several limitations of the available selective drugs against NMDA receptors are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIcnczNhYgM7Vg90H21EOLACvtfcHk0lghoqe3KDKvbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFaitr0%253D&md5=a04021d6cd5767e5a0f9652850469d7f</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5242-05.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5242-05.2006%26sid%3Dliteratum%253Aachs%26aulast%3DNeyton%26aufirst%3DJ.%26aulast%3DPaoletti%26aufirst%3DP.%26atitle%3DRelating%2520NMDA%2520receptor%2520function%2520to%2520receptor%2520subunit%2520composition%253A%2520limitations%2520of%2520the%2520pharmacological%2520approach%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D1331%26epage%3D1333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Hatton, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paoletti, P.</span><span> </span><span class="NLM_article-title">Modulation of triheteromeric NMDA receptors by N-terminal domain ligands</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=261-274&author=C.+J.+Hattonauthor=P.+Paoletti&title=Modulation+of+triheteromeric+NMDA+receptors+by+N-terminal+domain+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHatton%26aufirst%3DC.%2BJ.%26aulast%3DPaoletti%26aufirst%3DP.%26atitle%3DModulation%2520of%2520triheteromeric%2520NMDA%2520receptors%2520by%2520N-terminal%2520domain%2520ligands%26jtitle%3DNeuron%26date%3D2005%26volume%3D46%26spage%3D261%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Xia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, S. A.</span><span> </span><span class="NLM_article-title">Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">11246</span><span class="NLM_x">–</span> <span class="NLM_lpage">11250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1523%2FJNEUROSCI.2488-10.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20720132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWms7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=11246-11250&author=P.+Xiaauthor=H.+V.+Chenauthor=D.+Zhangauthor=S.+A.+Lipton&title=Memantine+preferentially+blocks+extrasynaptic+over+synaptic+NMDA+receptor+currents+in+hippocampal+autapses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses</span></div><div class="casAuthors">Xia, Peng; Chen, Huei-sheng Vincent; Zhang, Dongxian; Lipton, Stuart A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">11246-11250</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Glutamate is the major excitatory neurotransmitter in the brain.  The NMDA subtype of glutamate receptors (NMDAR) is known to mediate many physiol. neural functions.  However, excessive activation of NMDARs contributes to neuronal damage in various acute and chronic neurol. disorders.  To avoid unwanted adverse side effects, blockade of excessive NMDAR activity must therefore be achieved without affecting its physiol. function.  Memantine, an adamantane deriv., was used for the treatment of Alzheimer's disease with an excellent clin. safety profile.  We previously showed that memantine preferentially blocked neurotoxicity mediated by excessive NMDAR activity while relatively sparing normal neurotransmission, in part because of its uncompetitive antagonism with a fast off-rate.  Here, using rat autaptic hippocampal microcultures, we show that memantine at therapeutic concns. (1-10 μM) preferentially blocks extrasynaptic rather than synaptic currents mediated by NMDARs in the same neuron.  We found that memantine blocks extrasynaptic NMDAR-mediated currents induced by bath application of 100 μM NMDA/10 μM glycine with a twofold higher potency than its blockade of the NMDAR component of evoked EPSCs (EPSCsNMDAR); this effect persists under conditions of pathol. depolarization in the presence of 1 mM extracellular Mg2+.  Thus,these findings provide the first unequivocal evidence to explain the tolerability of memantine based on differential extrasynaptic/synaptic receptor blockade.  At therapeutic concns., memantine effectively blocks excessive extrasynaptic NMDAR-mediated currents, while relatively sparing normal synaptic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoBl6KMNuQ_bVg90H21EOLACvtfcHk0lghoqe3KDKvbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWms7rL&md5=5cc09de23ce4e996cfa637937911de1f</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2488-10.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2488-10.2010%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DH.%2BV.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DLipton%26aufirst%3DS.%2BA.%26atitle%3DMemantine%2520preferentially%2520blocks%2520extrasynaptic%2520over%2520synaptic%2520NMDA%2520receptor%2520currents%2520in%2520hippocampal%2520autapses%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D11246%26epage%3D11250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Okamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouladi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talantova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrnhoefer, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaidi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemente, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. K.</span><span> </span><span class="NLM_article-title">Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1407</span><span class="NLM_x">–</span> <span class="NLM_lpage">1413</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnm.2056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=19915593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWksbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=1407-1413&author=S.+Okamotoauthor=M.+A.+Pouladiauthor=M.+Talantovaauthor=D.+Yaoauthor=P.+Xiaauthor=D.+E.+Ehrnhoeferauthor=R.+Zaidiauthor=A.+Clementeauthor=M.+Kaulauthor=R.+K.+Graham&title=Balance+between+synaptic+versus+extrasynaptic+NMDA+receptor+activity+influences+inclusions+and+neurotoxicity+of+mutant+huntingtin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin</span></div><div class="casAuthors">Okamoto, Shu-Ichi; Pouladi, Mahmoud A.; Talantova, Maria; Yao, Dong-Dong; Xia, Peng; Ehrnhoefer, Dagmar E.; Zaidi, Rameez; Clemente, Arjay; Kaul, Marcus; Graham, Rona K.; Zhang, Dong-Xian; Chen, H.-S. Vincent; Tong, Gary; Hayden, Michael R.; Lipton, Stuart A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1407-1413</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Huntington's disease is caused by an expanded CAG repeat in the gene encoding huntingtin (HTT), resulting in loss of striatal and cortical neurons.  Given that the gene product is widely expressed, it remains unclear why neurons are selectively targeted.  Here we show the relationship between synaptic and extrasynaptic activity, inclusion formation of mutant huntingtin protein (mtHtt) and neuronal survival.  Synaptic N-methyl-D-aspartate-type glutamate receptor (NMDAR) activity induces mtHtt inclusions via a T complex-1 (TCP-1) ring complex (TRiC)-dependent mechanism, rendering neurons more resistant to mtHtt-mediated cell death.  In contrast, stimulation of extrasynaptic NMDARs increases the vulnerability of mtHtt-contg. neurons to cell death by impairing the neuroprotective cAMP response element-binding protein (CREB)-peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) cascade and increasing the level of the small guanine nucleotide-binding protein Rhes, which is known to sumoylate and disaggregate mtHtt.  Treatment of transgenic mice expressing a yeast artificial chromosome contg. 128 CAG repeats (YAC128) with low-dose memantine blocks extrasynaptic (but not synaptic) NMDARs and ameliorates neuropathol. and behavioral manifestations.  By contrast, high-dose memantine, which blocks both extrasynaptic and synaptic NMDAR activity, decreases neuronal inclusions and worsens these outcomes.  Our findings offer a rational therapeutic approach for protecting susceptible neurons in Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo918WjH9XorLVg90H21EOLACvtfcHk0ljVkoRlZG4g3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWksbrM&md5=58746cbedeb2e252c51ef74c368cf3e9</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1038%2Fnm.2056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2056%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DS.%26aulast%3DPouladi%26aufirst%3DM.%2BA.%26aulast%3DTalantova%26aufirst%3DM.%26aulast%3DYao%26aufirst%3DD.%26aulast%3DXia%26aufirst%3DP.%26aulast%3DEhrnhoefer%26aufirst%3DD.%2BE.%26aulast%3DZaidi%26aufirst%3DR.%26aulast%3DClemente%26aufirst%3DA.%26aulast%3DKaul%26aufirst%3DM.%26aulast%3DGraham%26aufirst%3DR.%2BK.%26atitle%3DBalance%2520between%2520synaptic%2520versus%2520extrasynaptic%2520NMDA%2520receptor%2520activity%2520influences%2520inclusions%2520and%2520neurotoxicity%2520of%2520mutant%2520huntingtin%26jtitle%3DNat.%2520Med.%26date%3D2009%26volume%3D15%26spage%3D1407%26epage%3D1413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Hardingham, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bading, H.</span><span> </span><span class="NLM_article-title">Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">682</span><span class="NLM_x">–</span> <span class="NLM_lpage">696</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnrn2911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20842175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGntL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=682-696&author=G.+E.+Hardinghamauthor=H.+Bading&title=Synaptic+versus+extrasynaptic+NMDA+receptor+signalling%3A+implications+for+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders</span></div><div class="casAuthors">Hardingham, Giles E.; Bading, Hilmar</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">682-696</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is a long-standing paradox that NMDA (N-methyl-D-aspartate) receptors (NMDARs) can both promote neuronal health and kill neurons.  Recent studies show that NMDAR-induced responses depend on the receptor location: stimulation of synaptic NMDARs, acting primarily through nuclear Ca2+ signalling, leads to the build-up of a neuroprotective 'shield', whereas stimulation of extrasynaptic NMDARs promotes cell death.  These differences result from the activation of distinct genomic programs and from opposing actions on intracellular signalling pathways.  Perturbations in the balance between synaptic and extrasynaptic NMDAR activity contribute to neuronal dysfunction in acute ischemia and Huntington's disease, and could be a common theme in the etiol. of neurodegenerative diseases.  Neuroprotective therapies should aim to both enhance the effect of synaptic activity and disrupt extrasynaptic NMDAR-dependent death signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9AZO8mCvsT7Vg90H21EOLACvtfcHk0lgNEx3Nn9vgpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGntL7P&md5=7884f06024ff58f8a72d94768d4e379f</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1038%2Fnrn2911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2911%26sid%3Dliteratum%253Aachs%26aulast%3DHardingham%26aufirst%3DG.%2BE.%26aulast%3DBading%26aufirst%3DH.%26atitle%3DSynaptic%2520versus%2520extrasynaptic%2520NMDA%2520receptor%2520signalling%253A%2520implications%2520for%2520neurodegenerative%2520disorders%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2010%26volume%3D11%26spage%3D682%26epage%3D696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Levine, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cepeda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">André, V. M.</span><span> </span><span class="NLM_article-title">Location, location, location: contrasting roles of synaptic and extrasynaptic NMDA receptors in Huntington’s disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2010&pages=145-147&author=M.+S.+Levineauthor=C.+Cepedaauthor=V.+M.+Andr%C3%A9&title=Location%2C+location%2C+location%3A+contrasting+roles+of+synaptic+and+extrasynaptic+NMDA+receptors+in+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DM.%2BS.%26aulast%3DCepeda%26aufirst%3DC.%26aulast%3DAndr%25C3%25A9%26aufirst%3DV.%2BM.%26atitle%3DLocation%252C%2520location%252C%2520location%253A%2520contrasting%2520roles%2520of%2520synaptic%2520and%2520extrasynaptic%2520NMDA%2520receptors%2520in%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D2010%26volume%3D65%26spage%3D145%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Surmeier, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Padilla, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, J. A.</span><span> </span><span class="NLM_article-title">The origins of oxidant stress in Parkinson’s disease and therapeutic strategies</span> <span class="citation_source-journal">Antioxid. Redox Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1289</span><span class="NLM_x">–</span> <span class="NLM_lpage">1301</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1089%2Fars.2010.3521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20712409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVGjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=1289-1301&author=D.+J.+Surmeierauthor=J.+N.+Guzmanauthor=J.+Sanchez-Padillaauthor=J.+A.+Goldberg&title=The+origins+of+oxidant+stress+in+Parkinson%E2%80%99s+disease+and+therapeutic+strategies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">The Origins of Oxidant Stress in Parkinson's Disease and Therapeutic Strategies</span></div><div class="casAuthors">Surmeier, Dalton James; Guzman, Jaime N.; Sanchez-Padilla, Javier; Goldberg, Joshua A.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1289-1301</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is a major world-wide health problem afflicting millions of the aged population.  Factors that act on most or all cell types (pan-cellular factors), particularly genetic mutations and environmental toxins, have dominated public discussions of disease etiol.  Although there is compelling evidence supporting an assocn. between disease risk and these factors, the pattern of neuronal pathol. and cell loss is difficult to explain without cell-specific factors.  This article focuses on recent studies showing that the neurons at greatest risk in PD-substantia nigra pars compacta dopamine neurons-have a distinctive physiol. phenotype that could contribute to their vulnerability.  The opening of L-type calcium channels during autonomous pacemaking results in sustained calcium entry into the cytoplasm of substantia nigra pars compacta dopamine neurons, resulting in elevated mitochondrial oxidant stress and susceptibility to toxins used to create animal models of PD. This cell-specific stress could increase the neg. consequences of pan-cellular factors that broadly challenge either mitochondrial or proteostatic competence. The availability of well-tolerated, orally deliverable antagonists for L-type calcium channels points to a novel neuroprotective strategy that could complement current attempts to boost mitochondrial function in the early stages of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot21d7HjTbW7Vg90H21EOLACvtfcHk0lgNEx3Nn9vgpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVGjtrY%253D&md5=7d17c52dd9f5e13e548a314403091599</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1089%2Fars.2010.3521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2010.3521%26sid%3Dliteratum%253Aachs%26aulast%3DSurmeier%26aufirst%3DD.%2BJ.%26aulast%3DGuzman%26aufirst%3DJ.%2BN.%26aulast%3DSanchez-Padilla%26aufirst%3DJ.%26aulast%3DGoldberg%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520origins%2520of%2520oxidant%2520stress%2520in%2520Parkinson%25E2%2580%2599s%2520disease%2520and%2520therapeutic%2520strategies%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2011%26volume%3D14%26spage%3D1289%26epage%3D1301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Youdim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J.</span><span> </span><span class="NLM_article-title">CNS targets for multi-functional drugs in the treatment of Alzheimer’s and Parkinson’s diseases</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2005&pages=519-537&author=M.+Youdimauthor=J.+Buccafusco&title=CNS+targets+for+multi-functional+drugs+in+the+treatment+of+Alzheimer%E2%80%99s+and+Parkinson%E2%80%99s+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%26aulast%3DBuccafusco%26aufirst%3DJ.%26atitle%3DCNS%2520targets%2520for%2520multi-functional%2520drugs%2520in%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520and%2520Parkinson%25E2%2580%2599s%2520diseases%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2005%26volume%3D112%26spage%3D519%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geldenhuys, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Schyf, C. J.</span><span> </span><span class="NLM_article-title">Why should we use multifunctional neuroprotective and neurorestorative drugs for Parkinson’s disease?</span> <span class="citation_source-journal">Parkinsonism Relat. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">S281</span><span class="NLM_x">–</span> <span class="NLM_lpage">S291</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=S281-S291&author=M.+B.+H.+Youdimauthor=W.+J.+Geldenhuysauthor=C.+J.+Van+der+Schyf&title=Why+should+we+use+multifunctional+neuroprotective+and+neurorestorative+drugs+for+Parkinson%E2%80%99s+disease%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DGeldenhuys%26aufirst%3DW.%2BJ.%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26atitle%3DWhy%2520should%2520we%2520use%2520multifunctional%2520neuroprotective%2520and%2520neurorestorative%2520drugs%2520for%2520Parkinson%25E2%2580%2599s%2520disease%253F%26jtitle%3DParkinsonism%2520Relat.%2520Disord.%26date%3D2007%26volume%3D13%26spage%3DS281%26epage%3DS291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Geldenhuys, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Schyf, C. J.</span><span> </span><span class="NLM_article-title">The emergence of designed multiple ligands for neurodegenerative disorders</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.pneurobio.2011.04.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=21536094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=347-359&author=W.+J.+Geldenhuysauthor=M.+B.+H.+Youdimauthor=R.+T.+Carrollauthor=C.+J.+Van+der+Schyf&title=The+emergence+of+designed+multiple+ligands+for+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">The emergence of designed multiple ligands for neurodegenerative disorders</span></div><div class="casAuthors">Geldenhuys, Werner J.; Youdim, Moussa B. H.; Carroll, Richard T.; Van der Schyf, Cornelis J.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">347-359</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The incidence of neurodegenerative diseases has seen a const. increase in the global population, and is likely to be the result of extended life expectancy brought about by better health care.  Despite this increase in the incidence of neurodegenerative diseases, there has been a dearth in the introduction of new disease-modifying therapies that are approved to prevent or delay the onset of these diseases, or reverse the degenerative processes in brain.  Mounting evidence in the peer-reviewed literature shows that the etiopathol. of these diseases is extremely complex and heterogeneous, resulting in significant comorbidity and therefore unlikely to be mitigated by any drug acting on a single pathway or target.  A recent trend in drug design and discovery is the rational design or serendipitous discovery of novel drug entities with the ability to address multiple drug targets that form part of the complex pathophysiol. of a particular disease state.  In this review we discuss the rationale for developing such multifunctional drugs (also called designed multiple ligands or DMLs), and why these drug candidates seem to offer better outcomes in many cases compared to single-targeted drugs in pre-clin. studies for neurodegenerative diseases such as Alzheimer's and Parkinson's disease.  Examples are drawn from the literature of drug candidates that have already reached the market, some unsuccessful attempts, and others that are still in the drug development pipeline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvmaYriBnlW7Vg90H21EOLACvtfcHk0lhJDg_qsXw_9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL7E&md5=9a59fe2d3dd4c10cb14ab973090b7975</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2011.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2011.04.010%26sid%3Dliteratum%253Aachs%26aulast%3DGeldenhuys%26aufirst%3DW.%2BJ.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DCarroll%26aufirst%3DR.%2BT.%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520emergence%2520of%2520designed%2520multiple%2520ligands%2520for%2520neurodegenerative%2520disorders%26jtitle%3DProg.%2520Neurobiol.%26date%3D2011%26spage%3D347%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezprozvanny, I.</span><span> </span><span class="NLM_article-title">Evaluation of Dimebon in cellular model of Huntington’s disease</span> <span class="citation_source-journal">Mol. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1186%2F1750-1326-3-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=18939977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD1cjhtlagtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=15&author=J.+Wuauthor=Q.+Liauthor=I.+Bezprozvanny&title=Evaluation+of+Dimebon+in+cellular+model+of+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Dimebon in cellular model of Huntington's disease</span></div><div class="casAuthors">Wu Jun; Li Qin; Bezprozvanny Ilya</div><div class="citationInfo"><span class="NLM_cas:title">Molecular neurodegeneration</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Dimebon is an antihistamine compound with a long history of clinical use in Russia.  Recently, Dimebon has been proposed to be useful for treating neurodegenerative disorders.  It has demonstrated efficacy in phase II Alzheimer's disease (AD) and Huntington's disease (HD) clinical trials.  The mechanisms responsible for the beneficial actions of Dimebon in AD and HD remain unclear.  It has been suggested that Dimebon may act by blocking NMDA receptors or voltage-gated Ca2+ channels and by preventing mitochondrial permeability pore transition.  RESULTS:  We evaluated the effects of Dimebon in experiments with primary striatal neuronal cultures (MSN) from wild type (WT) mice and YAC128 HD transgenic mice.  We found that Dimebon acts as an inhibitor of NMDA receptors (IC50 = 10 muM) and voltage-gated calcium channels (IC50 = 50 muM) in WT and YAC128 MSN.  We further found that application of 50 muM Dimebon stabilized glutamate-induced Ca2+ signals in YAC128 MSN and protected cultured YAC128 MSN from glutamate-induced apoptosis.  Lower concentrations of Dimebon (5 muM and 10 muM) did not stabilize glutamate-induced Ca2+ signals and did not exert neuroprotective effects in experiments with YAC128 MSN.  Evaluation of Dimebon against a set of biochemical targets indicated that Dimebon inhibits alpha-Adrenergic receptors (alpha1A, alpha1B, alpha1D, and alpha2A), Histamine H1 and H2 receptors and Serotonin 5-HT2c, 5-HT5A, 5-HT6 receptors with high affinity.  Dimebon also had significant effect on a number of additional receptors.  CONCLUSION:  Our results suggest that Ca2+ and mitochondria stabilizing effects may, in part, be responsible for beneficial clinical effects of Dimebon.  However, the high concentrations of Dimebon required to achieve Ca2+ stabilizing and neuroprotective effects in our in vitro studies (50 muM) indicate that properties of Dimebon as cognitive enhancer are most likely due to potent inhibition of H1 histamine receptors.  It is also possible that Dimebon acts on novel high affinity targets not present in cultured MSN preparation.  Unbiased evaluation of Dimebon against a set of biochemical targets indicated that Dimebon efficiently inhibited a number of additional receptors.  Potential interactions with these receptors need to be considered in interpretation of results obtained with Dimebon in clinical trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTDH3auL-ya7WGmni0r9GoKfW6udTcc2eb1EGC2eTaSvLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjhtlagtg%253D%253D&md5=82d7be080f7d6aaedae4a36c3f64ecff</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-3-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-3-15%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DBezprozvanny%26aufirst%3DI.%26atitle%3DEvaluation%2520of%2520Dimebon%2520in%2520cellular%2520model%2520of%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DMol.%2520Neurodegener.%26date%3D2008%26volume%3D3%26spage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Jones, R. W.</span><span> </span><span class="NLM_article-title">Dimebon disappointment</span> <span class="citation_source-journal">Alzheimer’s Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1186%2Falzrt49" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20836898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BC3cbnsVKksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=25&author=R.+W.+Jones&title=Dimebon+disappointment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Dimebon disappointment</span></div><div class="casAuthors">Jones Roy W</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's research & therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">25</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dimebon (latrepirdine) has received widespread publicity as a potential therapy for Alzheimer's disease following a very positive phase 2 study carried out in Russia and published in the Lancet in 2008.  In this study there were improvements over 6 months in all endpoints (cognitive, global, daily function and behaviour), with continuing improvement at 12 months in cognition and daily function.  A more recent multinational phase 3 study, however, showed no improvements whatsoever and no difference between the two drug-treated groups and the placebo group.  Of note, there was little deterioration in any of the groups after 6 months in contrast to the placebo group in the phase 2 study.  The potential reasons for these disappointing results are discussed, as well as the implication for dimebon and drug treatment in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQF38Y8DmqCPX6oPH0mYWL1fW6udTcc2eb1EGC2eTaSvLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbnsVKksw%253D%253D&md5=d6b4e50451bbdb83da41e90e4d030a21</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1186%2Falzrt49&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt49%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BW.%26atitle%3DDimebon%2520disappointment%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Res.%2520Ther.%26date%3D2010%26volume%3D2%26spage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Lermontova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redkozubov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shevtsova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serkova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kireeva, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachurin, S.</span><span> </span><span class="NLM_article-title">Dimebon and tacrine inhibit neurotoxic action of β-amyloid in culture and block L-type Ca<sup>2+</sup> channels</span> <span class="citation_source-journal">Bull. Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">1079</span><span class="NLM_x">–</span> <span class="NLM_lpage">1083</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1023%2FA%3A1017972709652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11865327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtFOhtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2001&pages=1079-1083&author=N.+Lermontovaauthor=A.+Redkozubovauthor=E.+Shevtsovaauthor=T.+Serkovaauthor=E.+Kireevaauthor=S.+Bachurin&title=Dimebon+and+tacrine+inhibit+neurotoxic+action+of+%CE%B2-amyloid+in+culture+and+block+L-type+Ca2%2B+channels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Dimebon and tacrine inhibit neurotoxic action of β-amyloid in culture and block L-type Ca2+ channels</span></div><div class="casAuthors">Lermontova, N. N.; Redkozubov, A. E.; Shevtsova, E. F.; Serkova, T. P.; Kireeva, E. G.; Bachurin, S. O.</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of Experimental Biology and Medicine (Translation of Byulleten Eksperimental'noi Biologii i Meditsiny)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1079-1083</span>CODEN:
                <span class="NLM_cas:coden">BEXBAN</span>;
        ISSN:<span class="NLM_cas:issn">0007-4888</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Consultants Bureau</span>)
        </div><div class="casAbstract">Dimebon, a Russian-made drug, inhibited toxic effects of β-amyloid on cultured neurons.  Excessive accumulation of β-amyloid in the brain is characteristic of Alzheimer dementias.  Anti-Alzheimer prepns. tacrine and dimebon improve survival of cerebellar granule cells during long-term incubation with Aβ25-35, the neurotoxic fragment of β-amyloid.  Both prepns. can block potential-dependent Ca2+ entry into neurons by about 20%, which is explained by their selective action on L-type Ca2+ channels.  It was assumed that the neuroprotective effect of dimebon and tacrine against Aβ25-35 partially depends on inhibition of potential-dependent Ca2+ entry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGST_I29hTtbVg90H21EOLACvtfcHk0lhefCsdf8t7Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtFOhtbk%253D&md5=da716770f509333da85cab7e45988edf</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1023%2FA%3A1017972709652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1017972709652%26sid%3Dliteratum%253Aachs%26aulast%3DLermontova%26aufirst%3DN.%26aulast%3DRedkozubov%26aufirst%3DA.%26aulast%3DShevtsova%26aufirst%3DE.%26aulast%3DSerkova%26aufirst%3DT.%26aulast%3DKireeva%26aufirst%3DE.%26aulast%3DBachurin%26aufirst%3DS.%26atitle%3DDimebon%2520and%2520tacrine%2520inhibit%2520neurotoxic%2520action%2520of%2520%25CE%25B2-amyloid%2520in%2520culture%2520and%2520block%2520L-type%2520Ca2%252B%2520channels%26jtitle%3DBull.%2520Exp.%2520Biol.%2520Med.%26date%3D2001%26volume%3D132%26spage%3D1079%26epage%3D1083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Grigor’ev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dranyi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachurin, S.</span><span> </span><span class="NLM_article-title">Comparative study of action mechanisms of dimebon and memantine on AMPA-and NMDA-subtypes glutamate receptors in rat cerebral neurons</span> <span class="citation_source-journal">Bull. Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">474</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1023%2FB%3ABEBM.0000017097.75818.14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=14968164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFSjt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2003&pages=474-477&author=V.+Grigor%E2%80%99evauthor=O.+Dranyiauthor=S.+Bachurin&title=Comparative+study+of+action+mechanisms+of+dimebon+and+memantine+on+AMPA-and+NMDA-subtypes+glutamate+receptors+in+rat+cerebral+neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative Study of Action Mechanisms of Dimebon and Memantine on AMPA- and NMDA-Subtypes Glutamate Receptors in Rat Cerebral Neurons</span></div><div class="casAuthors">Grigor'ev, V. V.; Dranyi, O. A.; Bachurin, S. O.</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of Experimental Biology and Medicine (Translation of Byulleten Eksperimental'noi Biologii i Meditsiny)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">474-477</span>CODEN:
                <span class="NLM_cas:coden">BEXBAN</span>;
        ISSN:<span class="NLM_cas:issn">0007-4888</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Consultants Bureau</span>)
        </div><div class="casAbstract">Dimebon in low concns. potentiated activity of AMPA-receptors in rat cerebellar Purkinje neurons, while memantine produced only an insignificant potentiation in a small group of these cells.  In cortical neurons of rat brain memantine efficiently blocked NMDA-induced currents in dimebon-insensitive neurons.  By contrast, its effect was far weaker in neurons, where the blocking action of dimebon on NMDA-receptors was most pronounced.  It was hypothesized that the differences in the effects of memantine and dimebon are detd. by their interaction with different sites of NMDA-receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIv2F-BnImHbVg90H21EOLACvtfcHk0lhefCsdf8t7Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFSjt78%253D&md5=6b5f2bc89c8b38b5b973db1fe866e292</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1023%2FB%3ABEBM.0000017097.75818.14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FB%253ABEBM.0000017097.75818.14%26sid%3Dliteratum%253Aachs%26aulast%3DGrigor%25E2%2580%2599ev%26aufirst%3DV.%26aulast%3DDranyi%26aufirst%3DO.%26aulast%3DBachurin%26aufirst%3DS.%26atitle%3DComparative%2520study%2520of%2520action%2520mechanisms%2520of%2520dimebon%2520and%2520memantine%2520on%2520AMPA-and%2520NMDA-subtypes%2520glutamate%2520receptors%2520in%2520rat%2520cerebral%2520neurons%26jtitle%3DBull.%2520Exp.%2520Biol.%2520Med.%26date%3D2003%26volume%3D136%26spage%3D474%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Blandini, F.</span><span> </span><span class="NLM_article-title">An update on the potential role of excitotoxicity in the pathogenesis of Parkinson’s disease</span> <span class="citation_source-journal">Funct. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0213-4853%2810%2970027-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20923603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BC3cfnsV2ntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2010&pages=65-71&author=F.+Blandini&title=An+update+on+the+potential+role+of+excitotoxicity+in+the+pathogenesis+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">An update on the potential role of excitotoxicity in the pathogenesis of Parkinson's disease</span></div><div class="casAuthors">Blandini Fabio</div><div class="citationInfo"><span class="NLM_cas:title">Functional neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">65-71</span>
        ISSN:<span class="NLM_cas:issn">0393-5264</span>.
    </div><div class="casAbstract">The primary cause of the neurodegenerative process that underlies Parkinson's disease (PD) is still unknown.  Different mechanisms probably contribute to triggering neuronal death in the nigrostriatal pathway, including mitochondrial defects, oxidative stress and proteolytic stress.  Glutamate-mediated excitotoxicity may be a further contributor.  Glutamate is the predominant fast excitatory neurotransmitter in the central nervous system and, in the presence of specific conditions, a potential neurotoxin.  Although excitotoxicity per se is unlikely to act as a major causative agent in PD pathogenesis, glutamate-mediated intracellular changes may contribute, in a more subtle way, to the mechanisms that trigger the neurodegenerative process in the substantia nigra pars compacta (SNc).  It is, therefore, likely that synergistic interactions between mitochondrial defects, oxidative stress and glutamatergic stimulation take place at the SNc level.  These interactions may create the conditions for the development of the nigrostriatal damage that characterizes PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXyPa3iKu727mQt-ICR3qNfW6udTcc2eaYjaklERVrybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfnsV2ntw%253D%253D&md5=dfda83f139e1e458e8386cd7fdea7311</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2FS0213-4853%2810%2970027-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0213-4853%252810%252970027-X%26sid%3Dliteratum%253Aachs%26aulast%3DBlandini%26aufirst%3DF.%26atitle%3DAn%2520update%2520on%2520the%2520potential%2520role%2520of%2520excitotoxicity%2520in%2520the%2520pathogenesis%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DFunct.%2520Neurol.%26date%3D2010%26volume%3D25%26spage%3D65%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Waldmeier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bozyczko-Coyne, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaught, J. L.</span><span> </span><span class="NLM_article-title">Recent clinical failures in Parkinson’s disease with apoptosis inhibitors underline the need for a paradigm shift in drug discovery for neurodegenerative diseases</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">1197</span><span class="NLM_x">–</span> <span class="NLM_lpage">1206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2006&pages=1197-1206&author=P.+Waldmeierauthor=D.+Bozyczko-Coyneauthor=M.+Williamsauthor=J.+L.+Vaught&title=Recent+clinical+failures+in+Parkinson%E2%80%99s+disease+with+apoptosis+inhibitors+underline+the+need+for+a+paradigm+shift+in+drug+discovery+for+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWaldmeier%26aufirst%3DP.%26aulast%3DBozyczko-Coyne%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DVaught%26aufirst%3DJ.%2BL.%26atitle%3DRecent%2520clinical%2520failures%2520in%2520Parkinson%25E2%2580%2599s%2520disease%2520with%2520apoptosis%2520inhibitors%2520underline%2520the%2520need%2520for%2520a%2520paradigm%2520shift%2520in%2520drug%2520discovery%2520for%2520neurodegenerative%2520diseases%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2006%26volume%3D72%26spage%3D1197%26epage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Kim, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, Y. H.</span><span> </span><span class="NLM_article-title">Minocycline and neurodegenerative diseases</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">196</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2009&pages=168-179&author=H.+S.+Kimauthor=Y.+H.+Suh&title=Minocycline+and+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DSuh%26aufirst%3DY.%2BH.%26atitle%3DMinocycline%2520and%2520neurodegenerative%2520diseases%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2009%26volume%3D196%26spage%3D168%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">X Sureda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junyent, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdaguer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auladell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelegri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilaplana, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maria Canudas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beas Zarate, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallas, M.</span><span> </span><span class="NLM_article-title">Antiapoptotic drugs: a therapeutic strategy for the prevention of neurodegenerative diseases</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.2174%2F138161211795049732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=21348832" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=230-245&author=F.+X+Suredaauthor=F.+Junyentauthor=E.+Verdaguerauthor=C.+Auladellauthor=C.+Pelegriauthor=J.+Vilaplanaauthor=J.+Folchauthor=A.+Maria+Canudasauthor=C.+Beas+Zarateauthor=M.+Pallas&title=Antiapoptotic+drugs%3A+a+therapeutic+strategy+for+the+prevention+of+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.2174%2F138161211795049732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161211795049732%26sid%3Dliteratum%253Aachs%26aulast%3DX%2BSureda%26aufirst%3DF.%26aulast%3DJunyent%26aufirst%3DF.%26aulast%3DVerdaguer%26aufirst%3DE.%26aulast%3DAuladell%26aufirst%3DC.%26aulast%3DPelegri%26aufirst%3DC.%26aulast%3DVilaplana%26aufirst%3DJ.%26aulast%3DFolch%26aufirst%3DJ.%26aulast%3DMaria%2BCanudas%26aufirst%3DA.%26aulast%3DBeas%2BZarate%26aufirst%3DC.%26aulast%3DPallas%26aufirst%3DM.%26atitle%3DAntiapoptotic%2520drugs%253A%2520a%2520therapeutic%2520strategy%2520for%2520the%2520prevention%2520of%2520neurodegenerative%2520diseases%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2011%26volume%3D17%26spage%3D230%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Malgouris, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doble, A.</span><span> </span><span class="NLM_article-title">Neuroprotective effects of riluzole on <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate- or veratridine-induced neurotoxicity in rat hippocampal slices</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">177</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=1994&pages=95-99&author=C.+Malgourisauthor=M.+Danielauthor=A.+Doble&title=Neuroprotective+effects+of+riluzole+on+N-methyl-d-aspartate-+or+veratridine-induced+neurotoxicity+in+rat+hippocampal+slices"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalgouris%26aufirst%3DC.%26aulast%3DDaniel%26aufirst%3DM.%26aulast%3DDoble%26aufirst%3DA.%26atitle%3DNeuroprotective%2520effects%2520of%2520riluzole%2520on%2520N-methyl-d-aspartate-%2520or%2520veratridine-induced%2520neurotoxicity%2520in%2520rat%2520hippocampal%2520slices%26jtitle%3DNeurosci.%2520Lett.%26date%3D1994%26volume%3D177%26spage%3D95%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Doble, A.</span><span> </span><span class="NLM_article-title">The pharmacology and mechanism of action of riluzole</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">233S</span><span class="NLM_x">–</span> <span class="NLM_lpage">241S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1996&pages=233S-241S&author=A.+Doble&title=The+pharmacology+and+mechanism+of+action+of+riluzole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoble%26aufirst%3DA.%26atitle%3DThe%2520pharmacology%2520and%2520mechanism%2520of%2520action%2520of%2520riluzole%26jtitle%3DNeurology%26date%3D1996%26volume%3D47%26spage%3D233S%26epage%3D241S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Bryson, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benfield, P.</span><span> </span><span class="NLM_article-title">Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">549</span><span class="NLM_x">–</span> <span class="NLM_lpage">563</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1996&pages=549-563&author=H.+M.+Brysonauthor=B.+Fultonauthor=P.+Benfield&title=Riluzole.+A+review+of+its+pharmacodynamic+and+pharmacokinetic+properties+and+therapeutic+potential+in+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBryson%26aufirst%3DH.%2BM.%26aulast%3DFulton%26aufirst%3DB.%26aulast%3DBenfield%26aufirst%3DP.%26atitle%3DRiluzole.%2520A%2520review%2520of%2520its%2520pharmacodynamic%2520and%2520pharmacokinetic%2520properties%2520and%2520therapeutic%2520potential%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DDrugs%26date%3D1996%26volume%3D52%26spage%3D549%26epage%3D563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Jankovic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, C.</span><span> </span><span class="NLM_article-title">A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson’s disease</span> <span class="citation_source-journal">Parkinsonism Relat. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS1353-8020%2801%2900040-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12039422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD383pvFeltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=271-276&author=J.+Jankovicauthor=C.+Hunter&title=A+double-blind%2C+placebo-controlled+and+longitudinal+study+of+riluzole+in+early+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson's disease</span></div><div class="casAuthors">Jankovic J; Hunter C</div><div class="citationInfo"><span class="NLM_cas:title">Parkinsonism & related disorders</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">271-6</span>
        ISSN:<span class="NLM_cas:issn">1353-8020</span>.
    </div><div class="casAbstract">BACKGROUND:  To the extent that excitotoxicity may play a role in the pathogenesis of certain neurodegenerative disorders, antagonists of glutamate, an excitatory neurotransmitter, should exert neuroprotective effects in these disorders, including Parkinson's disease (PD).  METHODS:  Patients in early stages of PD, not previously treated with levodopa, were randomized to receive riluzole 50mg capsules orally, taken twice daily or a matching placebo.  All subjects were evaluated at baseline (pre-treatment), at 1, 3 and 6 months (post-treatment), and following a 6-week washout.  After the washout, all subjects were offered an enrollment in an open label, 1-year, extension study.  The principal investigator (JJ), however, remained blinded to the original assignment during the entire study.  The patients were assessed by the Unified Parkinson's Disease Rating Scale (UPDRS), Activities of Daily Living (ADL), Hoehn & Yahr (HY) stage, and Schwab and England (SE) ADL scale.  The quantitative assessments included Movement Time (MT) and Reaction Time (RT).  Additionally, the time to initiate dopaminergic therapy was assessed.  Safety was determined at each visit by clinical history and examination, a panel of blood safety laboratory tests including complete blood count, chemistry profile, and liver function studies.  RESULTS:  Twenty patients with a mean age of 62+/-9.02 (range: 46-73) years and mean duration of symptoms of 18+/-9.53 (range: 6-36) months were enrolled.  One patient withdrew from the study because he needed more aggressive treatment of his symptoms.  Analysis of the efficacy variables showed no meaningful symptomatic effect of riluzole on UPDRS score.  Likewise, there was no significant change in the median HY stage, SE ADL rating, or the MT/RT.  Seventeen patients (mean age 62+/-9.26) elected to continue in the open label extension study.  Although the observed deterioration in UPDRS scores seemed to be more pronounced in the placebo group than in the riluzole group, the difference did not reach statistical significance.  There was no statistically significant difference in the latency between enrollment and start of symptomatic therapy when patients initially treated with riluzole were compared to those initially treated with placebo (8.3 vs 9 months).  CONCLUSIONS:  This pilot and extension study showed that riluzole, 100mg/day, was well tolerated in patients with early PD.  No evidence of symptomatic effect of riluzole was observed.  Because of the exploratory nature of the design and small size of the study, it was not possible to determine whether riluzole affected the natural history of PD.  The encouraging results from our study, however, suggest that larger, longitudinal studies are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwgbyGZno1elMGsG_HTXYFfW6udTcc2ebD5jIpAFOxsbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD383pvFeltA%253D%253D&md5=80f43b00c7d61590045e4dcaeb9843ca</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2FS1353-8020%2801%2900040-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1353-8020%252801%252900040-2%26sid%3Dliteratum%253Aachs%26aulast%3DJankovic%26aufirst%3DJ.%26aulast%3DHunter%26aufirst%3DC.%26atitle%3DA%2520double-blind%252C%2520placebo-controlled%2520and%2520longitudinal%2520study%2520of%2520riluzole%2520in%2520early%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DParkinsonism%2520Relat.%2520Disord.%26date%3D2002%26volume%3D8%26spage%3D271%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Landwehrmeyer, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Yébenes, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaus, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przuntek, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dib, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doble, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, W.</span><span> </span><span class="NLM_article-title">Riluzole in Huntington’s disease: a 3-year, randomized controlled study</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1002%2Fana.21181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=17702031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1CntrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2007&pages=262-272&author=G.+B.+Landwehrmeyerauthor=B.+Duboisauthor=J.+G.+de+Y%C3%A9benesauthor=B.+Kremerauthor=W.+Gausauthor=P.+H.+Krausauthor=H.+Przuntekauthor=M.+Dibauthor=A.+Dobleauthor=W.+Fischer&title=Riluzole+in+Huntington%E2%80%99s+disease%3A+a+3-year%2C+randomized+controlled+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Riluzole in Huntington's disease: a 3-year, randomized controlled study</span></div><div class="casAuthors">Landwehrmeyer, G. Bernhard; Dubois, Bruno; Garcia de Yebenes, Justo; Kremer, Berry; Gaus, Wilhelm; Kraus, Peter H.; Przuntek, Horst; Dib, Michel; Doble, Adam; Fischer, Wilhelm; Ludolph, Albert C.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">262-272</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Objective: We conducted a randomized double-blind trial of riluzole in Huntington's disease to investigate the efficacy of this antiexcitotoxic drug in slowing disease progression.  Methods: The study included 537 adult patients with a clin. diagnosis of Huntington's disease confirmed by genotyping.  Patients were randomized (2:1) to treatment with riluzole (50mg twice daily) or placebo for 3 years.  Concomitant use of antichoreic medication was forbidden, and introduction of such medication was a predefined end point.  The primary outcome measure was change in a combined score derived from the motor and total functional capacity subscores of the Unified Huntington's Disease Rating Scale.  Safety was also evaluated.  Results: A total of 379 patients completed the study (mean age, 47 [std. deviation, 9.5] years; 50% female patients).  The principal reason for discontinuation was introduction of antichoreic medication.  The median change from baseline in the combined score (primary outcome) for the "per protocol" population was 13.7 (95% confidence interval, 11.1-17.2) in the placebo group and 14.3 (95% confidence interval, 11.7-16.6) in the riluzole group.  No intergroup difference in outcome could thus be demonstrated (p = 0.93, Mann-Whitney U test).  No differences in secondary efficacy outcome variables were obsd. except for more frequent recourse to antichoreic medication in the placebo group.  No unexpected adverse events were reported, and tolerability was acceptable.  Interpretation: No neuroprotective or beneficial symptomatic effects of riluzole in Huntington's disease were demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE8dqPKeW6FLVg90H21EOLACvtfcHk0lgT3Z8vgzP9RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1CntrvO&md5=d1c4e80b7e583fb63b1b5f73501aeece</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1002%2Fana.21181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.21181%26sid%3Dliteratum%253Aachs%26aulast%3DLandwehrmeyer%26aufirst%3DG.%2BB.%26aulast%3DDubois%26aufirst%3DB.%26aulast%3Dde%2BY%25C3%25A9benes%26aufirst%3DJ.%2BG.%26aulast%3DKremer%26aufirst%3DB.%26aulast%3DGaus%26aufirst%3DW.%26aulast%3DKraus%26aufirst%3DP.%2BH.%26aulast%3DPrzuntek%26aufirst%3DH.%26aulast%3DDib%26aufirst%3DM.%26aulast%3DDoble%26aufirst%3DA.%26aulast%3DFischer%26aufirst%3DW.%26atitle%3DRiluzole%2520in%2520Huntington%25E2%2580%2599s%2520disease%253A%2520a%25203-year%252C%2520randomized%2520controlled%2520study%26jtitle%3DAnn.%2520Neurol.%26date%3D2007%26volume%3D62%26spage%3D262%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Lee, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Z. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emdad, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borjabad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volsky, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, P. B.</span><span> </span><span class="NLM_article-title">Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">13116</span><span class="NLM_x">–</span> <span class="NLM_lpage">13123</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=13116-13123&author=S.+G.+Leeauthor=Z.+Z.+Suauthor=L.+Emdadauthor=P.+Guptaauthor=D.+Sarkarauthor=A.+Borjabadauthor=D.+J.+Volskyauthor=P.+B.+Fisher&title=Mechanism+of+ceftriaxone+induction+of+excitatory+amino+acid+transporter-2+expression+and+glutamate+uptake+in+primary+human+astrocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BG.%26aulast%3DSu%26aufirst%3DZ.%2BZ.%26aulast%3DEmdad%26aufirst%3DL.%26aulast%3DGupta%26aufirst%3DP.%26aulast%3DSarkar%26aufirst%3DD.%26aulast%3DBorjabad%26aufirst%3DA.%26aulast%3DVolsky%26aufirst%3DD.%2BJ.%26aulast%3DFisher%26aufirst%3DP.%2BB.%26atitle%3DMechanism%2520of%2520ceftriaxone%2520induction%2520of%2520excitatory%2520amino%2520acid%2520transporter-2%2520expression%2520and%2520glutamate%2520uptake%2520in%2520primary%2520human%2520astrocytes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D13116%26epage%3D13123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Nicoletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casabona, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knöpfel, T.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders?</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1996&pages=267-271&author=F.+Nicolettiauthor=V.+Brunoauthor=A.+Copaniauthor=G.+Casabonaauthor=T.+Kn%C3%B6pfel&title=Metabotropic+glutamate+receptors%3A+a+new+target+for+the+therapy+of+neurodegenerative+disorders%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNicoletti%26aufirst%3DF.%26aulast%3DBruno%26aufirst%3DV.%26aulast%3DCopani%26aufirst%3DA.%26aulast%3DCasabona%26aufirst%3DG.%26aulast%3DKn%25C3%25B6pfel%26aufirst%3DT.%26atitle%3DMetabotropic%2520glutamate%2520receptors%253A%2520a%2520new%2520target%2520for%2520the%2520therapy%2520of%2520neurodegenerative%2520disorders%253F%26jtitle%3DTrends%2520Neurosci.%26date%3D1996%26volume%3D19%26spage%3D267%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Caraci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battaglia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sortino, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spampinato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, V.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptors in neurodegeneration/neuroprotection: Still a hot topic?</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">565</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.neuint.2012.01.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=22306345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvFGiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=559-565&author=F.+Caraciauthor=G.+Battagliaauthor=M.+A.+Sortinoauthor=S.+Spampinatoauthor=G.+Molinaroauthor=A.+Copaniauthor=F.+Nicolettiauthor=V.+Bruno&title=Metabotropic+glutamate+receptors+in+neurodegeneration%2Fneuroprotection%3A+Still+a+hot+topic%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Metabotropic glutamate receptors in neurodegeneration/neuroprotection: Still a hot topic?</span></div><div class="casAuthors">Caraci, Filippo; Battaglia, Giuseppe; Sortino, Maria Angela; Spampinato, Simona; Molinaro, Gemma; Copani, Agata; Nicoletti, Ferdinando; Bruno, Valeria</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">559-565</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Moving from early studies, we here review the most recent evidence linking metabotropic glutamate (mGlu) receptors to processes of neurodegeneration/neuroprotection.  The use of knockout mice and subtype-selective drugs has increased our knowledge of the precise role played by individual mGlu receptor subtypes in these processes.  Activation of mGlu1 and mGlu5 receptors may either amplify or reduce neuronal damage depending on the context and the nature of the toxic insults.  In contrast, mGlu1 and mGlu5 receptors antagonists are consistently protective in in vitro and in vivo models of neuronal death.  A series of studies suggest that mGlu1 receptor antagonists or neg. allosteric modulators (NAMs) are promising candidates for the treatment of ischemic brain damage, whereas mGlu5 receptor NAMs, which have been clin. developed for the treatment of Parkinson's disease (PD) and l-DOPA-induced dyskinesias, protect nigro-striatal dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity in mice and monkeys.  Activation of glial mGlu3 receptors promotes the formation of various neurotrophic factors, such as transforming growth factor-β (TGF-β), glial-derived neurotrophic factor (GDNF), nerve growth factor (NGF), and brain-derived neurotrophic factor (BDNF).  Hence, selective mGlu3 receptor agonists or pos. allosteric modulators (PAMs) (not yet available) are potentially helpful in the treatment of chronic neurodegenerative disorders such as PD, Alzheimer's disease (AD), and amyotrophic lateral sclerosis.  Selective mGlu2 receptor PAMs should be used with caution in AD patients because these drugs are shown to amplify β-amyloid neurotoxicity.  Finally, mGlu4 receptor agonists/PAMs share with mGlu5 receptor NAMs the ability to improve motor symptoms assocd. with PD and attenuate nigro-striatal degeneration at the same time.  No data are yet available on the role of mGlu7 and mGlu8 receptors in neurodegeneration/neuroprotection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfeMJzXS3HjrVg90H21EOLACvtfcHk0lgT3Z8vgzP9RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvFGiurs%253D&md5=9ba8e6da902ee0e7063fbe4fe7a9d529</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2012.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2012.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DCaraci%26aufirst%3DF.%26aulast%3DBattaglia%26aufirst%3DG.%26aulast%3DSortino%26aufirst%3DM.%2BA.%26aulast%3DSpampinato%26aufirst%3DS.%26aulast%3DMolinaro%26aufirst%3DG.%26aulast%3DCopani%26aufirst%3DA.%26aulast%3DNicoletti%26aufirst%3DF.%26aulast%3DBruno%26aufirst%3DV.%26atitle%3DMetabotropic%2520glutamate%2520receptors%2520in%2520neurodegeneration%252Fneuroprotection%253A%2520Still%2520a%2520hot%2520topic%253F%26jtitle%3DNeurochem.%2520Int.%26date%3D2012%26volume%3D61%26spage%3D559%26epage%3D565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Gregory, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meiler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Allosteric modulation of metabotropic glutamate receptors: structural insights and therapeutic potential</span> <span class="citation_source-journal">Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.neuropharm.2010.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20637216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVaitLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=66-81&author=K.+J.+Gregoryauthor=E.+N.+Dongauthor=J.+Meilerauthor=P.+J.+Conn&title=Allosteric+modulation+of+metabotropic+glutamate+receptors%3A+structural+insights+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulation of metabotropic glutamate receptors: Structural insights and therapeutic potential</span></div><div class="casAuthors">Gregory, Karen J.; Dong, Elizabeth N.; Meiler, Jens; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-81</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Allosteric modulation of G protein-coupled receptors (GPCRs) represents a novel approach to the development of probes and therapeutics that is expected to enable subtype-specific regulation of central nervous system target receptors.  The metabotropic glutamate receptors (mGlus) are class C GPCRs that play important neuromodulatory roles throughout the brain, as such they are attractive targets for therapeutic intervention for a no. of psychiatric and neurol. disorders including anxiety, depression, Fragile X Syndrome, Parkinson's disease and schizophrenia.  Over the last fifteen years, selective allosteric modulators have been identified for many members of the mGlu family.  The vast majority of these allosteric modulators are thought to bind within the transmembrane-spanning domains of the receptors to enhance or inhibit functional responses.  A combination of mutagenesis-based studies and pharmacol. approaches are beginning to provide a better understanding of mGlu allosteric sites.  Collectively, when mapped onto a homol. model of the different mGlu subtypes based on the β2-adrenergic receptor, the previous mutagenesis studies suggest commonalities in the location of allosteric sites across different members of the mGlu family.  In addn., there is evidence for multiple allosteric binding pockets within the transmembrane region that can interact to modulate one another.  In the absence of a class C GPCR crystal structure, this approach has shown promise with respect to the interpretation of mutagenesis data and understanding structure-activity relationships of allosteric modulator pharmacophores.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMx_dBAbcb-7Vg90H21EOLACvtfcHk0lgT3Z8vgzP9RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVaitLzE&md5=18c401c0442d322a116e6f3ff871c096</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2010.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2010.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DGregory%26aufirst%3DK.%2BJ.%26aulast%3DDong%26aufirst%3DE.%2BN.%26aulast%3DMeiler%26aufirst%3DJ.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DAllosteric%2520modulation%2520of%2520metabotropic%2520glutamate%2520receptors%253A%2520structural%2520insights%2520and%2520therapeutic%2520potential%26jtitle%3DNeuropharmacol.%26date%3D2011%26volume%3D60%26spage%3D66%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Striggow, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrlich, B. E.</span><span> </span><span class="NLM_article-title">Ligand-gated calcium channels inside and out</span> <span class="citation_source-journal">Curr. Opin. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">495</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0955-0674%2896%2980025-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=8791458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK28Xks1Gqtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1996&pages=490-495&author=F.+Striggowauthor=B.+E.+Ehrlich&title=Ligand-gated+calcium+channels+inside+and+out"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand-gated calcium channels inside and out</span></div><div class="casAuthors">Striggow, Frank; Ehrlich, Barbara E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">490-495</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">A review with 57 refs.  Calcium release from intracellular stores occurs through two types of channels assocd. with intracellular membranes, namely, the ryanodine receptor and the inositol 1,4,5-trisphosphate receptor.  Recently, it has been shown that these channels are regulated by allosteric mechanisms and assocd. proteins.  Release of intracellular calcium induces the opening of calcium-permeable channels on the plasma membrane.  Current work has focused on the mol. and functional characterization of these channels which have been identified as store-operated channels or calcium release activated channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJHAyoeCJshLVg90H21EOLACvtfcHk0liLctsrFbBKug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xks1Gqtbg%253D&md5=b7cae19ec73d798958ff79d73f65c7ad</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2FS0955-0674%2896%2980025-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0955-0674%252896%252980025-1%26sid%3Dliteratum%253Aachs%26aulast%3DStriggow%26aufirst%3DF.%26aulast%3DEhrlich%26aufirst%3DB.%2BE.%26atitle%3DLigand-gated%2520calcium%2520channels%2520inside%2520and%2520out%26jtitle%3DCurr.%2520Opin.%2520Cell.%2520Biol.%26date%3D1996%26volume%3D8%26spage%3D490%26epage%3D495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Zamponi, G. W.</span> <span class="citation_source-book">Voltage-Gated Calcium Channels</span>; <span class="NLM_publisher-name">Kluwer Academic</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=G.+W.+Zamponi&title=Voltage-Gated+Calcium+Channels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DZamponi%26aufirst%3DG.%2BW.%26btitle%3DVoltage-Gated%2520Calcium%2520Channels%26pub%3DKluwer%2520Academic%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Berridge, M. J.</span><span> </span><span class="NLM_article-title">Neuronal calcium signaling</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0896-6273%2800%2980510-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=9697848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1cXltFyiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1998&pages=13-26&author=M.+J.+Berridge&title=Neuronal+calcium+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal calcium signaling</span></div><div class="casAuthors">Berridge, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-26</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review, with ∼140 refs., on the idea that the endoplasmic reticulum and the plasma membrane form a binary membrane system that functions to regulate a variety of neuronal processes including excitability, associativity, neurotransmitter release, synaptic plasticity, and gene transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyPCiryD0p87Vg90H21EOLACvtfcHk0liLctsrFbBKug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltFyiu7s%253D&md5=281b01e305302373a2b92a86d709eedc</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2800%2980510-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252800%252980510-3%26sid%3Dliteratum%253Aachs%26aulast%3DBerridge%26aufirst%3DM.%2BJ.%26atitle%3DNeuronal%2520calcium%2520signaling%26jtitle%3DNeuron%26date%3D1998%26volume%3D21%26spage%3D13%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Catterall, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Striessnig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snutch, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Reyes, E.</span><span> </span><span class="NLM_article-title">International Union of Pharmacology. XL. Compendium of voltage-gated ion channels: calcium channels</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">581</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2003&pages=579-581&author=W.+A.+Catterallauthor=J.+Striessnigauthor=T.+P.+Snutchauthor=E.+Perez-Reyes&title=International+Union+of+Pharmacology.+XL.+Compendium+of+voltage-gated+ion+channels%3A+calcium+channels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCatterall%26aufirst%3DW.%2BA.%26aulast%3DStriessnig%26aufirst%3DJ.%26aulast%3DSnutch%26aufirst%3DT.%2BP.%26aulast%3DPerez-Reyes%26aufirst%3DE.%26atitle%3DInternational%2520Union%2520of%2520Pharmacology.%2520XL.%2520Compendium%2520of%2520voltage-gated%2520ion%2520channels%253A%2520calcium%2520channels%26jtitle%3DPharmacol.%2520Rev.%26date%3D2003%26volume%3D55%26spage%3D579%26epage%3D581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Eisenberg, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brox, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bestawros, A. N.</span><span> </span><span class="NLM_article-title">Calcium channel blockers: an update</span> <span class="citation_source-journal">Am. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.amjmed.2003.08.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=14706664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptVar" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2004&pages=35-43&author=M.+J.+Eisenbergauthor=A.+Broxauthor=A.+N.+Bestawros&title=Calcium+channel+blockers%3A+an+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium channel blockers: an update</span></div><div class="casAuthors">Eisenberg, Mark J.; Brox, Anya; Bestawros, Alain N.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-43</span>CODEN:
                <span class="NLM_cas:coden">AJMEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0002-9343</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  This paper reviews the current literature pertaining to calcium channel blockers, including their classification, properties, and therapeutic indications, in light of several recent trials that have addressed their safety.  Calcium channel blockers are a structurally and functionally heterogeneous group of medications that are used widely to control blood pressure and manage symptoms of angina.  They are classified as dihydropyridines or nondihydropyridines.  As a class, they are well tolerated and are assocd. with few side effects.  The question of whether they may ppt. cardiovascular events has been largely settled by recent trials, such as the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), the International Verapamil Slow-Release/Trandolapril Study (INVEST), and the Controlled Onset Verapamil Investigation of Cardiovascular Endpoints (CONVINCE) study, in which no such assocn. was found.  Even so, the use of these agents has been linked with an increased risk of heart failure.  Thus, long-acting calcium channel blockers may be safely used in the management of hypertension and angina.  However, as a class, they are not as protective as other antihypertensive agents against heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5AKwsyK8bMbVg90H21EOLACvtfcHk0liLctsrFbBKug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptVar&md5=32fe50b365109ee5efb0694e7d368d0f</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.amjmed.2003.08.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjmed.2003.08.027%26sid%3Dliteratum%253Aachs%26aulast%3DEisenberg%26aufirst%3DM.%2BJ.%26aulast%3DBrox%26aufirst%3DA.%26aulast%3DBestawros%26aufirst%3DA.%2BN.%26atitle%3DCalcium%2520channel%2520blockers%253A%2520an%2520update%26jtitle%3DAm.%2520J.%2520Med.%26date%3D2004%26volume%3D116%26spage%3D35%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Striessnig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koschak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinnegger-Brauns, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hetzenauer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busquet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelster, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singewald, N.</span><span> </span><span class="NLM_article-title">Role of voltage-gated L-type Ca<sup>2+</sup> channel isoforms for brain function</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">903</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1042%2FBST0340903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=17052224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWnsb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=903-909&author=J.+Striessnigauthor=A.+Koschakauthor=M.+J.+Sinnegger-Braunsauthor=A.+Hetzenauerauthor=N.+K.+Nguyenauthor=P.+Busquetauthor=G.+Pelsterauthor=N.+Singewald&title=Role+of+voltage-gated+L-type+Ca2%2B+channel+isoforms+for+brain+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Role of voltage-gated L-type Ca2+ channel isoforms for brain function</span></div><div class="casAuthors">Striessnig, J.; Koschak, A.; Sinnegger-brauns, M. J.; Hetzenauer, A.; Nguyen, N. K.; Busquet, P.; Pelster, G.; Singewald, N.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">903-909</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Voltage-gated L-type Ca2+ channels (LTCCs) are established drug targets for the treatment of cardiovascular diseases.  LTCCs are also expressed outside the cardiovascular system.  In the brain, LTCCs control synaptic plasticity in neurons, and dihydropyridine (DHP) LTCC blockers such as nifedipine modulate brain function (such as fear memory extinction and depression-like behavior).  Voltage-sensitive Ca2+ channels Cav1.2 and Cav1.3 are the predominant brain LTCCs.  As DHPs and other classes of org. LTCC blockers inhibit both isoforms, their pharmacol. distinction is impossible and their individual contributions to defined brain functions remain largely unknown.  Here, the authors summarize their recent expts. with 2 genetically modified mouse strains, which they generated to explore the individual biophys. features of Cav1.2 and Cav1.3 LTCCs and to det. their relative contributions to various physiol. peripheral and neuronal functions.  The results described here also allow predictions about the pharmacotherapeutic potential of isoform-selective LTCC modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLb1-8LxXKC7Vg90H21EOLACvtfcHk0lhfpuOTVscDgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWnsb%252FM&md5=8ed33de666e79a9946a835ee2ecbcdda</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1042%2FBST0340903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0340903%26sid%3Dliteratum%253Aachs%26aulast%3DStriessnig%26aufirst%3DJ.%26aulast%3DKoschak%26aufirst%3DA.%26aulast%3DSinnegger-Brauns%26aufirst%3DM.%2BJ.%26aulast%3DHetzenauer%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DN.%2BK.%26aulast%3DBusquet%26aufirst%3DP.%26aulast%3DPelster%26aufirst%3DG.%26aulast%3DSingewald%26aufirst%3DN.%26atitle%3DRole%2520of%2520voltage-gated%2520L-type%2520Ca2%252B%2520channel%2520isoforms%2520for%2520brain%2520function%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2006%26volume%3D34%26spage%3D903%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Helton, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipscombe, D.</span><span> </span><span class="NLM_article-title">Neuronal L-type calcium channels open quickly and are inhibited slowly</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">10247</span><span class="NLM_x">–</span> <span class="NLM_lpage">10251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1523%2FJNEUROSCI.1089-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=16267232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Wqt7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=10247-10251&author=T.+D.+Heltonauthor=W.+Xuauthor=D.+Lipscombe&title=Neuronal+L-type+calcium+channels+open+quickly+and+are+inhibited+slowly"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal L-type calcium channels open quickly and are inhibited slowly</span></div><div class="casAuthors">Helton, Thomas D.; Xu, Weifeng; Lipscombe, Diane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">10247-10251</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Neuronal L-type calcium channels are essential for regulating activity-dependent gene expression, but they are thought to open too slowly to contribute to action potential-dependent calcium entry.  A complication of studying native L-type channels is that they represent a minor fraction of the whole-cell calcium current in most neurons.  Dihydropyridine antagonists are therefore widely used to establish the contribution of L-type channels to various neuronal processes and to study their underlying biophys. properties.  The effectiveness of these antagonists on L-type channels, however, varies with stimulus and channel subtype.  Here, we study recombinant neuronal L-type calcium channels, Cav1.2 and Cav1.3.  We show that these channels open with fast kinetics and carry substantial calcium entry in response to individual action potential waveforms, contrary to most studies of native L-type currents.  Neuronal Cav1.3 L-type channels were as efficient as Cav2.2 N-type channels at supporting calcium entry during action potential-like stimuli.  We conclude that the apparent slow activation of native L-type currents and their lack of contribution to single action potentials reflect the state-dependent nature of the dihydropyridine antagonists used to study them, not the underlying properties of L-type channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIqLsXeUuipLVg90H21EOLACvtfcHk0lhfpuOTVscDgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Wqt7%252FN&md5=30ece670e34eba79670085f3b81c9e67</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1089-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1089-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DHelton%26aufirst%3DT.%2BD.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DLipscombe%26aufirst%3DD.%26atitle%3DNeuronal%2520L-type%2520calcium%2520channels%2520open%2520quickly%2520and%2520are%2520inhibited%2520slowly%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D10247%26epage%3D10251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Epstein, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, B. F.</span><span> </span><span class="NLM_article-title">Dihydropyridine calcium channel antagonists in the management of hypertension</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1309</span><span class="NLM_x">–</span> <span class="NLM_lpage">1327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=1309-1327&author=B.+J.+Epsteinauthor=K.+Vogelauthor=B.+F.+Palmer&title=Dihydropyridine+calcium+channel+antagonists+in+the+management+of+hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEpstein%26aufirst%3DB.%2BJ.%26aulast%3DVogel%26aufirst%3DK.%26aulast%3DPalmer%26aufirst%3DB.%2BF.%26atitle%3DDihydropyridine%2520calcium%2520channel%2520antagonists%2520in%2520the%2520management%2520of%2520hypertension%26jtitle%3DDrugs%26date%3D2007%26volume%3D67%26spage%3D1309%26epage%3D1327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Chan, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilijic, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rick, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tkatch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surmeier, D. J.</span><span> </span><span class="NLM_article-title">“Rejuvenation” protects neurons in mouse models of Parkinson’s disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">447</span><span class="NLM_x">, </span> <span class="NLM_fpage">1081</span><span class="NLM_x">–</span> <span class="NLM_lpage">1086</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2007&pages=1081-1086&author=C.+S.+Chanauthor=J.+N.+Guzmanauthor=E.+Ilijicauthor=J.+N.+Mercerauthor=C.+Rickauthor=T.+Tkatchauthor=G.+E.+Meredithauthor=D.+J.+Surmeier&title=%E2%80%9CRejuvenation%E2%80%9D+protects+neurons+in+mouse+models+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DC.%2BS.%26aulast%3DGuzman%26aufirst%3DJ.%2BN.%26aulast%3DIlijic%26aufirst%3DE.%26aulast%3DMercer%26aufirst%3DJ.%2BN.%26aulast%3DRick%26aufirst%3DC.%26aulast%3DTkatch%26aufirst%3DT.%26aulast%3DMeredith%26aufirst%3DG.%2BE.%26aulast%3DSurmeier%26aufirst%3DD.%2BJ.%26atitle%3D%25E2%2580%259CRejuvenation%25E2%2580%259D%2520protects%2520neurons%2520in%2520mouse%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D2007%26volume%3D447%26spage%3D1081%26epage%3D1086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Brevetti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaduce, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breglio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perna, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marconi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campanella, G.</span><span> </span><span class="NLM_article-title">Parkinson’s disease and hypotension: 24-hour blood pressure recording in ambulant patients</span> <span class="citation_source-journal">Clin. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">474</span><span class="NLM_x">–</span> <span class="NLM_lpage">478</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1002%2Fclc.4960130709" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=2364581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADyaK3czgsFahtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1990&pages=474-478&author=G.+Brevettiauthor=D.+Bonaduceauthor=R.+Breglioauthor=S.+Pernaauthor=P.+Simonelliauthor=R.+Marconiauthor=G.+Campanella&title=Parkinson%E2%80%99s+disease+and+hypotension%3A+24-hour+blood+pressure+recording+in+ambulant+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Parkinson's disease and hypotension: 24-hour blood pressure recording in ambulant patients</span></div><div class="casAuthors">Brevetti G; Bonaduce D; Breglio R; Perna S; Simonelli P; Marconi R; Campanella G</div><div class="citationInfo"><span class="NLM_cas:title">Clinical cardiology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">474-8</span>
        ISSN:<span class="NLM_cas:issn">0160-9289</span>.
    </div><div class="casAbstract">Continuous intra-arterial blood pressure was recorded in 5 ambulatory patients with Parkinson's disease and in 5 control subjects.  The 24-h mean systolic blood pressure was 135 +/- 7.6 mmHg in controls and 123.8 +/- 8.1 mmHg (p less than 0.01) in the parkinsonian group.  Similarly, diastolic blood pressure was 89 +/- 8.1 mmHg in the control group while in the parkinsonian patients it was lower, 69.4 +/- 5.8 (p less than 0.01).  Averages were also calculated for 8-h periods, the results of which indicate that both systolic and diastolic blood pressure were significantly lower in patients than in controls in all three 8-h periods of the day.  We normalized the blood pressure curve to mealtimes and arousal times and did not observe any difference between parkinsonian patients and controls.  This first study reporting continuous intra-arterial blood pressure measurements in ambulant parkinsonian patients demonstrates that blood pressure in such patients is lower than the mean for their age group.  This finding may be of direct relevance in the management of idiopathic parkinsonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQhFUz3M74nee3MPKNEWB5RfW6udTcc2eYT_88Lkt8Rnrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3czgsFahtw%253D%253D&md5=f8717c427d26d2d3b167ab198e5e48bb</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1002%2Fclc.4960130709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fclc.4960130709%26sid%3Dliteratum%253Aachs%26aulast%3DBrevetti%26aufirst%3DG.%26aulast%3DBonaduce%26aufirst%3DD.%26aulast%3DBreglio%26aufirst%3DR.%26aulast%3DPerna%26aufirst%3DS.%26aulast%3DSimonelli%26aufirst%3DP.%26aulast%3DMarconi%26aufirst%3DR.%26aulast%3DCampanella%26aufirst%3DG.%26atitle%3DParkinson%25E2%2580%2599s%2520disease%2520and%2520hypotension%253A%252024-hour%2520blood%2520pressure%2520recording%2520in%2520ambulant%2520patients%26jtitle%3DClin.%2520Cardiol.%26date%3D1990%26volume%3D13%26spage%3D474%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Sinnegger-Brauns, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koschak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wild, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obermair, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einzinger, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoda, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartori, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Striessnig, J.</span><span> </span><span class="NLM_article-title">Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">414</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2009&pages=407-414&author=M.+J.+Sinnegger-Braunsauthor=I.+G.+Huberauthor=A.+Koschakauthor=C.+Wildauthor=G.+J.+Obermairauthor=U.+Einzingerauthor=J.+C.+Hodaauthor=S.+B.+Sartoriauthor=J.+Striessnig&title=Expression+and+1%2C4-dihydropyridine-binding+properties+of+brain+L-type+calcium+channel+isoforms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSinnegger-Brauns%26aufirst%3DM.%2BJ.%26aulast%3DHuber%26aufirst%3DI.%2BG.%26aulast%3DKoschak%26aufirst%3DA.%26aulast%3DWild%26aufirst%3DC.%26aulast%3DObermair%26aufirst%3DG.%2BJ.%26aulast%3DEinzinger%26aufirst%3DU.%26aulast%3DHoda%26aufirst%3DJ.%2BC.%26aulast%3DSartori%26aufirst%3DS.%2BB.%26aulast%3DStriessnig%26aufirst%3DJ.%26atitle%3DExpression%2520and%25201%252C4-dihydropyridine-binding%2520properties%2520of%2520brain%2520L-type%2520calcium%2520channel%2520isoforms%26jtitle%3DMol.%2520Pharmacol.%26date%3D2009%26volume%3D75%26spage%3D407%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipscombe, D.</span><span> </span><span class="NLM_article-title">Neuronal Ca(V)1.3alpha(1) L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5944</span><span class="NLM_x">–</span> <span class="NLM_lpage">5951</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11487617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvFKms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=5944-5951&author=W.+Xuauthor=D.+Lipscombe&title=Neuronal+Ca%28V%291.3alpha%281%29+L-type+channels+activate+at+relatively+hyperpolarized+membrane+potentials+and+are+incompletely+inhibited+by+dihydropyridines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal CaV1.3α1 L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines</span></div><div class="casAuthors">Xu, Weifeng; Lipscombe, Diane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5944-5951</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">L-type calcium channels regulate a diverse array of cellular functions within excitable cells.  Of the 4 molecularly defined subclasses of L-type Ca channels, 2 are expressed ubiquitously in the mammalian nervous system (CaV1.2α1 and CaV1.3α1).  Despite diversity at the mol. level, neuronal L-type channels are generally assumed to be functionally and pharmacol. similar, i.e., high-voltage activated and highly sensitive to dihydropyridines.  We now show that CaV1.3α1 L-type channels activate at membrane potentials ∼25 mV more hyperpolarized, compared with CaV1.2α1.  This unusually neg. activation threshold for CaV1.3α1 channels is independent of the specific auxiliary subunits coexpressed, of alternative splicing in domains I-II, IVS3-IVS4, and the C terminus, and of the expression system.  The use of high concns. of extracellular divalent cations has possibly obscured the unique voltage-dependent properties of CaV1.3α1 in certain previous studies.  We also demonstrate that CaV1.3α1 channels are pharmacol. distinct from CaV1.2α1.  The IC50 for nimodipine block of CaV1.3α1 L-type calcium channel currents is 2.7 μM, a value 20-fold higher than the concn. required to block CaV1.2α1.  The relatively low sensitivity of the CaV1.3α1 subunit to inhibition by dihydropyridine is unaffected by alternative splicing in the IVS3-IVS4 linker.  Our results suggest that functional and pharmacol. criteria used commonly to distinguish among different Ca currents greatly underestimate the biol. importance of L-type channels in cells expressing CaV1.3α1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRRfO-OII9w7Vg90H21EOLACvtfcHk0ljBeNbmO2vxEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvFKms7o%253D&md5=6d9b9f0cba3dd45cbdc3b6a9e7d4011d</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DW.%26aulast%3DLipscombe%26aufirst%3DD.%26atitle%3DNeuronal%2520Ca%2528V%25291.3alpha%25281%2529%2520L-type%2520channels%2520activate%2520at%2520relatively%2520hyperpolarized%2520membrane%2520potentials%2520and%2520are%2520incompletely%2520inhibited%2520by%2520dihydropyridines%26jtitle%3DJ.%2520Neurosci.%26date%3D2001%26volume%3D21%26spage%3D5944%26epage%3D5951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Chang, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunne, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luan, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surmeier, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Antagonism of 4-substituted 1,4-dihydropyridine-3,5-dicarboxylates toward voltage-dependent L-type Ca<sup>2+</sup> channels Ca V 1.3 and Ca V 1.2</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3147</span><span class="NLM_x">–</span> <span class="NLM_lpage">3158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=3147-3158&author=C.+C.+Changauthor=S.+Caoauthor=S.+Kangauthor=L.+Kaiauthor=X.+Tianauthor=P.+Pandeyauthor=S.+F.+Dunneauthor=C.+H.+Luanauthor=D.+J.+Surmeierauthor=R.+B.+Silverman&title=Antagonism+of+4-substituted+1%2C4-dihydropyridine-3%2C5-dicarboxylates+toward+voltage-dependent+L-type+Ca2%2B+channels+Ca+V+1.3+and+Ca+V+1.2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DC.%2BC.%26aulast%3DCao%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DKai%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DPandey%26aufirst%3DP.%26aulast%3DDunne%26aufirst%3DS.%2BF.%26aulast%3DLuan%26aufirst%3DC.%2BH.%26aulast%3DSurmeier%26aufirst%3DD.%2BJ.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DAntagonism%2520of%25204-substituted%25201%252C4-dihydropyridine-3%252C5-dicarboxylates%2520toward%2520voltage-dependent%2520L-type%2520Ca2%252B%2520channels%2520Ca%2520V%25201.3%2520and%2520Ca%2520V%25201.2%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D3147%26epage%3D3158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Sorkin, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clissold, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogden, R. N.</span><span> </span><span class="NLM_article-title">Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1985&pages=182-274&author=E.+M.+Sorkinauthor=S.+P.+Clissoldauthor=R.+N.+Brogden&title=Nifedipine.+A+review+of+its+pharmacodynamic+and+pharmacokinetic+properties%2C+and+therapeutic+efficacy%2C+in+ischaemic+heart+disease%2C+hypertension+and+related+cardiovascular+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSorkin%26aufirst%3DE.%2BM.%26aulast%3DClissold%26aufirst%3DS.%2BP.%26aulast%3DBrogden%26aufirst%3DR.%2BN.%26atitle%3DNifedipine.%2520A%2520review%2520of%2520its%2520pharmacodynamic%2520and%2520pharmacokinetic%2520properties%252C%2520and%2520therapeutic%2520efficacy%252C%2520in%2520ischaemic%2520heart%2520disease%252C%2520hypertension%2520and%2520related%2520cardiovascular%2520disorders%26jtitle%3DDrugs%26date%3D1985%26volume%3D30%26spage%3D182%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Xia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benmohamed, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arvanites, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morimoto, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrante, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirsch, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Pyrimidine-2,4,6-trione derivatives and their inhibition of mutant SOD1-dependent protein aggregation. Toward a treatment for amyotrophic lateral sclerosis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2409</span><span class="NLM_x">–</span> <span class="NLM_lpage">2421</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101549k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2409-2421&author=G.+Xiaauthor=R.+Benmohamedauthor=J.+Kimauthor=A.+C.+Arvanitesauthor=R.+I.+Morimotoauthor=R.+J.+Ferranteauthor=D.+R.+Kirschauthor=R.+B.+Silverman&title=Pyrimidine-2%2C4%2C6-trione+derivatives+and+their+inhibition+of+mutant+SOD1-dependent+protein+aggregation.+Toward+a+treatment+for+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Fjm101549k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101549k%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DG.%26aulast%3DBenmohamed%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DArvanites%26aufirst%3DA.%2BC.%26aulast%3DMorimoto%26aufirst%3DR.%2BI.%26aulast%3DFerrante%26aufirst%3DR.%2BJ.%26aulast%3DKirsch%26aufirst%3DD.%2BR.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DPyrimidine-2%252C4%252C6-trione%2520derivatives%2520and%2520their%2520inhibition%2520of%2520mutant%2520SOD1-dependent%2520protein%2520aggregation.%2520Toward%2520a%2520treatment%2520for%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2409%26epage%3D2421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunne, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dusel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luan, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surmeier, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Ca(V)1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson’s disease</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fncomms2149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252Fns1Gnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1146&author=S.+Kangauthor=G.+Cooperauthor=S.+F.+Dunneauthor=B.+Duselauthor=C.+H.+Luanauthor=D.+J.+Surmeierauthor=R.+B.+Silverman&title=Ca%28V%291.3-selective+L-type+calcium+channel+antagonists+as+potential+new+therapeutics+for+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease</span></div><div class="casAuthors">Kang Soosung; Cooper Garry; Dunne Sara F; Dusel Brendon; Luan Chi-Hao; Surmeier D James; Silverman Richard B</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1146</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">L-type calcium channels expressed in the brain are heterogeneous.  The predominant class of L-type calcium channels has a Ca(V)1.2 pore-forming subunit.  L-type calcium channels with a Ca(V)1.3 pore-forming subunit are much less abundant, but have been implicated in the generation of mitochondrial oxidant stress underlying pathogenesis in Parkinson's disease.  Thus, selectively antagonizing Ca(V)1.3 L-type calcium channels could provide a means of diminishing cell loss in Parkinson's disease without producing side effects accompanying general antagonism of L-type calcium channels.  However, there are no known selective antagonists of Ca(V)1.3 L-type calcium channel.  Here we report high-throughput screening of commercial and 'in-house' chemical libraries and modification of promising hits.  Pyrimidine-2,4,6-triones were identified as a potential scaffold; structure-activity relationship-based modification of this scaffold led to 1-(3-chlorophenethyl)-3-cyclopentylpyrimidine-2,4,6-(1H,3H,5H)-trione (8), a potent and highly selective Ca(V)1.3 L-type calcium channel antagonist.  The biological relevance was confirmed by whole-cell patch-clamp electrophysiology.  These studies describe the first highly selective Ca(V)1.3 L-type calcium channel antagonist and point to a novel therapeutic strategy for Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIlgKYfUH9FVWTCLT8lX9SfW6udTcc2eafMq_TVzLjErntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252Fns1Gnuw%253D%253D&md5=a55b56a37686004d5f9852e4f0c2b53a</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1038%2Fncomms2149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms2149%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DS.%26aulast%3DCooper%26aufirst%3DG.%26aulast%3DDunne%26aufirst%3DS.%2BF.%26aulast%3DDusel%26aufirst%3DB.%26aulast%3DLuan%26aufirst%3DC.%2BH.%26aulast%3DSurmeier%26aufirst%3DD.%2BJ.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DCa%2528V%25291.3-selective%2520L-type%2520calcium%2520channel%2520antagonists%2520as%2520potential%2520new%2520therapeutics%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Commun.%26date%3D2012%26volume%3D3%26spage%3D1146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, S. A.</span><span> </span><span class="NLM_article-title">Cell death: protein misfolding and neurodegenerative diseases</span> <span class="citation_source-journal">Apoptosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=455-468&author=T.+Nakamuraauthor=S.+A.+Lipton&title=Cell+death%3A+protein+misfolding+and+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DLipton%26aufirst%3DS.%2BA.%26atitle%3DCell%2520death%253A%2520protein%2520misfolding%2520and%2520neurodegenerative%2520diseases%26jtitle%3DApoptosis%26date%3D2009%26volume%3D14%26spage%3D455%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Chung, K. K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, K. K.</span><span> </span><span class="NLM_article-title">Emerging roles of nitric oxide in neurodegeneration</span> <span class="citation_source-journal">Nitric Oxide</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">290</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2010&pages=290-295&author=K.+K.+K.+Chungauthor=K.+K.+David&title=Emerging+roles+of+nitric+oxide+in+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DK.%2BK.%2BK.%26aulast%3DDavid%26aufirst%3DK.%2BK.%26atitle%3DEmerging%2520roles%2520of%2520nitric%2520oxide%2520in%2520neurodegeneration%26jtitle%3DNitric%2520Oxide%26date%3D2010%26volume%3D22%26spage%3D290%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Giasson, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duda, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souza, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurtig, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ischiropoulos, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span> </span><span class="NLM_article-title">Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">985</span><span class="NLM_x">–</span> <span class="NLM_lpage">989</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1126%2Fscience.290.5493.985" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11062131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvVWkurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2000&pages=985-989&author=B.+I.+Giassonauthor=J.+E.+Dudaauthor=I.+V.+Murrayauthor=Q.+Chenauthor=J.+M.+Souzaauthor=H.+I.+Hurtigauthor=H.+Ischiropoulosauthor=J.+Q.+Trojanowskiauthor=V.+M.+Lee&title=Oxidative+damage+linked+to+neurodegeneration+by+selective+alpha-synuclein+nitration+in+synucleinopathy+lesions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions</span></div><div class="casAuthors">Giasson, Benoit I.; Duda, John E.; Murray, Ian V. J.; Chen, Qiping; Souza, Jose M.; Hurtig, Howard I.; Ischiropoulos, Harry; Trojanowski, John Q.; Lee, Virginia M.-Y.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">5493</span>),
    <span class="NLM_cas:pages">985-989</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Aggregated α-synuclein proteins form brain lesions that are hallmarks of neurodegenerative synucleinopathies, and oxidative stress has been implicated in the pathogenesis of some of these disorders.  Using antibodies to specific nitrated tyrosine residues in α-synuclein, the authors demonstrate extensive and wide-spread accumulations of nitrated α-synuclein in the signature inclusions of Parkinson's disease, dementia with Lewy bodies, the Lewy body variant of Alzheimer's disease, and multiple system atrophy brains.  The authors also show that nitrated α-synuclein is present in the major filamentous building blocks of these inclusions, as well as in the insol. fractions of affected brain regions of synucleinopathies.  The selective and specific nitration of α-synuclein in these disorders provides evidence to directly link oxidative and nitrative damage to the onset and progression of neurodegenerative synucleinopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0c019GCOzeLVg90H21EOLACvtfcHk0lh2ZoPl02plPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvVWkurY%253D&md5=2b1934a77639403caf4285764d6228c1</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1126%2Fscience.290.5493.985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.290.5493.985%26sid%3Dliteratum%253Aachs%26aulast%3DGiasson%26aufirst%3DB.%2BI.%26aulast%3DDuda%26aufirst%3DJ.%2BE.%26aulast%3DMurray%26aufirst%3DI.%2BV.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DSouza%26aufirst%3DJ.%2BM.%26aulast%3DHurtig%26aufirst%3DH.%2BI.%26aulast%3DIschiropoulos%26aufirst%3DH.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DOxidative%2520damage%2520linked%2520to%2520neurodegeneration%2520by%2520selective%2520alpha-synuclein%2520nitration%2520in%2520synucleinopathy%2520lesions%26jtitle%3DScience%26date%3D2000%26volume%3D290%26spage%3D985%26epage%3D989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Chung, K. K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pletnikova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troncoso, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span> </span><span class="NLM_article-title">S-Nitrosylation of parkin regulates ubiquitination and compromises parkin’s protective function</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">1328</span><span class="NLM_x">–</span> <span class="NLM_lpage">1331</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2004&pages=1328-1331&author=K.+K.+K.+Chungauthor=B.+Thomasauthor=X.+Liauthor=O.+Pletnikovaauthor=J.+C.+Troncosoauthor=L.+Marshauthor=V.+L.+Dawsonauthor=T.+M.+Dawson&title=S-Nitrosylation+of+parkin+regulates+ubiquitination+and+compromises+parkin%E2%80%99s+protective+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DK.%2BK.%2BK.%26aulast%3DThomas%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DPletnikova%26aufirst%3DO.%26aulast%3DTroncoso%26aufirst%3DJ.%2BC.%26aulast%3DMarsh%26aufirst%3DL.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26atitle%3DS-Nitrosylation%2520of%2520parkin%2520regulates%2520ubiquitination%2520and%2520compromises%2520parkin%25E2%2580%2599s%2520protective%2520function%26jtitle%3DScience%26date%3D2004%26volume%3D304%26spage%3D1328%26epage%3D1331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Yao, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Z. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Z.-Q. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaston, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, L. A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockenstein, E. M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masliah, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uehara, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, S. A. S.</span><span> </span><span class="NLM_article-title">Nitrosative stress linked to sporadic Parkinson’s disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">10810</span><span class="NLM_x">–</span> <span class="NLM_lpage">10814</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=10810-10814&author=D.+D.+Yaoauthor=Z.+Z.+Guauthor=T.+T.+Nakamuraauthor=Z.-Q.+Z.+Shiauthor=Y.+Y.+Maauthor=B.+B.+Gastonauthor=L.+A.+L.+Palmerauthor=E.+M.+E.+Rockensteinauthor=Z.+Z.+Zhangauthor=E.+E.+Masliahauthor=T.+T.+Ueharaauthor=S.+A.+S.+Lipton&title=Nitrosative+stress+linked+to+sporadic+Parkinson%E2%80%99s+disease%3A+S-nitrosylation+of+parkin+regulates+its+E3+ubiquitin+ligase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DD.%2BD.%26aulast%3DGu%26aufirst%3DZ.%2BZ.%26aulast%3DNakamura%26aufirst%3DT.%2BT.%26aulast%3DShi%26aufirst%3DZ.-Q.%2BZ.%26aulast%3DMa%26aufirst%3DY.%2BY.%26aulast%3DGaston%26aufirst%3DB.%2BB.%26aulast%3DPalmer%26aufirst%3DL.%2BA.%2BL.%26aulast%3DRockenstein%26aufirst%3DE.%2BM.%2BE.%26aulast%3DZhang%26aufirst%3DZ.%2BZ.%26aulast%3DMasliah%26aufirst%3DE.%2BE.%26aulast%3DUehara%26aufirst%3DT.%2BT.%26aulast%3DLipton%26aufirst%3DS.%2BA.%2BS.%26atitle%3DNitrosative%2520stress%2520linked%2520to%2520sporadic%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520S-nitrosylation%2520of%2520parkin%2520regulates%2520its%2520E3%2520ubiquitin%2520ligase%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D10810%26epage%3D10814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span> </span><span class="NLM_article-title">Nitric oxide in neurodegeneration</span> <span class="citation_source-journal">Prog. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0079-6123%2808%2963210-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=9932444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1cXnvFynsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1998&pages=215-229&author=V.+L.+Dawsonauthor=T.+M.+Dawson&title=Nitric+oxide+in+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide in neurodegeneration</span></div><div class="casAuthors">Dawson, Valina L.; Dawson, Ted M.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Brain Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">Nitric Oxide in Brain Development, Plasticity, and Disease</span>),
    <span class="NLM_cas:pages">215-229</span>CODEN:
                <span class="NLM_cas:coden">PBRRA4</span>;
        ISSN:<span class="NLM_cas:issn">0079-6123</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with 142 refs.  Nitric oxide (NO) is a unique biol. messenger mol. which mediates diverse physiol. roles.  NO mediates blood vessel relaxation by endothelium, immune activity of macrophages and neurotransmission of central and peripheral neurons.  NO is produced from three NO synthase (NOS) isoforms: neuronal NOS (nNOS), endothelial NOS, and inducible NOS (iNOS).  In the central nervous system, NO may play important roles in neurotransmitter release, neurotransmitter reuptake, neurodevelopment, synaptic plasticity, and regulation of gene expression.  However, excessive prodn. of NO following a pathol. insult can lead to neurotoxicity.  NO plays a role in mediating neurotoxicity assocd. with a variety of neurol. disorders, including stroke, Parkinson's disease, and HIV dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFnKDg2Zofr7Vg90H21EOLACvtfcHk0lhixzY1ZLHkmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvFynsbY%253D&md5=93866cb93206194ca52b37929410d2f3</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2FS0079-6123%2808%2963210-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6123%252808%252963210-0%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26atitle%3DNitric%2520oxide%2520in%2520neurodegeneration%26jtitle%3DProg.%2520Brain%2520Res.%26date%3D1998%26volume%3D118%26spage%3D215%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Martínez-Ruiz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villanueva, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González de Orduña, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Ferrer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higueras, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarín, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Crespo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vázquez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamas, S.</span><span> </span><span class="NLM_article-title">S-Nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">8525</span><span class="NLM_x">–</span> <span class="NLM_lpage">8530</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=8525-8530&author=A.+Mart%C3%ADnez-Ruizauthor=L.+Villanuevaauthor=C.+Gonz%C3%A1lez+de+Ordu%C3%B1aauthor=D.+L%C3%B3pez-Ferrerauthor=M.+A.+Higuerasauthor=C.+Tar%C3%ADnauthor=I.+Rodr%C3%ADguez-Crespoauthor=J.+V%C3%A1zquezauthor=S.+Lamas&title=S-Nitrosylation+of+Hsp90+promotes+the+inhibition+of+its+ATPase+and+endothelial+nitric+oxide+synthase+regulatory+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMart%25C3%25ADnez-Ruiz%26aufirst%3DA.%26aulast%3DVillanueva%26aufirst%3DL.%26aulast%3DGonz%25C3%25A1lez%2Bde%2BOrdu%25C3%25B1a%26aufirst%3DC.%26aulast%3DL%25C3%25B3pez-Ferrer%26aufirst%3DD.%26aulast%3DHigueras%26aufirst%3DM.%2BA.%26aulast%3DTar%25C3%25ADn%26aufirst%3DC.%26aulast%3DRodr%25C3%25ADguez-Crespo%26aufirst%3DI.%26aulast%3DV%25C3%25A1zquez%26aufirst%3DJ.%26aulast%3DLamas%26aufirst%3DS.%26atitle%3DS-Nitrosylation%2520of%2520Hsp90%2520promotes%2520the%2520inhibition%2520of%2520its%2520ATPase%2520and%2520endothelial%2520nitric%2520oxide%2520synthase%2520regulatory%2520activities%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D8525%26epage%3D8530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Tsang, A. H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, K. K. K.</span><span> </span><span class="NLM_article-title">Oxidative and nitrosative stress in Parkinson’s disease</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1792</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">650</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1792&publication_year=2009&pages=643-650&author=A.+H.+K.+Tsangauthor=K.+K.+K.+Chung&title=Oxidative+and+nitrosative+stress+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsang%26aufirst%3DA.%2BH.%2BK.%26aulast%3DChung%26aufirst%3DK.%2BK.%2BK.%26atitle%3DOxidative%2520and%2520nitrosative%2520stress%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2009%26volume%3D1792%26spage%3D643%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Daff, S.</span><span> </span><span class="NLM_article-title">NO synthase: structures and mechanisms</span> <span class="citation_source-journal">Nitric Oxide</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.niox.2010.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20303412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFCgu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=1-11&author=S.+Daff&title=NO+synthase%3A+structures+and+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">NO synthase: Structures and mechanisms</span></div><div class="casAuthors">Daff, Simon</div><div class="citationInfo"><span class="NLM_cas:title">Nitric Oxide</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">NIOXF5</span>;
        ISSN:<span class="NLM_cas:issn">1089-8603</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Prodn. of NO from arginine and mol. oxygen is a complex chem. reaction unique to biol.  Our understanding of the chem. and regulation mechanisms of the NO synthases has developed over the past two decades, uncovering some extraordinary features.  This article reviews recent progress and highlights current issues and controversies.  The structure of the enzyme has now been detd. almost in entirety, although it is as a selection of fragments, which are difficult to assemble unambiguously.  NO synthesis is driven by electron transfer through FAD and FMN cofactors, which is controlled by calmodulin binding in the constitutive mammalian enzymes.  Many of the unique structural features involved have been characterized, but the mechanics of calmodulin-dependent activation are largely unresolved.  Ultimately, NO is produced in the active site by the reaction of arginine with activated heme-bound oxygen in two distinct cycles.  The unique role of the tetrahydrobiopterin cofactor as an electron donor in this process has now been established, but the subsequent chem. events are currently a matter of intense speculation and debate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr3kdAXwpBLrVg90H21EOLACvtfcHk0lhixzY1ZLHkmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFCgu7s%253D&md5=eb3d07f5dade81e6f5ea3d6ec8ea657f</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.niox.2010.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.niox.2010.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DDaff%26aufirst%3DS.%26atitle%3DNO%2520synthase%253A%2520structures%2520and%2520mechanisms%26jtitle%3DNitric%2520Oxide%26date%3D2010%26volume%3D23%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Erdal, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litzinger, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Selective neuronal nitric oxide synthase inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.2174%2F1568026054679317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=16101423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFGhtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=603-624&author=E.+P.+Erdalauthor=E.+A.+Litzingerauthor=J.+Seoauthor=Y.+Zhuauthor=H.+Jiauthor=R.+B.+Silverman&title=Selective+neuronal+nitric+oxide+synthase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Selective neuronal nitric oxide synthase inhibitors</span></div><div class="casAuthors">Erdal, Erik P.; Litzinger, Elizabeth A.; Seo, Jiwon; Zhu, Yaoqiu; Ji, Haitao; Silverman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">603-624</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This review includes the non-patent literature up to Oct. 2004 that deals with selective neuronal nitric oxide synthase inhibitors (highest potency is for the neuronal isoenzyme).  Some non-selective inhibitors or selective inducible nitric oxide synthase inhibitors are mentioned if they are related to compds. that are discussed; structures of these compds. generally are not given.  In vitro inhibition consts. are given either as IC50 values or as Ki values.  An IC50 value, the inhibitor concn. that produces 50% inhibition in the presence of a const. concn. of substrate, is obtained by extrapolation of several rate data points to 50% inhibition.  Ki values are derived from several types of plots that relate the concn. of inhibitor with enzyme velocity in the presence of a variety of substrate concns.  The Ki value can be estd. from the IC50 value.  Although the two inhibition consts. are related, they are not the same; generally, the reported Ki values tend to be lower than the IC50 values.  If specifics are desired about how the data were collected, then the reader will have to look in the literature cited.  No attempt was made to be exhaustive in citing all refs. related to specific inhibitors; rather, examples of literature refs. are given for each inhibitor described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD4wFCjsRzF7Vg90H21EOLACvtfcHk0liB4rjac9tfQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFGhtr4%253D&md5=c338f82141c7af37470fd1cf9afecc75</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.2174%2F1568026054679317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054679317%26sid%3Dliteratum%253Aachs%26aulast%3DErdal%26aufirst%3DE.%2BP.%26aulast%3DLitzinger%26aufirst%3DE.%2BA.%26aulast%3DSeo%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DSelective%2520neuronal%2520nitric%2520oxide%2520synthase%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D603%26epage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Furfine, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paith, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, E. P.</span><span> </span><span class="NLM_article-title">Selective inhibition of constitutive nitric oxide synthase by L-NG-nitroarginine</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">8512</span><span class="NLM_x">–</span> <span class="NLM_lpage">8517</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00084a017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK3sXltFWqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1993&pages=8512-8517&author=E.+S.+Furfineauthor=M.+F.+Harmonauthor=J.+E.+Paithauthor=E.+P.+Garvey&title=Selective+inhibition+of+constitutive+nitric+oxide+synthase+by+L-NG-nitroarginine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of constitutive nitric oxide synthase by L-NG-nitroarginine</span></div><div class="casAuthors">Furfine, Eric S.; Harmon, Marilyn F.; Paith, Jerilin E.; Garvey, Edward P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">8512-17</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">L-NG-nitroarginine (NA) inhibited both the L-arginine oxidn. and the L-arginine-independent NADPH oxidn. reactions catalyzed by the calcium/calmodulin-dependent constitutive nitric oxide synthase (cNOS) from bovine brain.  NA binding did not require calmodulin, calcium, or NADPH.  The onset of inhibition was slow with a second-order assocn. rate const. (kon) of 4.4 x 104 M-1 s-1.  The dissocn. rate const. (koff) was 6.5 x 10-4 s-1.  The Kd value (koff/kon) of bovine brain cNOS for NA was 15 ± 2 nM.  L-Arginine was a competitive inhibitor of NA binding with a Ks value of 0.8 μM.  The Km for L-arginine in the cNOS reaction was 1.2 μM.  The NA binding sites of cNOS were titrated with NA, which enabled a kcat of 0.7 s-1, for the oxidn. of L-arginine, to be calcd.  Finally, a brain cNOS-(3H)NA complex was isolated.  In contrast to the potent and slow onset of NA inhibition of brain cNOS, NA inhibition of inducible mouse macrophage NOS (iNOS) was weaker (Ki = 4.4 μM) and rapidly reversible.  Thus, NA was a 300-fold more potent inhibitor of bovine brain cNOS than mouse macrophage iNOS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLhA06x44BabVg90H21EOLACvtfcHk0liB4rjac9tfQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltFWqu78%253D&md5=2f9a5c60f0f09c327e2e6db59d1d1026</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1021%2Fbi00084a017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00084a017%26sid%3Dliteratum%253Aachs%26aulast%3DFurfine%26aufirst%3DE.%2BS.%26aulast%3DHarmon%26aufirst%3DM.%2BF.%26aulast%3DPaith%26aufirst%3DJ.%2BE.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26atitle%3DSelective%2520inhibition%2520of%2520constitutive%2520nitric%2520oxide%2520synthase%2520by%2520L-NG-nitroarginine%26jtitle%3DBiochemistry%26date%3D1993%26volume%3D32%26spage%3D8512%26epage%3D8517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Yamamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekiguchi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunano, S.</span><span> </span><span class="NLM_article-title">Effects of NG-nitro-<span class="smallcaps smallerCapital">l</span>-arginine on the blood pressure of spontaneously hypertensive rats with different degrees of hypertension</span> <span class="citation_source-journal">Clin. Exper. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">544</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1081%2FCEH-100106824" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11710755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotlylurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2001&pages=533-544&author=K.+Yamamotoauthor=K.+Shimamuraauthor=F.+Sekiguchiauthor=S.+Sunano&title=Effects+of+NG-nitro-l-arginine+on+the+blood+pressure+of+spontaneously+hypertensive+rats+with+different+degrees+of+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of NG-nitro-L-arginine on the blood pressure of spontaneously hypertensive rats with different degrees of hypertension</span></div><div class="casAuthors">Yamamoto, Kazuo; Shimamura, Keiichi; Sekiguchi, Fumiko; Sunano, Satoru</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Hypertension</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">533-544</span>CODEN:
                <span class="NLM_cas:coden">CEHYER</span>;
        ISSN:<span class="NLM_cas:issn">1064-1963</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">The effects of NG-nitro-L-arginine (L-NNA) on blood pressure of various strains of spontaneously hypertensive rats were studied.  Blood pressure of the rats was higher in the order of WKY, SHR, SHRSP, M-SHRSP.  L-NNA caused an elevation of the blood pressure, which was greatest in SHR and smallest in WKY and M-SHRSP.  Endothelium-dependent relaxation of aortae by acetylcholine was greatest in prepns. from WKY and it decreased as the blood pressure of rats increased.  Phenylephrine (higher than 10-6 mg/kg) caused an elevation of the blood pressure, which was greatest in SHR and smallest in M-SHRSP.  It was suggested that L-NNA elevated blood pressure by inhibiting the basal or flow-induced release of nitric oxide from the endothelium that is causing a redn. in vascular smooth muscle tone.  The smaller effect of L-NNA in WKY was due to weak smooth muscle tone, while the smaller effect in SHRSP and M-SHRSP is due to impaired function of endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO4kZnjKxOOrVg90H21EOLACvtfcHk0liB4rjac9tfQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotlylurg%253D&md5=d1968a8647aa5a652e7a8ff815d5665e</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1081%2FCEH-100106824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FCEH-100106824%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DShimamura%26aufirst%3DK.%26aulast%3DSekiguchi%26aufirst%3DF.%26aulast%3DSunano%26aufirst%3DS.%26atitle%3DEffects%2520of%2520NG-nitro-l-arginine%2520on%2520the%2520blood%2520pressure%2520of%2520spontaneously%2520hypertensive%2520rats%2520with%2520different%2520degrees%2520of%2520hypertension%26jtitle%3DClin.%2520Exper.%2520Hypertens.%26date%3D2001%26volume%3D23%26spage%3D533%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Silverman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marletta, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span> </span><span class="NLM_article-title">Selective inhibition of neuronal nitric oxide synthase by <i>N</i><sup>ω</sup>-nitroarginine- and phenylalanine-containing dipeptides and dipeptide esters</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2813</span><span class="NLM_x">–</span> <span class="NLM_lpage">2817</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970200u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=2813-2817&author=R.+B.+Silvermanauthor=H.+Huangauthor=M.+A.+Marlettaauthor=P.+Mart%C3%A1sek&title=Selective+inhibition+of+neuronal+nitric+oxide+synthase+by+N%CF%89-nitroarginine-+and+phenylalanine-containing+dipeptides+and+dipeptide+esters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Fjm970200u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970200u%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DMarletta%26aufirst%3DM.%2BA.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26atitle%3DSelective%2520inhibition%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%2520by%2520N%25CF%2589-nitroarginine-%2520and%2520phenylalanine-containing%2520dipeptides%2520and%2520dipeptide%2520esters%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D2813%26epage%3D2817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, B. S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>ω</sup>-Nitroarginine-containing dipeptide amides. Potent and highly selective inhibitors of neuronal nitric oxide synthase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3147</span><span class="NLM_x">–</span> <span class="NLM_lpage">3153</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990111c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=3147-3153&author=H.+Huangauthor=P.+Mart%C3%A1sekauthor=L.+J.+Romanauthor=B.+S.+S.+Mastersauthor=R.+B.+Silverman&title=N%CF%89-Nitroarginine-containing+dipeptide+amides.+Potent+and+highly+selective+inhibitors+of+neuronal+nitric+oxide+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Fjm990111c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990111c%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DMasters%26aufirst%3DB.%2BS.%2BS.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DN%25CF%2589-Nitroarginine-containing%2520dipeptide%2520amides.%2520Potent%2520and%2520highly%2520selective%2520inhibitors%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D3147%26epage%3D3153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of peptidomimetics as selective inhibitors and active site probes of nitric oxide synthases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2938</span><span class="NLM_x">–</span> <span class="NLM_lpage">2945</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000127z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2938-2945&author=H.+Huangauthor=P.+Mart%C3%A1sekauthor=L.+J.+Romanauthor=R.+B.+Silverman&title=Synthesis+and+evaluation+of+peptidomimetics+as+selective+inhibitors+and+active+site+probes+of+nitric+oxide+synthases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1021%2Fjm000127z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000127z%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520peptidomimetics%2520as%2520selective%2520inhibitors%2520and%2520active%2520site%2520probes%2520of%2520nitric%2520oxide%2520synthases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2938%26epage%3D2945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Gómez-Vidal, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Potent and selective conformationally restricted neuronal nitric oxide synthase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030297m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=703-710&author=J.+A.+G%C3%B3mez-Vidalauthor=P.+Mart%C3%A1sekauthor=L.+J.+Romanauthor=R.+B.+Silverman&title=Potent+and+selective+conformationally+restricted+neuronal+nitric+oxide+synthase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Fjm030297m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030297m%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B3mez-Vidal%26aufirst%3DJ.%2BA.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DPotent%2520and%2520selective%2520conformationally%2520restricted%2520neuronal%2520nitric%2520oxide%2520synthase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D703%26epage%3D710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Hah, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Reduced amide bond peptidomimetics. (4<i>S</i>)-<i>N</i>-(4-Amino-5-[aminoakyl]aminopentyl)-<i>N</i>′-nitroguanidines, potent and highly selective inhibitors of neuronal nitric oxide synthase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2667</span><span class="NLM_x">–</span> <span class="NLM_lpage">2670</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0101491" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2667-2670&author=J.-M.+Hahauthor=L.+J.+Romanauthor=P.+Mart%C3%A1sekauthor=R.+B.+Silverman&title=Reduced+amide+bond+peptidomimetics.+%284S%29-N-%284-Amino-5-%5Baminoakyl%5Daminopentyl%29-N%E2%80%B2-nitroguanidines%2C+potent+and+highly+selective+inhibitors+of+neuronal+nitric+oxide+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1021%2Fjm0101491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0101491%26sid%3Dliteratum%253Aachs%26aulast%3DHah%26aufirst%3DJ.-M.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DReduced%2520amide%2520bond%2520peptidomimetics.%2520%25284S%2529-N-%25284-Amino-5-%255Baminoakyl%255Daminopentyl%2529-N%25E2%2580%25B2-nitroguanidines%252C%2520potent%2520and%2520highly%2520selective%2520inhibitors%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2667%26epage%3D2670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Hah, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1661</span><span class="NLM_x">–</span> <span class="NLM_lpage">1669</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0202932" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1661-1669&author=J.-M.+Hahauthor=P.+Mart%C3%A1sekauthor=L.+J.+Romanauthor=R.+B.+Silverman&title=Aromatic+reduced+amide+bond+peptidomimetics+as+selective+inhibitors+of+neuronal+nitric+oxide+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1021%2Fjm0202932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0202932%26sid%3Dliteratum%253Aachs%26aulast%3DHah%26aufirst%3DJ.-M.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DAromatic%2520reduced%2520amide%2520bond%2520peptidomimetics%2520as%2520selective%2520inhibitors%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1661%26epage%3D1669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Crane, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arvai, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gachhui, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getzoff, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuehr, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tainer, J. A.</span><span> </span><span class="NLM_article-title">The structure of nitric oxide synthase oxygenase domain and inhibitor complexes</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=1997&pages=425-431&author=B.+R.+Craneauthor=A.+S.+Arvaiauthor=R.+Gachhuiauthor=C.+Wuauthor=D.+K.+Ghoshauthor=E.+D.+Getzoffauthor=D.+J.+Stuehrauthor=J.+A.+Tainer&title=The+structure+of+nitric+oxide+synthase+oxygenase+domain+and+inhibitor+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrane%26aufirst%3DB.%2BR.%26aulast%3DArvai%26aufirst%3DA.%2BS.%26aulast%3DGachhui%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DGhosh%26aufirst%3DD.%2BK.%26aulast%3DGetzoff%26aufirst%3DE.%2BD.%26aulast%3DStuehr%26aufirst%3DD.%2BJ.%26aulast%3DTainer%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520structure%2520of%2520nitric%2520oxide%2520synthase%2520oxygenase%2520domain%2520and%2520inhibitor%2520complexes%26jtitle%3DScience%26date%3D1997%26volume%3D278%26spage%3D425%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Raman, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Král, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, B. S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulos, T. L.</span><span> </span><span class="NLM_article-title">Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">939</span><span class="NLM_x">–</span> <span class="NLM_lpage">950</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0092-8674%2800%2981718-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=9875848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1MXjslylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=939-950&author=C.+S.+Ramanauthor=H.+Liauthor=P.+Mart%C3%A1sekauthor=V.+Kr%C3%A1lauthor=B.+S.+S.+Mastersauthor=T.+L.+Poulos&title=Crystal+structure+of+constitutive+endothelial+nitric+oxide+synthase%3A+a+paradigm+for+pterin+function+involving+a+novel+metal+center"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center</span></div><div class="casAuthors">Raman, C. S.; Li, Huiying; Martasek, Pavel; Kral, Vladimir; Masters, Bettie Sue S.; Poulos, Thomas L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">939-950</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Nitric oxide, a key signaling mol., is produced by a family of enzymes collectively called nitric oxide synthases (NOS).  Here, we report the crystal structure of the heme domain of endothelial NOS in tetrahydrobiopterin (H4B)-free and -bound forms at 1.95 Å and 1.9 Å resoln., resp.  In both structures a zinc ion is tetrahedrally coordinated to pairs of symmetry-related cysteine residues at the dimer interface.  The phylogenetically conserved Cys-(X)4-Cys motif and its strategic location establish a structural role for the metal center in maintaining the integrity of the H4B-binding site.  The unexpected recognition of the substrate, L-arginine, at the H4B site indicates that this site is poised to stabilize a pos. charged pterin ring and suggests a model involving a cationic pterin radical in the catalytic cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJtFVAWnJlS7Vg90H21EOLACvtfcHk0lixSZrQEop9uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjslylug%253D%253D&md5=be75ef6125b6a5a8db8621b1e1735bc9</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981718-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981718-3%26sid%3Dliteratum%253Aachs%26aulast%3DRaman%26aufirst%3DC.%2BS.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DKr%25C3%25A1l%26aufirst%3DV.%26aulast%3DMasters%26aufirst%3DB.%2BS.%2BS.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26atitle%3DCrystal%2520structure%2520of%2520constitutive%2520endothelial%2520nitric%2520oxide%2520synthase%253A%2520a%2520paradigm%2520for%2520pterin%2520function%2520involving%2520a%2520novel%2520metal%2520center%26jtitle%3DCell%26date%3D1998%26volume%3D95%26spage%3D939%26epage%3D950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulos, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Discovery of highly potent and selective inhibitors of neuronal nitric oxide synthase by fragment hopping</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">797</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801220a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=779-797&author=H.+Jiauthor=H.+Liauthor=P.+Mart%C3%A1sekauthor=L.+J.+Romanauthor=T.+L.+Poulosauthor=R.+B.+Silverman&title=Discovery+of+highly+potent+and+selective+inhibitors+of+neuronal+nitric+oxide+synthase+by+fragment+hopping"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1021%2Fjm801220a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801220a%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DDiscovery%2520of%2520highly%2520potent%2520and%2520selective%2520inhibitors%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%2520by%2520fragment%2520hopping%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D779%26epage%3D797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, B. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulos, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Minimal pharmacophoric elements and fragment hopping, an approach directed at molecular diversity and isozyme selectivity. Design of selective neuronal nitric oxide synthase inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">3900</span><span class="NLM_x">–</span> <span class="NLM_lpage">3914</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0772041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=3900-3914&author=H.+Jiauthor=B.+Z.+Stantonauthor=J.+Igarashiauthor=H.+Liauthor=P.+Mart%C3%A1sekauthor=L.+J.+Romanauthor=T.+L.+Poulosauthor=R.+B.+Silverman&title=Minimal+pharmacophoric+elements+and+fragment+hopping%2C+an+approach+directed+at+molecular+diversity+and+isozyme+selectivity.+Design+of+selective+neuronal+nitric+oxide+synthase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Fja0772041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0772041%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DH.%26aulast%3DStanton%26aufirst%3DB.%2BZ.%26aulast%3DIgarashi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DMinimal%2520pharmacophoric%2520elements%2520and%2520fragment%2520hopping%252C%2520an%2520approach%2520directed%2520at%2520molecular%2520diversity%2520and%2520isozyme%2520selectivity.%2520Design%2520of%2520selective%2520neuronal%2520nitric%2520oxide%2520synthase%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D3900%26epage%3D3914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derrick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vásquez-Vivar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulos, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsy</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1002%2Fana.21555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=19235180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVynu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=209-217&author=H.+Jiauthor=S.+Tanauthor=J.+Igarashiauthor=H.+Liauthor=M.+Derrickauthor=P.+Mart%C3%A1sekauthor=L.+J.+Romanauthor=J.+V%C3%A1squez-Vivarauthor=T.+L.+Poulosauthor=R.+B.+Silverman&title=Selective+neuronal+nitric+oxide+synthase+inhibitors+and+the+prevention+of+cerebral+palsy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsy</span></div><div class="casAuthors">Ji, Haitao; Tan, Sidhartha; Igarashi, Jotaro; Li, Huiying; Derrick, Matthew; Martasek, Pavel; Roman, Linda J.; Vasquez-Vivar, Jeannette; Poulos, Thomas L.; Silverman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">209-217</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">To design a new class of selective neuronal nitric oxide synthase (NOS) inhibitors, and demonstrate that administration in a rabbit model for cerebral palsy (CP) prevents hypoxia-ischemia-induced deaths and reduces the no. of newborn kits exhibiting signs of CP.  We used a novel computer-based drug design method called fragment hopping to identify new chem. entities, synthesized them, and conducted in vitro enzyme inhibition studies with the three isoenzymes of NOS and in vivo expts. to monitor cardiovascular effects on pregnant rabbit dams, NOS activity, and NOx (NO and NO2) concn. in fetal brain, and assess neurobehavioral effects on kits born to saline- and compd. treated dams.  The computer-based design led to the development of powerful and highly selective compds. for inhibition of neuronal NOS over the other isoenzymes.  After maternal administration in a rabbit model of CP, these compds. were found to distribute to fetal brain, to be nontoxic, without cardiovascular effects, inhibit fetal brain NOS activity in vivo, reduce NO concn. in fetal brain, and dramatically ameliorate deaths and no. of newborn kits exhibiting signs of CP.  This approach may lead to new preventive strategies for CP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRq8EX0vjbkbVg90H21EOLACvtfcHk0ljmSSLdw1T4sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVynu78%253D&md5=d2d866c273450dc8169b6aefec8aa092</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1002%2Fana.21555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.21555%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DS.%26aulast%3DIgarashi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DDerrick%26aufirst%3DM.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DV%25C3%25A1squez-Vivar%26aufirst%3DJ.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DSelective%2520neuronal%2520nitric%2520oxide%2520synthase%2520inhibitors%2520and%2520the%2520prevention%2520of%2520cerebral%2520palsy%26jtitle%3DAnn.%2520Neurol.%26date%3D2009%26volume%3D65%26spage%3D209%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Delker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulos, T. L.</span><span> </span><span class="NLM_article-title">Unexpected binding modes of nitric oxide synthase inhibitors effective in the prevention of a cerebral palsy phenotype in an animal model</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">5437</span><span class="NLM_x">–</span> <span class="NLM_lpage">5442</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja910228a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=5437-5442&author=S.+L.+Delkerauthor=H.+Jiauthor=H.+Liauthor=J.+Jamalauthor=J.+Fangauthor=F.+Xueauthor=R.+B.+Silvermanauthor=T.+L.+Poulos&title=Unexpected+binding+modes+of+nitric+oxide+synthase+inhibitors+effective+in+the+prevention+of+a+cerebral+palsy+phenotype+in+an+animal+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Unexpected Binding Modes of Nitric Oxide Synthase Inhibitors Effective in the Prevention of a Cerebral Palsy Phenotype in an Animal Model</span></div><div class="casAuthors">Delker, Silvia L.; Ji, Haitao; Li, Huiying; Jamal, Joumana; Fang, Jianguo; Xue, Fengtian; Silverman, Richard B.; Poulos, Thomas L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5437-5442</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective inhibition of the neuronal isoform of nitric oxide synthase NOS (nNOS) has been shown to prevent brain injury and is important for the treatment of various neurodegenerative disorders.  However, given the high active site conservation among all three NOS isoforms, the design of selective inhibitors is an extremely challenging problem.  Here we present the structural basis for why novel and potent nNOS inhibitors exhibit the highest level of selectivity over eNOS reported so far (∼3,800-fold).  By using a combination of crystallog., computational methods, and site-directed mutagenesis, we found that inhibitor chirality and an unanticipated structural change of the target enzyme control both the orientation and selectivity of these novel nNOS inhibitors.  A new hot spot generated as a result of enzyme elasticity provides important information for the future fragment-based design of selective NOS inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvsA-51wZgRLVg90H21EOLACvtfcHk0ljmSSLdw1T4sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtLw%253D&md5=77f308ca289c6c599f683fe601240cad</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fja910228a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja910228a%26sid%3Dliteratum%253Aachs%26aulast%3DDelker%26aufirst%3DS.%2BL.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DJamal%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DXue%26aufirst%3DF.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26atitle%3DUnexpected%2520binding%2520modes%2520of%2520nitric%2520oxide%2520synthase%2520inhibitors%2520effective%2520in%2520the%2520prevention%2520of%2520a%2520cerebral%2520palsy%2520phenotype%2520in%2520an%2520animal%2520model%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D5437%26epage%3D5442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulos, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Exploration of the active site of neuronal nitric oxide synthase by the design and synthesis of pyrrolidinomethyl 2-aminopyridine derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7804</span><span class="NLM_x">–</span> <span class="NLM_lpage">7824</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100947x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7804-7824&author=H.+Jiauthor=S.+L.+Delkerauthor=H.+Liauthor=P.+Mart%C3%A1sekauthor=L.+J.+Romanauthor=T.+L.+Poulosauthor=R.+B.+Silverman&title=Exploration+of+the+active+site+of+neuronal+nitric+oxide+synthase+by+the+design+and+synthesis+of+pyrrolidinomethyl+2-aminopyridine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1021%2Fjm100947x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100947x%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DH.%26aulast%3DDelker%26aufirst%3DS.%2BL.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DExploration%2520of%2520the%2520active%2520site%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%2520by%2520the%2520design%2520and%2520synthesis%2520of%2520pyrrolidinomethyl%25202-aminopyridine%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7804%26epage%3D7824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Xue, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulos, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Symmetric double-headed aminopyridines, a novel strategy for potent and membrane-permeable inhibitors of neuronal nitric oxide synthase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2039</span><span class="NLM_x">–</span> <span class="NLM_lpage">2048</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101071n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2039-2048&author=F.+Xueauthor=J.+Fangauthor=S.+L.+Delkerauthor=H.+Liauthor=P.+Mart%C3%A1sekauthor=L.+J.+Romanauthor=T.+L.+Poulosauthor=R.+B.+Silverman&title=Symmetric+double-headed+aminopyridines%2C+a+novel+strategy+for+potent+and+membrane-permeable+inhibitors+of+neuronal+nitric+oxide+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1021%2Fjm101071n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101071n%26sid%3Dliteratum%253Aachs%26aulast%3DXue%26aufirst%3DF.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DDelker%26aufirst%3DS.%2BL.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DSymmetric%2520double-headed%2520aminopyridines%252C%2520a%2520novel%2520strategy%2520for%2520potent%2520and%2520membrane-permeable%2520inhibitors%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2039%26epage%3D2048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Faraci, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagel, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdries, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labasi, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettipher, E. R.</span><span> </span><span class="NLM_article-title">2-Amino-4-methylpyridine as a potent inhibitor of inducible NO synthase activity in vitro and in vivo</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">1101</span><span class="NLM_x">–</span> <span class="NLM_lpage">1108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1111%2Fj.1476-5381.1996.tb16010.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=8937711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK28Xntlent70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1996&pages=1101-1108&author=W.+S.+Faraciauthor=A.+A.+Nagelauthor=K.+A.+Verdriesauthor=L.+A.+Vincentauthor=H.+Xuauthor=L.+E.+Nicholsauthor=J.+M.+Labasiauthor=E.+D.+Salterauthor=E.+R.+Pettipher&title=2-Amino-4-methylpyridine+as+a+potent+inhibitor+of+inducible+NO+synthase+activity+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">2-Amino-4-methylpyridine as a potent inhibitor of inducible NO synthase activity in vitro and in vivo</span></div><div class="casAuthors">Faraci, W. Stephen; Nagel, Arthur A.; Verdries, Kimberly A.; Vincent, Lawrence A.; Xu, Hong; Nichols, Lois E.; Labasi, Jeffrey M.; Salter, Eben D.; Pettipher, E. Roy</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1101-1108</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">The ability of 2-amino-4-methylpyridine to inhibit the catalytic activity of the inducible NO synthase (NOS II) enzyme was characterized in vitro and in vivo.  In vitro, 2-amino-4-methylpyridine inhibited NOS II activity derived from mouse RAW 264.7 cells with an IC50 of 6 nM.  Enzyme kinetic studies indicated that inhibition is competitive with respect to arginine.  2-Amino-4-methylpyridine was less potent on human recombinant NOS II (IC50=40 nM) and was still less potent on human recombinant NOS I and NOS III (IC50=100 nM).  NG-monomethyl-L-arginine (L-NMMA), N6-iminoethyl-L-lysine (L-NIL) and aminoguanidine were much weaker inhibitors of murine NOS II than 2-amino-4-methylpyridine but, unlike 2-amino-4-methylpyridine, retained similar activity on human recombinant NOS II.  L-NMMA inhibited all three NOS isoforms with similar potency (IC50s 3-7 μM).  In contrast, compared to activity on human recombinant NOS III, L-NIL displayed 10 × selectivity for murine NOS II and 11 × selectivity for human recombinant NOS II while aminoguanidine displayed 7.3× selectivity for murine NOS II and 3.7× selectivity for human recombinant NOS II.  Mouse RAW 264.7 macrophages produced high levels of nitrite when cultured overnight in the presence of lipopolysaccharide (LPS) and interferon-γ.  Addn. of 2-amino-4-methylpyridine at the same time as the LPS and IFN-γ, dose-dependently reduced the levels of nitrite (IC50=1.5 μM) without affecting the induction of NOS II protein.  Increasing the extracellular concn. of arginine decreased the potency of 2-amino-4-methylpyridine but at concns. up to 10 μM, 2-amino-4-methylpyridine did not inhibit the uptake of [3H]-arginine into the cell.  Addn. of 2-amino-4-methylpyridine after the enzyme was induced also dose-dependently inhibited nitrite prodn.  Together, these data suggest that 2-amino-4-methylpyridine reduces cellular prodn. of NO by competitive inhibition of the catalytic activity of NOS II, in agreement with results obtained from in vitro enzyme kinetic studies.  When infused i.v. in conscious unrestrained rats, 2-amino-4-methylpyridine inhibited the rise in plasma nitrate produced in response to i.p. injection of LPS (ID50-0.009 mg kg-1 min-1).  Larger doses of 2-amino-4-methylpyridine were required to raise mean arterial pressure in untreated conscious rats (ED50=0.060 mg kg-1 min-1) indicating 6.9 × selectivity for NOS II over NOS III in vivo.  Under the same conditions, L-NMMA was nonselective while L-NIL and aminoguanidine displayed 5.2 × and 8.6 × selectivity, resp.  All of these compds. caused significant increases in mean arterial pressure at doses above the ID50 for inhibition of NOS II activity in vivo.  2-Amino-4-methylpyridine also inhibited LPS-induced elevation in plasma nitrate after either s.c. (ID50=0.3 mg kg-1) or oral (ID50=20.8 mg kg-1) administration.  These data indicate that 2-amino-4-methylpyridine is a potent inhibitor of NOS II activity in vitro and in vivo with a similar degree of isoenzyme selectivity to that of L-NIL and aminoguanidine in rodents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEBa3UdtL3ILVg90H21EOLACvtfcHk0ljvxDoW2IefuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xntlent70%253D&md5=199acaee16943d816a72e2322c5b352a</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1996.tb16010.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1996.tb16010.x%26sid%3Dliteratum%253Aachs%26aulast%3DFaraci%26aufirst%3DW.%2BS.%26aulast%3DNagel%26aufirst%3DA.%2BA.%26aulast%3DVerdries%26aufirst%3DK.%2BA.%26aulast%3DVincent%26aufirst%3DL.%2BA.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DNichols%26aufirst%3DL.%2BE.%26aulast%3DLabasi%26aufirst%3DJ.%2BM.%26aulast%3DSalter%26aufirst%3DE.%2BD.%26aulast%3DPettipher%26aufirst%3DE.%2BR.%26atitle%3D2-Amino-4-methylpyridine%2520as%2520a%2520potent%2520inhibitor%2520of%2520inducible%2520NO%2520synthase%2520activity%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D119%26spage%3D1101%26epage%3D1108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Hagmann, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durette, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esser, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanza, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopka, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guthikonda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabin, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humes, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meurer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacholok, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavia, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. K.</span><span> </span><span class="NLM_article-title">Substituted 2-aminopyridines as inhibitors of nitric oxide synthases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1975</span><span class="NLM_x">–</span> <span class="NLM_lpage">1978</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1975-1978&author=W.+K.+Hagmannauthor=C.+G.+Caldwellauthor=P.+Chenauthor=P.+L.+Duretteauthor=C.+K.+Esserauthor=T.+J.+Lanzaauthor=I.+E.+Kopkaauthor=R.+Guthikondaauthor=S.+K.+Shahauthor=M.+MacCossauthor=R.+M.+Chabinauthor=D.+Fletcherauthor=S.+K.+Grantauthor=B.+G.+Greenauthor=J.+L.+Humesauthor=T.+M.+Kellyauthor=S.+Luellauthor=R.+Meurerauthor=V.+Mooreauthor=S.+G.+Pacholokauthor=T.+Paviaauthor=H.+R.+Williamsauthor=K.+K.+Wong&title=Substituted+2-aminopyridines+as+inhibitors+of+nitric+oxide+synthases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHagmann%26aufirst%3DW.%2BK.%26aulast%3DCaldwell%26aufirst%3DC.%2BG.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DDurette%26aufirst%3DP.%2BL.%26aulast%3DEsser%26aufirst%3DC.%2BK.%26aulast%3DLanza%26aufirst%3DT.%2BJ.%26aulast%3DKopka%26aufirst%3DI.%2BE.%26aulast%3DGuthikonda%26aufirst%3DR.%26aulast%3DShah%26aufirst%3DS.%2BK.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DChabin%26aufirst%3DR.%2BM.%26aulast%3DFletcher%26aufirst%3DD.%26aulast%3DGrant%26aufirst%3DS.%2BK.%26aulast%3DGreen%26aufirst%3DB.%2BG.%26aulast%3DHumes%26aufirst%3DJ.%2BL.%26aulast%3DKelly%26aufirst%3DT.%2BM.%26aulast%3DLuell%26aufirst%3DS.%26aulast%3DMeurer%26aufirst%3DR.%26aulast%3DMoore%26aufirst%3DV.%26aulast%3DPacholok%26aufirst%3DS.%2BG.%26aulast%3DPavia%26aufirst%3DT.%26aulast%3DWilliams%26aufirst%3DH.%2BR.%26aulast%3DWong%26aufirst%3DK.%2BK.%26atitle%3DSubstituted%25202-aminopyridines%2520as%2520inhibitors%2520of%2520nitric%2520oxide%2520synthases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D1975%26epage%3D1978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Lowe, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkmann, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowakowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanase, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraci, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdries, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittle, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefaniak, M.</span><span> </span><span class="NLM_article-title">A new class of selective and potent inhibitors of neuronal nitric oxide synthase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2569</span><span class="NLM_x">–</span> <span class="NLM_lpage">2572</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=2569-2572&author=J.+A.+Loweauthor=W.+Qianauthor=R.+A.+Volkmannauthor=S.+Heckauthor=J.+Nowakowskiauthor=R.+Nelsonauthor=C.+Nolanauthor=D.+Listonauthor=K.+Wardauthor=S.+Zornauthor=C.+Johnsonauthor=M.+Vanaseauthor=W.+S.+Faraciauthor=K.+A.+Verdriesauthor=J.+Baxterauthor=S.+Doranauthor=M.+Sandersauthor=M.+Ashtonauthor=P.+Whittleauthor=M.+Stefaniak&title=A+new+class+of+selective+and+potent+inhibitors+of+neuronal+nitric+oxide+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLowe%26aufirst%3DJ.%2BA.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DVolkmann%26aufirst%3DR.%2BA.%26aulast%3DHeck%26aufirst%3DS.%26aulast%3DNowakowski%26aufirst%3DJ.%26aulast%3DNelson%26aufirst%3DR.%26aulast%3DNolan%26aufirst%3DC.%26aulast%3DListon%26aufirst%3DD.%26aulast%3DWard%26aufirst%3DK.%26aulast%3DZorn%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DC.%26aulast%3DVanase%26aufirst%3DM.%26aulast%3DFaraci%26aufirst%3DW.%2BS.%26aulast%3DVerdries%26aufirst%3DK.%2BA.%26aulast%3DBaxter%26aufirst%3DJ.%26aulast%3DDoran%26aufirst%3DS.%26aulast%3DSanders%26aufirst%3DM.%26aulast%3DAshton%26aufirst%3DM.%26aulast%3DWhittle%26aufirst%3DP.%26aulast%3DStefaniak%26aufirst%3DM.%26atitle%3DA%2520new%2520class%2520of%2520selective%2520and%2520potent%2520inhibitors%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D2569%26epage%3D2572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Lowe, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drozda, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkmann, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nason, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdries, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majchrzak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, W. F.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of potent, selective inhibitors of neuronal nitric oxide synthase based on the 6-phenyl-2-aminopyridine structure</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1575</span><span class="NLM_x">–</span> <span class="NLM_lpage">1586</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030519g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1575-1586&author=J.+A.+Loweauthor=W.+Qianauthor=S.+E.+Drozdaauthor=R.+A.+Volkmannauthor=D.+Nasonauthor=R.+B.+Nelsonauthor=C.+Nolanauthor=D.+Listonauthor=K.+Wardauthor=S.+Faraciauthor=K.+Verdriesauthor=P.+Seymourauthor=M.+Majchrzakauthor=A.+Villalobosauthor=W.+F.+White&title=Structure%E2%80%93activity+relationships+of+potent%2C+selective+inhibitors+of+neuronal+nitric+oxide+synthase+based+on+the+6-phenyl-2-aminopyridine+structure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1021%2Fjm030519g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030519g%26sid%3Dliteratum%253Aachs%26aulast%3DLowe%26aufirst%3DJ.%2BA.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DDrozda%26aufirst%3DS.%2BE.%26aulast%3DVolkmann%26aufirst%3DR.%2BA.%26aulast%3DNason%26aufirst%3DD.%26aulast%3DNelson%26aufirst%3DR.%2BB.%26aulast%3DNolan%26aufirst%3DC.%26aulast%3DListon%26aufirst%3DD.%26aulast%3DWard%26aufirst%3DK.%26aulast%3DFaraci%26aufirst%3DS.%26aulast%3DVerdries%26aufirst%3DK.%26aulast%3DSeymour%26aufirst%3DP.%26aulast%3DMajchrzak%26aufirst%3DM.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWhite%26aufirst%3DW.%2BF.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520potent%252C%2520selective%2520inhibitors%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%2520based%2520on%2520the%25206-phenyl-2-aminopyridine%2520structure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1575%26epage%3D1586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">McCall, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feelisch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moncada, S.</span><span> </span><span class="NLM_article-title">Identification of <i>N</i>-iminoethyl-<span class="smallcaps smallerCapital">l</span>-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">234</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1111%2Fj.1476-5381.1991.tb12159.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=1710525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK3MXpvFyhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1991&pages=234-238&author=T.+B.+McCallauthor=M.+Feelischauthor=R.+M.+Palmerauthor=S.+Moncada&title=Identification+of+N-iminoethyl-l-ornithine+as+an+irreversible+inhibitor+of+nitric+oxide+synthase+in+phagocytic+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells</span></div><div class="casAuthors">McCall, T. B.; Feelisch, M.; Palmer, R. M. J.; Moncada, S.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">234-8</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">The synthesis of nitric oxide (NO) from L-arginine by rat peritoneal neutrophils (PMN) and the murine macrophage cell-line J774 and the inhibition of this synthesis by N-iminoethyl-L-ornithine (L-NIO), NG-monomethyl-L-arginine (L-NMMA), NG-nitro-L-arginine (L-NNA) and its Me ester (L-NAME) was investigated.  L-NIO was the most potent inhibitor in both types of cells while L-NMMA was less active.  L-NNA and L-NAME had no significant effect in PMN and L-NNA produced only approx. 40% inhibition of the generation of NO in J774 cells at the highest concn. tested (300 μM).  The inhibitor effect of L-NIO was rapid in onset, requiring 10 min pre-incubation to achieve its full inhibitory activity, while the other compds. required 20-60 min pre-incubation to achieve their full effect.  The inhibitory effect of L-NIO (10 μM) on intact cells could not be reversed by L-arginine (300 μM) but could be prevented by concomitant incubation with this compd. (300 μM), while the effect of the other inhibitors could be reversed by a 3-5 fold molar excess of L-arginine.  The NO synthase from both PMN and J774 cells was cytosolic and NADPH- but not Ca2+-dependent, with Km values for L-arginine of 3.3 and 4.2 μM resp.  L-NIO was the most potent inhibitor of the neutrophil and J774 enzymes with IC50 values of 0.8 and 3 μM resp.  Furthermore, the effect of L-NIO was irreversible.  The other 3 compds. were less potent, reversible inhibitors.  The inhibitory effects of all these compds. were enantiomerically specific.  These data indicate that L-NIO is a novel, potent, rapid in onset and irreversible inhibitor of NO synthase in phagocytic cells.  The rapid uptake of L-NIO compared with the other compds. indicates that phagocytic cells have different uptake mechanisms for L-arginine and analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOfoSEiO1AYrVg90H21EOLACvtfcHk0lgS1RXwmZ4BDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXpvFyhtA%253D%253D&md5=334f61786b58ce73a3e2b5fcf2fc76cc</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1991.tb12159.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1991.tb12159.x%26sid%3Dliteratum%253Aachs%26aulast%3DMcCall%26aufirst%3DT.%2BB.%26aulast%3DFeelisch%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DR.%2BM.%26aulast%3DMoncada%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520N-iminoethyl-l-ornithine%2520as%2520an%2520irreversible%2520inhibitor%2520of%2520nitric%2520oxide%2520synthase%2520in%2520phagocytic%2520cells%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1991%26volume%3D102%26spage%3D234%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Collins, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearer, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oplinger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnette, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furfine, E. S.</span><span> </span><span class="NLM_article-title"><i>N</i>-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: structure–activity studies and demonstration of in vivo activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2858</span><span class="NLM_x">–</span> <span class="NLM_lpage">2871</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980072p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2858-2871&author=J.+L.+Collinsauthor=B.+G.+Shearerauthor=J.+A.+Oplingerauthor=S.+Leeauthor=E.+P.+Garveyauthor=M.+Salterauthor=C.+Duffyauthor=T.+C.+Burnetteauthor=E.+S.+Furfine&title=N-Phenylamidines+as+selective+inhibitors+of+human+neuronal+nitric+oxide+synthase%3A+structure%E2%80%93activity+studies+and+demonstration+of+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1021%2Fjm980072p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980072p%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DJ.%2BL.%26aulast%3DShearer%26aufirst%3DB.%2BG.%26aulast%3DOplinger%26aufirst%3DJ.%2BA.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DSalter%26aufirst%3DM.%26aulast%3DDuffy%26aufirst%3DC.%26aulast%3DBurnette%26aufirst%3DT.%2BC.%26aulast%3DFurfine%26aufirst%3DE.%2BS.%26atitle%3DN-Phenylamidines%2520as%2520selective%2520inhibitors%2520of%2520human%2520neuronal%2520nitric%2520oxide%2520synthase%253A%2520structure%25E2%2580%2593activity%2520studies%2520and%2520demonstration%2520of%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D2858%26epage%3D2871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Garvey, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oplinger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furfine, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiff, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laszlo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittle, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knowles, R. G.</span><span> </span><span class="NLM_article-title">1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">4959</span><span class="NLM_x">–</span> <span class="NLM_lpage">4963</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=4959-4963&author=E.+P.+Garveyauthor=J.+A.+Oplingerauthor=E.+S.+Furfineauthor=R.+J.+Kiffauthor=F.+Laszloauthor=B.+J.+Whittleauthor=R.+G.+Knowles&title=1400W+is+a+slow%2C+tight+binding%2C+and+highly+selective+inhibitor+of+inducible+nitric-oxide+synthase+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DOplinger%26aufirst%3DJ.%2BA.%26aulast%3DFurfine%26aufirst%3DE.%2BS.%26aulast%3DKiff%26aufirst%3DR.%2BJ.%26aulast%3DLaszlo%26aufirst%3DF.%26aulast%3DWhittle%26aufirst%3DB.%2BJ.%26aulast%3DKnowles%26aufirst%3DR.%2BG.%26atitle%3D1400W%2520is%2520a%2520slow%252C%2520tight%2520binding%252C%2520and%2520highly%2520selective%2520inhibitor%2520of%2520inducible%2520nitric-oxide%2520synthase%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D4959%26epage%3D4963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Maccallini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patruno, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lannutti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammazzalorso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Filippis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantacuzzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franceschelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giampietro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masella, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felaco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Re, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amoroso, R.</span><span> </span><span class="NLM_article-title">N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6495</span><span class="NLM_x">–</span> <span class="NLM_lpage">6499</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6495-6499&author=C.+Maccalliniauthor=A.+Patrunoauthor=F.+Lannuttiauthor=A.+Ammazzalorsoauthor=B.+De+Filippisauthor=M.+Fantacuzziauthor=S.+Franceschelliauthor=L.+Giampietroauthor=S.+Masellaauthor=M.+Felacoauthor=N.+Reauthor=R.+Amoroso&title=N-Substituted+acetamidines+and+2-methylimidazole+derivatives+as+selective+inhibitors+of+neuronal+nitric+oxide+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaccallini%26aufirst%3DC.%26aulast%3DPatruno%26aufirst%3DA.%26aulast%3DLannutti%26aufirst%3DF.%26aulast%3DAmmazzalorso%26aufirst%3DA.%26aulast%3DDe%2BFilippis%26aufirst%3DB.%26aulast%3DFantacuzzi%26aufirst%3DM.%26aulast%3DFranceschelli%26aufirst%3DS.%26aulast%3DGiampietro%26aufirst%3DL.%26aulast%3DMasella%26aufirst%3DS.%26aulast%3DFelaco%26aufirst%3DM.%26aulast%3DRe%26aufirst%3DN.%26aulast%3DAmoroso%26aufirst%3DR.%26atitle%3DN-Substituted%2520acetamidines%2520and%25202-methylimidazole%2520derivatives%2520as%2520selective%2520inhibitors%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6495%26epage%3D6499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group">Reif, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cregan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, J. E.</span><span> </span><span class="NLM_article-title">Discovery and development of neuronal nitric oxide synthase inhibitors</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1470</span><span class="NLM_x">–</span> <span class="NLM_lpage">1477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0891-5849%2800%2900250-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=10927171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltlWgurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=1470-1477&author=D.+W.+Reifauthor=D.+J.+McCarthyauthor=E.+Creganauthor=J.+E.+Macdonald&title=Discovery+and+development+of+neuronal+nitric+oxide+synthase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of neuronal nitric oxide synthase inhibitors</span></div><div class="casAuthors">Reif, D. W.; McCarthy, D. J.; Cregan, E.; Macdonald, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1470-1477</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The role of neuronally derived nitric oxide (NO) in neurotransmission and neural injury remains an area of active investigation.  NO generation has been postulated to be involved in the deleterious events surrounding ischemia/reperfusion injury either directly or via the prodn. of more reactive oxidants such as peroxynitrite.  In our search for novel therapeutics for the treatment of a variety of neurol. diseases including stroke, we have discovered novel, potent, and selective inhibitors of the neuronal nitric oxide synthase (nNOS) isoform.  These compds. have proven to be effective in models of ischemia/reperfusion supporting the role of nNOS in these processes.  The effects of these compds. as well as addnl. aspects crit. to their development will be presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzomMpZL9Od7Vg90H21EOLACvtfcHk0li950fl6BT3ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltlWgurw%253D&md5=4f9b80de4e010baec016f96d66578628</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2800%2900250-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252800%252900250-1%26sid%3Dliteratum%253Aachs%26aulast%3DReif%26aufirst%3DD.%2BW.%26aulast%3DMcCarthy%26aufirst%3DD.%2BJ.%26aulast%3DCregan%26aufirst%3DE.%26aulast%3DMacdonald%26aufirst%3DJ.%2BE.%26atitle%3DDiscovery%2520and%2520development%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%2520inhibitors%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2000%26volume%3D28%26spage%3D1470%26epage%3D1477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group">O’Neill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarty, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicks, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dell, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiernicki, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleisch, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span> </span><span class="NLM_article-title">ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemia</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">871</span><span class="NLM_x">, </span> <span class="NLM_fpage">234</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0006-8993%2800%2902471-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=10899290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFSgt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=871&publication_year=2000&pages=234-244&author=M.+J.+O%E2%80%99Neillauthor=T.+K.+Murrayauthor=D.+R.+McCartyauthor=C.+A.+Hicksauthor=C.+P.+Dellauthor=K.+E.+Patrickauthor=M.+A.+Wardauthor=D.+J.+Osborneauthor=T.+R.+Wiernickiauthor=C.+R.+Romanauthor=D.+Lodgeauthor=J.+H.+Fleischauthor=J.+Singh&title=ARL+17477%2C+a+selective+nitric+oxide+synthase+inhibitor%2C+with+neuroprotective+effects+in+animal+models+of+global+and+focal+cerebral+ischaemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischemia</span></div><div class="casAuthors">O'Neill, M. J.; Murray, T. K.; McCarty, D. R.; Hicks, C. A.; Dell, C. P.; Patrick, K. E.; Ward, M. A.; Osborne, D. J.; Wiernicki, T. R.; Roman, C. R.; Lodge, D.; Fleisch, J. H.; Singh, J.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">871</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">234-244</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">In the present studies, we have evaluated the effects of N-[4-(2-{[(3-Chlorophenyl)methyl]amino}ethyl)phenyl]-2-thiophenecarboximidamide dihydrochloride (ARL 17477) on recombinant human neuronal NOS (nNOS) and endothelial NOS (eNOS).  We then carried out pharmacokinetic studies and measured cortical nitric oxide synthase (NOS) inhibition to det. that the compd. crossed the blood brain barrier.  Finally, the compd. was evaluated in a model of global ischemia in the gerbil and two models of transient focal ischemia in the rat.  The IC50 values for ARL 17477 on human recombinant human nNOS and eNOS were 1 and 17 μM, resp.  ARL 17477 (50 mg/kg i.p.) produced a significant redn. in the ischemia-induced hippocampal damage following global ischemia when administered immediately post-occlusion, but failed to protect when administration was delayed until 30 min post-occlusion.  In the endothelin-1 model of focal ischemia, ARL 17477 (1 mg/kg i.v.) significantly attenuated the infarct vol. when administered at either 0, 1 or 2 h post-endothelin-1 (P<0.05).  In the intraluminal suture model, ARL 17477 at both 1 and 3 mg/kg i.v. failed to reduce the infarct vol. measured at 1, 3 or 7 days post-occlusion.  These results demonstrate that ARL 17477 protects against global ischemia in gerbils and provides some redn. in infarct vol. following transient middle cerebral artery occlusion in rats, indicating that nNOS inhibition may be a useful treatment of ischemic conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSnwwa_fNHhLVg90H21EOLACvtfcHk0li950fl6BT3ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFSgt7Y%253D&md5=1fc64ac43699e9bc54747a3a1a35eef5</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2800%2902471-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252800%252902471-9%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DM.%2BJ.%26aulast%3DMurray%26aufirst%3DT.%2BK.%26aulast%3DMcCarty%26aufirst%3DD.%2BR.%26aulast%3DHicks%26aufirst%3DC.%2BA.%26aulast%3DDell%26aufirst%3DC.%2BP.%26aulast%3DPatrick%26aufirst%3DK.%2BE.%26aulast%3DWard%26aufirst%3DM.%2BA.%26aulast%3DOsborne%26aufirst%3DD.%2BJ.%26aulast%3DWiernicki%26aufirst%3DT.%2BR.%26aulast%3DRoman%26aufirst%3DC.%2BR.%26aulast%3DLodge%26aufirst%3DD.%26aulast%3DFleisch%26aufirst%3DJ.%2BH.%26aulast%3DSingh%26aufirst%3DJ.%26atitle%3DARL%252017477%252C%2520a%2520selective%2520nitric%2520oxide%2520synthase%2520inhibitor%252C%2520with%2520neuroprotective%2520effects%2520in%2520animal%2520models%2520of%2520global%2520and%2520focal%2520cerebral%2520ischaemia%26jtitle%3DBrain%2520Res.%26date%3D2000%26volume%3D871%26spage%3D234%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Fedorov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlichting, I.</span><span> </span><span class="NLM_article-title">Structures of nitric oxide synthase isoforms complexed with the inhibitor AR-R17477 suggest a rational basis for specificity and inhibitor design</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">5892</span><span class="NLM_x">–</span> <span class="NLM_lpage">5897</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=5892-5897&author=R.+Fedorovauthor=R.+Vasanauthor=D.+K.+Ghoshauthor=I.+Schlichting&title=Structures+of+nitric+oxide+synthase+isoforms+complexed+with+the+inhibitor+AR-R17477+suggest+a+rational+basis+for+specificity+and+inhibitor+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFedorov%26aufirst%3DR.%26aulast%3DVasan%26aufirst%3DR.%26aulast%3DGhosh%26aufirst%3DD.%2BK.%26aulast%3DSchlichting%26aufirst%3DI.%26atitle%3DStructures%2520of%2520nitric%2520oxide%2520synthase%2520isoforms%2520complexed%2520with%2520the%2520inhibitor%2520AR-R17477%2520suggest%2520a%2520rational%2520basis%2520for%2520specificity%2520and%2520inhibitor%2520design%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D5892%26epage%3D5897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group">Renton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddaford, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakhit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, J. S.</span><span> </span><span class="NLM_article-title">Novel dual action neuronal nitric oxide synthase inhibitors with μ-opioid agonist activity</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml200268w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=227-231&author=P.+Rentonauthor=B.+Greenauthor=S.+P.+Maddafordauthor=S.+Rakhitauthor=J.+S.+Andrews&title=Novel+dual+action+neuronal+nitric+oxide+synthase+inhibitors+with+%CE%BC-opioid+agonist+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1021%2Fml200268w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200268w%26sid%3Dliteratum%253Aachs%26aulast%3DRenton%26aufirst%3DP.%26aulast%3DGreen%26aufirst%3DB.%26aulast%3DMaddaford%26aufirst%3DS.%2BP.%26aulast%3DRakhit%26aufirst%3DS.%26aulast%3DAndrews%26aufirst%3DJ.%2BS.%26atitle%3DNovel%2520dual%2520action%2520neuronal%2520nitric%2520oxide%2520synthase%2520inhibitors%2520with%2520%25CE%25BC-opioid%2520agonist%2520activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D227%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group">Annedi, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramnauth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddaford, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakhit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mladenova, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dove, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felice, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span> </span><span class="NLM_article-title">Discovery of <i>cis</i>-<i>N</i>-(1-(4-(methylamino)cyclohexyl)indolin-6-yl)thiophene-2-carboximidamide: a 1,6-disubstituted indoline derivative as a highly selective inhibitor of human neuronal nitric oxide synthase (nNOS) without any cardiovascular liabilities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">943</span><span class="NLM_x">–</span> <span class="NLM_lpage">955</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201564u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=943-955&author=S.+C.+Annediauthor=J.+Ramnauthauthor=S.+P.+Maddafordauthor=P.+Rentonauthor=S.+Rakhitauthor=G.+Mladenovaauthor=P.+Doveauthor=S.+Silvermanauthor=J.+S.+Andrewsauthor=M.+D.+Feliceauthor=F.+Porreca&title=Discovery+of+cis-N-%281-%284-%28methylamino%29cyclohexyl%29indolin-6-yl%29thiophene-2-carboximidamide%3A+a+1%2C6-disubstituted+indoline+derivative+as+a+highly+selective+inhibitor+of+human+neuronal+nitric+oxide+synthase+%28nNOS%29+without+any+cardiovascular+liabilities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1021%2Fjm201564u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201564u%26sid%3Dliteratum%253Aachs%26aulast%3DAnnedi%26aufirst%3DS.%2BC.%26aulast%3DRamnauth%26aufirst%3DJ.%26aulast%3DMaddaford%26aufirst%3DS.%2BP.%26aulast%3DRenton%26aufirst%3DP.%26aulast%3DRakhit%26aufirst%3DS.%26aulast%3DMladenova%26aufirst%3DG.%26aulast%3DDove%26aufirst%3DP.%26aulast%3DSilverman%26aufirst%3DS.%26aulast%3DAndrews%26aufirst%3DJ.%2BS.%26aulast%3DFelice%26aufirst%3DM.%2BD.%26aulast%3DPorreca%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520cis-N-%25281-%25284-%2528methylamino%2529cyclohexyl%2529indolin-6-yl%2529thiophene-2-carboximidamide%253A%2520a%25201%252C6-disubstituted%2520indoline%2520derivative%2520as%2520a%2520highly%2520selective%2520inhibitor%2520of%2520human%2520neuronal%2520nitric%2520oxide%2520synthase%2520%2528nNOS%2529%2520without%2520any%2520cardiovascular%2520liabilities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D943%26epage%3D955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group">Maddaford, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annedi, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramnauth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakhit, S.</span><span> </span><span class="NLM_article-title">Advancements in the development of nitric oxide synthase inhibitors</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=27-50&author=S.+Maddafordauthor=S.+C.+Annediauthor=J.+Ramnauthauthor=S.+Rakhit&title=Advancements+in+the+development+of+nitric+oxide+synthase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaddaford%26aufirst%3DS.%26aulast%3DAnnedi%26aufirst%3DS.%2BC.%26aulast%3DRamnauth%26aufirst%3DJ.%26aulast%3DRakhit%26aufirst%3DS.%26atitle%3DAdvancements%2520in%2520the%2520development%2520of%2520nitric%2520oxide%2520synthase%2520inhibitors%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D27%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group">Serafim, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Primi, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trossini, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, E. I.</span><span> </span><span class="NLM_article-title">Nitric oxide: state of the art in drug design</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">386</span><span class="NLM_x">–</span> <span class="NLM_lpage">405</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.2174%2F092986712803414321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=22335514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=386-405&author=R.+A.+Serafimauthor=M.+C.+Primiauthor=G.+H.+Trossiniauthor=E.+I.+Ferreira&title=Nitric+oxide%3A+state+of+the+art+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide: state of the art in drug design</span></div><div class="casAuthors">Serafim, R. A. M.; Primi, M. C.; Trossini, G. H. G.; Ferreira, E. I.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">386-405</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Since the great discovery of Furchgott, Ignarro and Murad in the late 90's, nitric oxide (NO) is considered one of the most versatile endogenous mols., which is involved in important signaling biochem. pathways of the human body.  Thus, it is directly related to pathol. processes and its over- or low-prodn. is able to cause damage in systems that are involved.  By using certain functional groups present in mols. that already have potential therapeutic value, hybrid compds., by means of inclusion of NO-donors (e.g., ester nitrates, furoxans, benzofuroxans, NONOates, S-nitrosothiols, metal complexes), can be generated that have a NO release benefit along with maintaining the activity of the native drug.  This approach has proved to be useful in many spheres of Medicinal Chem., such as cardiovascular, inflammatory, bacterial, fungal, viral, parasitic, ocular diseases and cancer.  Potent and selective nitric oxide synthase inhibitors are being designed, mainly through enzyme structure based process, however, due to high homol. between the isoforms, these studies have proved to be very difficult.  The objective of the research is to achieve a balance between the release of therapeutic amts. of NO, esp. in specific site of action, and maintaining the native drug activity.  The search for new and effective NO-donor hybrid drugs, as well as selective nitric oxide synthase inhibitors, is an important focus in modern drug design in order to manipulate biochem. pathways involving NO that influence many dysfunctions of the human organism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3_yT_6c0DALVg90H21EOLACvtfcHk0lhGZdgp81crGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqtro%253D&md5=67e1c78173020957b89e009e5e605860</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.2174%2F092986712803414321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712803414321%26sid%3Dliteratum%253Aachs%26aulast%3DSerafim%26aufirst%3DR.%2BA.%26aulast%3DPrimi%26aufirst%3DM.%2BC.%26aulast%3DTrossini%26aufirst%3DG.%2BH.%26aulast%3DFerreira%26aufirst%3DE.%2BI.%26atitle%3DNitric%2520oxide%253A%2520state%2520of%2520the%2520art%2520in%2520drug%2520design%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D386%26epage%3D405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group">Payne, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnefous, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sablad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rozenkrants, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yazdani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiau, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rix, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassig, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, N. D.</span><span> </span><span class="NLM_article-title">Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-(2-cyclobutyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1<i>H</i>)-one (KD7332). Part 2: Identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS dimerization inhibitors that are orally active in pain models</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7739</span><span class="NLM_x">–</span> <span class="NLM_lpage">7755</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100828n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7739-7755&author=J.+E.+Payneauthor=C.+Bonnefousauthor=K.+T.+Symonsauthor=P.+M.+Nguyenauthor=M.+Sabladauthor=N.+Rozenkrantsauthor=Y.+Zhangauthor=L.+Wangauthor=N.+Yazdaniauthor=A.+K.+Shiauauthor=S.+A.+Nobleauthor=P.+Rixauthor=T.+S.+Raoauthor=C.+A.+Hassigauthor=N.+D.+Smith&title=Discovery+of+dual+inducible%2Fneuronal+nitric+oxide+synthase+%28iNOS%2FnNOS%29+inhibitor+development+candidate+4-%282-cyclobutyl-1H-imidazo%5B4%2C5-b%5Dpyrazin-1-yl%29methyl%29-7%2C8-difluoroquinolin-2%281H%29-one+%28KD7332%29.+Part+2%3A+Identification+of+a+novel%2C+potent%2C+and+selective+series+of+benzimidazole-quinolinone+iNOS%2FnNOS+dimerization+inhibitors+that+are+orally+active+in+pain+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1021%2Fjm100828n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100828n%26sid%3Dliteratum%253Aachs%26aulast%3DPayne%26aufirst%3DJ.%2BE.%26aulast%3DBonnefous%26aufirst%3DC.%26aulast%3DSymons%26aufirst%3DK.%2BT.%26aulast%3DNguyen%26aufirst%3DP.%2BM.%26aulast%3DSablad%26aufirst%3DM.%26aulast%3DRozenkrants%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYazdani%26aufirst%3DN.%26aulast%3DShiau%26aufirst%3DA.%2BK.%26aulast%3DNoble%26aufirst%3DS.%2BA.%26aulast%3DRix%26aufirst%3DP.%26aulast%3DRao%26aufirst%3DT.%2BS.%26aulast%3DHassig%26aufirst%3DC.%2BA.%26aulast%3DSmith%26aufirst%3DN.%2BD.%26atitle%3DDiscovery%2520of%2520dual%2520inducible%252Fneuronal%2520nitric%2520oxide%2520synthase%2520%2528iNOS%252FnNOS%2529%2520inhibitor%2520development%2520candidate%25204-%25282-cyclobutyl-1H-imidazo%255B4%252C5-b%255Dpyrazin-1-yl%2529methyl%2529-7%252C8-difluoroquinolin-2%25281H%2529-one%2520%2528KD7332%2529.%2520Part%25202%253A%2520Identification%2520of%2520a%2520novel%252C%2520potent%252C%2520and%2520selective%2520series%2520of%2520benzimidazole-quinolinone%2520iNOS%252FnNOS%2520dimerization%2520inhibitors%2520that%2520are%2520orally%2520active%2520in%2520pain%2520models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7739%26epage%3D7755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group">Matter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, H. S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotsonis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fröhlich, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reif, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfleiderer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheurer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlichting, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, H. H. H. W.</span><span> </span><span class="NLM_article-title">Structural analysis of isoform-specific inhibitors targeting the tetrahydrobiopterin binding site of human nitric oxide synthases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4783</span><span class="NLM_x">–</span> <span class="NLM_lpage">4792</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4783-4792&author=H.+Matterauthor=H.+S.+A.+Kumarauthor=R.+Fedorovauthor=A.+Freyauthor=P.+Kotsonisauthor=E.+Hartmannauthor=L.+G.+Fr%C3%B6hlichauthor=A.+Reifauthor=W.+Pfleidererauthor=P.+Scheurerauthor=D.+K.+Ghoshauthor=I.+Schlichtingauthor=H.+H.+H.+W.+Schmidt&title=Structural+analysis+of+isoform-specific+inhibitors+targeting+the+tetrahydrobiopterin+binding+site+of+human+nitric+oxide+synthases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1021%2Fjm050007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050007x%26sid%3Dliteratum%253Aachs%26aulast%3DMatter%26aufirst%3DH.%26aulast%3DKumar%26aufirst%3DH.%2BS.%2BA.%26aulast%3DFedorov%26aufirst%3DR.%26aulast%3DFrey%26aufirst%3DA.%26aulast%3DKotsonis%26aufirst%3DP.%26aulast%3DHartmann%26aufirst%3DE.%26aulast%3DFr%25C3%25B6hlich%26aufirst%3DL.%2BG.%26aulast%3DReif%26aufirst%3DA.%26aulast%3DPfleiderer%26aufirst%3DW.%26aulast%3DScheurer%26aufirst%3DP.%26aulast%3DGhosh%26aufirst%3DD.%2BK.%26aulast%3DSchlichting%26aufirst%3DI.%26aulast%3DSchmidt%26aufirst%3DH.%2BH.%2BH.%2BW.%26atitle%3DStructural%2520analysis%2520of%2520isoform-specific%2520inhibitors%2520targeting%2520the%2520tetrahydrobiopterin%2520binding%2520site%2520of%2520human%2520nitric%2520oxide%2520synthases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4783%26epage%3D4792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group">Behl, C.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease and oxidative stress: implications for novel therapeutic approaches</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0301-0082%2898%2900055-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=10096843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1MXkslyltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1999&pages=301-323&author=C.+Behl&title=Alzheimer%E2%80%99s+disease+and+oxidative+stress%3A+implications+for+novel+therapeutic+approaches"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease and oxidative stress: Implications for novel therapeutic approaches</span></div><div class="casAuthors">Behl, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">301-323</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 293 refs.  Alzheimer's disease (AD) is a progressive neurodegenerative disorder with a deadly outcome.  AD is the leading cause of senile dementia and although the pathogenesis of this disorder is not known, various hypotheses have been developed based on exptl. data accumulated since the initial description of this disease by Alois Alzheimer about 90 yr ago.  Most approaches to explain the pathogenesis of AD focus on its two histopathol. hallmarks, the amyloid β protein- (Aβ-) loaded senile plaques and the neurofibrillary tangles, which consist of the filament protein tau.  Various lines of genetic evidence support a central role of Aβ in the pathogenesis of AD and an increasing no. of studies show that oxidn. reactions occur in AD and that Aβ may be one mol. link between oxidative stress and AD-assocd. neuronal cell death.  Aβ itself can be neurotoxic and can induce oxidative stress in cultivated neurons.  Aβ is, therefore, one player in the concert of oxidative reactions that challenge neurons besides inflammatory reactions which are also assocd. with the AD pathol.  Consequently, antioxidant approaches for the prevention and therapy of AD are of central interest.  Exptl. as well as clin. data show that lipophilic antioxidants, such as vitamin E and estrogens, are neuroprotective and may help patients suffering from AD.  While an addnl. intensive elucidation of the cellular and mol. events of neuronal cell death in AD will, ultimately, lead to novel drug targets, various antioxidants are already available for a further exploitation of their preventive and therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN-ulfiWkcxLVg90H21EOLACvtfcHk0ljYX-QsOpxqiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkslyltQ%253D%253D&md5=10be10b699e72402337e4dc8c4635d5f</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1016%2FS0301-0082%2898%2900055-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-0082%252898%252900055-0%26sid%3Dliteratum%253Aachs%26aulast%3DBehl%26aufirst%3DC.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520and%2520oxidative%2520stress%253A%2520implications%2520for%2520novel%2520therapeutic%2520approaches%26jtitle%3DProg.%2520Neurobiol.%26date%3D1999%26volume%3D57%26spage%3D301%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group">Christen, Y.</span><span> </span><span class="NLM_article-title">Oxidative stress and Alzheimer disease</span> <span class="citation_source-journal">Am. J. Clin. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">621S</span><span class="NLM_x">–</span> <span class="NLM_lpage">629S</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1093%2Fajcn%2F71.2.621s" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=10681270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD3c7kt1Oguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2000&pages=621S-629S&author=Y.+Christen&title=Oxidative+stress+and+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress and Alzheimer disease</span></div><div class="casAuthors">Christen Y</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of clinical nutrition</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">621S-629S</span>
        ISSN:<span class="NLM_cas:issn">0002-9165</span>.
    </div><div class="casAbstract">Research in the field of molecular biology has helped to provide a better understanding of both the cascade of biochemical events that occurs with Alzheimer disease (AD) and the heterogeneous nature of the disease.  One hypothesis that accounts for both the heterogeneous nature of AD and the fact that aging is the most obvious risk factor is that free radicals are involved.  The probability of this involvement is supported by the fact that neurons are extremely sensitive to attacks by destructive free radicals.  Furthermore, lesions are present in the brains of AD patients that are typically associated with attacks by free radicals (eg, damage to DNA, protein oxidation, lipid peroxidation, and advanced glycosylation end products), and metals (eg, iron, copper, zinc, and aluminum) are present that have catalytic activity that produce free radicals. beta-Amyloid is aggregated and produces more free radicals in the presence of free radicals; beta-amyloid toxicity is eliminated by free radical scavengers.  Apolipoprotein E is subject to attacks by free radicals, and apolipoprotein E peroxidation has been correlated with AD.  In contrast, apolipoprotein E can act as a free radical scavenger and this behavior is isoform dependent.  AD has been linked to mitochondrial anomalies affecting cytochrome-c oxidase, and these anomalies may contribute to the abnormal production of free radicals.  Finally, many free radical scavengers (eg, vitamin E, selegeline, and Ginkgo biloba extract EGb 761) have produced promising results in relation to AD, as has desferrioxamine-an iron-chelating agent-and antiinflammatory drugs and estrogens, which also have an antioxidant effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRjZRhxHc0mgYFEOhA_Im3cfW6udTcc2eaJNBqeg83D6rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7kt1Oguw%253D%253D&md5=e47395137b1aa3c380f1190ff3f5d29c</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1093%2Fajcn%2F71.2.621s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fajcn%252F71.2.621s%26sid%3Dliteratum%253Aachs%26aulast%3DChristen%26aufirst%3DY.%26atitle%3DOxidative%2520stress%2520and%2520Alzheimer%2520disease%26jtitle%3DAm.%2520J.%2520Clin.%2520Nutr.%26date%3D2000%26volume%3D71%26spage%3D621S%26epage%3D629S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group">Harman, D.</span><span> </span><span class="NLM_article-title">A hypothesis on the pathogenesis of Alzheimer’s disease</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">786</span><span class="NLM_x">, </span> <span class="NLM_fpage">152</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=786&publication_year=1996&pages=152-168&author=D.+Harman&title=A+hypothesis+on+the+pathogenesis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarman%26aufirst%3DD.%26atitle%3DA%2520hypothesis%2520on%2520the%2520pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D1996%26volume%3D786%26spage%3D152%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group">Joseph, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukitt-Hale, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denisova, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. A.</span><span> </span><span class="NLM_article-title">Copernicus revisited: amyloid beta in Alzheimer’s disease</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0197-4580%2800%2900211-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11164287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD3MzgtVGntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2001&pages=131-146&author=J.+Josephauthor=B.+Shukitt-Haleauthor=N.+A.+Denisovaauthor=A.+Martinauthor=G.+Perryauthor=M.+A.+Smith&title=Copernicus+revisited%3A+amyloid+beta+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Copernicus revisited: amyloid beta in Alzheimer's disease</span></div><div class="casAuthors">Joseph J; Shukitt-Hale B; Denisova N A; Martin A; Perry G; Smith M A</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of aging</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">131-46</span>
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    </div><div class="casAbstract">The beta-amyloid hypothesis of Alzheimer's Disease (AD) has dominated the thinking and research in this area for over a decade and a half.  While there has been a great deal of effort in attempting to prove its centrality in this devastating disease, and while an enormous amount has been learned about its properties (e.g., putative toxicity, processing and signaling), Abeta has not proven to be both necessary and sufficient for the development, neurotoxicity, and cognitive deficits associated with this disease.  Instead, the few treatments that are available have emerged from aging research and are primarily directed toward modification of acetylcholine levels.  Clearly, it is time to rethink this position and to propose instead that future approaches should focus upon altering the age-related sensitivity of the neuronal environment to insults involving such factors as inflammation and oxidative stress.  In other words "solve the problems of aging and by extension those of AD will also be reduced." This review is being submitted as a rather Lutherian attempt to "nail an alternative thesis" to the gate of the Church of the Holy Amyloid to open its doors to the idea that aging is the most pervasive element in this disease and Abeta is merely one of the planets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTLOmhNe5JnPZZoeNcnHOQ9fW6udTcc2eaJNBqeg83D6rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MzgtVGntg%253D%253D&md5=bfae663fb0e1c8d41ce28196a5eb5109</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1016%2FS0197-4580%2800%2900211-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-4580%252800%252900211-6%26sid%3Dliteratum%253Aachs%26aulast%3DJoseph%26aufirst%3DJ.%26aulast%3DShukitt-Hale%26aufirst%3DB.%26aulast%3DDenisova%26aufirst%3DN.%2BA.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DPerry%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26atitle%3DCopernicus%2520revisited%253A%2520amyloid%2520beta%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2001%26volume%3D22%26spage%3D131%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group">Markesbery, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carney, J. M.</span><span> </span><span class="NLM_article-title">Oxidative alterations in Alzheimer’s disease</span> <span class="citation_source-journal">Brain Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1111%2Fj.1750-3639.1999.tb00215.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=9989456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1MXht1Cmsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=133-146&author=W.+R.+Markesberyauthor=J.+M.+Carney&title=Oxidative+alterations+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative alterations in Alzheimer's disease</span></div><div class="casAuthors">Markesbery, William R.; Carney, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Pathology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">133-146</span>CODEN:
                <span class="NLM_cas:coden">BRPAE7</span>;
        ISSN:<span class="NLM_cas:issn">1015-6305</span>.
    
            (<span class="NLM_cas:orgname">International Society of Neuropathology</span>)
        </div><div class="casAbstract">A review with 136 refs.  There is increasing evidence that free radical damage to brain lipids, carbohydrates, proteins, and DNA is involved in neuron death in neurodegenerative disorders.  The largest no. of studies have been performed in Alzheimer's disease (AD) where there is considerable support for the oxidative stress hypothesis in the pathogenesis of neuron degeneration.  In autopsied brain there is an increase in lipid peroxidn., a decline in polyunsatd. fatty acids (PUFA) and an increase in 4-hydroxynonenal (HNE), a neurotoxic aldehyde product of PUFA oxidn.  Increased protein oxidn. and a marked decline in oxidative-sensitive enzymes, glutamine synthetase and creatinine kinase, are found in the brain in AD.  Increased DNA oxidn., esp. 8-hydroxy-2'-deoxyguanosine (8-OHdG) is present in the brain in AD.  Immunohistochem. studies show the presence of oxidative stress products in neurofibrillary tangles and senile plaques in AD.  Markers of lipid peroxidn. (HNE, isoprostanes) and DNA (8-OHdG) are increased in CSF in AD.  In addn., inflammatory response markers (the complement cascade, cytokines, acute phase reactants and proteases) are present in the brain in AD.  These findings, coupled with epidemiol. studies showing that anti-inflammatory agents slow the progression or delay the onset of AD, suggest that inflammation plays a role in AD.  Overall these studies indicate that oxidative stress and the inflammatory cascade, working in concert, are important in the pathogenetic cascade of neurodegeneration in AD, suggesting that therapeutic efforts aimed at both of these mechanisms may be beneficial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQLMrceQruxrVg90H21EOLACvtfcHk0lgka6VQGpss4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXht1Cmsbw%253D&md5=e79d14e67f9ae9f1c00ca6a667dc8c6c</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1111%2Fj.1750-3639.1999.tb00215.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1750-3639.1999.tb00215.x%26sid%3Dliteratum%253Aachs%26aulast%3DMarkesbery%26aufirst%3DW.%2BR.%26aulast%3DCarney%26aufirst%3DJ.%2BM.%26atitle%3DOxidative%2520alterations%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBrain%2520Pathol.%26date%3D1999%26volume%3D9%26spage%3D133%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group">Prasad, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hovland, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nahreini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards-Prasad, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreatta, C. P.</span><span> </span><span class="NLM_article-title">Multiple antioxidants in the prevention and treatment of Alzheimer disease: analysis of biologic rationale</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2000&pages=2-13&author=K.+N.+Prasadauthor=A.+R.+Hovlandauthor=W.+C.+Coleauthor=K.+C.+Prasadauthor=P.+Nahreiniauthor=J.+Edwards-Prasadauthor=C.+P.+Andreatta&title=Multiple+antioxidants+in+the+prevention+and+treatment+of+Alzheimer+disease%3A+analysis+of+biologic+rationale"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrasad%26aufirst%3DK.%2BN.%26aulast%3DHovland%26aufirst%3DA.%2BR.%26aulast%3DCole%26aufirst%3DW.%2BC.%26aulast%3DPrasad%26aufirst%3DK.%2BC.%26aulast%3DNahreini%26aufirst%3DP.%26aulast%3DEdwards-Prasad%26aufirst%3DJ.%26aulast%3DAndreatta%26aufirst%3DC.%2BP.%26atitle%3DMultiple%2520antioxidants%2520in%2520the%2520prevention%2520and%2520treatment%2520of%2520Alzheimer%2520disease%253A%2520analysis%2520of%2520biologic%2520rationale%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2000%26volume%3D23%26spage%3D2%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group">Beal, M. F.</span><span> </span><span class="NLM_article-title">Experimental models of Parkinson’s disease</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2F35072550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11331916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjs1Ogtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=325-334&author=M.+F.+Beal&title=Experimental+models+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental models of Parkinson's disease</span></div><div class="casAuthors">Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">325-332</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review, with 105 refs.  Research into the pathogenesis of Parkinson's disease has been rapidly advanced by the development of animal models.  Initial models were developed by using toxins that specifically targeted dopamine neurons, the most successful of which used 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a toxin that causes parkinsonism in man.  More recently, the identification of α-synuclein mutations as a rare cause of Parkinson's disease has led to the development of α-synuclein transgenic mice and Drosophila.  Here, I discuss the merits and limitations of these different animal models in our attempts to understand the physiol. of parkinson's disease and to develop new therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1Lsui9cNvDbVg90H21EOLACvtfcHk0lgka6VQGpss4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjs1Ogtrs%253D&md5=cf528476d8ad3bbf95b9bd8ed3701c6e</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1038%2F35072550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35072550%26sid%3Dliteratum%253Aachs%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DExperimental%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2001%26volume%3D2%26spage%3D325%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group">Blum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nissou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benabid, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadoul, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verna, J. M.</span><span> </span><span class="NLM_article-title">Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson’s disease</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0301-0082%2801%2900003-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11403877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkt1Kitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2001&pages=135-172&author=D.+Blumauthor=S.+Torchauthor=N.+Lambengauthor=M.+Nissouauthor=A.+L.+Benabidauthor=R.+Sadoulauthor=J.+M.+Verna&title=Molecular+pathways+involved+in+the+neurotoxicity+of+6-OHDA%2C+dopamine+and+MPTP%3A+contribution+to+the+apoptotic+theory+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease</span></div><div class="casAuthors">Blum, D.; Torch, S.; Lambeng, N.; Nissou, M.-F.; Benabid, A.-L.; Sadoul, R.; Verna, J.-M.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-172</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is a neurodegenerative disorder characterized by a preferential loss of the dopaminergic neurons of the substantia nigra pars compacta.  Although the etiol. of PD is unknown, major biochem. processes such as oxidative stress and mitochondrial inhibition are largely described.  However, despite these findings, the actual therapeutics are essentially symptomatical and are not able to block the degenerative process.  Recent histol. studies performed on brains from PD patients suggest that nigral cell death could be apoptotic.  However, since post-mortem studies do not allow precise detn. of the sequence of events leading to this apoptotic cell death, the mol. pathways involved in this process have been essentially studied on exptl. models reproducing the human disease.  These latter are created by using neurotoxic compds. such as 6-hydroxydopamine (6-OHDA), 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or dopamine (DA).  Extensive study of these models have shown that they mimic, in vitro and in vivo, the histol. and/or the biochem. characteristics of PD and thus help to define important cellular actors of cell death presumably crit. for the nigral degeneration.  This review reports recent data concerning the biochem. and mol. apoptotic mechanisms underlying the exptl. models of PD and correlates them to the phenomena occurring in human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp06yzzR3ObwbVg90H21EOLACvtfcHk0lgka6VQGpss4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkt1Kitbo%253D&md5=61afe1d88da62953d6b34b1f87482e5f</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1016%2FS0301-0082%2801%2900003-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-0082%252801%252900003-X%26sid%3Dliteratum%253Aachs%26aulast%3DBlum%26aufirst%3DD.%26aulast%3DTorch%26aufirst%3DS.%26aulast%3DLambeng%26aufirst%3DN.%26aulast%3DNissou%26aufirst%3DM.%26aulast%3DBenabid%26aufirst%3DA.%2BL.%26aulast%3DSadoul%26aufirst%3DR.%26aulast%3DVerna%26aufirst%3DJ.%2BM.%26atitle%3DMolecular%2520pathways%2520involved%2520in%2520the%2520neurotoxicity%2520of%25206-OHDA%252C%2520dopamine%2520and%2520MPTP%253A%2520contribution%2520to%2520the%2520apoptotic%2520theory%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DProg.%2520Neurobiol.%26date%3D2001%26volume%3D65%26spage%3D135%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group">Foley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, P.</span><span> </span><span class="NLM_article-title">Influence of neurotoxins and oxidative stress on the onset and progression of Parkinson’s disease</span> <span class="citation_source-journal">J. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">247</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">II82</span><span class="NLM_x">–</span> <span class="NLM_lpage">II94</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=247&publication_year=2000&pages=II82-II94&issue=Suppl.+2&author=P.+Foleyauthor=P.+Riederer&title=Influence+of+neurotoxins+and+oxidative+stress+on+the+onset+and+progression+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoley%26aufirst%3DP.%26aulast%3DRiederer%26aufirst%3DP.%26atitle%3DInfluence%2520of%2520neurotoxins%2520and%2520oxidative%2520stress%2520on%2520the%2520onset%2520and%2520progression%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurol.%26date%3D2000%26volume%3D247%26issue%3DSuppl.%25202%26spage%3DII82%26epage%3DII94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group">Gerlach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, P.</span><span> </span><span class="NLM_article-title">Animal models of Parkinson’s disease: an empirical comparison with the phenomenology of the disease in man</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">1041</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1996&pages=987-1041&author=M.+Gerlachauthor=P.+Riederer&title=Animal+models+of+Parkinson%E2%80%99s+disease%3A+an+empirical+comparison+with+the+phenomenology+of+the+disease+in+man"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGerlach%26aufirst%3DM.%26aulast%3DRiederer%26aufirst%3DP.%26atitle%3DAnimal%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520an%2520empirical%2520comparison%2520with%2520the%2520phenomenology%2520of%2520the%2520disease%2520in%2520man%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D1996%26volume%3D103%26spage%3D987%26epage%3D1041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group">Browne, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrante, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, M. F.</span><span> </span><span class="NLM_article-title">Oxidative stress in Huntington’s disease</span> <span class="citation_source-journal">Brain Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1111%2Fj.1750-3639.1999.tb00216.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=9989457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1MXht1Cmsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=147-163&author=S.+E.+Browneauthor=R.+J.+Ferranteauthor=M.+F.+Beal&title=Oxidative+stress+in+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress in Huntington's disease</span></div><div class="casAuthors">Browne, Susan E.; Ferrante, Robert J.; Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Brain Pathology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">147-163</span>CODEN:
                <span class="NLM_cas:coden">BRPAE7</span>;
        ISSN:<span class="NLM_cas:issn">1015-6305</span>.
    
            (<span class="NLM_cas:orgname">International Society of Neuropathology</span>)
        </div><div class="casAbstract">A review with 105 refs.  It has been five years since the elucidation of the genetic mutation underlying the pathogenesis of Huntington's disease (HD) (97), however the precise mechanism of the selective neuronal death it propagates still remains an enigma.  Several different etiol. processes may play roles, and strong evidence from studies in both humans and animal models suggests the involvement of energy metab. dysfunction, excitotoxic processes, and oxidative stress.  Importantly, the recent development of transgenic mouse models of HD led to the identification of neuronal intranuclear inclusion bodies in affected brain regions in both mouse models and in HD brain, consisting of protein aggregates contg. fragments of mutant huntingtin protein.  These observations opened new avenues of investigation into possible huntingtin protein interactions and their putative pathogenetic sequelae.  Amongst these studies, findings of elevated levels of oxidative damage products such as malondialdehyde, 8-hydroxy-deoxyguanosine, 3-nitrotyrosine and heme oxygenase in areas of degeneration in HD brain, and of increased free radical prodn. in animal models, indicate the involvement of oxidative stress either as a causative event, or as a secondary constituent of the cell death cascade in the disease.  Here the authors review the evidence for oxidative damage and potential mechanisms of neuronal death in HD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdG6l3odjA7LVg90H21EOLACvtfcHk0liPnoILTbh5sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXht1Cmsb0%253D&md5=7d5f3ea8cef42c6bb3f102554889aefe</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1111%2Fj.1750-3639.1999.tb00216.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1750-3639.1999.tb00216.x%26sid%3Dliteratum%253Aachs%26aulast%3DBrowne%26aufirst%3DS.%2BE.%26aulast%3DFerrante%26aufirst%3DR.%2BJ.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DOxidative%2520stress%2520in%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DBrain%2520Pathol.%26date%3D1999%26volume%3D9%26spage%3D147%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group">Pedersen, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markesbery, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasarskis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, M. P.</span><span> </span><span class="NLM_article-title">Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">819</span><span class="NLM_x">–</span> <span class="NLM_lpage">824</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1002%2Fana.410440518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=9818940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1cXnsFChtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1998&pages=819-824&author=W.+A.+Pedersenauthor=W.+Fuauthor=J.+N.+Kellerauthor=W.+R.+Markesberyauthor=S.+Appelauthor=R.+G.+Smithauthor=E.+Kasarskisauthor=M.+P.+Mattson&title=Protein+modification+by+the+lipid+peroxidation+product+4-hydroxynonenal+in+the+spinal+cords+of+amyotrophic+lateral+sclerosis+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients</span></div><div class="casAuthors">Pedersen, Ward A.; Fu, Weiming; Keller, Jeffrey N.; Markesbery, William R.; Appel, Stanley; Smith, Glenn; Kasarskis, Edward; Mattson, Mark P.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">819-824</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">We report increased modification of proteins by 4-hydroxynonenal (HNE), a product of membrane lipid peroxidn., in the lumbar spinal cord of sporadic amyotrophic lateral sclerosis (ALS) patients vs. that of neurol. normal controls.  By immunohistochem., HNE-protein modification was detected in ventral horn motor neurons, and immunopptn. anal. revealed that one of the proteins modified by HNE was the astrocytic glutamate transporter EAAT2.  Given that the function of proteins modified by HNE can be severely compromised as previously demonstrated for glutamate transporters in cortical synaptosome prepns., our findings suggest a scenario in which oxidative stress leads to the prodn. of HNE, impairment of glutamate transport, and excitotoxic motor neuron degeneration in ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIlWrEwLxZALVg90H21EOLACvtfcHk0liPnoILTbh5sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnsFChtr8%253D&md5=253cc45834141872113db1f5b22ff392</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1002%2Fana.410440518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410440518%26sid%3Dliteratum%253Aachs%26aulast%3DPedersen%26aufirst%3DW.%2BA.%26aulast%3DFu%26aufirst%3DW.%26aulast%3DKeller%26aufirst%3DJ.%2BN.%26aulast%3DMarkesbery%26aufirst%3DW.%2BR.%26aulast%3DAppel%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DKasarskis%26aufirst%3DE.%26aulast%3DMattson%26aufirst%3DM.%2BP.%26atitle%3DProtein%2520modification%2520by%2520the%2520lipid%2520peroxidation%2520product%25204-hydroxynonenal%2520in%2520the%2520spinal%2520cords%2520of%2520amyotrophic%2520lateral%2520sclerosis%2520patients%26jtitle%3DAnn.%2520Neurol.%26date%3D1998%26volume%3D44%26spage%3D819%26epage%3D824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group">Sayre, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, G.</span><span> </span><span class="NLM_article-title">Chemistry and biochemistry of oxidative stress in neurodegenerative disease</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.2174%2F0929867013372922" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11375746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsVChtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=721-738&author=L.+M.+Sayreauthor=M.+A.+Smithauthor=G.+Perry&title=Chemistry+and+biochemistry+of+oxidative+stress+in+neurodegenerative+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry and biochemistry of oxidative stress in neurodegenerative disease</span></div><div class="casAuthors">Sayre, Lawrence M.; Smith, Mark A.; Perry, George</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">721-738</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with 234 refs.  The age-related neurodegenerative diseases exemplified by Alzheimer's disease (AD), Lewy body diseases such as Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington's disease are characterized by the deposition of abnormal forms of specific proteins in the brain.  Although several factors appear to underlie the pathol. depositions, the cause of neuronal death in each disease appears to be multifactorial.  In this regard, evidence in each case for a role of oxidative stress is provided by the finding that the pathol. deposits are immunoreactive to antibodies recognizing protein side-chains modified either directly by reactive oxygen or nitrogen species, or by products of lipid peroxidn. or glycoxidn.  Although the source(s) of increased oxidative damage are not entirely clear, the findings of increased localization of redox-active transition metals in the brain regions most affected is consistent with their contribution to oxidative stress.  It is tempting to speculate that free radical oxygen chem. plays a pathogenetic role in all these neurodegenerative conditions, though it is as yet undetd. what types of oxidative damage occur early in pathogenesis, and what types are secondary manifestations of dying neurons.  Delineation of the profile of oxidative damage in each disease will provide clues to how the specific neuronal populations are differentially affected by the individual disease conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9DAa0j4fYwbVg90H21EOLACvtfcHk0liPnoILTbh5sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsVChtbs%253D&md5=ff9d8a618f96b8fc7b6994e88e07191c</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.2174%2F0929867013372922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867013372922%26sid%3Dliteratum%253Aachs%26aulast%3DSayre%26aufirst%3DL.%2BM.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26aulast%3DPerry%26aufirst%3DG.%26atitle%3DChemistry%2520and%2520biochemistry%2520of%2520oxidative%2520stress%2520in%2520neurodegenerative%2520disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2001%26volume%3D8%26spage%3D721%26epage%3D738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group">Grodstein, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, W. C.</span><span> </span><span class="NLM_article-title">High-dose antioxidant supplements and cognitive function in community-dwelling elderly women</span> <span class="citation_source-journal">Am. J. Clin. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">984</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12663300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsVSrt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2003&pages=975-984&author=F.+Grodsteinauthor=J.+Chenauthor=W.+C.+Willett&title=High-dose+antioxidant+supplements+and+cognitive+function+in+community-dwelling+elderly+women"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">High-dose antioxidant supplements and cognitive function in community-dwelling elderly women</span></div><div class="casAuthors">Grodstein, Francine; Chen, Jennifer; Willett, Walter C.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Clinical Nutrition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">975-984</span>CODEN:
                <span class="NLM_cas:coden">AJCNAC</span>;
        ISSN:<span class="NLM_cas:issn">0002-9165</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Nutrition</span>)
        </div><div class="casAbstract">Exptl. data suggest that oxygen free radicals may be involved in the deterioration of cognitive processes.  The relations of high-dose dietary antioxidant supplementation to cognition were studied.  Information on the use of specific supplements contg. vitamins E and C was collected biennially via mailed questionnaires beginning in 1980 from 14968 community-dwelling women participating in the Nurses' Health Study.  From 1995 to 2000, telephone tests of cognitive function [Telephone Interview of Cognitive Status (TICS), delayed recall of the TICS 10-word list, immediate and delayed recall of a short paragraph, test of verbal fluency, digit span backwards test] were administered to the women 70-79 yr old at that time.  Linear and logistic regression models were used to calc. multivariate-adjusted mean differences in test scores and relative risks of a low score for specific supplement users compared with nonusers.  Long-term current users of vitamin E with vitamin C had better mean performance, as judged by a global score that combined individual test scores, than did women who had never used vitamin E or C; there was a trend for increasingly higher mean scores with increasing duration of supplement use.  These assocns. were strongest in women with low dietary intakes of α-tocopherol.  Benefits were less consistent in women taking vitamin E alone, with no evidence of higher scores with longer durations of use.  Use of specific vitamin C supplements alone had little relation to performance in the cognitive tests used.  Thus, the use of specific vitamin E supplements, but not specific vitamin C supplements, may be related to modest cognitive benefits in older women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTwoPqvdVtl7Vg90H21EOLACvtfcHk0lixWCWQmStjVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsVSrt7g%253D&md5=7811b0796cb34ae25316a25b9f15c1c0</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrodstein%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWillett%26aufirst%3DW.%2BC.%26atitle%3DHigh-dose%2520antioxidant%2520supplements%2520and%2520cognitive%2520function%2520in%2520community-dwelling%2520elderly%2520women%26jtitle%3DAm.%2520J.%2520Clin.%2520Nutr.%26date%3D2003%26volume%3D77%26spage%3D975%26epage%3D984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group">Laurin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masaki, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Launer, L. J.</span><span> </span><span class="NLM_article-title">Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia aging study</span> <span class="citation_source-journal">Am. J. Epidemiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">959</span><span class="NLM_x">–</span> <span class="NLM_lpage">967</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1093%2Faje%2Fkwh124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=15128608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ivFCrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2004&pages=959-967&author=D.+Laurinauthor=K.+H.+Masakiauthor=D.+J.+Foleyauthor=L.+R.+Whiteauthor=L.+J.+Launer&title=Midlife+dietary+intake+of+antioxidants+and+risk+of+late-life+incident+dementia%3A+the+Honolulu-Asia+aging+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study</span></div><div class="casAuthors">Laurin Danielle; Masaki Kamal H; Foley Daniel J; White Lon R; Launer Lenore J</div><div class="citationInfo"><span class="NLM_cas:title">American journal of epidemiology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">959-67</span>
        ISSN:<span class="NLM_cas:issn">0002-9262</span>.
    </div><div class="casAbstract">Antioxidants have been hypothesized to protect against Alzheimer's disease, but studies conducted in late life have been inconsistent.  Risk factors measured in midlife may better predict dementia in late life because they are less affected by the disease process.  The authors examined the association of midlife dietary intake of antioxidants to late-life dementia and its subtypes.  Data were obtained from the Honolulu-Asia Aging Study, a prospective community-based study of Japanese-American men who were aged 45-68 years in 1965-1968, when a 24-hour dietary recall was administered.  The analysis included 2,459 men with complete dietary data who were dementia-free at the first assessment in 1991-1993 and were examined up to two times for dementia between 1991 and 1999.  The sample included 235 incident cases of dementia (102 cases of Alzheimer's disease, 38 cases of Alzheimer's disease with contributing cerebrovascular disease, and 44 cases of vascular dementia).  Relative risks by quartile of intake were calculated using Cox proportional hazards models with age as the time scale, after adjustment for sociodemographic and lifestyle factors, cardiovascular risk factors, other dietary constituents, and apolipoprotein E e4.  Intakes of beta-carotene, flavonoids, and vitamins E and C were not associated with the risk of dementia or its subtypes.  This analysis suggests that midlife dietary intake of antioxidants does not modify the risk of late-life dementia or its most prevalent subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR-PI_JCgD5aZ0d-O_J5C0AfW6udTcc2eZeo3DZzaSXmLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ivFCrsg%253D%253D&md5=8c3ab79a313897b5ebfe7c12c4943075</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1093%2Faje%2Fkwh124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Faje%252Fkwh124%26sid%3Dliteratum%253Aachs%26aulast%3DLaurin%26aufirst%3DD.%26aulast%3DMasaki%26aufirst%3DK.%2BH.%26aulast%3DFoley%26aufirst%3DD.%2BJ.%26aulast%3DWhite%26aufirst%3DL.%2BR.%26aulast%3DLauner%26aufirst%3DL.%2BJ.%26atitle%3DMidlife%2520dietary%2520intake%2520of%2520antioxidants%2520and%2520risk%2520of%2520late-life%2520incident%2520dementia%253A%2520the%2520Honolulu-Asia%2520aging%2520study%26jtitle%3DAm.%2520J.%2520Epidemiol.%26date%3D2004%26volume%3D159%26spage%3D959%26epage%3D967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group">Petersen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doody, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galasko, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dyck, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thal, L. J.</span><span> </span><span class="NLM_article-title">Vitamin E and donepezil for the treatment of mild cognitive impairment</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">2379</span><span class="NLM_x">–</span> <span class="NLM_lpage">2388</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1056%2FNEJMoa050151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=15829527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVCjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=2379-2388&author=R.+C.+Petersenauthor=R.+G.+Thomasauthor=M.+Grundmanauthor=D.+Bennettauthor=R.+Doodyauthor=S.+Ferrisauthor=D.+Galaskoauthor=S.+Jinauthor=J.+Kayeauthor=A.+Leveyauthor=E.+Pfeifferauthor=M.+Sanoauthor=C.+H.+van+Dyckauthor=L.+J.+Thal&title=Vitamin+E+and+donepezil+for+the+treatment+of+mild+cognitive+impairment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">Vitamin E and Donepezil for the treatment of mild cognitive impairment</span></div><div class="casAuthors">Petersen, Ronald C.; Thomas, Ronald G.; Grundman, Michael; Bennett, David; Doody, Rachelle; Ferris, Steven; Galasko, Douglas; Jin, Shelia; Kaye, Jeffrey; Levey, Allan; Pfeiffer, Eric; Sano, Mary; van Dyck, Christopher H.; Thal, Leon J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2379-2388</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Mild cognitive impairment is a transitional state between the cognitive changes of normal aging and early Alzheimer's disease.  Methods: In a double-blind study, we evaluated subjects with the amnestic subtype of mild cognitive impairment.  Subjects were randomly assigned to receive 2000 IU of vitamin E daily, 10 mg of donepezil daily, or placebo for three years.  The primary outcome was clin. possible or probable Alzheimer's disease; secondary outcomes were cognition and function.  Results: A total of 769 subjects were enrolled, and possible or probable Alzheimer's disease developed in 212.  The overall rate of progression from mild cognitive impairment to Alzheimer's disease was 16 % per yr.  As compared with the placebo group, there were no significant differences in the probability of progression to Alzheimer's disease in the vitamin E group (hazard ratio, 1.02; 95 % confidence interval, 0.74 to 1.41; P = 0.91) or the donepezil group (hazard ratio, 0.80; 95 % confidence interval, 0.57 to 1.13; P = 0.42) during the three years of treatment.  Prespecified analyses of the treatment effects at 6-mo intervals showed that as compared with the placebo group, the donepezil group had a reduced likelihood of progression to Alzheimer's disease during the first 12 mo of the study (P = 0.04), a finding supported by the secondary outcome measures.  Among carriers of one or more apolipoprotein E ε4 alleles, the benefit of donepezil was evident throughout the three-year follow-up.  There were no significant differences in the rate of progression to Alzheimer's disease between the vitamin E and placebo groups at any point, either among all patients or among apolipoprotein E ε4 carriers.  Conclusions: Vitamin E had no benefit in patients with mild cognitive impairment.  Although donepezil therapy was assocd. with a lower rate of progression to Alzheimer's disease during the first 12 mo of treatment, the rate of progression to Alzheimer's disease after three years was not lower among patients treated with donepezil than among those given placebo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXAHw4M6-5u7Vg90H21EOLACvtfcHk0lixWCWQmStjVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVCjsbg%253D&md5=af3c48d4cfaa74b18828b4ea143eae68</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa050151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa050151%26sid%3Dliteratum%253Aachs%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DThomas%26aufirst%3DR.%2BG.%26aulast%3DGrundman%26aufirst%3DM.%26aulast%3DBennett%26aufirst%3DD.%26aulast%3DDoody%26aufirst%3DR.%26aulast%3DFerris%26aufirst%3DS.%26aulast%3DGalasko%26aufirst%3DD.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKaye%26aufirst%3DJ.%26aulast%3DLevey%26aufirst%3DA.%26aulast%3DPfeiffer%26aufirst%3DE.%26aulast%3DSano%26aufirst%3DM.%26aulast%3Dvan%2BDyck%26aufirst%3DC.%2BH.%26aulast%3DThal%26aufirst%3DL.%2BJ.%26atitle%3DVitamin%2520E%2520and%2520donepezil%2520for%2520the%2520treatment%2520of%2520mild%2520cognitive%2520impairment%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D2379%26epage%3D2388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group">Hayden, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsh-Bohmer, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wengreen, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zandi, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyketsos, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitner, J. C.</span><span> </span><span class="NLM_article-title">Risk of mortality with vitamin E supplements: the Cache County study</span> <span class="citation_source-journal">Am. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">180</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.amjmed.2006.03.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=17275460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlSqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2007&pages=180-184&author=K.+M.+Haydenauthor=K.+A.+Welsh-Bohmerauthor=H.+J.+Wengreenauthor=P.+P.+Zandiauthor=C.+G.+Lyketsosauthor=J.+C.+Breitner&title=Risk+of+mortality+with+vitamin+E+supplements%3A+the+Cache+County+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Risk of Mortality with Vitamin E Supplements: The Cache County Study</span></div><div class="casAuthors">Hayden, Kathleen M.; Welsh-Bohmer, Kathleen A.; Wengreen, Heidi J.; Zandi, Peter P.; Lyketsos, Constantine G.; Breitner, John C. S.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">180-184</span>CODEN:
                <span class="NLM_cas:coden">AJMEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0002-9343</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Purpose: A recent meta-anal. reported increased mortality in clin. trial participants randomized to high-dose vitamin E. We sought to det. whether these mortality risks with vitamin E reflect adverse consequences of its use in the presence of cardiovascular disease.  Methods: In a defined population aged 65 years or older, baseline interviews captured self- or proxy-reported history of cardiovascular illness.  A medicine cabinet inventory verified nutritional supplement and medication use.  Three sources identified subsequent deaths.  Cox proportional hazards methods examd. the assocn. between vitamin E use and mortality.  Results: After adjustment for age and sex, there was no assocn. in this population between vitamin E use and mortality (adjusted hazard ratio [aHR] 0.93; 95% confidence interval [CI], 0.74-1.15).  Predictably, deaths were more frequent with a history of diabetes, stroke, coronary artery bypass graft surgery, or myocardial infarction, and with the use of warfarin, nitrates, or diuretics.  None of these conditions or treatments altered the null main effect with vitamin E, but mortality was increased in vitamin E users who had a history of stroke (aHR 3.64; CI, 1.73-7.68), coronary bypass graft surgery (aHR 4.40; CI, 2.83-6.83), or myocardial infarction (aHR 1.95; CI, 1.29-2.95) and, independently, in those taking nitrates (aHR 3.95; CI, 2.04-7.65), warfarin (aHR 3.71; CI, 2.22-6.21), or diuretics (aHR 1.83; CI, 1.35-2.49).  Although not definitive, a consistent trend toward reduced mortality was seen in vitamin E users without these conditions or treatments.  Conclusions: In this population-based study, vitamin E use was unrelated to mortality, but this apparently null finding seems to represent a combination of increased mortality in those with severe cardiovascular disease and a possible protective effect in those without.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq55TOu2Y2lGrVg90H21EOLACvtfcHk0ljvg5tpa6VKsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlSqtr4%253D&md5=ffef9e596815036b6d1e0538a4c8c1b3</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1016%2Fj.amjmed.2006.03.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjmed.2006.03.039%26sid%3Dliteratum%253Aachs%26aulast%3DHayden%26aufirst%3DK.%2BM.%26aulast%3DWelsh-Bohmer%26aufirst%3DK.%2BA.%26aulast%3DWengreen%26aufirst%3DH.%2BJ.%26aulast%3DZandi%26aufirst%3DP.%2BP.%26aulast%3DLyketsos%26aufirst%3DC.%2BG.%26aulast%3DBreitner%26aufirst%3DJ.%2BC.%26atitle%3DRisk%2520of%2520mortality%2520with%2520vitamin%2520E%2520supplements%253A%2520the%2520Cache%2520County%2520study%26jtitle%3DAm.%2520J.%2520Med.%26date%3D2007%26volume%3D120%26spage%3D180%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group">Luchsinger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, M. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shea, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayeux, R.</span><span> </span><span class="NLM_article-title">Antioxidant vitamin intake and risk of Alzheimer disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1001%2Farchneur.60.2.203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12580704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD3s%252FntVyltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2003&pages=203-208&author=J.+A.+Luchsingerauthor=M.+X.+Tangauthor=S.+Sheaauthor=R.+Mayeux&title=Antioxidant+vitamin+intake+and+risk+of+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant vitamin intake and risk of Alzheimer disease</span></div><div class="casAuthors">Luchsinger Jose A; Tang Ming-Xin; Shea Steven; Mayeux Richard</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">203-8</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">BACKGROUND:  The generation of oxygen free radicals is involved in the pathogenesis of Alzheimer disease (AD).  OBJECTIVE:  To determine whether the intake of antioxidant vitamins decreases the risk of AD.  METHODS:  We investigated the relationship between AD and the intake of carotenes, vitamin C, and vitamin E in 980 elderly subjects in the Washington Heights-Inwood Columbia Aging Project who were free of dementia at baseline and were followed for a mean time of 4 years.  Semiquantitative food frequency questionnaires were administered between baseline and the first follow-up visit.  Cox proportional hazards regression models were conducted with quartiles of each vitamin intake as the exposure of interest and incident AD as the outcome, adjusted for age, level of education, sex, APOE epsilon4 status, ethnicity, and smoking.  RESULTS:  There were 242 incident cases of AD in 4,023 person-years of follow-up (6 per 100 person-years).  Intake of carotenes and vitamin C, or vitamin E in supplemental or dietary (nonsupplemental) form or in both forms, was not related to a decreased risk of AD.  Trend tests for the association between quartiles of total intake of vitamins C and E also were not significant.  CONCLUSION:  Neither dietary, supplemental, nor total intake of carotenes and vitamins C and E was associated with a decreased risk of AD in this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRyvow083js2C6Ufuk_1xoTfW6udTcc2eY61hg3fAmv6bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s%252FntVyltg%253D%253D&md5=cd5f302276eda558d29c8322c8b5cd58</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1001%2Farchneur.60.2.203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.60.2.203%26sid%3Dliteratum%253Aachs%26aulast%3DLuchsinger%26aufirst%3DJ.%2BA.%26aulast%3DTang%26aufirst%3DM.%2BX.%26aulast%3DShea%26aufirst%3DS.%26aulast%3DMayeux%26aufirst%3DR.%26atitle%3DAntioxidant%2520vitamin%2520intake%2520and%2520risk%2520of%2520Alzheimer%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D2003%26volume%3D60%26spage%3D203%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group">Sinha, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhary, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, Y. K.</span><span> </span><span class="NLM_article-title">Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">665</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2002&pages=655-665&author=K.+Sinhaauthor=G.+Chaudharyauthor=Y.+K.+Gupta&title=Protective+effect+of+resveratrol+against+oxidative+stress+in+middle+cerebral+artery+occlusion+model+of+stroke+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DK.%26aulast%3DChaudhary%26aufirst%3DG.%26aulast%3DGupta%26aufirst%3DY.%2BK.%26atitle%3DProtective%2520effect%2520of%2520resveratrol%2520against%2520oxidative%2520stress%2520in%2520middle%2520cerebral%2520artery%2520occlusion%2520model%2520of%2520stroke%2520in%2520rats%26jtitle%3DLife%2520Sci.%26date%3D2002%26volume%3D71%26spage%3D655%26epage%3D665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group">The Parkinson Study Group</span><span> </span><span class="NLM_article-title">Effects of tocopherol and deprenyl on the progression of disability in early Parkinson’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">176</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1056%2FNEJM199301213280305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=8417384" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=1993&pages=176-183&author=The+Parkinson+Study+Group&title=Effects+of+tocopherol+and+deprenyl+on+the+progression+of+disability+in+early+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1056%2FNEJM199301213280305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199301213280305%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DEffects%2520of%2520tocopherol%2520and%2520deprenyl%2520on%2520the%2520progression%2520of%2520disability%2520in%2520early%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1993%26volume%3D328%26spage%3D176%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group">Kieburtz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Como, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Growdon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanigan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saint-Cyr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tennis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thelen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoulson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkinson Study Group</span><span> </span><span class="NLM_article-title">The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson’s disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1756</span><span class="NLM_x">–</span> <span class="NLM_lpage">1759</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1994&pages=1756-1759&author=K.+Kieburtzauthor=M.+McDermottauthor=P.+Comoauthor=J.+Growdonauthor=J.+Bradyauthor=J.+Carterauthor=S.+Huberauthor=B.+Kaniganauthor=E.+Landowauthor=A.+Rudolphauthor=J.+Saint-Cyrauthor=Y.+Sternauthor=M.+Tennisauthor=J.+Thelenauthor=I.+Shoulsonauthor=Parkinson+Study+Group&title=The+effect+of+deprenyl+and+tocopherol+on+cognitive+performance+in+early+untreated+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKieburtz%26aufirst%3DK.%26aulast%3DMcDermott%26aufirst%3DM.%26aulast%3DComo%26aufirst%3DP.%26aulast%3DGrowdon%26aufirst%3DJ.%26aulast%3DBrady%26aufirst%3DJ.%26aulast%3DCarter%26aufirst%3DJ.%26aulast%3DHuber%26aufirst%3DS.%26aulast%3DKanigan%26aufirst%3DB.%26aulast%3DLandow%26aufirst%3DE.%26aulast%3DRudolph%26aufirst%3DA.%26aulast%3DSaint-Cyr%26aufirst%3DJ.%26aulast%3DStern%26aufirst%3DY.%26aulast%3DTennis%26aufirst%3DM.%26aulast%3DThelen%26aufirst%3DJ.%26aulast%3DShoulson%26aufirst%3DI.%26aulast%3D%26atitle%3DThe%2520effect%2520of%2520deprenyl%2520and%2520tocopherol%2520on%2520cognitive%2520performance%2520in%2520early%2520untreated%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D1994%26volume%3D44%26spage%3D1756%26epage%3D1759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group">Mihatsch, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russ, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przuntek, H.</span><span> </span><span class="NLM_article-title">Treatment with antioxidants does not prevent loss of dopamine in the striatum of MPTP-treated common marmosets: preliminary observations</span> <span class="citation_source-journal">J. Neural Transm.: Parkinson’s Dis. Dementia Sect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1007%2FBF02251138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=1905937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK3sXltlWntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1991&pages=73-78&author=W.+Mihatschauthor=H.+Russauthor=M.+Gerlachauthor=P.+Riedererauthor=H.+Przuntek&title=Treatment+with+antioxidants+does+not+prevent+loss+of+dopamine+in+the+striatum+of+MPTP-treated+common+marmosets%3A+preliminary+observations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment with antioxidants does not prevent loss of dopamine in the striatum of MPTP-treated common marmosets: preliminary observations</span></div><div class="casAuthors">Mihatsch, W.; Russ, H.; Gerlach, M.; Riederer, P.; Przuntek, H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neural Transmission:  Parkinson's Disease and Dementia Section</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-8</span>CODEN:
                <span class="NLM_cas:coden">JNPSEJ</span>;
        ISSN:<span class="NLM_cas:issn">0936-3076</span>.
    </div><div class="casAbstract">Administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to common marmosets causes a profound loss of dopamine and serotonin in the striatum.  Addnl. daily systemic treatment of monkeys with the antioxidants ascorbic acid (100 mg/kg) and α-tocopherol (2,350 mg/kg) prior to, during and following administration of MPTP does not prevent the loss of dopamine and serotonin in the striatum, suggesting that these antioxidants are unable to protect dopaminergic neurons against neurotoxicity of MPTP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovr1XgkuMldrVg90H21EOLACvtfcHk0ljvg5tpa6VKsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltlWntbw%253D&md5=e5d66a3cf8ac0431f33052d4f5e1f290</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1007%2FBF02251138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02251138%26sid%3Dliteratum%253Aachs%26aulast%3DMihatsch%26aufirst%3DW.%26aulast%3DRuss%26aufirst%3DH.%26aulast%3DGerlach%26aufirst%3DM.%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DPrzuntek%26aufirst%3DH.%26atitle%3DTreatment%2520with%2520antioxidants%2520does%2520not%2520prevent%2520loss%2520of%2520dopamine%2520in%2520the%2520striatum%2520of%2520MPTP-treated%2520common%2520marmosets%253A%2520preliminary%2520observations%26jtitle%3DJ.%2520Neural%2520Transm.%253A%2520Parkinson%25E2%2580%2599s%2520Dis.%2520Dementia%2520Sect.%26date%3D1991%26volume%3D3%26spage%3D73%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group">Perry, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foulks, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J. M.</span><span> </span><span class="NLM_article-title">Alpha-tocopherol and beta-carotene do not protect marmosets against the dopaminergic neurotoxicity of <i>N</i>-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</span> <span class="citation_source-journal">J. Neurol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2F0022-510X%2887%2990106-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=3121800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaL1cXhslyi" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1987&pages=321-331&author=T.+L.+Perryauthor=V.+W.+Yongauthor=S.+Hansenauthor=K.+Jonesauthor=C.+Bergeronauthor=J.+G.+Foulksauthor=J.+M.+Wright&title=Alpha-tocopherol+and+beta-carotene+do+not+protect+marmosets+against+the+dopaminergic+neurotoxicity+of+N-methyl-4-phenyl-1%2C2%2C3%2C6-tetrahydropyridine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">α-Tocopherol and β-carotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</span></div><div class="casAuthors">Perry, Thomas L.; Yong, Voon Wee; Hansen, Shirley; Jones, Karen; Bergeron, Catherine; Foulks, James G.; Wright, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Neurological Sciences</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">321-31</span>CODEN:
                <span class="NLM_cas:coden">JNSCAG</span>;
        ISSN:<span class="NLM_cas:issn">0022-510X</span>.
    </div><div class="casAbstract">MPTP (I) is an exptl. neurotoxin which produces biochem. and neuropathol. changes in humans, lower primates, and mice that closely resemble those found in Parkinson's disease (PD).  Because the mechanisms of neuronal damage in both idiopathic PD and in the I model of PD may involve free radical formation in the substantia nigra, antioxidants might protect dopaminergic neurons.  Neither α-tocopherol nor β-carotene, each administered in massive doses, had any demonstrable protective effect for dopaminergic nigrostriatal neurons in marmosets injected with low doses of I.  Whether these 2 antioxidants might be clin. useful in preventing or ameliorating PD was discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTXn6WsBIq67Vg90H21EOLACvtfcHk0lgVTFeIjw88fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhslyi&md5=39eca82f8824aa369e2b60b51c1471ea</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1016%2F0022-510X%2887%2990106-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-510X%252887%252990106-7%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DT.%2BL.%26aulast%3DYong%26aufirst%3DV.%2BW.%26aulast%3DHansen%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DBergeron%26aufirst%3DC.%26aulast%3DFoulks%26aufirst%3DJ.%2BG.%26aulast%3DWright%26aufirst%3DJ.%2BM.%26atitle%3DAlpha-tocopherol%2520and%2520beta-carotene%2520do%2520not%2520protect%2520marmosets%2520against%2520the%2520dopaminergic%2520neurotoxicity%2520of%2520N-methyl-4-phenyl-1%252C2%252C3%252C6-tetrahydropyridine%26jtitle%3DJ.%2520Neurol.%2520Sci.%26date%3D1987%26volume%3D81%26spage%3D321%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group">Peyser, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starkstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockrell, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bylsma, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyle, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folstein, S. E.</span><span> </span><span class="NLM_article-title">Trial of <span class="smallcaps smallerCapital">d</span>-alpha-tocopherol in Huntington’s disease</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">1771</span><span class="NLM_x">–</span> <span class="NLM_lpage">1775</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=8526244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADyaK28%252FotVSisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=1995&pages=1771-1775&author=C.+E.+Peyserauthor=M.+Folsteinauthor=G.+A.+Chaseauthor=S.+Starksteinauthor=J.+Brandtauthor=J.+R.+Cockrellauthor=F.+Bylsmaauthor=J.+T.+Coyleauthor=P.+R.+McHughauthor=S.+E.+Folstein&title=Trial+of+d-alpha-tocopherol+in+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Trial of d-alpha-tocopherol in Huntington's disease</span></div><div class="casAuthors">Peyser C E; Folstein M; Chase G A; Starkstein S; Brandt J; Cockrell J R; Bylsma F; Coyle J T; McHugh P R; Folstein S E</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1771-5</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Evidence suggests that the neuropathology of Huntington's disease, a neuropsychiatric disorder due to a mutation on chromosome 4, results from excessive activation of glutamate-gated ion channels, which kills neurons by oxidative stress.  Therefore, the authors hypothesized that alpha-tocopherol, which reduces oxyradical damage to cell membranes, might slow the course of Huntington's disease.  METHOD:  A prospective, double-blind; placebo-controlled study of high-dose d-alpha-tocopherol treatment was carried out with a cohort of 73 patients with Huntington's disease who were randomly assigned to either d-alpha-tocopherol or placebo.  Patients were monitored for changes in neurologic and neuropsychologic symptoms.  RESULTS:  Treatment with d-alpha-tocopherol had no effect on neurologic and neuropsychiatric symptoms in the treatment group overall.  However, post hoc analysis revealed a significant selective therapeutic effect on neurologic symptoms for patients early in the course of the disorder.  CONCLUSIONS:  Antioxidant therapy may slow the rate of motor decline early in the course of Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSkXXm882wPXIJKJbLTgsvCfW6udTcc2eZFR2FdKB_F5bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28%252FotVSisQ%253D%253D&md5=180c5a035234968965ece270542d13c3</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeyser%26aufirst%3DC.%2BE.%26aulast%3DFolstein%26aufirst%3DM.%26aulast%3DChase%26aufirst%3DG.%2BA.%26aulast%3DStarkstein%26aufirst%3DS.%26aulast%3DBrandt%26aufirst%3DJ.%26aulast%3DCockrell%26aufirst%3DJ.%2BR.%26aulast%3DBylsma%26aufirst%3DF.%26aulast%3DCoyle%26aufirst%3DJ.%2BT.%26aulast%3DMcHugh%26aufirst%3DP.%2BR.%26aulast%3DFolstein%26aufirst%3DS.%2BE.%26atitle%3DTrial%2520of%2520d-alpha-tocopherol%2520in%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D1995%26volume%3D152%26spage%3D1771%26epage%3D1775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group">Desnuelle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dib, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favier, A.</span><span> </span><span class="NLM_article-title">A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS Riluzole-Tocopherol Study Group</span> <span class="citation_source-journal">Amyotrophic Lateral Scler. Other Mot. Neuron Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1080%2F146608201300079364" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11465936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktlCjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=9-18&author=C.+Desnuelleauthor=M.+Dibauthor=C.+Garrelauthor=A.+Favier&title=A+double-blind%2C+placebo-controlled+randomized+clinical+trial+of+alpha-tocopherol+%28vitamin+E%29+in+the+treatment+of+amyotrophic+lateral+sclerosis.+ALS+Riluzole-Tocopherol+Study+Group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">A double-blind, placebo-controlled randomized clinical trial of α-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis</span></div><div class="casAuthors">Desnuelle, Claude; Dib, Michel; Garrel, Catherine; Favier, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-18</span>CODEN:
                <span class="NLM_cas:coden">ALSCFA</span>;
        ISSN:<span class="NLM_cas:issn">1466-0822</span>.
    
            (<span class="NLM_cas:orgname">Martin Dunitz Ltd.</span>)
        </div><div class="casAbstract">Increasing evidence suggests that oxidative stress may be involved in the pathogenesis of amyotrophic lateral sclerosis (ALS).  The antioxidant vitamin E (α-tocopherol) has been shown to slow down the onset and progression of paralysis in transgenic mice expressing a mutation in superoxide dismutase found in certain forms of familial ALS.  The current study was designed to det. whether α-tocopherol (500 mg b.i.d.) may be efficacious in the treatment of ALS.  Two hundred and eighty-nine patients with ALS of less than 5 yr duration, treated with riluzole, were enrolled in this study, and were randomly assigned to receive either α-tocopherol or placebo daily for one year.  The primary outcome measure was the rate of deterioration of function assessed by the modified Norris limb scale.  Patients were assessed at entry, and every 3 mo thereafter during the study period.  Survival was also recorded.  Biochem. markers of oxidative stress were measured in a subset of patients on entry and after 3 mo of treatment.  After 12 mo of treatment, α-tocopherol had no effect on the primary outcome measure.  Survival was not influenced by treatment.  Among secondary outcome measures, patients given α-tocopherol were less likely to progress from the milder state A to the more severe state B (P = 0.046) of the ALS Health State scale.  After 3 mo treatment, anal. of oxidative stress markers showed an increase in glutathione peroxidase activity in plasma (P = 0.0389) and a decrease in plasma levels of thiobarbituric acid reactive species (P = 0.0055) in the group of patients given α-tocopherol in combination with riluzole.  Although α-tocopherol did not appear to affect the survival and motor function in ALS, patients receiving riluzole plus α-tocopherol remained longer in the milder states of the ALS Health State scale and showed, after 3 mo, changes in biochem. markers of oxidative stress.  Further studies are required to confirm the greater sensitivity of the ALS Health State scale over other clin. endpoints.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp3exQmY8SUbVg90H21EOLACvtfcHk0lgVTFeIjw88fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktlCjt7g%253D&md5=645e48abad59fd982db3eda2d1ab0a77</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1080%2F146608201300079364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F146608201300079364%26sid%3Dliteratum%253Aachs%26aulast%3DDesnuelle%26aufirst%3DC.%26aulast%3DDib%26aufirst%3DM.%26aulast%3DGarrel%26aufirst%3DC.%26aulast%3DFavier%26aufirst%3DA.%26atitle%3DA%2520double-blind%252C%2520placebo-controlled%2520randomized%2520clinical%2520trial%2520of%2520alpha-tocopherol%2520%2528vitamin%2520E%2529%2520in%2520the%2520treatment%2520of%2520amyotrophic%2520lateral%2520sclerosis.%2520ALS%2520Riluzole-Tocopherol%2520Study%2520Group%26jtitle%3DAmyotrophic%2520Lateral%2520Scler.%2520Other%2520Mot.%2520Neuron%2520Disord.%26date%3D2001%26volume%3D2%26spage%3D9%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group">Gurney, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutting, F. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doble, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrus, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, E. D.</span><span> </span><span class="NLM_article-title">Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1002%2Fana.410390203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=8967745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK28XitlKktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=147-157&author=M.+E.+Gurneyauthor=F.+B.+Cuttingauthor=P.+Zhaiauthor=A.+Dobleauthor=C.+P.+Taylorauthor=P.+K.+Andrusauthor=E.+D.+Hall&title=Benefit+of+vitamin+E%2C+riluzole%2C+and+gabapentin+in+a+transgenic+model+of+familial+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis</span></div><div class="casAuthors">Gurney, Mark E.; Cutting, Frank B.; Zhai, Ping; Doble, Adam; Taylor, Charles P.; Andrus, Paula K.; Hall, Edward D.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-57</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Little, Brown</span>)
        </div><div class="casAbstract">Familial amyotrophic lateral sclerosis (FALS) has been linked in some families to dominant mutations of the SOD1 gene encoding Cu,Zn-superoxide dismutase (Cu,Zn SOD).  We have used a transgenic model of FALS based on expression of mutant human Cu,Zn SOD to explore the etiol. and therapy of the genetic disease.  Expression of mutant, but not wild-type, human Cu,Zn SOD in mice places the brain and spinal cord under oxidative stress.  This causes depletion of vitamin E, rather than the typical age-dependent increase in vitamin E content as occurs in nontransgenic mice and in mice expressing wild-type human Cu,Zn SOD.  Dietary supplementation with vitamin E delays onset of clin. disease and slows progression in the transgenic model but does not prolong survival.  In contrast, two putative inhibitors of the glutamatergic system, riluzole and gabapentin, prolong survival.  However, riluzole did not delay disease onset.  Thus, there was clear sepn. of effects on onset, progression, and survival by the three therapeutics tested.  This suggests the hypothesis that oxidative damage produced by the expression of mutant Cu,Zn SOD causes slow or weak excitotoxicity that can be inhibited in part by altering glutamate release or biosynthesis presynaptically.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW4p9cWtj_yLVg90H21EOLACvtfcHk0lilOPhFidu4JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitlKktLw%253D&md5=24a897326b265ac0188f8b1ee62ee5dc</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1002%2Fana.410390203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410390203%26sid%3Dliteratum%253Aachs%26aulast%3DGurney%26aufirst%3DM.%2BE.%26aulast%3DCutting%26aufirst%3DF.%2BB.%26aulast%3DZhai%26aufirst%3DP.%26aulast%3DDoble%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DC.%2BP.%26aulast%3DAndrus%26aufirst%3DP.%2BK.%26aulast%3DHall%26aufirst%3DE.%2BD.%26atitle%3DBenefit%2520of%2520vitamin%2520E%252C%2520riluzole%252C%2520and%2520gabapentin%2520in%2520a%2520transgenic%2520model%2520of%2520familial%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DAnn.%2520Neurol.%26date%3D1996%26volume%3D39%26spage%3D147%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group">Asthana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craft, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanczyk, F. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veith, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raskind, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plymate, S. R.</span><span> </span><span class="NLM_article-title">High-dose estradiol improves cognition for women with AD: results of a randomized study</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">–</span> <span class="NLM_lpage">612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2001&pages=605-612&author=S.+Asthanaauthor=L.+D.+Bakerauthor=S.+Craftauthor=F.+Z.+Stanczykauthor=R.+C.+Veithauthor=M.+A.+Raskindauthor=S.+R.+Plymate&title=High-dose+estradiol+improves+cognition+for+women+with+AD%3A+results+of+a+randomized+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAsthana%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DL.%2BD.%26aulast%3DCraft%26aufirst%3DS.%26aulast%3DStanczyk%26aufirst%3DF.%2BZ.%26aulast%3DVeith%26aufirst%3DR.%2BC.%26aulast%3DRaskind%26aufirst%3DM.%2BA.%26aulast%3DPlymate%26aufirst%3DS.%2BR.%26atitle%3DHigh-dose%2520estradiol%2520improves%2520cognition%2520for%2520women%2520with%2520AD%253A%2520results%2520of%2520a%2520randomized%2520study%26jtitle%3DNeurology%26date%3D2001%26volume%3D57%26spage%3D605%26epage%3D612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group">Carlson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zandi, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plassman, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschanz, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsh-Bohmer, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffens, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastian, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitner, J. C.</span><span> </span><span class="NLM_article-title">Hormone replacement therapy and reduced cognitive decline in older women: the Cache County study</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2210</span><span class="NLM_x">–</span> <span class="NLM_lpage">2216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2001&pages=2210-2216&author=M.+C.+Carlsonauthor=P.+P.+Zandiauthor=B.+L.+Plassmanauthor=J.+T.+Tschanzauthor=K.+A.+Welsh-Bohmerauthor=D.+C.+Steffensauthor=L.+A.+Bastianauthor=K.+M.+Mehtaauthor=J.+C.+Breitner&title=Hormone+replacement+therapy+and+reduced+cognitive+decline+in+older+women%3A+the+Cache+County+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarlson%26aufirst%3DM.%2BC.%26aulast%3DZandi%26aufirst%3DP.%2BP.%26aulast%3DPlassman%26aufirst%3DB.%2BL.%26aulast%3DTschanz%26aufirst%3DJ.%2BT.%26aulast%3DWelsh-Bohmer%26aufirst%3DK.%2BA.%26aulast%3DSteffens%26aufirst%3DD.%2BC.%26aulast%3DBastian%26aufirst%3DL.%2BA.%26aulast%3DMehta%26aufirst%3DK.%2BM.%26aulast%3DBreitner%26aufirst%3DJ.%2BC.%26atitle%3DHormone%2520replacement%2520therapy%2520and%2520reduced%2520cognitive%2520decline%2520in%2520older%2520women%253A%2520the%2520Cache%2520County%2520study%26jtitle%3DNeurology%26date%3D2001%26volume%3D57%26spage%3D2210%26epage%3D2216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group">Henderson, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paganini-Hill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elble, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyes, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoupe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCleary, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hake, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farlow, M. R.</span><span> </span><span class="NLM_article-title">Estrogen for Alzheimer’s disease in women: randomized, double-blind, placebo-controlled trial</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2000&pages=295-301&author=V.+W.+Hendersonauthor=A.+Paganini-Hillauthor=B.+L.+Millerauthor=R.+J.+Elbleauthor=P.+F.+Reyesauthor=D.+Shoupeauthor=C.+A.+McClearyauthor=R.+A.+Kleinauthor=A.+M.+Hakeauthor=M.+R.+Farlow&title=Estrogen+for+Alzheimer%E2%80%99s+disease+in+women%3A+randomized%2C+double-blind%2C+placebo-controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DV.%2BW.%26aulast%3DPaganini-Hill%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DB.%2BL.%26aulast%3DElble%26aufirst%3DR.%2BJ.%26aulast%3DReyes%26aufirst%3DP.%2BF.%26aulast%3DShoupe%26aufirst%3DD.%26aulast%3DMcCleary%26aufirst%3DC.%2BA.%26aulast%3DKlein%26aufirst%3DR.%2BA.%26aulast%3DHake%26aufirst%3DA.%2BM.%26aulast%3DFarlow%26aufirst%3DM.%2BR.%26atitle%3DEstrogen%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520in%2520women%253A%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520trial%26jtitle%3DNeurology%26date%3D2000%26volume%3D54%26spage%3D295%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group">Mulnard, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotman, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dyck, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doody, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koss, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamst, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thal, L. J.</span><span> </span><span class="NLM_article-title">Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer’s disease cooperative study</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2000&pages=1007-1015&author=R.+A.+Mulnardauthor=C.+W.+Cotmanauthor=C.+Kawasauthor=C.+H.+van+Dyckauthor=M.+Sanoauthor=R.+Doodyauthor=E.+Kossauthor=E.+Pfeifferauthor=S.+Jinauthor=A.+Gamstauthor=M.+Grundmanauthor=R.+Thomasauthor=L.+J.+Thal&title=Estrogen+replacement+therapy+for+treatment+of+mild+to+moderate+Alzheimer+disease%3A+a+randomized+controlled+trial.+Alzheimer%E2%80%99s+disease+cooperative+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMulnard%26aufirst%3DR.%2BA.%26aulast%3DCotman%26aufirst%3DC.%2BW.%26aulast%3DKawas%26aufirst%3DC.%26aulast%3Dvan%2BDyck%26aufirst%3DC.%2BH.%26aulast%3DSano%26aufirst%3DM.%26aulast%3DDoody%26aufirst%3DR.%26aulast%3DKoss%26aufirst%3DE.%26aulast%3DPfeiffer%26aufirst%3DE.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DGamst%26aufirst%3DA.%26aulast%3DGrundman%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DR.%26aulast%3DThal%26aufirst%3DL.%2BJ.%26atitle%3DEstrogen%2520replacement%2520therapy%2520for%2520treatment%2520of%2520mild%2520to%2520moderate%2520Alzheimer%2520disease%253A%2520a%2520randomized%2520controlled%2520trial.%2520Alzheimer%25E2%2580%2599s%2520disease%2520cooperative%2520study%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2000%26volume%3D283%26spage%3D1007%26epage%3D1015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group">Wang, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, S. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H. C.</span><span> </span><span class="NLM_article-title">Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2061</span><span class="NLM_x">–</span> <span class="NLM_lpage">2066</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2000&pages=2061-2066&author=P.+N.+Wangauthor=S.+Q.+Liaoauthor=R.+S.+Liuauthor=C.+Y.+Liuauthor=H.+T.+Chaoauthor=S.+R.+Luauthor=H.+Y.+Yuauthor=S.+J.+Wangauthor=H.+C.+Liu&title=Effects+of+estrogen+on+cognition%2C+mood%2C+and+cerebral+blood+flow+in+AD%3A+a+controlled+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%2BN.%26aulast%3DLiao%26aufirst%3DS.%2BQ.%26aulast%3DLiu%26aufirst%3DR.%2BS.%26aulast%3DLiu%26aufirst%3DC.%2BY.%26aulast%3DChao%26aufirst%3DH.%2BT.%26aulast%3DLu%26aufirst%3DS.%2BR.%26aulast%3DYu%26aufirst%3DH.%2BY.%26aulast%3DWang%26aufirst%3DS.%2BJ.%26aulast%3DLiu%26aufirst%3DH.%2BC.%26atitle%3DEffects%2520of%2520estrogen%2520on%2520cognition%252C%2520mood%252C%2520and%2520cerebral%2520blood%2520flow%2520in%2520AD%253A%2520a%2520controlled%2520study%26jtitle%3DNeurology%26date%3D2000%26volume%3D54%26spage%3D2061%26epage%3D2066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group">Blanchet, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyland, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouradian, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, T. N.</span><span> </span><span class="NLM_article-title">Short-term effects of high-dose 17beta-estradiol in postmenopausal PD patients: a crossover study</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1999&pages=91-95&author=P.+J.+Blanchetauthor=J.+Fangauthor=K.+Hylandauthor=L.+A.+Arnoldauthor=M.+M.+Mouradianauthor=T.+N.+Chase&title=Short-term+effects+of+high-dose+17beta-estradiol+in+postmenopausal+PD+patients%3A+a+crossover+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlanchet%26aufirst%3DP.%2BJ.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DHyland%26aufirst%3DK.%26aulast%3DArnold%26aufirst%3DL.%2BA.%26aulast%3DMouradian%26aufirst%3DM.%2BM.%26aulast%3DChase%26aufirst%3DT.%2BN.%26atitle%3DShort-term%2520effects%2520of%2520high-dose%252017beta-estradiol%2520in%2520postmenopausal%2520PD%2520patients%253A%2520a%2520crossover%2520study%26jtitle%3DNeurology%26date%3D1999%26volume%3D53%26spage%3D91%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group">Fernandez, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapane, K. L.</span><span> </span><span class="NLM_article-title">Estrogen use among nursing home residents with a diagnosis of Parkinson’s disease</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1119</span><span class="NLM_x">–</span> <span class="NLM_lpage">1124</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2000&pages=1119-1124&author=H.+H.+Fernandezauthor=K.+L.+Lapane&title=Estrogen+use+among+nursing+home+residents+with+a+diagnosis+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez%26aufirst%3DH.%2BH.%26aulast%3DLapane%26aufirst%3DK.%2BL.%26atitle%3DEstrogen%2520use%2520among%2520nursing%2520home%2520residents%2520with%2520a%2520diagnosis%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DMov.%2520Disord.%26date%3D2000%26volume%3D15%26spage%3D1119%26epage%3D1124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group">Tsang, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, S. K.</span><span> </span><span class="NLM_article-title">Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2292</span><span class="NLM_x">–</span> <span class="NLM_lpage">2298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2000&pages=2292-2298&author=K.+L.+Tsangauthor=S.+L.+Hoauthor=S.+K.+Lo&title=Estrogen+improves+motor+disability+in+parkinsonian+postmenopausal+women+with+motor+fluctuations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsang%26aufirst%3DK.%2BL.%26aulast%3DHo%26aufirst%3DS.%2BL.%26aulast%3DLo%26aufirst%3DS.%2BK.%26atitle%3DEstrogen%2520improves%2520motor%2520disability%2520in%2520parkinsonian%2520postmenopausal%2520women%2520with%2520motor%2520fluctuations%26jtitle%3DNeurology%26date%3D2000%26volume%3D54%26spage%3D2292%26epage%3D2298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group">Baldereschi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Carlo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocca, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perissinotto, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grigoletto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaducci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inzitari, D.</span><span> </span><span class="NLM_article-title">Parkinson’s disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian longitudinal study on aging</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1358</span><span class="NLM_x">–</span> <span class="NLM_lpage">1363</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2000&pages=1358-1363&author=M.+Baldereschiauthor=A.+Di+Carloauthor=W.+A.+Roccaauthor=P.+Vanniauthor=S.+Maggiauthor=E.+Perissinottoauthor=F.+Grigolettoauthor=L.+Amaducciauthor=D.+Inzitari&title=Parkinson%E2%80%99s+disease+and+parkinsonism+in+a+longitudinal+study%3A+two-fold+higher+incidence+in+men.+ILSA+Working+Group.+Italian+longitudinal+study+on+aging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaldereschi%26aufirst%3DM.%26aulast%3DDi%2BCarlo%26aufirst%3DA.%26aulast%3DRocca%26aufirst%3DW.%2BA.%26aulast%3DVanni%26aufirst%3DP.%26aulast%3DMaggi%26aufirst%3DS.%26aulast%3DPerissinotto%26aufirst%3DE.%26aulast%3DGrigoletto%26aufirst%3DF.%26aulast%3DAmaducci%26aufirst%3DL.%26aulast%3DInzitari%26aufirst%3DD.%26atitle%3DParkinson%25E2%2580%2599s%2520disease%2520and%2520parkinsonism%2520in%2520a%2520longitudinal%2520study%253A%2520two-fold%2520higher%2520incidence%2520in%2520men.%2520ILSA%2520Working%2520Group.%2520Italian%2520longitudinal%2520study%2520on%2520aging%26jtitle%3DNeurology%26date%3D2000%26volume%3D55%26spage%3D1358%26epage%3D1363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group">Mayeux, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marder, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cote, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denaro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemenegildo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mejia, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, M. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lantigua, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilder, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurland, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, A.</span><span> </span><span class="NLM_article-title">The frequency of idiopathic Parkinson’s disease by age, ethnic group, and sex in northern Manhattan, 1988–1993</span> <span class="citation_source-journal">Am. J. Epidemiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">820</span><span class="NLM_x">–</span> <span class="NLM_lpage">827</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=7572958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADyaK28%252FhslCjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=1995&pages=820-827&author=R.+Mayeuxauthor=K.+Marderauthor=L.+J.+Coteauthor=J.+Denaroauthor=N.+Hemenegildoauthor=H.+Mejiaauthor=M.+X.+Tangauthor=R.+Lantiguaauthor=D.+Wilderauthor=B.+Gurlandauthor=A.+Hauser&title=The+frequency+of+idiopathic+Parkinson%E2%80%99s+disease+by+age%2C+ethnic+group%2C+and+sex+in+northern+Manhattan%2C+1988%E2%80%931993"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993</span></div><div class="casAuthors">Mayeux R; Marder K; Cote L J; Denaro J; Hemenegildo N; Mejia H; Tang M X; Lantigua R; Wilder D; Gurland B; et al</div><div class="citationInfo"><span class="NLM_cas:title">American journal of epidemiology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">820-7</span>
        ISSN:<span class="NLM_cas:issn">0002-9262</span>.
    </div><div class="casAbstract">Sex and ethnic differences in the frequency of Parkinson's disease have become increasingly important, because putative genetic and environmental risk factors have been identified.  The authors estimated the prevalence and incidence of Parkinson's disease in a culturally diverse community in New York City over a 4-year period (January 1, 1988-December 31, 1991) using a disease registry substantiated, for older individuals, by a subsequent survey of a random sample of Medicare recipients between January 1, 1992, and December 31, 1993.  The prevalence rate was 107 per 100,000 persons, and over a 3-year period the average incidence rate was 13 per 100,000 person-years.  Age-adjusted prevalence rates were lower for women than for men in each ethnic group and were lower for blacks than for whites and Hispanics.  Incidence rates were highest among black men, but they were otherwise comparable across the sex and ethnic groups.  The estimated cumulative incidence of Parkinson's disease up to age 90 years was lower for women than for men, which could partially explain the lower prevalence rate.  By ethnic group, the cumulative incidence was higher for blacks than for whites and Hispanics, but more deaths occurred among incident black cases.  Discrepant prevalence and incidence rates of Parkinson's disease among blacks and women warrant further investigation.  While selective mortality could partially account for this paradox, it is also possible that a delay in diagnosis due to limited access to appropriate health services among these individuals could have resulted in the observed discordant rates of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAmRjLvYKK2T0SWnHPWbmmfW6udTcc2eZN5V0TU9HHBLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28%252FhslCjtw%253D%253D&md5=4c96dd0406b55685875a9d760b150d8d</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMayeux%26aufirst%3DR.%26aulast%3DMarder%26aufirst%3DK.%26aulast%3DCote%26aufirst%3DL.%2BJ.%26aulast%3DDenaro%26aufirst%3DJ.%26aulast%3DHemenegildo%26aufirst%3DN.%26aulast%3DMejia%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DM.%2BX.%26aulast%3DLantigua%26aufirst%3DR.%26aulast%3DWilder%26aufirst%3DD.%26aulast%3DGurland%26aufirst%3DB.%26aulast%3DHauser%26aufirst%3DA.%26atitle%3DThe%2520frequency%2520of%2520idiopathic%2520Parkinson%25E2%2580%2599s%2520disease%2520by%2520age%252C%2520ethnic%2520group%252C%2520and%2520sex%2520in%2520northern%2520Manhattan%252C%25201988%25E2%2580%25931993%26jtitle%3DAm.%2520J.%2520Epidemiol.%26date%3D1995%26volume%3D142%26spage%3D820%26epage%3D827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group">Aggarwal, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harikumar, K. B.</span><span> </span><span class="NLM_article-title">Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.biocel.2008.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=18662800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWnu73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=40-59&author=B.+B.+Aggarwalauthor=K.+B.+Harikumar&title=Potential+therapeutic+effects+of+curcumin%2C+the+anti-inflammatory+agent%2C+against+neurodegenerative%2C+cardiovascular%2C+pulmonary%2C+metabolic%2C+autoimmune+and+neoplastic+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune, and neoplastic diseases</span></div><div class="casAuthors">Aggarwal, Bharat B.; Harikumar, Kuzhuvelil B.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-59</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Although safe in most cases, ancient treatments are ignored because neither their active component nor their mol. targets are well defined.  This is not the case, however, with curcumin, a yellow-pigment substance and component of turmeric (Curcuma longa), which was identified more than a century ago.  For centuries it was known that turmeric exhibits anti-inflammatory activity, but extensive research performed within the past 2 decades has shown that this activity of turmeric is due to curcumin (diferuloylmethane).  This agent was shown to regulate numerous transcription factors, cytokines, protein kinases, adhesion mols., redox status, and enzymes that were linked to inflammation.  The process of inflammation was shown to play a major role in most chronic illnesses, including neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune, and neoplastic diseases.  In the current review, we provide evidence for the potential role of curcumin in the prevention and treatment of various proinflammatory chronic diseases.  These features, combined with the pharmacol. safety and negligible cost, render curcumin an attractive agent to explore further.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6QcBf26uTvrVg90H21EOLACvtfcHk0ljEkLv7ac0gqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWnu73P&md5=258bcc5b059184d67211b805b2d5303d</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2008.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2008.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26aulast%3DHarikumar%26aufirst%3DK.%2BB.%26atitle%3DPotential%2520therapeutic%2520effects%2520of%2520curcumin%252C%2520the%2520anti-inflammatory%2520agent%252C%2520against%2520neurodegenerative%252C%2520cardiovascular%252C%2520pulmonary%252C%2520metabolic%252C%2520autoimmune%2520and%2520neoplastic%2520diseases%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2009%26volume%3D41%26spage%3D40%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group">Richard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlus, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iglesias, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedrot, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waffo-Teguo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merillon, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, J. P.</span><span> </span><span class="NLM_article-title">Neuroprotective properties of resveratrol and derivatives</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1215</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1215&publication_year=2011&pages=103-108&author=T.+Richardauthor=A.+D.+Pawlusauthor=M.+L.+Iglesiasauthor=E.+Pedrotauthor=P.+Waffo-Teguoauthor=J.+M.+Merillonauthor=J.+P.+Monti&title=Neuroprotective+properties+of+resveratrol+and+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichard%26aufirst%3DT.%26aulast%3DPawlus%26aufirst%3DA.%2BD.%26aulast%3DIglesias%26aufirst%3DM.%2BL.%26aulast%3DPedrot%26aufirst%3DE.%26aulast%3DWaffo-Teguo%26aufirst%3DP.%26aulast%3DMerillon%26aufirst%3DJ.%2BM.%26aulast%3DMonti%26aufirst%3DJ.%2BP.%26atitle%3DNeuroprotective%2520properties%2520of%2520resveratrol%2520and%2520derivatives%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2011%26volume%3D1215%26spage%3D103%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group">Heim, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagliaferro, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobilya, D. J.</span><span> </span><span class="NLM_article-title">Flavonoid antioxidants: chemistry, metabolism and structure–activity relationships</span> <span class="citation_source-journal">J. Nutr. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">572</span><span class="NLM_x">–</span> <span class="NLM_lpage">584</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0955-2863%2802%2900208-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12550068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVeqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=572-584&author=K.+E.+Heimauthor=A.+R.+Tagliaferroauthor=D.+J.+Bobilya&title=Flavonoid+antioxidants%3A+chemistry%2C+metabolism+and+structure%E2%80%93activity+relationships"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships</span></div><div class="casAuthors">Heim, Kelly E.; Tagliaferro, Anthony R.; Bobilya, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nutritional Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">572-584</span>CODEN:
                <span class="NLM_cas:coden">JNBIEL</span>;
        ISSN:<span class="NLM_cas:issn">0955-2863</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  Flavonoids are a class of secondary plant phenolics with significant antioxidant and chelating properties.  In the human diet, they are most concd. in fruits, vegetables, wines, teas and cocoa.  Their cardioprotective effects stem from the ability to inhibit lipid peroxidn., chelate redox-active metals, and attenuate other processes involving reactive oxygen species.  Flavonoids occur in foods primarily as glycosides and polymers that are degraded to variable extents in the digestive tract.  Although metab. of these compds. remains elusive, enteric absorption occurs sufficiently to reduce plasma indexes of oxidant status.  The propensity of a flavonoid to inhibit free-radical mediated events is governed by its chem. structure.  Since these compds. are based on the flavan nucleus, the no., positions, and types of substitutions influence radical scavenging and chelating activity.  The diversity and multiple mechanisms of flavonoid action, together with the numerous methods of initiation, detection and measurement of oxidative processes in vitro and in vivo offer plausible explanations for existing discrepancies in structure-activity relationships.  Despite some inconsistent lines of evidence, several structure-activity relationships are well established in vitro.  Multiple hydroxyl groups confer upon the mol. substantial antioxidant, chelating and prooxidant activity.  Methoxy groups introduce unfavorable steric effects and increase lipophilicity and membrane partitioning.  A double bond and carbonyl function in the heterocycle or polymn. of the nuclear structure increases activity by affording a more stable flavonoid radical through conjugation and electron delocalization.  Further investigation of the metab. of these phytochems. is justified to extend structure-activity relationships (SAR) to preventive and therapeutic nutritional strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbPogyXeMwNrVg90H21EOLACvtfcHk0ljEkLv7ac0gqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVeqs7s%253D&md5=ee7b9144f4f578b0ee7cd09e6b26ec04</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1016%2FS0955-2863%2802%2900208-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0955-2863%252802%252900208-5%26sid%3Dliteratum%253Aachs%26aulast%3DHeim%26aufirst%3DK.%2BE.%26aulast%3DTagliaferro%26aufirst%3DA.%2BR.%26aulast%3DBobilya%26aufirst%3DD.%2BJ.%26atitle%3DFlavonoid%2520antioxidants%253A%2520chemistry%252C%2520metabolism%2520and%2520structure%25E2%2580%2593activity%2520relationships%26jtitle%3DJ.%2520Nutr.%2520Biochem.%26date%3D2002%26volume%3D13%26spage%3D572%26epage%3D584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref207"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref207'); return false;" data-citation="" class="refNumLink">207</a></strong><div class="NLM_citation" id="cit207"><span><span class="NLM_contrib-group">Pietta, P. G.</span><span> </span><span class="NLM_article-title">Flavonoids as antioxidants</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1042</span></span><div class="citationLinks">[<a href="/doi/10.1021/np9904509" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjsFOrsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2000&pages=1035-1042&author=P.+G.+Pietta&title=Flavonoids+as+antioxidants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Flavonoids as Antioxidants</span></div><div class="casAuthors">Pietta, Pier-Giorgio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1035-1042</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The natural occurrence and antioxidant activity of flavonoids were reviewed with 91 refs.  Flavonoids are phenolic substances isolated from a wide range of vascular plants, with over 8000 individual compds. known.  They act in plants as antioxidants, antimicrobials, photoreceptors, visual attractors, feeding repellents, and for light screening.  Many studies have suggested that flavonoids exhibit biol. activities, including antiallergenic, antiviral, antiinflammatory, and vasodilating actions. However, most interest has been devoted to the antioxidant activity of flavonoids, which is due to their ability to reduce free radical formation and to scavenge free radicals.  The capacity of flavonoids to act as antioxidants in vitro has been the subject of several studies in the past years, and important structure-activity relationships of the antioxidant activity have been established.  The antioxidant efficacy of flavonoids in vivo is less documented, presumably because of the limited knowledge on their uptake in humans.  Most ingested flavonoids are extensively degraded to various phenolic acids, some of which still possess a radical-scavenging ability.  Both the absorbed flavonoids and their metabolites may display an in vivo antioxidant activity, which is evidenced exptl. by the increase of the plasma antioxidant status, the sparing effect on vitamin E of erythrocyte membranes and low-d. lipoproteins, and the preservation of erythrocyte membrane polyunsatd. fatty acids.  This review presents the current knowledge on structural aspects and in vitro antioxidant capacity of most common flavonoids as well as in vivo antioxidant activity and effects on endogenous antioxidants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGR_upjsM_DLVg90H21EOLACvtfcHk0ljEkLv7ac0gqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjsFOrsrY%253D&md5=5dbcbd974984fbb92075e556232f6f83</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1021%2Fnp9904509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp9904509%26sid%3Dliteratum%253Aachs%26aulast%3DPietta%26aufirst%3DP.%2BG.%26atitle%3DFlavonoids%2520as%2520antioxidants%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2000%26volume%3D63%26spage%3D1035%26epage%3D1042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref208"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref208'); return false;" data-citation="" class="refNumLink">208</a></strong><div class="NLM_citation" id="cit208"><span><span class="NLM_contrib-group">Dickinson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forman, H. J.</span><span> </span><span class="NLM_article-title">Cellular glutathione and thiols metabolism</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1019</span><span class="NLM_x">–</span> <span class="NLM_lpage">1026</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0006-2952%2802%2901172-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12213601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1ymsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2002&pages=1019-1026&author=D.+A.+Dickinsonauthor=H.+J.+Forman&title=Cellular+glutathione+and+thiols+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular glutathione and thiols metabolism</span></div><div class="casAuthors">Dickinson, Dale A.; Forman, Henry Jay</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">1019-1026</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  Low-mol.-wt. thiol-contg. compds. have an essential role in many biochem. and pharmacol. reactions due to the ease with which they are oxidized, and the rapidity with which they can be regenerated.  Thioredoxin and glutathione (GSH) are 2 of the major small-mol.-wt. thiol-contg. compds. synthesized de novo in mammalian cells that participate in those functions.  Understanding the mechanisms of thiol metab. has special relevance to understanding the cell's defense against toxicant exposure and as the focal point in redox signaling.  This commentary will, however, focus on GSH consumption and synthesis, and the role of thiols in signaling.  The chem. reactions of GSH, including conjugation reactions mediated by glutathione S-transferases (GST) and oxidn. reactions mediated by glutathione peroxidases, will be described.  The regulation of GSH synthesis will be illustrated from a compilation of studies designed to understand the various levels at which enzymic GSH biosynthesis is controlled, and the signaling pathways that mediate them.  The response of the cell to 4-hydroxynonenal (4HNE), a reactive aldehyde produced physiol. in response to inflammation and various air pollutants, will be explored in detail.  Finally, the direct role of thiols as signaling mols. will be addressed, with particular attention given to redox state.  It is the aim that this commentary will lead the reader to appreciate that studies investigating the signaling for and regulation of thiol metab. must never be generalized, and that perturbations in any one step of thiol metab. may have etiol. roles in genetically, virally, and environmentally borne pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMxQAnLLSLzbVg90H21EOLACvtfcHk0liJWKwWMUcm5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1ymsb4%253D&md5=7859b19b7c1434237f00d79154389c93</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2802%2901172-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252802%252901172-3%26sid%3Dliteratum%253Aachs%26aulast%3DDickinson%26aufirst%3DD.%2BA.%26aulast%3DForman%26aufirst%3DH.%2BJ.%26atitle%3DCellular%2520glutathione%2520and%2520thiols%2520metabolism%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2002%26volume%3D64%26spage%3D1019%26epage%3D1026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref209"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref209'); return false;" data-citation="" class="refNumLink">209</a></strong><div class="NLM_citation" id="cit209"><span><span class="NLM_contrib-group">Owuor, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, A. N.</span><span> </span><span class="NLM_article-title">Antioxidants and oxidants regulated signal transduction pathways</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">765</span><span class="NLM_x">–</span> <span class="NLM_lpage">770</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2002&pages=765-770&author=E.+D.+Owuorauthor=A.+N.+Kong&title=Antioxidants+and+oxidants+regulated+signal+transduction+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOwuor%26aufirst%3DE.%2BD.%26aulast%3DKong%26aufirst%3DA.%2BN.%26atitle%3DAntioxidants%2520and%2520oxidants%2520regulated%2520signal%2520transduction%2520pathways%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2002%26volume%3D64%26spage%3D765%26epage%3D770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref210"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref210'); return false;" data-citation="" class="refNumLink">210</a></strong><div class="NLM_citation" id="cit210"><span><span class="NLM_contrib-group">Filomeni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotilio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciriolo, M. R.</span><span> </span><span class="NLM_article-title">Cell signalling and the glutathione redox system</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1057</span><span class="NLM_x">–</span> <span class="NLM_lpage">1064</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2002&pages=1057-1064&author=G.+Filomeniauthor=G.+Rotilioauthor=M.+R.+Ciriolo&title=Cell+signalling+and+the+glutathione+redox+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFilomeni%26aufirst%3DG.%26aulast%3DRotilio%26aufirst%3DG.%26aulast%3DCiriolo%26aufirst%3DM.%2BR.%26atitle%3DCell%2520signalling%2520and%2520the%2520glutathione%2520redox%2520system%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2002%26volume%3D64%26spage%3D1057%26epage%3D1064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref211"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref211'); return false;" data-citation="" class="refNumLink">211</a></strong><div class="NLM_citation" id="cit211"><span><span class="NLM_contrib-group">Paolicchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominici, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maellaro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompella, A.</span><span> </span><span class="NLM_article-title">Glutathione catabolism as a signaling mechanism</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1035</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2002&pages=1027-1035&author=A.+Paolicchiauthor=S.+Dominiciauthor=L.+Pieriauthor=E.+Maellaroauthor=A.+Pompella&title=Glutathione+catabolism+as+a+signaling+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaolicchi%26aufirst%3DA.%26aulast%3DDominici%26aufirst%3DS.%26aulast%3DPieri%26aufirst%3DL.%26aulast%3DMaellaro%26aufirst%3DE.%26aulast%3DPompella%26aufirst%3DA.%26atitle%3DGlutathione%2520catabolism%2520as%2520a%2520signaling%2520mechanism%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2002%26volume%3D64%26spage%3D1027%26epage%3D1035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref212"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref212'); return false;" data-citation="" class="refNumLink">212</a></strong><div class="NLM_citation" id="cit212"><span><span class="NLM_contrib-group">Fridovich, I.</span><span> </span><span class="NLM_article-title">Superoxide anion radical (O<sub>2</sub><sup>–•</sup>), superoxide dismutases, and related matters</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">18515</span><span class="NLM_x">–</span> <span class="NLM_lpage">18517</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=18515-18517&author=I.+Fridovich&title=Superoxide+anion+radical+%28O2%E2%80%93%E2%80%A2%29%2C+superoxide+dismutases%2C+and+related+matters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFridovich%26aufirst%3DI.%26atitle%3DSuperoxide%2520anion%2520radical%2520%2528O2%25E2%2580%2593%25E2%2580%25A2%2529%252C%2520superoxide%2520dismutases%252C%2520and%2520related%2520matters%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D18515%26epage%3D18517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref213"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref213'); return false;" data-citation="" class="refNumLink">213</a></strong><div class="NLM_citation" id="cit213"><span><span class="NLM_contrib-group">Masumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sies, H.</span><span> </span><span class="NLM_article-title">The reaction of 2-(methylseleno)benzanilide with peroxynitrite</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1057</span><span class="NLM_x">–</span> <span class="NLM_lpage">1062</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx9600560" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1996&pages=1057-1062&author=H.+Masumotoauthor=H.+Sies&title=The+reaction+of+2-%28methylseleno%29benzanilide+with+peroxynitrite"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1021%2Ftx9600560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx9600560%26sid%3Dliteratum%253Aachs%26aulast%3DMasumoto%26aufirst%3DH.%26aulast%3DSies%26aufirst%3DH.%26atitle%3DThe%2520reaction%2520of%25202-%2528methylseleno%2529benzanilide%2520with%2520peroxynitrite%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D1996%26volume%3D9%26spage%3D1057%26epage%3D1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref214"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref214'); return false;" data-citation="" class="refNumLink">214</a></strong><div class="NLM_citation" id="cit214"><span><span class="NLM_contrib-group">Parnham, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sies, H.</span><span> </span><span class="NLM_article-title">Ebselen: prospective therapy for cerebral ischaemia</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1517%2F13543784.9.3.607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11060699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhslKnsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=607-619&author=M.+Parnhamauthor=H.+Sies&title=Ebselen%3A+prospective+therapy+for+cerebral+ischaemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Ebselen: prospective therapy for cerebral ischaemia</span></div><div class="casAuthors">Parnham, Michael; Sies, Helmut</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">607-619</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications</span>)
        </div><div class="casAbstract">A review with 82 refs.  Stroke occurs due to hemorrhage or occlusive injury and results in ischemia and reperfusion injury.  A variety of destructive mechanisms are involved including oxygen radical generation, calcium overload, cytotoxicity and apoptosis as well as the generation of inflammatory mediators.  Ebselen, 2-phenyl-1,2-benzisoselenazol-3(2H)-one (PZ 51, DR3305), is a mimic of GSH peroxidase which also reacts with peroxynitrite and can inhibit enzymes such as lipoxygenases, NO synthases, NADPH oxidase, protein kinase C and H+/K+-ATPase.  Ebselen is in a late stage of development for the treatment of stroke.  The mol. actions of ebselen contribute to its anti-inflammatory and anti-oxidant properties, which have been demonstrated in a variety of in vivo models.  Numerous in vitro expts. using isolated LDL, liposomes, microsomes, isolated cells and organs have established that ebselen protects against oxidative challenge.  Unlike many inorg. and aliph. selenium compds., ebselen has low toxicity as metab. of the compd. does not liberate the selenium moiety, which remains within the ring structure.  Subsequent metab. involves methylation, glucuronidation and hydroxylation.  Exptl. studies in rats and dogs have revealed that ebselen is able to inhibit both vasospasm and tissue damage in stroke models, which correlates with its inhibitory effects on oxidative processes.  Results from randomized, placebo-controlled, double-blind clin. studies on the neurol. consequences of acute ischemic stroke, subarachnoid hemorrhage and acute middle cerebral artery occlusion, have revealed that ebselen significantly enhances outcome in patients who have experienced occlusive cerebral ischemia of limited duration.  The benefit achieved with ebselen is closely related to the rapidity with which the treatment is initiated, following the onset of the stroke attack.  Safety and tolerability are good and no adverse effects have become apparent.  Ebselen is currently at the pre-registration stage for subarachnoid hemorrhage and stroke in Japan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGRNMF1u9z8rVg90H21EOLACvtfcHk0liJWKwWMUcm5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhslKnsbs%253D&md5=4f5cd68b3073784362ce3b43ce474a7d</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1517%2F13543784.9.3.607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.9.3.607%26sid%3Dliteratum%253Aachs%26aulast%3DParnham%26aufirst%3DM.%26aulast%3DSies%26aufirst%3DH.%26atitle%3DEbselen%253A%2520prospective%2520therapy%2520for%2520cerebral%2520ischaemia%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs.%26date%3D2000%26volume%3D9%26spage%3D607%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref215"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref215'); return false;" data-citation="" class="refNumLink">215</a></strong><div class="NLM_citation" id="cit215"><span><span class="NLM_contrib-group">Moussaoui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obinu, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reibaud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imperato, A.</span><span> </span><span class="NLM_article-title">The antioxidant ebselen prevents neurotoxicity and clinical symptoms in a primate model of Parkinson’s disease</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1006%2Fexnr.2000.7516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11085889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotFCrsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2000&pages=235-245&author=S.+Moussaouiauthor=M.+C.+Obinuauthor=N.+Danielauthor=M.+Reibaudauthor=V.+Blanchardauthor=A.+Imperato&title=The+antioxidant+ebselen+prevents+neurotoxicity+and+clinical+symptoms+in+a+primate+model+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">The Antioxidant Ebselen Prevents Neurotoxicity and Clinical Symptoms in a Primate Model of Parkinson's Disease</span></div><div class="casAuthors">Moussaoui, Saliha; Obinu, Maria-Carmen; Daniel, Nadine; Reibaud, Michel; Blanchard, Veronique; Imperato, Assunta</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">235-245</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), via its major metabolite 1-methyl-4-phenylpyridinium (MPP+), produces in primates including humans clin., biochem., and neuropathol. changes similar to those which occur in idiopathic Parkinson's disease.  Ebselen is an antioxidant drug with glutathione peroxidase-like activity and a proven neuroprotective action in stroke patients.  Here we show that Ebselen, when administered before, during, and after MPTP injections, prevents both neuronal loss and clin. symptoms in a primate MPTP model of Parkinson's disease.  Ebselen also prevents peroxide radical overprodn. induced by serum withdrawal in cultured PC12 cells and hydroxyl radical generation induced by the mitochondrial toxin, MPP+, in vivo in rat brain.  Moreover, Ebselen inhibits MPP+-induced toxicity in PC12 cells, without interacting with the dopamine uptake system.  Our results demonstrate that compds. which prevent mitochondrial dysfunction and free radical prodn. may be useful as preventive treatment of Parkinson's disease.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCwoSO7nWsBrVg90H21EOLACvtfcHk0lgSBRrD_4qzsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotFCrsLY%253D&md5=3fc30382959d83231a314b4bfe66d350</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1006%2Fexnr.2000.7516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexnr.2000.7516%26sid%3Dliteratum%253Aachs%26aulast%3DMoussaoui%26aufirst%3DS.%26aulast%3DObinu%26aufirst%3DM.%2BC.%26aulast%3DDaniel%26aufirst%3DN.%26aulast%3DReibaud%26aufirst%3DM.%26aulast%3DBlanchard%26aufirst%3DV.%26aulast%3DImperato%26aufirst%3DA.%26atitle%3DThe%2520antioxidant%2520ebselen%2520prevents%2520neurotoxicity%2520and%2520clinical%2520symptoms%2520in%2520a%2520primate%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DExp.%2520Neurol.%26date%3D2000%26volume%3D166%26spage%3D235%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref216"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref216'); return false;" data-citation="" class="refNumLink">216</a></strong><div class="NLM_citation" id="cit216"><span><span class="NLM_contrib-group">Aitken, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lay, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witting, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, G. I.</span><span> </span><span class="NLM_article-title">Synchrotron radiation induced X-ray emission studies of the antioxidant mechanism of the organoselenium drug ebselen</span> <span class="citation_source-journal">J. Biol. Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="NLM_x">–</span> <span class="NLM_lpage">598</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1007%2Fs00775-012-0879-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=22327627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38XitFaksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=589-598&author=J.+B.+Aitkenauthor=P.+A.+Layauthor=T.+T.+Duongauthor=R.+Aranauthor=P.+K.+Wittingauthor=H.+H.+Harrisauthor=B.+Laiauthor=S.+Vogtauthor=G.+I.+Giles&title=Synchrotron+radiation+induced+X-ray+emission+studies+of+the+antioxidant+mechanism+of+the+organoselenium+drug+ebselen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Synchrotron radiation induced X-ray emission studies of the antioxidant mechanism of the organoselenium drug ebselen</span></div><div class="casAuthors">Aitken, Jade B.; Lay, Peter A.; Duong, T. T. Hong; Aran, Roshanak; Witting, Paul K.; Harris, Hugh H.; Lai, Barry; Vogt, Stefan; Giles, Gregory I.</div><div class="citationInfo"><span class="NLM_cas:title">JBIC, Journal of Biological Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">589-598</span>CODEN:
                <span class="NLM_cas:coden">JJBCFA</span>;
        ISSN:<span class="NLM_cas:issn">0949-8257</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Synchrotron radiation induced X-ray emission (SRIXE) spectroscopy was used to map the cellular uptake of the organoselenium-based antioxidant drug ebselen using differentiated ND15 cells as a neuronal model.  The cellular SRIXE spectra, acquired using a hard X-ray microprobe beam (12.8-keV), showed a large enhancement of fluorescence at the Kα line for Se (11.2-keV) following treatment with ebselen (10 μM) at time periods from 60 to 240 min.  Drug uptake was quantified and ebselen was shown to induce time-dependent changes in cellular elemental content that were characteristic of oxidative stress with the efflux of K, Cl, and Ca species.  The SRIXE cellular Se distribution map revealed that ebselen was predominantly localized to a discreet region of the cell which, by comparison with the K and P elemental maps, is postulated to correspond to the endoplasmic reticulum.  On the basis of these findings, it is hypothesized that a major outcome of ebselen redox catalysis is the induction of cellular stress.  A mechanism of action of ebselen is proposed that involves the cell responding to drug-induced stress by increasing the expression of antioxidant genes.  This hypothesis is supported by the observation that ebselen also regulated the homeostasis of the transition metals Mn, Cu, Fe, and Zn, with increases in transition metal uptake paralleling known induction times for the expression of antioxidant metalloenzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK4qZe0bds6rVg90H21EOLACvtfcHk0lgSBRrD_4qzsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitFaksLs%253D&md5=d11c1780c730712cce8a8c55aafa0472</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1007%2Fs00775-012-0879-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00775-012-0879-y%26sid%3Dliteratum%253Aachs%26aulast%3DAitken%26aufirst%3DJ.%2BB.%26aulast%3DLay%26aufirst%3DP.%2BA.%26aulast%3DDuong%26aufirst%3DT.%2BT.%26aulast%3DAran%26aufirst%3DR.%26aulast%3DWitting%26aufirst%3DP.%2BK.%26aulast%3DHarris%26aufirst%3DH.%2BH.%26aulast%3DLai%26aufirst%3DB.%26aulast%3DVogt%26aufirst%3DS.%26aulast%3DGiles%26aufirst%3DG.%2BI.%26atitle%3DSynchrotron%2520radiation%2520induced%2520X-ray%2520emission%2520studies%2520of%2520the%2520antioxidant%2520mechanism%2520of%2520the%2520organoselenium%2520drug%2520ebselen%26jtitle%3DJ.%2520Biol.%2520Inorg.%2520Chem.%26date%3D2012%26volume%3D17%26spage%3D589%26epage%3D598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref217"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref217'); return false;" data-citation="" class="refNumLink">217</a></strong><div class="NLM_citation" id="cit217"><span><span class="NLM_contrib-group">d’Alessio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moutet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coudrier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darquenne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudiere, J.</span><span> </span><span class="NLM_article-title">ICAM-1 and VCAM-1 expression induced by TNF-alpha are inhibited by a glutathione peroxidase mimic</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">987</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0891-5849%2897%2900396-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=9607608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1cXjtVWkurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1998&pages=979-987&author=P.+d%E2%80%99Alessioauthor=M.+Moutetauthor=E.+Coudrierauthor=S.+Darquenneauthor=J.+Chaudiere&title=ICAM-1+and+VCAM-1+expression+induced+by+TNF-alpha+are+inhibited+by+a+glutathione+peroxidase+mimic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit217R"><div class="casContent"><span class="casTitleNuber">217</span><div class="casTitle"><span class="NLM_cas:atitle">ICAM-1 and VCAM-1 expression induced by TNF-α are inhibited by a glutathione peroxidase mimic</span></div><div class="casAuthors">D'Alessio, Patrizia; Moutet, Marc; Coudrier, Evelyne; Darquenne, Sophie; Chaudiere, Jean</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">979-987</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Intercellular adhesion mol.-1 (ICAM-1) and vascular cell adhesion mol.-1 (VCAM-1) are resp. involved in the endothelial recruitment of neutrophils, and in that of lymphocytes or tumor cells, in response to specific signals.  We have used the glutathione peroxidase (GPx) mimic BXT-51072 to assess the possibility that endogenous hydroperoxides play a role in the tumor necrosis factor-α (TNFα)-induced expression of ICAM-1 and VCAM-1 by monolayers of human endothelial cells.  The GPx mimic BXT-51072 strongly inhibits the TNFα-induced and cycloheximide-sensitive expression of ICAM-1 and VCAM-1.  It also inhibits the TNFa-induced reorganization of the actin network and the assocd. formation of stress fibers.  Actin reorganization induced by cytochalasin D treatment did not inhibit ICAM-1 expression.  Our results are compatible with specific and synergistic effects of endogenous hydroperoxides on the biosynthesis and processing of cell adhesion mols. and cytoskeleton components.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDMA_6aTavXrVg90H21EOLACvtfcHk0lgSBRrD_4qzsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtVWkurs%253D&md5=741c12f7fecd934c9a9e9e9563c8cc21</span></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2897%2900396-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252897%252900396-1%26sid%3Dliteratum%253Aachs%26aulast%3Dd%25E2%2580%2599Alessio%26aufirst%3DP.%26aulast%3DMoutet%26aufirst%3DM.%26aulast%3DCoudrier%26aufirst%3DE.%26aulast%3DDarquenne%26aufirst%3DS.%26aulast%3DChaudiere%26aufirst%3DJ.%26atitle%3DICAM-1%2520and%2520VCAM-1%2520expression%2520induced%2520by%2520TNF-alpha%2520are%2520inhibited%2520by%2520a%2520glutathione%2520peroxidase%2520mimic%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D1998%26volume%3D24%26spage%3D979%26epage%3D987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref218"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref218'); return false;" data-citation="" class="refNumLink">218</a></strong><div class="NLM_citation" id="cit218"><span><span class="NLM_contrib-group">Moutet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">d’Alessio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malette, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devaux, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudiere, J.</span><span> </span><span class="NLM_article-title">Glutathione peroxidase mimics prevent TNFalpha- and neutrophil-induced endothelial alterations</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0891-5849%2898%2900038-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=9680172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1cXks1Chtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1998&pages=270-281&author=M.+Moutetauthor=P.+d%E2%80%99Alessioauthor=P.+Maletteauthor=V.+Devauxauthor=J.+Chaudiere&title=Glutathione+peroxidase+mimics+prevent+TNFalpha-+and+neutrophil-induced+endothelial+alterations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">Glutathione peroxidase mimics prevent TNFα- and neutrophil-induced endothelial alterations</span></div><div class="casAuthors">Moutet, Marc; D'alessio, Patrizia; Malette, Patricia; Devaux, Veronique; Chaudiere, Jean</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">270-281</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Based on the assumption that glutathione peroxidase (GPx) activity might be limiting in preventing peroxide-induced impairment of endothelial regulatory functions, we studied the effect of a series of new selenium-contg. GPx mimics on endothelial cells exposed to an inflammatory stress.  The two compds. that have the highest GPx activity, BXT-51072 and BXT-51077, were shown to be the most efficient inhibitors of leukocyte recruitment by human umbilical vein endothelial cells (HUVEC), upon incubation with neutrophils (10-fold excess over HUVEC) and with 1 ng/mL TNF-α for 1 or 3.5 h.  When HUVEC were pre- and cotreated with 10 μM of either compd., neutrophil adhesion and endothelial alteration were markedly inhibited, as assessed by immunoassays of myeloperoxidase and von Willebrand factor, resp.  These two GPx mimics were also found to be the most efficient inhibitors of the TNFα-induced endothelial expression of P- and E-selectin and of the TNFα- or interleukin-1-induced endothelial release of interleukin-8.  Our results demonstrate that GPx mimics such as BXT-51072 behave as potent antagonists of TNF-α and interleukin-1 through the downregulation of endothelial proinflammatory responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPIFsCDDD2IbVg90H21EOLACvtfcHk0lgp_iGqwTP8ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXks1Chtb8%253D&md5=91b9045691ccaaedb8f6ff7f30f058ec</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2898%2900038-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252898%252900038-0%26sid%3Dliteratum%253Aachs%26aulast%3DMoutet%26aufirst%3DM.%26aulast%3Dd%25E2%2580%2599Alessio%26aufirst%3DP.%26aulast%3DMalette%26aufirst%3DP.%26aulast%3DDevaux%26aufirst%3DV.%26aulast%3DChaudiere%26aufirst%3DJ.%26atitle%3DGlutathione%2520peroxidase%2520mimics%2520prevent%2520TNFalpha-%2520and%2520neutrophil-induced%2520endothelial%2520alterations%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D1998%26volume%3D25%26spage%3D270%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref219"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref219'); return false;" data-citation="" class="refNumLink">219</a></strong><div class="NLM_citation" id="cit219"><span><span class="NLM_contrib-group">Batinic-Haberle, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benov, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spasojevic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridovich, I.</span><span> </span><span class="NLM_article-title">The ortho effect makes manganese(III) meso-tetrakis(<i>N</i>-methylpyridinium-2-yl)porphyrin a powerful and potentially useful superoxide dismutase mimic</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">24521</span><span class="NLM_x">–</span> <span class="NLM_lpage">24528</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=24521-24528&author=I.+Batinic-Haberleauthor=L.+Benovauthor=I.+Spasojevicauthor=I.+Fridovich&title=The+ortho+effect+makes+manganese%28III%29+meso-tetrakis%28N-methylpyridinium-2-yl%29porphyrin+a+powerful+and+potentially+useful+superoxide+dismutase+mimic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBatinic-Haberle%26aufirst%3DI.%26aulast%3DBenov%26aufirst%3DL.%26aulast%3DSpasojevic%26aufirst%3DI.%26aulast%3DFridovich%26aufirst%3DI.%26atitle%3DThe%2520ortho%2520effect%2520makes%2520manganese%2528III%2529%2520meso-tetrakis%2528N-methylpyridinium-2-yl%2529porphyrin%2520a%2520powerful%2520and%2520potentially%2520useful%2520superoxide%2520dismutase%2520mimic%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D24521%26epage%3D24528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref220"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref220'); return false;" data-citation="" class="refNumLink">220</a></strong><div class="NLM_citation" id="cit220"><span><span class="NLM_contrib-group">Bowler, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enghild, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearlstein, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crapo, J. D.</span><span> </span><span class="NLM_article-title">A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1141</span><span class="NLM_x">–</span> <span class="NLM_lpage">1152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0891-5849%2802%2901008-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12374626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD38Xns1Sitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2002&pages=1141-1152&author=R.+P.+Bowlerauthor=H.+Shengauthor=J.+J.+Enghildauthor=R.+D.+Pearlsteinauthor=D.+S.+Warnerauthor=J.+D.+Crapo&title=A+catalytic+antioxidant+%28AEOL+10150%29+attenuates+expression+of+inflammatory+genes+in+stroke"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit220R"><div class="casContent"><span class="casTitleNuber">220</span><div class="casTitle"><span class="NLM_cas:atitle">A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke</span></div><div class="casAuthors">Bowler, Russell P.; Sheng, Huaxin; Enghild, Jan J.; Pearlstein, Robert D.; Warner, David S.; Crapo, James D.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1141-1152</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Oxidative stress is a major source of injury from cerebral ischemia and reperfusion.  We hypothesized that a catalytic antioxidant AEOL 10150 [manganese (III) meso-tetrakis (di-N-ethylimidazole) porphyrin] would attenuate changes in brain gene expression in a mouse model of transient middle cerebral artery occlusion (MCAO).  C57BL/6J mice were subjected to either sham surgery or 60 min of right MCAO.  AEOL 10150 or phosphate-buffered saline was given i.v. 5 min after onset of reperfusion (n = 6 per group).  Six hours later, parenchyma within the MCA distribution was harvested.  RNA from the six brains in each group was pooled and mRNA expression detd. using an Affymetrix murine MG_74A v. 2.0 expression microarray.  Each expt. was performed three times.  The largest changes in expression occurred in stress response and inflammatory genes such as heat shock protein, interleukin-6, and macrophage inflammatory protein-2.  Treatment with AEOL 10150 attenuated only the increase in expression of inflammatory genes.  This suggests that AEOL 10150 protects brain by attenuating the immune response to ischemia and reperfusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9YVEXTO_hSbVg90H21EOLACvtfcHk0lgp_iGqwTP8ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xns1Sitro%253D&md5=2bfefa35475b6857221a35d432a2c4e6</span></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2802%2901008-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252802%252901008-0%26sid%3Dliteratum%253Aachs%26aulast%3DBowler%26aufirst%3DR.%2BP.%26aulast%3DSheng%26aufirst%3DH.%26aulast%3DEnghild%26aufirst%3DJ.%2BJ.%26aulast%3DPearlstein%26aufirst%3DR.%2BD.%26aulast%3DWarner%26aufirst%3DD.%2BS.%26aulast%3DCrapo%26aufirst%3DJ.%2BD.%26atitle%3DA%2520catalytic%2520antioxidant%2520%2528AEOL%252010150%2529%2520attenuates%2520expression%2520of%2520inflammatory%2520genes%2520in%2520stroke%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2002%26volume%3D33%26spage%3D1141%26epage%3D1152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref221"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref221'); return false;" data-citation="" class="refNumLink">221</a></strong><div class="NLM_citation" id="cit221"><span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, B. J.</span><span> </span><span class="NLM_article-title">Metalloporphyrin class of therapeutic catalytic antioxidants</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=359-364&author=M.+Patelauthor=B.+J.+Day&title=Metalloporphyrin+class+of+therapeutic+catalytic+antioxidants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DDay%26aufirst%3DB.%2BJ.%26atitle%3DMetalloporphyrin%2520class%2520of%2520therapeutic%2520catalytic%2520antioxidants%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1999%26volume%3D20%26spage%3D359%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref222"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref222'); return false;" data-citation="" class="refNumLink">222</a></strong><div class="NLM_citation" id="cit222"><span><span class="NLM_contrib-group">Peng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, X. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, J. K.</span><span> </span><span class="NLM_article-title">The herbicide paraquat induces dopaminergic nigral apoptosis through sustained activation of the JNK pathway</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">32626</span><span class="NLM_x">–</span> <span class="NLM_lpage">32632</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=32626-32632&author=J.+Pengauthor=X.+O.+Maoauthor=F.+F.+Stevensonauthor=M.+Hsuauthor=J.+K.+Andersen&title=The+herbicide+paraquat+induces+dopaminergic+nigral+apoptosis+through+sustained+activation+of+the+JNK+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit222&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DX.%2BO.%26aulast%3DStevenson%26aufirst%3DF.%2BF.%26aulast%3DHsu%26aufirst%3DM.%26aulast%3DAndersen%26aufirst%3DJ.%2BK.%26atitle%3DThe%2520herbicide%2520paraquat%2520induces%2520dopaminergic%2520nigral%2520apoptosis%2520through%2520sustained%2520activation%2520of%2520the%2520JNK%2520pathway%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D32626%26epage%3D32632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref223"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref223'); return false;" data-citation="" class="refNumLink">223</a></strong><div class="NLM_citation" id="cit223"><span><span class="NLM_contrib-group">Peng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doctrow, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, J. K.</span><span> </span><span class="NLM_article-title">Superoxide dismutase/catalase mimetics are neuroprotective against selective paraquat-mediated dopaminergic neuron death in the substantial nigra: implications for Parkinson disease</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">29194</span><span class="NLM_x">–</span> <span class="NLM_lpage">29198</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=29194-29198&author=J.+Pengauthor=F.+F.+Stevensonauthor=S.+R.+Doctrowauthor=J.+K.+Andersen&title=Superoxide+dismutase%2Fcatalase+mimetics+are+neuroprotective+against+selective+paraquat-mediated+dopaminergic+neuron+death+in+the+substantial+nigra%3A+implications+for+Parkinson+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DStevenson%26aufirst%3DF.%2BF.%26aulast%3DDoctrow%26aufirst%3DS.%2BR.%26aulast%3DAndersen%26aufirst%3DJ.%2BK.%26atitle%3DSuperoxide%2520dismutase%252Fcatalase%2520mimetics%2520are%2520neuroprotective%2520against%2520selective%2520paraquat-mediated%2520dopaminergic%2520neuron%2520death%2520in%2520the%2520substantial%2520nigra%253A%2520implications%2520for%2520Parkinson%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D29194%26epage%3D29198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref224"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref224'); return false;" data-citation="" class="refNumLink">224</a></strong><div class="NLM_citation" id="cit224"><span><span class="NLM_contrib-group">Young, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, G. M.</span><span> </span><span class="NLM_article-title">Antioxidant and prooxidant properties of carotenoids</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">385</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1006%2Fabbi.2000.2149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11361018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovFyjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=2001&pages=20-27&author=A.+J.+Youngauthor=G.+M.+Lowe&title=Antioxidant+and+prooxidant+properties+of+carotenoids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit224R"><div class="casContent"><span class="casTitleNuber">224</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant and Prooxidant properties of Carotenoids</span></div><div class="casAuthors">Young, Andrew J.; Lowe, Gordon M.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">385</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-27</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review with 62 refs.  The ability of dietary carotenoids such as β-carotene and lycopene to act as antioxidants in biol. systems is dependent upon a no. of factors.  While the structure of carotenoids, esp. the conjugated double bond system, gives rise to many of the fundamental properties of these mols., it also affects how these mols. are incorporated into biol. membranes.  This, in turn, alters the way these mols. interact with reactive oxygen species, so that the in vivo behavior may be quite different from that seen in soln.  The effectiveness of carotenoids as antioxidants is also dependent upon their interaction with other coantioxidants, esp. vitamins E and C. Carotenoids may, however, lose their effectiveness as antioxidants at high concns. or at high partial pressures of oxygen.  It is unlikely that carotenoids actually act as prooxidants in biol. systems; rather they exhibit a tendency to lose their effectiveness as antioxidants.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvMKoZA8g1lbVg90H21EOLACvtfcHk0lhQLb1EYgoA-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovFyjs7g%253D&md5=dbc4956f7e18a2a1639c5c427c536bbf</span></div><a href="/servlet/linkout?suffix=cit224&amp;dbid=16384&amp;doi=10.1006%2Fabbi.2000.2149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.2000.2149%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DA.%2BJ.%26aulast%3DLowe%26aufirst%3DG.%2BM.%26atitle%3DAntioxidant%2520and%2520prooxidant%2520properties%2520of%2520carotenoids%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2001%26volume%3D385%26spage%3D20%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref225"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref225'); return false;" data-citation="" class="refNumLink">225</a></strong><div class="NLM_citation" id="cit225"><span><span class="NLM_contrib-group">Di Mascio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sies, H.</span><span> </span><span class="NLM_article-title">Lycopene as the most efficient biological carotenoid singlet oxygen quencher</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">532</span><span class="NLM_x">–</span> <span class="NLM_lpage">538</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2F0003-9861%2889%2990467-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=2802626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaL1MXlvVOjt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1989&pages=532-538&author=P.+Di+Mascioauthor=S.+Kaiserauthor=H.+Sies&title=Lycopene+as+the+most+efficient+biological+carotenoid+singlet+oxygen+quencher"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit225R"><div class="casContent"><span class="casTitleNuber">225</span><div class="casTitle"><span class="NLM_cas:atitle">Lycopene as the most efficient biological carotenoid singlet oxygen quencher</span></div><div class="casAuthors">Di Mascio, Paolo; Kaiser, Stephan; Sies, Helmut</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">532-8</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    </div><div class="casAbstract">Of a no. of carotenoids and related compds. tested, lycopene, a biol. occurring carotenoid, exhibited the highest phys. quenching rate const. with singlet O (kq = 31 × 109 M-1 s-1); its plasma levels in humans is slightly higher than that of β-carotene (kq = 14 × 109 M-1 s-1).  This is of considerable general interest, since nutritional carotenoids, particularly β-carotene, and other antioxidants such as α-tocopherol (kq = 0.3 × 109 M-1 s-1) have been implicated in the defense against prooxidant states; epidemiol. evidence reveals that such compds. exert a protective action against certain types of cancer.  Also, albumin-bound bilirubin is a known singlet O quencher (kq = 3.2 × 109 M-1 s-1).  Interestingly, those compds. with low kq values occur at relatively high plasma levels.  When these differences are taken into account, the singlet O-quenching capacities of lycopene (0.7 μM in plasm), β-carotene (0.5 μM in plasma), albumin-bound bilirubin (15 μM in plasma), and α-tocopherol (22 μM in plasma) are of comparable magnitude.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJjfCKpLEnnbVg90H21EOLACvtfcHk0lgaWHyMsRTMaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXlvVOjt7c%253D&md5=f3fe1399c994331ab8f44a5ff1c5fbdd</span></div><a href="/servlet/linkout?suffix=cit225&amp;dbid=16384&amp;doi=10.1016%2F0003-9861%2889%2990467-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-9861%252889%252990467-0%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMascio%26aufirst%3DP.%26aulast%3DKaiser%26aufirst%3DS.%26aulast%3DSies%26aufirst%3DH.%26atitle%3DLycopene%2520as%2520the%2520most%2520efficient%2520biological%2520carotenoid%2520singlet%2520oxygen%2520quencher%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1989%26volume%3D274%26spage%3D532%26epage%3D538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref226"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref226'); return false;" data-citation="" class="refNumLink">226</a></strong><div class="NLM_citation" id="cit226"><span><span class="NLM_contrib-group">Burton, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingold, K. U.</span><span> </span><span class="NLM_article-title">beta-Carotene: an unusual type of lipid antioxidant</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">224</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">573</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=224&publication_year=1984&pages=569-573&author=G.+W.+Burtonauthor=K.+U.+Ingold&title=beta-Carotene%3A+an+unusual+type+of+lipid+antioxidant"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit226&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurton%26aufirst%3DG.%2BW.%26aulast%3DIngold%26aufirst%3DK.%2BU.%26atitle%3Dbeta-Carotene%253A%2520an%2520unusual%2520type%2520of%2520lipid%2520antioxidant%26jtitle%3DScience%26date%3D1984%26volume%3D224%26spage%3D569%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref227"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref227'); return false;" data-citation="" class="refNumLink">227</a></strong><div class="NLM_citation" id="cit227"><span><span class="NLM_contrib-group">Goodman, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardee, A. B.</span><span> </span><span class="NLM_article-title">Evidence for defective retinoid transport and function in late onset Alzheimer’s disease</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">2901</span><span class="NLM_x">–</span> <span class="NLM_lpage">2905</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=2901-2905&author=A.+B.+Goodmanauthor=A.+B.+Pardee&title=Evidence+for+defective+retinoid+transport+and+function+in+late+onset+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit227&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoodman%26aufirst%3DA.%2BB.%26aulast%3DPardee%26aufirst%3DA.%2BB.%26atitle%3DEvidence%2520for%2520defective%2520retinoid%2520transport%2520and%2520function%2520in%2520late%2520onset%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2003%26volume%3D100%26spage%3D2901%26epage%3D2905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref228"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref228'); return false;" data-citation="" class="refNumLink">228</a></strong><div class="NLM_citation" id="cit228"><span><span class="NLM_contrib-group">Goodman, A. B.</span><span> </span><span class="NLM_article-title">Retinoid receptors, transporters, and metabolizers as therapeutic targets in late onset Alzheimer disease</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">209</span><span class="NLM_x">, </span> <span class="NLM_fpage">598</span><span class="NLM_x">–</span> <span class="NLM_lpage">603</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1002%2Fjcp.20784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=17001693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOktLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=209&publication_year=2006&pages=598-603&author=A.+B.+Goodman&title=Retinoid+receptors%2C+transporters%2C+and+metabolizers+as+therapeutic+targets+in+late+onset+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit228R"><div class="casContent"><span class="casTitleNuber">228</span><div class="casTitle"><span class="NLM_cas:atitle">Retinoid receptors, transporters, and metabolizers as therapeutic targets in late onset Alzheimer disease</span></div><div class="casAuthors">Goodman, Ann B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">209</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">598-603</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Vitamin A (retinoid) is required in the adult brain to enable cognition, learning, and memory.  While brain levels of retinoid diminish over the course of normal aging, retinoid deficit is greater in late onset Alzheimer disease (LOAD) brains than in normal-aged controls.  This paper reviews recent evidence supporting these statements and further suggests that genes necessary for the synthesis, transport and function of retinoid to and within the aging brain are appropriate targets for treatment of LOAD.  These genes tend to be clustered with genes that have been proposed as candidates in LOAD, are found at chromosomal regions linked to LOAD, and suggest the possibility of an overall coordinated regulation.  This phenomenon is termed Chromeron and is analogous to the operon mechanism obsd. in prokaryotes.  Suggested treatment targets are the retinoic-acid inactivating enzymes (CYP26)s, the retinol binding and transport proteins, retinol-binding protein (RBP)4 and transthyretin (TTR), and the retinoid receptors.  TTR as a LOAD target is the subject of active investigation.  The retinoid receptors and the retinoid-inactivating enzymes have previously been proposed as targets.  This is the first report to suggest that RBP4 is an amenable treatment target in LOAD.  RBP4 is elevated in type-2 diabetes and obesity, conditions assocd. with increased risk for LOAD.  Fenretinide, a novel synthetic retinoic acid (RA) analog lowers RBP4 in glucose intolerant obese mice.  The feasibility of using fenretinide either as an adjunct to present LOAD therapies, or on its own as an early prevention strategy should be detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpivWzk2D77hrVg90H21EOLACvtfcHk0lgaWHyMsRTMaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOktLzL&md5=def975d68db7ecae2277e93e7a6f09a9</span></div><a href="/servlet/linkout?suffix=cit228&amp;dbid=16384&amp;doi=10.1002%2Fjcp.20784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.20784%26sid%3Dliteratum%253Aachs%26aulast%3DGoodman%26aufirst%3DA.%2BB.%26atitle%3DRetinoid%2520receptors%252C%2520transporters%252C%2520and%2520metabolizers%2520as%2520therapeutic%2520targets%2520in%2520late%2520onset%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2006%26volume%3D209%26spage%3D598%26epage%3D603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref229"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref229'); return false;" data-citation="" class="refNumLink">229</a></strong><div class="NLM_citation" id="cit229"><span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodwin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allsbrook, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, G. H.</span><span> </span><span class="NLM_article-title">Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer’s disease transgenic mouse model</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">11622</span><span class="NLM_x">–</span> <span class="NLM_lpage">11634</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1523%2FJNEUROSCI.3153-08.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=18987198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOgt7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=11622-11634&author=Y.+Dingauthor=A.+Qiaoauthor=Z.+Wangauthor=J.+S.+Goodwinauthor=E.+S.+Leeauthor=M.+L.+Blockauthor=M.+Allsbrookauthor=M.+P.+McDonaldauthor=G.+H.+Fan&title=Retinoic+acid+attenuates+beta-amyloid+deposition+and+rescues+memory+deficits+in+an+Alzheimer%E2%80%99s+disease+transgenic+mouse+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit229R"><div class="casContent"><span class="casTitleNuber">229</span><div class="casTitle"><span class="NLM_cas:atitle">Retinoic acid attenuates β-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model</span></div><div class="casAuthors">Ding, Yun; Qiao, Aimin; Wang, Ziqing; Goodwin, J. Shawn; Lee, Eun-Sook; Block, Michelle L.; Allsbrook, Matthew; McDonald, Michael P.; Fan, Guo-Huang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">11622-11634</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Recent studies have revealed that disruption of vitamin A signaling obsd. in Alzheimer's disease (AD) leads to β-amyloid (Aβ) accumulation and memory deficits in rodents.  The aim of the present study was to evaluate the therapeutic effect of all-trans retinoic acid (ATRA), an active metabolite of vitamin A, on the neuropathol. and deficits of spatial learning and memory in amyloid precursor protein (APP) and presenilin 1 (PS1) double-transgenic mice, a well established AD mouse model.  Here we report a robust decrease in brain Aβ deposition and tau phosphorylation in the blinded study of APP/PS1 transgenic mice treated i.p. for 8 wk with ATRA (20 mg/kg, three times weekly, initiated when the mice were 5 mo old).  This was accompanied by a significant decrease in the APP phosphorylation and processing.  The activity of cyclin-dependent kinase 5, a major kinase involved in both APP and tau phosphorylation, was markedly downregulated by ATRA treatment.  The ATRA-treated APP/PS1 mice showed decreased activation of microglia and astrocytes, attenuated neuronal degeneration, and improved spatial learning and memory compared with the vehicle-treated APP/PS1 mice.  These results support ATRA as an effective therapeutic agent for the prevention and treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeaBvX8Xo-vbVg90H21EOLACvtfcHk0lgaWHyMsRTMaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOgt7%252FP&md5=4e01293117a02d5516f64190ecb34eb4</span></div><a href="/servlet/linkout?suffix=cit229&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3153-08.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3153-08.2008%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DY.%26aulast%3DQiao%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DGoodwin%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DE.%2BS.%26aulast%3DBlock%26aufirst%3DM.%2BL.%26aulast%3DAllsbrook%26aufirst%3DM.%26aulast%3DMcDonald%26aufirst%3DM.%2BP.%26aulast%3DFan%26aufirst%3DG.%2BH.%26atitle%3DRetinoic%2520acid%2520attenuates%2520beta-amyloid%2520deposition%2520and%2520rescues%2520memory%2520deficits%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520transgenic%2520mouse%2520model%26jtitle%3DJ.%2520Neurosci.%26date%3D2008%26volume%3D28%26spage%3D11622%26epage%3D11634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref230"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref230'); return false;" data-citation="" class="refNumLink">230</a></strong><div class="NLM_citation" id="cit230"><span><span class="NLM_contrib-group">Mann, K. G.</span><span> </span><span class="NLM_article-title">Biochemistry and physiology of blood coagulation</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1055%2Fs-0037-1615780" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=10605701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1MXnsVWnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1999&pages=165-174&author=K.+G.+Mann&title=Biochemistry+and+physiology+of+blood+coagulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit230R"><div class="casContent"><span class="casTitleNuber">230</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemistry and physiology of blood coagulation</span></div><div class="casAuthors">Mann, Kenneth G.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">165-174</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">F. K. Schattauer Verlagsgesellschaft mbH</span>)
        </div><div class="casAbstract">A review is given with 54 refs.  The accomplishments of many colleagues in the field of coagulation over the past 150 yr portens a bright future for advances in the intervention for hemorrhagic and thrombotic diseases in the 21st century.  The principal limitation will be the attraction of new basic and clin. scientists into the relevant fields of biochem., mol. genetics, hematol., cardiol., pathol., and surgery.  Future research will exploit existing advances in technol. in the pursuit of better techniques for diagnosis, prophylaxis, and intervention in cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPZK7SvwQDBbVg90H21EOLACvtfcHk0lhwkNg-5Ew4EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnsVWnur8%253D&md5=77570b86fe68de8e57cc14b0296cd5de</span></div><a href="/servlet/linkout?suffix=cit230&amp;dbid=16384&amp;doi=10.1055%2Fs-0037-1615780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0037-1615780%26sid%3Dliteratum%253Aachs%26aulast%3DMann%26aufirst%3DK.%2BG.%26atitle%3DBiochemistry%2520and%2520physiology%2520of%2520blood%2520coagulation%26jtitle%3DThromb.%2520Haemostasis%26date%3D1999%26volume%3D82%26spage%3D165%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref231"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref231'); return false;" data-citation="" class="refNumLink">231</a></strong><div class="NLM_citation" id="cit231"><span><span class="NLM_contrib-group">Price, P. A.</span><span> </span><span class="NLM_article-title">Role of vitamin-K-dependent proteins in bone metabolism</span> <span class="citation_source-journal">Annu. Rev. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1988&pages=565-583&author=P.+A.+Price&title=Role+of+vitamin-K-dependent+proteins+in+bone+metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit231&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DP.%2BA.%26atitle%3DRole%2520of%2520vitamin-K-dependent%2520proteins%2520in%2520bone%2520metabolism%26jtitle%3DAnnu.%2520Rev.%2520Nutr.%26date%3D1988%26volume%3D8%26spage%3D565%26epage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref232"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref232'); return false;" data-citation="" class="refNumLink">232</a></strong><div class="NLM_citation" id="cit232"><span><span class="NLM_contrib-group">Allison, A. C.</span><span> </span><span class="NLM_article-title">The possible role of vitamin K deficiency in the pathogenesis of Alzheimer’s disease and in augmenting brain damage associated with cardiovascular disease</span> <span class="citation_source-journal">Med. Hypotheses</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1054%2Fmehy.2001.1307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11461163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtVymt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2001&pages=151-155&author=A.+C.+Allison&title=The+possible+role+of+vitamin+K+deficiency+in+the+pathogenesis+of+Alzheimer%E2%80%99s+disease+and+in+augmenting+brain+damage+associated+with+cardiovascular+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit232R"><div class="casContent"><span class="casTitleNuber">232</span><div class="casTitle"><span class="NLM_cas:atitle">The possible role of vitamin K deficiency in the pathogenesis of Alzheimer's disease and in augmenting brain damage associated with cardiovascular disease</span></div><div class="casAuthors">Allison, A. C.</div><div class="citationInfo"><span class="NLM_cas:title">Medical Hypotheses</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-155</span>CODEN:
                <span class="NLM_cas:coden">MEHYDY</span>;
        ISSN:<span class="NLM_cas:issn">0306-9877</span>.
    
            (<span class="NLM_cas:orgname">Churchill Livingstone</span>)
        </div><div class="casAbstract">A review.  The incidence of Alzheimer's disease (AD) increases with age and in carriers of the apolipoprotein E4 genotype.  A relative deficiency of vitamin K, affecting the extrahepatic functions of the vitamin, is common in ageing men and women.  The concn. of vitamin K is lower in the circulating blood of APOE4 carriers than in that of persons with other APOE genotypes.  Evidence is accumulating that vitamin K has important functions in the brain, including the regulation of sulfotransferase activity and the activity of a growth factor/tyrosine kinase receptor (Gas 6/Axl).  The hypothesis is now proposed that vitamin K deficiency contributes to the pathogenesis of AD and that vitamin K supplementation may have a beneficial effect in preventing or treating the disease.  Vitamin K may also reduce neuronal damage assocd. with cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRHNf86TqCTLVg90H21EOLACvtfcHk0lhwkNg-5Ew4EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtVymt78%253D&md5=4bf44b2a7039ccbc513f9aebb460812e</span></div><a href="/servlet/linkout?suffix=cit232&amp;dbid=16384&amp;doi=10.1054%2Fmehy.2001.1307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1054%252Fmehy.2001.1307%26sid%3Dliteratum%253Aachs%26aulast%3DAllison%26aufirst%3DA.%2BC.%26atitle%3DThe%2520possible%2520role%2520of%2520vitamin%2520K%2520deficiency%2520in%2520the%2520pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520in%2520augmenting%2520brain%2520damage%2520associated%2520with%2520cardiovascular%2520disease%26jtitle%3DMed.%2520Hypotheses%26date%3D2001%26volume%3D57%26spage%3D151%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref233"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref233'); return false;" data-citation="" class="refNumLink">233</a></strong><div class="NLM_citation" id="cit233"><span><span class="NLM_contrib-group">Beal, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shults, C. W.</span><span> </span><span class="NLM_article-title">Effects of coenzyme Q10 in Huntington’s disease and early Parkinson’s disease</span> <span class="citation_source-journal">BioFactors</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=153-161&author=M.+F.+Bealauthor=C.+W.+Shults&title=Effects+of+coenzyme+Q10+in+Huntington%E2%80%99s+disease+and+early+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit233&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeal%26aufirst%3DM.%2BF.%26aulast%3DShults%26aufirst%3DC.%2BW.%26atitle%3DEffects%2520of%2520coenzyme%2520Q10%2520in%2520Huntington%25E2%2580%2599s%2520disease%2520and%2520early%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DBioFactors%26date%3D2003%26volume%3D18%26spage%3D153%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref234"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref234'); return false;" data-citation="" class="refNumLink">234</a></strong><div class="NLM_citation" id="cit234"><span><span class="NLM_contrib-group">Bhat, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, W. J.</span><span> </span><span class="NLM_article-title">Parkinson’s disease. Diagnosis and the initiation of therapy</span> <span class="citation_source-journal">Minerva Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=16175158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD2MrgtlSitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2005&pages=145-154&author=V.+Bhatauthor=W.+J.+Weiner&title=Parkinson%E2%80%99s+disease.+Diagnosis+and+the+initiation+of+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit234R"><div class="casContent"><span class="casTitleNuber">234</span><div class="casTitle"><span class="NLM_cas:atitle">Parkinson's disease. Diagnosis and the initiation of therapy</span></div><div class="casAuthors">Bhat V; Weiner W J</div><div class="citationInfo"><span class="NLM_cas:title">Minerva medica</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">145-54</span>
        ISSN:<span class="NLM_cas:issn">0026-4806</span>.
    </div><div class="casAbstract">Parkinson's disease (PD) is the most common cause of parkinsonism.  Parkinsonism is characterized by resting tremor, bradykinesia, rigidity and gait impairment.  There is no specific diagnostic test for PD and it is important for clinicians to understand the clinical signs which help to distinguish PD from parkinsonism.  It is equally important to be aware of the clinical signs which can be an indication that the diagnosis is not PD.  These so-called Parkinson-plus syndromes include progressive supranuclear palsy (PSP), multiple systems atrophy (MSA), corticobasal degeneration (CBD), vascular parkinsonism (VP) and parkinsonism with dementia (Lewy body dementia, LBD).  The differential diagnosis of parkinsonism will be discussed.  Initiating pharmacologic therapy for PD must take into consideration the degree of dysfunction the patient is experiencing, the question of neuroprotection, the degree of motor response required, and the potential complications of long-term treatment.  Neuropro-tective trials of coenzyme Q10 (CoQ), vitamin C, vitamin E, monoamine oxidase B inhibitors (MAO-I) and dopamine agonists do not support the use of any of these drugs for a neuroprotective effect.  There is recent supportive evidence that levodopa may have a neuroprotective effect.  Either dopamine agonists or levodopa may be initiated.  Dopamine agonists are associated with fewer motor fluctuations and dyskinesias, while levodopa is associated with better motor performance.  Initiation of therapy should be tailored to individual patients with the emphasis on symptom control, with the hope that new approaches to treatment of PD (including neuroprotection) will be forthcoming.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPK209odsbaQqdek-gHSrIfW6udTcc2eb8KjPpr6Wz-7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MrgtlSitA%253D%253D&md5=0eebdb3d82f76300c857d310123f4aa1</span></div><a href="/servlet/linkout?suffix=cit234&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DV.%26aulast%3DWeiner%26aufirst%3DW.%2BJ.%26atitle%3DParkinson%25E2%2580%2599s%2520disease.%2520Diagnosis%2520and%2520the%2520initiation%2520of%2520therapy%26jtitle%3DMinerva%2520Med.%26date%3D2005%26volume%3D96%26spage%3D145%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref235"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref235'); return false;" data-citation="" class="refNumLink">235</a></strong><div class="NLM_citation" id="cit235"><span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E. S.</span><span> </span><span class="NLM_article-title">Coenzyme Q10 attenuates beta-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation</span> <span class="citation_source-journal">J. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1007%2Fs12031-007-9033-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=18181031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFOhtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2008&pages=165-171&author=X.+Yangauthor=Y.+Yangauthor=G.+Liauthor=J.+Wangauthor=E.+S.+Yang&title=Coenzyme+Q10+attenuates+beta-amyloid+pathology+in+the+aged+transgenic+mice+with+Alzheimer+presenilin+1+mutation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit235R"><div class="casContent"><span class="casTitleNuber">235</span><div class="casTitle"><span class="NLM_cas:atitle">Coenzyme Q10 attenuates β-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation</span></div><div class="casAuthors">Yang, Xifei; Yang, Ying; Li, Geng; Wang, Jianzhi; Yang, Edward S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">165-171</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">One of the neuropathol. features of Alzheimer's disease (AD) is the deposition of senile plaques contg. β-amyloid (Aβ).  There is limited evidence for the treatment to arrest Aβ pathol. of AD.  In our present study, we tested the effect of coenzyme Q10 (CoQ10), an endogenous antioxidant and a powerful free radical scavenger, on Aβ in the aged transgenic mice overexpressing Alzheimer presenilin 1-L235P (leucine-to-proline mutation at codon 235, 16-17 mo old).  The treatment by feeding the transgenic mice with CoQ10 for 60 days (1,200 mg kg-1 day-1) partially attenuated Aβ overprodn. and intracellular Aβ deposit in the cortex of the transgenic mice compared with the age-matched untreated transgenic mice.  Meanwhile, an increased oxidative stress reaction was detected as evidenced by elevated level of malondialdehyde (MDA) and decreased activity of superoxide dismutase (SOD) in the transgenic mice relative to the wild-type mice, and supplementation of CoQ10 partially decreased MDA level and upregulated the activity of SOD.  The results indicate that oxidative stress is enhanced in the brain of the transgenic mice, that this enhancement may further promote Aβ42 overprodn. in a vicious formation, and that CoQ10 would be beneficial for the therapy of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3P840SlD4ULVg90H21EOLACvtfcHk0lhwkNg-5Ew4EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFOhtLc%253D&md5=8f2cced90d89e0e8b8e5118f33b482df</span></div><a href="/servlet/linkout?suffix=cit235&amp;dbid=16384&amp;doi=10.1007%2Fs12031-007-9033-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12031-007-9033-7%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DE.%2BS.%26atitle%3DCoenzyme%2520Q10%2520attenuates%2520beta-amyloid%2520pathology%2520in%2520the%2520aged%2520transgenic%2520mice%2520with%2520Alzheimer%2520presenilin%25201%2520mutation%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2008%26volume%3D34%26spage%3D165%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref236"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref236'); return false;" data-citation="" class="refNumLink">236</a></strong><div class="NLM_citation" id="cit236"><span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E. S.</span><span> </span><span class="NLM_article-title">Coenzyme Q10 reduces beta-amyloid plaque in an APP/PS1 transgenic mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">J. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1007%2Fs12031-009-9297-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=19834824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs1OgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2010&pages=110-113&author=X.+Yangauthor=G.+Daiauthor=G.+Liauthor=E.+S.+Yang&title=Coenzyme+Q10+reduces+beta-amyloid+plaque+in+an+APP%2FPS1+transgenic+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit236R"><div class="casContent"><span class="casTitleNuber">236</span><div class="casTitle"><span class="NLM_cas:atitle">Coenzyme Q10 Reduces β-Amyloid Plaque in an APP/PS1 Transgenic Mouse Model of Alzheimer's Disease</span></div><div class="casAuthors">Yang, Xifei; Dai, George; Li, Geng; Yang, Edward S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">110-113</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We previously reported that coenzyme Q10 (CoQ10) could reduce intracellular deposition in an aged transgenic mouse model.  Here, we further tested the effect of CoQ10 on amyloid plaque in an amyloid precursor protein/presenilin 1 transgenic mouse model of Alzheimer's disease (AD).  By using immunohistochem. and magnetic resonance imaging to det. the burden of amyloid plaque, we found that oral administration of CoQ10 can efficiently reduce the burden of the plaques in this mouse model.  These data demonstrate that in addn. to reducing intracellular deposition of Aβ, CoQ10 can also reduce plaque pathol.  Our study further supports the use of CoQ10 as a therapeutic candidate for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDZAa6xs0F2bVg90H21EOLACvtfcHk0lisk_CNjMD11g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs1OgsLY%253D&md5=8a9458cf9d9758bf5f409e8f6767367c</span></div><a href="/servlet/linkout?suffix=cit236&amp;dbid=16384&amp;doi=10.1007%2Fs12031-009-9297-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12031-009-9297-1%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3DDai%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DE.%2BS.%26atitle%3DCoenzyme%2520Q10%2520reduces%2520beta-amyloid%2520plaque%2520in%2520an%2520APP%252FPS1%2520transgenic%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2010%26volume%3D41%26spage%3D110%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref237"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref237'); return false;" data-citation="" class="refNumLink">237</a></strong><div class="NLM_citation" id="cit237"><span><span class="NLM_contrib-group">Skulachev, V. P.</span><span> </span><span class="NLM_article-title">Mitochondria-targeted antioxidants as promising drugs for treatment of age-related brain diseases</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=21987592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVerur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2012&pages=283-289&author=V.+P.+Skulachev&title=Mitochondria-targeted+antioxidants+as+promising+drugs+for+treatment+of+age-related+brain+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit237R"><div class="casContent"><span class="casTitleNuber">237</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria-Targeted Antioxidants as Promising Drugs for Treatment of Age-Related Brain Diseases</span></div><div class="casAuthors">Skulachev, Vladimir P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">283-289</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Much exptl. evidence suggests that age-related brain pathologies are most often mediated by reactive oxygen species primarily originating from mitochondria (mROS).  Two papers with such evidence have been recently published in the Journal of Alzheimer's Disease (Stefanova et al., J Alzheimers Dis 21, 476-491, 2010; Lloret et al., J Alzheimers Dis, doi: 10.3233/JAD-2011-110890).  In the first paper, it was shown that appearance of a typical behavioral trait of aging in rats (that old animals do not enter an open arm in a maze) was completely reversed by ten weeks treatment of the old rats with the mitochondria-targeted antioxidant SkQ1.  In the second article, the authors identified mol. mechanisms by which amyloid-β-induced mROS can mediate hyperphosphorylation of the tau protein, a key event in Alzheimer's disease.  Conventional antioxidants prevented such hyperphosphorylation.  In this article, I will summarize the present state of the art in this field.  I conclude that mitochondria-targeted rechargeable antioxidants are promising as tools to treat brain pathologies developing in elderly humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp10YLEATJJV7Vg90H21EOLACvtfcHk0lisk_CNjMD11g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVerur0%253D&md5=e717a80140b4ad05752ca68cd6a71d6c</span></div><a href="/servlet/linkout?suffix=cit237&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkulachev%26aufirst%3DV.%2BP.%26atitle%3DMitochondria-targeted%2520antioxidants%2520as%2520promising%2520drugs%2520for%2520treatment%2520of%2520age-related%2520brain%2520diseases%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2012%26volume%3D28%26spage%3D283%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref238"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref238'); return false;" data-citation="" class="refNumLink">238</a></strong><div class="NLM_citation" id="cit238"><span><span class="NLM_contrib-group">Szeto, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiller, P. W.</span><span> </span><span class="NLM_article-title">Novel therapies targeting inner mitochondrial membrane—from discovery to clinical development</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">2669</span><span class="NLM_x">–</span> <span class="NLM_lpage">2679</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2011&pages=2669-2679&author=H.+H.+Szetoauthor=P.+W.+Schiller&title=Novel+therapies+targeting+inner+mitochondrial+membrane%E2%80%94from+discovery+to+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit238&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSzeto%26aufirst%3DH.%2BH.%26aulast%3DSchiller%26aufirst%3DP.%2BW.%26atitle%3DNovel%2520therapies%2520targeting%2520inner%2520mitochondrial%2520membrane%25E2%2580%2594from%2520discovery%2520to%2520clinical%2520development%26jtitle%3DPharm.%2520Res.%26date%3D2011%26volume%3D28%26spage%3D2669%26epage%3D2679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref239"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref239'); return false;" data-citation="" class="refNumLink">239</a></strong><div class="NLM_citation" id="cit239"><span><span class="NLM_contrib-group">Floyd, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensley, K.</span><span> </span><span class="NLM_article-title">Nitrone inhibition of age-associated oxidative damage</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">899</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=899&publication_year=2000&pages=222-237&author=R.+A.+Floydauthor=K.+Hensley&title=Nitrone+inhibition+of+age-associated+oxidative+damage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit239&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFloyd%26aufirst%3DR.%2BA.%26aulast%3DHensley%26aufirst%3DK.%26atitle%3DNitrone%2520inhibition%2520of%2520age-associated%2520oxidative%2520damage%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2000%26volume%3D899%26spage%3D222%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref240"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref240'); return false;" data-citation="" class="refNumLink">240</a></strong><div class="NLM_citation" id="cit240"><span><span class="NLM_contrib-group">Floyd, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bing, G.</span><span> </span><span class="NLM_article-title">Evidence for enhanced neuro-inflammatory processes in neurodegenerative diseases and the action of nitrones as potential therapeutics</span> <span class="citation_source-journal">J. Neural Transm., Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">414</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11205157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD3M3gt1Ohug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=387-414&author=R.+A.+Floydauthor=K.+Hensleyauthor=G.+Bing&title=Evidence+for+enhanced+neuro-inflammatory+processes+in+neurodegenerative+diseases+and+the+action+of+nitrones+as+potential+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit240R"><div class="casContent"><span class="casTitleNuber">240</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for enhanced neuro-inflammatory processes in neurodegenerative diseases and the action of nitrones as potential therapeutics</span></div><div class="casAuthors">Floyd R A; Hensley K; Bing G</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neural transmission. Supplementum</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">60</span>),
    <span class="NLM_cas:pages">387-414</span>
        ISSN:<span class="NLM_cas:issn">0303-6995</span>.
    </div><div class="casAbstract">A brief review is presented on observations leading to the current notions regarding neuro-inflammatory processes.  The greatest focus is on Alzheimer's disease (AD) since this is where the most convincing data has been obtained.  A brief summary of observations on the neuroprotective action of alpha-phenyl-tert-butyl-nitrone (PBN) as well as results of research designed to understand its mechanism of action is presented.  We hypothesize that the mechanism of action of PBN involves inhibition of signal transduction processes, which are involved in the upregulation of genes mediated by pro-inflammatory cytokines and H2O2 that cause formation of toxic gene products.  Results from recent experiments on Kainic acid (KA) mediated brain damage are provided to suggest the validity of the in vivo action of PBN to inhibit neuro-inflammatory processes.  The accumulating scientific facts are helping to provide concepts that may become the basis for novel therapeutic approaches to the treatment of several neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRj2Aw68nvLXQqdek-gHSrIfW6udTcc2eYaV18fk0lsILntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M3gt1Ohug%253D%253D&md5=3101c65abe629bf48c7b4b994ba108b6</span></div><a href="/servlet/linkout?suffix=cit240&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFloyd%26aufirst%3DR.%2BA.%26aulast%3DHensley%26aufirst%3DK.%26aulast%3DBing%26aufirst%3DG.%26atitle%3DEvidence%2520for%2520enhanced%2520neuro-inflammatory%2520processes%2520in%2520neurodegenerative%2520diseases%2520and%2520the%2520action%2520of%2520nitrones%2520as%2520potential%2520therapeutics%26jtitle%3DJ.%2520Neural%2520Transm.%252C%2520Suppl.%26date%3D2000%26spage%3D387%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref241"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref241'); return false;" data-citation="" class="refNumLink">241</a></strong><div class="NLM_citation" id="cit241"><span><span class="NLM_contrib-group">Das, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voss, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doseff, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villamena, F. A.</span><span> </span><span class="NLM_article-title">Inhibition of ROS-induced apoptosis in endothelial cells by nitrone spin traps via induction of phase II enzymes and suppression of mitochondria-dependent pro-apoptotic signaling</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=486-497&author=A.+Dasauthor=B.+Gopalakrishnanauthor=O.+H.+Vossauthor=A.+I.+Doseffauthor=F.+A.+Villamena&title=Inhibition+of+ROS-induced+apoptosis+in+endothelial+cells+by+nitrone+spin+traps+via+induction+of+phase+II+enzymes+and+suppression+of+mitochondria-dependent+pro-apoptotic+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit241&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DA.%26aulast%3DGopalakrishnan%26aufirst%3DB.%26aulast%3DVoss%26aufirst%3DO.%2BH.%26aulast%3DDoseff%26aufirst%3DA.%2BI.%26aulast%3DVillamena%26aufirst%3DF.%2BA.%26atitle%3DInhibition%2520of%2520ROS-induced%2520apoptosis%2520in%2520endothelial%2520cells%2520by%2520nitrone%2520spin%2520traps%2520via%2520induction%2520of%2520phase%2520II%2520enzymes%2520and%2520suppression%2520of%2520mitochondria-dependent%2520pro-apoptotic%2520signaling%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D84%26spage%3D486%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref242"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref242'); return false;" data-citation="" class="refNumLink">242</a></strong><div class="NLM_citation" id="cit242"><span><span class="NLM_contrib-group">Floyd, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffery, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maidt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, C.</span><span> </span><span class="NLM_article-title">Increased oxidative stress brought on by pro-inflammatory cytokines in neurodegenerative processes and the protective role of nitrone-based free radical traps</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1893</span><span class="NLM_x">–</span> <span class="NLM_lpage">1899</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1999&pages=1893-1899&author=R.+A.+Floydauthor=K.+Hensleyauthor=F.+Jafferyauthor=L.+Maidtauthor=K.+Robinsonauthor=Q.+Pyeauthor=C.+Stewart&title=Increased+oxidative+stress+brought+on+by+pro-inflammatory+cytokines+in+neurodegenerative+processes+and+the+protective+role+of+nitrone-based+free+radical+traps"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit242&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFloyd%26aufirst%3DR.%2BA.%26aulast%3DHensley%26aufirst%3DK.%26aulast%3DJaffery%26aufirst%3DF.%26aulast%3DMaidt%26aufirst%3DL.%26aulast%3DRobinson%26aufirst%3DK.%26aulast%3DPye%26aufirst%3DQ.%26aulast%3DStewart%26aufirst%3DC.%26atitle%3DIncreased%2520oxidative%2520stress%2520brought%2520on%2520by%2520pro-inflammatory%2520cytokines%2520in%2520neurodegenerative%2520processes%2520and%2520the%2520protective%2520role%2520of%2520nitrone-based%2520free%2520radical%2520traps%26jtitle%3DLife%2520Sci.%26date%3D1999%26volume%3D65%26spage%3D1893%26epage%3D1899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref243"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref243'); return false;" data-citation="" class="refNumLink">243</a></strong><div class="NLM_citation" id="cit243"><span><span class="NLM_contrib-group">Floyd, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forster, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelleher-Andersson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, P. L.</span><span> </span><span class="NLM_article-title">Nitrones, their value as therapeutics and probes to understand aging</span> <span class="citation_source-journal">Mech. Ageing Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1031</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0047-6374%2801%2900385-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12044951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD38XktFOls7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2002&pages=1021-1031&author=R.+A.+Floydauthor=K.+Hensleyauthor=M.+J.+Forsterauthor=J.+A.+Kelleher-Anderssonauthor=P.+L.+Wood&title=Nitrones%2C+their+value+as+therapeutics+and+probes+to+understand+aging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit243R"><div class="casContent"><span class="casTitleNuber">243</span><div class="casTitle"><span class="NLM_cas:atitle">Nitrones, their value as therapeutics and probes to understand aging</span></div><div class="casAuthors">Floyd, Robert A.; Hensley, Kenneth; Forster, Michael J.; Kelleher-Andersson, Judith A.; Wood, Paul L.</div><div class="citationInfo"><span class="NLM_cas:title">Mechanisms of Ageing and Development</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1021-1031</span>CODEN:
                <span class="NLM_cas:coden">MAGDA3</span>;
        ISSN:<span class="NLM_cas:issn">0047-6374</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  The nitrone-based free radical traps have significant potential in the treatment of neurodegenerative diseases as well as in the prolongation of life span.  The mass action free radical trapping activity of these compds. is the property, which first brought them to the attention of the scientific community.  Nevertheless extensive research has demonstrated that these reactions are not responsible for their therapeutic mechanistic basis of activity.  Rather the mechanism of action in the case of their neuroprotective activity appears to involve the inhibition of enhanced signal transduction processes that mediate the upregulation of genes, which produce neurotoxic products.  The most widely used compd. in this series, α-phenyl-tert-butyl-nitrone (PBN), has been shown to extend life span in three published studies, i.e. two mouse models and one rat model.  Significant prolongation of life span was noted in all three studies.  We report the summary of a recent study with a novel nitrone, CPI-1429, which demonstrated the ability to extend life span even though administration of the compd. was begun in older animals.  Despite these promising studies, much more rigorous research examg. the anti-aging activity of the nitrones needs to be conducted.  It is not known exactly why the nitrones possess anti-aging activity.  They have been shown to quell enhanced signal transduction processes assocd. with enhanced pro-inflammatory cytokine mediated events.  The nitrones interfere in some unknown steps preventing receptor triggered MAP kinase phosphorylation cascades.  Stabilization of phosphorylation networks assocd. with checkpoint proteins could slow cell cycle processes and this could be the basis of the nitrones anti-senescent activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplDsHg8sWik7Vg90H21EOLACvtfcHk0lgPdZm_t8dLQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktFOls7c%253D&md5=ced7eca28eafa53da1565d324a8ecc5d</span></div><a href="/servlet/linkout?suffix=cit243&amp;dbid=16384&amp;doi=10.1016%2FS0047-6374%2801%2900385-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0047-6374%252801%252900385-2%26sid%3Dliteratum%253Aachs%26aulast%3DFloyd%26aufirst%3DR.%2BA.%26aulast%3DHensley%26aufirst%3DK.%26aulast%3DForster%26aufirst%3DM.%2BJ.%26aulast%3DKelleher-Andersson%26aufirst%3DJ.%2BA.%26aulast%3DWood%26aufirst%3DP.%2BL.%26atitle%3DNitrones%252C%2520their%2520value%2520as%2520therapeutics%2520and%2520probes%2520to%2520understand%2520aging%26jtitle%3DMech.%2520Ageing%2520Dev.%26date%3D2002%26volume%3D123%26spage%3D1021%26epage%3D1031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref244"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref244'); return false;" data-citation="" class="refNumLink">244</a></strong><div class="NLM_citation" id="cit244"><span><span class="NLM_contrib-group">Shuaib, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyden, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davalos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diener, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasiewski, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emeribe, U.</span><span> </span><span class="NLM_article-title">NXY-059 for the treatment of acute ischemic stroke</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">562</span><span class="NLM_x">–</span> <span class="NLM_lpage">571</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1056%2FNEJMoa070240" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=17687131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptVSjsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2007&pages=562-571&author=A.+Shuaibauthor=K.+R.+Leesauthor=P.+Lydenauthor=J.+Grottaauthor=A.+Davalosauthor=S.+M.+Davisauthor=H.+C.+Dienerauthor=T.+Ashwoodauthor=W.+W.+Wasiewskiauthor=U.+Emeribe&title=NXY-059+for+the+treatment+of+acute+ischemic+stroke"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit244R"><div class="casContent"><span class="casTitleNuber">244</span><div class="casTitle"><span class="NLM_cas:atitle">NXY-059 for the treatment of acute ischemic stroke</span></div><div class="casAuthors">Shuaib, Ashfaq; Lees, Kennedy R.; Lyden, Patrick; Grotta, James; Davalos, Antonio; Davis, Stephen M.; Diener, Hans-Christoph; Ashwood, Tim; Wasiewski, Warren W.; Emeribe, Ugochi</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">562-571</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: The free-radical-trapping agent NXY-059 showed promise as a neuroprotectant in the Stroke-Acute Ischemic NXY Treatment I (SAINT I) trial, reducing disability when given to patients who had acute ischemic stroke.  We sought confirmation of efficacy in a second, larger trial.  Methods: We enrolled 3306 patients with acute ischemic stroke in a randomized, double-blind trial to receive a 72-h infusion of i.v. NXY-059 or placebo within 6 h after the. onset of stroke symptoms.  Our primary end point was the distribution of disability scores on the modified Rankin scale at 90 days.  We examd. scores on neurol. and activities-of-daily-living scales as secondary end points.  We also tested the hypothesis that NXY-059 would reduce alteplase-related intracranial hemorrhages.  Results: The efficacy anal. was based on 3195 patients.  Prognostic factors were well balanced between the treatment groups.  Mortality was equal in the two groups, and adverse-event rates were similar.  The distribution of scores on the modified Rankin scale did not differ between the group treated with NXY-059 (1588 patients) and the placebo group (1607 patients; P = 0.33 by the Cochran-Mantel-Haenszel test; odds ratio for limiting disability, 0.94; 95% confidence interval [CI], 0.83 to 1.06).  Anal. of categorized scores on the modified Rankin scale confirmed the lack of benefit: the odds ratio for trichotomization into modified Rankin scale scores of 0 to 1 vs. 2 to 3 vs. 4 to 6 was 0.92 (95% CI, 0.80 to 1.06).  There was no evidence of efficacy for any of the secondary end points.  Among patients treated with alteplase, there was no difference between the NXY-059 group and the placebo group in the frequency of symptomatic or asymptomatic hemorrhage.  Conclusions: NXY-059 is ineffective for the treatment of acute ischemic stroke within 6 h after the onset of symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF9Lz8mJUaG7Vg90H21EOLACvtfcHk0lgPdZm_t8dLQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptVSjsLc%253D&md5=4a249bb6f8aa45b485496c9c91bede82</span></div><a href="/servlet/linkout?suffix=cit244&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa070240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa070240%26sid%3Dliteratum%253Aachs%26aulast%3DShuaib%26aufirst%3DA.%26aulast%3DLees%26aufirst%3DK.%2BR.%26aulast%3DLyden%26aufirst%3DP.%26aulast%3DGrotta%26aufirst%3DJ.%26aulast%3DDavalos%26aufirst%3DA.%26aulast%3DDavis%26aufirst%3DS.%2BM.%26aulast%3DDiener%26aufirst%3DH.%2BC.%26aulast%3DAshwood%26aufirst%3DT.%26aulast%3DWasiewski%26aufirst%3DW.%2BW.%26aulast%3DEmeribe%26aufirst%3DU.%26atitle%3DNXY-059%2520for%2520the%2520treatment%2520of%2520acute%2520ischemic%2520stroke%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2007%26volume%3D357%26spage%3D562%26epage%3D571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref245"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref245'); return false;" data-citation="" class="refNumLink">245</a></strong><div class="NLM_citation" id="cit245"><span><span class="NLM_contrib-group">Klivenyi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wermer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacGarvey, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, M. F.</span><span> </span><span class="NLM_article-title">Azulenyl nitrone spin traps protect against MPTP neurotoxicity</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1006%2Fexnr.1998.6824" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=9682023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1cXlsFKrsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=1998&pages=163-166&author=P.+Klivenyiauthor=R.+T.+Matthewsauthor=M.+Wermerauthor=L.+Yangauthor=U.+MacGarveyauthor=D.+A.+Beckerauthor=R.+Nateroauthor=M.+F.+Beal&title=Azulenyl+nitrone+spin+traps+protect+against+MPTP+neurotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit245R"><div class="casContent"><span class="casTitleNuber">245</span><div class="casTitle"><span class="NLM_cas:atitle">Azulenyl nitrone spin traps protect against MPTP neurotoxicity</span></div><div class="casAuthors">Klivenyi, Peter; Matthews, Russell T.; Wermer, Marieke; Yang, Lichuan; MacGarvey, Usha; Becker, David A.; Natero, Reina; Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">163-166</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Azulenyl nitrones are a unique class of free radical spin-trapping compds.  The authors administered both a water-sol. and a lipid-sol. azulenyl nitrone to mice prior to administration of MPTP.  Both compds. produced significant neuroprotection against depletions of dopamine and its metabolites measured 1 wk after MPTP administration.  There were no effects on MPP+ levels.  These findings provide further evidence that free radical scavengers can produce significant neuroprotection against MPTP neurotoxicity.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroLtahi2GDibVg90H21EOLACvtfcHk0lhRshI8zyBHwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsFKrsrY%253D&md5=e34ca7e6871b4ba6ebe2268c61e1a892</span></div><a href="/servlet/linkout?suffix=cit245&amp;dbid=16384&amp;doi=10.1006%2Fexnr.1998.6824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexnr.1998.6824%26sid%3Dliteratum%253Aachs%26aulast%3DKlivenyi%26aufirst%3DP.%26aulast%3DMatthews%26aufirst%3DR.%2BT.%26aulast%3DWermer%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DMacGarvey%26aufirst%3DU.%26aulast%3DBecker%26aufirst%3DD.%2BA.%26aulast%3DNatero%26aufirst%3DR.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DAzulenyl%2520nitrone%2520spin%2520traps%2520protect%2520against%2520MPTP%2520neurotoxicity%26jtitle%3DExp.%2520Neurol.%26date%3D1998%26volume%3D152%26spage%3D163%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref246"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref246'); return false;" data-citation="" class="refNumLink">246</a></strong><div class="NLM_citation" id="cit246"><span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calingasan, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, M. F.</span><span> </span><span class="NLM_article-title">A novel azulenyl nitrone antioxidant protects against MPTP and 3-nitropropionic acid neurotoxicities</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.expneurol.2004.07.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=15589515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKltL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2005&pages=86-93&author=L.+Yangauthor=N.+Y.+Calingasanauthor=J.+Chenauthor=J.+J.+Leyauthor=D.+A.+Beckerauthor=M.+F.+Beal&title=A+novel+azulenyl+nitrone+antioxidant+protects+against+MPTP+and+3-nitropropionic+acid+neurotoxicities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit246R"><div class="casContent"><span class="casTitleNuber">246</span><div class="casTitle"><span class="NLM_cas:atitle">A novel azulenyl nitrone antioxidant protects against MPTP and 3-nitropropionic acid neurotoxicities</span></div><div class="casAuthors">Yang, Lichuan; Calingasan, Noel Y.; Chen, Junyu; Ley, James J.; Becker, David A.; Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">86-93</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Oxidative stress plays an important role in neuronal death in neurodegenerative disorders such as Parkinson's disease (PD) and Huntington's disease (HD).  Animal models of PD or HD, produced by administration of the mitochondrial toxins 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or 3-nitropropionic acid (3NP), resp., show increased free radical generation.  Free radicals generated in biol. systems can react with spin-trapping compds., such as nitrones, to form stable adducts.  In recent years, the utility of nitrones has moved beyond anal. applications and into the realm of neuroprotection as antioxidants in both brain ischemia and models of neurodegenerative diseases.  In the present study, we administered a new nitrone antioxidant, stilbazulenyl nitrone (STAZN), with either MPTP or 3NP.  STAZN attenuated MPTP-induced striatal dopamine depletion by 40% and showed a tendency to dose-dependent neuroprotection.  STAZN dose-dependently protected against loss of tyrosine hydroxylase immunoreactive neurons in the substantia nigra pars compacta.  STAZN reduced the striatal lesion vol. caused by systemic 3NP administration from 44 ± 9 to 20 ± 6 mm3.  The lipid peroxidn. marker, malondialdehyde(MDA), was significantly increased in the striatum, cortex, and cerebellum of rats after administration of 3NP.  These increases were blocked by co-injection of STAZN.  Our data provide further evidence that STAZN is a neuroprotective free radical spin trap, and suggest that the development of new antioxidants will broaden our therapeutic strategies for neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3f9FMQ2iaA7Vg90H21EOLACvtfcHk0lhRshI8zyBHwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKltL7M&md5=3e2db3bd5211d99799f3fc2464c68a10</span></div><a href="/servlet/linkout?suffix=cit246&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2004.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2004.07.012%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DCalingasan%26aufirst%3DN.%2BY.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLey%26aufirst%3DJ.%2BJ.%26aulast%3DBecker%26aufirst%3DD.%2BA.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DA%2520novel%2520azulenyl%2520nitrone%2520antioxidant%2520protects%2520against%2520MPTP%2520and%25203-nitropropionic%2520acid%2520neurotoxicities%26jtitle%3DExp.%2520Neurol.%26date%3D2005%26volume%3D191%26spage%3D86%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref247"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref247'); return false;" data-citation="" class="refNumLink">247</a></strong><div class="NLM_citation" id="cit247"><span><span class="NLM_contrib-group">Padayatty, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corpe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, M.</span><span> </span><span class="NLM_article-title">Vitamin C as an antioxidant: evaluation of its role in disease prevention</span> <span class="citation_source-journal">J. Am. Coll. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1080%2F07315724.2003.10719272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12569111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhs12isL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=18-35&author=S.+J.+Padayattyauthor=A.+Katzauthor=Y.+Wangauthor=P.+Eckauthor=O.+Kwonauthor=J.+H.+Leeauthor=S.+Chenauthor=C.+Corpeauthor=A.+Duttaauthor=S.+K.+Duttaauthor=M.+Levine&title=Vitamin+C+as+an+antioxidant%3A+evaluation+of+its+role+in+disease+prevention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit247R"><div class="casContent"><span class="casTitleNuber">247</span><div class="casTitle"><span class="NLM_cas:atitle">Vitamin C as an antioxidant: evaluation of its role in disease prevention</span></div><div class="casAuthors">Padayatty, Sebastian J.; Katz, Arie; Wang, Yaohui; Eck, Peter; Kwon, Oran; Lee, Je-Hyuk; Chen, Shenglin; Corpe, Christopher; Dutta, Anand; Dutta, Sudhir K.; Levine, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Nutrition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-35</span>CODEN:
                <span class="NLM_cas:coden">JONUDL</span>;
        ISSN:<span class="NLM_cas:issn">0731-5724</span>.
    
            (<span class="NLM_cas:orgname">American College of Nutrition</span>)
        </div><div class="casAbstract">A review.  Vitamin C in humans must be ingested for survival.  Vitamin C is an electron donor, and this property accounts for all its known functions.  As an electron donor, vitamin C is a potent water-sol. antioxidant in humans.  Antioxidant effects of vitamin C were demonstrated in many expts. in vitro.  Human diseases such as atherosclerosis and cancer might occur in part from oxidant damage to tissues.  Oxidn. of lipids, proteins and DNA results in specific oxidn. products that can be measured in the lab.  While these biomarkers of oxidn. were measured in humans such assays have not yet been validated or standardized and the relationship of oxidant markers to human disease conditions is not clear.  Epidemiol. studies show that diets high in fruits and vegetables are assocd. with lower risk of cardiovascular disease, stroke and cancer, and with increased longevity.  Whether these protective effects are directly attributable to vitamin C is not known.  Intervention studies with vitamin C have shown no change in markers of oxidn. or clin. benefit.  Dose concn. studies of vitamin C in healthy people showed a sigmoidal relationship between oral dose and plasma and tissue vitamin C concns.  Hence, optimal dosing is crit. to intervention studies using vitamin C.  Ideally, future studies of antioxidant actions of vitamin C should target selected patient groups.  These groups should be known to have increased oxidative damage as assessed by a reliable biomarker or should have high morbidity and mortality due to diseases thought to be caused or exacerbated by oxidant damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk1Rk3zu39_bVg90H21EOLACvtfcHk0lhRshI8zyBHwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhs12isL0%253D&md5=d6022179b92e8eb38cbc96072db55298</span></div><a href="/servlet/linkout?suffix=cit247&amp;dbid=16384&amp;doi=10.1080%2F07315724.2003.10719272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07315724.2003.10719272%26sid%3Dliteratum%253Aachs%26aulast%3DPadayatty%26aufirst%3DS.%2BJ.%26aulast%3DKatz%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DEck%26aufirst%3DP.%26aulast%3DKwon%26aufirst%3DO.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DCorpe%26aufirst%3DC.%26aulast%3DDutta%26aufirst%3DA.%26aulast%3DDutta%26aufirst%3DS.%2BK.%26aulast%3DLevine%26aufirst%3DM.%26atitle%3DVitamin%2520C%2520as%2520an%2520antioxidant%253A%2520evaluation%2520of%2520its%2520role%2520in%2520disease%2520prevention%26jtitle%3DJ.%2520Am.%2520Coll.%2520Nutr.%26date%3D2003%26volume%3D22%26spage%3D18%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref248"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref248'); return false;" data-citation="" class="refNumLink">248</a></strong><div class="NLM_citation" id="cit248"><span><span class="NLM_contrib-group">Dringen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamprecht, B.</span><span> </span><span class="NLM_article-title">Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">562</span><span class="NLM_x">–</span> <span class="NLM_lpage">569</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1523%2FJNEUROSCI.19-02-00562.1999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=9880576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1MXltlagtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=562-569&author=R.+Dringenauthor=B.+Pfeifferauthor=B.+Hamprecht&title=Synthesis+of+the+antioxidant+glutathione+in+neurons%3A+supply+by+astrocytes+of+CysGly+as+precursor+for+neuronal+glutathione"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit248R"><div class="casContent"><span class="casTitleNuber">248</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione</span></div><div class="casAuthors">Dringen, Ralf; Pfeiffer, Brigitte; Hamprecht, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">562-569</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Deficiency of the antioxidant glutathione in brain appears to be connected with several diseases characterized by neuronal loss.  To study neuronal glutathione metab. and metabolic interactions between neurons and astrocytes in this respect, neuron-rich primary cultures and transient cocultures of neurons and astroglial cells were used.  Coincubation of neurons with astroglial cells resulted within 24 h of incubation in a neuronal glutathione content twice that of neurons incubated in the absence of astroglial cells.  In cultured neurons, the availability of cysteine limited the cellular level of glutathione.  During a 4 h incubation in a minimal medium lacking all amino acids except cysteine, the amt. of neuronal glutathione was doubled.  Besides cysteine, also the dipeptides CysGly and γGluCys were able to serve as glutathione precursors and caused a concn.-dependent increase in glutathione content.  Concns. giving half-maximal effects were 5, 5, and 200 μM for cysteine, CysGly, and γGluCys, resp.  In the transient cocultures, the astroglia-mediated increase in neuronal glutathione was suppressed by acivicin, an inhibitor of the astroglial ectoenzyme γ-glutamyl transpeptidase, which generates CysGly from glutathione.  These data suggest the following metabolic interaction in glutathione metab. of brain cells: the ectoenzyme γ-glutamyl transpeptidase uses as substrate the glutathione released by astrocytes to generate the dipeptide CysGly that is subsequently used by neurons as precursor for glutathione synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoroZ8fOfsF-bVg90H21EOLACvtfcHk0lgCV2Xms5h_cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltlagtA%253D%253D&md5=7366ee20452ce0d555e27926a5b56729</span></div><a href="/servlet/linkout?suffix=cit248&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.19-02-00562.1999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.19-02-00562.1999%26sid%3Dliteratum%253Aachs%26aulast%3DDringen%26aufirst%3DR.%26aulast%3DPfeiffer%26aufirst%3DB.%26aulast%3DHamprecht%26aufirst%3DB.%26atitle%3DSynthesis%2520of%2520the%2520antioxidant%2520glutathione%2520in%2520neurons%253A%2520supply%2520by%2520astrocytes%2520of%2520CysGly%2520as%2520precursor%2520for%2520neuronal%2520glutathione%26jtitle%3DJ.%2520Neurosci.%26date%3D1999%26volume%3D19%26spage%3D562%26epage%3D569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref249"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref249'); return false;" data-citation="" class="refNumLink">249</a></strong><div class="NLM_citation" id="cit249"><span><span class="NLM_contrib-group">Dringen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamprecht, B.</span><span> </span><span class="NLM_article-title"><i>N</i>-Acetylcysteine, but not methionine or 2-oxothiazolidine-4-carboxylate, serves as cysteine donor for the synthesis of glutathione in cultured neurons derived from embryonal rat brain</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">259</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=259&publication_year=1999&pages=79-82&author=R.+Dringenauthor=B.+Hamprecht&title=N-Acetylcysteine%2C+but+not+methionine+or+2-oxothiazolidine-4-carboxylate%2C+serves+as+cysteine+donor+for+the+synthesis+of+glutathione+in+cultured+neurons+derived+from+embryonal+rat+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit249&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDringen%26aufirst%3DR.%26aulast%3DHamprecht%26aufirst%3DB.%26atitle%3DN-Acetylcysteine%252C%2520but%2520not%2520methionine%2520or%25202-oxothiazolidine-4-carboxylate%252C%2520serves%2520as%2520cysteine%2520donor%2520for%2520the%2520synthesis%2520of%2520glutathione%2520in%2520cultured%2520neurons%2520derived%2520from%2520embryonal%2520rat%2520brain%26jtitle%3DNeurosci.%2520Lett.%26date%3D1999%26volume%3D259%26spage%3D79%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref250"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref250'); return false;" data-citation="" class="refNumLink">250</a></strong><div class="NLM_citation" id="cit250"><span><span class="NLM_contrib-group">Cudkowicz, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayden, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwilt, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whalen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. H.,  Jr.</span><span> </span><span class="NLM_article-title">The pharmacokinetics and pharmaco-dynamics of procysteine in amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1492</span><span class="NLM_x">–</span> <span class="NLM_lpage">1494</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=1492-1494&author=M.+E.+Cudkowiczauthor=P.+M.+Sextonauthor=T.+Ellisauthor=D.+L.+Haydenauthor=P.+R.+Gwiltauthor=J.+Whalenauthor=R.+H.+Brown&title=The+pharmacokinetics+and+pharmaco-dynamics+of+procysteine+in+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit250&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCudkowicz%26aufirst%3DM.%2BE.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DEllis%26aufirst%3DT.%26aulast%3DHayden%26aufirst%3DD.%2BL.%26aulast%3DGwilt%26aufirst%3DP.%2BR.%26aulast%3DWhalen%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DR.%2BH.%26atitle%3DThe%2520pharmacokinetics%2520and%2520pharmaco-dynamics%2520of%2520procysteine%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DNeurology%26date%3D1999%26volume%3D52%26spage%3D1492%26epage%3D1494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref251"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref251'); return false;" data-citation="" class="refNumLink">251</a></strong><div class="NLM_citation" id="cit251"><span><span class="NLM_contrib-group">Dinkova-Kostova, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtzclaw, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakabayashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talalay, P.</span><span> </span><span class="NLM_article-title">Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">11908</span><span class="NLM_x">–</span> <span class="NLM_lpage">11913</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1073%2Fpnas.172398899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12193649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD38XntFWqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=11908-11913&author=A.+T.+Dinkova-Kostovaauthor=W.+D.+Holtzclawauthor=R.+N.+Coleauthor=K.+Itohauthor=N.+Wakabayashiauthor=Y.+Katohauthor=M.+Yamamotoauthor=P.+Talalay&title=Direct+evidence+that+sulfhydryl+groups+of+Keap1+are+the+sensors+regulating+induction+of+phase+2+enzymes+that+protect+against+carcinogens+and+oxidants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit251R"><div class="casContent"><span class="casTitleNuber">251</span><div class="casTitle"><span class="NLM_cas:atitle">Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants</span></div><div class="casAuthors">Dinkova-Kostova, Albena T.; Holtzclaw, W. David; Cole, Robert N.; Itoh, Ken; Wakabayashi, Nobunao; Katoh, Yasutake; Yamamoto, Masayuki; Talalay, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">11908-11913</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Coordinate induction of phase 2 proteins and elevation of glutathione protect cells against the toxic and carcinogenic effects of electrophiles and oxidants.  All inducers react covalently with thiols at rates that are closely related to their potencies.  Inducers disrupt the cytoplasmic complex between the actin-bound protein Keap1 and the transcription factor Nrf2, thereby releasing Nrf2 to migrate to the nucleus where it activates the antioxidant response element (ARE) of phase 2 genes and accelerates their transcription.  We cloned, overexpressed, and purified murine Keap1 and demonstrated on native gels the formation of complexes of Keap1 with the Neh2 domain of Nrf2 and their concn.-dependent disruption by inducers such as sulforaphane and bis(2-hydroxybenzylidene)acetone.  The kinetics, stoichiometry, and order of reactivities of the most reactive of the 25 cysteine thiol groups of Keap1 have been detd. by tritium incorporation from [3H]dexamethasone mesylate (an inducer and irreversible modifier of thiols) and by UV spectroscopy with sulforaphane, 2,2'-dipyridyl disulfide and 4,4'-dipyridyl disulfide (titrants of thiol groups), and two closely related Michael reaction acceptors [bis(2- and 4-hydroxybenzylidene)acetones] that differ 100-fold in inducer potency and the UV spectra of which are bleached by thiol addn.  With large excesses of these reagents nearly all thiols of Keap1 react, but sequential reaction with three successive single equiv. (per cysteine residue) of dipyridyl disulfides revealed excellent agreement with pseudo-first order kinetics, rapid successive declines in reaction velocity, and the stoichiometric formation of two equiv. of thiopyridone per reacted cysteine.  This finding suggests that reaction of cysteine thiols is followed by rapid formation of protein disulfide linkages.  The most reactive residues of Keap1 (C257, C273, C288, and C297) were identified by mapping the dexamethasone-modified cysteines by mass spectrometry of tryptic peptides.  These residues are located in the intervening region between BTB and Kelch repeat domains of Keap1 and probably are the direct sensors of inducers of the phase 2 system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAg7V1wdZgxLVg90H21EOLACvtfcHk0lgCV2Xms5h_cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntFWqtb0%253D&md5=83a3b1b0549cf21153805e9c04f36620</span></div><a href="/servlet/linkout?suffix=cit251&amp;dbid=16384&amp;doi=10.1073%2Fpnas.172398899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.172398899%26sid%3Dliteratum%253Aachs%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DHoltzclaw%26aufirst%3DW.%2BD.%26aulast%3DCole%26aufirst%3DR.%2BN.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DWakabayashi%26aufirst%3DN.%26aulast%3DKatoh%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DTalalay%26aufirst%3DP.%26atitle%3DDirect%2520evidence%2520that%2520sulfhydryl%2520groups%2520of%2520Keap1%2520are%2520the%2520sensors%2520regulating%2520induction%2520of%2520phase%25202%2520enzymes%2520that%2520protect%2520against%2520carcinogens%2520and%2520oxidants%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D11908%26epage%3D11913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref252"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref252'); return false;" data-citation="" class="refNumLink">252</a></strong><div class="NLM_citation" id="cit252"><span><span class="NLM_contrib-group">Surh, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kundu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Na, H. K.</span><span> </span><span class="NLM_article-title">Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals</span> <span class="citation_source-journal">Planta Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1526</span><span class="NLM_x">–</span> <span class="NLM_lpage">1539</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2008&pages=1526-1539&author=Y.+J.+Surhauthor=J.+K.+Kunduauthor=H.+K.+Na&title=Nrf2+as+a+master+redox+switch+in+turning+on+the+cellular+signaling+involved+in+the+induction+of+cytoprotective+genes+by+some+chemopreventive+phytochemicals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit252&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSurh%26aufirst%3DY.%2BJ.%26aulast%3DKundu%26aufirst%3DJ.%2BK.%26aulast%3DNa%26aufirst%3DH.%2BK.%26atitle%3DNrf2%2520as%2520a%2520master%2520redox%2520switch%2520in%2520turning%2520on%2520the%2520cellular%2520signaling%2520involved%2520in%2520the%2520induction%2520of%2520cytoprotective%2520genes%2520by%2520some%2520chemopreventive%2520phytochemicals%26jtitle%3DPlanta%2520Med.%26date%3D2008%26volume%3D74%26spage%3D1526%26epage%3D1539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref253"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref253'); return false;" data-citation="" class="refNumLink">253</a></strong><div class="NLM_citation" id="cit253"><span><span class="NLM_contrib-group">Magesh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L. Q.</span><span> </span><span class="NLM_article-title">Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1002%2Fmed.21257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=22549716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVegsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=687-726&author=S.+Mageshauthor=Y.+Chenauthor=L.+Q.+Hu&title=Small+molecule+modulators+of+Keap1-Nrf2-ARE+pathway+as+potential+preventive+and+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit253R"><div class="casContent"><span class="casTitleNuber">253</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Modulators of Keap1-Nrf2-ARE Pathway as Potential Preventive and Therapeutic Agents</span></div><div class="casAuthors">Magesh, Sadagopan; Chen, Yu; Hu, Longqin</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">687-726</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Kelch-like ECH-assocd. protein 1 (Keap1)-nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response elements (ARE) pathway represents one of the most important cellular defense mechanisms against oxidative stress and xenobiotic damage.  Activation of Nrf2 signaling induces the transcriptional regulation of ARE-dependent expression of various detoxifying and antioxidant defense enzymes and proteins.  Keap1-Nrf2-ARE signaling has become an attractive target for the prevention and treatment of oxidative stress-related diseases and conditions including cancer, neurodegenerative, cardiovascular, metabolic, and inflammatory diseases.  Over the last few decades, numerous Nrf2 inducers have been developed and some of them are currently undergoing clin. trials.  Recently, overactivation of Nrf2 has been implicated in cancer progression as well as in drug resistance to cancer chemotherapy.  Thus, Nrf2 inhibitors could potentially be used to improve the effectiveness of cancer therapy.  Herein, we review the signaling mechanism of Keap1-Nrf2-ARE pathway, its disease relevance, and currently known classes of small mol. modulators.  We also discuss several aspects of Keap1-Nrf2 interaction, Nrf2-based peptide inhibitor design, and the screening assays currently used for the discovery of direct inhibitors of Keap1-Nrf2 interaction. © 2012 Wiley Periodicals, Inc.  Med Res Rev., 32, No. 4, 687-726, 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhLmdkuTSh7Vg90H21EOLACvtfcHk0limn-5ImoE2gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVegsrw%253D&md5=2104d731cb251e0d9b6d2ad73a735175</span></div><a href="/servlet/linkout?suffix=cit253&amp;dbid=16384&amp;doi=10.1002%2Fmed.21257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21257%26sid%3Dliteratum%253Aachs%26aulast%3DMagesh%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DL.%2BQ.%26atitle%3DSmall%2520molecule%2520modulators%2520of%2520Keap1-Nrf2-ARE%2520pathway%2520as%2520potential%2520preventive%2520and%2520therapeutic%2520agents%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2012%26volume%3D32%26spage%3D687%26epage%3D726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref254"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref254'); return false;" data-citation="" class="refNumLink">254</a></strong><div class="NLM_citation" id="cit254"><span><span class="NLM_contrib-group">Calkins, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowell, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraft, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. A.</span><span> </span><span class="NLM_article-title">The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease</span> <span class="citation_source-journal">Antioxid. Redox Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">497</span><span class="NLM_x">–</span> <span class="NLM_lpage">508</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1089%2Fars.2008.2242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=18717629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=497-508&author=M.+J.+Calkinsauthor=D.+A.+Johnsonauthor=J.+A.+Townsendauthor=M.+R.+Vargasauthor=J.+A.+Dowellauthor=T.+P.+Williamsonauthor=A.+D.+Kraftauthor=J.+M.+Leeauthor=J.+Liauthor=J.+A.+Johnson&title=The+Nrf2%2FARE+pathway+as+a+potential+therapeutic+target+in+neurodegenerative+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit254R"><div class="casContent"><span class="casTitleNuber">254</span><div class="casTitle"><span class="NLM_cas:atitle">The Nrf2/ARE Pathway as a Potential Therapeutic Target in Neurodegenerative Disease</span></div><div class="casAuthors">Calkins, Marcus J.; Johnson, Delinda A.; Townsend, Jessica A.; Vargas, Marcelo R.; Dowell, James A.; Williamson, Tracy P.; Kraft, Andrew D.; Lee, Jong-Min; Li, Jiang; Johnson, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">497-508</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Nuclear factor E2-related factor 2 (Nrf2) is a transcription factor known to induce expression of a variety of cytoprotective and detoxification genes.  Several of the genes commonly regulated by Nrf2 have been implicated in protection from neurodegenerative conditions.  Work from several labs. has uncovered the potential for Nrf2-mediated transcription to protect from neurodegeneration resulting from mechanisms involving oxidative stress.  For this reason, Nrf2 may be considered a therapeutic target for conditions that are known to involve free radical damage.  Because common mechanisms of neurodegeneration, such as mitochondrial dysfunction and build-up of reactive oxygen species, are currently being uncovered, targeting Nrf2 may be valuable in combating conditions with variable causes and etiologies.  Most effectively to target this protein in neurodegenerative conditions, a description of the involvement of Nrf2 and potential for neuroprotection must come from lab. models.  Herein, we review the current literature that suggests that Nrf2 may be a valuable therapeutic target for neurodegenerative disease, as well as expts. that illustrate potential mechanisms of protection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR_DaElYFTArVg90H21EOLACvtfcHk0limn-5ImoE2gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOrtLg%253D&md5=7d96372e6c308f88810c8b03bb9f3dd3</span></div><a href="/servlet/linkout?suffix=cit254&amp;dbid=16384&amp;doi=10.1089%2Fars.2008.2242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2008.2242%26sid%3Dliteratum%253Aachs%26aulast%3DCalkins%26aufirst%3DM.%2BJ.%26aulast%3DJohnson%26aufirst%3DD.%2BA.%26aulast%3DTownsend%26aufirst%3DJ.%2BA.%26aulast%3DVargas%26aufirst%3DM.%2BR.%26aulast%3DDowell%26aufirst%3DJ.%2BA.%26aulast%3DWilliamson%26aufirst%3DT.%2BP.%26aulast%3DKraft%26aufirst%3DA.%2BD.%26aulast%3DLee%26aufirst%3DJ.%2BM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520Nrf2%252FARE%2520pathway%2520as%2520a%2520potential%2520therapeutic%2520target%2520in%2520neurodegenerative%2520disease%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2009%26volume%3D11%26spage%3D497%26epage%3D508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref255"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref255'); return false;" data-citation="" class="refNumLink">255</a></strong><div class="NLM_citation" id="cit255"><span><span class="NLM_contrib-group">Jung, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, M. K.</span><span> </span><span class="NLM_article-title">The Nrf2 system as a potential target for the development of indirect antioxidants</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">7266</span><span class="NLM_x">–</span> <span class="NLM_lpage">7291</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=7266-7291&author=K.+A.+Jungauthor=M.+K.+Kwak&title=The+Nrf2+system+as+a+potential+target+for+the+development+of+indirect+antioxidants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit255&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DK.%2BA.%26aulast%3DKwak%26aufirst%3DM.%2BK.%26atitle%3DThe%2520Nrf2%2520system%2520as%2520a%2520potential%2520target%2520for%2520the%2520development%2520of%2520indirect%2520antioxidants%26jtitle%3DMolecules%26date%3D2010%26volume%3D15%26spage%3D7266%26epage%3D7291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref256"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref256'); return false;" data-citation="" class="refNumLink">256</a></strong><div class="NLM_citation" id="cit256"><span><span class="NLM_contrib-group">Vargas, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pehar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassina, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbeito, L.</span><span> </span><span class="NLM_article-title">Increased glutathione biosynthesis by Nrf2 activation in astrocytes prevents p75(NTR)-dependent motor neuron apoptosis</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">696</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1111%2Fj.1471-4159.2006.03742.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=16524372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslCjsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2006&pages=687-696&author=M.+R.+Vargasauthor=M.+Peharauthor=P.+Cassinaauthor=J.+S.+Beckmanauthor=L.+Barbeito&title=Increased+glutathione+biosynthesis+by+Nrf2+activation+in+astrocytes+prevents+p75%28NTR%29-dependent+motor+neuron+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit256R"><div class="casContent"><span class="casTitleNuber">256</span><div class="casTitle"><span class="NLM_cas:atitle">Increased glutathione biosynthesis by Nrf2 activation in astrocytes prevents p75NTR-dependent motor neuron apoptosis</span></div><div class="casAuthors">Vargas, Marcelo R.; Pehar, Mariana; Cassina, Patricia; Beckman, Joseph S.; Barbeito, Luis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">687-696</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Astrocytes may modulate the survival of motor neurons in amyotrophic lateral sclerosis (ALS).  We have previously shown that fibroblast growth factor-1 (FGF-1) activates astrocytes to increase secretion of nerve growth factor (NGF).  NGF in turn induces apoptosis in co-cultured motor neurons expressing the p75 neurotrophin receptor (p75NTR) by a mechanism involving nitric oxide (NO) and peroxynitrite formation.  We show here that FGF-1 increased the expression of inducible nitric oxide synthase and NO prodn. in astrocytes, making adjacent motor neurons vulnerable to NGF-induced apoptosis.  Spinal cord astrocytes isolated from transgenic SOD1G93A rats displayed increased NO prodn. and spontaneously induced apoptosis of co-cultured motor neurons.  FGF-1 also activates the redox-sensitive transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) in astrocytes.  Because Nrf2 increases glutathione (GSH) biosynthesis, we investigated the role of GSH prodn. by astrocytes on p75NTR-dependent motor neuron apoptosis.  The combined treatment of astrocytes with FGF-1 and t-butylhydroquinone (tBHQ) increased GSH prodn. and secretion, preventing motor neuron apoptosis.  Moreover, Nrf2 activation in SOD1G93A astrocytes abolished their apoptotic activity.  The protection exerted by increased Nrf2 activity was overcome by adding the NO donor DETA-NONOate to the co-cultures or by inhibiting GSH synthesis and release from astrocytes.  These results suggest that activation of Nrf2 in astrocytes can reduce NO-dependent toxicity to motor neurons by increasing GSH biosynthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI9qGU4JROsrVg90H21EOLACvtfcHk0limn-5ImoE2gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslCjsrk%253D&md5=d3a252123e5b1823aa4bc518e8edd693</span></div><a href="/servlet/linkout?suffix=cit256&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.03742.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.03742.x%26sid%3Dliteratum%253Aachs%26aulast%3DVargas%26aufirst%3DM.%2BR.%26aulast%3DPehar%26aufirst%3DM.%26aulast%3DCassina%26aufirst%3DP.%26aulast%3DBeckman%26aufirst%3DJ.%2BS.%26aulast%3DBarbeito%26aufirst%3DL.%26atitle%3DIncreased%2520glutathione%2520biosynthesis%2520by%2520Nrf2%2520activation%2520in%2520astrocytes%2520prevents%2520p75%2528NTR%2529-dependent%2520motor%2520neuron%2520apoptosis%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D97%26spage%3D687%26epage%3D696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref257"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref257'); return false;" data-citation="" class="refNumLink">257</a></strong><div class="NLM_citation" id="cit257"><span><span class="NLM_contrib-group">Kirby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halligan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baptista, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heath, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holden, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barber, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loynes, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood-Allum, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunec, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, P. J.</span><span> </span><span class="NLM_article-title">Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">1686</span><span class="NLM_x">–</span> <span class="NLM_lpage">1706</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2005&pages=1686-1706&author=J.+Kirbyauthor=E.+Halliganauthor=M.+J.+Baptistaauthor=S.+Allenauthor=P.+R.+Heathauthor=H.+Holdenauthor=S.+C.+Barberauthor=C.+A.+Loynesauthor=C.+A.+Wood-Allumauthor=J.+Lunecauthor=P.+J.+Shaw&title=Mutant+SOD1+alters+the+motor+neuronal+transcriptome%3A+implications+for+familial+ALS"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit257&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKirby%26aufirst%3DJ.%26aulast%3DHalligan%26aufirst%3DE.%26aulast%3DBaptista%26aufirst%3DM.%2BJ.%26aulast%3DAllen%26aufirst%3DS.%26aulast%3DHeath%26aufirst%3DP.%2BR.%26aulast%3DHolden%26aufirst%3DH.%26aulast%3DBarber%26aufirst%3DS.%2BC.%26aulast%3DLoynes%26aufirst%3DC.%2BA.%26aulast%3DWood-Allum%26aufirst%3DC.%2BA.%26aulast%3DLunec%26aufirst%3DJ.%26aulast%3DShaw%26aufirst%3DP.%2BJ.%26atitle%3DMutant%2520SOD1%2520alters%2520the%2520motor%2520neuronal%2520transcriptome%253A%2520implications%2520for%2520familial%2520ALS%26jtitle%3DBrain%26date%3D2005%26volume%3D128%26spage%3D1686%26epage%3D1706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref258"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref258'); return false;" data-citation="" class="refNumLink">258</a></strong><div class="NLM_citation" id="cit258"><span><span class="NLM_contrib-group">Trinh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wes, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchowski, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallanck, L. J.</span><span> </span><span class="NLM_article-title">Induction of the phase II detoxification pathway suppresses neuron loss in <i>Drosophila</i> models of Parkinson’s disease</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1523%2FJNEUROSCI.4778-07.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=18184789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252Fit1Gksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=465-472&author=K.+Trinhauthor=K.+Mooreauthor=P.+D.+Wesauthor=P.+J.+Muchowskiauthor=J.+Deyauthor=L.+Andrewsauthor=L.+J.+Pallanck&title=Induction+of+the+phase+II+detoxification+pathway+suppresses+neuron+loss+in+Drosophila+models+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit258R"><div class="casContent"><span class="casTitleNuber">258</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of the phase II detoxification pathway suppresses neuron loss in Drosophila models of Parkinson's disease</span></div><div class="casAuthors">Trinh Kien; Moore Katherine; Wes Paul D; Muchowski Paul J; Dey Joyoti; Andrews Laurie; Pallanck Leo J</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of neuroscience : the official journal of the Society for Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">465-72</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alpha-synuclein aggregates are a common feature of sporadic Parkinson's disease (PD), and mutations that increase alpha-synuclein abundance confer rare heritable forms of PD.  Although these findings suggest that alpha-synuclein plays a central role in the pathogenesis of this disorder, little is known of the mechanism by which alpha-synuclein promotes neuron loss or the factors that regulate alpha-synuclein toxicity.  To address these matters, we tested candidate modifiers of alpha-synuclein toxicity using a Drosophila model of PD.  In the current work, we focused on phase II detoxification enzymes involved in glutathione metabolism.  We find that the neuronal death accompanying alpha-synuclein expression in Drosophila is enhanced by loss-of-function mutations in genes that promote glutathione synthesis and glutathione conjugation.  This neuronal loss can be overcome by genetic or pharmacological interventions that increase glutathione synthesis or glutathione conjugation activity.  Moreover, these same pharmacological agents suppress neuron loss in Drosophila parkin mutants, a loss-of-function model of PD.  Our results suggest that oxidative stress is a feature of alpha-synuclein toxicity and that induction of the phase II detoxification pathway represents a potential preventative therapy for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQif2_pEJNWVkEgZCMqtRBifW6udTcc2eZXvmCFL-0Xr7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252Fit1Gksw%253D%253D&md5=1b31c42a2249f5bc433e546d5ce52c20</span></div><a href="/servlet/linkout?suffix=cit258&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4778-07.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4778-07.2008%26sid%3Dliteratum%253Aachs%26aulast%3DTrinh%26aufirst%3DK.%26aulast%3DMoore%26aufirst%3DK.%26aulast%3DWes%26aufirst%3DP.%2BD.%26aulast%3DMuchowski%26aufirst%3DP.%2BJ.%26aulast%3DDey%26aufirst%3DJ.%26aulast%3DAndrews%26aufirst%3DL.%26aulast%3DPallanck%26aufirst%3DL.%2BJ.%26atitle%3DInduction%2520of%2520the%2520phase%2520II%2520detoxification%2520pathway%2520suppresses%2520neuron%2520loss%2520in%2520Drosophila%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D2008%26volume%3D28%26spage%3D465%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref259"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref259'); return false;" data-citation="" class="refNumLink">259</a></strong><div class="NLM_citation" id="cit259"><span><span class="NLM_contrib-group">Ramsey, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindl, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritson, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chia, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan-Sciutto, K. L.</span><span> </span><span class="NLM_article-title">Expression of Nrf2 in neurodegenerative diseases</span> <span class="citation_source-journal">J. Neuropathol. Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1097%2Fnen.0b013e31802d6da9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=17204939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsV2qtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2007&pages=75-85&author=C.+P.+Ramseyauthor=C.+A.+Glassauthor=M.+B.+Montgomeryauthor=K.+A.+Lindlauthor=G.+P.+Ritsonauthor=L.+A.+Chiaauthor=R.+L.+Hamiltonauthor=C.+T.+Chuauthor=K.+L.+Jordan-Sciutto&title=Expression+of+Nrf2+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit259R"><div class="casContent"><span class="casTitleNuber">259</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of Nrf2 in neurodegenerative diseases</span></div><div class="casAuthors">Ramsey, Chenere P.; Glass, Charles A.; Montgomery, Marshall B.; Lindl, Kathryn A.; Ritson, Gillian P.; Chia, Luis A.; Hamilton, Ronald L.; Chu, Charleen T.; Jordan-Sciutto, Kelly L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuropathology & Experimental Neurology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-85</span>CODEN:
                <span class="NLM_cas:coden">JNENAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">In response to oxidative stress, the nuclear factor E2-related factor 2 (Nrf2) transcription factor translocates from the cytoplasm into the nucleus and transactivates expression of genes with antioxidant activity.  Despite this cellular mechanism, oxidative damage is abundant in Alzheimer and Parkinson disease (AD and PD).  To investigate mechanisms by which Nrf2 activity may be aberrant or insufficient in neurodegenerative conditions, we assessed Nrf2 localization in affected brain regions of AD, Lewy body variant of AD (LBVAD), and PD.  By immunohistochem., Nrf2 is expressed in both the nucleus and the cytoplasm of neurons in normal hippocampi with predominant expression in the nucleus.  In AD and LBVAD, Nrf2 was predominantly cytoplasmic in hippocampal neurons and was not a major component of beta amyloid plaques or neurofibrillary tangles.  By immunoblotting, we obsd. a significant decrease in nuclear Nrf2 levels in AD cases.  In contrast, Nrf2 was strongly nuclear in PD nigral neurons but cytoplasmic in substantia nigra of normal, AD, and LBVAD cases.  These findings suggest that Nrf2-mediated transcription is not induced in neurons in AD despite the presence of oxidative stress.  In PD, nuclear localization of Nrf2 is strongly induced, but this response may be insufficient to protect neurons from degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxUT2O_7i7C7Vg90H21EOLACvtfcHk0liJL0j64UxGbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsV2qtb4%253D&md5=af62d8ddc814ca4272250cf815366674</span></div><a href="/servlet/linkout?suffix=cit259&amp;dbid=16384&amp;doi=10.1097%2Fnen.0b013e31802d6da9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252Fnen.0b013e31802d6da9%26sid%3Dliteratum%253Aachs%26aulast%3DRamsey%26aufirst%3DC.%2BP.%26aulast%3DGlass%26aufirst%3DC.%2BA.%26aulast%3DMontgomery%26aufirst%3DM.%2BB.%26aulast%3DLindl%26aufirst%3DK.%2BA.%26aulast%3DRitson%26aufirst%3DG.%2BP.%26aulast%3DChia%26aufirst%3DL.%2BA.%26aulast%3DHamilton%26aufirst%3DR.%2BL.%26aulast%3DChu%26aufirst%3DC.%2BT.%26aulast%3DJordan-Sciutto%26aufirst%3DK.%2BL.%26atitle%3DExpression%2520of%2520Nrf2%2520in%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D2007%26volume%3D66%26spage%3D75%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref260"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref260'); return false;" data-citation="" class="refNumLink">260</a></strong><div class="NLM_citation" id="cit260"><span><span class="NLM_contrib-group">Stack, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wille, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calingasan, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liby, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sporn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumont, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, M. F.</span><span> </span><span class="NLM_article-title">Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington’s disease</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref260/cit260&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.freeradbiomed.2010.03.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref260/cit260&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20338236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref260/cit260&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntVOntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=147-158&author=C.+Stackauthor=D.+Hoauthor=E.+Willeauthor=N.+Y.+Calingasanauthor=C.+Williamsauthor=K.+Libyauthor=M.+Spornauthor=M.+Dumontauthor=M.+F.+Beal&title=Triterpenoids+CDDO-ethyl+amide+and+CDDO-trifluoroethyl+amide+improve+the+behavioral+phenotype+and+brain+pathology+in+a+transgenic+mouse+model+of+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit260R"><div class="casContent"><span class="casTitleNuber">260</span><div class="casTitle"><span class="NLM_cas:atitle">Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease</span></div><div class="casAuthors">Stack, Cliona; Ho, Daniel; Wille, Elizabeth; Calingasan, Noel Y.; Williams, Charlotte; Liby, Karen; Sporn, Michael; Dumont, Magali; Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-158</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Oxidative stress is a prominent feature of Huntington's disease (HD) due to mitochondrial dysfunction and the ensuing overprodn. of reactive oxygen species (ROS).  This phenomenon ultimately contributes to cognitive and motor impairment, as well as brain pathol., esp. in the striatum.  Targeting the transcription of the endogenous antioxidant machinery could be a promising therapeutic approach.  The NF-E2-related factor-2 (Nrf2)/antioxidant response element (ARE) signaling pathway is an important pathway involved in antioxidant and anti-inflammatory responses.  Synthetic triterpenoids, which are derived from 2-Cyano-3,12-Dioxooleana-1,9-Dien-28-Oic acid (CDDO) activate the Nrf2/ARE pathway and reduce oxidative stress in animal models of neurodegenerative diseases.  We investigated the effects of CDDO-Et amide (CDDO-EA) and CDDO-trifluoroethyl amide (CDDO-TFEA) in N171-82Q mice, a transgenic mouse model of HD.  CDDO-EA or CDDO-TFEA were administered in the diet at various concns., starting at 30 days of age.  CDDO-EA and CDDO-TFEA upregulated Nrf2/ARE induced genes in the brain and peripheral tissues, reduced oxidative stress, improved motor impairment and increased longevity.  They also rescued striatal atrophy in the brain and vacuolation in the brown adipose tissue.  Therefore compds. targeting the Nrf2/ARE pathway show great promise for the treatment of HD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnPF1FYjzbwLVg90H21EOLACvtfcHk0liJL0j64UxGbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntVOntrc%253D&md5=a717e61f8a636c33ec1d82237155f710</span></div><a href="/servlet/linkout?suffix=cit260&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2010.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2010.03.017%26sid%3Dliteratum%253Aachs%26aulast%3DStack%26aufirst%3DC.%26aulast%3DHo%26aufirst%3DD.%26aulast%3DWille%26aufirst%3DE.%26aulast%3DCalingasan%26aufirst%3DN.%2BY.%26aulast%3DWilliams%26aufirst%3DC.%26aulast%3DLiby%26aufirst%3DK.%26aulast%3DSporn%26aufirst%3DM.%26aulast%3DDumont%26aufirst%3DM.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DTriterpenoids%2520CDDO-ethyl%2520amide%2520and%2520CDDO-trifluoroethyl%2520amide%2520improve%2520the%2520behavioral%2520phenotype%2520and%2520brain%2520pathology%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2010%26volume%3D49%26spage%3D147%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref261"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref261'); return false;" data-citation="" class="refNumLink">261</a></strong><div class="NLM_citation" id="cit261"><span><span class="NLM_contrib-group">Ross, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M. A.</span><span> </span><span class="NLM_article-title">Protein aggregation and neurodegenerative disease</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">S10</span><span class="NLM_x">–</span> <span class="NLM_lpage">S17</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=S10-S17&issue=Suppl.&author=C.+A.+Rossauthor=M.+A.+Poirier&title=Protein+aggregation+and+neurodegenerative+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit261&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DC.%2BA.%26aulast%3DPoirier%26aufirst%3DM.%2BA.%26atitle%3DProtein%2520aggregation%2520and%2520neurodegenerative%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26issue%3DSuppl%26spage%3DS10%26epage%3DS17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref262"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref262'); return false;" data-citation="" class="refNumLink">262</a></strong><div class="NLM_citation" id="cit262"><span><span class="NLM_contrib-group">Aguzzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, T.</span><span> </span><span class="NLM_article-title">Protein aggregation diseases: pathogenicity and therapeutic perspectives</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnrd3050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20190788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFeksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=237-248&author=A.+Aguzziauthor=T.+O%E2%80%99Connor&title=Protein+aggregation+diseases%3A+pathogenicity+and+therapeutic+perspectives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit262R"><div class="casContent"><span class="casTitleNuber">262</span><div class="casTitle"><span class="NLM_cas:atitle">Protein aggregation diseases: pathogenicity and therapeutic perspectives</span></div><div class="casAuthors">Aguzzi, Adriano; O'Connor, Tracy</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">237-248</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A growing no. of diseases seem to be assocd. with inappropriate deposition of protein aggregates.  Some of these diseases - such as Alzheimer's disease and systemic amyloidoses - were recognized for a long time.  However, it is now clear that ordered aggregation of pathogenic proteins does not only occur in the extracellular space, but in the cytoplasm and nucleus as well, indicating that many other diseases may also qualify as amyloidoses.  The common structural and pathogenic features of these diverse protein aggregation diseases is only now being fully understood, and may provide novel opportunities for overarching therapeutic approaches such as depleting the monomeric precursor protein, inhibiting aggregation, enhancing aggregate clearance or blocking common aggregation-induced cellular toxicity pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZPeSFBYjDwLVg90H21EOLACvtfcHk0lhUQIUV0jDxAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFeksbo%253D&md5=6a70e6af3dd4cd4dcba8de1d7faa78f2</span></div><a href="/servlet/linkout?suffix=cit262&amp;dbid=16384&amp;doi=10.1038%2Fnrd3050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3050%26sid%3Dliteratum%253Aachs%26aulast%3DAguzzi%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DT.%26atitle%3DProtein%2520aggregation%2520diseases%253A%2520pathogenicity%2520and%2520therapeutic%2520perspectives%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D237%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref263"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref263'); return false;" data-citation="" class="refNumLink">263</a></strong><div class="NLM_citation" id="cit263"><span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span> </span><span class="NLM_article-title">Strategies for the inhibition of protein aggregation in human diseases</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1018</span><span class="NLM_x">–</span> <span class="NLM_lpage">1035</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=1018-1035&author=M.+Bartoliniauthor=V.+Andrisano&title=Strategies+for+the+inhibition+of+protein+aggregation+in+human+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit263&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26atitle%3DStrategies%2520for%2520the%2520inhibition%2520of%2520protein%2520aggregation%2520in%2520human%2520diseases%26jtitle%3DChemBioChem%26date%3D2010%26volume%3D11%26spage%3D1018%26epage%3D1035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref264"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref264'); return false;" data-citation="" class="refNumLink">264</a></strong><div class="NLM_citation" id="cit264"><span><span class="NLM_contrib-group">Schneider, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Tau based treatment strategies in neurodegenerative diseases</span> <span class="citation_source-journal">Neurotherapeutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">457</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=443-457&author=A.+Schneiderauthor=E.+Mandelkow&title=Tau+based+treatment+strategies+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit264&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DA.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DTau%2520based%2520treatment%2520strategies%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNeurotherapeutics%26date%3D2008%26volume%3D5%26spage%3D443%26epage%3D457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref265"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref265'); return false;" data-citation="" class="refNumLink">265</a></strong><div class="NLM_citation" id="cit265"><span><span class="NLM_contrib-group">Shelton, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, G. V.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinase-5 in neurodegeneration</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">1313</span><span class="NLM_x">–</span> <span class="NLM_lpage">1326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref265/cit265&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1111%2Fj.1471-4159.2003.02328.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref265/cit265&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=15009631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref265/cit265&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivVCit7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2004&pages=1313-1326&author=S.+B.+Sheltonauthor=G.+V.+Johnson&title=Cyclin-dependent+kinase-5+in+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit265R"><div class="casContent"><span class="casTitleNuber">265</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-dependent kinase-5 in neurodegeneration</span></div><div class="casAuthors">Shelton, Shirley B.; Johnson, Gail V. W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1313-1326</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Cyclin-dependent kinase-5 (CDK5) is predominantly active in the nervous system and it is well established that CDK5 is essential in neuronal development.  In addn. to its recognized role in development, there is increasing evidence that CDK5 may be involved in the pathogenesis of several neurodegenerative disorders.  Although studies have shown that CDK5 can modulate cell death and survival, controversy still exists as to the exact role CDK5 may play in neurodegenerative processes.  This review will highlight recent data on the possible roles of CDK5 in neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFnp9yVi3hq7Vg90H21EOLACvtfcHk0lhUQIUV0jDxAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivVCit7w%253D&md5=6d306157d802a45c18bf480a3bb028ee</span></div><a href="/servlet/linkout?suffix=cit265&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2003.02328.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2003.02328.x%26sid%3Dliteratum%253Aachs%26aulast%3DShelton%26aufirst%3DS.%2BB.%26aulast%3DJohnson%26aufirst%3DG.%2BV.%26atitle%3DCyclin-dependent%2520kinase-5%2520in%2520neurodegeneration%26jtitle%3DJ.%2520Neurochem.%26date%3D2004%26volume%3D88%26spage%3D1313%26epage%3D1326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref266"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref266'); return false;" data-citation="" class="refNumLink">266</a></strong><div class="NLM_citation" id="cit266"><span><span class="NLM_contrib-group">Hanger, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderton, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, W.</span><span> </span><span class="NLM_article-title">Tau phosphorylation: the therapeutic challenge for neurodegenerative disease</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">119</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.molmed.2009.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=19246243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjt1ahu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=112-119&author=D.+P.+Hangerauthor=B.+H.+Andertonauthor=W.+Noble&title=Tau+phosphorylation%3A+the+therapeutic+challenge+for+neurodegenerative+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit266R"><div class="casContent"><span class="casTitleNuber">266</span><div class="casTitle"><span class="NLM_cas:atitle">Tau phosphorylation: the therapeutic challenge for neurodegenerative disease</span></div><div class="casAuthors">Hanger, Diane P.; Anderton, Brian H.; Noble, Wendy</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">112-119</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The microtubule-assocd. protein tau is integral to the pathogenesis of Alzheimer's disease (AD), as well as several related disorders, termed tauopathies, in which tau is deposited in affected brain regions.  In the tauopathies, pathol. tau is in an elevated state of phosphorylation and is aberrantly cleaved.  It also exhibits abnormal conformations and becomes aggregated, resulting in neurofibrillary tau pathol.  Recent evidence suggests that relatively early disease-assocd. changes in sol. tau proteins, including phosphorylation, are involved in the induction of neuronal death.  Here, we summarize recent developments that suggest new therapeutic strategies to prevent or reduce the progression of pathol. in the tauopathies.  A list of tau phosphorylation sites identified in the tauopathies and in controls accompanies this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8l3EQ3bznVLVg90H21EOLACvtfcHk0ljvz8_jhBoq0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjt1ahu7w%253D&md5=116159eeaae25800a22b687f36df70e2</span></div><a href="/servlet/linkout?suffix=cit266&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2009.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2009.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DHanger%26aufirst%3DD.%2BP.%26aulast%3DAnderton%26aufirst%3DB.%2BH.%26aulast%3DNoble%26aufirst%3DW.%26atitle%3DTau%2520phosphorylation%253A%2520the%2520therapeutic%2520challenge%2520for%2520neurodegenerative%2520disease%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2009%26volume%3D15%26spage%3D112%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref267"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref267'); return false;" data-citation="" class="refNumLink">267</a></strong><div class="NLM_citation" id="cit267"><span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thunnissen, A. M. W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleverley, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salinas, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettit, G. R.</span><span> </span><span class="NLM_article-title">Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS1074-5521%2800%2900063-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=10662688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotFertA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=51-63&author=L.+Meijerauthor=A.+M.+W.+H.+Thunnissenauthor=A.+W.+Whiteauthor=M.+Garnierauthor=M.+Nikolicauthor=L.+H.+Tsaiauthor=J.+Walterauthor=K.+E.+Cleverleyauthor=P.+C.+Salinasauthor=Y.+Z.+Wuauthor=J.+Biernatauthor=E.+Mandelkowauthor=S.+H.+Kimauthor=G.+R.+Pettit&title=Inhibition+of+cyclin-dependent+kinases%2C+GSK-3beta+and+CK1+by+hymenialdisine%2C+a+marine+sponge+constituent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit267R"><div class="casContent"><span class="casTitleNuber">267</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of cyclin-dependent kinases, GSK-3β and CK1 by hymenialdisine, a marine sponge constituent</span></div><div class="casAuthors">Meijer, L.; Thunnissen, A. M. W. H.; White, A. W.; Garnier, M.; Nikolic, M.; Tsai, L. H.; Walter, J.; Cleverley, K. E.; Salinas, P. C.; Wu, Y. Z.; Biernat, J.; Mandelkow, E. M.; Kim, S. H.; Pettit, G. R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-63</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Over 2000 protein kinases regulate cellular functions.  Screening for inhibitors of some of these kinases has already yielded some potent and selective compds. with promising potential for the treatment of human diseases.  Here, the marine sponge constituent, hymenialdisine (I), was found to be a potent inhibitor of cyclin-dependent kinases (CDKs), glycogen synthase kinase-3β (GSK-3β), and casein kinase 1 (CK1).  I was found to compete with ATP for binding to these kinases.  A CDK2-I complex crystal structure showed that 3 H-bonds linked I to the Glu-81 and Leu-83 residues of CDK2, as obsd. with other inhibitors.  I inhibited CDK5/p35 in vivo as demonstrated by the lack of phosphorylation/down-regulation of Pak1 kinase in E18 rat cortical neurons, and also inhibited GSK-3 in vivo as shown by the inhibition of microtubule-assocd. protein-1B phosphorylation.  I also blocked the in vivo phosphorylation of the microtubule-binding protein, tau, at sites that were hyperphosphorylated by GSK-3 and CDK5/p35 in Alzheimer's disease (cross-reacting with Alzheimer's-specific AT100 antibodies) and blocked presenilin-2 phosphorylation in vitro.  Thus, the natural product, I, is a new kinase inhibitor with promising potential applications for treating neurodegenerative disorders such as Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp80sKXSk6kF7Vg90H21EOLACvtfcHk0ljvz8_jhBoq0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotFertA%253D%253D&md5=62a4e11bc0d13980751cadd2d1ec723a</span></div><a href="/servlet/linkout?suffix=cit267&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2800%2900063-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252800%252900063-6%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DThunnissen%26aufirst%3DA.%2BM.%2BW.%2BH.%26aulast%3DWhite%26aufirst%3DA.%2BW.%26aulast%3DGarnier%26aufirst%3DM.%26aulast%3DNikolic%26aufirst%3DM.%26aulast%3DTsai%26aufirst%3DL.%2BH.%26aulast%3DWalter%26aufirst%3DJ.%26aulast%3DCleverley%26aufirst%3DK.%2BE.%26aulast%3DSalinas%26aufirst%3DP.%2BC.%26aulast%3DWu%26aufirst%3DY.%2BZ.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26atitle%3DInhibition%2520of%2520cyclin-dependent%2520kinases%252C%2520GSK-3beta%2520and%2520CK1%2520by%2520hymenialdisine%252C%2520a%2520marine%2520sponge%2520constituent%26jtitle%3DChem.%2520Biol.%26date%3D2000%26volume%3D7%26spage%3D51%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref268"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref268'); return false;" data-citation="" class="refNumLink">268</a></strong><div class="NLM_citation" id="cit268"><span><span class="NLM_contrib-group">Palomo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span> </span><span class="NLM_article-title">The potential role of glycogen synthase kinase 3 inhibitors as amyotrophic lateral sclerosis pharmacological therapy</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3028</span><span class="NLM_x">–</span> <span class="NLM_lpage">3034</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.2174%2F092986711796391697" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=21651477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsl2ru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=3028-3034&author=V.+Palomoauthor=D.+I.+Perezauthor=C.+Gilauthor=A.+Martinez&title=The+potential+role+of+glycogen+synthase+kinase+3+inhibitors+as+amyotrophic+lateral+sclerosis+pharmacological+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit268R"><div class="casContent"><span class="casTitleNuber">268</span><div class="casTitle"><span class="NLM_cas:atitle">The potential role of glycogen synthase kinase 3 inhibitors as amyotrophic lateral sclerosis pharmacological therapy</span></div><div class="casAuthors">Palomo, V.; Perez, D. I.; Gil, C.; Martinez, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3028-3034</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects motor neurons.  Lately, this disease has often been related to the protein kinase called glycogen synthase kinase 3 (GSK-3), through the exptl. evidence of alterations of this enzyme on ALS patients.  Therefore, there have been several exptl. studies using GSK-3 inhibitors, in cellular and animal models and also in clin. studies that showed the potential of the therapeutic role of these mols.  GSK-3 inhibitors might play a pivotal role in the pharmacol. of ALS disease with no curative treatment nowadays.  In this review we give an overview of the current research in the area, showing all the evidences of the implication of dysfunctional GSK-3 in this disease on one hand, and on the other presenting the potential role of the GSK-3 inhibitors as a future pharmacol. ALS therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO18DQpfwsk7Vg90H21EOLACvtfcHk0ljvz8_jhBoq0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsl2ru7g%253D&md5=0082dde65a2d81fbcafe5d6d43cc1374</span></div><a href="/servlet/linkout?suffix=cit268&amp;dbid=16384&amp;doi=10.2174%2F092986711796391697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711796391697%26sid%3Dliteratum%253Aachs%26aulast%3DPalomo%26aufirst%3DV.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DThe%2520potential%2520role%2520of%2520glycogen%2520synthase%2520kinase%25203%2520inhibitors%2520as%2520amyotrophic%2520lateral%2520sclerosis%2520pharmacological%2520therapy%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D3028%26epage%3D3034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref269"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref269'); return false;" data-citation="" class="refNumLink">269</a></strong><div class="NLM_citation" id="cit269"><span><span class="NLM_contrib-group">Chen, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaisina, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Khodor, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramboz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makhortova, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Identification of a maleimide-based glycogen synthase kinase-3 (GSK-3) inhibitor, BIP-135, that prolongs the median survival time of Delta 7 SMA KO mouse model of spinal muscular atrophy</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200085z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlaqsLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=5-11&author=P.+C.+Chenauthor=I.+N.+Gaisinaauthor=B.+F.+El-Khodorauthor=S.+Rambozauthor=N.+R.+Makhortovaauthor=L.+L.+Rubinauthor=A.+P.+Kozikowski&title=Identification+of+a+maleimide-based+glycogen+synthase+kinase-3+%28GSK-3%29+inhibitor%2C+BIP-135%2C+that+prolongs+the+median+survival+time+of+Delta+7+SMA+KO+mouse+model+of+spinal+muscular+atrophy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit269R"><div class="casContent"><span class="casTitleNuber">269</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitor, BIP-135, That Prolongs the Median Survival Time of Δ7 SMA KO Mouse Model of Spinal Muscular Atrophy</span></div><div class="casAuthors">Chen, Po C.; Gaisina, Irina N.; El-Khodor, Bassem F.; Ramboz, Sylvie; Makhortova, Nina R.; Rubin, Lee L.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-11</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of upregulated glycogen synthase kinase-3 (GSK-3) in various pathol. conditions has led to the development of a host of chem. diverse small mol. GSK-3 inhibitors, such as BIP-135 (I).  GSK-3 inhibition emerged as an alternative therapeutic target for treating spinal muscular atrophy (SMA) when a no. of GSK-3 inhibitors were shown to elevate survival motor neuron (SMN) levels in vitro and to rescue motor neurons when their intrinsic SMN level was diminished by SMN-specific short hairpin RNA (shRNA).  Despite their cellular potency, the in vivo efficacy of GSK-3 inhibitors has yet to be evaluated in an animal model of SMA.  Herein, we disclose that a potent and reasonably selective GSK-3 inhibitor, namely BIP-135, was tested in a transgenic Δ7 SMA KO mouse model of SMA and found to prolong the median survival of these animals.  In addn., this compd. was shown to elevate the SMN protein level in SMA patient-derived fibroblast cells as detd. by Western blot, and was neuroprotective in a cell-based, SMA-related model of oxidative stress-induced neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcySOXJLoZx7Vg90H21EOLACvtfcHk0ljMC1E_WcKKfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlaqsLfL&md5=728c77967169f3fa99263b1a2622d084</span></div><a href="/servlet/linkout?suffix=cit269&amp;dbid=16384&amp;doi=10.1021%2Fcn200085z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200085z%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%2BC.%26aulast%3DGaisina%26aufirst%3DI.%2BN.%26aulast%3DEl-Khodor%26aufirst%3DB.%2BF.%26aulast%3DRamboz%26aufirst%3DS.%26aulast%3DMakhortova%26aufirst%3DN.%2BR.%26aulast%3DRubin%26aufirst%3DL.%2BL.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DIdentification%2520of%2520a%2520maleimide-based%2520glycogen%2520synthase%2520kinase-3%2520%2528GSK-3%2529%2520inhibitor%252C%2520BIP-135%252C%2520that%2520prolongs%2520the%2520median%2520survival%2520time%2520of%2520Delta%25207%2520SMA%2520KO%2520mouse%2520model%2520of%2520spinal%2520muscular%2520atrophy%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D5%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref270"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref270'); return false;" data-citation="" class="refNumLink">270</a></strong><div class="NLM_citation" id="cit270"><span><span class="NLM_contrib-group">Koh, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span> </span><span class="NLM_article-title">Inhibition of glycogen synthase kinase-3 suppresses the onset of symptoms and disease progression of G93A-SOD1 mouse model of ALS</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">205</span><span class="NLM_x">, </span> <span class="NLM_fpage">336</span><span class="NLM_x">–</span> <span class="NLM_lpage">346</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.expneurol.2007.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=17433298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2sXls1aisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=2007&pages=336-346&author=S.+H.+Kohauthor=Y.+Kimauthor=H.+Y.+Kimauthor=S.+Hwangauthor=C.+H.+Leeauthor=S.+H.+Kim&title=Inhibition+of+glycogen+synthase+kinase-3+suppresses+the+onset+of+symptoms+and+disease+progression+of+G93A-SOD1+mouse+model+of+ALS"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit270R"><div class="casContent"><span class="casTitleNuber">270</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of glycogen synthase kinase-3 suppresses the onset of symptoms and disease progression of G93A-SOD1 mouse model of ALS</span></div><div class="casAuthors">Koh, Seong-Ho; Kim, Youngchul; Kim, Hyun Y.; Hwang, Sejin; Lee, Chang Ho; Kim, Seung H.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">336-346</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Glycogen synthase kinase (GSK)-3 has recently been implicated in the pathogenesis of neurodegenerative diseases.  Although the neuroprotective effects of GSK-3 inhibitors in Alzheimer's disease have been established, their effects on amyotrophic lateral sclerosis (ALS) have not been well defined.  This study was undertaken to evaluate the effects of GSK-3 inhibition in the G93A-SOD1 mouse model of ALS.  Groups of G93A-SOD1 mice were treated with varying concns. of GSK-3 inhibitor VIII, a specific GSK-3 inhibitor that crosses the BBB, i.p. 5 days a week after 60 days of age.  The GSK-3 inhibitor VIII treatment significantly delayed the onset of symptoms and prolonged the life span of the animals, and inhibited the activity of GSK-3 in a concn.-dependent manner.  Furthermore, this treatment preserved survival signals and attenuated death and inflammatory signals.  These data suggest that GSK-3 plays an important role in the pathogenic mechanisms of ALS and that inhibition of GSK-3 could be a potential therapeutic candidate for ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgAkuwj5gV4bVg90H21EOLACvtfcHk0ljMC1E_WcKKfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXls1aisLY%253D&md5=09429c1fbeb544eef6cb75d4da00b179</span></div><a href="/servlet/linkout?suffix=cit270&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2007.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2007.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DKoh%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DH.%2BY.%26aulast%3DHwang%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BH.%26atitle%3DInhibition%2520of%2520glycogen%2520synthase%2520kinase-3%2520suppresses%2520the%2520onset%2520of%2520symptoms%2520and%2520disease%2520progression%2520of%2520G93A-SOD1%2520mouse%2520model%2520of%2520ALS%26jtitle%3DExp.%2520Neurol.%26date%3D2007%26volume%3D205%26spage%3D336%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref271"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref271'); return false;" data-citation="" class="refNumLink">271</a></strong><div class="NLM_citation" id="cit271"><span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parisiadou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, X. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao-Cheng, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudow, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troncoso, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, H.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson’s-disease-related mutant alpha-synuclein</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">807</span><span class="NLM_x">–</span> <span class="NLM_lpage">827</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2009&pages=807-827&author=X.+Linauthor=L.+Parisiadouauthor=X.+L.+Guauthor=L.+Wangauthor=H.+Shimauthor=L.+Sunauthor=C.+Xieauthor=C.+X.+Longauthor=W.+J.+Yangauthor=J.+Dingauthor=Z.+Z.+Chenauthor=P.+E.+Gallantauthor=J.+H.+Tao-Chengauthor=G.+Rudowauthor=J.+C.+Troncosoauthor=Z.+Liuauthor=Z.+Liauthor=H.+Cai&title=Leucine-rich+repeat+kinase+2+regulates+the+progression+of+neuropathology+induced+by+Parkinson%E2%80%99s-disease-related+mutant+alpha-synuclein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit271&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DX.%26aulast%3DParisiadou%26aufirst%3DL.%26aulast%3DGu%26aufirst%3DX.%2BL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DShim%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DXie%26aufirst%3DC.%26aulast%3DLong%26aufirst%3DC.%2BX.%26aulast%3DYang%26aufirst%3DW.%2BJ.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%2BZ.%26aulast%3DGallant%26aufirst%3DP.%2BE.%26aulast%3DTao-Cheng%26aufirst%3DJ.%2BH.%26aulast%3DRudow%26aufirst%3DG.%26aulast%3DTroncoso%26aufirst%3DJ.%2BC.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DCai%26aufirst%3DH.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520regulates%2520the%2520progression%2520of%2520neuropathology%2520induced%2520by%2520Parkinson%25E2%2580%2599s-disease-related%2520mutant%2520alpha-synuclein%26jtitle%3DNeuron%26date%3D2009%26volume%3D64%26spage%3D807%26epage%3D827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref272"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref272'); return false;" data-citation="" class="refNumLink">272</a></strong><div class="NLM_citation" id="cit272"><span><span class="NLM_contrib-group">Ballatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huryn, D. M.</span><span> </span><span class="NLM_article-title">Modulation of protein–protein interactions as a therapeutic strategy for the treatment of neurodegenerative tauopathies</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.2174%2F156802611794072605" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=21320060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslahsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=317-330&author=C.+Ballatoreauthor=K.+R.+Brundenauthor=J.+Q.+Trojanowskiauthor=V.+M.+Leeauthor=A.+B.+Smithauthor=D.+M.+Huryn&title=Modulation+of+protein%E2%80%93protein+interactions+as+a+therapeutic+strategy+for+the+treatment+of+neurodegenerative+tauopathies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit272R"><div class="casContent"><span class="casTitleNuber">272</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of protein-protein interactions as a therapeutic strategy for the treatment of neurodegenerative tauopathies</span></div><div class="casAuthors">Ballatore, C.; Brunden, K. R.; Trojanowski, J. Q.; Lee, V. M.-Y.; Smith, A. B., III; Huryn, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">317-330</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The recognition that malfunction of the microtubule (MT) assocd. protein tau is likely to play a defining role in the onset and/or progression of a no. of neurodegenerative diseases, including Alzheimer's disease, has resulted in the initiation of drug discovery programs that target this protein.  Tau is an endogenous MT-stabilizing agent that is highly expressed in the axons of neurons.  The MT-stabilizing function of tau is essential for the axonal transport of proteins, neurotransmitters and other cellular constituents.  Under pathol. conditions, tau misfolding and aggregation results in axonal transport deficits that appear to have deleterious consequences for the affected neurons, leading to synapse dysfunction and, ultimately, neuronal loss.  This review focuses on both progress and unresolved issues surrounding the development of novel therapeutics for the treatment of neurodegenerative tauopathies, which are based on (A) MT-stabilizing agents to compensate for the loss of normal tau function and (B) small mol. inhibitors of tau aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRv3v9WR9uIrVg90H21EOLACvtfcHk0ljMC1E_WcKKfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslahsLk%253D&md5=b35d6ff9dac27b56e59f1e2fd5b8fafd</span></div><a href="/servlet/linkout?suffix=cit272&amp;dbid=16384&amp;doi=10.2174%2F156802611794072605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611794072605%26sid%3Dliteratum%253Aachs%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DHuryn%26aufirst%3DD.%2BM.%26atitle%3DModulation%2520of%2520protein%25E2%2580%2593protein%2520interactions%2520as%2520a%2520therapeutic%2520strategy%2520for%2520the%2520treatment%2520of%2520neurodegenerative%2520tauopathies%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D317%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref273"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref273'); return false;" data-citation="" class="refNumLink">273</a></strong><div class="NLM_citation" id="cit273"><span><span class="NLM_contrib-group">Wischik, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, C. R.</span><span> </span><span class="NLM_article-title">Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">11213</span><span class="NLM_x">–</span> <span class="NLM_lpage">11218</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref273/cit273&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1073%2Fpnas.93.20.11213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref273/cit273&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=8855335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref273/cit273&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK28XmtVOqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=11213-11218&author=C.+M.+Wischikauthor=P.+C.+Edwardsauthor=R.+Y.+Laiauthor=M.+Rothauthor=C.+R.+Harrington&title=Selective+inhibition+of+Alzheimer+disease-like+tau+aggregation+by+phenothiazines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit273R"><div class="casContent"><span class="casTitleNuber">273</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines</span></div><div class="casAuthors">Wischik, C. M.; Edwards, P. C.; Lai, R. Y.; Roth, M.; Harrington, C. R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">11213-11218</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">In Alzheimer disease (AD) the microtubule-assocd. protein tau is redistributed exponentially into paired helical filaments (PHFs) forming neurofibrillary tangles, which correlate with pyramidal cell destruction and dementia.  Amorphous neuronal deposits and PHFs in AD are characterized by aggregation through the repeat domain and C-terminal truncation at Glu-391 by endogenous proteases.  We show that a similar proteolytically stable complex can be generated in vitro following the self-aggregation of tau protein through a high-affinity binding site in the repeat domain.  Once started, tau capture can be propagated by seeding the further accumulation of truncated tau in the presence of proteases.  We have identified a non-neuroleptic phenothiazine previously used in man (methylene blue, MB), which reverses the proteolytic stability of protease-resistant PHFs by blocking the tau-tau binding interaction through the repeat domain.  Although MB is inhibitory at a higher concn. than may be achieved clin., the tau-tau binding assay was used to identify desmethyl derivs. of MB that have Ki values in the nanomolar range.  Neuroleptic phenothiazines are inactive.  Tau aggregation inhibitors do not affect the tau-tubulin interaction, which also occurs through the repeat domain.  Our findings demonstrate that biol. selective pharmaceutical agents could be developed to facilitate the proteolytic degrdn. of tau aggregates and prevent the further propagation of tau capture in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogZyJ57Clqp7Vg90H21EOLACvtfcHk0lj6MrClP116Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmtVOqsLg%253D&md5=d586f688ffc47cc4129ed6407bd15720</span></div><a href="/servlet/linkout?suffix=cit273&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.20.11213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.20.11213%26sid%3Dliteratum%253Aachs%26aulast%3DWischik%26aufirst%3DC.%2BM.%26aulast%3DEdwards%26aufirst%3DP.%2BC.%26aulast%3DLai%26aufirst%3DR.%2BY.%26aulast%3DRoth%26aufirst%3DM.%26aulast%3DHarrington%26aufirst%3DC.%2BR.%26atitle%3DSelective%2520inhibition%2520of%2520Alzheimer%2520disease-like%2520tau%2520aggregation%2520by%2520phenothiazines%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1996%26volume%3D93%26spage%3D11213%26epage%3D11218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref274"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref274'); return false;" data-citation="" class="refNumLink">274</a></strong><div class="NLM_citation" id="cit274"><span><span class="NLM_contrib-group">Ballatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossidivito, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.,  3rd.</span><span> </span><span class="NLM_article-title">Aminothienopyridazine inhibitors of tau aggregation: evaluation of structure–activity relationship leads to selection of candidates with desirable in vivo properties</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4451</span><span class="NLM_x">–</span> <span class="NLM_lpage">4461</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=4451-4461&author=C.+Ballatoreauthor=A.+Croweauthor=F.+Piscitelliauthor=M.+Jamesauthor=K.+Louauthor=G.+Rossidivitoauthor=Y.+Yaoauthor=J.+Q.+Trojanowskiauthor=V.+M.+Leeauthor=K.+R.+Brundenauthor=A.+B.+Smith&title=Aminothienopyridazine+inhibitors+of+tau+aggregation%3A+evaluation+of+structure%E2%80%93activity+relationship+leads+to+selection+of+candidates+with+desirable+in+vivo+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit274&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DCrowe%26aufirst%3DA.%26aulast%3DPiscitelli%26aufirst%3DF.%26aulast%3DJames%26aufirst%3DM.%26aulast%3DLou%26aufirst%3DK.%26aulast%3DRossidivito%26aufirst%3DG.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26atitle%3DAminothienopyridazine%2520inhibitors%2520of%2520tau%2520aggregation%253A%2520evaluation%2520of%2520structure%25E2%2580%2593activity%2520relationship%2520leads%2520to%2520selection%2520of%2520candidates%2520with%2520desirable%2520in%2520vivo%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D4451%26epage%3D4461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref275"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref275'); return false;" data-citation="" class="refNumLink">275</a></strong><div class="NLM_citation" id="cit275"><span><span class="NLM_contrib-group">Messing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span> </span><span class="NLM_article-title">Cascade of tau toxicity in inducible hippocampal brain slices and prevention by aggregation inhibitors</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1343</span><span class="NLM_x">–</span> <span class="NLM_lpage">1354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.neurobiolaging.2012.10.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=23158765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslSmu7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1343-1354&author=L.+Messingauthor=J.+M.+Deckerauthor=M.+Josephauthor=E.+Mandelkowauthor=E.+M.+Mandelkow&title=Cascade+of+tau+toxicity+in+inducible+hippocampal+brain+slices+and+prevention+by+aggregation+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit275R"><div class="casContent"><span class="casTitleNuber">275</span><div class="casTitle"><span class="NLM_cas:atitle">Cascade of tau toxicity in inducible hippocampal brain slices and prevention by aggregation inhibitors</span></div><div class="casAuthors">Messing, Lars; Decker, Jochen Martin; Joseph, Maria; Mandelkow, Eckhard; Mandelkow, Eva-Maria</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1343-1354</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Mislocalization and aggregation of the axonal protein tau are hallmarks of Alzheimer's disease and other tauopathies.  Here, we studied the relationship between tau aggregation, loss of spines and neurons, and reversibility by aggregation inhibitors.  To this end we established an in vitro model of tauopathy based on regulatable transgenic hippocampal organotypic slice cultures prepd. from mice expressing proaggregant Tau repeat domain with mutation ΔK280 (TauRDΔK).  Transgene expression was monitored by a bioluminescence reporter assay.  We obsd. abnormal tau phosphorylation and mislocalization of exogenous and endogenous tau into the somatodendritic compartment.  This was paralleled by a redn. of dendritic spines, altered dendritic spine morphol., dysregulation of Ca++ dynamics and elevated activation of microglia.  Neurotoxicity was mediated by Caspase-3 activation and correlated with the expression level of proaggregant TauRDΔK.  Finally, tau aggregates appeared in areas CA1 and CA3 after three weeks in vitro.  Neurodegeneration was relieved by aggregation inhibitors or by switching off transgene expression.  Thus the slice culture model is suitable for monitoring the development of tauopathy and the therapeutic benefit of antiaggregation drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC_PnWs0hCu7Vg90H21EOLACvtfcHk0lj6MrClP116Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslSmu7rO&md5=795880e4fc8b1dd1f21f4d5fd0c09d59</span></div><a href="/servlet/linkout?suffix=cit275&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2012.10.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2012.10.024%26sid%3Dliteratum%253Aachs%26aulast%3DMessing%26aufirst%3DL.%26aulast%3DDecker%26aufirst%3DJ.%2BM.%26aulast%3DJoseph%26aufirst%3DM.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26atitle%3DCascade%2520of%2520tau%2520toxicity%2520in%2520inducible%2520hippocampal%2520brain%2520slices%2520and%2520prevention%2520by%2520aggregation%2520inhibitors%26jtitle%3DNeurobiol.%2520Aging%26date%3D2013%26volume%3D34%26spage%3D1343%26epage%3D1354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref276"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref276'); return false;" data-citation="" class="refNumLink">276</a></strong><div class="NLM_citation" id="cit276"><span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brindisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Developing beta-secretase inhibitors for treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref276/cit276&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1111%2Fj.1471-4159.2011.07476.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref276/cit276&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=22122681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref276/cit276&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFyns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=71-83&author=A.+K.+Ghoshauthor=M.+Brindisiauthor=J.+Tang&title=Developing+beta-secretase+inhibitors+for+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit276R"><div class="casContent"><span class="casTitleNuber">276</span><div class="casTitle"><span class="NLM_cas:atitle">Developing β-secretase inhibitors for treatment of Alzheimer's disease</span></div><div class="casAuthors">Ghosh, Arun K.; Brindisi, Margherita; Tang, Jordan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">71-83</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  β-Secretase (memapsin 2; BACE-1) is the first protease in the processing of amyloid precursor protein leading to the prodn. of amyloid-β (Aβ) in the brain.  It is believed that high levels of brain Aβ are responsible for the pathogenesis of Alzheimer's disease (AD).  Therefore, β-secretase is a major therapeutic target for the development of inhibitor drugs.  During the past decade, steady progress has been made in the evolution of β-secretase inhibitors toward better drug properties.  Recent inhibitors are potent, selective and have been shown to penetrate the blood-brain barrier to inhibit Aβ levels in the brains of exptl. animals.  Moreover, continuous administration of a β-secretase inhibitor was shown to rescue age-related cognitive decline in transgenic AD mice.  A small no. of β-secretase inhibitors have also entered early phase clin. trials.  These developments offer some optimism for the clin. development of a disease-modifying drug for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvY0fxn2hBubVg90H21EOLACvtfcHk0lj6MrClP116Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFyns78%253D&md5=186d6ccadd1c207ecd7aaa9cb7584684</span></div><a href="/servlet/linkout?suffix=cit276&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07476.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07476.x%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DDeveloping%2520beta-secretase%2520inhibitors%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2012%26volume%3D120%26spage%3D71%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref277"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref277'); return false;" data-citation="" class="refNumLink">277</a></strong><div class="NLM_citation" id="cit277"><span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith Labell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greg Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Robust central reduction of amyloid-beta in humans with an orally available, non-peptidic beta-secretase inhibitor</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">16507</span><span class="NLM_x">–</span> <span class="NLM_lpage">16516</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+Smith+Labellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+Greg+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-beta+in+humans+with+an+orally+available%2C+non-peptidic+beta-secretase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit277R"><div class="casContent"><span class="casTitleNuber">277</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0ljb2W7G9EXjhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit277&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DSmith%2BLabell%26aufirst%3DE.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DGreg%2BHall%26aufirst%3DD.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-beta%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520beta-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref278"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref278'); return false;" data-citation="" class="refNumLink">278</a></strong><div class="NLM_citation" id="cit278"><span><span class="NLM_contrib-group">D’Onofrio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panza, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frisardi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solfrizzi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paroni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascavilla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seripa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilotto, A.</span><span> </span><span class="NLM_article-title">Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=19-37&author=G.+D%E2%80%99Onofrioauthor=F.+Panzaauthor=V.+Frisardiauthor=V.+Solfrizziauthor=B.+P.+Imbimboauthor=G.+Paroniauthor=L.+Cascavillaauthor=D.+Seripaauthor=A.+Pilotto&title=Advances+in+the+identification+of+%CE%B3-secretase+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit278&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Onofrio%26aufirst%3DG.%26aulast%3DPanza%26aufirst%3DF.%26aulast%3DFrisardi%26aufirst%3DV.%26aulast%3DSolfrizzi%26aufirst%3DV.%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26aulast%3DParoni%26aufirst%3DG.%26aulast%3DCascavilla%26aufirst%3DL.%26aulast%3DSeripa%26aufirst%3DD.%26aulast%3DPilotto%26aufirst%3DA.%26atitle%3DAdvances%2520in%2520the%2520identification%2520of%2520%25CE%25B3-secretase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2012%26volume%3D7%26spage%3D19%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref279"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref279'); return false;" data-citation="" class="refNumLink">279</a></strong><div class="NLM_citation" id="cit279"><span><span class="NLM_contrib-group">Gillman, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starrett, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcin, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElhone, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mate, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barten, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaczek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decicco, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. E.</span><span> </span><span class="NLM_article-title">Discovery and evaluation of BMS-708163, a potent, selective and orally bioavailable gamma-secretase inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml1000239" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=120-124&author=K.+W.+Gillmanauthor=J.+E.+Starrettauthor=M.+F.+Parkerauthor=K.+Xieauthor=J.+J.+Bronsonauthor=L.+R.+Marcinauthor=K.+E.+McElhoneauthor=C.+P.+Bergstromauthor=R.+A.+Mateauthor=R.+Williamsauthor=J.+E.+Meredithauthor=C.+R.+Burtonauthor=D.+M.+Bartenauthor=J.+H.+Toynauthor=S.+B.+Robertsauthor=K.+A.+Lentzauthor=J.+G.+Houstonauthor=R.+Zaczekauthor=C.+F.+Albrightauthor=C.+P.+Deciccoauthor=J.+E.+Macorauthor=R.+E.+Olson&title=Discovery+and+evaluation+of+BMS-708163%2C+a+potent%2C+selective+and+orally+bioavailable+gamma-secretase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit279&amp;dbid=16384&amp;doi=10.1021%2Fml1000239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1000239%26sid%3Dliteratum%253Aachs%26aulast%3DGillman%26aufirst%3DK.%2BW.%26aulast%3DStarrett%26aufirst%3DJ.%2BE.%26aulast%3DParker%26aufirst%3DM.%2BF.%26aulast%3DXie%26aufirst%3DK.%26aulast%3DBronson%26aufirst%3DJ.%2BJ.%26aulast%3DMarcin%26aufirst%3DL.%2BR.%26aulast%3DMcElhone%26aufirst%3DK.%2BE.%26aulast%3DBergstrom%26aufirst%3DC.%2BP.%26aulast%3DMate%26aufirst%3DR.%2BA.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DMeredith%26aufirst%3DJ.%2BE.%26aulast%3DBurton%26aufirst%3DC.%2BR.%26aulast%3DBarten%26aufirst%3DD.%2BM.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DRoberts%26aufirst%3DS.%2BB.%26aulast%3DLentz%26aufirst%3DK.%2BA.%26aulast%3DHouston%26aufirst%3DJ.%2BG.%26aulast%3DZaczek%26aufirst%3DR.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DDecicco%26aufirst%3DC.%2BP.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26atitle%3DDiscovery%2520and%2520evaluation%2520of%2520BMS-708163%252C%2520a%2520potent%252C%2520selective%2520and%2520orally%2520bioavailable%2520gamma-secretase%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D120%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref280"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref280'); return false;" data-citation="" class="refNumLink">280</a></strong><div class="NLM_citation" id="cit280"><span><span class="NLM_contrib-group">Panza, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solfrizzi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frisardi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capurso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Introno, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colacicco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vendemiale, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capurso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span> </span><span class="NLM_article-title">Disease-modifying approach to the treatment of Alzheimer’s disease: from alpha-secretase activators to gamma-secretase inhibitors and modulators</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref280/cit280&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.2165%2F11315770-000000000-00000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref280/cit280&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=19655822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref280/cit280&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOju7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2009&pages=537-555&author=F.+Panzaauthor=V.+Solfrizziauthor=V.+Frisardiauthor=C.+Capursoauthor=A.+D%E2%80%99Intronoauthor=A.+M.+Colaciccoauthor=G.+Vendemialeauthor=A.+Capursoauthor=B.+P.+Imbimbo&title=Disease-modifying+approach+to+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+from+alpha-secretase+activators+to+gamma-secretase+inhibitors+and+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit280R"><div class="casContent"><span class="casTitleNuber">280</span><div class="casTitle"><span class="NLM_cas:atitle">Disease-modifying approach to the treatment of Alzheimer's disease: from α-secretase activators to γ-secretase inhibitors and modulators</span></div><div class="casAuthors">Panza, Francesco; Solfrizzi, Vincenzo; Frisardi, Vincenza; Capurso, Cristiano; D'Introno, Alessia; Colacicco, Anna M.; Vendemiale, Gianluigi; Capurso, Antonio; Imbimbo, Bruno P.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">537-555</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Wolters Kluwer Health</span>)
        </div><div class="casAbstract">A review.  In the last decade, advances in understanding the neurobiol. of Alzheimer's disease (AD) have translated into an increase in clin. trials assessing various potential AD treatments.  At present, drugs used for the treatment of AD only slightly delay the inevitable symptomatic progression of the disease and do not affect the main neuropathol. hallmarks of the disease, i.e. senile plaques and neurofibrillary tangles.  Brain accumulation of oligomeric species of β-amyloid (Aβ) peptides, the principal components of senile plaques, is believed to play a crucial role in the development of AD.  Based on this hypothesis, huge efforts are being made to identify drugs able to interfere with proteases regulating Aβ formation from amyloid precursor protein (APP).  Compds. that stimulate α-secretase, the enzyme responsible for non-amyloidogenic metab. of APP, are being developed and one of these, EHT-0202, has recently commenced evaluation in a phase II study.  The discovery of inhibitors of β-secretase (memapsin-2, β-amyloid cleaving enzyme-1 [BACE-1]), the enzyme that regulates the first step of amyloidogenic APP metab., has proved to be particularly difficult because of inherent medicinal chem. issues and only one compd. (CTS-21166) has proceeded to clin. testing.  Conversely, several compds. that inhibit γ-secretase, the pivotal enzyme that generates Aβ, have been identified, the most advanced being LY-450139 (semagacestat), presently in phase III clin. development.  There has been considerable disappointment over the failure of a phase III study of tarenflurbil, a compd. believed to modulate the activity of y-secretase, after encouraging phase II findings.  Nevertheless, other promising y-secretase modulators are being developed and are approaching clin. testing.  All these therapeutic approaches increase the hope of slowing the rate of decline in patients with AD and modifying the natural history of this devastating disease within the next 5 years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzAE5mGxaRkLVg90H21EOLACvtfcHk0lieYC0bK8Cn7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOju7rE&md5=4c311efa2d1d777d67eba5ef68285e6e</span></div><a href="/servlet/linkout?suffix=cit280&amp;dbid=16384&amp;doi=10.2165%2F11315770-000000000-00000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F11315770-000000000-00000%26sid%3Dliteratum%253Aachs%26aulast%3DPanza%26aufirst%3DF.%26aulast%3DSolfrizzi%26aufirst%3DV.%26aulast%3DFrisardi%26aufirst%3DV.%26aulast%3DCapurso%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Introno%26aufirst%3DA.%26aulast%3DColacicco%26aufirst%3DA.%2BM.%26aulast%3DVendemiale%26aufirst%3DG.%26aulast%3DCapurso%26aufirst%3DA.%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26atitle%3DDisease-modifying%2520approach%2520to%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520from%2520alpha-secretase%2520activators%2520to%2520gamma-secretase%2520inhibitors%2520and%2520modulators%26jtitle%3DDrugs%2520Aging%26date%3D2009%26volume%3D26%26spage%3D537%26epage%3D555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref281"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref281'); return false;" data-citation="" class="refNumLink">281</a></strong><div class="NLM_citation" id="cit281"><span><span class="NLM_contrib-group">Khan, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wender, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alkon, D. L.</span><span> </span><span class="NLM_article-title">A cellular model of Alzheimer’s disease therapeutic efficacy: PKC activation reverses Abeta-induced biomarker abnormality on cultured fibroblasts</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span><span class="NLM_x">–</span> <span class="NLM_lpage">339</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref281/cit281&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.nbd.2009.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref281/cit281&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=19233276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref281/cit281&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkslKrsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=332-339&author=T.+K.+Khanauthor=T.+J.+Nelsonauthor=V.+A.+Vermaauthor=P.+A.+Wenderauthor=D.+L.+Alkon&title=A+cellular+model+of+Alzheimer%E2%80%99s+disease+therapeutic+efficacy%3A+PKC+activation+reverses+Abeta-induced+biomarker+abnormality+on+cultured+fibroblasts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit281R"><div class="casContent"><span class="casTitleNuber">281</span><div class="casTitle"><span class="NLM_cas:atitle">A cellular model of Alzheimer's disease therapeutic efficacy: PKC activation reverses Aβ-induced biomarker abnormality on cultured fibroblasts</span></div><div class="casAuthors">Khan, Tapan K.; Nelson, Thomas J.; Verma, Vishal A.; Wender, Paul A.; Alkon, Daniel L.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">332-339</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">PKC signaling is crit. for the non-toxic degrdn. of amyloid precursor protein (APP) and inhibition of GSK3β, which controls phosphorylation of tau protein in Alzheimer's disease (AD).  Thus the misregulation of PKC signaling could contribute to the origins of AD.  Bryostatin, a potent PKC modulator, has the potential to ameliorate both the neurodegeneration and the recent memory loss assocd. with AD.  As reported herein bryostatin and a potent synthetic analog (picolog) are found to cause stimulation of non-amyloidogenic pathways by increasing α-secretase activity and thus lowering the amt. of toxic Aβ produced.  Both bryostatin and picolog increased the secretion of the α-secretase product (s-APP-α) of APP at sub-nanomolar to nanomolar concns.  A peripheral AD-Biomarker has previously been autopsy-validated.  This Biomarker, based on bradykinin-induced differential phosphorylation of Erk1 and Erk2, has been used here to test the therapeutic efficacy both for bryostatin and picolog.  Both of these PKC activators are then shown to convert the AD Erk1/2 phenotype of fibroblasts into the phenotype of "normal" control skin fibroblasts.  This conversion occurred for both the abnormal Erk1/2 phenotype induced by application of Aβ1-42 to the fibroblasts or the phenotype obsd. for fibroblasts of AD patients.  The Aβ1-42-induction, and PKC modulator reversal of the AD Erk1/2 biomarker phenotype demonstrate the AD-Biomarker's potential to monitor both disease progression and treatment response.  Addnl., this first demonstration of the therapeutic potential in AD of a synthetically accessible bryostatin analog warrants further preclin. advancement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH-nc7eUhdP7Vg90H21EOLACvtfcHk0lieYC0bK8Cn7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkslKrsrc%253D&md5=646689af5b2d94bbcfec3a92f8c26320</span></div><a href="/servlet/linkout?suffix=cit281&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2009.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2009.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DT.%2BK.%26aulast%3DNelson%26aufirst%3DT.%2BJ.%26aulast%3DVerma%26aufirst%3DV.%2BA.%26aulast%3DWender%26aufirst%3DP.%2BA.%26aulast%3DAlkon%26aufirst%3DD.%2BL.%26atitle%3DA%2520cellular%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapeutic%2520efficacy%253A%2520PKC%2520activation%2520reverses%2520Abeta-induced%2520biomarker%2520abnormality%2520on%2520cultured%2520fibroblasts%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2009%26volume%3D34%26spage%3D332%26epage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref282"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref282'); return false;" data-citation="" class="refNumLink">282</a></strong><div class="NLM_citation" id="cit282"><span><span class="NLM_contrib-group">Wender, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baryza, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeChristopher, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loy, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, V. A.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of potent bryostatin analogs that modulate PKC translocation selectivity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">6721</span><span class="NLM_x">–</span> <span class="NLM_lpage">6726</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref282/cit282&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1073%2Fpnas.1015270108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref282/cit282&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=21415363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref282/cit282&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlslyrurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=6721-6726&author=P.+A.+Wenderauthor=J.+L.+Baryzaauthor=S.+E.+Brennerauthor=B.+A.+DeChristopherauthor=B.+A.+Loyauthor=A.+J.+Schrierauthor=V.+A.+Verma&title=Design%2C+synthesis%2C+and+evaluation+of+potent+bryostatin+analogs+that+modulate+PKC+translocation+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit282R"><div class="casContent"><span class="casTitleNuber">282</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and evaluation of potent bryostatin analogs that modulate PKC translocation selectivity</span></div><div class="casAuthors">Wender, Paul A.; Baryza, Jeremy L.; Brenner, Stacey E.; DeChristopher, Brian A.; Loy, Brian A.; Schrier, Adam J.; Verma, Vishal A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6721-6726, S6721/1-S6721/29</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Modern methods for the identification of therapeutic leads include chem. or virtual screening of compd. libraries.  Nature's library represents a vast and diverse source of leads, often exhibiting exquisite biol. activities.  However, the advancement of natural product leads into the clinic is often impeded by their scarcity, complexity, and nonoptimal properties or efficacy as well as the challenges assocd. with their synthesis or modification.  Function-oriented synthesis represents a strategy to address these issues through the design of simpler and therefore synthetically more accessible analogs that incorporate the activity-detg. features of the natural product leads.  This study illustrates the application of this strategy to the design and synthesis of functional analogs of the bryostatin marine natural products.  It is specifically directed at exploring the activity-detg. role of bryostatin A-ring functionality on PKC affinity and selectivity.  The resultant functional analogs, which were prepd. by a flexible, modular synthetic strategy, exhibit excellent affinity to PKC and differential isoform selectivity.  These and related studies provide the basic information needed for the design of simplified and thus synthetically more accessible functional analogs that target PKC isoforms, major targets of therapeutic interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQmWfq9UqT9LVg90H21EOLACvtfcHk0lieYC0bK8Cn7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlslyrurg%253D&md5=2d45927ddd5dab065ae42578fe288ca4</span></div><a href="/servlet/linkout?suffix=cit282&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1015270108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1015270108%26sid%3Dliteratum%253Aachs%26aulast%3DWender%26aufirst%3DP.%2BA.%26aulast%3DBaryza%26aufirst%3DJ.%2BL.%26aulast%3DBrenner%26aufirst%3DS.%2BE.%26aulast%3DDeChristopher%26aufirst%3DB.%2BA.%26aulast%3DLoy%26aufirst%3DB.%2BA.%26aulast%3DSchrier%26aufirst%3DA.%2BJ.%26aulast%3DVerma%26aufirst%3DV.%2BA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520potent%2520bryostatin%2520analogs%2520that%2520modulate%2520PKC%2520translocation%2520selectivity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D6721%26epage%3D6726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref283"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref283'); return false;" data-citation="" class="refNumLink">283</a></strong><div class="NLM_citation" id="cit283"><span><span class="NLM_contrib-group">Simons, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dichgans, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, J. B.</span><span> </span><span class="NLM_article-title">Cholesterol and Alzheimer’s disease: Is there a link?</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1089</span><span class="NLM_x">–</span> <span class="NLM_lpage">1093</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2001&pages=1089-1093&author=M.+Simonsauthor=P.+Kellerauthor=J.+Dichgansauthor=J.+B.+Schulz&title=Cholesterol+and+Alzheimer%E2%80%99s+disease%3A+Is+there+a+link%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit283&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSimons%26aufirst%3DM.%26aulast%3DKeller%26aufirst%3DP.%26aulast%3DDichgans%26aufirst%3DJ.%26aulast%3DSchulz%26aufirst%3DJ.%2BB.%26atitle%3DCholesterol%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Is%2520there%2520a%2520link%253F%26jtitle%3DNeurology%26date%3D2001%26volume%3D57%26spage%3D1089%26epage%3D1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref284"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref284'); return false;" data-citation="" class="refNumLink">284</a></strong><div class="NLM_citation" id="cit284"><span><span class="NLM_contrib-group">Simons, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutjohann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Bergmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyreuther, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dichgans, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wormstall, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, J. B.</span><span> </span><span class="NLM_article-title">Treatment with simvastatin in normocholesterolemic patients with Alzheimer’s disease: a 26-week randomized, placebo-controlled, double-blind trial</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">350</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref284/cit284&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1002%2Fana.10292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref284/cit284&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12205648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref284/cit284&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD38Xns1amtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2002&pages=346-350&author=M.+Simonsauthor=F.+Schwarzlerauthor=D.+Lutjohannauthor=K.+von+Bergmannauthor=K.+Beyreutherauthor=J.+Dichgansauthor=H.+Wormstallauthor=T.+Hartmannauthor=J.+B.+Schulz&title=Treatment+with+simvastatin+in+normocholesterolemic+patients+with+Alzheimer%E2%80%99s+disease%3A+a+26-week+randomized%2C+placebo-controlled%2C+double-blind+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit284R"><div class="casContent"><span class="casTitleNuber">284</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial</span></div><div class="casAuthors">Simons, Mikael; Schwaerzler, Frank; Luetjohann, Dieter; von Bergmann, Klaus; Beyreuther, Konrad; Dichgans, Johannes; Wormstall, Henning; Hartmann, Tobias; Schulz, Joerg B.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">346-350</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">In a randomized, placebo-controlled, double-blind study, we investigated whether statins alter cholesterol metabolites and reduce Aβ levels in the cerebrospinal fluid of 44 patients with Alzheimer's disease.  Individuals were given up to 80mg simvastatin daily or placebo for 26 wk.  Overall, simvastatin did not significantly alter cerebrospinal fluid levels of Aβ40 and Aβ42.  In post hoc anal., simvastatin significantly decreased Aβ40 levels in the cerebrospinal fluid of patients with mild Alzheimer's disease.  The redn. of Aβ40 correlated with the redn. of 24S-hydroxycholesterol.  These changes were not obsd. in more severely affected patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgNs2i4vKKW7Vg90H21EOLACvtfcHk0liZDCSaNNMU9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xns1amtr4%253D&md5=763034bf80e2d706392118bce7093024</span></div><a href="/servlet/linkout?suffix=cit284&amp;dbid=16384&amp;doi=10.1002%2Fana.10292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.10292%26sid%3Dliteratum%253Aachs%26aulast%3DSimons%26aufirst%3DM.%26aulast%3DSchwarzler%26aufirst%3DF.%26aulast%3DLutjohann%26aufirst%3DD.%26aulast%3Dvon%2BBergmann%26aufirst%3DK.%26aulast%3DBeyreuther%26aufirst%3DK.%26aulast%3DDichgans%26aufirst%3DJ.%26aulast%3DWormstall%26aufirst%3DH.%26aulast%3DHartmann%26aufirst%3DT.%26aulast%3DSchulz%26aufirst%3DJ.%2BB.%26atitle%3DTreatment%2520with%2520simvastatin%2520in%2520normocholesterolemic%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%252026-week%2520randomized%252C%2520placebo-controlled%252C%2520double-blind%2520trial%26jtitle%3DAnn.%2520Neurol.%26date%3D2002%26volume%3D52%26spage%3D346%26epage%3D350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref285"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref285'); return false;" data-citation="" class="refNumLink">285</a></strong><div class="NLM_citation" id="cit285"><span><span class="NLM_contrib-group">Puglielli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovacs, D. M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: the cholesterol connection</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">351</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref285/cit285&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnn0403-345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref285/cit285&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12658281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref285/cit285&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlequrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2003&pages=345-351&author=L.+Puglielliauthor=R.+E.+Tanziauthor=D.+M.+Kovacs&title=Alzheimer%E2%80%99s+disease%3A+the+cholesterol+connection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit285R"><div class="casContent"><span class="casTitleNuber">285</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: the cholesterol connection</span></div><div class="casAuthors">Puglielli, Luigi; Tanzi, Rudolph E.; Kovacs, Dora M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">345-351</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A hallmark of all forms of Alzheimer's disease (AD) is an abnormal accumulation of the β-amyloid protein (Aβ) in specific brain regions.  Both the generation and clearance of Aβ are regulated by cholesterol.  Elevated cholesterol levels increase Aβ in cellular and most animals models of AD, and drugs that inhibit cholesterol synthesis lower Aβ in these models.  Recent studies show that not only the total amt., but also the distribution of cholesterol within neurons, impacts Aβ biogenesis.  The identification of a variant of the apolipoprotein E (APOE) gene as a major genetic risk factor for AD is also consistent with a role for cholesterol in the pathogenesis of AD.  Clin. trials have recently been initiated to test whether lowering plasma and/or neuronal cholesterol levels is a viable strategy for treating and preventing AD.  In this review, we describe recent findings concerning the mol. mechanisms underlying the cholesterol-AD connection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjyel5PRPC67Vg90H21EOLACvtfcHk0liZDCSaNNMU9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlequrY%253D&md5=cd4d7f72ad850c6601b80f77eced97d4</span></div><a href="/servlet/linkout?suffix=cit285&amp;dbid=16384&amp;doi=10.1038%2Fnn0403-345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn0403-345%26sid%3Dliteratum%253Aachs%26aulast%3DPuglielli%26aufirst%3DL.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DKovacs%26aufirst%3DD.%2BM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520cholesterol%2520connection%26jtitle%3DNat.%2520Neurosci.%26date%3D2003%26volume%3D6%26spage%3D345%26epage%3D351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref286"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref286'); return false;" data-citation="" class="refNumLink">286</a></strong><div class="NLM_citation" id="cit286"><span><span class="NLM_contrib-group">Roy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pahan, K.</span><span> </span><span class="NLM_article-title">Prospects of statins in Parkinson disease</span> <span class="citation_source-journal">Neuroscientist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">244</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=244-255&author=A.+Royauthor=K.+Pahan&title=Prospects+of+statins+in+Parkinson+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit286&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DA.%26aulast%3DPahan%26aufirst%3DK.%26atitle%3DProspects%2520of%2520statins%2520in%2520Parkinson%2520disease%26jtitle%3DNeuroscientist%26date%3D2011%26volume%3D17%26spage%3D244%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref287"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref287'); return false;" data-citation="" class="refNumLink">287</a></strong><div class="NLM_citation" id="cit287"><span><span class="NLM_contrib-group">Valenza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattaneo, E.</span><span> </span><span class="NLM_article-title">Emerging roles for cholesterol in Huntington’s disease</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">474</span><span class="NLM_x">–</span> <span class="NLM_lpage">486</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2011&pages=474-486&author=M.+Valenzaauthor=E.+Cattaneo&title=Emerging+roles+for+cholesterol+in+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit287&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DValenza%26aufirst%3DM.%26aulast%3DCattaneo%26aufirst%3DE.%26atitle%3DEmerging%2520roles%2520for%2520cholesterol%2520in%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Neurosci.%26date%3D2011%26volume%3D34%26spage%3D474%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref288"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref288'); return false;" data-citation="" class="refNumLink">288</a></strong><div class="NLM_citation" id="cit288"><span><span class="NLM_contrib-group">Bate, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tayebi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, A.</span><span> </span><span class="NLM_article-title">Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation</span> <span class="citation_source-journal">BMC Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref288/cit288&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1186%2F1741-7007-6-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref288/cit288&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=18269734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref288/cit288&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD1c3gslKjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=8&author=C.+Bateauthor=M.+Tayebiauthor=A.+Williams&title=Sequestration+of+free+cholesterol+in+cell+membranes+by+prions+correlates+with+cytoplasmic+phospholipase+A2+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit288R"><div class="casContent"><span class="casTitleNuber">288</span><div class="casTitle"><span class="NLM_cas:atitle">Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation</span></div><div class="casAuthors">Bate Clive; Tayebi Mourad; Williams Alun</div><div class="citationInfo"><span class="NLM_cas:title">BMC biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The transmissible spongiform encephalopathies (TSEs), otherwise known as the prion diseases, occur following the conversion of the normal cellular prion protein (PrPC) to an alternatively folded isoform (PrPSc).  The accumulation of PrPSc within the brain leads to neurodegeneration through an unidentified mechanism.  Since many neurodegenerative disorders including prion, Parkinson's and Alzheimer's diseases may be modified by cholesterol synthesis inhibitors, the effects of prion infection on the cholesterol balance within neuronal cells were examined.  RESULTS:  We report the novel observation that prion infection altered the membrane composition and significantly increased total cholesterol levels in two neuronal cell lines (ScGT1 and ScN2a cells).  There was a significant correlation between the concentration of free cholesterol in ScGT1 cells and the amounts of PrPSc.  This increase was entirely a result of increased amounts of free cholesterol, as prion infection reduced the amounts of cholesterol esters in cells.  These effects were reproduced in primary cortical neurons by the addition of partially purified PrPSc, but not by PrPC.  Crucially, the effects of prion infection were not a result of increased cholesterol synthesis.  Stimulating cholesterol synthesis via the addition of mevalonate, or adding exogenous cholesterol, had the opposite effect to prion infection on the cholesterol balance.  It did not affect the amounts of free cholesterol within neurons; rather, it significantly increased the amounts of cholesterol esters.  Immunoprecipitation studies have shown that cytoplasmic phospholipase A2 (cPLA2) co-precipitated with PrPSc in ScGT1 cells.  Furthermore, prion infection greatly increased both the phosphorylation of cPLA2 and prostaglandin E2 production.  CONCLUSION:  Prion infection, or the addition of PrPSc, increased the free cholesterol content of cells, a process that could not be replicated by the stimulation of cholesterol synthesis.  The presence of PrPSc increased solubilisation of free cholesterol in cell membranes and affected their function.  It increased activation of the PLA2 pathway, previously implicated in PrPSc formation and in PrPSc-mediated neurotoxicity.  These observations suggest that the neuropathogenesis of prion diseases results from PrPSc altering cholesterol-sensitive processes.  Furthermore, they raise the possibility that disturbances in membrane cholesterol are major triggering events in neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRCrVkxYmEnhMyail4HZd-ifW6udTcc2ebrWFkFwnAi_7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3gslKjsQ%253D%253D&md5=35f6a86cd96f0f5a35dabdfe370c37cb</span></div><a href="/servlet/linkout?suffix=cit288&amp;dbid=16384&amp;doi=10.1186%2F1741-7007-6-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1741-7007-6-8%26sid%3Dliteratum%253Aachs%26aulast%3DBate%26aufirst%3DC.%26aulast%3DTayebi%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DA.%26atitle%3DSequestration%2520of%2520free%2520cholesterol%2520in%2520cell%2520membranes%2520by%2520prions%2520correlates%2520with%2520cytoplasmic%2520phospholipase%2520A2%2520activation%26jtitle%3DBMC%2520Biol.%26date%3D2008%26volume%3D6%26spage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref289"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref289'); return false;" data-citation="" class="refNumLink">289</a></strong><div class="NLM_citation" id="cit289"><span><span class="NLM_contrib-group">Tobert, J. A.</span><span> </span><span class="NLM_article-title">Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">526</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=517-526&author=J.+A.+Tobert&title=Lovastatin+and+beyond%3A+the+history+of+the+HMG-CoA+reductase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit289&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTobert%26aufirst%3DJ.%2BA.%26atitle%3DLovastatin%2520and%2520beyond%253A%2520the%2520history%2520of%2520the%2520HMG-CoA%2520reductase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D517%26epage%3D526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref290"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref290'); return false;" data-citation="" class="refNumLink">290</a></strong><div class="NLM_citation" id="cit290"><span><span class="NLM_contrib-group">Arawaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machiya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, T.</span><span> </span><span class="NLM_article-title">Heat shock proteins as suppressors of accumulation of toxic prefibrillar intermediates and misfolded proteins in neurodegenerative diseases</span> <span class="citation_source-journal">Curr. Pharm. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref290/cit290&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.2174%2F138920110790909713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref290/cit290&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20170473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref290/cit290&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFeitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=158-166&author=S.+Arawakaauthor=Y.+Machiyaauthor=T.+Kato&title=Heat+shock+proteins+as+suppressors+of+accumulation+of+toxic+prefibrillar+intermediates+and+misfolded+proteins+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit290R"><div class="casContent"><span class="casTitleNuber">290</span><div class="casTitle"><span class="NLM_cas:atitle">Heat shock proteins as suppressors of accumulation of toxic prefibrillar intermediates and misfolded proteins in neurodegenerative diseases</span></div><div class="casAuthors">Arawaka, Shigeki; Machiya, Youhei; Kato, Takeo</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Biotechnology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">158-166</span>CODEN:
                <span class="NLM_cas:coden">CPBUBP</span>;
        ISSN:<span class="NLM_cas:issn">1389-2010</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The most characteristic feature of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and Huntington's disease, is the occurrence of extra- or intracellular fibrillar aggregates contg. misfolded proteins with beta-sheet conformation.  These aggregates are composed of distinct proteins in each neurodegenerative disease.  However, mutations in genes encoding major constituents of aggregates, such as Abeta, tau, α-synuclein, SOD1 and huntingtin, were identified to causally assoc. with familial forms of the diseases.  Biochem. studies demonstrate that these mutant and some wild-type proteins tend to be misfolded or form aggregates.  It was proposed that these diseases are caused by a common mechanism involving misfolded proteins that trigger a toxic cascade leading to neuronal degeneration.  This hypothesis is the basis of the therapeutic potential of heat shock proteins (HSPs), which prevent protein misfolding and aggregation.  Transgenic animal models of the diseases have demonstrated that induction or overexpression of HSPs can suppress neuronal dysfunction and degeneration.  Do the results promise clin. success for HSP-based therapy in neurodegenerative diseases.  Recent findings regarding the pathogenic species generated during fibril formation have highlighted some of the beneficial and problematic aspects of HSP-based therapy.  In this review, we focus on the pathogenic role of prefibrillar intermediates, including sol. oligomers and protofibrils, on neurodegeneration, and the relationship between prefibrillar intermediates and the proteins targeted by HSPs.  We discuss in vitro and in vivo exptl. data showing that HSPs counteract disease progression by acting as suppressors of toxic prefibrillar intermediates and toxic misfolded proteins in neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr30J1Nolw8-7Vg90H21EOLACvtfcHk0ljTysnIfIoIhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFeitbk%253D&md5=c12affb12d00d0b106dafd4d33495dd8</span></div><a href="/servlet/linkout?suffix=cit290&amp;dbid=16384&amp;doi=10.2174%2F138920110790909713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920110790909713%26sid%3Dliteratum%253Aachs%26aulast%3DArawaka%26aufirst%3DS.%26aulast%3DMachiya%26aufirst%3DY.%26aulast%3DKato%26aufirst%3DT.%26atitle%3DHeat%2520shock%2520proteins%2520as%2520suppressors%2520of%2520accumulation%2520of%2520toxic%2520prefibrillar%2520intermediates%2520and%2520misfolded%2520proteins%2520in%2520neurodegenerative%2520diseases%26jtitle%3DCurr.%2520Pharm.%2520Biotechnol.%26date%3D2010%26volume%3D11%26spage%3D158%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref291"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref291'); return false;" data-citation="" class="refNumLink">291</a></strong><div class="NLM_citation" id="cit291"><span><span class="NLM_contrib-group">Wyttenbach, A.; Arrigo, A. P.</span><span> </span><span class="NLM_article-title">The Role of Heat Shock Proteins during Neurodegeneration in Alzheimer’s, Parkinson’s and Huntington’s Disease</span>. In  <span class="citation_source-book">Heat Shock Proteins in Neural Cells</span>; <span class="NLM_contrib-group">Richter-Landsberg, C.</span>, Ed.; <span class="NLM_publisher-name">Springer and R. G. Landes</span>: <span class="NLM_publisher-loc">Georgetown, TX, U.S.</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">125</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=125&author=A.+Wyttenbach&author=A.+P.+Arrigoauthor=C.+Richter-Landsberg&title=Heat+Shock+Proteins+in+Neural+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit291&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWyttenbach%26aufirst%3DA.%26atitle%3DThe%2520Role%2520of%2520Heat%2520Shock%2520Proteins%2520during%2520Neurodegeneration%2520in%2520Alzheimer%25E2%2580%2599s%252C%2520Parkinson%25E2%2580%2599s%2520and%2520Huntington%25E2%2580%2599s%2520Disease%26btitle%3DHeat%2520Shock%2520Proteins%2520in%2520Neural%2520Cells%26aulast%3DRichter-Landsberg%26aufirst%3DC.%26pub%3DSpringer%2520and%2520R.%2520G.%2520Landes%26date%3D2009%26spage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref292"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref292'); return false;" data-citation="" class="refNumLink">292</a></strong><div class="NLM_citation" id="cit292"><span><span class="NLM_contrib-group">Neef, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeger, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiele, D. J.</span><span> </span><span class="NLM_article-title">Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">944</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=930-944&author=D.+W.+Neefauthor=A.+M.+Jaegerauthor=D.+J.+Thiele&title=Heat+shock+transcription+factor+1+as+a+therapeutic+target+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit292&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeef%26aufirst%3DD.%2BW.%26aulast%3DJaeger%26aufirst%3DA.%2BM.%26aulast%3DThiele%26aufirst%3DD.%2BJ.%26atitle%3DHeat%2520shock%2520transcription%2520factor%25201%2520as%2520a%2520therapeutic%2520target%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D930%26epage%3D944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref293"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref293'); return false;" data-citation="" class="refNumLink">293</a></strong><div class="NLM_citation" id="cit293"><span><span class="NLM_contrib-group">Luo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Heat shock protein 90 in neurodegenerative diseases</span> <span class="citation_source-journal">Mol. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref293/cit293&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1186%2F1750-1326-5-24" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref293/cit293&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20525284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref293/cit293&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BC3cnkslCruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=24&author=W.+Luoauthor=W.+Sunauthor=T.+Tadoneauthor=A.+Rodinaauthor=G.+Chiosis&title=Heat+shock+protein+90+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit293R"><div class="casContent"><span class="casTitleNuber">293</span><div class="casTitle"><span class="NLM_cas:atitle">Heat shock protein 90 in neurodegenerative diseases</span></div><div class="casAuthors">Luo Wenjie; Sun Weilin; Taldone Tony; Rodina Anna; Chiosis Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Molecular neurodegeneration</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Hsp90 is a molecular chaperone with important roles in regulating pathogenic transformation.  In addition to its well-characterized functions in malignancy, recent evidence from several laboratories suggests a role for Hsp90 in maintaining the functional stability of neuronal proteins of aberrant capacity, whether mutated or over-activated, allowing and sustaining the accumulation of toxic aggregates.  In addition, Hsp90 regulates the activity of the transcription factor heat shock factor-1 (HSF-1), the master regulator of the heat shock response, mechanism that cells use for protection when exposed to conditions of stress.  These biological functions therefore propose Hsp90 inhibition as a dual therapeutic modality in neurodegenerative diseases.  First, by suppressing aberrant neuronal activity, Hsp90 inhibitors may ameliorate protein aggregation and its associated toxicity.  Second, by activation of HSF-1 and the subsequent induction of heat shock proteins, such as Hsp70, Hsp90 inhibitors may redirect neuronal aggregate formation, and protect against protein toxicity.  This mini-review will summarize our current knowledge on Hsp90 in neurodegeneration and will focus on the potential beneficial application of Hsp90 inhibitors in neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSYuS3z9s_ui5dYoSR9eyvsfW6udTcc2eaq4WpnmEqOyLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cnkslCruw%253D%253D&md5=dd686137ecbf1860adf2d5607eb9b229</span></div><a href="/servlet/linkout?suffix=cit293&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-5-24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-5-24%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DTadone%26aufirst%3DT.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DHeat%2520shock%2520protein%252090%2520in%2520neurodegenerative%2520diseases%26jtitle%3DMol.%2520Neurodegener.%26date%3D2010%26volume%3D5%26spage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref294"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref294'); return false;" data-citation="" class="refNumLink">294</a></strong><div class="NLM_citation" id="cit294"><span><span class="NLM_contrib-group">Trott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westerheide, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morimoto, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morano, K. A.</span><span> </span><span class="NLM_article-title">Activation of heat shock and antioxidant responses by the natural product celastrol: transcriptional signatures of a thiol-targeted molecule</span> <span class="citation_source-journal">Mol. Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1104</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref294/cit294&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1091%2Fmbc.e07-10-1004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref294/cit294&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=18199679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref294/cit294&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslemsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=1104-1112&author=A.+Trottauthor=J.+D.+Westauthor=L.+Klaicauthor=S.+D.+Westerheideauthor=R.+B.+Silvermanauthor=R.+I.+Morimotoauthor=K.+A.+Morano&title=Activation+of+heat+shock+and+antioxidant+responses+by+the+natural+product+celastrol%3A+transcriptional+signatures+of+a+thiol-targeted+molecule"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit294R"><div class="casContent"><span class="casTitleNuber">294</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of heat shock and antioxidant responses by the natural product celastrol: transcriptional signatures of a thiol-targeted molecule</span></div><div class="casAuthors">Trott, Amy; West, James D.; Klaic, Lada; Westerheide, Sandy D.; Silverman, Richard B.; Morimoto, Richard I.; Morano, Kevin A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1104-1112</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1939-4586</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Stress response pathways allow cells to sense and respond to environmental changes and adverse pathophysiol. states.  Pharmacol. modulation of cellular stress pathways has implications in the treatment of human diseases, including neurodegenerative disorders, cardiovascular disease, and cancer.  The quinone methide triterpene celastrol, derived from a traditional Chinese medicinal herb, has numerous pharmacol. properties, and it is a potent activator of the mammalian heat shock transcription factor HSF1.  However, its mode of action and spectrum of cellular targets are poorly understood.  We show here that celastrol activates Hsf1 in Saccharomyces cerevisiae at a similar effective concn. seen in mammalian cells.  Transcriptional profiling revealed that celastrol treatment induces a battery of oxidant defense genes in addn. to heat shock genes.  Celastrol activated the yeast Yap1 oxidant defense transcription factor via the carboxy-terminal redox center that responds to electrophilic compds.  Antioxidant response genes were likewise induced in mammalian cells, demonstrating that the activation of two major cell stress pathways by celastrol is conserved.  We report that celastrol's biol. effects, including inhibition of glucocorticoid receptor activity, can be blocked by the addn. of excess free thiol, suggesting a chem. mechanism for biol. activity based on modification of key reactive thiols by this natural product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUo9eonQNoz7Vg90H21EOLACvtfcHk0ljn_9DaqdFMHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslemsLg%253D&md5=3ed78a4b64b8c5471803a07b84a72e26</span></div><a href="/servlet/linkout?suffix=cit294&amp;dbid=16384&amp;doi=10.1091%2Fmbc.e07-10-1004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.e07-10-1004%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DA.%26aulast%3DWest%26aufirst%3DJ.%2BD.%26aulast%3DKlaic%26aufirst%3DL.%26aulast%3DWesterheide%26aufirst%3DS.%2BD.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26aulast%3DMorimoto%26aufirst%3DR.%2BI.%26aulast%3DMorano%26aufirst%3DK.%2BA.%26atitle%3DActivation%2520of%2520heat%2520shock%2520and%2520antioxidant%2520responses%2520by%2520the%2520natural%2520product%2520celastrol%253A%2520transcriptional%2520signatures%2520of%2520a%2520thiol-targeted%2520molecule%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2008%26volume%3D19%26spage%3D1104%26epage%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref295"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref295'); return false;" data-citation="" class="refNumLink">295</a></strong><div class="NLM_citation" id="cit295"><span><span class="NLM_contrib-group">Klaic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trippier, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morimoto, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Remarkable stereospecific conjugate additions to the Hsp90 inhibitor celastrol</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">19634</span><span class="NLM_x">–</span> <span class="NLM_lpage">19637</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja208359a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=19634-19637&author=L.+Klaicauthor=P.+C.+Trippierauthor=R.+K.+Mishraauthor=R.+I.+Morimotoauthor=R.+B.+Silverman&title=Remarkable+stereospecific+conjugate+additions+to+the+Hsp90+inhibitor+celastrol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit295&amp;dbid=16384&amp;doi=10.1021%2Fja208359a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja208359a%26sid%3Dliteratum%253Aachs%26aulast%3DKlaic%26aufirst%3DL.%26aulast%3DTrippier%26aufirst%3DP.%2BC.%26aulast%3DMishra%26aufirst%3DR.%2BK.%26aulast%3DMorimoto%26aufirst%3DR.%2BI.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DRemarkable%2520stereospecific%2520conjugate%2520additions%2520to%2520the%2520Hsp90%2520inhibitor%2520celastrol%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D19634%26epage%3D19637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref296"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref296'); return false;" data-citation="" class="refNumLink">296</a></strong><div class="NLM_citation" id="cit296"><span><span class="NLM_contrib-group">Kieran, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalmar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddoch-Contreras, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnstock, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greensmith, L.</span><span> </span><span class="NLM_article-title">Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">402</span><span class="NLM_x">–</span> <span class="NLM_lpage">405</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref296/cit296&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnm1021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref296/cit296&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=15034571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref296/cit296&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1ektL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=402-405&author=D.+Kieranauthor=B.+Kalmarauthor=J.+R.+Dickauthor=J.+Riddoch-Contrerasauthor=G.+Burnstockauthor=L.+Greensmith&title=Treatment+with+arimoclomol%2C+a+coinducer+of+heat+shock+proteins%2C+delays+disease+progression+in+ALS+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit296R"><div class="casContent"><span class="casTitleNuber">296</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice</span></div><div class="casAuthors">Kieran, Dairin; Kalmar, Bernadett; Dick, James R. T.; Riddoch-Contreras, Joanna; Burnstock, Geoffrey; Greensmith, Linda</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">402-405</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative condition in which motoneurons of the spinal cord and motor cortex die, resulting in progressive paralysis.  This condition has no cure and results in eventual death, usually within 1-5 yr of diagnosis.  Although the specific etiol. of ALS is unknown, 20% of familial cases of the disease carry mutations in the gene encoding Cu/Zn superoxide dismutase-1 (SOD1).  Transgenic mice overexpressing human mutant SOD1 have a phenotype and pathol. that are very similar to that seen in human ALS patients.  Here we show that treatment with arimoclomol, a coinducer of heat shock proteins (HSPs), significantly delays disease progression in mice expressing a SOD1 mutant in which glycine is substituted with alanine at position 93 (SOD1G93A).  Arimoclomol-treated SOD1G93A mice show marked improvement in hind limb muscle function and motoneuron survival in the later stages of the disease, resulting in a 22% increase in lifespan.  Pharmacol. activation of the heat shock response may therefore be a successful therapeutic approach to treating ALS, and possibly other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBaaFjZGbFG7Vg90H21EOLACvtfcHk0ljn_9DaqdFMHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1ektL0%253D&md5=9bed550d76bcc6a34f71f404aa378392</span></div><a href="/servlet/linkout?suffix=cit296&amp;dbid=16384&amp;doi=10.1038%2Fnm1021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1021%26sid%3Dliteratum%253Aachs%26aulast%3DKieran%26aufirst%3DD.%26aulast%3DKalmar%26aufirst%3DB.%26aulast%3DDick%26aufirst%3DJ.%2BR.%26aulast%3DRiddoch-Contreras%26aufirst%3DJ.%26aulast%3DBurnstock%26aufirst%3DG.%26aulast%3DGreensmith%26aufirst%3DL.%26atitle%3DTreatment%2520with%2520arimoclomol%252C%2520a%2520coinducer%2520of%2520heat%2520shock%2520proteins%252C%2520delays%2520disease%2520progression%2520in%2520ALS%2520mice%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D402%26epage%3D405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref297"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref297'); return false;" data-citation="" class="refNumLink">297</a></strong><div class="NLM_citation" id="cit297"><span><span class="NLM_contrib-group">Evans, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gestwicki, J. E.</span><span> </span><span class="NLM_article-title">Heat shock protein 70 (Hsp70) as an emerging drug target</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4585</span><span class="NLM_x">–</span> <span class="NLM_lpage">4602</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100054f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref297/cit297&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4585-4602&author=C.+G.+Evansauthor=L.+Changauthor=J.+E.+Gestwicki&title=Heat+shock+protein+70+%28Hsp70%29+as+an+emerging+drug+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit297R"><div class="casContent"><span class="casTitleNuber">297</span><div class="casTitle"><span class="NLM_cas:atitle">Heat Shock Protein 70 (Hsp70) as an Emerging Drug Target</span></div><div class="casAuthors">Evans, Christopher G.; Chang, Lyra; Gestwicki, Jason E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4585-4602</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5hrQMA77XsrVg90H21EOLACvtfcHk0ljn_9DaqdFMHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejsLc%253D&md5=b87bdc9b76e66d62c130a162037387b5</span></div><a href="/servlet/linkout?suffix=cit297&amp;dbid=16384&amp;doi=10.1021%2Fjm100054f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100054f%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DC.%2BG.%26aulast%3DChang%26aufirst%3DL.%26aulast%3DGestwicki%26aufirst%3DJ.%2BE.%26atitle%3DHeat%2520shock%2520protein%252070%2520%2528Hsp70%2529%2520as%2520an%2520emerging%2520drug%2520target%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4585%26epage%3D4602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref298"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref298'); return false;" data-citation="" class="refNumLink">298</a></strong><div class="NLM_citation" id="cit298"><span><span class="NLM_contrib-group">Fleming, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubinsztein, D. C.</span><span> </span><span class="NLM_article-title">Chemical modulators of autophagy as biological probes and potential therapeutics</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref298/cit298&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnchembio.500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref298/cit298&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=21164513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref298/cit298&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFOjtrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=9-17&author=A.+Flemingauthor=T.+Nodaauthor=T.+Yoshimoriauthor=D.+C.+Rubinsztein&title=Chemical+modulators+of+autophagy+as+biological+probes+and+potential+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit298R"><div class="casContent"><span class="casTitleNuber">298</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical modulators of autophagy as biological probes and potential therapeutics</span></div><div class="casAuthors">Fleming, Angeleen; Noda, Takeshi; Yoshimori, Tamotsu; Rubinsztein, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-17</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Autophagy is an evolutionarily conserved mechanism for protein degrdn. that is crit. for the maintenance of homeostasis in man.  Autophagy has unexpected pleiotropic functions that favor survival of the cell, including nutrient supply under starvation, cleaning of the cellular interior, defense against infection and antigen presentation.  Moreover, defective autophagy is assocd. with a diverse range of disease states, including neurodegeneration, cancer and Crohn's disease.  Here we discuss the roles of mammalian autophagy in health and disease and highlight recent advances in pharmacol. manipulation of autophagic pathways as a therapeutic strategy for a variety of pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhtwNQMxbsPbVg90H21EOLACvtfcHk0lixPJiXSzdLzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFOjtrrP&md5=5b4a84766cb3bb3d5a095254b4b36d04</span></div><a href="/servlet/linkout?suffix=cit298&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.500%26sid%3Dliteratum%253Aachs%26aulast%3DFleming%26aufirst%3DA.%26aulast%3DNoda%26aufirst%3DT.%26aulast%3DYoshimori%26aufirst%3DT.%26aulast%3DRubinsztein%26aufirst%3DD.%2BC.%26atitle%3DChemical%2520modulators%2520of%2520autophagy%2520as%2520biological%2520probes%2520and%2520potential%2520therapeutics%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D9%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref299"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref299'); return false;" data-citation="" class="refNumLink">299</a></strong><div class="NLM_citation" id="cit299"><span><span class="NLM_contrib-group">Bove, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Vicente, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vila, M.</span><span> </span><span class="NLM_article-title">Fighting neurodegeneration with rapamycin: mechanistic insights</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref299/cit299&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnrn3068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref299/cit299&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=21772323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref299/cit299&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptV2isbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=437-452&author=J.+Boveauthor=M.+Martinez-Vicenteauthor=M.+Vila&title=Fighting+neurodegeneration+with+rapamycin%3A+mechanistic+insights"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit299R"><div class="casContent"><span class="casTitleNuber">299</span><div class="casTitle"><span class="NLM_cas:atitle">Fighting neurodegeneration with rapamycin: mechanistic insights</span></div><div class="casAuthors">Bove, Jordi; Martinez-Vicente, Marta; Vila, Miquel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">437-452</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A growing no. of studies point to rapamycin as a pharmacol. compd. that is able to provide neuroprotection in several exptl. models of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, Huntington's disease and spinocerebellar ataxia type 3.  In addn., rapamycin exerts strong anti-ageing effects in several species, including mammals.  By inhibiting the activity of mammalian target of rapamycin (mTOR), rapamycin influences a variety of essential cellular processes, such as cell growth and proliferation, protein synthesis and autophagy.  Here, we review the mol. mechanisms underlying the neuroprotective effects of rapamycin and discuss the therapeutic potential of this compd. for neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlSMJw9qqEE7Vg90H21EOLACvtfcHk0lixPJiXSzdLzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptV2isbs%253D&md5=9877fdf5ed611a5454e95153f086b7d9</span></div><a href="/servlet/linkout?suffix=cit299&amp;dbid=16384&amp;doi=10.1038%2Fnrn3068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3068%26sid%3Dliteratum%253Aachs%26aulast%3DBove%26aufirst%3DJ.%26aulast%3DMartinez-Vicente%26aufirst%3DM.%26aulast%3DVila%26aufirst%3DM.%26atitle%3DFighting%2520neurodegeneration%2520with%2520rapamycin%253A%2520mechanistic%2520insights%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2011%26volume%3D12%26spage%3D437%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref300"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref300'); return false;" data-citation="" class="refNumLink">300</a></strong><div class="NLM_citation" id="cit300"><span><span class="NLM_contrib-group">Casarejos, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solano, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perucho, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Yebenes, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mena, M. A.</span><span> </span><span class="NLM_article-title">The accumulation of neurotoxic proteins, induced by proteasome inhibition, is reverted by trehalose, an enhancer of autophagy, in human neuroblastoma cells</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">512</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref300/cit300&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.neuint.2011.01.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref300/cit300&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=21232572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref300/cit300&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFGnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2011&pages=512-520&author=M.+J.+Casarejosauthor=R.+M.+Solanoauthor=A.+Gomezauthor=J.+Peruchoauthor=J.+G.+de+Yebenesauthor=M.+A.+Mena&title=The+accumulation+of+neurotoxic+proteins%2C+induced+by+proteasome+inhibition%2C+is+reverted+by+trehalose%2C+an+enhancer+of+autophagy%2C+in+human+neuroblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit300R"><div class="casContent"><span class="casTitleNuber">300</span><div class="casTitle"><span class="NLM_cas:atitle">The accumulation of neurotoxic proteins, induced by proteasome inhibition, is reverted by trehalose, an enhancer of autophagy, in human neuroblastoma cells</span></div><div class="casAuthors">Casarejos, M. J.; Solano, R. M.; Gomez, A.; Perucho, J.; de Yebenes, J. G.; Mena, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">512-520</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Neurodegenerative diseases like Parkinson's disease, Alzheimer's disease, Huntington's disease and others are due to accumulation of abnormal proteins which fold improperly and impair neuronal function.  Accumulation of these proteins could be achieved by several mechanisms including mutation, overprodn. or impairment of its degrdn.  Inhibition of the normal protein degrdn. is produced by blockade of the ubiquitin proteasome system.  We have shown that epoxomicin, a proteasome inhibitor, increases the levels of proteins involved in neurodegenerative disorders such as α-synuclein and hyper phosphorylated tau in NB69 human neuroblastoma cells and that such increase correlates with an enhanced rate of cell death.  We then investigated whether the stimulation of autophagy, an alternative mechanism for elimination of abnormal proteins, by treatment with trehalose, counteracts the effects of proteasomal blockade.  Trehalose, a disaccharide present in many non-mammalian species, known to enhance autophagy, protects cells against various environmental stresses.  Treatment with trehalose produced a dose and time-dependent increase in the no. of autophagosomes and markers of autophagy in NB69 cells.  Trehalose did not change the no. of total neither the no. of dividing cells in the culture but it completely prevented the necrosis of NB69 induced by epoxomicin.  In addn., the treatment with trehalose reverted the accumulation, induced by epoxomicin, of polyubiquitinated proteins, total and phosphorylated tau, p-GSK-3, and α-synuclein, as well as the α-synuclein intracellular aggregates.  The effects of trehalose were not mediated through activation of free radical scavenging compds., like GSH, or mitochondrial proteins, like DJ1, but trehalose reduced the activation of ERK and chaperone HSP-70 induced by epoxomicin.  Inhibition of ERK phosphorylation prevented the epoxomicin-induced cell death.  Inhibition of autophagy reverted the neuroprotective effects of trehalose in epoxomicin-induced cell death.  These results suggest that trehalose is a powerful modifier of abnormal protein accumulation in neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqm4ZwgOMkH7Vg90H21EOLACvtfcHk0lixPJiXSzdLzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFGnsb8%253D&md5=1d8884f23645d4324b7834cd2ed6d00c</span></div><a href="/servlet/linkout?suffix=cit300&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2011.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2011.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DCasarejos%26aufirst%3DM.%2BJ.%26aulast%3DSolano%26aufirst%3DR.%2BM.%26aulast%3DGomez%26aufirst%3DA.%26aulast%3DPerucho%26aufirst%3DJ.%26aulast%3Dde%2BYebenes%26aufirst%3DJ.%2BG.%26aulast%3DMena%26aufirst%3DM.%2BA.%26atitle%3DThe%2520accumulation%2520of%2520neurotoxic%2520proteins%252C%2520induced%2520by%2520proteasome%2520inhibition%252C%2520is%2520reverted%2520by%2520trehalose%252C%2520an%2520enhancer%2520of%2520autophagy%252C%2520in%2520human%2520neuroblastoma%2520cells%26jtitle%3DNeurochem.%2520Int.%26date%3D2011%26volume%3D58%26spage%3D512%26epage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref301"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref301'); return false;" data-citation="" class="refNumLink">301</a></strong><div class="NLM_citation" id="cit301"><span><span class="NLM_contrib-group">Dennissen, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kholod, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Leeuwen, F. W.</span><span> </span><span class="NLM_article-title">The ubiquitin proteasome system in neurodegenerative diseases: Culprit, accomplice or victim?</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref301/cit301&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.pneurobio.2012.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref301/cit301&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=22270043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref301/cit301&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFGgt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2012&pages=190-207&author=F.+J.+Dennissenauthor=N.+Kholodauthor=F.+W.+van+Leeuwen&title=The+ubiquitin+proteasome+system+in+neurodegenerative+diseases%3A+Culprit%2C+accomplice+or+victim%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit301R"><div class="casContent"><span class="casTitleNuber">301</span><div class="casTitle"><span class="NLM_cas:atitle">The ubiquitin proteasome system in neurodegenerative diseases: Culprit, accomplice or victim?</span></div><div class="casAuthors">Dennissen, F. J. A.; Kholod, N.; van Leeuwen, F. W.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">190-207</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A shared hallmark for many neurodegenerative disorders is the accumulation of toxic protein species which is assumed to be the cause for these diseases.  Since the ubiquitin proteasome system (UPS) is the most important pathway for selective protein degrdn. it is likely that it is involved in the etiol. neurodegenerative disorders.  Indeed, impairment of the UPS has been reported to occur during neurodegeneration.  Although accumulation of toxic protein species (amyloid β) are in turn known to impair the UPS the relationship is not necessarily causal.  We provide an overview of the most recent insights in the roles the UPS plays in protein degrdn. and other processes.  Addnl., we discuss the role of the UPS in clearance of the toxic proteins known to accumulate in the hallmarks of neurodegenerative diseases.  The present paper will focus on critically reviewing the involvement of the UPS in specific neurodegenerative diseases and will discuss if UPS impairment is a cause, a consequence or both of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvnTK0w6-dVLVg90H21EOLACvtfcHk0lid3ueyDMDdMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFGgt7w%253D&md5=3d88d59d10a89458bb7cc89553194f39</span></div><a href="/servlet/linkout?suffix=cit301&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2012.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2012.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DDennissen%26aufirst%3DF.%2BJ.%26aulast%3DKholod%26aufirst%3DN.%26aulast%3Dvan%2BLeeuwen%26aufirst%3DF.%2BW.%26atitle%3DThe%2520ubiquitin%2520proteasome%2520system%2520in%2520neurodegenerative%2520diseases%253A%2520Culprit%252C%2520accomplice%2520or%2520victim%253F%26jtitle%3DProg.%2520Neurobiol.%26date%3D2012%26volume%3D96%26spage%3D190%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref302"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref302'); return false;" data-citation="" class="refNumLink">302</a></strong><div class="NLM_citation" id="cit302"><span><span class="NLM_contrib-group">Luo, G.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, W.-D.</span><span> </span><span class="NLM_article-title">Are heat shock proteins therapeutic target for Parkinson’s disease?</span> <span class="citation_source-journal">Int. J. Biol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref302/cit302&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.7150%2Fijbs.3.20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref302/cit302&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCmtr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=20-26&author=G.-R.+Luoauthor=S.+Chenauthor=W.-D.+Le&title=Are+heat+shock+proteins+therapeutic+target+for+Parkinson%E2%80%99s+disease%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit302R"><div class="casContent"><span class="casTitleNuber">302</span><div class="casTitle"><span class="NLM_cas:atitle">Are heat shock proteins therapeutic target for Parkinson's disease?</span></div><div class="casAuthors">Luo, Guang-Rui; Chen, Sheng; Le, Wei-Dong</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biological Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-26</span>CODEN:
                <span class="NLM_cas:coden">IJBSB9</span>;
        ISSN:<span class="NLM_cas:issn">1449-2288</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">A review.  Heat shock proteins (HSPs), known as mol. chaperone to assist protein folding, have recently become a research focus in Parkinson's disease (PD) because the pathogenesis of this disease is highlighted by the intracellular protein misfolding and inclusion body formation.  The present review will focus on the functions of different HSPs and their protective roles in PD.  It is postulated that HSPs may serve as protein folding machinery and work together with ubiquitin-proteasome system (UPS) to assist in decompg. aberrant proteins.  Failure of UPS is thought to play a key role in the pathogenesis of PD.  In addn., HSPs may possess anti-apoptotic effects and keep the homeostasis of dopaminergic neurons against stress conditions.  The crit. role of HSPs and recent discovery of some novel HSPs inducers suggest that HSPs may be potential therapeutic targets for PD and other neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3IzDIptaAiLVg90H21EOLACvtfcHk0lid3ueyDMDdMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCmtr%252FP&md5=9f0df828092b3be4d825d6234d8dba38</span></div><a href="/servlet/linkout?suffix=cit302&amp;dbid=16384&amp;doi=10.7150%2Fijbs.3.20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fijbs.3.20%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DG.-R.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DLe%26aufirst%3DW.-D.%26atitle%3DAre%2520heat%2520shock%2520proteins%2520therapeutic%2520target%2520for%2520Parkinson%25E2%2580%2599s%2520disease%253F%26jtitle%3DInt.%2520J.%2520Biol.%2520Sci.%26date%3D2007%26volume%3D3%26spage%3D20%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref303"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref303'); return false;" data-citation="" class="refNumLink">303</a></strong><div class="NLM_citation" id="cit303"><span><span class="NLM_contrib-group">Zhao, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. Y.</span><span> </span><span class="NLM_article-title">Chemical chaperone and inhibitor discovery: potential treatments for protein conformational diseases</span> <span class="citation_source-journal">Perspect. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref303/cit303&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD1MnnslSgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2008&pages=39-48&author=J.+H.+Zhaoauthor=H.+L.+Liuauthor=H.+Y.+Linauthor=C.+H.+Huangauthor=H.+W.+Fangauthor=S.+S.+Chenauthor=Y.+Hoauthor=W.+B.+Tsaiauthor=W.+Y.+Chen&title=Chemical+chaperone+and+inhibitor+discovery%3A+potential+treatments+for+protein+conformational+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit303R"><div class="casContent"><span class="casTitleNuber">303</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical chaperone and inhibitor discovery: potential treatments for protein conformational diseases</span></div><div class="casAuthors">Zhao Jian-Hua; Liu Hsuan-Liang; Lin Hsin-Yi; Huang Chih-Hung; Fang Hsu-Wei; Chen Shiao-Shing; Ho Yih; Tsai Wei-Bor; Chen Wen-Yih</div><div class="citationInfo"><span class="NLM_cas:title">Perspectives in medicinal chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">39-48</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Protein misfolding and aggregation cause a large number of neurodegenerative diseases in humans due to (i) gain of function as observed in Alzheimer's disease, Huntington's disease, Parkinson's disease, and Prion's disease or (ii) loss of function as observed in cystic fibrosis and alpha1-antitrypsin deficiency.  These misfolded proteins could either lead to the formation of harmful amyloids that become toxic for the cells or to be recognized and prematurely degraded by the protein quality control system.  An increasing number of studies has indicated that some low-molecular-weight compounds named as chemical chaperones can reverse the mislocalization and/or aggregation of proteins associated with human conformational diseases.  These small molecules are thought to non-selectively stabilize proteins and facilitate their folding.  In this review, we summarize the probable mechanisms of protein conformational diseases in humans and the use of chemical chaperones and inhibitors as potential therapeutic agents against these diseases.  Furthermore, recent advanced experimental and theoretical approaches underlying the detailed mechanisms of protein conformational changes and current structure-based drug designs towards protein conformational diseases are also discussed.  It is believed that a better understanding of the mechanisms of conformational changes as well as the biological functions of these proteins will lead to the development and design of potential interfering compounds against amyloid formation associated with protein conformational diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTXM2ChGVrbaP6BottYdIAWfW6udTcc2eY4ikrXbQNL3Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MnnslSgtw%253D%253D&md5=d1fd333b602c2c25a35f369e24507fe9</span></div><a href="/servlet/linkout?suffix=cit303&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%2BH.%26aulast%3DLiu%26aufirst%3DH.%2BL.%26aulast%3DLin%26aufirst%3DH.%2BY.%26aulast%3DHuang%26aufirst%3DC.%2BH.%26aulast%3DFang%26aufirst%3DH.%2BW.%26aulast%3DChen%26aufirst%3DS.%2BS.%26aulast%3DHo%26aufirst%3DY.%26aulast%3DTsai%26aufirst%3DW.%2BB.%26aulast%3DChen%26aufirst%3DW.%2BY.%26atitle%3DChemical%2520chaperone%2520and%2520inhibitor%2520discovery%253A%2520potential%2520treatments%2520for%2520protein%2520conformational%2520diseases%26jtitle%3DPerspect.%2520Med.%2520Chem.%26date%3D2008%26volume%3D1%26spage%3D39%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref304"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref304'); return false;" data-citation="" class="refNumLink">304</a></strong><div class="NLM_citation" id="cit304"><span><span class="NLM_contrib-group">Ali, Y. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitay, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, R. G.</span><span> </span><span class="NLM_article-title">Dealing with misfolded proteins: examining the neuroprotective role of molecular chaperones in neurodegeneration</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">6859</span><span class="NLM_x">–</span> <span class="NLM_lpage">6887</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=6859-6887&author=Y.+O.+Aliauthor=B.+M.+Kitayauthor=R.+G.+Zhai&title=Dealing+with+misfolded+proteins%3A+examining+the+neuroprotective+role+of+molecular+chaperones+in+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit304&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DY.%2BO.%26aulast%3DKitay%26aufirst%3DB.%2BM.%26aulast%3DZhai%26aufirst%3DR.%2BG.%26atitle%3DDealing%2520with%2520misfolded%2520proteins%253A%2520examining%2520the%2520neuroprotective%2520role%2520of%2520molecular%2520chaperones%2520in%2520neurodegeneration%26jtitle%3DMolecules%26date%3D2010%26volume%3D15%26spage%3D6859%26epage%3D6887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref305"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref305'); return false;" data-citation="" class="refNumLink">305</a></strong><div class="NLM_citation" id="cit305"><span><span class="NLM_contrib-group">Cuajungco, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faget, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, A. I.</span><span> </span><span class="NLM_article-title">Metal chelation as a potential therapy for Alzheimer’s disease</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">920</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=920&publication_year=2000&pages=292-304&author=M.+P.+Cuajungcoauthor=K.+Y.+Fagetauthor=X.+Huangauthor=R.+E.+Tanziauthor=A.+I.+Bush&title=Metal+chelation+as+a+potential+therapy+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit305&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCuajungco%26aufirst%3DM.%2BP.%26aulast%3DFaget%26aufirst%3DK.%2BY.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DMetal%2520chelation%2520as%2520a%2520potential%2520therapy%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2000%26volume%3D920%26spage%3D292%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref306"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref306'); return false;" data-citation="" class="refNumLink">306</a></strong><div class="NLM_citation" id="cit306"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span> </span><span class="NLM_article-title">Inhibitory action of macrocyclic platiniferous chelators on metal-induced Ab aggregation</span> <span class="citation_source-journal">Chem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1304</span><span class="NLM_x">–</span> <span class="NLM_lpage">1312</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref306/cit306&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1039%2Fc2sc01100j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref306/cit306&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1Onu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1304-1312&author=X.+Wangauthor=X.+Wangauthor=C.+Zhangauthor=Y.+Jiaoauthor=Z.+Guo&title=Inhibitory+action+of+macrocyclic+platiniferous+chelators+on+metal-induced+Ab+aggregation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit306R"><div class="casContent"><span class="casTitleNuber">306</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory action of macrocyclic platiniferous chelators on metal-induced Aβ aggregation</span></div><div class="casAuthors">Wang, Xiaohui; Wang, Xiaoyong; Zhang, Changli; Jiao, Yang; Guo, Zijian</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1304-1312</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative illness assocd. with amyloid β-peptide (Aβ) aggregation in the brain.  Aβ shows high affinity for metal ions such as Zn2+ and Cu2+, which constitutes the major reason for the Aβ aggregation and related neurotoxicity.  Metal chelators are potential therapeutic agents for AD because they could sequester metal ions from the Aβ aggregates and reverse the aggregation.  In this study, two macrocyclic platiniferous chelators (PC1, PC2) with cyclen as the metal-chelating unit and Pt(bipyridine)Cl2 as the Aβ-binding unit have been designed as novel bifunctional inhibitors of the metal-induced Aβ aggregation.  The interactions between the chelators and Aβ40 aggregates are studied by tandem mass spectrometry and 1H NMR.  The platinum centers in PC1 and PC2 are shown to coordinate with histidine residues (His-14 or -13) of Aβ40.  The inhibitory effect of the chelators on Aβ40 aggregation induced by Zn2+ and Cu2+ ions is investigated using turbidimetry, a BCA protein assay, and transmission electron microscopy.  PC1 and PC2 show significant inhibition against the Aβ aggregation and the action is more effective than that exerted by cyclen.  By contrast, the corresponding anticancer drug cisplatin exhibits no inhibition against the Aβ aggregation.  PC1 and PC2 can also suppress the Cu-Aβ40 mediated generation of reactive oxygen species and their corresponding neurotoxicity in cortical neuronal cells of mice, and reduce the extent of Aβ aggregation in the brain homogenates of transgenic mice.  These chelators may work through simultaneous metal chelation and peptide modification to interfere with the Aβ aggregation.  Such an intramol. synergism distinguishes PC1 and PC2 from other chelators as potential anti-AD agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9O3gp9Njxh7Vg90H21EOLACvtfcHk0lg3iNl_WmyGvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1Onu7Y%253D&md5=c2ef80922e9e352ae003a33a41f2e48e</span></div><a href="/servlet/linkout?suffix=cit306&amp;dbid=16384&amp;doi=10.1039%2Fc2sc01100j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2sc01100j%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DJiao%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DZ.%26atitle%3DInhibitory%2520action%2520of%2520macrocyclic%2520platiniferous%2520chelators%2520on%2520metal-induced%2520Ab%2520aggregation%26jtitle%3DChem.%2520Sci.%26date%3D2012%26volume%3D3%26spage%3D1304%26epage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref307"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref307'); return false;" data-citation="" class="refNumLink">307</a></strong><div class="NLM_citation" id="cit307"><span><span class="NLM_contrib-group">Wisniewski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadowski, M.</span><span> </span><span class="NLM_article-title">Preventing beta-amyloid fibrillization and deposition: beta-sheet breakers and pathological chaperone inhibitors</span> <span class="citation_source-journal">BMC Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S5</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=S5&issue=Suppl.+2&author=T.+Wisniewskiauthor=M.+Sadowski&title=Preventing+beta-amyloid+fibrillization+and+deposition%3A+beta-sheet+breakers+and+pathological+chaperone+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit307&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWisniewski%26aufirst%3DT.%26aulast%3DSadowski%26aufirst%3DM.%26atitle%3DPreventing%2520beta-amyloid%2520fibrillization%2520and%2520deposition%253A%2520beta-sheet%2520breakers%2520and%2520pathological%2520chaperone%2520inhibitors%26jtitle%3DBMC%2520Neurosci.%26date%3D2008%26volume%3D9%26issue%3DSuppl.%25202%26spage%3DS5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref308"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref308'); return false;" data-citation="" class="refNumLink">308</a></strong><div class="NLM_citation" id="cit308"><span><span class="NLM_contrib-group">Simons, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caprathe, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeVine, H.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipinski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakkab, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augelli-Szafran, C. E.</span><span> </span><span class="NLM_article-title">The synthesis and structure–activity relationship of substituted <i>N</i>-phenyl anthranilic acid analogs as amyloid aggregation inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">654</span><span class="NLM_x">–</span> <span class="NLM_lpage">657</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=654-657&author=L.+J.+Simonsauthor=B.+W.+Capratheauthor=M.+Callahanauthor=J.+M.+Grahamauthor=T.+Kimuraauthor=Y.+Laiauthor=H.+LeVineauthor=W.+Lipinskiauthor=A.+T.+Sakkabauthor=Y.+Tasakiauthor=L.+C.+Walkerauthor=T.+Yasunagaauthor=Y.+Yeauthor=N.+Zhuangauthor=C.+E.+Augelli-Szafran&title=The+synthesis+and+structure%E2%80%93activity+relationship+of+substituted+N-phenyl+anthranilic+acid+analogs+as+amyloid+aggregation+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit308&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSimons%26aufirst%3DL.%2BJ.%26aulast%3DCaprathe%26aufirst%3DB.%2BW.%26aulast%3DCallahan%26aufirst%3DM.%26aulast%3DGraham%26aufirst%3DJ.%2BM.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DLeVine%26aufirst%3DH.%26aulast%3DLipinski%26aufirst%3DW.%26aulast%3DSakkab%26aufirst%3DA.%2BT.%26aulast%3DTasaki%26aufirst%3DY.%26aulast%3DWalker%26aufirst%3DL.%2BC.%26aulast%3DYasunaga%26aufirst%3DT.%26aulast%3DYe%26aufirst%3DY.%26aulast%3DZhuang%26aufirst%3DN.%26aulast%3DAugelli-Szafran%26aufirst%3DC.%2BE.%26atitle%3DThe%2520synthesis%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520substituted%2520N-phenyl%2520anthranilic%2520acid%2520analogs%2520as%2520amyloid%2520aggregation%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D654%26epage%3D657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref309"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref309'); return false;" data-citation="" class="refNumLink">309</a></strong><div class="NLM_citation" id="cit309"><span><span class="NLM_contrib-group">Heiser, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engernann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunkel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeddrich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waelter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordhoff, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lurz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schugardt, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rautenberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herhaus, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnickel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottcher, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehrach, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanker, E. E.</span><span> </span><span class="NLM_article-title">Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington’s disease by using an automated filter retardation assay</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">16400</span><span class="NLM_x">–</span> <span class="NLM_lpage">16406</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=16400-16406&author=V.+Heiserauthor=S.+Engernannauthor=W.+Brockerauthor=I.+Dunkelauthor=A.+Boeddrichauthor=S.+Waelterauthor=E.+Nordhoffauthor=R.+Lurzauthor=N.+Schugardtauthor=S.+Rautenbergauthor=C.+Herhausauthor=G.+Barnickelauthor=H.+Bottcherauthor=H.+Lehrachauthor=E.+E.+Wanker&title=Identification+of+benzothiazoles+as+potential+polyglutamine+aggregation+inhibitors+of+Huntington%E2%80%99s+disease+by+using+an+automated+filter+retardation+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit309&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeiser%26aufirst%3DV.%26aulast%3DEngernann%26aufirst%3DS.%26aulast%3DBrocker%26aufirst%3DW.%26aulast%3DDunkel%26aufirst%3DI.%26aulast%3DBoeddrich%26aufirst%3DA.%26aulast%3DWaelter%26aufirst%3DS.%26aulast%3DNordhoff%26aufirst%3DE.%26aulast%3DLurz%26aufirst%3DR.%26aulast%3DSchugardt%26aufirst%3DN.%26aulast%3DRautenberg%26aufirst%3DS.%26aulast%3DHerhaus%26aufirst%3DC.%26aulast%3DBarnickel%26aufirst%3DG.%26aulast%3DBottcher%26aufirst%3DH.%26aulast%3DLehrach%26aufirst%3DH.%26aulast%3DWanker%26aufirst%3DE.%2BE.%26atitle%3DIdentification%2520of%2520benzothiazoles%2520as%2520potential%2520polyglutamine%2520aggregation%2520inhibitors%2520of%2520Huntington%25E2%2580%2599s%2520disease%2520by%2520using%2520an%2520automated%2520filter%2520retardation%2520assay%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D16400%26epage%3D16406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref310"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref310'); return false;" data-citation="" class="refNumLink">310</a></strong><div class="NLM_citation" id="cit310"><span><span class="NLM_contrib-group">Geldenhuys, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Schyf, C. J.</span><span> </span><span class="NLM_article-title">Designing drugs with multi-target activity: the next step in the treatment of neurodegenerative disorders</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=115-129&author=W.+J.+Geldenhuysauthor=C.+J.+Van+der+Schyf&title=Designing+drugs+with+multi-target+activity%3A+the+next+step+in+the+treatment+of+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit310&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeldenhuys%26aufirst%3DW.%2BJ.%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26atitle%3DDesigning%2520drugs%2520with%2520multi-target%2520activity%253A%2520the%2520next%2520step%2520in%2520the%2520treatment%2520of%2520neurodegenerative%2520disorders%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2013%26volume%3D8%26spage%3D115%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref311"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref311'); return false;" data-citation="" class="refNumLink">311</a></strong><div class="NLM_citation" id="cit311"><span><span class="NLM_contrib-group">Rizzo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Costa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligresti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrelia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span> </span><span class="NLM_article-title">2-Arylbenzofuran-based molecules as multipotent Alzheimer’s disease modifying agents</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2012&pages=519-532&author=S.+Rizzoauthor=A.+Tarozziauthor=M.+Bartoliniauthor=G.+Da+Costaauthor=A.+Bisiauthor=S.+Gobbiauthor=F.+Bellutiauthor=A.+Ligrestiauthor=M.+Allaraauthor=J.+P.+Montiauthor=V.+Andrisanoauthor=V.+Di+Marzoauthor=P.+Hreliaauthor=A.+Rampa&title=2-Arylbenzofuran-based+molecules+as+multipotent+Alzheimer%E2%80%99s+disease+modifying+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit311&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRizzo%26aufirst%3DS.%26aulast%3DTarozzi%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DDa%2BCosta%26aufirst%3DG.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DAllara%26aufirst%3DM.%26aulast%3DMonti%26aufirst%3DJ.%2BP.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DHrelia%26aufirst%3DP.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3D2-Arylbenzofuran-based%2520molecules%2520as%2520multipotent%2520Alzheimer%25E2%2580%2599s%2520disease%2520modifying%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D58%26spage%3D519%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref312"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref312'); return false;" data-citation="" class="refNumLink">312</a></strong><div class="NLM_citation" id="cit312"><span><span class="NLM_contrib-group">Sorrenti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salerno, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Giacomo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acquaviva, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siracusa, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanella, A.</span><span> </span><span class="NLM_article-title">Imidazole derivatives as antioxidants and selective inhibitors of nNOS</span> <span class="citation_source-journal">Nitric Oxide</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=45-50&author=V.+Sorrentiauthor=L.+Salernoauthor=C.+Di+Giacomoauthor=R.+Acquavivaauthor=M.+A.+Siracusaauthor=A.+Vanella&title=Imidazole+derivatives+as+antioxidants+and+selective+inhibitors+of+nNOS"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit312&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSorrenti%26aufirst%3DV.%26aulast%3DSalerno%26aufirst%3DL.%26aulast%3DDi%2BGiacomo%26aufirst%3DC.%26aulast%3DAcquaviva%26aufirst%3DR.%26aulast%3DSiracusa%26aufirst%3DM.%2BA.%26aulast%3DVanella%26aufirst%3DA.%26atitle%3DImidazole%2520derivatives%2520as%2520antioxidants%2520and%2520selective%2520inhibitors%2520of%2520nNOS%26jtitle%3DNitric%2520Oxide%26date%3D2006%26volume%3D14%26spage%3D45%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref313"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref313'); return false;" data-citation="" class="refNumLink">313</a></strong><div class="NLM_citation" id="cit313"><span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formosa, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Relat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmona, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minguillon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Munoz, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bidon-Chanal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Huprine–tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer’s and prion diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">669</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200840c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=661-669&author=C.+Galdeanoauthor=E.+Viaynaauthor=I.+Solaauthor=X.+Formosaauthor=P.+Campsauthor=A.+Badiaauthor=M.+V.+Closauthor=J.+Relatauthor=M.+Ratiaauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=M.+Salmonaauthor=C.+Minguillonauthor=G.+C.+Gonzalez-Munozauthor=M.+I.+Rodriguez-Francoauthor=A.+Bidon-Chanalauthor=F.+J.+Luqueauthor=D.+Munoz-Torrero&title=Huprine%E2%80%93tacrine+heterodimers+as+anti-amyloidogenic+compounds+of+potential+interest+against+Alzheimer%E2%80%99s+and+prion+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit313&amp;dbid=16384&amp;doi=10.1021%2Fjm200840c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200840c%26sid%3Dliteratum%253Aachs%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DFormosa%26aufirst%3DX.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DRelat%26aufirst%3DJ.%26aulast%3DRatia%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DMinguillon%26aufirst%3DC.%26aulast%3DGonzalez-Munoz%26aufirst%3DG.%2BC.%26aulast%3DRodriguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMunoz-Torrero%26aufirst%3DD.%26atitle%3DHuprine%25E2%2580%2593tacrine%2520heterodimers%2520as%2520anti-amyloidogenic%2520compounds%2520of%2520potential%2520interest%2520against%2520Alzheimer%25E2%2580%2599s%2520and%2520prion%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D661%26epage%3D669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206'],'ref207':['cit207'],'ref208':['cit208'],'ref209':['cit209'],'ref210':['cit210'],'ref211':['cit211'],'ref212':['cit212'],'ref213':['cit213'],'ref214':['cit214'],'ref215':['cit215'],'ref216':['cit216'],'ref217':['cit217'],'ref218':['cit218'],'ref219':['cit219'],'ref220':['cit220'],'ref221':['cit221'],'ref222':['cit222'],'ref223':['cit223'],'ref224':['cit224'],'ref225':['cit225'],'ref226':['cit226'],'ref227':['cit227'],'ref228':['cit228'],'ref229':['cit229'],'ref230':['cit230'],'ref231':['cit231'],'ref232':['cit232'],'ref233':['cit233'],'ref234':['cit234'],'ref235':['cit235'],'ref236':['cit236'],'ref237':['cit237'],'ref238':['cit238'],'ref239':['cit239'],'ref240':['cit240'],'ref241':['cit241'],'ref242':['cit242'],'ref243':['cit243'],'ref244':['cit244'],'ref245':['cit245'],'ref246':['cit246'],'ref247':['cit247'],'ref248':['cit248'],'ref249':['cit249'],'ref250':['cit250'],'ref251':['cit251'],'ref252':['cit252'],'ref253':['cit253'],'ref254':['cit254'],'ref255':['cit255'],'ref256':['cit256'],'ref257':['cit257'],'ref258':['cit258'],'ref259':['cit259'],'ref260':['cit260'],'ref261':['cit261'],'ref262':['cit262'],'ref263':['cit263'],'ref264':['cit264'],'ref265':['cit265'],'ref266':['cit266'],'ref267':['cit267'],'ref268':['cit268'],'ref269':['cit269'],'ref270':['cit270'],'ref271':['cit271'],'ref272':['cit272'],'ref273':['cit273'],'ref274':['cit274'],'ref275':['cit275'],'ref276':['cit276'],'ref277':['cit277'],'ref278':['cit278'],'ref279':['cit279'],'ref280':['cit280'],'ref281':['cit281'],'ref282':['cit282'],'ref283':['cit283'],'ref284':['cit284'],'ref285':['cit285'],'ref286':['cit286'],'ref287':['cit287'],'ref288':['cit288'],'ref289':['cit289'],'ref290':['cit290'],'ref291':['cit291'],'ref292':['cit292'],'ref293':['cit293'],'ref294':['cit294'],'ref295':['cit295'],'ref296':['cit296'],'ref297':['cit297'],'ref298':['cit298'],'ref299':['cit299'],'ref300':['cit300'],'ref301':['cit301'],'ref302':['cit302'],'ref303':['cit303'],'ref304':['cit304'],'ref305':['cit305'],'ref306':['cit306'],'ref307':['cit307'],'ref308':['cit308'],'ref309':['cit309'],'ref310':['cit310'],'ref311':['cit311'],'ref312':['cit312'],'ref313':['cit313']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 89 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Nihar Kinarivala, Ahmed Morsy, Ronak Patel, Angelica V. Carmona, Md. Sanaullah Sajib, Snehal Raut, Constantinos M. Mikelis, Abraham Al-Ahmad, <span class="NLM_string-name hlFld-ContribAuthor">Paul C. Trippier</span>. </span><span class="cited-content_cbyCitation_article-title">An iPSC-Derived Neuron Model of CLN3 Disease Facilitates Small Molecule Phenotypic Screening. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2020,</strong> <em>3 </em>
                                    (5)
                                     , 931-947. <a href="https://doi.org/10.1021/acsptsci.0c00077" title="DOI URL">https://doi.org/10.1021/acsptsci.0c00077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.0c00077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.0c00077%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DAn%252BiPSC-Derived%252BNeuron%252BModel%252Bof%252BCLN3%252BDisease%252BFacilitates%252BSmall%252BMolecule%252BPhenotypic%252BScreening%26aulast%3DKinarivala%26aufirst%3DNihar%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29062020%26date%3D22092020%26date%3D01092020%26volume%3D3%26issue%3D5%26spage%3D931%26epage%3D947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Maris A. Cinelli, Cory T. Reidl, Huiying Li, Georges Chreifi, Thomas L. Poulos, <span class="NLM_string-name hlFld-ContribAuthor">Richard B. Silverman</span>. </span><span class="cited-content_cbyCitation_article-title">First Contact: 7-Phenyl-2-Aminoquinolines, Potent and Selective Neuronal Nitric Oxide Synthase Inhibitors That Target an Isoform-Specific Aspartate. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (9)
                                     , 4528-4554. <a href="https://doi.org/10.1021/acs.jmedchem.9b01573" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01573</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01573%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFirst%252BContact%25253A%252B7-Phenyl-2-Aminoquinolines%25252C%252BPotent%252Band%252BSelective%252BNeuronal%252BNitric%252BOxide%252BSynthase%252BInhibitors%252BThat%252BTarget%252Ban%252BIsoform-Specific%252BAspartate%26aulast%3DCinelli%26aufirst%3DMaris%2BA.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D20092019%26date%3D17042020%26volume%3D63%26issue%3D9%26spage%3D4528%26epage%3D4554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Feifei Bai, Baoxin Zhang, Yanan Hou, Juan Yao, Qianhe Xu, Jianqiang Xu, <span class="NLM_string-name hlFld-ContribAuthor">Jianguo Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Xanthohumol Analogues as Potent Nrf2 Activators against Oxidative Stress Mediated Damages of PC12 Cells. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (6)
                                     , 2956-2966. <a href="https://doi.org/10.1021/acschemneuro.9b00171" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00171</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00171%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DXanthohumol%252BAnalogues%252Bas%252BPotent%252BNrf2%252BActivators%252Bagainst%252BOxidative%252BStress%252BMediated%252BDamages%252Bof%252BPC12%252BCells%26aulast%3DBai%26aufirst%3DFeifei%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D22032019%26date%3D22052019%26date%3D04062019%26date%3D22052019%26volume%3D10%26issue%3D6%26spage%3D2956%26epage%3D2966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ahmed Morsy, <span class="NLM_string-name hlFld-ContribAuthor">Paul C. Trippier</span>. </span><span class="cited-content_cbyCitation_article-title">Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (9)
                                     , 4252-4264. <a href="https://doi.org/10.1021/acs.jmedchem.8b01530" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01530</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01530%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAmyloid-Binding%252BAlcohol%252BDehydrogenase%252B%252528ABAD%252529%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DMorsy%26aufirst%3DAhmed%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D01102018%26date%3D30112018%26date%3D16112018%26volume%3D62%26issue%3D9%26spage%3D4252%26epage%3D4264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nihar  Kinarivala</span>, <span class="hlFld-ContribAuthor ">Ronak  Patel</span>, <span class="hlFld-ContribAuthor ">Rose-Mary  Boustany</span>, <span class="hlFld-ContribAuthor ">Abraham  Al-Ahmad</span>, and <span class="hlFld-ContribAuthor ">Paul C.  Trippier</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Aromatic Carbamates that Confer Neuroprotective Activity by Enhancing Autophagy and Inducing the Anti-Apoptotic Protein B-Cell Lymphoma 2 (Bcl-2). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (23)
                                     , 9739-9756. <a href="https://doi.org/10.1021/acs.jmedchem.7b01199" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01199</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01199%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BAromatic%252BCarbamates%252Bthat%252BConfer%252BNeuroprotective%252BActivity%252Bby%252BEnhancing%252BAutophagy%252Band%252BInducing%252Bthe%252BAnti-Apoptotic%252BProtein%252BB-Cell%252BLymphoma%252B2%252B%252528Bcl-2%252529%26aulast%3DKinarivala%26aufirst%3DNihar%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D15082017%26date%3D22112017%26date%3D14122017%26date%3D07112017%26volume%3D60%26issue%3D23%26spage%3D9739%26epage%3D9756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amin Reza  Zolghadr</span> and <span class="hlFld-ContribAuthor ">Maryam  Heydari Dokoohaki</span>  . </span><span class="cited-content_cbyCitation_article-title">How Does the P7C3-Series of Neuroprotective Small Molecules Prevent Membrane Disruption?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (8)
                                     , 2009-2019. <a href="https://doi.org/10.1021/acs.jcim.7b00151" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00151</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00151%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DHow%252BDoes%252Bthe%252BP7C3-Series%252Bof%252BNeuroprotective%252BSmall%252BMolecules%252BPrevent%252BMembrane%252BDisruption%25253F%26aulast%3DZolghadr%26aufirst%3DAmin%2BReza%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D15032017%26date%3D20072017%26date%3D28082017%26date%3D10072017%26volume%3D57%26issue%3D8%26spage%3D2009%26epage%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nihar  Kinarivala</span> and <span class="hlFld-ContribAuthor ">Paul C.  Trippier</span>  . </span><span class="cited-content_cbyCitation_article-title">Progress in the Development of Small Molecule Therapeutics for the Treatment of Neuronal Ceroid Lipofuscinoses (NCLs). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (10)
                                     , 4415-4427. <a href="https://doi.org/10.1021/acs.jmedchem.5b01020" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01020%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProgress%252Bin%252Bthe%252BDevelopment%252Bof%252BSmall%252BMolecule%252BTherapeutics%252Bfor%252Bthe%252BTreatment%252Bof%252BNeuronal%252BCeroid%252BLipofuscinoses%252B%252528NCLs%252529%26aulast%3DKinarivala%26aufirst%3DNihar%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D29062015%26date%3D24112015%26date%3D26052016%26date%3D13112015%26volume%3D59%26issue%3D10%26spage%3D4415%26epage%3D4427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eugenie  Nepovimova</span>, <span class="hlFld-ContribAuthor ">Jan  Korabecny</span>, <span class="hlFld-ContribAuthor ">Rafael  Dolezal</span>, <span class="hlFld-ContribAuthor ">Katerina  Babkova</span>, <span class="hlFld-ContribAuthor ">Ales  Ondrejicek</span>, <span class="hlFld-ContribAuthor ">Daniel  Jun</span>, <span class="hlFld-ContribAuthor ">Vendula  Sepsova</span>, <span class="hlFld-ContribAuthor ">Anna  Horova</span>, <span class="hlFld-ContribAuthor ">Martina  Hrabinova</span>, <span class="hlFld-ContribAuthor ">Ondrej  Soukup</span>, <span class="hlFld-ContribAuthor ">Neslihan  Bukum</span>, <span class="hlFld-ContribAuthor ">Petr  Jost</span>, <span class="hlFld-ContribAuthor ">Lubica  Muckova</span>, <span class="hlFld-ContribAuthor ">Jiri  Kassa</span>, <span class="hlFld-ContribAuthor ">David  Malinak</span>, <span class="hlFld-ContribAuthor ">Martin  Andrs</span>, and <span class="hlFld-ContribAuthor ">Kamil  Kuca</span>  . </span><span class="cited-content_cbyCitation_article-title">Tacrine–Trolox Hybrids: A Novel Class of Centrally Active, Nonhepatotoxic Multi-Target-Directed Ligands Exerting Anticholinesterase and Antioxidant Activities with Low In Vivo Toxicity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (22)
                                     , 8985-9003. <a href="https://doi.org/10.1021/acs.jmedchem.5b01325" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01325</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01325%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTacrine%2525E2%252580%252593Trolox%252BHybrids%25253A%252BA%252BNovel%252BClass%252Bof%252BCentrally%252BActive%25252C%252BNonhepatotoxic%252BMulti-Target-Directed%252BLigands%252BExerting%252BAnticholinesterase%252Band%252BAntioxidant%252BActivities%252Bwith%252BLow%252BIn%252BVivo%252BToxicity%26aulast%3DNepovimova%26aufirst%3DEugenie%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D27082015%26date%3D10112015%26date%3D25112015%26date%3D27102015%26volume%3D58%26issue%3D22%26spage%3D8985%26epage%3D9003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roberta  Farina</span>, <span class="hlFld-ContribAuthor ">Leonardo  Pisani</span>, <span class="hlFld-ContribAuthor ">Marco  Catto</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>, <span class="hlFld-ContribAuthor ">Domenico  Gadaleta</span>, <span class="hlFld-ContribAuthor ">Nunzio  Denora</span>, <span class="hlFld-ContribAuthor ">Ramon  Soto-Otero</span>, <span class="hlFld-ContribAuthor ">Estefania  Mendez-Alvarez</span>, <span class="hlFld-ContribAuthor ">Carolina S.  Passos</span>, <span class="hlFld-ContribAuthor ">Giovanni  Muncipinto</span>, <span class="hlFld-ContribAuthor ">Cosimo D.  Altomare</span>, <span class="hlFld-ContribAuthor ">Alessandra  Nurisso</span>, <span class="hlFld-ContribAuthor ">Pierre-Alain  Carrupt</span>, and <span class="hlFld-ContribAuthor ">Angelo  Carotti</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (14)
                                     , 5561-5578. <a href="https://doi.org/10.1021/acs.jmedchem.5b00599" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00599</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00599%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Band%252BOptimization%252Bof%252BMultitarget-Directed%252B2H-Chromen-2-one%252BDerivatives%252Bas%252BPotent%252BInhibitors%252Bof%252BMonoamine%252BOxidase%252BB%252Band%252BCholinesterases%26aulast%3DFarina%26aufirst%3DRoberta%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D17042015%26date%3D09072015%26date%3D23072015%26date%3D24062015%26volume%3D58%26issue%3D14%26spage%3D5561%26epage%3D5578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shoujiao  Peng</span>, <span class="hlFld-ContribAuthor ">Baoxin  Zhang</span>, <span class="hlFld-ContribAuthor ">Xianke  Meng</span>, <span class="hlFld-ContribAuthor ">Juan  Yao</span>, and <span class="hlFld-ContribAuthor ">Jianguo  Fang</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of Piperlongumine Analogues and Discovery of Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators as Potential Neuroprotective Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (13)
                                     , 5242-5255. <a href="https://doi.org/10.1021/acs.jmedchem.5b00410" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00410</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00410%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252BPiperlongumine%252BAnalogues%252Band%252BDiscovery%252Bof%252BNuclear%252BFactor%252BErythroid%252B2-Related%252BFactor%252B2%252B%252528Nrf2%252529%252BActivators%252Bas%252BPotential%252BNeuroprotective%252BAgents%26aulast%3DPeng%26aufirst%3DShoujiao%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D13032015%26date%3D26062015%26date%3D09072015%26date%3D16062015%26volume%3D58%26issue%3D13%26spage%3D5242%26epage%3D5255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan  Yao</span>, <span class="hlFld-ContribAuthor ">Baoxin  Zhang</span>, <span class="hlFld-ContribAuthor ">Chunpo  Ge</span>, <span class="hlFld-ContribAuthor ">Shoujiao  Peng</span>, and <span class="hlFld-ContribAuthor ">Jianguo  Fang</span>  . </span><span class="cited-content_cbyCitation_article-title">Xanthohumol, a Polyphenol Chalcone Present in Hops, Activating Nrf2 Enzymes To Confer Protection against Oxidative Damage in PC12 Cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Agricultural and Food Chemistry</span><span> <strong>2015,</strong> <em>63 </em>
                                    (5)
                                     , 1521-1531. <a href="https://doi.org/10.1021/jf505075n" title="DOI URL">https://doi.org/10.1021/jf505075n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jf505075n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjf505075n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Agricultural%2520and%2520Food%2520Chemistry%26atitle%3DXanthohumol%25252C%252Ba%252BPolyphenol%252BChalcone%252BPresent%252Bin%252BHops%25252C%252BActivating%252BNrf2%252BEnzymes%252BTo%252BConfer%252BProtection%252Bagainst%252BOxidative%252BDamage%252Bin%252BPC12%252BCells%26aulast%3DYao%26aufirst%3DJuan%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D2015%26date%3D20102014%26date%3D14012015%26date%3D07012015%26date%3D28012015%26date%3D11022015%26date%3D14012015%26volume%3D63%26issue%3D5%26spage%3D1521%26epage%3D1531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiren  Wang</span>, <span class="hlFld-ContribAuthor ">Yali  Wang</span>, <span class="hlFld-ContribAuthor ">Wenrui  Li</span>, <span class="hlFld-ContribAuthor ">Fei  Mao</span>, <span class="hlFld-ContribAuthor ">Yang  Sun</span>, <span class="hlFld-ContribAuthor ">Ling  Huang</span>, and <span class="hlFld-ContribAuthor ">Xingshu  Li</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Evaluation of Multitarget-Directed Selenium-Containing Clioquinol Derivatives for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2014,</strong> <em>5 </em>
                                    (10)
                                     , 952-962. <a href="https://doi.org/10.1021/cn500119g" title="DOI URL">https://doi.org/10.1021/cn500119g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn500119g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn500119g%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BEvaluation%252Bof%252BMultitarget-Directed%252BSelenium-Containing%252BClioquinol%252BDerivatives%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DWang%26aufirst%3DZhiren%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D30052014%26date%3D28072014%26date%3D22082014%26date%3D15102014%26date%3D14082014%26volume%3D5%26issue%3D10%26spage%3D952%26epage%3D962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xianling  Ning</span>, <span class="hlFld-ContribAuthor ">Ying  Guo</span>, <span class="hlFld-ContribAuthor ">Xiaowei  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoyan  Ma</span>, <span class="hlFld-ContribAuthor ">Chao  Tian</span>, <span class="hlFld-ContribAuthor ">Xueqi  Shi</span>, <span class="hlFld-ContribAuthor ">Renzong  Zhu</span>, <span class="hlFld-ContribAuthor ">Can  Cheng</span>, <span class="hlFld-ContribAuthor ">Yansheng  Du</span>, <span class="hlFld-ContribAuthor ">Zhizhong  Ma</span>, <span class="hlFld-ContribAuthor ">Zhili  Zhang</span>, and <span class="hlFld-ContribAuthor ">Junyi  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of (E)-3,4-Dihydroxystyryl Aralkyl Sulfones and Sulfoxides as Novel Multifunctional Neuroprotective Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (10)
                                     , 4302-4312. <a href="https://doi.org/10.1021/jm500258v" title="DOI URL">https://doi.org/10.1021/jm500258v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500258v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500258v%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252B%252528E%252529-3%25252C4-Dihydroxystyryl%252BAralkyl%252BSulfones%252Band%252BSulfoxides%252Bas%252BNovel%252BMultifunctional%252BNeuroprotective%252BAgents%26aulast%3DNing%26aufirst%3DXianling%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D17022014%26date%3D06052014%26date%3D22052014%26date%3D03042014%26volume%3D57%26issue%3D10%26spage%3D4302%26epage%3D4312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michela  Rosini</span>, <span class="hlFld-ContribAuthor ">Elena  Simoni</span>, <span class="hlFld-ContribAuthor ">Andrea  Milelli</span>, <span class="hlFld-ContribAuthor ">Anna  Minarini</span>, and <span class="hlFld-ContribAuthor ">Carlo  Melchiorre</span>  . </span><span class="cited-content_cbyCitation_article-title">Oxidative Stress in Alzheimer’s Disease: Are We Connecting the Dots?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (7)
                                     , 2821-2831. <a href="https://doi.org/10.1021/jm400970m" title="DOI URL">https://doi.org/10.1021/jm400970m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400970m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400970m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOxidative%252BStress%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BAre%252BWe%252BConnecting%252Bthe%252BDots%25253F%26aulast%3DRosini%26aufirst%3DMichela%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D27062013%26date%3D05112013%26date%3D10042014%26date%3D16102013%26volume%3D57%26issue%3D7%26spage%3D2821%26epage%3D2831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xueli  Zhang</span>, <span class="hlFld-ContribAuthor ">Yanli  Tian</span>, <span class="hlFld-ContribAuthor ">Zeng  Li</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Tian</span>, <span class="hlFld-ContribAuthor ">Hongbin  Sun</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>, <span class="hlFld-ContribAuthor ">Anna  Moore</span>, and <span class="hlFld-ContribAuthor ">Chongzhao  Ran</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Curcumin Analogues for in Vivo Fluorescence Imaging and Inhibiting Copper-Induced Cross-Linking of Amyloid Beta Species in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2013,</strong> <em>135 </em>
                                    (44)
                                     , 16397-16409. <a href="https://doi.org/10.1021/ja405239v" title="DOI URL">https://doi.org/10.1021/ja405239v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja405239v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja405239v%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BCurcumin%252BAnalogues%252Bfor%252Bin%252BVivo%252BFluorescence%252BImaging%252Band%252BInhibiting%252BCopper-Induced%252BCross-Linking%252Bof%252BAmyloid%252BBeta%252BSpecies%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DZhang%26aufirst%3DXueli%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D24052013%26date%3D25102013%26date%3D06112013%26date%3D11102013%26volume%3D135%26issue%3D44%26spage%3D16397%26epage%3D16409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min-Tae  Jeon</span>, <span class="hlFld-ContribAuthor ">Kyu-Sung  Kim</span>, <span class="hlFld-ContribAuthor ">Eun Seon  Kim</span>, <span class="hlFld-ContribAuthor ">Suji  Lee</span>, <span class="hlFld-ContribAuthor ">Jieun  Kim</span>, <span class="hlFld-ContribAuthor ">Hyang-Sook  Hoe</span>, <span class="hlFld-ContribAuthor ">Do-Geun  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging pathogenic role of peripheral blood factors following BBB disruption in neurodegenerative disease. </span><span class="cited-content_cbyCitation_journal-name">Ageing Research Reviews</span><span> <strong>2021,</strong> <em>68 </em>, 101333. <a href="https://doi.org/10.1016/j.arr.2021.101333" title="DOI URL">https://doi.org/10.1016/j.arr.2021.101333</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.arr.2021.101333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.arr.2021.101333%26sid%3Dliteratum%253Aachs%26jtitle%3DAgeing%2520Research%2520Reviews%26atitle%3DEmerging%252Bpathogenic%252Brole%252Bof%252Bperipheral%252Bblood%252Bfactors%252Bfollowing%252BBBB%252Bdisruption%252Bin%252Bneurodegenerative%252Bdisease%26aulast%3DJeon%26aufirst%3DMin-Tae%26date%3D2021%26volume%3D68%26spage%3D101333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiabing  Wang</span>, <span class="hlFld-ContribAuthor ">Jiali  Yao</span>, <span class="hlFld-ContribAuthor ">Yugang  Liu</span>, <span class="hlFld-ContribAuthor ">Lili  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the gasdermin D as a strategy for ischemic stroke therapy. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2021,</strong> <em>188 </em>, 114585. <a href="https://doi.org/10.1016/j.bcp.2021.114585" title="DOI URL">https://doi.org/10.1016/j.bcp.2021.114585</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2021.114585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2021.114585%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DTargeting%252Bthe%252Bgasdermin%252BD%252Bas%252Ba%252Bstrategy%252Bfor%252Bischemic%252Bstroke%252Btherapy%26aulast%3DWang%26aufirst%3DJiabing%26date%3D2021%26volume%3D188%26spage%3D114585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabio  Arias</span>, <span class="hlFld-ContribAuthor ">Francisco  Franco-Montalban</span>, <span class="hlFld-ContribAuthor ">Miguel  Romero</span>, <span class="hlFld-ContribAuthor ">M.  Dora Carrión</span>, <span class="hlFld-ContribAuthor ">M.  Encarnación Camacho</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Bioevaluation and Docking Studies of New Imidamide Derivatives as Nitric Oxide Synthase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>1 </em>, 116294. <a href="https://doi.org/10.1016/j.bmc.2021.116294" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116294</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116294%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252BBioevaluation%252Band%252BDocking%252BStudies%252Bof%252BNew%252BImidamide%252BDerivatives%252Bas%252BNitric%252BOxide%252BSynthase%252BInhibitors%26aulast%3DArias%26aufirst%3DFabio%26date%3D2021%26volume%3D1%26spage%3D116294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">João  Bernardo</span>, <span class="hlFld-ContribAuthor ">Inês  Malheiro</span>, <span class="hlFld-ContribAuthor ">Romeu A.  Videira</span>, <span class="hlFld-ContribAuthor ">Patrícia  Valentão</span>, <span class="hlFld-ContribAuthor ">Ana Cláudia  Santos</span>, <span class="hlFld-ContribAuthor ">Francisco  Veiga</span>, <span class="hlFld-ContribAuthor ">Paula B.  Andrade</span>. </span><span class="cited-content_cbyCitation_article-title">Trichilia catigua and Turnera diffusa extracts: In vitro inhibition of tyrosinase, antiglycation activity and effects on enzymes and pathways engaged in the neuroinflammatory process. </span><span class="cited-content_cbyCitation_journal-name">Journal of Ethnopharmacology</span><span> <strong>2021,</strong> <em>271 </em>, 113865. <a href="https://doi.org/10.1016/j.jep.2021.113865" title="DOI URL">https://doi.org/10.1016/j.jep.2021.113865</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jep.2021.113865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jep.2021.113865%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Ethnopharmacology%26atitle%3DTrichilia%252Bcatigua%252Band%252BTurnera%252Bdiffusa%252Bextracts%25253A%252BIn%252Bvitro%252Binhibition%252Bof%252Btyrosinase%25252C%252Bantiglycation%252Bactivity%252Band%252Beffects%252Bon%252Benzymes%252Band%252Bpathways%252Bengaged%252Bin%252Bthe%252Bneuroinflammatory%252Bprocess%26aulast%3DBernardo%26aufirst%3DJo%25C3%25A3o%26date%3D2021%26volume%3D271%26spage%3D113865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luigia  Serpico</span>, <span class="hlFld-ContribAuthor ">Mauro  De Nisco</span>, <span class="hlFld-ContribAuthor ">Flavio  Cermola</span>, <span class="hlFld-ContribAuthor ">Michele  Manfra</span>, <span class="hlFld-ContribAuthor ">Silvana  Pedatella</span>. </span><span class="cited-content_cbyCitation_article-title">Stereoselective Synthesis of Selenium-Containing Glycoconjugates via the Mitsunobu Reaction. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (9)
                                     , 2541. <a href="https://doi.org/10.3390/molecules26092541" title="DOI URL">https://doi.org/10.3390/molecules26092541</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26092541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26092541%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DStereoselective%252BSynthesis%252Bof%252BSelenium-Containing%252BGlycoconjugates%252Bvia%252Bthe%252BMitsunobu%252BReaction%26aulast%3DSerpico%26aufirst%3DLuigia%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D9%26spage%3D2541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zi-Long  Song</span>, <span class="hlFld-ContribAuthor ">Yanan  Hou</span>, <span class="hlFld-ContribAuthor ">Feifei  Bai</span>, <span class="hlFld-ContribAuthor ">Jianguo  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Generation of potent Nrf2 activators via tuning the electrophilicity and steric hindrance of vinyl sulfones for neuroprotection. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>107 </em>, 104520. <a href="https://doi.org/10.1016/j.bioorg.2020.104520" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104520</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104520%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DGeneration%252Bof%252Bpotent%252BNrf2%252Bactivators%252Bvia%252Btuning%252Bthe%252Belectrophilicity%252Band%252Bsteric%252Bhindrance%252Bof%252Bvinyl%252Bsulfones%252Bfor%252Bneuroprotection%26aulast%3DSong%26aufirst%3DZi-Long%26date%3D2021%26volume%3D107%26spage%3D104520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alvin V.  Terry</span>. </span><span class="cited-content_cbyCitation_article-title">Neurodegeneration. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-11. <a href="https://doi.org/10.1007/978-3-030-21573-6_98-1" title="DOI URL">https://doi.org/10.1007/978-3-030-21573-6_98-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-21573-6_98-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-21573-6_98-1%26sid%3Dliteratum%253Aachs%26atitle%3DNeurodegeneration%26aulast%3DTerry%26aufirst%3DAlvin%2BV.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D11%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DEncyclopedia%252Bof%252BMolecular%252BPharmacology%26aulast%3DOffermanns%26aufirst%3DStefan%26date%3D2020%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shoaib  Manzoor</span>, <span class="hlFld-ContribAuthor ">Nasimul  Hoda</span>. </span><span class="cited-content_cbyCitation_article-title">A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer’s disease agents: A review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>206 </em>, 112787. <a href="https://doi.org/10.1016/j.ejmech.2020.112787" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112787</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112787%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Bcomprehensive%252Breview%252Bof%252Bmonoamine%252Boxidase%252Binhibitors%252Bas%252BAnti-Alzheimer%2525E2%252580%252599s%252Bdisease%252Bagents%25253A%252BA%252Breview%26aulast%3DManzoor%26aufirst%3DShoaib%26date%3D2020%26volume%3D206%26spage%3D112787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J. B. Senthil  Kumar</span>, <span class="hlFld-ContribAuthor ">Bhawna  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">A review on neuropharmacological role of erucic acid: an omega-9 fatty acid from edible oils. </span><span class="cited-content_cbyCitation_journal-name">Nutritional Neuroscience</span><span> <strong>2020,</strong> <em>224 </em>, 1-15. <a href="https://doi.org/10.1080/1028415X.2020.1831262" title="DOI URL">https://doi.org/10.1080/1028415X.2020.1831262</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1028415X.2020.1831262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1028415X.2020.1831262%26sid%3Dliteratum%253Aachs%26jtitle%3DNutritional%2520Neuroscience%26atitle%3DA%252Breview%252Bon%252Bneuropharmacological%252Brole%252Bof%252Berucic%252Bacid%25253A%252Ban%252Bomega-9%252Bfatty%252Bacid%252Bfrom%252Bedible%252Boils%26aulast%3DKumar%26aufirst%3DJ.%2BB.%2BSenthil%26date%3D2020%26date%3D2020%26volume%3D224%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vyacheslav E.  Semenov</span>, <span class="hlFld-ContribAuthor ">Irina V.  Zueva</span>, <span class="hlFld-ContribAuthor ">Marat A.  Mukhamedyarov</span>, <span class="hlFld-ContribAuthor ">Sofya V.  Lushchekina</span>, <span class="hlFld-ContribAuthor ">Elena O.  Petukhova</span>, <span class="hlFld-ContribAuthor ">Lilya M.  Gubaidullina</span>, <span class="hlFld-ContribAuthor ">Evgeniya S.  Krylova</span>, <span class="hlFld-ContribAuthor ">Lilya F.  Saifina</span>, <span class="hlFld-ContribAuthor ">Oksana A.  Lenina</span>, <span class="hlFld-ContribAuthor ">Konstantin A.  Petrov</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Acetylcholinesterase Inhibitors Based on Uracil Moiety for Possible Treatment of Alzheimer Disease. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (18)
                                     , 4191. <a href="https://doi.org/10.3390/molecules25184191" title="DOI URL">https://doi.org/10.3390/molecules25184191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25184191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25184191%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DNovel%252BAcetylcholinesterase%252BInhibitors%252BBased%252Bon%252BUracil%252BMoiety%252Bfor%252BPossible%252BTreatment%252Bof%252BAlzheimer%252BDisease%26aulast%3DSemenov%26aufirst%3DVyacheslav%2BE.%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D18%26spage%3D4191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monika  Rana</span>, <span class="hlFld-ContribAuthor ">Abhishek  Pareek</span>, <span class="hlFld-ContribAuthor ">Shivani  Bhardwaj</span>, <span class="hlFld-ContribAuthor ">Geeta  Arya</span>, <span class="hlFld-ContribAuthor ">Surendra  Nimesh</span>, <span class="hlFld-ContribAuthor ">Hemant  Arya</span>, <span class="hlFld-ContribAuthor ">Tarun K.  Bhatt</span>, <span class="hlFld-ContribAuthor ">Srinivasarao  Yaragorla</span>, <span class="hlFld-ContribAuthor ">Anuj K.  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Aryldiazoquinoline based multifunctional small molecules for modulating Aβ
              42
              aggregation and cholinesterase activity related to Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (48)
                                     , 28827-28837. <a href="https://doi.org/10.1039/D0RA05172A" title="DOI URL">https://doi.org/10.1039/D0RA05172A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA05172A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA05172A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DAryldiazoquinoline%252Bbased%252Bmultifunctional%252Bsmall%252Bmolecules%252Bfor%252Bmodulating%252BA%2525CE%2525B2%252B42%252Baggregation%252Band%252Bcholinesterase%252Bactivity%252Brelated%252Bto%252BAlzheimer%252527s%252Bdisease%26aulast%3DRana%26aufirst%3DMonika%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D48%26spage%3D28827%26epage%3D28837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Peters</span>, <span class="hlFld-ContribAuthor ">Denisse  Bascuñán</span>, <span class="hlFld-ContribAuthor ">Carlos F.  Burgos</span>, <span class="hlFld-ContribAuthor ">Catalina  Bobadilla</span>, <span class="hlFld-ContribAuthor ">Juliana  González-Sanmiguel</span>, <span class="hlFld-ContribAuthor ">Subramanian  Boopathi</span>, <span class="hlFld-ContribAuthor ">Nicolás  Riffo</span>, <span class="hlFld-ContribAuthor ">Eduardo J.  Fernández-Pérez</span>, <span class="hlFld-ContribAuthor ">María Elena  Tarnok</span>, <span class="hlFld-ContribAuthor ">Luis Felipe  Aguilar</span>, <span class="hlFld-ContribAuthor ">Wendy  Gonzalez</span>, <span class="hlFld-ContribAuthor ">Luis G.  Aguayo</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of a new molecule capable of inhibiting several steps of the amyloid cascade in Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Neurobiology of Disease</span><span> <strong>2020,</strong> <em>141 </em>, 104938. <a href="https://doi.org/10.1016/j.nbd.2020.104938" title="DOI URL">https://doi.org/10.1016/j.nbd.2020.104938</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nbd.2020.104938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nbd.2020.104938%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurobiology%2520of%2520Disease%26atitle%3DCharacterization%252Bof%252Ba%252Bnew%252Bmolecule%252Bcapable%252Bof%252Binhibiting%252Bseveral%252Bsteps%252Bof%252Bthe%252Bamyloid%252Bcascade%252Bin%252BAlzheimer%252527s%252Bdisease%26aulast%3DPeters%26aufirst%3DChristian%26date%3D2020%26volume%3D141%26spage%3D104938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Scott A.  Steiger</span>, <span class="hlFld-ContribAuthor ">Chun  Li</span>, <span class="hlFld-ContribAuthor ">Christina  Gates</span>, <span class="hlFld-ContribAuthor ">Nicholas R.  Natale</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and crystal structures of a bis(3-hydroxy-cyclohex-2-en-1-one) and two hexahydroquinoline derivatives. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section E Crystallographic Communications</span><span> <strong>2020,</strong> <em>76 </em>
                                    (2)
                                     , 125-131. <a href="https://doi.org/10.1107/S2056989019017018" title="DOI URL">https://doi.org/10.1107/S2056989019017018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S2056989019017018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS2056989019017018%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520E%2520Crystallographic%2520Communications%26atitle%3DSynthesis%252Band%252Bcrystal%252Bstructures%252Bof%252Ba%252Bbis%2525283-hydroxy-cyclohex-2-en-1-one%252529%252Band%252Btwo%252Bhexahydroquinoline%252Bderivatives%26aulast%3DSteiger%26aufirst%3DScott%2BA.%26date%3D2020%26date%3D2020%26volume%3D76%26issue%3D2%26spage%3D125%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Meng</span>, <span class="hlFld-ContribAuthor ">Shi-jian  Wang</span>, <span class="hlFld-ContribAuthor ">Yi  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Cytoprotection Activity Evaluation of (E)-3-(3,4-Dichlorophenyl)-1-(3,4-Dihydroxyphenyl)- Prop-2-En-1-One as a New Antioxidant Against H2O2-Induced Oxidative Damage in PC12 Cells. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Chemistry Journal</span><span> <strong>2020,</strong> <em>53 </em>
                                    (10)
                                     , 942-946. <a href="https://doi.org/10.1007/s11094-020-02102-4" title="DOI URL">https://doi.org/10.1007/s11094-020-02102-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11094-020-02102-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11094-020-02102-4%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Chemistry%2520Journal%26atitle%3DCytoprotection%252BActivity%252BEvaluation%252Bof%252B%252528E%252529-3-%2525283%25252C4-Dichlorophenyl%252529-1-%2525283%25252C4-Dihydroxyphenyl%252529-%252BProp-2-En-1-One%252Bas%252Ba%252BNew%252BAntioxidant%252BAgainst%252BH2O2-Induced%252BOxidative%252BDamage%252Bin%252BPC12%252BCells%26aulast%3DMeng%26aufirst%3DJing%26date%3D2020%26date%3D2020%26volume%3D53%26issue%3D10%26spage%3D942%26epage%3D946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed  Morsy</span>, <span class="hlFld-ContribAuthor ">Paul C.  Trippier</span>, . </span><span class="cited-content_cbyCitation_article-title">Current and Emerging Pharmacological Targets for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Alzheimer's Disease</span><span> <strong>2019,</strong> <em>72 </em>
                                    (s1)
                                     , S145-S176. <a href="https://doi.org/10.3233/JAD-190744" title="DOI URL">https://doi.org/10.3233/JAD-190744</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JAD-190744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJAD-190744%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DCurrent%252Band%252BEmerging%252BPharmacological%252BTargets%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DMorsy%26aufirst%3DAhmed%26date%3D2019%26volume%3D72%26issue%3Ds1%26spage%3DS145%26epage%3DS176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samuel  Morales-Navarro</span>, <span class="hlFld-ContribAuthor ">Luis  Prent-Peñaloza</span>, <span class="hlFld-ContribAuthor ">Yeray A.  Rodríguez Núñez</span>, <span class="hlFld-ContribAuthor ">Laura  Sánchez-Aros</span>, <span class="hlFld-ContribAuthor ">Oscar  Forero-Doria</span>, <span class="hlFld-ContribAuthor ">Wendy  González</span>, <span class="hlFld-ContribAuthor ">Nuria E.  Campilllo</span>, <span class="hlFld-ContribAuthor ">Miguel  Reyes-Parada</span>, <span class="hlFld-ContribAuthor ">Ana  Martínez</span>, <span class="hlFld-ContribAuthor ">David  Ramírez</span>. </span><span class="cited-content_cbyCitation_article-title">Theoretical and Experimental Approaches Aimed at Drug Design Targeting Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name">Processes</span><span> <strong>2019,</strong> <em>7 </em>
                                    (12)
                                     , 940. <a href="https://doi.org/10.3390/pr7120940" title="DOI URL">https://doi.org/10.3390/pr7120940</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pr7120940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpr7120940%26sid%3Dliteratum%253Aachs%26jtitle%3DProcesses%26atitle%3DTheoretical%252Band%252BExperimental%252BApproaches%252BAimed%252Bat%252BDrug%252BDesign%252BTargeting%252BNeurodegenerative%252BDiseases%26aulast%3DMorales-Navarro%26aufirst%3DSamuel%26date%3D2019%26date%3D2019%26volume%3D7%26issue%3D12%26spage%3D940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jakaria</span>, <span class="hlFld-ContribAuthor ">Azam</span>, <span class="hlFld-ContribAuthor ">Jo</span>, <span class="hlFld-ContribAuthor ">Kim</span>, <span class="hlFld-ContribAuthor ">Dash</span>, <span class="hlFld-ContribAuthor ">Choi</span>. </span><span class="cited-content_cbyCitation_article-title">Potential Therapeutic Targets of Quercetin and Its Derivatives: Its Role in the Therapy of Cognitive Impairment. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Medicine</span><span> <strong>2019,</strong> <em>8 </em>
                                    (11)
                                     , 1789. <a href="https://doi.org/10.3390/jcm8111789" title="DOI URL">https://doi.org/10.3390/jcm8111789</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/jcm8111789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fjcm8111789%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Medicine%26atitle%3DPotential%252BTherapeutic%252BTargets%252Bof%252BQuercetin%252Band%252BIts%252BDerivatives%25253A%252BIts%252BRole%252Bin%252Bthe%252BTherapy%252Bof%252BCognitive%252BImpairment%26aulast%3DJakaria%26date%3D2019%26date%3D2019%26volume%3D8%26issue%3D11%26spage%3D1789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harbinder  Singh</span>, <span class="hlFld-ContribAuthor ">Nihar  Kinarivala</span>, <span class="hlFld-ContribAuthor ">Sahil  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-Targeting Anticancer Agents: Rational Approaches, Synthetic Routes and Structure Activity Relationship. </span><span class="cited-content_cbyCitation_journal-name">Anti-Cancer Agents in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (7)
                                     , 842-874. <a href="https://doi.org/10.2174/1871520619666190118120708" title="DOI URL">https://doi.org/10.2174/1871520619666190118120708</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1871520619666190118120708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1871520619666190118120708%26sid%3Dliteratum%253Aachs%26jtitle%3DAnti-Cancer%2520Agents%2520in%2520Medicinal%2520Chemistry%26atitle%3DMulti-Targeting%252BAnticancer%252BAgents%25253A%252BRational%252BApproaches%25252C%252BSynthetic%252BRoutes%252Band%252BStructure%252BActivity%252BRelationship%26aulast%3DSingh%26aufirst%3DHarbinder%26date%3D2019%26volume%3D19%26issue%3D7%26spage%3D842%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laleh  Faraji</span>, <span class="hlFld-ContribAuthor ">Hamid  Nadri</span>, <span class="hlFld-ContribAuthor ">Alireza  Moradi</span>, <span class="hlFld-ContribAuthor ">Syed Nasir Abbas  Bukhari</span>, <span class="hlFld-ContribAuthor ">Bahar  Pakseresht</span>, <span class="hlFld-ContribAuthor ">Farshad Homayouni  Moghadam</span>, <span class="hlFld-ContribAuthor ">Setareh  Moghimi</span>, <span class="hlFld-ContribAuthor ">Mohammad  Abdollahi</span>, <span class="hlFld-ContribAuthor ">Mehdi  Khoobi</span>, <span class="hlFld-ContribAuthor ">Alireza  Foroumadi</span>. </span><span class="cited-content_cbyCitation_article-title">Aminoalkyl-substituted flavonoids: synthesis, cholinesterase inhibition, β-amyloid aggregation, and neuroprotective study. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2019,</strong> <em>28 </em>
                                    (7)
                                     , 974-983. <a href="https://doi.org/10.1007/s00044-019-02350-4" title="DOI URL">https://doi.org/10.1007/s00044-019-02350-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-019-02350-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-019-02350-4%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DAminoalkyl-substituted%252Bflavonoids%25253A%252Bsynthesis%25252C%252Bcholinesterase%252Binhibition%25252C%252B%2525CE%2525B2-amyloid%252Baggregation%25252C%252Band%252Bneuroprotective%252Bstudy%26aulast%3DFaraji%26aufirst%3DLaleh%26date%3D2019%26date%3D2019%26volume%3D28%26issue%3D7%26spage%3D974%26epage%3D983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arti  Rana</span>, <span class="hlFld-ContribAuthor ">Shamsher  Singh</span>, <span class="hlFld-ContribAuthor ">Ruchika  Sharma</span>, <span class="hlFld-ContribAuthor ">Anoop  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Traumatic Brain Injury Altered Normal Brain Signaling Pathways: Implications for Novel Therapeutics Approaches. </span><span class="cited-content_cbyCitation_journal-name">Current Neuropharmacology</span><span> <strong>2019,</strong> <em>17 </em>
                                    (7)
                                     , 614-629. <a href="https://doi.org/10.2174/1570159X16666180911121847" title="DOI URL">https://doi.org/10.2174/1570159X16666180911121847</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570159X16666180911121847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570159X16666180911121847%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Neuropharmacology%26atitle%3DTraumatic%252BBrain%252BInjury%252BAltered%252BNormal%252BBrain%252BSignaling%252BPathways%25253A%252BImplications%252Bfor%252BNovel%252BTherapeutics%252BApproaches%26aulast%3DRana%26aufirst%3DArti%26date%3D2019%26volume%3D17%26issue%3D7%26spage%3D614%26epage%3D629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sulunay  Parlar</span>, <span class="hlFld-ContribAuthor ">Gozde  Sayar</span>, <span class="hlFld-ContribAuthor ">Ayse Hande  Tarikogullari</span>, <span class="hlFld-ContribAuthor ">Sumru Sozer  Karadagli</span>, <span class="hlFld-ContribAuthor ">Vildan  Alptuzun</span>, <span class="hlFld-ContribAuthor ">Ercin  Erciyas</span>, <span class="hlFld-ContribAuthor ">Ulrike  Holzgrabe</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, bioactivity and molecular modeling studies on potential anti-Alzheimer piperidinehydrazide-hydrazones. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>87 </em>, 888-900. <a href="https://doi.org/10.1016/j.bioorg.2018.11.051" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.11.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.11.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.11.051%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%25252C%252Bbioactivity%252Band%252Bmolecular%252Bmodeling%252Bstudies%252Bon%252Bpotential%252Banti-Alzheimer%252Bpiperidinehydrazide-hydrazones%26aulast%3DParlar%26aufirst%3DSulunay%26date%3D2019%26volume%3D87%26spage%3D888%26epage%3D900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ali  Chaari</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular chaperones biochemistry and role in neurodegenerative diseases. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Macromolecules</span><span> <strong>2019,</strong> <em>131 </em>, 396-411. <a href="https://doi.org/10.1016/j.ijbiomac.2019.02.148" title="DOI URL">https://doi.org/10.1016/j.ijbiomac.2019.02.148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijbiomac.2019.02.148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijbiomac.2019.02.148%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Macromolecules%26atitle%3DMolecular%252Bchaperones%252Bbiochemistry%252Band%252Brole%252Bin%252Bneurodegenerative%252Bdiseases%26aulast%3DChaari%26aufirst%3DAli%26date%3D2019%26volume%3D131%26spage%3D396%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dalinda Isabel  Sánchez-Vidaña</span>, <span class="hlFld-ContribAuthor ">Jason Ka Wing  Chow</span>, <span class="hlFld-ContribAuthor ">Sheng Quan  Hu</span>, <span class="hlFld-ContribAuthor ">Benson Wui Man  Lau</span>, <span class="hlFld-ContribAuthor ">Yi-Fan  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Targets of Bis (7)-Cognitin and Its Relevance in Neurological Disorders: A Systematic Review. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neuroscience</span><span> <strong>2019,</strong> <em>13 </em><a href="https://doi.org/10.3389/fnins.2019.00445" title="DOI URL">https://doi.org/10.3389/fnins.2019.00445</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnins.2019.00445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnins.2019.00445%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neuroscience%26atitle%3DMolecular%252BTargets%252Bof%252BBis%252B%2525287%252529-Cognitin%252Band%252BIts%252BRelevance%252Bin%252BNeurological%252BDisorders%25253A%252BA%252BSystematic%252BReview%26aulast%3DS%25C3%25A1nchez-Vida%25C3%25B1a%26aufirst%3DDalinda%2BIsabel%26date%3D2019%26date%3D2019%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia Hui  Wang</span>, <span class="hlFld-ContribAuthor ">Song Hui  Hu</span>, <span class="hlFld-ContribAuthor ">Ji Yan  Su</span>, <span class="hlFld-ContribAuthor ">Jun Ping  Pan</span>, <span class="hlFld-ContribAuthor ">Xiang Nan  Mi</span>, <span class="hlFld-ContribAuthor ">Hai Ju  Geng</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Liang  Cai</span>, <span class="hlFld-ContribAuthor ">Chao Fen  Su</span>, <span class="hlFld-ContribAuthor ">Ai Hua  Hong</span>, <span class="hlFld-ContribAuthor ">Huan Min  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Determination of the Pharmacokinetics and Tissue Distribution of Methyl 3,4-Dihydroxybenzoate (MDHB) in Mice Using Liquid Chromatography-Tandem Mass Spectrometry. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Drug Metabolism and Pharmacokinetics</span><span> <strong>2019,</strong> <em>44 </em>
                                    (2)
                                     , 237-249. <a href="https://doi.org/10.1007/s13318-018-0512-8" title="DOI URL">https://doi.org/10.1007/s13318-018-0512-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13318-018-0512-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13318-018-0512-8%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Drug%2520Metabolism%2520and%2520Pharmacokinetics%26atitle%3DDetermination%252Bof%252Bthe%252BPharmacokinetics%252Band%252BTissue%252BDistribution%252Bof%252BMethyl%252B3%25252C4-Dihydroxybenzoate%252B%252528MDHB%252529%252Bin%252BMice%252BUsing%252BLiquid%252BChromatography-Tandem%252BMass%252BSpectrometry%26aulast%3DWang%26aufirst%3DJia%2BHui%26date%3D2019%26date%3D2018%26volume%3D44%26issue%3D2%26spage%3D237%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiabing  Wang</span>, <span class="hlFld-ContribAuthor ">Lili  Huang</span>, <span class="hlFld-ContribAuthor ">Chanchan  Cheng</span>, <span class="hlFld-ContribAuthor ">Ge  Li</span>, <span class="hlFld-ContribAuthor ">Jingwen  Xie</span>, <span class="hlFld-ContribAuthor ">Mengya  Shen</span>, <span class="hlFld-ContribAuthor ">Qian  Chen</span>, <span class="hlFld-ContribAuthor ">Wulan  Li</span>, <span class="hlFld-ContribAuthor ">Wenfei  He</span>, <span class="hlFld-ContribAuthor ">Peihong  Qiu</span>, <span class="hlFld-ContribAuthor ">Jianzhang  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of chalcone analogues with novel dual antioxidant mechanisms as potential anti-ischemic stroke agents. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2019,</strong> <em>9 </em>
                                    (2)
                                     , 335-350. <a href="https://doi.org/10.1016/j.apsb.2019.01.003" title="DOI URL">https://doi.org/10.1016/j.apsb.2019.01.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2019.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2019.01.003%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bchalcone%252Banalogues%252Bwith%252Bnovel%252Bdual%252Bantioxidant%252Bmechanisms%252Bas%252Bpotential%252Banti-ischemic%252Bstroke%252Bagents%26aulast%3DWang%26aufirst%3DJiabing%26date%3D2019%26volume%3D9%26issue%3D2%26spage%3D335%26epage%3D350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Renyuan  Hong</span>, <span class="hlFld-ContribAuthor ">Xun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of monoamine oxidase inhibitors by medicinal chemistry approaches. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     , 10-25. <a href="https://doi.org/10.1039/C8MD00446C" title="DOI URL">https://doi.org/10.1039/C8MD00446C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8MD00446C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8MD00446C%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDiscovery%252Bof%252Bmonoamine%252Boxidase%252Binhibitors%252Bby%252Bmedicinal%252Bchemistry%252Bapproaches%26aulast%3DHong%26aufirst%3DRenyuan%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D1%26spage%3D10%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikita M.  Chernov</span>, <span class="hlFld-ContribAuthor ">Roman V.  Shutov</span>, <span class="hlFld-ContribAuthor ">Oleg I.  Barygin</span>, <span class="hlFld-ContribAuthor ">Mikhail Y.  Dron</span>, <span class="hlFld-ContribAuthor ">Galina L.  Starova</span>, <span class="hlFld-ContribAuthor ">Nikolay N.  Kuz'mich</span>, <span class="hlFld-ContribAuthor ">Igor P.  Yakovlev</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Chromone-Containing Allylmorpholines through a Morita-Baylis-Hillman-Type Reaction. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (45)
                                     , 6304-6313. <a href="https://doi.org/10.1002/ejoc.201801159" title="DOI URL">https://doi.org/10.1002/ejoc.201801159</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201801159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201801159%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BChromone-Containing%252BAllylmorpholines%252Bthrough%252Ba%252BMorita-Baylis-Hillman-Type%252BReaction%26aulast%3DChernov%26aufirst%3DNikita%2BM.%26date%3D2018%26date%3D2018%26volume%3D2018%26issue%3D45%26spage%3D6304%26epage%3D6313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Scott A.  Steiger</span>, <span class="hlFld-ContribAuthor ">Chun  Li</span>, <span class="hlFld-ContribAuthor ">Nicholas R.  Natale</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal structure of ethyl 4-[4-(dimethylamino)phenyl]-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section E Crystallographic Communications</span><span> <strong>2018,</strong> <em>74 </em>
                                    (10)
                                     , 1417-1420. <a href="https://doi.org/10.1107/S2056989018011982" title="DOI URL">https://doi.org/10.1107/S2056989018011982</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S2056989018011982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS2056989018011982%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520E%2520Crystallographic%2520Communications%26atitle%3DCrystal%252Bstructure%252Bof%252Bethyl%252B4-%25255B4-%252528dimethylamino%252529phenyl%25255D-2%25252C7%25252C7-trimethyl-5-oxo-1%25252C4%25252C5%25252C6%25252C7%25252C8-hexahydroquinoline-3-carboxylate%26aulast%3DSteiger%26aufirst%3DScott%2BA.%26date%3D2018%26date%3D2018%26volume%3D74%26issue%3D10%26spage%3D1417%26epage%3D1420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yunxiaozhu  Zheng</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Qiang</span>, <span class="hlFld-ContribAuthor ">Rui  Xu</span>, <span class="hlFld-ContribAuthor ">Qing  Song</span>, <span class="hlFld-ContribAuthor ">Chaoquan  Tian</span>, <span class="hlFld-ContribAuthor ">Hongyan  Liu</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Zhenghuai  Tan</span>, <span class="hlFld-ContribAuthor ">Yong  Deng</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of pterostilbene β-amino alcohol derivatives as multifunctional agents for Alzheimer's disease treatment. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>78 </em>, 298-306. <a href="https://doi.org/10.1016/j.bioorg.2018.03.016" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.03.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.03.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.03.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bpterostilbene%252B%2525CE%2525B2-amino%252Balcohol%252Bderivatives%252Bas%252Bmultifunctional%252Bagents%252Bfor%252BAlzheimer%252527s%252Bdisease%252Btreatment%26aulast%3DZheng%26aufirst%3DYunxiaozhu%26date%3D2018%26volume%3D78%26spage%3D298%26epage%3D306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yameng  Hao</span>, <span class="hlFld-ContribAuthor ">Bolin  Wu</span>, <span class="hlFld-ContribAuthor ">Ying  Chen</span>, <span class="hlFld-ContribAuthor ">Xuefeng  Sun</span>, <span class="hlFld-ContribAuthor ">Yixing  Sun</span>, <span class="hlFld-ContribAuthor ">Junyi  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaowei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Study on Dual Inhibitors of HIV-1 IN/CCR5 Caffeoyl Derivatives as Neuroprotective Agents. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2018,</strong> <em>3 </em>
                                    (22)
                                     , 6170-6173. <a href="https://doi.org/10.1002/slct.201801313" title="DOI URL">https://doi.org/10.1002/slct.201801313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201801313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201801313%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DStudy%252Bon%252BDual%252BInhibitors%252Bof%252BHIV-1%252BIN%25252FCCR5%252BCaffeoyl%252BDerivatives%252Bas%252BNeuroprotective%252BAgents%26aulast%3DHao%26aufirst%3DYameng%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D22%26spage%3D6170%26epage%3D6173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linkui  Zhang</span>, <span class="hlFld-ContribAuthor ">Ying  Zhao</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Donglin  Yang</span>, <span class="hlFld-ContribAuthor ">Chenwen  Zhao</span>, <span class="hlFld-ContribAuthor ">Changli  Wang</span>, <span class="hlFld-ContribAuthor ">Chao  Ma</span>, <span class="hlFld-ContribAuthor ">Maosheng  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and bioevaluation of 1,2,3,9-tetrahydropyrrolo[2,1-b]quinazoline-1-carboxylic acid derivatives as potent neuroprotective agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>151 </em>, 27-38. <a href="https://doi.org/10.1016/j.ejmech.2018.03.052" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.03.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.03.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.03.052%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbioevaluation%252Bof%252B1%25252C2%25252C3%25252C9-tetrahydropyrrolo%25255B2%25252C1-b%25255Dquinazoline-1-carboxylic%252Bacid%252Bderivatives%252Bas%252Bpotent%252Bneuroprotective%252Bagents%26aulast%3DZhang%26aufirst%3DLinkui%26date%3D2018%26volume%3D151%26spage%3D27%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nurettin  Menges</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Green Solvents and Catalysts at the Future of Drug Design and of Synthesis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,<a href="https://doi.org/10.5772/intechopen.71018" title="DOI URL">https://doi.org/10.5772/intechopen.71018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5772/intechopen.71018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5772%2Fintechopen.71018%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BRole%252Bof%252BGreen%252BSolvents%252Band%252BCatalysts%252Bat%252Bthe%252BFuture%252Bof%252BDrug%252BDesign%252Band%252Bof%252BSynthesis%26aulast%3DMenges%26aufirst%3DNurettin%26date%3D2018%26date%3D2018%26pub%3DInTech%26atitle%3DGreen%252BChemistry%26aulast%3DSaleh%26aufirst%3DHosam%2BEl-Din%2BM.%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Syeda S.  Khatoon</span>, <span class="hlFld-ContribAuthor ">M.  Rehman</span>, <span class="hlFld-ContribAuthor ">A.  Rahman</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Natural Products in Alzheimer's and Parkinson's Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 69-127. <a href="https://doi.org/10.1016/B978-0-444-64058-1.00003-0" title="DOI URL">https://doi.org/10.1016/B978-0-444-64058-1.00003-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-444-64058-1.00003-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-444-64058-1.00003-0%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BRole%252Bof%252BNatural%252BProducts%252Bin%252BAlzheimer%252527s%252Band%252BParkinson%252527s%252BDisease%26aulast%3DKhatoon%26aufirst%3DSyeda%2BS.%26date%3D2018%26spage%3D69%26epage%3D127%26pub%3DElsevier%26date%3D2018%26volume%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lili  Huang</span>, <span class="hlFld-ContribAuthor ">Jiabing  Wang</span>, <span class="hlFld-ContribAuthor ">Liping  Chen</span>, <span class="hlFld-ContribAuthor ">Min  Zhu</span>, <span class="hlFld-ContribAuthor ">Shoubiao  Wu</span>, <span class="hlFld-ContribAuthor ">Shenghui  Chu</span>, <span class="hlFld-ContribAuthor ">Yuantie  Zheng</span>, <span class="hlFld-ContribAuthor ">Ziliang  Fan</span>, <span class="hlFld-ContribAuthor ">Jiafeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Wulan  Li</span>, <span class="hlFld-ContribAuthor ">Dahui  Chen</span>, <span class="hlFld-ContribAuthor ">Xiufei  Yang</span>, <span class="hlFld-ContribAuthor ">Sicen  Wang</span>, <span class="hlFld-ContribAuthor ">Peihong  Qiu</span>, <span class="hlFld-ContribAuthor ">Jianzhang  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and evaluation of NDGA analogues as potential anti-ischemic stroke agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>143 </em>, 1165-1173. <a href="https://doi.org/10.1016/j.ejmech.2017.09.028" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.09.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.09.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.09.028%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252BNDGA%252Banalogues%252Bas%252Bpotential%252Banti-ischemic%252Bstroke%252Bagents%26aulast%3DHuang%26aufirst%3DLili%26date%3D2018%26volume%3D143%26spage%3D1165%26epage%3D1173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sajad  Shahbazi</span>, <span class="hlFld-ContribAuthor ">Jagdeep  Kaur</span>, <span class="hlFld-ContribAuthor ">Shikha  Singh</span>, <span class="hlFld-ContribAuthor ">K Gopinath  Achary</span>, <span class="hlFld-ContribAuthor ">Sameena  Wani</span>, <span class="hlFld-ContribAuthor ">Sobhagyalaxmi  Jema</span>, <span class="hlFld-ContribAuthor ">Jabed  Akhtar</span>, <span class="hlFld-ContribAuthor ">Ranbir Chander  Sobti</span>. </span><span class="cited-content_cbyCitation_article-title">Impact of novel
              N
              -aryl piperamide NO donors on NF-κB translocation in neuroinflammation: rational drug-designing synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Innate Immunity</span><span> <strong>2018,</strong> <em>24 </em>
                                    (1)
                                     , 24-39. <a href="https://doi.org/10.1177/1753425917740727" title="DOI URL">https://doi.org/10.1177/1753425917740727</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1753425917740727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1753425917740727%26sid%3Dliteratum%253Aachs%26jtitle%3DInnate%2520Immunity%26atitle%3DImpact%252Bof%252Bnovel%252BN%252B-aryl%252Bpiperamide%252BNO%252Bdonors%252Bon%252BNF-%2525CE%2525BAB%252Btranslocation%252Bin%252Bneuroinflammation%25253A%252Brational%252Bdrug-designing%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DShahbazi%26aufirst%3DSajad%26date%3D2018%26date%3D2017%26volume%3D24%26issue%3D1%26spage%3D24%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huan-Cheng  Wu</span>, <span class="hlFld-ContribAuthor ">Qun-Liang  Hu</span>, <span class="hlFld-ContribAuthor ">Shi-Jun  Zhang</span>, <span class="hlFld-ContribAuthor ">Yan-Min  Wang</span>, <span class="hlFld-ContribAuthor ">Zhan-Kui  Jin</span>, <span class="hlFld-ContribAuthor ">Ling-Fu  Lv</span>, <span class="hlFld-ContribAuthor ">Sai  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhen-Lin  Liu</span>, <span class="hlFld-ContribAuthor ">Hong-Lian  Wu</span>, <span class="hlFld-ContribAuthor ">Ou-Mei  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Neuroprotective effects of genistein on SH-SY5Y cells overexpressing A53T mutant α-synuclein. </span><span class="cited-content_cbyCitation_journal-name">Neural Regeneration Research</span><span> <strong>2018,</strong> <em>13 </em>
                                    (8)
                                     , 1375. <a href="https://doi.org/10.4103/1673-5374.235250" title="DOI URL">https://doi.org/10.4103/1673-5374.235250</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4103/1673-5374.235250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4103%2F1673-5374.235250%26sid%3Dliteratum%253Aachs%26jtitle%3DNeural%2520Regeneration%2520Research%26atitle%3DNeuroprotective%252Beffects%252Bof%252Bgenistein%252Bon%252BSH-SY5Y%252Bcells%252Boverexpressing%252BA53T%252Bmutant%252B%2525CE%2525B1-synuclein%26aulast%3DWu%26aufirst%3DHuan-Cheng%26date%3D2018%26volume%3D13%26issue%3D8%26spage%3D1375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julien  Lalut</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>. </span><span class="cited-content_cbyCitation_article-title">Multiple Ligands in Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 477-508. <a href="https://doi.org/10.1002/9783527674381.ch16" title="DOI URL">https://doi.org/10.1002/9783527674381.ch16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527674381.ch16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527674381.ch16%26sid%3Dliteratum%253Aachs%26atitle%3DMultiple%252BLigands%252Bin%252BNeurodegenerative%252BDiseases%26aulast%3DLalut%26aufirst%3DJulien%26date%3D2017%26date%3D2017%26spage%3D477%26epage%3D508%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DDrug%252BSelectivity%26aulast%3DHandler%26aufirst%3DNorbert%26date%3D2017%26volume%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Morgana  Moretti</span>, <span class="hlFld-ContribAuthor ">Daiane Bittencourt  Fraga</span>, <span class="hlFld-ContribAuthor ">Ana Lúcia S.  Rodrigues</span>. </span><span class="cited-content_cbyCitation_article-title">Preventive and therapeutic potential of ascorbic acid in neurodegenerative diseases. </span><span class="cited-content_cbyCitation_journal-name">CNS Neuroscience & Therapeutics</span><span> <strong>2017,</strong> <em>23 </em>
                                    (12)
                                     , 921-929. <a href="https://doi.org/10.1111/cns.12767" title="DOI URL">https://doi.org/10.1111/cns.12767</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cns.12767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcns.12767%26sid%3Dliteratum%253Aachs%26jtitle%3DCNS%2520Neuroscience%2520%2526%2520Therapeutics%26atitle%3DPreventive%252Band%252Btherapeutic%252Bpotential%252Bof%252Bascorbic%252Bacid%252Bin%252Bneurodegenerative%252Bdiseases%26aulast%3DMoretti%26aufirst%3DMorgana%26date%3D2017%26date%3D2017%26volume%3D23%26issue%3D12%26spage%3D921%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonardo  Pisani</span>, <span class="hlFld-ContribAuthor ">Annalisa  De Palma</span>, <span class="hlFld-ContribAuthor ">Nicola  Giangregorio</span>, <span class="hlFld-ContribAuthor ">Daniela V.  Miniero</span>, <span class="hlFld-ContribAuthor ">Paolo  Pesce</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>, <span class="hlFld-ContribAuthor ">Francesco  Campagna</span>, <span class="hlFld-ContribAuthor ">Cosimo D.  Altomare</span>, <span class="hlFld-ContribAuthor ">Marco  Catto</span>. </span><span class="cited-content_cbyCitation_article-title">Mannich base approach to 5-methoxyisatin 3-(4-isopropylphenyl)hydrazone: A water-soluble prodrug for a multitarget inhibition of cholinesterases, beta-amyloid fibrillization and oligomer-induced cytotoxicity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2017,</strong> <em>109 </em>, 381-388. <a href="https://doi.org/10.1016/j.ejps.2017.08.004" title="DOI URL">https://doi.org/10.1016/j.ejps.2017.08.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2017.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2017.08.004%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DMannich%252Bbase%252Bapproach%252Bto%252B5-methoxyisatin%252B3-%2525284-isopropylphenyl%252529hydrazone%25253A%252BA%252Bwater-soluble%252Bprodrug%252Bfor%252Ba%252Bmultitarget%252Binhibition%252Bof%252Bcholinesterases%25252C%252Bbeta-amyloid%252Bfibrillization%252Band%252Boligomer-induced%252Bcytotoxicity%26aulast%3DPisani%26aufirst%3DLeonardo%26date%3D2017%26volume%3D109%26spage%3D381%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leili  Jalili-Baleh</span>, <span class="hlFld-ContribAuthor ">Hamid  Nadri</span>, <span class="hlFld-ContribAuthor ">Alireza  Moradi</span>, <span class="hlFld-ContribAuthor ">Syed Nasir Abbas  Bukhari</span>, <span class="hlFld-ContribAuthor ">Mojtaba  Shakibaie</span>, <span class="hlFld-ContribAuthor ">Mandana  Jafari</span>, <span class="hlFld-ContribAuthor ">Mostafa  Golshani</span>, <span class="hlFld-ContribAuthor ">Farshad  Homayouni Moghadam</span>, <span class="hlFld-ContribAuthor ">Loghman  Firoozpour</span>, <span class="hlFld-ContribAuthor ">Ali  Asadipour</span>, <span class="hlFld-ContribAuthor ">Saeed  Emami</span>, <span class="hlFld-ContribAuthor ">Mehdi  Khoobi</span>, <span class="hlFld-ContribAuthor ">Alireza  Foroumadi</span>. </span><span class="cited-content_cbyCitation_article-title">New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>139 </em>, 280-289. <a href="https://doi.org/10.1016/j.ejmech.2017.07.072" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.07.072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.07.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.07.072%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252Bracemic%252Bannulated%252Bpyrazolo%25255B1%25252C2-b%25255Dphthalazines%252Bas%252Btacrine-like%252BAChE%252Binhibitors%252Bwith%252Bpotential%252Buse%252Bin%252BAlzheimer%252527s%252Bdisease%26aulast%3DJalili-Baleh%26aufirst%3DLeili%26date%3D2017%26volume%3D139%26spage%3D280%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jakub  Chwastek</span>, <span class="hlFld-ContribAuthor ">Danuta  Jantas</span>, <span class="hlFld-ContribAuthor ">Władysław  Lasoń</span>. </span><span class="cited-content_cbyCitation_article-title">The ATM kinase inhibitor KU-55933 provides neuroprotection against hydrogen peroxide-induced cell damage via a γH2AX/p-p53/caspase-3-independent mechanism: Inhibition of calpain and cathepsin D. </span><span class="cited-content_cbyCitation_journal-name">The International Journal of Biochemistry & Cell Biology</span><span> <strong>2017,</strong> <em>87 </em>, 38-53. <a href="https://doi.org/10.1016/j.biocel.2017.03.015" title="DOI URL">https://doi.org/10.1016/j.biocel.2017.03.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biocel.2017.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biocel.2017.03.015%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520International%2520Journal%2520of%2520Biochemistry%2520%2526%2520Cell%2520Biology%26atitle%3DThe%252BATM%252Bkinase%252Binhibitor%252BKU-55933%252Bprovides%252Bneuroprotection%252Bagainst%252Bhydrogen%252Bperoxide-induced%252Bcell%252Bdamage%252Bvia%252Ba%252B%2525CE%2525B3H2AX%25252Fp-p53%25252Fcaspase-3-independent%252Bmechanism%25253A%252BInhibition%252Bof%252Bcalpain%252Band%252Bcathepsin%252BD%26aulast%3DChwastek%26aufirst%3DJakub%26date%3D2017%26volume%3D87%26spage%3D38%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shambhunath  Bose</span>, <span class="hlFld-ContribAuthor ">Jungsook  Cho</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting chaperones, heat shock factor-1, and unfolded protein response: Promising therapeutic approaches for neurodegenerative disorders. </span><span class="cited-content_cbyCitation_journal-name">Ageing Research Reviews</span><span> <strong>2017,</strong> <em>35 </em>, 155-175. <a href="https://doi.org/10.1016/j.arr.2016.09.004" title="DOI URL">https://doi.org/10.1016/j.arr.2016.09.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.arr.2016.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.arr.2016.09.004%26sid%3Dliteratum%253Aachs%26jtitle%3DAgeing%2520Research%2520Reviews%26atitle%3DTargeting%252Bchaperones%25252C%252Bheat%252Bshock%252Bfactor-1%25252C%252Band%252Bunfolded%252Bprotein%252Bresponse%25253A%252BPromising%252Btherapeutic%252Bapproaches%252Bfor%252Bneurodegenerative%252Bdisorders%26aulast%3DBose%26aufirst%3DShambhunath%26date%3D2017%26volume%3D35%26spage%3D155%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chun-Li  Xia</span>, <span class="hlFld-ContribAuthor ">Ning  Wang</span>, <span class="hlFld-ContribAuthor ">Qian-Liang  Guo</span>, <span class="hlFld-ContribAuthor ">Zhen-Quan  Liu</span>, <span class="hlFld-ContribAuthor ">Jia-Qiang  Wu</span>, <span class="hlFld-ContribAuthor ">Shi-Liang  Huang</span>, <span class="hlFld-ContribAuthor ">Tian-Miao  Ou</span>, <span class="hlFld-ContribAuthor ">Jia-Heng  Tan</span>, <span class="hlFld-ContribAuthor ">Hong-Gen  Wang</span>, <span class="hlFld-ContribAuthor ">Ding  Li</span>, <span class="hlFld-ContribAuthor ">Zhi-Shu  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of 2-arylethenyl- N -methylquinolinium derivatives as effective multifunctional agents for Alzheimer's disease treatment. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>130 </em>, 139-153. <a href="https://doi.org/10.1016/j.ejmech.2017.02.042" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.02.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.02.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.02.042%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252B2-arylethenyl-%252BN%252B-methylquinolinium%252Bderivatives%252Bas%252Beffective%252Bmultifunctional%252Bagents%252Bfor%252BAlzheimer%252527s%252Bdisease%252Btreatment%26aulast%3DXia%26aufirst%3DChun-Li%26date%3D2017%26volume%3D130%26spage%3D139%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael K.  Leuchter</span>, <span class="hlFld-ContribAuthor ">Elissa J.  Donzis</span>, <span class="hlFld-ContribAuthor ">Carlos  Cepeda</span>, <span class="hlFld-ContribAuthor ">Aimee M.  Hunter</span>, <span class="hlFld-ContribAuthor ">Ana María  Estrada-Sánchez</span>, <span class="hlFld-ContribAuthor ">Ian A.  Cook</span>, <span class="hlFld-ContribAuthor ">Michael S.  Levine</span>, <span class="hlFld-ContribAuthor ">Andrew F.  Leuchter</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative Electroencephalographic Biomarkers in Preclinical and Human Studies of Huntington’s Disease: Are They Fit-for-Purpose for Treatment Development?. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neurology</span><span> <strong>2017,</strong> <em>8 </em><a href="https://doi.org/10.3389/fneur.2017.00091" title="DOI URL">https://doi.org/10.3389/fneur.2017.00091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fneur.2017.00091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffneur.2017.00091%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neurology%26atitle%3DQuantitative%252BElectroencephalographic%252BBiomarkers%252Bin%252BPreclinical%252Band%252BHuman%252BStudies%252Bof%252BHuntington%2525E2%252580%252599s%252BDisease%25253A%252BAre%252BThey%252BFit-for-Purpose%252Bfor%252BTreatment%252BDevelopment%25253F%26aulast%3DLeuchter%26aufirst%3DMichael%2BK.%26date%3D2017%26date%3D2017%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pablo  San Segundo-Acosta</span>, <span class="hlFld-ContribAuthor ">María  Garranzo-Asensio</span>, <span class="hlFld-ContribAuthor ">Ana  Montero-Calle</span>, <span class="hlFld-ContribAuthor ">Carmen  Oeo-Santos</span>, <span class="hlFld-ContribAuthor ">Mayte  Villalba</span>, <span class="hlFld-ContribAuthor ">Ana  Guzman-Aranguez</span>, <span class="hlFld-ContribAuthor ">Rodrigo  Barderas</span>. </span><span class="cited-content_cbyCitation_article-title">Protein Microarrays in Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 43-62. <a href="https://doi.org/10.1007/978-1-4939-7119-0_4" title="DOI URL">https://doi.org/10.1007/978-1-4939-7119-0_4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-7119-0_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-7119-0_4%26sid%3Dliteratum%253Aachs%26atitle%3DProtein%252BMicroarrays%252Bin%252BNeurodegenerative%252BDiseases%26aulast%3DSan%2BSegundo-Acosta%26aufirst%3DPablo%26date%3D2017%26date%3D2017%26spage%3D43%26epage%3D62%26pub%3DSpringer%2520New%2520York%26atitle%3DCurrent%252BProteomic%252BApproaches%252BApplied%252Bto%252BBrain%252BFunction%26aulast%3DSantamar%25C3%25ADa%26aufirst%3DEnrique%26date%3D2017%26volume%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hayley J.  Nell</span>, <span class="hlFld-ContribAuthor ">Jennifer. L.  Au</span>, <span class="hlFld-ContribAuthor ">Courtney R.  Giordano</span>, <span class="hlFld-ContribAuthor ">Stanley R.  Terlecky</span>, <span class="hlFld-ContribAuthor ">Paul A.  Walton</span>, <span class="hlFld-ContribAuthor ">Shawn N.  Whitehead</span>, <span class="hlFld-ContribAuthor ">David.F.  Cechetto</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Antioxidant, Catalase-SKL, Reduces Beta-Amyloid Toxicity in the Rat Brain. </span><span class="cited-content_cbyCitation_journal-name">Brain Pathology</span><span> <strong>2017,</strong> <em>27 </em>
                                    (1)
                                     , 86-94. <a href="https://doi.org/10.1111/bpa.12368" title="DOI URL">https://doi.org/10.1111/bpa.12368</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bpa.12368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbpa.12368%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Pathology%26atitle%3DTargeted%252BAntioxidant%25252C%252BCatalase-SKL%25252C%252BReduces%252BBeta-Amyloid%252BToxicity%252Bin%252Bthe%252BRat%252BBrain%26aulast%3DNell%26aufirst%3DHayley%2BJ.%26date%3D2017%26date%3D2016%26volume%3D27%26issue%3D1%26spage%3D86%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hena  Khanam</span>, <span class="hlFld-ContribAuthor ">Abad  Ali</span>, <span class="hlFld-ContribAuthor ">Mohd  Asif</span>, <span class="hlFld-ContribAuthor ">Shamsuzzaman</span>. </span><span class="cited-content_cbyCitation_article-title">Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: A review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>124 </em>, 1121-1141. <a href="https://doi.org/10.1016/j.ejmech.2016.08.006" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.08.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.08.006%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNeurodegenerative%252Bdiseases%252Blinked%252Bto%252Bmisfolded%252Bproteins%252Band%252Btheir%252Btherapeutic%252Bapproaches%25253A%252BA%252Breview%26aulast%3DKhanam%26aufirst%3DHena%26date%3D2016%26volume%3D124%26spage%3D1121%26epage%3D1141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gisele S.  da Silva</span>, <span class="hlFld-ContribAuthor ">Micheli  Figueiró</span>, <span class="hlFld-ContribAuthor ">Claudio F.  Tormena</span>, <span class="hlFld-ContribAuthor ">Fernando  Coelho</span>, <span class="hlFld-ContribAuthor ">Wanda P  Almeida</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of novel acylhydrazones derived from 4-quinolone on the acetylcholinesterase activity and A
              β
              42 peptide fibrils formation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2016,</strong> <em>31 </em>
                                    (6)
                                     , 1464-1470. <a href="https://doi.org/10.3109/14756366.2016.1144597" title="DOI URL">https://doi.org/10.3109/14756366.2016.1144597</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/14756366.2016.1144597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F14756366.2016.1144597%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DEffects%252Bof%252Bnovel%252Bacylhydrazones%252Bderived%252Bfrom%252B4-quinolone%252Bon%252Bthe%252Bacetylcholinesterase%252Bactivity%252Band%252BA%252B%2525CE%2525B2%252B42%252Bpeptide%252Bfibrils%252Bformation%26aulast%3Dda%2BSilva%26aufirst%3DGisele%2BS.%26date%3D2016%26date%3D2016%26volume%3D31%26issue%3D6%26spage%3D1464%26epage%3D1470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María  Porres-Martínez</span>, <span class="hlFld-ContribAuthor ">Elena  González-Burgos</span>, <span class="hlFld-ContribAuthor ">M. Emilia  Carretero</span>, <span class="hlFld-ContribAuthor ">M. Pilar  Gómez-Serranillos</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro
              neuroprotective potential of the monoterpenes α-pinene and 1,8-cineole against H
              2
              O
              2
              -induced oxidative stress in PC12 cells. </span><span class="cited-content_cbyCitation_journal-name">Zeitschrift für Naturforschung C</span><span> <strong>2016,</strong> <em>71 </em>
                                    (7-8)
                                     , 191-199. <a href="https://doi.org/10.1515/znc-2014-4135" title="DOI URL">https://doi.org/10.1515/znc-2014-4135</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/znc-2014-4135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fznc-2014-4135%26sid%3Dliteratum%253Aachs%26jtitle%3DZeitschrift%2520f%25C3%25BCr%2520Naturforschung%2520C%26atitle%3DIn%252Bvitro%252Bneuroprotective%252Bpotential%252Bof%252Bthe%252Bmonoterpenes%252B%2525CE%2525B1-pinene%252Band%252B1%25252C8-cineole%252Bagainst%252BH%252B2%252BO%252B2%252B-induced%252Boxidative%252Bstress%252Bin%252BPC12%252Bcells%26aulast%3DPorres-Mart%25C3%25ADnez%26aufirst%3DMar%25C3%25ADa%26date%3D2016%26date%3D2016%26volume%3D71%26issue%3D7-8%26spage%3D191%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">In-Hyun  Ryu</span>, <span class="hlFld-ContribAuthor ">Ki-Young  Lee</span>, <span class="hlFld-ContribAuthor ">Su-Il  Do</span>. </span><span class="cited-content_cbyCitation_article-title">Aβ-affected pathogenic induction of S-nitrosylation of OGT and identification of Cys-NO linkage triplet. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics</span><span> <strong>2016,</strong> <em>1864 </em>
                                    (5)
                                     , 609-621. <a href="https://doi.org/10.1016/j.bbapap.2016.02.003" title="DOI URL">https://doi.org/10.1016/j.bbapap.2016.02.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbapap.2016.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbapap.2016.02.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Proteins%2520and%2520Proteomics%26atitle%3DA%2525CE%2525B2-affected%252Bpathogenic%252Binduction%252Bof%252BS-nitrosylation%252Bof%252BOGT%252Band%252Bidentification%252Bof%252BCys-NO%252Blinkage%252Btriplet%26aulast%3DRyu%26aufirst%3DIn-Hyun%26date%3D2016%26volume%3D1864%26issue%3D5%26spage%3D609%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhipeng  Ke</span>, <span class="hlFld-ContribAuthor ">Xinzhuang  Zhang</span>, <span class="hlFld-ContribAuthor ">Zeyu  Cao</span>, <span class="hlFld-ContribAuthor ">Yue  Ding</span>, <span class="hlFld-ContribAuthor ">Na  Li</span>, <span class="hlFld-ContribAuthor ">Liang  Cao</span>, <span class="hlFld-ContribAuthor ">Tuanjie  Wang</span>, <span class="hlFld-ContribAuthor ">Chenfeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Gang  Ding</span>, <span class="hlFld-ContribAuthor ">Zhenzhong  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaojie  Xu</span>, <span class="hlFld-ContribAuthor ">Wei  Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">Drug discovery of neurodegenerative disease through network pharmacology approach in herbs. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2016,</strong> <em>78 </em>, 272-279. <a href="https://doi.org/10.1016/j.biopha.2016.01.021" title="DOI URL">https://doi.org/10.1016/j.biopha.2016.01.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2016.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2016.01.021%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DDrug%252Bdiscovery%252Bof%252Bneurodegenerative%252Bdisease%252Bthrough%252Bnetwork%252Bpharmacology%252Bapproach%252Bin%252Bherbs%26aulast%3DKe%26aufirst%3DZhipeng%26date%3D2016%26volume%3D78%26spage%3D272%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naohide  Kondo</span>, <span class="hlFld-ContribAuthor ">Masahisa  Katsuno</span>, <span class="hlFld-ContribAuthor ">Yuichi  Riku</span>, <span class="hlFld-ContribAuthor ">Gen  Sobue</span>. </span><span class="cited-content_cbyCitation_article-title">HSF Inhibits the Progression of Age-Related Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 213-242. <a href="https://doi.org/10.1007/978-4-431-55852-1_11" title="DOI URL">https://doi.org/10.1007/978-4-431-55852-1_11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-4-431-55852-1_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-4-431-55852-1_11%26sid%3Dliteratum%253Aachs%26atitle%3DHSF%252BInhibits%252Bthe%252BProgression%252Bof%252BAge-Related%252BNeurodegenerative%252BDiseases%26aulast%3DKondo%26aufirst%3DNaohide%26date%3D2016%26date%3D2016%26spage%3D213%26epage%3D242%26pub%3DSpringer%2520Japan%26atitle%3DHeat%252BShock%252BFactor%26aulast%3DNakai%26aufirst%3DAkira%26date%3D2016%26volume%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dana  Rabinovich</span>, <span class="hlFld-ContribAuthor ">Shiri P.  Yaniv</span>, <span class="hlFld-ContribAuthor ">Idan  Alyagor</span>, <span class="hlFld-ContribAuthor ">Oren  Schuldiner</span>. </span><span class="cited-content_cbyCitation_article-title">Nitric Oxide as a Switching Mechanism between Axon Degeneration and Regrowth during Developmental Remodeling. </span><span class="cited-content_cbyCitation_journal-name">Cell</span><span> <strong>2016,</strong> <em>164 </em>
                                    (1-2)
                                     , 170-182. <a href="https://doi.org/10.1016/j.cell.2015.11.047" title="DOI URL">https://doi.org/10.1016/j.cell.2015.11.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cell.2015.11.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cell.2015.11.047%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%26atitle%3DNitric%252BOxide%252Bas%252Ba%252BSwitching%252BMechanism%252Bbetween%252BAxon%252BDegeneration%252Band%252BRegrowth%252Bduring%252BDevelopmental%252BRemodeling%26aulast%3DRabinovich%26aufirst%3DDana%26date%3D2016%26volume%3D164%26issue%3D1-2%26spage%3D170%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yaping  Liu</span>, <span class="hlFld-ContribAuthor ">Huilong  Ma</span>, <span class="hlFld-ContribAuthor ">Liangwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yajing  Cui</span>, <span class="hlFld-ContribAuthor ">Xiaoting  Liu</span>, <span class="hlFld-ContribAuthor ">Jianguo  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">A small molecule probe reveals declined mitochondrial thioredoxin reductase activity in a Parkinson's disease model. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2016,</strong> <em>52 </em>
                                    (11)
                                     , 2296-2299. <a href="https://doi.org/10.1039/C5CC09998F" title="DOI URL">https://doi.org/10.1039/C5CC09998F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5CC09998F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5CC09998F%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DA%252Bsmall%252Bmolecule%252Bprobe%252Breveals%252Bdeclined%252Bmitochondrial%252Bthioredoxin%252Breductase%252Bactivity%252Bin%252Ba%252BParkinson%252527s%252Bdisease%252Bmodel%26aulast%3DLiu%26aufirst%3DYaping%26date%3D2016%26date%3D2016%26volume%3D52%26issue%3D11%26spage%3D2296%26epage%3D2299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiren  Wang</span>, <span class="hlFld-ContribAuthor ">Wenrui  Li</span>, <span class="hlFld-ContribAuthor ">Yali  Wang</span>, <span class="hlFld-ContribAuthor ">Xiruo  Li</span>, <span class="hlFld-ContribAuthor ">Ling  Huang</span>, <span class="hlFld-ContribAuthor ">Xingshu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of clioquinol–ebselen hybrids as multi-target-directed ligands against Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (9)
                                     , 7139-7158. <a href="https://doi.org/10.1039/C5RA26797H" title="DOI URL">https://doi.org/10.1039/C5RA26797H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA26797H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA26797H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bclioquinol%2525E2%252580%252593ebselen%252Bhybrids%252Bas%252Bmulti-target-directed%252Bligands%252Bagainst%252BAlzheimer%252527s%252Bdisease%26aulast%3DWang%26aufirst%3DZhiren%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D9%26spage%3D7139%26epage%3D7158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vyacheslav E.  Semenov</span>, <span class="hlFld-ContribAuthor ">Irina V.  Zueva</span>, <span class="hlFld-ContribAuthor ">Marat A.  Mukhamedyarov</span>, <span class="hlFld-ContribAuthor ">Sofya V.  Lushchekina</span>, <span class="hlFld-ContribAuthor ">Alexandra D.  Kharlamova</span>, <span class="hlFld-ContribAuthor ">Elena O.  Petukhova</span>, <span class="hlFld-ContribAuthor ">Anatoly S.  Mikhailov</span>, <span class="hlFld-ContribAuthor ">Sergey N.  Podyachev</span>, <span class="hlFld-ContribAuthor ">Lilya F.  Saifina</span>, <span class="hlFld-ContribAuthor ">Konstantin A.  Petrov</span>, <span class="hlFld-ContribAuthor ">Oksana A.  Minnekhanova</span>, <span class="hlFld-ContribAuthor ">Vladimir V.  Zobov</span>, <span class="hlFld-ContribAuthor ">Evgeny E.  Nikolsky</span>, <span class="hlFld-ContribAuthor ">Patrick  Masson</span>, <span class="hlFld-ContribAuthor ">Vladimir S.  Reznik</span>. </span><span class="cited-content_cbyCitation_article-title">6-Methyluracil Derivatives as Bifunctional Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2015,</strong> <em>10 </em>
                                    (11)
                                     , 1863-1874. <a href="https://doi.org/10.1002/cmdc.201500334" title="DOI URL">https://doi.org/10.1002/cmdc.201500334</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201500334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201500334%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3D6-Methyluracil%252BDerivatives%252Bas%252BBifunctional%252BAcetylcholinesterase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%252527s%252BDisease%26aulast%3DSemenov%26aufirst%3DVyacheslav%2BE.%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D11%26spage%3D1863%26epage%3D1874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eva  Cabet</span>, <span class="hlFld-ContribAuthor ">Sabrina  Batonnet-Pichon</span>, <span class="hlFld-ContribAuthor ">Florence  Delort</span>, <span class="hlFld-ContribAuthor ">Blandine  Gausserès</span>, <span class="hlFld-ContribAuthor ">Patrick  Vicart</span>, <span class="hlFld-ContribAuthor ">Alain  Lilienbaum</span>, . </span><span class="cited-content_cbyCitation_article-title">Antioxidant Treatment and Induction of Autophagy Cooperate to Reduce Desmin Aggregation in a Cellular Model of Desminopathy. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2015,</strong> <em>10 </em>
                                    (9)
                                     , e0137009. <a href="https://doi.org/10.1371/journal.pone.0137009" title="DOI URL">https://doi.org/10.1371/journal.pone.0137009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0137009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0137009%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DAntioxidant%252BTreatment%252Band%252BInduction%252Bof%252BAutophagy%252BCooperate%252Bto%252BReduce%252BDesmin%252BAggregation%252Bin%252Ba%252BCellular%252BModel%252Bof%252BDesminopathy%26aulast%3DCabet%26aufirst%3DEva%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D9%26spage%3De0137009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jong Hwan  Kwak</span>, <span class="hlFld-ContribAuthor ">Zhigang  Yang</span>, <span class="hlFld-ContribAuthor ">Byungkwon  Yoon</span>, <span class="hlFld-ContribAuthor ">Yanxia  He</span>, <span class="hlFld-ContribAuthor ">Soojin  Uhm</span>, <span class="hlFld-ContribAuthor ">Hyeon-Cheol  Shin</span>, <span class="hlFld-ContribAuthor ">Bong Ho  Lee</span>, <span class="hlFld-ContribAuthor ">Yung Choon  Yoo</span>, <span class="hlFld-ContribAuthor ">Kyung Bok  Lee</span>, <span class="hlFld-ContribAuthor ">Seung-Yun  Han</span>, <span class="hlFld-ContribAuthor ">Jong Seung  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Blood-brain barrier-permeable fluorone-labeled dieckols acting as neuronal ER stress signaling inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Biomaterials</span><span> <strong>2015,</strong> <em>61 </em>, 52-60. <a href="https://doi.org/10.1016/j.biomaterials.2015.04.045" title="DOI URL">https://doi.org/10.1016/j.biomaterials.2015.04.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biomaterials.2015.04.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biomaterials.2015.04.045%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomaterials%26atitle%3DBlood-brain%252Bbarrier-permeable%252Bfluorone-labeled%252Bdieckols%252Bacting%252Bas%252Bneuronal%252BER%252Bstress%252Bsignaling%252Binhibitors%26aulast%3DKwak%26aufirst%3DJong%2BHwan%26date%3D2015%26volume%3D61%26spage%3D52%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cornelis J  Van der Schyf</span>. </span><span class="cited-content_cbyCitation_article-title">Rational drug discovery design approaches for treating Parkinson’s disease. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2015,</strong> <em>10 </em>
                                    (7)
                                     , 713-741. <a href="https://doi.org/10.1517/17460441.2015.1041495" title="DOI URL">https://doi.org/10.1517/17460441.2015.1041495</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2015.1041495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2015.1041495%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DRational%252Bdrug%252Bdiscovery%252Bdesign%252Bapproaches%252Bfor%252Btreating%252BParkinson%2525E2%252580%252599s%252Bdisease%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DCornelis%2BJ%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D7%26spage%3D713%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.D.  Rollnik</span>. </span><span class="cited-content_cbyCitation_article-title">Morbus Huntington. </span><span class="cited-content_cbyCitation_journal-name">Der Nervenarzt</span><span> <strong>2015,</strong> <em>86 </em>
                                    (6)
                                     , 725-735. <a href="https://doi.org/10.1007/s00115-015-4306-9" title="DOI URL">https://doi.org/10.1007/s00115-015-4306-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00115-015-4306-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00115-015-4306-9%26sid%3Dliteratum%253Aachs%26jtitle%3DDer%2520Nervenarzt%26atitle%3DMorbus%252BHuntington%26aulast%3DRollnik%26aufirst%3DJ.D.%26date%3D2015%26date%3D2015%26volume%3D86%26issue%3D6%26spage%3D725%26epage%3D735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhipei  Sang</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Qiang</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Wen  Yuan</span>, <span class="hlFld-ContribAuthor ">Qiang  Liu</span>, <span class="hlFld-ContribAuthor ">Yikun  Shi</span>, <span class="hlFld-ContribAuthor ">Wei  Ang</span>, <span class="hlFld-ContribAuthor ">Youfu  Luo</span>, <span class="hlFld-ContribAuthor ">Zhenghuai  Tan</span>, <span class="hlFld-ContribAuthor ">Yong  Deng</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>94 </em>, 348-366. <a href="https://doi.org/10.1016/j.ejmech.2015.02.063" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.02.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.02.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.02.063%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bscutellarein-O-alkylamines%252Bas%252Bmultifunctional%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DSang%26aufirst%3DZhipei%26date%3D2015%26volume%3D94%26spage%3D348%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kemal  Yelekci</span>, <span class="hlFld-ContribAuthor ">Bahanur  Örtmen</span>. </span><span class="cited-content_cbyCitation_article-title">De Novo Design of Potent and Selective Neuronal Nitric Oxide Synthase (nNOS) Inhibitors by a Fragment-Based Approach. </span><span class="cited-content_cbyCitation_journal-name">JOURNAL OF PHARMACEUTICAL CHEMISTRY</span><span> <strong>2015,</strong> <em>1 </em>
                                    (4)
                                     , 68. <a href="https://doi.org/10.14805/jphchem.2014.art31" title="DOI URL">https://doi.org/10.14805/jphchem.2014.art31</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.14805/jphchem.2014.art31&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.14805%2Fjphchem.2014.art31%26sid%3Dliteratum%253Aachs%26jtitle%3DJOURNAL%2520OF%2520PHARMACEUTICAL%2520CHEMISTRY%26atitle%3DDe%252BNovo%252BDesign%252Bof%252BPotent%252Band%252BSelective%252BNeuronal%252BNitric%252BOxide%252BSynthase%252B%252528nNOS%252529%252BInhibitors%252Bby%252Ba%252BFragment-Based%252BApproach%26aulast%3DYelekci%26aufirst%3DKemal%26date%3D2015%26date%3D2015%26volume%3D1%26issue%3D4%26spage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria João  Matos</span>, <span class="hlFld-ContribAuthor ">Fernanda  Rodríguez-Enríquez</span>, <span class="hlFld-ContribAuthor ">Santiago  Vilar</span>, <span class="hlFld-ContribAuthor ">Lourdes  Santana</span>, <span class="hlFld-ContribAuthor ">Eugenio  Uriarte</span>, <span class="hlFld-ContribAuthor ">George  Hripcsak</span>, <span class="hlFld-ContribAuthor ">Martín  Estrada</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>, <span class="hlFld-ContribAuthor ">Dolores  Viña</span>. </span><span class="cited-content_cbyCitation_article-title">Potent and selective MAO-B inhibitory activity: Amino- versus nitro-3-arylcoumarin derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (3)
                                     , 642-648. <a href="https://doi.org/10.1016/j.bmcl.2014.12.001" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.12.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.12.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPotent%252Band%252Bselective%252BMAO-B%252Binhibitory%252Bactivity%25253A%252BAmino-%252Bversus%252Bnitro-3-arylcoumarin%252Bderivatives%26aulast%3DMatos%26aufirst%3DMaria%2BJo%25C3%25A3o%26date%3D2015%26volume%3D25%26issue%3D3%26spage%3D642%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mette H.  Poulsen</span>, <span class="hlFld-ContribAuthor ">Jacob  Andersen</span>, <span class="hlFld-ContribAuthor ">Rune  Christensen</span>, <span class="hlFld-ContribAuthor ">Kasper B.  Hansen</span>, <span class="hlFld-ContribAuthor ">Stephen F.  Traynelis</span>, <span class="hlFld-ContribAuthor ">Kristian  Strømgaard</span>, <span class="hlFld-ContribAuthor ">Anders Skov  Kristensen</span>. </span><span class="cited-content_cbyCitation_article-title">Binding of ArgTX-636 in the NMDA Receptor Ion Channel. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Biology</span><span> <strong>2015,</strong> <em>427 </em>
                                    (1)
                                     , 176-189. <a href="https://doi.org/10.1016/j.jmb.2014.05.017" title="DOI URL">https://doi.org/10.1016/j.jmb.2014.05.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmb.2014.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmb.2014.05.017%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Biology%26atitle%3DBinding%252Bof%252BArgTX-636%252Bin%252Bthe%252BNMDA%252BReceptor%252BIon%252BChannel%26aulast%3DPoulsen%26aufirst%3DMette%2BH.%26date%3D2015%26volume%3D427%26issue%3D1%26spage%3D176%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiren  Wang</span>, <span class="hlFld-ContribAuthor ">Yali  Wang</span>, <span class="hlFld-ContribAuthor ">Wenrui  Li</span>, <span class="hlFld-ContribAuthor ">Zhihong  Liu</span>, <span class="hlFld-ContribAuthor ">Zonghua  Luo</span>, <span class="hlFld-ContribAuthor ">Yang  Sun</span>, <span class="hlFld-ContribAuthor ">Ruibo  Wu</span>, <span class="hlFld-ContribAuthor ">Ling  Huang</span>, <span class="hlFld-ContribAuthor ">Xingshu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Computer-assisted designed “selenoxy–chinolin”: a new catalytic mechanism of the GPx-like cycle and inhibition of metal-free and metal-associated Aβ aggregation. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2015,</strong> <em>44 </em>
                                    (48)
                                     , 20913-20925. <a href="https://doi.org/10.1039/C5DT02130H" title="DOI URL">https://doi.org/10.1039/C5DT02130H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5DT02130H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5DT02130H%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DComputer-assisted%252Bdesigned%252B%2525E2%252580%25259Cselenoxy%2525E2%252580%252593chinolin%2525E2%252580%25259D%25253A%252Ba%252Bnew%252Bcatalytic%252Bmechanism%252Bof%252Bthe%252BGPx-like%252Bcycle%252Band%252Binhibition%252Bof%252Bmetal-free%252Band%252Bmetal-associated%252BA%2525CE%2525B2%252Baggregation%26aulast%3DWang%26aufirst%3DZhiren%26date%3D2015%26date%3D2015%26volume%3D44%26issue%3D48%26spage%3D20913%26epage%3D20925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shoujiao  Peng</span>, <span class="hlFld-ContribAuthor ">Juan  Yao</span>, <span class="hlFld-ContribAuthor ">Yaping  Liu</span>, <span class="hlFld-ContribAuthor ">Dongzhu  Duan</span>, <span class="hlFld-ContribAuthor ">Xiaolong  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianguo  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Activation of Nrf2 target enzymes conferring protection against oxidative stress in PC12 cells by ginger principal constituent 6-shogaol. </span><span class="cited-content_cbyCitation_journal-name">Food & Function</span><span> <strong>2015,</strong> <em>6 </em>
                                    (8)
                                     , 2813-2823. <a href="https://doi.org/10.1039/C5FO00214A" title="DOI URL">https://doi.org/10.1039/C5FO00214A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5FO00214A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5FO00214A%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520%2526%2520Function%26atitle%3DActivation%252Bof%252BNrf2%252Btarget%252Benzymes%252Bconferring%252Bprotection%252Bagainst%252Boxidative%252Bstress%252Bin%252BPC12%252Bcells%252Bby%252Bginger%252Bprincipal%252Bconstituent%252B6-shogaol%26aulast%3DPeng%26aufirst%3DShoujiao%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D8%26spage%3D2813%26epage%3D2823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuesong  Wang</span>, <span class="hlFld-ContribAuthor ">Dengsen  Zhu</span>, <span class="hlFld-ContribAuthor ">Cong  Zhao</span>, <span class="hlFld-ContribAuthor ">Lei  He</span>, <span class="hlFld-ContribAuthor ">Weihong  Du</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitory effects of NAMI-A-like ruthenium complexes on prion neuropeptide fibril formation. </span><span class="cited-content_cbyCitation_journal-name">Metallomics</span><span> <strong>2015,</strong> <em>7 </em>
                                    (5)
                                     , 837-846. <a href="https://doi.org/10.1039/C5MT00029G" title="DOI URL">https://doi.org/10.1039/C5MT00029G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MT00029G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MT00029G%26sid%3Dliteratum%253Aachs%26jtitle%3DMetallomics%26atitle%3DInhibitory%252Beffects%252Bof%252BNAMI-A-like%252Bruthenium%252Bcomplexes%252Bon%252Bprion%252Bneuropeptide%252Bfibril%252Bformation%26aulast%3DWang%26aufirst%3DXuesong%26date%3D2015%26date%3D2015%26volume%3D7%26issue%3D5%26spage%3D837%26epage%3D846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vanessa  Nascimento</span>, <span class="hlFld-ContribAuthor ">Natasha L.  Ferreira</span>, <span class="hlFld-ContribAuthor ">Rômulo F.S.  Canto</span>, <span class="hlFld-ContribAuthor ">Karen L.  Schott</span>, <span class="hlFld-ContribAuthor ">Emily P.  Waczuk</span>, <span class="hlFld-ContribAuthor ">Luca  Sancineto</span>, <span class="hlFld-ContribAuthor ">Claudio  Santi</span>, <span class="hlFld-ContribAuthor ">João B.T.  Rocha</span>, <span class="hlFld-ContribAuthor ">Antonio L.  Braga</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of new nitrogen-containing diselenides. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>87 </em>, 131-139. <a href="https://doi.org/10.1016/j.ejmech.2014.09.022" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.09.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.09.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.09.022%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnew%252Bnitrogen-containing%252Bdiselenides%26aulast%3DNascimento%26aufirst%3DVanessa%26date%3D2014%26volume%3D87%26spage%3D131%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Scott A.  Steiger</span>, <span class="hlFld-ContribAuthor ">Anthony J.  Monacelli</span>, <span class="hlFld-ContribAuthor ">Chun  Li</span>, <span class="hlFld-ContribAuthor ">Janet L.  Hunting</span>, <span class="hlFld-ContribAuthor ">Nicholas R.  Natale</span>. </span><span class="cited-content_cbyCitation_article-title">The effect of bromine scanning around the phenyl group of 4-phenylquinolone derivatives. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section C Structural Chemistry</span><span> <strong>2014,</strong> <em>70 </em>
                                    (8)
                                     , 790-795. <a href="https://doi.org/10.1107/S2053229614015617" title="DOI URL">https://doi.org/10.1107/S2053229614015617</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S2053229614015617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS2053229614015617%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520C%2520Structural%2520Chemistry%26atitle%3DThe%252Beffect%252Bof%252Bbromine%252Bscanning%252Baround%252Bthe%252Bphenyl%252Bgroup%252Bof%252B4-phenylquinolone%252Bderivatives%26aulast%3DSteiger%26aufirst%3DScott%2BA.%26date%3D2014%26date%3D2014%26volume%3D70%26issue%3D8%26spage%3D790%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert E.  Boyd</span>, <span class="hlFld-ContribAuthor ">Kenneth J.  Valenzano</span>. </span><span class="cited-content_cbyCitation_article-title">Correction of lysosomal dysfunction as a therapeutic strategy for neurodegenerative diseases. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (14)
                                     , 3001-3005. <a href="https://doi.org/10.1016/j.bmcl.2014.04.108" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.04.108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.04.108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.04.108%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCorrection%252Bof%252Blysosomal%252Bdysfunction%252Bas%252Ba%252Btherapeutic%252Bstrategy%252Bfor%252Bneurodegenerative%252Bdiseases%26aulast%3DBoyd%26aufirst%3DRobert%2BE.%26date%3D2014%26volume%3D24%26issue%3D14%26spage%3D3001%26epage%3D3005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gema C.  González-Muñoz</span>, <span class="hlFld-ContribAuthor ">Mariana P.  Arce</span>, <span class="hlFld-ContribAuthor ">Concepción  Pérez</span>, <span class="hlFld-ContribAuthor ">Alejandro  Romero</span>, <span class="hlFld-ContribAuthor ">Mercedes  Villarroya</span>, <span class="hlFld-ContribAuthor ">Manuela G.  López</span>, <span class="hlFld-ContribAuthor ">Santiago  Conde</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>. </span><span class="cited-content_cbyCitation_article-title">Dibenzo[1,4,5]thiadiazepine: A hardly-known heterocyclic system with neuroprotective properties of potential usefulness in the treatment of neurodegenerative diseases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>81 </em>, 350-358. <a href="https://doi.org/10.1016/j.ejmech.2014.04.075" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.04.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.04.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.04.075%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDibenzo%25255B1%25252C4%25252C5%25255Dthiadiazepine%25253A%252BA%252Bhardly-known%252Bheterocyclic%252Bsystem%252Bwith%252Bneuroprotective%252Bproperties%252Bof%252Bpotential%252Busefulness%252Bin%252Bthe%252Btreatment%252Bof%252Bneurodegenerative%252Bdiseases%26aulast%3DGonz%25C3%25A1lez-Mu%25C3%25B1oz%26aufirst%3DGema%2BC.%26date%3D2014%26volume%3D81%26spage%3D350%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paramita  Mukherjee</span>, <span class="hlFld-ContribAuthor ">Maris A.  Cinelli</span>, <span class="hlFld-ContribAuthor ">Soosung  Kang</span>, <span class="hlFld-ContribAuthor ">Richard B.  Silverman</span>. </span><span class="cited-content_cbyCitation_article-title">Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain. </span><span class="cited-content_cbyCitation_journal-name">Chem. Soc. Rev.</span><span> <strong>2014,</strong> <em>43 </em>
                                    (19)
                                     , 6814-6838. <a href="https://doi.org/10.1039/C3CS60467E" title="DOI URL">https://doi.org/10.1039/C3CS60467E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C3CS60467E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC3CS60467E%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Soc.%2520Rev.%26atitle%3DDevelopment%252Bof%252Bnitric%252Boxide%252Bsynthase%252Binhibitors%252Bfor%252Bneurodegeneration%252Band%252Bneuropathic%252Bpain%26aulast%3DMukherjee%26aufirst%3DParamita%26date%3D2014%26date%3D2014%26volume%3D43%26issue%3D19%26spage%3D6814%26epage%3D6838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rômulo F. S.  Canto</span>, <span class="hlFld-ContribAuthor ">Flavio A. R.  Barbosa</span>, <span class="hlFld-ContribAuthor ">Vanessa  Nascimento</span>, <span class="hlFld-ContribAuthor ">Aldo S.  de Oliveira</span>, <span class="hlFld-ContribAuthor ">Inês M. C.  Brighente</span>, <span class="hlFld-ContribAuthor ">Antonio Luiz  Braga</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of seleno-dihydropyrimidinones as potential multi-targeted therapeutics for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Org. Biomol. Chem.</span><span> <strong>2014,</strong> <em>12 </em>
                                    (21)
                                     , 3470-3477. <a href="https://doi.org/10.1039/C4OB00598H" title="DOI URL">https://doi.org/10.1039/C4OB00598H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4OB00598H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4OB00598H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bseleno-dihydropyrimidinones%252Bas%252Bpotential%252Bmulti-targeted%252Btherapeutics%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DCanto%26aufirst%3DR%25C3%25B4mulo%2BF.%2BS.%26date%3D2014%26date%3D2014%26volume%3D12%26issue%3D21%26spage%3D3470%26epage%3D3477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiang-Bao  Meng</span>, <span class="hlFld-ContribAuthor ">Gui-Bo  Sun</span>, <span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Jing  Sun</span>, <span class="hlFld-ContribAuthor ">Meng  Qin</span>, <span class="hlFld-ContribAuthor ">Xiao-Bo  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">P90RSK and Nrf2 Activation via MEK1/2-ERK1/2 Pathways Mediated by Notoginsenoside R2 to Prevent 6-Hydroxydopamine-Induced Apoptotic Death in SH-SY5Y Cells. </span><span class="cited-content_cbyCitation_journal-name">Evidence-Based Complementary and Alternative Medicine</span><span> <strong>2013,</strong> <em>2013 </em>, 1-15. <a href="https://doi.org/10.1155/2013/971712" title="DOI URL">https://doi.org/10.1155/2013/971712</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2013/971712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2013%2F971712%26sid%3Dliteratum%253Aachs%26jtitle%3DEvidence-Based%2520Complementary%2520and%2520Alternative%2520Medicine%26atitle%3DP90RSK%252Band%252BNrf2%252BActivation%252Bvia%252BMEK1%25252F2-ERK1%25252F2%252BPathways%252BMediated%252Bby%252BNotoginsenoside%252BR2%252Bto%252BPrevent%252B6-Hydroxydopamine-Induced%252BApoptotic%252BDeath%252Bin%252BSH-SY5Y%252BCells%26aulast%3DMeng%26aufirst%3DXiang-Bao%26date%3D2013%26volume%3D2013%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0038.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/large/jm-2012-015926_0038.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3015926&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/large/jm-2012-015926_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Common targets and mechanisms associated with many neurodegenerative diseases that are highlighted in this Perspective.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/large/jm-2012-015926_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3015926&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/large/jm-2012-015926_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. NMDA receptor showing agonist and antagonist binding site domains.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/large/jm-2012-015926_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3015926&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/medium/jm-2012-015926_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/large/jm-2012-015926_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Mechanism of ARE-promoted gene expression by Nrf2. Disruption of the Keap1-Nrf2 complex allows for Nrf2 migration to the nucleus, where it joins with other transcription factors that bind to ARE regions of genes and initiate their transcription.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm3015926/production/images/large/jm-2012-015926_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3015926&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i23">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14712" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14712" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 313 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Lin, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, M. F.</span><span> </span><span class="NLM_article-title">Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">443</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnature05292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=17051205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyktbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=443&publication_year=2006&pages=787-795&author=M.+T.+Linauthor=M.+F.+Beal&title=Mitochondrial+dysfunction+and+oxidative+stress+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases</span></div><div class="casAuthors">Lin, Michael T.; Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">443</span>
        (<span class="NLM_cas:issue">7113</span>),
    <span class="NLM_cas:pages">787-795</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Many lines of evidence suggest that mitochondria have a central role in aging-related neurodegenerative diseases.  Mitochondria are crit. regulators of cell death, a key feature of neurodegeneration.  Mutations in mitochondrial DNA and oxidative stress both contribute to aging, which is the greatest risk factor for neurodegenerative diseases.  In all major examples of these diseases there is strong evidence that mitochondrial dysfunction occurs early and acts causally in disease pathogenesis.  Moreover, an impressive no. of disease-specific proteins interact with mitochondria.  Thus, therapies targeting basic mitochondrial processes, such as energy metab. or free-radical generation, or specific interactions of disease-related proteins with mitochondria, hold great promise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ_a_kJVRRZbVg90H21EOLACvtfcHk0lge2tdaE1AOJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyktbbO&md5=f1f1e0773f62373232ff10156e630cae</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnature05292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05292%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DM.%2BT.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DMitochondrial%2520dysfunction%2520and%2520oxidative%2520stress%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNature%26date%3D2006%26volume%3D443%26spage%3D787%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Hebert, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherr, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienias, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D. A.</span><span> </span><span class="NLM_article-title">Alzheimer disease in the US population: prevalence estimates using the 2000 census</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1119</span><span class="NLM_x">–</span> <span class="NLM_lpage">1122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1001%2Farchneur.60.8.1119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12925369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD3szovVSlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2003&pages=1119-1122&author=L.+E.+Hebertauthor=P.+A.+Scherrauthor=J.+L.+Bieniasauthor=D.+A.+Bennettauthor=D.+A.+Evans&title=Alzheimer+disease+in+the+US+population%3A+prevalence+estimates+using+the+2000+census"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer disease in the US population: prevalence estimates using the 2000 census</span></div><div class="casAuthors">Hebert Liesi E; Scherr Paul A; Bienias Julia L; Bennett David A; Evans Denis A</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1119-22</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">CONTEXT:  Current and future estimates of Alzheimer disease (AD) are essential for public health planning.  OBJECTIVE:  To provide prevalence estimates of AD for the US population from 2000 through 2050.  DESIGN:  Alzheimer disease incidence estimates from a population-based, biracial, urban study, using a stratified random sampling design, were converted to prevalence estimates and applied to US Census Bureau estimates of US population growth.  SETTING:  A geographically defined community of 3 adjacent neighborhoods in Chicago, Ill, applied to the US population.  PARTICIPANTS:  Alzheimer disease incidence was measured in 3838 persons free of AD at baseline; 835 persons were evaluated for disease incidence.  Main Outcome Measure Current and future estimates of prevalence of clinically diagnosed AD in the US population.  RESULTS:  In 2000, there were 4.5 million persons with AD in the US population.  By 2050, this number will increase by almost 3-fold, to 13.2 million.  Owing to the rapid growth of the oldest age groups of the US population, the number who are 85 years and older will more than quadruple to 8.0 million.  The number who are 75 to 84 years old will double to 4.8 million, while the number who are 65 to 74 years old will remain fairly constant at 0.3 to 0.5 million.  CONCLUSION:  The number of persons with AD in the US population will continue to increase unless new discoveries facilitate prevention of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSC6alhM6KljM25P7XSLhESfW6udTcc2eYj6AlUA-DouLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3szovVSlsw%253D%253D&md5=c891d749b9d9205514169c1ab401abba</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1001%2Farchneur.60.8.1119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.60.8.1119%26sid%3Dliteratum%253Aachs%26aulast%3DHebert%26aufirst%3DL.%2BE.%26aulast%3DScherr%26aufirst%3DP.%2BA.%26aulast%3DBienias%26aufirst%3DJ.%2BL.%26aulast%3DBennett%26aufirst%3DD.%2BA.%26aulast%3DEvans%26aufirst%3DD.%2BA.%26atitle%3DAlzheimer%2520disease%2520in%2520the%2520US%2520population%253A%2520prevalence%2520estimates%2520using%2520the%25202000%2520census%26jtitle%3DArch.%2520Neurol.%26date%3D2003%26volume%3D60%26spage%3D1119%26epage%3D1122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Wancata, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musalek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexandrowicz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krautgartner, M.</span><span> </span><span class="NLM_article-title">Number of dementia sufferers in Europe between the years 2000 and 2050</span> <span class="citation_source-journal">Eur. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">313</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.eurpsy.2003.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=14611926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD3srjtlKguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=306-313&author=J.+Wancataauthor=M.+Musalekauthor=R.+Alexandrowiczauthor=M.+Krautgartner&title=Number+of+dementia+sufferers+in+Europe+between+the+years+2000+and+2050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Number of dementia sufferers in Europe between the years 2000 and 2050</span></div><div class="casAuthors">Wancata Johannes; Musalek M; Alexandrowicz R; Krautgartner M</div><div class="citationInfo"><span class="NLM_cas:title">European psychiatry : the journal of the Association of European Psychiatrists</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">306-13</span>
        ISSN:<span class="NLM_cas:issn">0924-9338</span>.
    </div><div class="casAbstract">Several authors have pointed out that in the next few decades dementia will affect a considerably increasing number of the elderly.  To our knowledge there exist no calculations of the number of demented persons for the whole European region.  We made calculations on the number of dementia cases for the period 2000-2050 based on the population projections of the United Nations.  For this purpose, we used the results of several meta-analyses of epidemiological studies.  The number of prevalent dementia cases in the year 2000 was 7.1 million.  Within the next 50 years, this number will rise to about 16.2 million dementia sufferers.  The number of new dementia cases per year will increase from about 1.9 million in the year 2000 to about 4.1 million in the year 2050.  Contrarily, the working-age population will considerably decrease during the next 50 years.  In the year 2000, 7.1 million dementia cases faced 493 million persons in working-age.  This equals a ratio of 69.4 persons in working-age per one demented person.  Until the year 2050, this ratio will decrease to only 21.1.  Thus, the financial and emotional burden placed by dementia on the working-age population will markedly rise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_G_cqutvGMBKDYG3bNImrfW6udTcc2eYj6AlUA-DouLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srjtlKguw%253D%253D&md5=e38980ebf6fcdc8c503f9da7bdb383ab</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.eurpsy.2003.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.eurpsy.2003.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DWancata%26aufirst%3DJ.%26aulast%3DMusalek%26aufirst%3DM.%26aulast%3DAlexandrowicz%26aufirst%3DR.%26aulast%3DKrautgartner%26aufirst%3DM.%26atitle%3DNumber%2520of%2520dementia%2520sufferers%2520in%2520Europe%2520between%2520the%2520years%25202000%2520and%25202050%26jtitle%3DEur.%2520Psychiatry%26date%3D2003%26volume%3D18%26spage%3D306%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Forman, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M. Y.</span><span> </span><span class="NLM_article-title">Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1055</span><span class="NLM_x">–</span> <span class="NLM_lpage">1063</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnm1113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=15459709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvFyntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=1055-1063&author=M.+S.+Formanauthor=J.+Q.+Trojanowskiauthor=V.+M.+Y.+Lee&title=Neurodegenerative+diseases%3A+a+decade+of+discoveries+paves+the+way+for+therapeutic+breakthroughs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs</span></div><div class="casAuthors">Forman, Mark S.; Trojanowski, John Q.; Lee, Virginia M-Y.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1055-1063</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  A wide variety of neurodegenerative diseases are characterized by the accumulation of intracellular or extracellular protein aggregates.  More recently, the genetic identification of mutations in familial counterparts to the sporadic disorders, leading to the development of in vitro and in vivo model systems, has provided insights into disease pathogenesis.  The effect of many of these mutations is the abnormal processing of misfolded proteins that overwhelms the quality-control systems of the cell, resulting in the deposition of protein aggregates in the nucleus, cytosol and/or extracellular space.  Further understanding of mechanisms regulating protein processing and aggregation, as well as of the toxic effects of misfolded neurodegenerative disease proteins, will facilitate development of rationally designed therapies to treat and prevent these disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoedYkRDtkl5bVg90H21EOLACvtfcHk0ljmVMXBtwWJOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvFyntbY%253D&md5=f5b1711b04c37db9b27ba3f2b47f3d39</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnm1113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1113%26sid%3Dliteratum%253Aachs%26aulast%3DForman%26aufirst%3DM.%2BS.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%2BY.%26atitle%3DNeurodegenerative%2520diseases%253A%2520a%2520decade%2520of%2520discoveries%2520paves%2520the%2520way%2520for%2520therapeutic%2520breakthroughs%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D1055%26epage%3D1063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Bossy-Wetzel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzenbacher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, S. A.</span><span> </span><span class="NLM_article-title">Molecular pathways to neurodegeneration</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">S2</span><span class="NLM_x">–</span> <span class="NLM_lpage">S9</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=S2-S9&issue=Suppl.&author=E.+Bossy-Wetzelauthor=R.+Schwarzenbacherauthor=S.+A.+Lipton&title=Molecular+pathways+to+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBossy-Wetzel%26aufirst%3DE.%26aulast%3DSchwarzenbacher%26aufirst%3DR.%26aulast%3DLipton%26aufirst%3DS.%2BA.%26atitle%3DMolecular%2520pathways%2520to%2520neurodegeneration%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26issue%3DSuppl%26spage%3DS2%26epage%3DS9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Pardo, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Duijn, C. M.</span><span> </span><span class="NLM_article-title">In search of genes involved in neurodegenerative disorders</span> <span class="citation_source-journal">Mutat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">592</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.mrfmmm.2005.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=16009383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1OmsL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=592&publication_year=2005&pages=89-101&author=L.+M.+Pardoauthor=C.+M.+van+Duijn&title=In+search+of+genes+involved+in+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">In search of genes involved in neurodegenerative disorders</span></div><div class="casAuthors">Pardo, Luba M.; van Duijn, Cornelia M.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">592</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">89-101</span>CODEN:
                <span class="NLM_cas:coden">MUREAV</span>;
        ISSN:<span class="NLM_cas:issn">0027-5107</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Dissecting the genetics of Alzheimer's disease (AD) and Parkinson's disease (PD) has contributed significantly to our understanding of the pathogenesis of neurodegeneration in these two complex disorders.  For AD, three highly penetrant genes amyloid precursor protein (APP, PSEN1, and PSEN2), and one susceptibility gene APOE have been identified.  For PD, seven genes (SNCA, Parkin, UCHL1, NR4A2, DJ1, PINK1 and LRRK2) have been found.  These genes explain only a small proportion of AD and PD patients and are mostly assocd. with an early onset presentation of the disease.  APOE remains the only common gene, which increases the risk of both rare early and late onset AD.  The ongoing challenge is to unravel the genetics of the most frequent forms of these complex disorders.  In the present paper, we briefly review the state of the art in the genetics of AD and PD.  We also discuss the prospects of finding new genes assocd. with common forms of these diseases in light of two hypotheses concerning the genetic variation of complex diseases: common disease/common variants and common disease/rare variants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTP1o6fjj6mrVg90H21EOLACvtfcHk0ljmVMXBtwWJOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1OmsL3P&md5=f83d28b845ce20f5c107f8d19cb4867b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.mrfmmm.2005.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mrfmmm.2005.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DPardo%26aufirst%3DL.%2BM.%26aulast%3Dvan%2BDuijn%26aufirst%3DC.%2BM.%26atitle%3DIn%2520search%2520of%2520genes%2520involved%2520in%2520neurodegenerative%2520disorders%26jtitle%3DMutat.%2520Res.%26date%3D2005%26volume%3D592%26spage%3D89%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Amor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puentes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Valk, P.</span><span> </span><span class="NLM_article-title">Inflammation in neurodegenerative diseases</span> <span class="citation_source-journal">Immunology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1111%2Fj.1365-2567.2009.03225.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20561356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1ert7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2010&pages=154-169&author=S.+Amorauthor=F.+Puentesauthor=D.+Bakerauthor=P.+van+der+Valk&title=Inflammation+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation in neurodegenerative diseases</span></div><div class="casAuthors">Amor, Sandra; Puentes, Fabiola; Baker, David; van der Valk, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">154-169</span>CODEN:
                <span class="NLM_cas:coden">IMMUAM</span>;
        ISSN:<span class="NLM_cas:issn">0019-2805</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Neurodegeneration, the slow and progressive dysfunction and loss of neurons and axons in the central nervous system, is the primary pathol. feature of acute and chronic neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease, neurotropic viral infections, stroke, paraneoplastic disorders, traumatic brain injury and multiple sclerosis.  Despite different triggering events, a common feature is chronic immune activation, in particular of microglia, the resident macrophages of the central nervous system.  Apart from the pathogenic role of immune responses, emerging evidence indicates that immune responses are also crit. for neuroregeneration.  Here, we review the impact of innate and adaptive immune responses on the central nervous system in autoimmune, viral and other neurodegenerative disorders, and discuss their contribution to either damage or repair.  We also discuss potential therapies aimed at the immune responses within the central nervous system.  A better understanding of the interaction between the immune and nervous systems will be crucial to either target pathogenic responses, or augment the beneficial effects of immune responses as a strategy to intervene in chronic neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAfLAZyEDLZrVg90H21EOLACvtfcHk0ljmVMXBtwWJOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1ert7w%253D&md5=25a55887688ccba95e7e1fe1488ad324</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2567.2009.03225.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2567.2009.03225.x%26sid%3Dliteratum%253Aachs%26aulast%3DAmor%26aufirst%3DS.%26aulast%3DPuentes%26aufirst%3DF.%26aulast%3DBaker%26aufirst%3DD.%26aulast%3Dvan%2Bder%2BValk%26aufirst%3DP.%26atitle%3DInflammation%2520in%2520neurodegenerative%2520diseases%26jtitle%3DImmunology%26date%3D2010%26volume%3D129%26spage%3D154%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Glass, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saijo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchetto, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gage, F. H.</span><span> </span><span class="NLM_article-title">Mechanisms underlying inflammation in neurodegeneration</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">918</span><span class="NLM_x">–</span> <span class="NLM_lpage">934</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.cell.2010.02.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20303880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSgu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2010&pages=918-934&author=C.+K.+Glassauthor=K.+Saijoauthor=B.+Winnerauthor=M.+C.+Marchettoauthor=F.+H.+Gage&title=Mechanisms+underlying+inflammation+in+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms underlying inflammation in neurodegeneration</span></div><div class="casAuthors">Glass, Christopher K.; Saijo, Kaoru; Winner, Beate; Marchetto, Maria Carolina; Gage, Fred H.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">918-934</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Inflammation is assocd. with many neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis.  In this Review, the authors discuss inducers, sensors, transducers, and effectors of neuroinflammation that contribute to neuronal dysfunction and death.  Although inducers of inflammation may be generated in a disease-specific manner, there is evidence for a remarkable convergence in the mechanisms responsible for the sensing, transduction, and amplification of inflammatory processes that result in the prodn. of neurotoxic mediators.  A major unanswered question is whether pharmacol. inhibition of inflammation pathways will be able to safely reverse or slow the course of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXo1ncn5lVrbVg90H21EOLACvtfcHk0ljmVMXBtwWJOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSgu7Y%253D&md5=67b2963df2ff70d6ab744f6a1bbb1b87</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.02.016%26sid%3Dliteratum%253Aachs%26aulast%3DGlass%26aufirst%3DC.%2BK.%26aulast%3DSaijo%26aufirst%3DK.%26aulast%3DWinner%26aufirst%3DB.%26aulast%3DMarchetto%26aufirst%3DM.%2BC.%26aulast%3DGage%26aufirst%3DF.%2BH.%26atitle%3DMechanisms%2520underlying%2520inflammation%2520in%2520neurodegeneration%26jtitle%3DCell%26date%3D2010%26volume%3D140%26spage%3D918%26epage%3D934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Czirr, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyss-Coray, T.</span><span> </span><span class="NLM_article-title">The immunology of neurodegeneration</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">1156</span><span class="NLM_x">–</span> <span class="NLM_lpage">1163</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2012&pages=1156-1163&author=E.+Czirrauthor=T.+Wyss-Coray&title=The+immunology+of+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCzirr%26aufirst%3DE.%26aulast%3DWyss-Coray%26aufirst%3DT.%26atitle%3DThe%2520immunology%2520of%2520neurodegeneration%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2012%26volume%3D122%26spage%3D1156%26epage%3D1163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Schwarcz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchowski, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. Q.</span><span> </span><span class="NLM_article-title">Kynurenines in the mammalian brain: when physiology meets pathology</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnrn3257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=22678511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38Xot1CmsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=465-477&author=R.+Schwarczauthor=J.+P.+Brunoauthor=P.+J.+Muchowskiauthor=H.+Q.+Wu&title=Kynurenines+in+the+mammalian+brain%3A+when+physiology+meets+pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Kynurenines in the mammalian brain: when physiology meets pathology</span></div><div class="casAuthors">Schwarcz, Robert; Bruno, John P.; Muchowski, Paul J.; Wu, Hui-Qiu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">465-477</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The essential amino acid tryptophan is not only a precursor of serotonin but is also degraded to several other neuroactive compds., including kynurenic acid, 3-hydroxykynurenine and quinolinic acid.  The synthesis of these metabolites is regulated by an enzymic cascade, known as the kynurenine pathway, that is tightly controlled by the immune system.  Dysregulation of this pathway, resulting in hyper- or hypofunction of active metabolites, is assocd. with neurodegenerative and other neurol. disorders, as well as with psychiatric diseases such as depression and schizophrenia.  With recently developed pharmacol. agents, it is now possible to restore metabolic equil. and envisage novel therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr7vLdWHblurVg90H21EOLACvtfcHk0lhKXuEPXxn9GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xot1CmsL4%253D&md5=b30a985543d32947138d98e6de82b9ea</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrn3257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3257%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarcz%26aufirst%3DR.%26aulast%3DBruno%26aufirst%3DJ.%2BP.%26aulast%3DMuchowski%26aufirst%3DP.%2BJ.%26aulast%3DWu%26aufirst%3DH.%2BQ.%26atitle%3DKynurenines%2520in%2520the%2520mammalian%2520brain%253A%2520when%2520physiology%2520meets%2520pathology%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2012%26volume%3D13%26spage%3D465%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Lugo-Huitron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanco-Ayala, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugalde-Muniz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrillo-Mora, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedraza-Chaverri, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva-Adaya, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldonado, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinzon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortiz-Islas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pineda, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres-Ramos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santamaria, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Cruz, V. P.</span><span> </span><span class="NLM_article-title">On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress</span> <span class="citation_source-journal">Neurotoxicol. Teratol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">538</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.ntt.2011.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=21763768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ejsbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2011&pages=538-547&author=R.+Lugo-Huitronauthor=T.+Blanco-Ayalaauthor=P.+Ugalde-Munizauthor=P.+Carrillo-Moraauthor=J.+Pedraza-Chaverriauthor=D.+Silva-Adayaauthor=P.+D.+Maldonadoauthor=I.+Torresauthor=E.+Pinzonauthor=E.+Ortiz-Islasauthor=T.+Lopezauthor=E.+Garciaauthor=B.+Pinedaauthor=M.+Torres-Ramosauthor=A.+Santamariaauthor=V.+P.+La+Cruz&title=On+the+antioxidant+properties+of+kynurenic+acid%3A+free+radical+scavenging+activity+and+inhibition+of+oxidative+stress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">On the antioxidant properties of kynurenic acid: Free radical scavenging activity and inhibition of oxidative stress</span></div><div class="casAuthors">Lugo-Huitron, R.; Blanco-Ayala, T.; Ugalde-Muniz, P.; Carrillo-Mora, P.; Pedraza-Chaverri, J.; Silva-Adaya, D.; Maldonado, P. D.; Torres, I.; Pinzon, E.; Ortiz-Islas, E.; Lopez, T.; Garcia, E.; Pineda, B.; Torres-Ramos, M.; Santamaria, A.; Perez-De La Cruz, V.</div><div class="citationInfo"><span class="NLM_cas:title">Neurotoxicology and Teratology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">538-547</span>CODEN:
                <span class="NLM_cas:coden">NETEEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-0362</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Kynurenic acid (KYNA) is an endogenous metabolite of the kynurenine pathway for tryptophan degrdn. and an antagonist of both N-methyl-D-aspartate (NMDA) and alpha-7 nicotinic acetylcholine (α7nACh) receptors.  KYNA has also been shown to scavenge hydroxyl radicals ([rad]OH) under controlled conditions of free radical prodn.  In this work we evaluated the ability of KYNA to scavenge superoxide anion (O2·-) and peroxynitrite (ONOO-).  The scavenging ability of KYNA (expressed as IC50 values) was as follows: [rad]OH = O2·- > ONOO-.  In parallel, the antiperoxidative and scavenging capacities of KYNA (0-150 μM) were tested in cerebellum and forebrain homogenates exposed to 5 μM FeSO4 and 2.5 mM 3-nitropropionic acid (3-NPA).  Both FeSO4 and 3-NPA increased lipid peroxidn. (LP) and ROS formation in a significant manner in these prepns., whereas KYNA significantly reduced these markers.  Reactive oxygen species (ROS) formation were detd. in the presence of FeSO4 and/or KYNA (0-100 μM), both at intra and extracellular levels.  An increase in ROS formation was induced by FeSO4 in forebrain and cerebellum in a time-dependent manner, and KYNA reduced this effect in a concn.-dependent manner.  To further know whether the effect of KYNA on oxidative stress is independent of NMDA and nicotinic receptors, we also tested KYNA (0-100 μM) in a biol. prepn. free of these receptors, defolliculated Xenopus laevis oocytes, incubated with FeSO4 for 1 h.  A 3-fold increase in LP and a 2-fold increase in ROS formation were seen after exposure to FeSO4, whereas KYNA attenuated these effects in a concn.-dependent manner.  In addn., the in vivo formation of ·OH evoked by an acute infusion of FeSO4 (100 μM) in the rat striatum was estd. by microdialysis and challenged by a topic infusion of KYNA (1 μM).  FeSO4 increased the striatal ·OH prodn., while KYNA mitigated this effect.  Altogether, these data strongly suggest that KYNA, in addn. to be a well-known antagonist acting on nicotinic and NMDA receptors, can be considered as a potential endogenous antioxidant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod9wpN_jkui7Vg90H21EOLACvtfcHk0lhKXuEPXxn9GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ejsbfJ&md5=c779fed276225e3f596499f36e7dcf88</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.ntt.2011.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ntt.2011.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DLugo-Huitron%26aufirst%3DR.%26aulast%3DBlanco-Ayala%26aufirst%3DT.%26aulast%3DUgalde-Muniz%26aufirst%3DP.%26aulast%3DCarrillo-Mora%26aufirst%3DP.%26aulast%3DPedraza-Chaverri%26aufirst%3DJ.%26aulast%3DSilva-Adaya%26aufirst%3DD.%26aulast%3DMaldonado%26aufirst%3DP.%2BD.%26aulast%3DTorres%26aufirst%3DI.%26aulast%3DPinzon%26aufirst%3DE.%26aulast%3DOrtiz-Islas%26aufirst%3DE.%26aulast%3DLopez%26aufirst%3DT.%26aulast%3DGarcia%26aufirst%3DE.%26aulast%3DPineda%26aufirst%3DB.%26aulast%3DTorres-Ramos%26aufirst%3DM.%26aulast%3DSantamaria%26aufirst%3DA.%26aulast%3DLa%2BCruz%26aufirst%3DV.%2BP.%26atitle%3DOn%2520the%2520antioxidant%2520properties%2520of%2520kynurenic%2520acid%253A%2520free%2520radical%2520scavenging%2520activity%2520and%2520inhibition%2520of%2520oxidative%2520stress%26jtitle%3DNeurotoxicol.%2520Teratol.%26date%3D2011%26volume%3D33%26spage%3D538%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Hanisch, U. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kipnis, J.</span><span> </span><span class="NLM_article-title">Toll-like receptors: roles in neuroprotection?</span> <span class="citation_source-journal">Trends Neurosci</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">176</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=176-182&author=U.+K.+Hanischauthor=T.+V.+Johnsonauthor=J.+Kipnis&title=Toll-like+receptors%3A+roles+in+neuroprotection%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanisch%26aufirst%3DU.%2BK.%26aulast%3DJohnson%26aufirst%3DT.%2BV.%26aulast%3DKipnis%26aufirst%3DJ.%26atitle%3DToll-like%2520receptors%253A%2520roles%2520in%2520neuroprotection%253F%26jtitle%3DTrends%2520Neurosci%26date%3D2008%26volume%3D31%26spage%3D176%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Drouin-Ouellet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cicchetti, F.</span><span> </span><span class="NLM_article-title">Inflammation and neurodegeneration: the story “retolled”</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">551</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=542-551&author=J.+Drouin-Ouelletauthor=F.+Cicchetti&title=Inflammation+and+neurodegeneration%3A+the+story+%E2%80%9Cretolled%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDrouin-Ouellet%26aufirst%3DJ.%26aulast%3DCicchetti%26aufirst%3DF.%26atitle%3DInflammation%2520and%2520neurodegeneration%253A%2520the%2520story%2520%25E2%2580%259Cretolled%25E2%2580%259D%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2012%26volume%3D33%26spage%3D542%26epage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Aquilano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotilio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciriolo, M. R.</span><span> </span><span class="NLM_article-title">Role of nitric oxide synthases in Parkinson’s disease: a review on the antioxidant and anti-inflammatory activity of polyphenols</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">2416</span><span class="NLM_x">–</span> <span class="NLM_lpage">2426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1007%2Fs11064-008-9697-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=18415676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOktL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=2416-2426&author=K.+Aquilanoauthor=S.+Baldelliauthor=G.+Rotilioauthor=M.+R.+Ciriolo&title=Role+of+nitric+oxide+synthases+in+Parkinson%E2%80%99s+disease%3A+a+review+on+the+antioxidant+and+anti-inflammatory+activity+of+polyphenols"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Nitric Oxide Synthases in Parkinson's Disease: A Review on the Antioxidant and Anti-inflammatory Activity of Polyphenols</span></div><div class="casAuthors">Aquilano, Katia; Baldelli, Sara; Rotilio, Giuseppe; Ciriolo, Maria Rosa</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2416-2426</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Natural polyphenols can exert protective action on a no. of pathol. conditions including neurodegenerative disorders.  The neuroprotective effects of many polyphenols rely on their ability to permeate brain barrier and here directly scavenge pathol. concn. of reactive oxygen and nitrogen species and chelate transition metal ions.  Importantly, polyphenols modulate neuroinflammation by inhibiting the expression of inflammatory genes and the level of intracellular antioxidants.  Parkinson's disease (PD) is a neurodegenerative disorder characterized by several abnormalities including inflammation, mitochondrial dysfunction, iron accumulation and oxidative stress.  There is considerable evidence showing that cellular oxidative damage occurring in PD might result also from the actions of altered prodn. of nitric oxide (NO).  Indeed, high levels of neuronal and inducible NO synthase (NOS) were found in substantia nigra of patients and animal models of PD.  Here, we evaluate the involvement of NOS/NO in PD and explore the neuroprotective activity of natural polyphenol compds. in terms of anti-inflammatory and antioxidant action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJnRn1WmEk1rVg90H21EOLACvtfcHk0ljD_Gl3n7trIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOktL3M&md5=4fed473750b90729d98e936339b6f4f4</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs11064-008-9697-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-008-9697-6%26sid%3Dliteratum%253Aachs%26aulast%3DAquilano%26aufirst%3DK.%26aulast%3DBaldelli%26aufirst%3DS.%26aulast%3DRotilio%26aufirst%3DG.%26aulast%3DCiriolo%26aufirst%3DM.%2BR.%26atitle%3DRole%2520of%2520nitric%2520oxide%2520synthases%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520a%2520review%2520on%2520the%2520antioxidant%2520and%2520anti-inflammatory%2520activity%2520of%2520polyphenols%26jtitle%3DNeurochem.%2520Res.%26date%3D2008%26volume%3D33%26spage%3D2416%26epage%3D2426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Frank-Cannon, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alto, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAlpine, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tansey, M. G.</span><span> </span><span class="NLM_article-title">Does neuroinflammation fan the flame in neurodegenerative diseases?</span> <span class="citation_source-journal">Mol. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1186%2F1750-1326-4-47" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=19917131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD1Mjos1yhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=47&author=T.+C.+Frank-Cannonauthor=L.+T.+Altoauthor=F.+E.+McAlpineauthor=M.+G.+Tansey&title=Does+neuroinflammation+fan+the+flame+in+neurodegenerative+diseases%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Does neuroinflammation fan the flame in neurodegenerative diseases?</span></div><div class="casAuthors">Frank-Cannon Tamy C; Alto Laura T; McAlpine Fiona E; Tansey Malu G</div><div class="citationInfo"><span class="NLM_cas:title">Molecular neurodegeneration</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">47</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract"> While peripheral immune access to the central nervous system (CNS) is restricted and tightly controlled, the CNS is capable of dynamic immune and inflammatory responses to a variety of insults.  Infections, trauma, stroke, toxins and other stimuli are capable of producing an immediate and short lived activation of the innate immune system within the CNS.  This acute neuroinflammatory response includes activation of the resident immune cells (microglia) resulting in a phagocytic phenotype and the release of inflammatory mediators such as cytokines and chemokines.  While an acute insult may trigger oxidative and nitrosative stress, it is typically short-lived and unlikely to be detrimental to long-term neuronal survival.  In contrast, chronic neuroinflammation is a long-standing and often self-perpetuating neuroinflammatory response that persists long after an initial injury or insult.  Chronic neuroinflammation includes not only long-standing activation of microglia and subsequent sustained release of inflammatory mediators, but also the resulting increased oxidative and nitrosative stress.  The sustained release of inflammatory mediators works to perpetuate the inflammatory cycle, activating additional microglia, promoting their proliferation, and resulting in further release of inflammatory factors.  Neurodegenerative CNS disorders, including multiple sclerosis (MS), Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), tauopathies, and age-related macular degeneration (ARMD), are associated with chronic neuroinflammation and elevated levels of several cytokines.  Here we review the hallmarks of acute and chronic inflammatory responses in the CNS, the reasons why microglial activation represents a convergence point for diverse stimuli that may promote or compromise neuronal survival, and the epidemiologic, pharmacologic and genetic evidence implicating neuroinflammation in the pathophysiology of several neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRzJ8CUclv_tsjl5L8hwNX0fW6udTcc2ebduULWIYh4yrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mjos1yhug%253D%253D&md5=83ecc85e481c4b3bf40477b8bd557fc1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-4-47&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-4-47%26sid%3Dliteratum%253Aachs%26aulast%3DFrank-Cannon%26aufirst%3DT.%2BC.%26aulast%3DAlto%26aufirst%3DL.%2BT.%26aulast%3DMcAlpine%26aufirst%3DF.%2BE.%26aulast%3DTansey%26aufirst%3DM.%2BG.%26atitle%3DDoes%2520neuroinflammation%2520fan%2520the%2520flame%2520in%2520neurodegenerative%2520diseases%253F%26jtitle%3DMol.%2520Neurodegener.%26date%3D2009%26volume%3D4%26spage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Mosley, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gendelman, H. E.</span><span> </span><span class="NLM_article-title">Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">222</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.expneurol.2009.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20044993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFGns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=222&publication_year=2010&pages=1-5&author=R.+L.+Mosleyauthor=H.+E.+Gendelman&title=Control+of+neuroinflammation+as+a+therapeutic+strategy+for+amyotrophic+lateral+sclerosis+and+other+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders</span></div><div class="casAuthors">Mosley, R. Lee; Gendelman, Howard E.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">222</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-5</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative diseases, Alzheimer's and Parkinson's diseases, and amyotrophic lateral sclerosis (ALS) are progressive and devastating disorders of the nervous system without cure.  Although a no. of distinct, but not mutually exclusive, mechanisms can affect disease pathogenesis, neuroinflammation stands in common.  Neuroinflammatory responses occur as a consequence of oxidative and excitotoxic neuronal damage, mitochondrial dysfunction, and protein aggregation.  Thus, it is believed drugs that modulate inflammation may combat disease progression.  Such strategies include those commented on in the report by Arie Neymotin et al. demonstrating lenalidomide's anti-inflammatory and neuroprotective responses in the G93A mutant superoxide dismutase-1 mouse model of ALS (Neymotin et al., ).  While anti-inflammatory interventions may be required, they may not be sufficient to pos. affect clin. outcomes.  The targeting of combinations of pathogenic events including clearance of disaggregated proteins together with neuroprotective and immune modulatory strategies may all be required to facilitate pos. therapeutic outcomes.  This may include the targeting of both innate and adaptive neurotoxic immune responses.  This commentary is designed to summarize the promises and perils in achieving immunoregulation for brain homeostatic responses and inevitable therapeutic gain.  Promising new ways to optimize immunization schemes and measure their clin. efficacy are discussed with a particular focus on ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcqlUFyjBZKrVg90H21EOLACvtfcHk0ljD_Gl3n7trIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFGns7o%253D&md5=410f09144b389dabc2516e6652d590ec</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2009.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2009.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DMosley%26aufirst%3DR.%2BL.%26aulast%3DGendelman%26aufirst%3DH.%2BE.%26atitle%3DControl%2520of%2520neuroinflammation%2520as%2520a%2520therapeutic%2520strategy%2520for%2520amyotrophic%2520lateral%2520sclerosis%2520and%2520other%2520neurodegenerative%2520disorders%26jtitle%3DExp.%2520Neurol.%26date%3D2010%26volume%3D222%26spage%3D1%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Neymotin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calingasan, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wille, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiaei, M.</span><span> </span><span class="NLM_article-title">Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">220</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.expneurol.2009.08.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=19733563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GmtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=220&publication_year=2009&pages=191-197&author=A.+Neymotinauthor=S.+Petriauthor=N.+Y.+Calingasanauthor=E.+Willeauthor=P.+Schaferauthor=C.+Stewartauthor=K.+Hensleyauthor=M.+F.+Bealauthor=M.+Kiaei&title=Lenalidomide+%28Revlimid%29+administration+at+symptom+onset+is+neuroprotective+in+a+mouse+model+of+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis</span></div><div class="casAuthors">Neymotin, Arie; Petri, Susanne; Calingasan, Noel Y.; Wille, Elizabeth; Schafer, Peter; Stewart, Charles; Hensley, Kenneth; Beal, M. Flint; Kiaei, Mahmoud</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">220</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">191-197</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease which is currently untreatable.  Inflammation plays a major role in the pathogenesis of motor neuron death in ALS.  Pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α) and Fas ligand (FasL) are amongst the most important mediators of neuro-inflammation.  We have previously demonstrated that elevation of these pro-inflammatory cytokines occurs in both ALS transgenic mice and in human ALS postmortem spinal cord tissues.  Lenalidomide is a potent immunomodulatory agent, with the ability to down-regulate pro-inflammatory cytokines and up-regulate anti-inflammatory cytokines.  We previously reported the neuroprotective effects of lenalidomide, when treatment was started 2 mo prior to onset of disease in the G93A SOD1 transgenic mouse model of ALS.  Since in ALS patients, treatment can only begin after the appearance of symptoms, we sought to det. the efficacy of lenalidomide administration starting at symptom onset in the G93A SOD1 mice.  We found that lenalidomide treatment extended the survival interval from the age of onset by 18.3 days (∼ 45%).  Addnl., lenalidomide treatment improved rotarod performance, reduced wt. loss, and attenuated neuronal cell death in the lumbar spinal cord.  Qual. histol. anal. showed that lenalidomide treatment modestly reduced the expression of the proinflammatory cytokines Fas Ligand, IL-1β, TNF-α and CD40 ligand.  RNA protection Assay (RPA) on a pre-selected panel of cytokines showed that proinflammatory cytokines were reduced and anti-inflammatory cytokines were up-regulated.  These data encourage further clin. evaluation of lenalidomide as therapeutic strategy to block or slow disease progression in human ALS patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFpqmn6J_A6rVg90H21EOLACvtfcHk0ljD_Gl3n7trIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GmtL3F&md5=ca86c5e88da2a26fb2e119731c1075ab</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2009.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2009.08.028%26sid%3Dliteratum%253Aachs%26aulast%3DNeymotin%26aufirst%3DA.%26aulast%3DPetri%26aufirst%3DS.%26aulast%3DCalingasan%26aufirst%3DN.%2BY.%26aulast%3DWille%26aufirst%3DE.%26aulast%3DSchafer%26aufirst%3DP.%26aulast%3DStewart%26aufirst%3DC.%26aulast%3DHensley%26aufirst%3DK.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26aulast%3DKiaei%26aufirst%3DM.%26atitle%3DLenalidomide%2520%2528Revlimid%2529%2520administration%2520at%2520symptom%2520onset%2520is%2520neuroprotective%2520in%2520a%2520mouse%2520model%2520of%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DExp.%2520Neurol.%26date%3D2009%26volume%3D220%26spage%3D191%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Greenfield, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaux, D. J.</span><span> </span><span class="NLM_article-title">Parkinson’s disease, Alzheimer’s disease and motor neurone disease: identifying a common mechanism</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">485</span><span class="NLM_x">–</span> <span class="NLM_lpage">492</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2002&pages=485-492&author=S.+Greenfieldauthor=D.+J.+Vaux&title=Parkinson%E2%80%99s+disease%2C+Alzheimer%E2%80%99s+disease+and+motor+neurone+disease%3A+identifying+a+common+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGreenfield%26aufirst%3DS.%26aulast%3DVaux%26aufirst%3DD.%2BJ.%26atitle%3DParkinson%25E2%2580%2599s%2520disease%252C%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520motor%2520neurone%2520disease%253A%2520identifying%2520a%2520common%2520mechanism%26jtitle%3DNeuroscience%26date%3D2002%26volume%3D113%26spage%3D485%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Calne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcgeer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, P.</span><span> </span><span class="NLM_article-title">Alzheimers-disease, Parkinsons-disease, and Motoneuron disease—abiotropic interaction between aging and environment</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1067</span><span class="NLM_x">–</span> <span class="NLM_lpage">1070</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1986&pages=1067-1070&author=D.+B.+Calneauthor=E.+Mcgeerauthor=A.+Eisenauthor=P.+Spencer&title=Alzheimers-disease%2C+Parkinsons-disease%2C+and+Motoneuron+disease%E2%80%94abiotropic+interaction+between+aging+and+environment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCalne%26aufirst%3DD.%2BB.%26aulast%3DMcgeer%26aufirst%3DE.%26aulast%3DEisen%26aufirst%3DA.%26aulast%3DSpencer%26aufirst%3DP.%26atitle%3DAlzheimers-disease%252C%2520Parkinsons-disease%252C%2520and%2520Motoneuron%2520disease%25E2%2580%2594abiotropic%2520interaction%2520between%2520aging%2520and%2520environment%26jtitle%3DLancet%26date%3D1986%26volume%3D2%26spage%3D1067%26epage%3D1070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Cooper-Knock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferraiuolo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heath, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattray, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, P. J.</span><span> </span><span class="NLM_article-title">Gene expression profiling in human neurodegenerative disease</span> <span class="citation_source-journal">Nat. Rev. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">518</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnrneurol.2012.156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlWhsL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=518-530&author=J.+Cooper-Knockauthor=J.+Kirbyauthor=L.+Ferraiuoloauthor=P.+R.+Heathauthor=M.+Rattrayauthor=P.+J.+Shaw&title=Gene+expression+profiling+in+human+neurodegenerative+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Gene expression profiling in human neurodegenerative disease</span></div><div class="casAuthors">Cooper-Knock, Johnathan; Kirby, Janine; Ferraiuolo, Laura; Heath, Paul R.; Rattray, Magnus; Shaw, Pamela J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">518-530</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Transcriptome study in neurodegenerative disease has advanced considerably in the past 5 years.  Increasing scientific rigour and improved anal. tools have led to more-reproducible data.  Many transcriptome anal. platforms assay the expression of the entire genome, enabling a complete biol. context to be captured.  Gene expression profiling (GEP) is, therefore, uniquely placed to discover pathways of disease pathogenesis, potential therapeutic targets, and biomarkers.  This Review summarizes microarray human GEP studies in the common neurodegenerative diseases amyotrophic lateral sclerosis (ALS), Parkinson disease (PD) and Alzheimer disease (AD).  Several interesting reports have compared pathol. gene expression in different patient groups, disease stages and anatomical areas.  In all three diseases, GEP has revealed dysregulation of genes related to neuroinflammation.  In ALS and PD, gene expression related to RNA splicing and protein turnover is disrupted, and several studies in ALS support involvement of the cytoskeleton.  GEP studies have implicated the ubiquitin-proteasome system in PD pathogenesis, and have provided evidence of mitochondrial dysfunction in PD and AD.  Lastly, in AD, a possible role for dysregulation of intracellular signalling pathways, including calcium signalling, has been highlighted.  This Review also provides a discussion of methodol. considerations in microarray sample prepn. and data anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCZ1bkpRySvLVg90H21EOLACvtfcHk0ljCUzkyRjK6Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlWhsL7E&md5=e7d16cb140ebfa305e749941a0bf37e8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2012.156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2012.156%26sid%3Dliteratum%253Aachs%26aulast%3DCooper-Knock%26aufirst%3DJ.%26aulast%3DKirby%26aufirst%3DJ.%26aulast%3DFerraiuolo%26aufirst%3DL.%26aulast%3DHeath%26aufirst%3DP.%2BR.%26aulast%3DRattray%26aufirst%3DM.%26aulast%3DShaw%26aufirst%3DP.%2BJ.%26atitle%3DGene%2520expression%2520profiling%2520in%2520human%2520neurodegenerative%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2012%26volume%3D8%26spage%3D518%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Cramer, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirrito, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlo, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinn, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casali, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Restivo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goebel, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landreth, G. E.</span><span> </span><span class="NLM_article-title">ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">1503</span><span class="NLM_x">–</span> <span class="NLM_lpage">1506</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2012&pages=1503-1506&author=P.+E.+Cramerauthor=J.+R.+Cirritoauthor=D.+W.+Wessonauthor=C.+Y.+Leeauthor=J.+C.+Karloauthor=A.+E.+Zinnauthor=B.+T.+Casaliauthor=J.+L.+Restivoauthor=W.+D.+Goebelauthor=M.+J.+Jamesauthor=K.+R.+Brundenauthor=D.+A.+Wilsonauthor=G.+E.+Landreth&title=ApoE-directed+therapeutics+rapidly+clear+beta-amyloid+and+reverse+deficits+in+AD+mouse+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCramer%26aufirst%3DP.%2BE.%26aulast%3DCirrito%26aufirst%3DJ.%2BR.%26aulast%3DWesson%26aufirst%3DD.%2BW.%26aulast%3DLee%26aufirst%3DC.%2BY.%26aulast%3DKarlo%26aufirst%3DJ.%2BC.%26aulast%3DZinn%26aufirst%3DA.%2BE.%26aulast%3DCasali%26aufirst%3DB.%2BT.%26aulast%3DRestivo%26aufirst%3DJ.%2BL.%26aulast%3DGoebel%26aufirst%3DW.%2BD.%26aulast%3DJames%26aufirst%3DM.%2BJ.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DWilson%26aufirst%3DD.%2BA.%26aulast%3DLandreth%26aufirst%3DG.%2BE.%26atitle%3DApoE-directed%2520therapeutics%2520rapidly%2520clear%2520beta-amyloid%2520and%2520reverse%2520deficits%2520in%2520AD%2520mouse%2520models%26jtitle%3DScience%26date%3D2012%26volume%3D335%26spage%3D1503%26epage%3D1506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Graff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennig, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieland, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fass, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samiei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haggarty, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delalle, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, L. H.</span><span> </span><span class="NLM_article-title">An epigenetic blockade of cognitive functions in the neurodegenerating brain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">483</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnature10849" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=22388814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BC383ptlCjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2012&pages=222-226&author=J.+Graffauthor=D.+Reiauthor=J.+S.+Guanauthor=W.+Y.+Wangauthor=J.+Seoauthor=K.+M.+Hennigauthor=T.+J.+Nielandauthor=D.+M.+Fassauthor=P.+F.+Kaoauthor=M.+Kahnauthor=S.+C.+Suauthor=A.+Samieiauthor=N.+Josephauthor=S.+J.+Haggartyauthor=I.+Delalleauthor=L.+H.+Tsai&title=An+epigenetic+blockade+of+cognitive+functions+in+the+neurodegenerating+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">An epigenetic blockade of cognitive functions in the neurodegenerating brain</span></div><div class="casAuthors">Graff Johannes; Rei Damien; Guan Ji-Song; Wang Wen-Yuan; Seo Jinsoo; Hennig Krista M; Nieland Thomas J F; Fass Daniel M; Kao Patricia F; Kahn Martin; Su Susan C; Samiei Alireza; Joseph Nadine; Haggarty Stephen J; Delalle Ivana; Tsai Li-Huei</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">483</span>
        (<span class="NLM_cas:issue">7388</span>),
    <span class="NLM_cas:pages">222-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cognitive decline is a debilitating feature of most neurodegenerative diseases of the central nervous system, including Alzheimer's disease.  The causes leading to such impairment are only poorly understood and effective treatments are slow to emerge.  Here we show that cognitive capacities in the neurodegenerating brain are constrained by an epigenetic blockade of gene transcription that is potentially reversible.  This blockade is mediated by histone deacetylase 2, which is increased by Alzheimer's-disease-related neurotoxic insults in vitro, in two mouse models of neurodegeneration and in patients with Alzheimer's disease.  Histone deacetylase 2 associates with and reduces the histone acetylation of genes important for learning and memory, which show a concomitant decrease in expression.  Importantly, reversing the build-up of histone deacetylase 2 by short-hairpin-RNA-mediated knockdown unlocks the repression of these genes, reinstates structural and synaptic plasticity, and abolishes neurodegeneration-associated memory impairments.  These findings advocate for the development of selective inhibitors of histone deacetylase 2 and suggest that cognitive capacities following neurodegeneration are not entirely lost, but merely impaired by this epigenetic blockade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_TBTrhihJh3WEEzDrymxmfW6udTcc2ebNjS9dBZKJCrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383ptlCjtw%253D%253D&md5=6e567f82c587972acbdf75fbb06d2954</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnature10849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10849%26sid%3Dliteratum%253Aachs%26aulast%3DGraff%26aufirst%3DJ.%26aulast%3DRei%26aufirst%3DD.%26aulast%3DGuan%26aufirst%3DJ.%2BS.%26aulast%3DWang%26aufirst%3DW.%2BY.%26aulast%3DSeo%26aufirst%3DJ.%26aulast%3DHennig%26aufirst%3DK.%2BM.%26aulast%3DNieland%26aufirst%3DT.%2BJ.%26aulast%3DFass%26aufirst%3DD.%2BM.%26aulast%3DKao%26aufirst%3DP.%2BF.%26aulast%3DKahn%26aufirst%3DM.%26aulast%3DSu%26aufirst%3DS.%2BC.%26aulast%3DSamiei%26aufirst%3DA.%26aulast%3DJoseph%26aufirst%3DN.%26aulast%3DHaggarty%26aufirst%3DS.%2BJ.%26aulast%3DDelalle%26aufirst%3DI.%26aulast%3DTsai%26aufirst%3DL.%2BH.%26atitle%3DAn%2520epigenetic%2520blockade%2520of%2520cognitive%2520functions%2520in%2520the%2520neurodegenerating%2520brain%26jtitle%3DNature%26date%3D2012%26volume%3D483%26spage%3D222%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Jellinger, K. A.</span><span> </span><span class="NLM_article-title">Recent advances in our understanding of neurodegeneration</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">1111</span><span class="NLM_x">–</span> <span class="NLM_lpage">1162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2009&pages=1111-1162&author=K.+A.+Jellinger&title=Recent+advances+in+our+understanding+of+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJellinger%26aufirst%3DK.%2BA.%26atitle%3DRecent%2520advances%2520in%2520our%2520understanding%2520of%2520neurodegeneration%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2009%26volume%3D116%26spage%3D1111%26epage%3D1162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Salloway, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintzer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, J. L.</span><span> </span><span class="NLM_article-title">Disease-modifying therapies in Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.jalz.2007.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=18631951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlSmtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=65-79&author=S.+Sallowayauthor=J.+Mintzerauthor=M.+F.+Weinerauthor=J.+L.+Cummings&title=Disease-modifying+therapies+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Disease-modifying therapies in Alzheimer's disease</span></div><div class="casAuthors">Salloway, Stephen; Mintzer, Jacobo; Weiner, Myron F.; Cummings, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & Dementia</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">65-79</span>CODEN:
                <span class="NLM_cas:coden">ADLEBN</span>;
        ISSN:<span class="NLM_cas:issn">1552-5260</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a chronic, progressive, neurodegenerative disorder that places a substantial burden on patients, their families, and society.  The disease affects approx. 5 million individuals in the United States, with an annual cost of care greater than $100 billion.  During the past dozen years, several agents have been approved that enhance cognition and global function of AD patients, and recent advances in understanding AD pathogenesis has led to the development of numerous compds. that might modify the disease process.  A wide array of antiamyloid and neuroprotective therapeutic approaches are under investigation on the basis of the hypothesis that amyloid beta (Aβ) protein plays a pivotal role in disease onset and progression and that secondary consequences of Aβ generation and deposition, including tau hyperphosphorylation and neurofibrillary tangle formation, oxidn., inflammation, and excitotoxicity, contribute to the disease process.  Interventions in these processes with agents that reduce amyloid prodn., limit aggregation, or increase removal might block the cascade of events comprising AD pathogenesis.  Reducing tau hyperphosphorylation, limiting oxidn. and excitotoxicity, and controlling inflammation might be beneficial disease-modifying strategies.  Potentially neuroprotective and restorative treatments such as neurotrophins, neurotrophic factor enhancers, and stem cell-related approaches are also under investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDVz15jwhEbrVg90H21EOLACvtfcHk0lhIVY8mmsT3hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlSmtb0%253D&md5=626e36a2b80a383e57173f52e7722a86</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2007.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2007.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DMintzer%26aufirst%3DJ.%26aulast%3DWeiner%26aufirst%3DM.%2BF.%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26atitle%3DDisease-modifying%2520therapies%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2008%26volume%3D4%26spage%3D65%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Zimmermann, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, C. T.</span><span> </span><span class="NLM_article-title">Multi-target therapeutics: when the whole is greater than the sum of the parts</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.drudis.2006.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=17198971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252Fgt1ygtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=34-42&author=G.+R.+Zimmermannauthor=J.+Leharauthor=C.+T.+Keith&title=Multi-target+therapeutics%3A+when+the+whole+is+greater+than+the+sum+of+the+parts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target therapeutics: when the whole is greater than the sum of the parts</span></div><div class="casAuthors">Zimmermann Grant R; Lehar Joseph; Keith Curtis T</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">34-42</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">Drugs designed to act against individual molecular targets cannot usually combat multigenic diseases such as cancer, or diseases that affect multiple tissues or cell types such as diabetes and immunoinflammatory disorders.  Combination drugs that impact multiple targets simultaneously are better at controlling complex disease systems, are less prone to drug resistance and are the standard of care in many important therapeutic areas.  The combination drugs currently employed are primarily of rational design, but the increased efficacy they provide justifies in vitro discovery efforts for identifying novel multi-target mechanisms.  In this review, we discuss the biological rationale for combination therapeutics, review some existing combination drugs and present a systematic approach to identify interactions between molecular pathways that could be leveraged for therapeutic benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTI14vYK2Q1LENHe_gFldTbfW6udTcc2eZEPA5KQgnht7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252Fgt1ygtQ%253D%253D&md5=66715499ce21c2855dc6c477aa87f161</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2006.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2006.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DG.%2BR.%26aulast%3DLehar%26aufirst%3DJ.%26aulast%3DKeith%26aufirst%3DC.%2BT.%26atitle%3DMulti-target%2520therapeutics%253A%2520when%2520the%2520whole%2520is%2520greater%2520than%2520the%2520sum%2520of%2520the%2520parts%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D34%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">De Raedt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yecies, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malone, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maertens, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebleu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalluri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haigis, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macleod, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cichowski, K.</span><span> </span><span class="NLM_article-title">Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">400</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=400-413&author=T.+De+Raedtauthor=Z.+Waltonauthor=J.+L.+Yeciesauthor=D.+Liauthor=Y.+Chenauthor=C.+F.+Maloneauthor=O.+Maertensauthor=S.+M.+Jeongauthor=R.+T.+Bronsonauthor=V.+Lebleuauthor=R.+Kalluriauthor=E.+Normantauthor=M.+C.+Haigisauthor=B.+D.+Manningauthor=K.+K.+Wongauthor=K.+F.+Macleodauthor=K.+Cichowski&title=Exploiting+cancer+cell+vulnerabilities+to+develop+a+combination+therapy+for+ras-driven+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BRaedt%26aufirst%3DT.%26aulast%3DWalton%26aufirst%3DZ.%26aulast%3DYecies%26aufirst%3DJ.%2BL.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DMalone%26aufirst%3DC.%2BF.%26aulast%3DMaertens%26aufirst%3DO.%26aulast%3DJeong%26aufirst%3DS.%2BM.%26aulast%3DBronson%26aufirst%3DR.%2BT.%26aulast%3DLebleu%26aufirst%3DV.%26aulast%3DKalluri%26aufirst%3DR.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DHaigis%26aufirst%3DM.%2BC.%26aulast%3DManning%26aufirst%3DB.%2BD.%26aulast%3DWong%26aufirst%3DK.%2BK.%26aulast%3DMacleod%26aufirst%3DK.%2BF.%26aulast%3DCichowski%26aufirst%3DK.%26atitle%3DExploiting%2520cancer%2520cell%2520vulnerabilities%2520to%2520develop%2520a%2520combination%2520therapy%2520for%2520ras-driven%2520tumors%26jtitle%3DCancer%2520Cell%26date%3D2011%26volume%3D20%26spage%3D400%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">McHutchison, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manns, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poynard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsay, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trepo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dienstag, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garaud, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, J. K.</span><span> </span><span class="NLM_article-title">Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">1061</span><span class="NLM_x">–</span> <span class="NLM_lpage">1069</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2002&pages=1061-1069&author=J.+G.+McHutchisonauthor=M.+Mannsauthor=K.+Patelauthor=T.+Poynardauthor=K.+L.+Lindsayauthor=C.+Trepoauthor=J.+Dienstagauthor=W.+M.+Leeauthor=C.+Makauthor=J.+J.+Garaudauthor=J.+K.+Albrecht&title=Adherence+to+combination+therapy+enhances+sustained+response+in+genotype-1-infected+patients+with+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26aulast%3DManns%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DPoynard%26aufirst%3DT.%26aulast%3DLindsay%26aufirst%3DK.%2BL.%26aulast%3DTrepo%26aufirst%3DC.%26aulast%3DDienstag%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DW.%2BM.%26aulast%3DMak%26aufirst%3DC.%26aulast%3DGaraud%26aufirst%3DJ.%2BJ.%26aulast%3DAlbrecht%26aufirst%3DJ.%2BK.%26atitle%3DAdherence%2520to%2520combination%2520therapy%2520enhances%2520sustained%2520response%2520in%2520genotype-1-infected%2520patients%2520with%2520chronic%2520hepatitis%2520C%26jtitle%3DGastroenterology%26date%3D2002%26volume%3D123%26spage%3D1061%26epage%3D1069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Ho, D. D.</span><span> </span><span class="NLM_article-title">Time to hit HIV, early and hard</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">450</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1056%2FNEJM199508173330710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=7616996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADyaK2Mzkt1Wquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=1995&pages=450-451&author=D.+D.+Ho&title=Time+to+hit+HIV%2C+early+and+hard"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Time to hit HIV, early and hard</span></div><div class="casAuthors">Ho D D</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">450-1</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQN6PDxc8sWzYMcDoIzZtNkfW6udTcc2eZEPA5KQgnht7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2Mzkt1Wquw%253D%253D&md5=d3b7657886ea7b7deb3eafc0dcdd5170</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1056%2FNEJM199508173330710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199508173330710%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DD.%2BD.%26atitle%3DTime%2520to%2520hit%2520HIV%252C%2520early%2520and%2520hard%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1995%26volume%3D333%26spage%3D450%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Kihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, M.</span><span> </span><span class="NLM_article-title">Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=7815331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK2MXjtFSqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1995&pages=177-183&author=T.+Kiharaauthor=M.+Ikeda&title=Effects+of+duloxetine%2C+a+new+serotonin+and+norepinephrine+uptake+inhibitor%2C+on+extracellular+monoamine+levels+in+rat+frontal+cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex</span></div><div class="casAuthors">Kihara, Tsuyoshi; Ikeda, Masato</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">177-83</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The effects of duloxetine (LY248686), a new inhibitor of serotonin (5-hydroxytryptamine; 5-HT) and norepinephrine (NE) uptake on extracellular levels of NE, 5-HT and dopamine (DA), were studied in the rat frontal cortex and nucleus accumbens, using in vivo microdialysis.  The oral administration of duloxetine (3. 125-12.5 mg/kg) produced a dose-dependent increase in the output of both NE and 5-HT from the frontal cortex, this increase being maintained throughout the 4-h observation period.  Chronic administration of duloxetine (6.25 mg/kg, p.o.) for 14 days failed to alter basal NE and 5-HT levels in the frontal cortex, but augmented the duloxetine-induced increase in output of NE and 5-HT.  Amitriptyline and maprotiline, administered p.o. at doses of 6.25 to 25 mg/kg, increased NE output, but the effect was weaker than that of duloxetine, and neither amitriptyline nor maprotiline changed 5-HT output from the frontal cortex.  Duloxetine, amitriptyline, and maprotiline brought about increases in DA levels in the rat frontal cortex, the increase in DA levels induced by duloxetine being approx. two or three times more potent than that induced by amitriptyline and maprotiline.  In the nucleus accumbens, duloxetine also produced a dose-dependent increase in DA output more potent than that produced by amitriptyline and maprotiline.  These results show that duloxetine causes a potent and sustained increase in the output of both NE and 5-HT in the rat frontal cortex, related to its inhibition of NE and 5-HT uptake; these results also show that duloxetine increases DA output in the frontal cortex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1L0O8hPzv07Vg90H21EOLACvtfcHk0ljWsxuSPYHhUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjtFSqtrs%253D&md5=e9fcc91cf637f65c08ad17a55ecc453f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKihara%26aufirst%3DT.%26aulast%3DIkeda%26aufirst%3DM.%26atitle%3DEffects%2520of%2520duloxetine%252C%2520a%2520new%2520serotonin%2520and%2520norepinephrine%2520uptake%2520inhibitor%252C%2520on%2520extracellular%2520monoamine%2520levels%2520in%2520rat%2520frontal%2520cortex%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1995%26volume%3D272%26spage%3D177%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Delgado, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, F. A.</span><span> </span><span class="NLM_article-title">Role of norepinephrine in depression</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=10703757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvFGhs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2000&pages=5-12&issue=Suppl.+1&author=P.+L.+Delgadoauthor=F.+A.+Moreno&title=Role+of+norepinephrine+in+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Role of norepinephrine in depression</span></div><div class="casAuthors">Delgado, Pedro L.; Moreno, Francisco A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">5-12</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press, Inc.</span>)
        </div><div class="casAbstract">A review is given with 72 refs. on the role of norepinephrine (NE) and serotonin (5-HT) in depression and the therapeutic effects of antidepressant drugs from the perspective of human neurotransmitter depletion studies.  The data reviewed suggest that both noradrenergic and serotonergic systems are involved in antidepressant action, but the specific impairment that underlies depression is unclear and is likely to vary among patients.  Results from neurotransmitter depletion studies in depressed patients who have responded to treatment suggest that, while interactions between NE and 5-HT are likely, neither of these 2 neurotransmitter systems is the final common pathway for the therapeutic effect of antidepressant drugs.  NE-selective antidepressant drugs appear to be primarily dependent on the availability of NE for their effects.  Likewise, 5-HT-selective antidepressants appear to be primarily dependent on the availability of 5-HT for their effects.  Antidepressants that cause effects on both noradrenergic and serotonergic systems-such as mirtazapine-may be dependent on the availability of both neurotransmitters for their effects.  Neither 5-HT nor NE depletion induced clin. depression in healthy subjects or worsened depression in unmedicated symptomatic patients with major depression.  This finding suggests that the cause of depression is more complex than just an alteration in the levels of 5-HT and/or NE.  For some patients, depression may be more directly caused by dysfunction in brain areas or neuronal systems modulated by monoamine systems.  The authors propose that antidepressant drugs may enhance neurotransmission in normal noradrenergic or serotonergic neurons and, through a time-dependent but as yet undiscovered process, restore function to brain areas modulated by monoamine neurons.  Future research should focus on understanding the adaptive changes that follow enhancement of synaptic levels of monoamines in neuronal circuits of the frontal cortex, amygdala, and hippocampus.  Research investigating the neurobiol. of depression may be more informed if the focus is shifted to investigating areas of the brain modulated by monoamine systems rather than the monoamine systems themselves.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3g2phmY5oxLVg90H21EOLACvtfcHk0ljWsxuSPYHhUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvFGhs78%253D&md5=26a84c53d447981467d59d618cfa4f16</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDelgado%26aufirst%3DP.%2BL.%26aulast%3DMoreno%26aufirst%3DF.%2BA.%26atitle%3DRole%2520of%2520norepinephrine%2520in%2520depression%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2000%26volume%3D61%26issue%3DSuppl.%25201%26spage%3D5%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Traynelis, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wollmuth, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBain, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span> </span><span class="NLM_article-title">Glutamate receptor ion channels: structure, regulation, and function</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1124%2Fpr.109.002451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20716669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=405-496&author=S.+F.+Traynelisauthor=L.+P.+Wollmuthauthor=C.+J.+McBainauthor=F.+S.+Mennitiauthor=K.+M.+Vanceauthor=K.+K.+Ogdenauthor=K.+B.+Hansenauthor=H.+Yuanauthor=S.+J.+Myersauthor=R.+Dingledine&title=Glutamate+receptor+ion+channels%3A+structure%2C+regulation%2C+and+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate receptor ion channels: structure, regulation, and function</span></div><div class="casAuthors">Traynelis, Stephen F.; Wollmuth, Lonnie P.; McBain, Chris J.; Menniti, Frank S.; Vance, Katie M.; Ogden, Kevin K.; Hansen, Kasper B.; Yuan, Hongjie; Myers, Scott J.; Dingledine, Ray</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">405-496</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The mammalian ionotropic glutamate receptor family encodes 18 gene products that coassemble to form ligand-gated ion channels contg. an agonist recognition site, a transmembrane ion permeation pathway, and gating elements that couple agonist-induced conformational changes to the opening or closing of the permeation pore.  Glutamate receptors mediate fast excitatory synaptic transmission in the central nervous system and are localized on neuronal and non-neuronal cells.  These receptors regulate a broad spectrum of processes in the brain, spinal cord, retina, and peripheral nervous system.  Glutamate receptors are postulated to play important roles in numerous neurol. diseases and have attracted intense scrutiny.  The description of glutamate receptor structure, including its transmembrane elements, reveals a complex assembly of multiple semiautonomous extracellular domains linked to a pore-forming element with striking resemblance to an inverted potassium channel.  In this review we discuss International Union of Basic and Clin. Pharmacol. glutamate receptor nomenclature, structure, assembly, accessory subunits, interacting proteins, gene expression and translation, post-translational modifications, agonist and antagonist pharmacol., allosteric modulation, mechanisms of gating and permeation, roles in normal physiol. function, as well as the potential therapeutic use of pharmacol. agents acting at glutamate receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov0rj4nMr5ObVg90H21EOLACvtfcHk0ljWsxuSPYHhUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbJ&md5=5d0a7945b5ad99113adf9f6312bafe13</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1124%2Fpr.109.002451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.109.002451%26sid%3Dliteratum%253Aachs%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DWollmuth%26aufirst%3DL.%2BP.%26aulast%3DMcBain%26aufirst%3DC.%2BJ.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DMyers%26aufirst%3DS.%2BJ.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DGlutamate%2520receptor%2520ion%2520channels%253A%2520structure%252C%2520regulation%252C%2520and%2520function%26jtitle%3DPharmacol.%2520Rev.%26date%3D2010%26volume%3D62%26spage%3D405%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Lipton, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, P. A.</span><span> </span><span class="NLM_article-title">Excitatory amino-acids as a final common pathway for neurologic disorders</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1056%2FNEJM199403033300907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=7905600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK2cXltVGhtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=1994&pages=613-622&author=S.+A.+Liptonauthor=P.+A.+Rosenberg&title=Excitatory+amino-acids+as+a+final+common+pathway+for+neurologic+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Excitatory amino acids as a final common pathway for neurologic disorders</span></div><div class="casAuthors">Lipton, Stuart A.; Rosenberg, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">613-22</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">A review with 89 refs. on types of excitatory amino acid receptors, intracellular calcium and neurotoxicity, pathogenesis of excitotoxicity, and pharmacotherapy for excitatory amino acid-induced neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRu6Iwoj1WVLVg90H21EOLACvtfcHk0ljWsxuSPYHhUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXltVGhtbk%253D&md5=d1d6678f75416d8d35c2ee090f61f950</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1056%2FNEJM199403033300907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199403033300907%26sid%3Dliteratum%253Aachs%26aulast%3DLipton%26aufirst%3DS.%2BA.%26aulast%3DRosenberg%26aufirst%3DP.%2BA.%26atitle%3DExcitatory%2520amino-acids%2520as%2520a%2520final%2520common%2520pathway%2520for%2520neurologic%2520disorders%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1994%26volume%3D330%26spage%3D613%26epage%3D622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Lynch, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guttmann, R. P.</span><span> </span><span class="NLM_article-title">Excitotoxicity: perspectives based on <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor subtypes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">300</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1124%2Fjpet.300.3.717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11861773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD38XitVemsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=2002&pages=717-723&author=D.+R.+Lynchauthor=R.+P.+Guttmann&title=Excitotoxicity%3A+perspectives+based+on+N-methyl-d-aspartate+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Excitotoxicity: perspectives based on N-methyl-D-aspartate receptor subtypes</span></div><div class="casAuthors">Lynch, David R.; Guttmann, Rodney P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">300</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">717-723</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Since excitotoxicity has been implicated in a variety of neuropathol. conditions, understanding the pathways involved in this type of cell death is of crit. importance to the future clin. treatment of many diseases.  The N-methyl-D-aspartate (NMDA) receptor has become a primary focus of excitotoxic research because early studies demonstrated that antagonism of this receptor subtype was neuroprotective.  However, initial pharmacol. agents were not clin. useful due to the adverse effects of complete NMDA receptor blockade.  Understanding the biochem. properties of the multitude of NMDA receptor subtypes offers the possibility of developing more effective and clin. useful drugs.  With the discovery of the basis of heterogeneity of NMDA receptors through mol. biol. approaches, many new potential therapeutic targets have been uncovered, and several model systems have been developed for the study of NMDA receptor-mediated cell death.  This review discusses these models and the current understanding of the relationship between NMDA receptor subtypes and excitotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkmgoUtyFzvLVg90H21EOLACvtfcHk0li18dU8dInzjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitVemsb8%253D&md5=ef53bded6e3807e2fc45ea58119eea65</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fjpet.300.3.717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.300.3.717%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DD.%2BR.%26aulast%3DGuttmann%26aufirst%3DR.%2BP.%26atitle%3DExcitotoxicity%253A%2520perspectives%2520based%2520on%2520N-methyl-d-aspartate%2520receptor%2520subtypes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D300%26spage%3D717%26epage%3D723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Waxman, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, D. R.</span><span> </span><span class="NLM_article-title"><i>N</i>-Methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease</span> <span class="citation_source-journal">Neuroscientist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=37-49&author=E.+A.+Waxmanauthor=D.+R.+Lynch&title=N-Methyl-d-aspartate+receptor+subtypes%3A+multiple+roles+in+excitotoxicity+and+neurological+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWaxman%26aufirst%3DE.%2BA.%26aulast%3DLynch%26aufirst%3DD.%2BR.%26atitle%3DN-Methyl-d-aspartate%2520receptor%2520subtypes%253A%2520multiple%2520roles%2520in%2520excitotoxicity%2520and%2520neurological%2520disease%26jtitle%3DNeuroscientist%26date%3D2005%26volume%3D11%26spage%3D37%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Hartley, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurth, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjerkness, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, D. W.</span><span> </span><span class="NLM_article-title">Glutamate receptor-induced <sup>45</sup>Ca<sup>2+</sup> accumulation in cortical cell culture correlates with subsequent neuronal degeneration</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1993</span><span class="NLM_x">–</span> <span class="NLM_lpage">2000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=7683048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK3sXkt1Squro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1993&pages=1993-2000&author=D.+M.+Hartleyauthor=M.+C.+Kurthauthor=L.+Bjerknessauthor=J.+H.+Weissauthor=D.+W.+Choi&title=Glutamate+receptor-induced+45Ca2%2B+accumulation+in+cortical+cell+culture+correlates+with+subsequent+neuronal+degeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate receptor-induced calcium-45 accumulation in cortical cell culture correlates with subsequent neuronal degeneration</span></div><div class="casAuthors">Hartley, Dean M.; Kurth, Matthias C.; Bjerkness, Lisa; Weiss, John H.; Choi, Dennis W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1993-2000</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    </div><div class="casAbstract">Murine neuronal and glial cell cultures exposed briefly to glutamate accumulated large amts. of 45Ca2+ from the extracellular medium during the exposure.  Most of the accumulation likely reflected influx into neurons, as little accumulation was obsd. in similarly treated glial cultures.  When the concn. of glutamate was varied between 10 and 1000 μM, or exposure duration was varied between 0 and 10 min, the amt. of 45Ca2+ accumulation correlated closely with the amt. of neuronal death 24 h later.  Both 45Ca2+ accumulation and cell death could be attenuated in a dose-dependent manner by the competitive NMDA antagonist D-aminophosphonovalerate or the noncompetitive antagonist dextrophan, with IC50 values of approx. 100 and 15 μM, resp.  In contrast, neither 45Ca2+ accumulation nor cell death was blocked by the α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)/kainate antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) in the presence of high glycine.  With brief exposure, high concns., of AMPA, kainate, or K+ produced much less death or 45Ca2 accumulation than produced by glutamate esp. if 10 μM MK-801 was included in the exposure medium to block NMDA receptor activation. .  Kainate- or AMPA-induced 45Ca2+ accumulation or neuronal cell death was blocked with CNQX.  However, high K+-triggered 45Ca2+ accumulation was only partially blocked with CNQX plus MK-801, consistent with mediation by voltage-gated Ca2+ channels.  In addn. to measuring the accumulation of 45Ca2+ occurring during agonist exposure, accumulations were also examd. during the 30 min immediately following completion of a 3-5 min exposure to 500 μM NMDA.  This late 45Ca2+ accumulation was approx. 1/2 that accumulated during the initial exposure period.  Delayed addn. of MK-801 blocked this late accumulation and produced a corresponding partial redn. in cell death.  These results support the hypothesis that excess net Ca2+ influx through NMDA receptor-gated channels is a key step in triggering the neuronal death induced by brief, intense glutamate exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr56x4lalLNrVg90H21EOLACvtfcHk0li18dU8dInzjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkt1Squro%253D&md5=572babae9913a86de41d9d32d6974d99</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHartley%26aufirst%3DD.%2BM.%26aulast%3DKurth%26aufirst%3DM.%2BC.%26aulast%3DBjerkness%26aufirst%3DL.%26aulast%3DWeiss%26aufirst%3DJ.%2BH.%26aulast%3DChoi%26aufirst%3DD.%2BW.%26atitle%3DGlutamate%2520receptor-induced%252045Ca2%252B%2520accumulation%2520in%2520cortical%2520cell%2520culture%2520correlates%2520with%2520subsequent%2520neuronal%2520degeneration%26jtitle%3DJ.%2520Neurosci.%26date%3D1993%26volume%3D13%26spage%3D1993%26epage%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Rothstein, J. D.</span><span> </span><span class="NLM_article-title">Excitotoxicity hypothesis</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">19S</span><span class="NLM_x">–</span> <span class="NLM_lpage">26S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1996&pages=19S-26S&author=J.+D.+Rothstein&title=Excitotoxicity+hypothesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRothstein%26aufirst%3DJ.%2BD.%26atitle%3DExcitotoxicity%2520hypothesis%26jtitle%3DNeurology%26date%3D1996%26volume%3D47%26spage%3D19S%26epage%3D26S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Hedegaard, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bräuner-Osborne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span> </span><span class="NLM_article-title">Molecular pharmacology of human NMDA receptors</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">609</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.neuint.2011.11.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=22197913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlSktrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=601-609&author=M.+K.+Hedegaardauthor=K.+B.+Hansenauthor=K.+T.+Andersenauthor=H.+Br%C3%A4uner-Osborneauthor=S.+F.+Traynelis&title=Molecular+pharmacology+of+human+NMDA+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular pharmacology of human NMDA receptors</span></div><div class="casAuthors">Hedegaard, Maiken; Hansen, Kasper B.; Andersen, Karen T.; Brauner-Osborne, Hans; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">601-609</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">N-methyl-D-aspartate (NMDA) receptors are ionotropic glutamate receptors that mediate excitatory neurotransmission.  NMDA receptors are also important drug targets that are implicated in a no. of pathophysiol. conditions.  To facilitate the transition from lead compds. in pre-clin. animal models to drug candidates for human use, it is important to establish whether NMDA receptor ligands have similar properties at rodent and human NMDA receptors.  Here, we compare amino acid sequences for human and rat NMDA receptor subunits and discuss inter-species variation in the context of our current knowledge of the relationship between NMDA receptor structure and function.  We summarize studies on the biophys. properties of human NMDA receptors and compare these properties to those of rat orthologs.  Finally, we provide a comprehensive pharmacol. characterization that allows side-by-side comparison of agonists, un-competitive antagonists, GluN2B-selective non-competitive antagonists, and GluN2C/D-selective modulators at recombinant human and rat NMDA receptors.  The evaluation of biophys. properties and pharmacol. probes acting at different sites on the receptor suggest that the binding sites and conformational changes leading to channel gating in response to agonist binding are highly conserved between human and rat NMDA receptors.  In summary, the results of this study suggest that no major detectable differences exist in the pharmacol. and functional properties of human and rat NMDA receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS0vde2fdkdbVg90H21EOLACvtfcHk0li18dU8dInzjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlSktrfE&md5=97fbf713df306543c9bf801d4ad3b39f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2011.11.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2011.11.016%26sid%3Dliteratum%253Aachs%26aulast%3DHedegaard%26aufirst%3DM.%2BK.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DAndersen%26aufirst%3DK.%2BT.%26aulast%3DBr%25C3%25A4uner-Osborne%26aufirst%3DH.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DMolecular%2520pharmacology%2520of%2520human%2520NMDA%2520receptors%26jtitle%3DNeurochem.%2520Int.%26date%3D2012%26volume%3D61%26spage%3D601%26epage%3D609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Papouin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladepeche, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labasque, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groc, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollegioni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mothet, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliet, S. H.</span><span> </span><span class="NLM_article-title">Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">150</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2012&pages=633-646&author=T.+Papouinauthor=L.+Ladepecheauthor=J.+Ruelauthor=S.+Sacchiauthor=M.+Labasqueauthor=M.+Haniniauthor=L.+Grocauthor=L.+Pollegioniauthor=J.+P.+Mothetauthor=S.+H.+Oliet&title=Synaptic+and+extrasynaptic+NMDA+receptors+are+gated+by+different+endogenous+coagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPapouin%26aufirst%3DT.%26aulast%3DLadepeche%26aufirst%3DL.%26aulast%3DRuel%26aufirst%3DJ.%26aulast%3DSacchi%26aufirst%3DS.%26aulast%3DLabasque%26aufirst%3DM.%26aulast%3DHanini%26aufirst%3DM.%26aulast%3DGroc%26aufirst%3DL.%26aulast%3DPollegioni%26aufirst%3DL.%26aulast%3DMothet%26aufirst%3DJ.%2BP.%26aulast%3DOliet%26aufirst%3DS.%2BH.%26atitle%3DSynaptic%2520and%2520extrasynaptic%2520NMDA%2520receptors%2520are%2520gated%2520by%2520different%2520endogenous%2520coagonists%26jtitle%3DCell%26date%3D2012%26volume%3D150%26spage%3D633%26epage%3D646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Kemp, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKernan, R. M.</span><span> </span><span class="NLM_article-title">NMDA receptor pathways as drug targets</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1042</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnn936" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12403981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1entLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2002&pages=1039-1042&author=J.+A.+Kempauthor=R.+M.+McKernan&title=NMDA+receptor+pathways+as+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor pathways as drug targets</span></div><div class="casAuthors">Kemp, John. A.; McKernan, Ruth M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">Suppl.</span>),
    <span class="NLM_cas:pages">1039-1042</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the mid 1980s, there has been a great deal of enthusiasm within both academia and industry about the therapeutic potential of drugs targeting the NMDA subtype of glutamate receptors.  That early promise is just beginning to translate into approvable drugs.  Here we review the reasons for this slow progress and critically assess the future prospects for drugs that act on NMDA receptor pathways, including potential treatments for some major disorders such as stroke and Alzheimer's disease, for which effective therapies are still lacking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2kTkiwztgKrVg90H21EOLACvtfcHk0ljvdOWeFGin5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1entLY%253D&md5=29b82e717cf4eebafb777ff0bafb9601</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnn936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn936%26sid%3Dliteratum%253Aachs%26aulast%3DKemp%26aufirst%3DJ.%2BA.%26aulast%3DMcKernan%26aufirst%3DR.%2BM.%26atitle%3DNMDA%2520receptor%2520pathways%2520as%2520drug%2520targets%26jtitle%3DNat.%2520Neurosci.%26date%3D2002%26volume%3D5%26spage%3D1039%26epage%3D1042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Paoletti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neyton, J.</span><span> </span><span class="NLM_article-title">NMDA receptor subunits: function and pharmacology</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.coph.2006.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=17088105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntlGitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=39-47&author=P.+Paolettiauthor=J.+Neyton&title=NMDA+receptor+subunits%3A+function+and+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor subunits: function and pharmacology</span></div><div class="casAuthors">Paoletti, Pierre; Neyton, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-47</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  N-methyl-D-aspartate receptors (NMDARs) are glutamate-gated ion channels widely expressed in the central nervous system that play key roles in excitatory synaptic transmission.  Because of their involvement in numerous neurol. disorders, NMDARs are also targets of therapeutic interest.  NMDARs occur as multiple subtypes which differ in their subunit compn. and in their biophys. and pharmacol. properties.  In particular, NMDARs contain a diversity of sites at which endogenous ligands or pharmacol. agents can act to modulate receptor activity in a subunit-selective manner, and recent structural and functional data have started to reveal the mol. determinants for this subunit selectivity.  These include the binding sites for glutamate, the ion-channel pore and the recently identified allosteric sites on the N-terminal domain.  Other potential sites yet unexplored by medicinal chem. programs are also considered, in particular at the interface between subunits.  Given the growing body of evidence that diverse brain disorders implicate different NMDAR subtypes, such as NR2B in pain or NR3A in white matter injury, there is a growing interest in exploiting the pharmacol. heterogeneity of NMDARs for the development of novel NMDAR subtype-selective compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ5E8KNWeeb7Vg90H21EOLACvtfcHk0ljvdOWeFGin5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntlGitQ%253D%253D&md5=18296410fb9b50af0b2a7ceae124faf4</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2006.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2006.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DPaoletti%26aufirst%3DP.%26aulast%3DNeyton%26aufirst%3DJ.%26atitle%3DNMDA%2520receptor%2520subunits%253A%2520function%2520and%2520pharmacology%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2007%26volume%3D7%26spage%3D39%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Beal, M. F.</span><span> </span><span class="NLM_article-title">Aging, energy, and oxidative stress in neurodegenerative diseases</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1002%2Fana.410380304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=7668820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK2MXosl2ls7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=357-366&author=M.+F.+Beal&title=Aging%2C+energy%2C+and+oxidative+stress+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Aging, energy, and oxidative stress in neurodegenerative diseases</span></div><div class="casAuthors">Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">357-66</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Little, Brown</span>)
        </div><div class="casAbstract">A review with 117 refs.  The etiol. of neurodegenerative diseases remains enigmatic; however, evidence for defects in energy metab., excitotoxicity, and for oxidative damage is increasingly compelling.  It is likely that there is a complex interplay between these mechanisms.  A defect in energy metab. may lead to neuronal depolarization, activation of N-methyl-D-aspartate excitatory amino acid receptors, and increases in intracellular calcium, which are buffered by mitochondria.  Mitochondria are the major intracellular source of free radicals, and increased mitochondrial calcium concns. enhance free radical generation.  Mitochondrial DNA is particularly susceptible to oxidative stress, and there is evidence of age-dependent damage and deterioration of respiratory enzyme activities with normal aging.  This may contribute to the delayed onset and age dependence of neurodegenerative diseases.  There is evidence for increased oxidative damage to macromols. in amyotrophic lateral sclerosis, Huntington's disease, Parkinson's disease, and Alzheimer's disease.  Potential therapeutic approaches include glutamate release inhibitors, excitatory amino acid antagonists, strategies to improve mitochondrial function, free radical scavengers, and trophic factors.  All of these approaches appear promising in exptl. studies and are now being applied to human studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCU8YQWvvyfbVg90H21EOLACvtfcHk0ljvdOWeFGin5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXosl2ls7c%253D&md5=cefb4160c5bd42e0ad069265ec644299</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fana.410380304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410380304%26sid%3Dliteratum%253Aachs%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DAging%252C%2520energy%252C%2520and%2520oxidative%2520stress%2520in%2520neurodegenerative%2520diseases%26jtitle%3DAnn.%2520Neurol.%26date%3D1995%26volume%3D38%26spage%3D357%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Coyle, J.</span><span> </span><span class="NLM_article-title">An animal model for Huntington’s disease</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=38864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaE1MXktFOlurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1979&pages=251-276&author=J.+Coyle&title=An+animal+model+for+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">An animal model for Huntington's disease</span></div><div class="casAuthors">Coyle, Joseph T.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">251-76</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    </div><div class="casAbstract">A review with 74 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokeFb203gEcrVg90H21EOLACvtfcHk0ljwS94fvgbMQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXktFOlurY%253D&md5=a14751f2b7448c2a8a712e58693db575</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoyle%26aufirst%3DJ.%26atitle%3DAn%2520animal%2520model%2520for%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DBiol.%2520Psychiatry%26date%3D1979%26volume%3D14%26spage%3D251%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Fan, M. M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, L. A.</span><span> </span><span class="NLM_article-title"><i>N</i>-Methyl-<span class="smallcaps smallerCapital">d</span>-aspartate (NMDA) receptor function and excitotoxicity in Huntington’s disease</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">272</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.pneurobio.2006.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=17188796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFGqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=272-293&author=M.+M.+Y.+Fanauthor=L.+A.+Raymond&title=N-Methyl-d-aspartate+%28NMDA%29+receptor+function+and+excitotoxicity+in+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">N-Methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease</span></div><div class="casAuthors">Fan, Mannie M. Y.; Raymond, Lynn A.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">272-293</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Many lines of evidence support a role for neuronal damage arising as a result of excessive activation of glutamate receptors by excitatory amino acids in the pathogenesis of Huntington disease.  The N-methyl-D-aspartate subclass of inotropic glutamate receptors (NMDARs) is more selective and effective than the other subclasses in mediating this damage.  As well, neurons expressing high levels of NMDARs are lost early from the striatum of individuals affected with Huntington's disease (HD), and injection of NMDAR agonists into the striatum of rodents or non-human primates recapitulates the pattern of neuronal damage obsd. in HD.  Altered NMDAR function has been reported in corticostriatal synapses in one mouse model of HD, and NMDAR-mediated current and/or toxicity have been found to be potentiated in striatal neurons from several HD mouse models as well as heterologous cells expressing the mutant huntington protein.  Changes in NMDAR activity have been correlated with altered calcium homeostasis, mitochondrial membrane depolarization and caspase activation.  NMDAR stimulation is also closely linked to mitochondrial activity, as treatment with mitochondrial toxins has been demonstrated to produce striatal damage that can be reversed by the addn. of NMDAR antagonists.  Recent efforts have focused on the elucidation of mol. pathways linking huntington to NMDARs, as well as the mechanisms which underlie the enhancement of NMDAR activity by mutant huntington.  Here, we review the literature to date and recent findings concerning the role of NMDARs in HD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWmSAU9WE51bVg90H21EOLACvtfcHk0ljwS94fvgbMQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFGqtLw%253D&md5=d6ed0834cf6cf86a2134887e459e6991</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2006.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2006.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DM.%2BM.%2BY.%26aulast%3DRaymond%26aufirst%3DL.%2BA.%26atitle%3DN-Methyl-d-aspartate%2520%2528NMDA%2529%2520receptor%2520function%2520and%2520excitotoxicity%2520in%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DProg.%2520Neurobiol.%26date%3D2007%26volume%3D81%26spage%3D272%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Good, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olanow, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perl, D. P.</span><span> </span><span class="NLM_article-title">Evidence of neuronal oxidative damage in Alzheimer’s disease</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=8686745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADyaK283nsFGntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=1996&pages=21-28&author=P.+F.+Goodauthor=P.+Wernerauthor=A.+Hsuauthor=C.+W.+Olanowauthor=D.+P.+Perl&title=Evidence+of+neuronal+oxidative+damage+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence of neuronal oxidative damage in Alzheimer's disease</span></div><div class="casAuthors">Good P F; Werner P; Hsu A; Olanow C W; Perl D P</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of pathology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-8</span>
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    </div><div class="casAbstract">Oxidative stress has been proposed as a pathogenetic mechanism in Alzheimer's disease.  One mechanism of oxidative damage is the nitration of tyrosine residues in proteins, mediated by peroxynitrite breakdown.  Peroxynitrite, a reaction product of nitric oxide and superoxide radicals, has been implicated in N-methyl-D-aspartate receptor-mediated excitotoxic damage.  Reported evidence of oxidative stress in Alzheimer's disease includes increased iron, alterations in protective enzymes, and markers of oxidative damage to proteins and lipids.  In this report, we demonstrate the presence of nitrotyrosine in neurofibrillary tangles of Alzheimer's disease.  Nitrotyrosine was not detected in controls lacking neurofibrillary tangles.  Immunolabeling was demonstrated to be specific nitrotyrosine in a series of control experiments.  These observations link oxidative stress with a key pathological lesion of Alzheimer's disease, the neurofibrillary tangle, and demonstrate a pathogenetic mechanism in common with the other major neurodegenerative diseases of aging, Parkinson's disease and amyotrophic lateral sclerosis.  These findings further implicate nitric oxide expression and excitotoxicity in the pathogenesis of cell death in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSwmVjLDGBOySm0e6ZOaemfW6udTcc2eb-XTqh-kJrw7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK283nsFGntw%253D%253D&md5=2ba6b91dae67e7b0e1c66fcc74052acd</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGood%26aufirst%3DP.%2BF.%26aulast%3DWerner%26aufirst%3DP.%26aulast%3DHsu%26aufirst%3DA.%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26aulast%3DPerl%26aufirst%3DD.%2BP.%26atitle%3DEvidence%2520of%2520neuronal%2520oxidative%2520damage%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D1996%26volume%3D149%26spage%3D21%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Plaitakis, A.</span><span> </span><span class="NLM_article-title">Glutamate dysfunction and selective motor neuron degeneration inamyotrophic lateral sclerosis: a hypothesis</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1002%2Fana.410280103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=1973889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK3MXktVGqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1990&pages=3-8&author=A.+Plaitakis&title=Glutamate+dysfunction+and+selective+motor+neuron+degeneration+inamyotrophic+lateral+sclerosis%3A+a+hypothesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis:  a hypothesis</span></div><div class="casAuthors">Plaitakis, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">A review with 48 refs.  Recent studies have provided evidence for a generalized defect in glutamate metab. in patients with amyotrophic lateral sclerosis, assocd. with widespread alterations in the central nervous system levels of this excitatory amino acid putative transmitter.  Present data support the hypothesis that altered presynaptic glutamatergic mechanisms may be responsible for a neuroexcitotoxic cell loss in this disorder.  High local concns. of glycine, released from glycinergic terminals, may disrupt adaptive process contributing to abnormal potentiation of excitatory transmission mediated by glutamate receptors and resultant selective degeneration of motor neurons.  These considerations offer new therapeutic strategies for amyotrophic lateral sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpat2FGrhK0CrVg90H21EOLACvtfcHk0ljwS94fvgbMQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXktVGqtrY%253D&md5=36ed932b1059beeb64aebf44d979280e</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2Fana.410280103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410280103%26sid%3Dliteratum%253Aachs%26aulast%3DPlaitakis%26aufirst%3DA.%26atitle%3DGlutamate%2520dysfunction%2520and%2520selective%2520motor%2520neuron%2520degeneration%2520inamyotrophic%2520lateral%2520sclerosis%253A%2520a%2520hypothesis%26jtitle%3DAnn.%2520Neurol.%26date%3D1990%26volume%3D28%26spage%3D3%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Rothstein, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuncl, R. W.</span><span> </span><span class="NLM_article-title">Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">1464</span><span class="NLM_x">–</span> <span class="NLM_lpage">1468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1056%2FNEJM199205283262204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=1349424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADyaK383ksVejug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=1992&pages=1464-1468&author=J.+D.+Rothsteinauthor=L.+J.+Martinauthor=R.+W.+Kuncl&title=Decreased+glutamate+transport+by+the+brain+and+spinal+cord+in+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis</span></div><div class="casAuthors">Rothstein J D; Martin L J; Kuncl R W</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1464-8</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND:  Amyotrophic lateral sclerosis (ALS) is a chronic degenerative neurologic disorder characterized by the death of motor neurons in the cerebral cortex and spinal cord.  Recent studies have suggested that the metabolism of glutamate, a potentially neurotoxic amino acid, is abnormal in patients with ALS.  We hypothesized that the high-affinity glutamate transporter is the site of the defect.  METHODS:  We measured high-affinity, sodium-dependent glutamate transport in synaptosomes from neural tissue obtained from 13 patients with ALS, 17 patients with no neurologic disease, and 27 patients with other neuro-degenerative diseases (Alzheimer's disease in 15 patients and Huntington's disease in 12 patients).  The groups were comparable with respect to age and the interval between death and autopsy.  Synaptosomes were prepared from spinal cord, motor cortex, sensory cortex, visual cortex, striatum, and hippocampus.  We also measured sodium-dependent transport of gamma-aminobutyric acid and phenylalanine in the synaptosomal preparations.  RESULTS:  In patients with ALS, there was a marked decrease in the maximal velocity of transport for high-affinity glutamate uptake in synaptosomes from spinal cord (-59 percent, P less than 0.001), motor cortex (-70 percent, P less than 0.001), and somatosensory cortex (-39 percent, P less than 0.05), but not in those from visual cortex, striatum, or hippocampus.  The affinity of the transporter for glutamate was not altered.  No abnormalities in glutamate transport were found in synaptosomes from patients with other chronic neurodegenerative disorders.  The transport of gamma-aminobutyric acid and phenylalanine was normal in patients with ALS.  CONCLUSIONS:  ALS is associated with a defect in high-affinity glutamate transport that has disease, region, and chemical specificity.  Defects in the clearance of extracellular glutamate because of a faulty transporter could lead to neurotoxic levels of extracellular glutamate and thus be pathogenic in ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSb-TqizNGf3TQLBVDQn4bCfW6udTcc2eZK3fWM1Akrb7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK383ksVejug%253D%253D&md5=ef942d464aa496ae655355af27de2e3a</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1056%2FNEJM199205283262204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199205283262204%26sid%3Dliteratum%253Aachs%26aulast%3DRothstein%26aufirst%3DJ.%2BD.%26aulast%3DMartin%26aufirst%3DL.%2BJ.%26aulast%3DKuncl%26aufirst%3DR.%2BW.%26atitle%3DDecreased%2520glutamate%2520transport%2520by%2520the%2520brain%2520and%2520spinal%2520cord%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1992%26volume%3D326%26spage%3D1464%26epage%3D1468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Rothstein, J.</span><span> </span><span class="NLM_article-title">Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Clin. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">348</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADyaK2s7ntlemsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1996&pages=348-359&author=J.+Rothstein&title=Excitotoxicity+and+neurodegeneration+in+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis</span></div><div class="casAuthors">Rothstein J D</div><div class="citationInfo"><span class="NLM_cas:title">Clinical neuroscience (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1995-1996</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">348-59</span>
        ISSN:<span class="NLM_cas:issn">1065-6766</span>.
    </div><div class="casAbstract">The pathogenesis of sporadic amyotrophic lateral sclerosis (ALS) is unknown, but several observations suggest that glutamate could participate in selective motor neuron degeneration.  Extracellular levels of glutamate are elevated in ALS.  Synaptic concentrations of glutamate are regulated by high-affinity glutamate transport, and defects in glutamate transport have also been observed in ALS tissue.  Three sodium-dependent glutamate transporters have now been identified: a neuronal transporter EAAC1, and two astroglial transporters GLT-1 and GLAST.  The defect in glutamate transport in ALS appears to be relatively specific for the GLT-1 subtype.  The role of chronic excess glutamate and glutamate transporter loss has been investigated in experimental paradigms, where it was found that excitotoxicity could account for selective motor neuron degeneration.  These culture paradigms have demonstrated that motor neurons are sensitive to glutamate toxicity via non-NMDA receptors and that various agents (e.g., antioxidants, glutamate release inhibitors, non-NMDA receptor antagonists) can be neuroprotective.  These experimental studies will provide a basis for understanding the primary and secondary role of glutamate in motor neuron death and will provide important insight into possible therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR-2zF9ydsEnb9KldV63DuefW6udTcc2eZK3fWM1Akrb7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s7ntlemsg%253D%253D&md5=10245b0efe8fde472a6430d573d46a13</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRothstein%26aufirst%3DJ.%26atitle%3DExcitotoxicity%2520and%2520neurodegeneration%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DClin.%2520Neurosci.%26date%3D1996%26volume%3D3%26spage%3D348%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Kalia, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalia, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter, M. W.</span><span> </span><span class="NLM_article-title">NMDA receptors in clinical neurology: excitatory times ahead</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS1474-4422%2808%2970165-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=18635022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVSku7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=742-755&author=L.+V.+Kaliaauthor=S.+K.+Kaliaauthor=M.+W.+Salter&title=NMDA+receptors+in+clinical+neurology%3A+excitatory+times+ahead"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptors in clinical neurology: excitatory times ahead</span></div><div class="casAuthors">Kalia, Lorraine V.; Kalia, Suneil K.; Salter, Michael W.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">742-755</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Since the N-methyl-D-aspartate receptor (NMDAR) subunits were cloned less than two decades ago, a substantial amt. of research has been invested into understanding their physiol. function in the healthy CNS.  Research has also been directed at their pathol. roles in various neurol. diseases, including disorders resulting from acute excitotoxic insults (eg, ischemic stroke, traumatic brain injury), diseases due to chronic neurodegeneration (eg, Alzheimer's, Parkinson's, and Huntington's diseases and amyotrophic lateral sclerosis), disorders arising from sensitization of neurons (eg, epilepsy, neuropathic pain), and neurodevelopmental disorders assocd. with NMDAR hypofunction (eg, schizophrenia).  Selective NMDAR antagonists have not produced pos. results in clin. trials.  However, there are other NMDAR-targeted therapies used in current practice that are effective for treating some neurol. disorders.  In this Review, we describe the evidence for the use of these therapies and provide an overview of drugs being investigated in clin. trials.  We also discuss new NMDAR-targeted strategies in clin. neurol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosefSpb6NE_LVg90H21EOLACvtfcHk0ljRwMZBxZMogQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVSku7rM&md5=add37ea63d62466ae78b939673339859</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2808%2970165-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252808%252970165-0%26sid%3Dliteratum%253Aachs%26aulast%3DKalia%26aufirst%3DL.%2BV.%26aulast%3DKalia%26aufirst%3DS.%2BK.%26aulast%3DSalter%26aufirst%3DM.%2BW.%26atitle%3DNMDA%2520receptors%2520in%2520clinical%2520neurology%253A%2520excitatory%2520times%2520ahead%26jtitle%3DLancet%2520Neurol.%26date%3D2008%26volume%3D7%26spage%3D742%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Monaghan, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irvine, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jane, D. E.</span><span> </span><span class="NLM_article-title">Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">581</span><span class="NLM_x">–</span> <span class="NLM_lpage">592</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.neuint.2012.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=22269804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVOrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=581-592&author=D.+T.+Monaghanauthor=M.+W.+Irvineauthor=B.+M.+Costaauthor=G.+Fangauthor=D.+E.+Jane&title=Pharmacological+modulation+of+NMDA+receptor+activity+and+the+advent+of+negative+and+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators</span></div><div class="casAuthors">Monaghan, Daniel T.; Irvine, Mark W.; Costa, Blaise Mathias; Fang, Guangyu; Jane, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">581-592</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The NMDA receptor (NMDAR) family of l-glutamate receptors are well known to have diverse roles in CNS function as well as in various neuropathol. and psychiatric conditions.  Until recently, the types of agents available to pharmacol. regulate NMDAR function have been quite limited in terms of mechanism of action and subtype selectivity.  This has changed significantly in the past two years.  The purpose of this review is to summarize the many drug classes now available for modulating NMDAR activity.  Previously, this included competitive antagonists at the l-glutamate and glycine binding sites, high and low affinity channel blockers, and GluN2B-selective N-terminal domain binding site antagonists.  More recently, we and others have identified new classes of NMDAR agents that are either pos. or neg. allosteric modulators (PAMs and NAMs, resp.).  These compds. include the pan potentiator UBP646, the GluN2A-selective potentiator/GluN2C and GluN2D inhibitor UBP512, the GluN2D-selective potentiator UBP551, the GluN2C/GluN2D-selective potentiator CIQ as well as the new NMDAR-NAMs such as the pan-inhibitor UBP618, the GluN2C/GluN2D-selective inhibitor QZN46 and the GluN2A inhibitors UBP608 and TCN201.  These new agents do not bind within the l-glutamate or glycine binding sites, the ion channel pore or the N-terminal regulatory domain.  Collectively, these new allosteric modulators appear to be acting at multiple novel sites on the NMDAR complex.  Importantly, these agents display improved subtype-selectivity and as NMDAR PAMs and NAMs, they represent a new generation of potential NMDAR therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbjX9esQoLw7Vg90H21EOLACvtfcHk0ljRwMZBxZMogQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVOrsLk%253D&md5=451c3bb058975f210b9936e67079392f</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2012.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2012.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DMonaghan%26aufirst%3DD.%2BT.%26aulast%3DIrvine%26aufirst%3DM.%2BW.%26aulast%3DCosta%26aufirst%3DB.%2BM.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DJane%26aufirst%3DD.%2BE.%26atitle%3DPharmacological%2520modulation%2520of%2520NMDA%2520receptor%2520activity%2520and%2520the%2520advent%2520of%2520negative%2520and%2520positive%2520allosteric%2520modulators%26jtitle%3DNeurochem.%2520Int.%26date%3D2012%26volume%3D61%26spage%3D581%26epage%3D592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Evans, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, J.</span><span> </span><span class="NLM_article-title">The effects of a series of omega-phosphonic alpha-carboxylic amino acids on electrically evoked and excitant amino acid-induced responses in isolated spinal cord preparations</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1111%2Fj.1476-5381.1982.tb08758.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=7042024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaL38XktVShu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1982&pages=65-75&author=R.+Evansauthor=A.+Francisauthor=A.+Jonesauthor=D.+Smithauthor=J.+Watkins&title=The+effects+of+a+series+of+omega-phosphonic+alpha-carboxylic+amino+acids+on+electrically+evoked+and+excitant+amino+acid-induced+responses+in+isolated+spinal+cord+preparations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of a series of ω-phosphonic α-carboxylic amino acids on electrically evoked and excitant amino acid-induced responses in isolated spinal cord preparations</span></div><div class="casAuthors">Evans, R. H.; Francis, A. A.; Jones, A. W.; Smith, D. A. S.; Watkins, J. C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-75</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">The depressant actions on evoked elec. activity and the excitant amino acid antagonist properties of a range of ω-phosphonic α-carboxylic amino acids ranging from 2-amino-3-phosphonopropionic acid  [5652-28-8] to 2-amino-8-phosphonooctanoic acid  [98517-63-6] were examd. in frog and rat isolated spinal cord prepns.  The results are discussed in relation to structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDFJha1E6AJ7Vg90H21EOLACvtfcHk0lh_9dz7-miKag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XktVShu70%253D&md5=71d6e95f4ca1fbc352e5347e265c661e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1982.tb08758.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1982.tb08758.x%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DR.%26aulast%3DFrancis%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DWatkins%26aufirst%3DJ.%26atitle%3DThe%2520effects%2520of%2520a%2520series%2520of%2520omega-phosphonic%2520alpha-carboxylic%2520amino%2520acids%2520on%2520electrically%2520evoked%2520and%2520excitant%2520amino%2520acid-induced%2520responses%2520in%2520isolated%2520spinal%2520cord%2520preparations%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1982%26volume%3D75%26spage%3D65%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Ogden, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span> </span><span class="NLM_article-title">New advances in NMDA receptor pharmacology</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">726</span><span class="NLM_x">–</span> <span class="NLM_lpage">733</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=726-733&author=K.+K.+Ogdenauthor=S.+F.+Traynelis&title=New+advances+in+NMDA+receptor+pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DNew%2520advances%2520in%2520NMDA%2520receptor%2520pharmacology%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2011%26volume%3D32%26spage%3D726%26epage%3D733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Löschmann, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jähnig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wachtel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, C.</span><span> </span><span class="NLM_article-title">Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-dopa in models of Parkinson’s disease</span> <span class="citation_source-journal">J. Neural Transm.: Parkinson’s Dis. Dementia Sect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1007%2FBF02259538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=1835581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADyaK38%252FmvVegsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1991&pages=203-213&author=P.+A.+L%C3%B6schmannauthor=K.+Langeauthor=M.+Kunowauthor=K.+J.+Rettigauthor=P.+J%C3%A4hnigauthor=T.+Honoreauthor=L.+Turskiauthor=H.+Wachtelauthor=P.+Jennerauthor=C.+Marsden&title=Synergism+of+the+AMPA-antagonist+NBQX+and+the+NMDA-antagonist+CPP+with+L-dopa+in+models+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-dopa in models of Parkinson's disease</span></div><div class="casAuthors">Loschmann P A; Lange K W; Kunow M; Rettig K J; Jahnig P; Honore T; Turski L; Wachtel H; Jenner P; Marsden C D</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neural transmission. Parkinson's disease and dementia section</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-13</span>
        ISSN:<span class="NLM_cas:issn">0936-3076</span>.
    </div><div class="casAbstract">Degeneration of dopaminergic nigrostriatal neurons in Parkinson's disease results in an overactivity of excitatory glutamatergic projections from the subthalamic nucleus to the output nuclei of the basal ganglia resulting in rigidity and akinesia.  In theory pharmacological blockade of these overactive systems should improve parkinsonian symptomatology.  The selective AMPA-antagonist NBQX and the competitive NMDA-antagonist CPP are not effective in animal models of Parkinson's disease when given alone but ameliorate parkinsonian symptomatology and stimulate locomotor activity when co-administered with a threshold dose of L-Dopa.  These synergistic effects are seen in the MPTP-treated (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) common marmoset and the rat with unilateral 6-hydroxydopamine (6-OHDA) lesions of the substantia nigra.  Therefore competitive NMDA and non-NMDA antagonists may offer a new therapeutic strategy for the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRgJ6XegtVkhP6BottYdIAWfW6udTcc2eYfU40t76aYT7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38%252FmvVegsw%253D%253D&md5=3fa0154e1867b5f84b48897fb2409be1</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2FBF02259538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02259538%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6schmann%26aufirst%3DP.%2BA.%26aulast%3DLange%26aufirst%3DK.%26aulast%3DKunow%26aufirst%3DM.%26aulast%3DRettig%26aufirst%3DK.%2BJ.%26aulast%3DJ%25C3%25A4hnig%26aufirst%3DP.%26aulast%3DHonore%26aufirst%3DT.%26aulast%3DTurski%26aufirst%3DL.%26aulast%3DWachtel%26aufirst%3DH.%26aulast%3DJenner%26aufirst%3DP.%26aulast%3DMarsden%26aufirst%3DC.%26atitle%3DSynergism%2520of%2520the%2520AMPA-antagonist%2520NBQX%2520and%2520the%2520NMDA-antagonist%2520CPP%2520with%2520L-dopa%2520in%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neural%2520Transm.%253A%2520Parkinson%25E2%2580%2599s%2520Dis.%2520Dementia%2520Sect.%26date%3D1991%26volume%3D3%26spage%3D203%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Veender, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J. C.</span><span> </span><span class="NLM_article-title">NMDA receptors: the first decade</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1994&pages=341-354&author=J.+R.+Veenderauthor=S.+N.+Nairauthor=J.+C.+Lehmann&title=NMDA+receptors%3A+the+first+decade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVeender%26aufirst%3DJ.%2BR.%26aulast%3DNair%26aufirst%3DS.%2BN.%26aulast%3DLehmann%26aufirst%3DJ.%2BC.%26atitle%3DNMDA%2520receptors%253A%2520the%2520first%2520decade%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D1994%26volume%3D3%26spage%3D341%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Bräuner-Osborne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egebjerg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krogsgaard-Larsen, P.</span><span> </span><span class="NLM_article-title">Ligands for glutamate receptors: design and therapeutic prospects</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2609</span><span class="NLM_x">–</span> <span class="NLM_lpage">2645</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000007r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2609-2645&author=H.+Br%C3%A4uner-Osborneauthor=J.+Egebjergauthor=E.+O.+Nielsenauthor=U.+Madsenauthor=P.+Krogsgaard-Larsen&title=Ligands+for+glutamate+receptors%3A+design+and+therapeutic+prospects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm000007r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000007r%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25A4uner-Osborne%26aufirst%3DH.%26aulast%3DEgebjerg%26aufirst%3DJ.%26aulast%3DNielsen%26aufirst%3DE.%2BO.%26aulast%3DMadsen%26aufirst%3DU.%26aulast%3DKrogsgaard-Larsen%26aufirst%3DP.%26atitle%3DLigands%2520for%2520glutamate%2520receptors%253A%2520design%2520and%2520therapeutic%2520prospects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2609%26epage%3D2645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Lehmann, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, P. L.</span><span> </span><span class="NLM_article-title">7-Chlorokynurenate prevents NMDA-induced and kainate-induced striatal lesions</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">620</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2F0006-8993%2893%2990263-M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=7691379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK3sXltlWnsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=620&publication_year=1993&pages=1-6&author=J.+C.+Lehmannauthor=P.+L.+Wood&title=7-Chlorokynurenate+prevents+NMDA-induced+and+kainate-induced+striatal+lesions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">7-Chlorokynurenate prevents NMDA-induced and kainate-induced striatal lesions</span></div><div class="casAuthors">Lehmann, John C.; Procureur, Dominique; Wood, Paul L.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">620</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">NMDA-induced lesions of striatal cholinergic interneurons were attenuated by 7-chlorokynurenate (7-ClKyn), an antagonist of the glycine site of the NMDA receptor complex.  However, it was not possible to demonstrate clearly that the mechanism of action of 7-ClKyn was in fact antagonism of the glycine site.  Thus, the agonists at the glycine site, D-serine and 1-aminocyclopropane-1-carboxylic acid, failed to reverse the protection afforded by 7-ClKyn.  Finally, 7-ClKyn also protected against lesions produced by kainate.  The selectivity of 7-ClKyn under intracerebral administration is apparently insufficient for detg. the role of the glycine site in NMDA-receptor mediated excitotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmvBEiGApML7Vg90H21EOLACvtfcHk0liyPkVGDfvMIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltlWnsL0%253D&md5=cc73ae0162f9ae3221dcecea2a6eef80</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2893%2990263-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252893%252990263-M%26sid%3Dliteratum%253Aachs%26aulast%3DLehmann%26aufirst%3DJ.%2BC.%26aulast%3DWood%26aufirst%3DP.%2BL.%26atitle%3D7-Chlorokynurenate%2520prevents%2520NMDA-induced%2520and%2520kainate-induced%2520striatal%2520lesions%26jtitle%3DBrain%2520Res.%26date%3D1993%26volume%3D620%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Wong, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priestley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodruff, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iversen, L. L.</span><span> </span><span class="NLM_article-title">The anticonvulsant MK-801 is a potent <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate antagonist</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">7104</span><span class="NLM_x">–</span> <span class="NLM_lpage">7108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1986&pages=7104-7108&author=E.+Wongauthor=J.+A.+Kempauthor=T.+Priestleyauthor=A.+R.+Knightauthor=G.+N.+Woodruffauthor=L.+L.+Iversen&title=The+anticonvulsant+MK-801+is+a+potent+N-methyl-d-aspartate+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DE.%26aulast%3DKemp%26aufirst%3DJ.%2BA.%26aulast%3DPriestley%26aufirst%3DT.%26aulast%3DKnight%26aufirst%3DA.%2BR.%26aulast%3DWoodruff%26aufirst%3DG.%2BN.%26aulast%3DIversen%26aufirst%3DL.%2BL.%26atitle%3DThe%2520anticonvulsant%2520MK-801%2520is%2520a%2520potent%2520N-methyl-d-aspartate%2520antagonist%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1986%26volume%3D83%26spage%3D7104%26epage%3D7108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Marin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engber, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonastre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolosa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, T.</span><span> </span><span class="NLM_article-title">MK-801 prevents levodopa-induced motor response alterations in parkinsonian rats</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">736</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2F0006-8993%2896%2900693-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=8930325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK28XmtV2jsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=736&publication_year=1996&pages=202-205&author=C.+Marinauthor=S.+Papaauthor=T.+M.+Engberauthor=M.+Bonastreauthor=E.+Tolosaauthor=T.+Chase&title=MK-801+prevents+levodopa-induced+motor+response+alterations+in+parkinsonian+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">MK-801 prevents levodopa-induced motor response alterations in parkinsonian rats</span></div><div class="casAuthors">Marin, Concepcio; Papa, Stella; Engber, Thomas M.; Bonastre, Merce; Tolosa, Eduardo; Chase, T. N.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">736</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">202-205</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The systemic administration of the N-methyl-D-aspartate (NMDA) receptor antagonist, MK801 ((+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine), has previously been found to reverse the motor response alterations that develop during long-term levodopa treatment of parkinsonian rats.  To det. whether co-administration of MK801 with levodopa might prevent the initial appearance of these response changes, rats, rendered parkinsonian by a 6-hydroxydopamine lesion of the medial forebrain bundle, received either levodopa alone or levodopa with the NMDA receptor antagonist.  After four weeks of treatment with levodopa alone, the duration of the turning response declined by 37 (P<0.05) and the no. of ineffectual levodopa injections had more than doubled (P<0.05).  MK801 co-treatment completely blocked the shortening in response duration and prevented the frequency of ineffectual levodopa injection from exceeding baseline levels in animals receiving levodopa alone.  The total magnitude of the turning response to levodopa was not affected.  These results suggest that NMDA receptor blockade may act prophylactically to prevent the appearance of motor response alterations in levodopa-treated parkinsonian rodents that resemble those occurring in levodopa-treated patients with Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbcHFV0esxAbVg90H21EOLACvtfcHk0liyPkVGDfvMIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmtV2jsrw%253D&md5=07f0dfd622fd5733648fc6264f27f8ee</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2896%2900693-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252896%252900693-2%26sid%3Dliteratum%253Aachs%26aulast%3DMarin%26aufirst%3DC.%26aulast%3DPapa%26aufirst%3DS.%26aulast%3DEngber%26aufirst%3DT.%2BM.%26aulast%3DBonastre%26aufirst%3DM.%26aulast%3DTolosa%26aufirst%3DE.%26aulast%3DChase%26aufirst%3DT.%26atitle%3DMK-801%2520prevents%2520levodopa-induced%2520motor%2520response%2520alterations%2520in%2520parkinsonian%2520rats%26jtitle%3DBrain%2520Res.%26date%3D1996%26volume%3D736%26spage%3D202%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Chen, H. S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, S. A.</span><span> </span><span class="NLM_article-title">The chemical biology of clinically tolerated NMDA receptor antagonists</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">1611</span><span class="NLM_x">–</span> <span class="NLM_lpage">1626</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1111%2Fj.1471-4159.2006.03991.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=16805772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnt1Ons7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2006&pages=1611-1626&author=H.+S.+V.+Chenauthor=S.+A.+Lipton&title=The+chemical+biology+of+clinically+tolerated+NMDA+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The chemical biology of clinically tolerated NMDA receptor antagonists</span></div><div class="casAuthors">Chen, Huei-Sheng Vincent; Lipton, Stuart A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1611-1626</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Most neuroprotective drugs have failed in clin. trials because of side-effects, causing normal brain function to become compromised.  A case in point concerns antagonists of the N-methyl-D-aspartate type of glutamate receptor (NMDAR).  Glutamate receptors are essential to the normal function of the central nervous system.  However, their excessive activation by excitatory amino acids, such as glutamate itself, is thought to contribute to neuronal damage in many neurol. disorders ranging from acute hypoxic-ischemic brain injury to chronic neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis.  The dual role of NMDARs in particular for normal and abnormal functioning of the nervous system imposes important constraints on possible therapeutic strategies aimed at ameliorating neurol. diseases.  Blockade of excessive NMDAR activity must therefore be achieved without interference with its normal function.  In general, NMDAR antagonists can be categorized pharmacol. according to the site of action on the receptor-channel complex.  These include drugs acting at the agonist (NMDA) or co-agonist (glycine) sites, channel pore, and modulatory sites, such as the S-nitrosylation site where nitric oxide (NO) reacts with crit. cysteine thiol groups.  Because glutamate is thought to be the major excitatory transmitter in the brain, generalized inhibition of a glutamate receptor subtype like the NMDAR causes side-effects that clearly limit the potential for clin. applications.  Both competitive NMDA and glycine antagonists, even although effective in preventing glutamate-mediated neurotoxicity, will cause generalized inhibition of NMDAR activities and thus have failed in many clin. trials.  Open-channel block with the property of uncompetitive antagonism is the most appealing strategy for therapeutic intervention during excessive NMDAR activation as this action of blockade requires prior activation of the receptor.  This property, in theory, leads to a higher degree of channel blockade in the presence of excessive levels of glutamate and little blockade at relatively lower levels, for example, during physiol. neurotransmission.  Utilizing this mol. strategy of action, we review here the logical process that we applied over the past decade to help develop memantine as the first clin. tolerated yet effective agent against NMDAR-mediated neurotoxicity.  Phase 3 (final) clin. trials have shown that memantine is effective in treating moderate-to-severe Alzheimer's disease while being well tolerated.  Memantine is also currently in trials for addnl. neurol. disorders, including other forms of dementia, glaucoma, and severe neuropathic pain.  Addnl., taking advantage of memantine's preferential binding to open channels and the fact that excessive NMDAR activity can be down-regulated by S-nitrosylation, we have recently developed combinatorial drugs called NitroMemantines.  These drugs use memantine as a homing signal to target NO to hyperactivated NMDARs in order to avoid systemic side-effects of NO such as hypotension (low blood pressure).  These second-generation memantine derivs. are designed as pathol. activated therapeutics, and in preliminary studies appear to have even greater neuroprotective properties than memantine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCWEVOUjqGi7Vg90H21EOLACvtfcHk0liyPkVGDfvMIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnt1Ons7o%253D&md5=2ba27dcb5100dd829611db45bc9cd0f7</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.03991.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.03991.x%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%2BS.%2BV.%26aulast%3DLipton%26aufirst%3DS.%2BA.%26atitle%3DThe%2520chemical%2520biology%2520of%2520clinically%2520tolerated%2520NMDA%2520receptor%2520antagonists%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D97%26spage%3D1611%26epage%3D1626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Crossman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peggs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luquin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambrook, M.</span><span> </span><span class="NLM_article-title">Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkey</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1271</span><span class="NLM_x">–</span> <span class="NLM_lpage">1273</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1989&pages=1271-1273&author=A.+Crossmanauthor=D.+Peggsauthor=S.+Boyceauthor=M.+Luquinauthor=M.+Sambrook&title=Effect+of+the+NMDA+antagonist+MK-801+on+MPTP-induced+parkinsonism+in+the+monkey"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrossman%26aufirst%3DA.%26aulast%3DPeggs%26aufirst%3DD.%26aulast%3DBoyce%26aufirst%3DS.%26aulast%3DLuquin%26aufirst%3DM.%26aulast%3DSambrook%26aufirst%3DM.%26atitle%3DEffect%2520of%2520the%2520NMDA%2520antagonist%2520MK-801%2520on%2520MPTP-induced%2520parkinsonism%2520in%2520the%2520monkey%26jtitle%3DNeuropharmacology%26date%3D1989%26volume%3D28%26spage%3D1271%26epage%3D1273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Blanpied, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. W.</span><span> </span><span class="NLM_article-title">Amantadine inhibits NMDA receptors by accelerating channel closure during channel block</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">3312</span><span class="NLM_x">–</span> <span class="NLM_lpage">3322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1523%2FJNEUROSCI.4262-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=15800186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlSmsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=3312-3322&author=T.+A.+Blanpiedauthor=R.+J.+Clarkeauthor=J.+W.+Johnson&title=Amantadine+inhibits+NMDA+receptors+by+accelerating+channel+closure+during+channel+block"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Amantadine inhibits NMDA receptors by accelerating channel closure during channel block</span></div><div class="casAuthors">Blanpied, Thomas A.; Clarke, Richard J.; Johnson, Jon W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3312-3322</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The channel of NMDA receptors is blocked by a wide variety of drugs.  NMDA receptor channel blockers include drugs of abuse that induce psychotic behavior, such as phencyclidine, and drugs with wide therapeutic utility, such as amantadine and memantine.  We describe here the mol. mechanism of amantadine inhibition.  In contrast to most other described channel-blocking mols., amantadine causes the channel gate of NMDA receptors to close more quickly.  Our results confirm that amantadine binding inhibits current flow through NMDA receptor channels but show that its main inhibitory action at pharmaceutically relevant concns. results from stabilization of closed states of the channel.  The surprising variation in the clin. utility of NMDA channel blockers may in part derive from their diverse effects on channel gating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSq2CI2BASrrVg90H21EOLACvtfcHk0ljwb6QG5u2sNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlSmsbY%253D&md5=25c2c601163f84bd8fe56ff1dbe0be87</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4262-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4262-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DBlanpied%26aufirst%3DT.%2BA.%26aulast%3DClarke%26aufirst%3DR.%2BJ.%26aulast%3DJohnson%26aufirst%3DJ.%2BW.%26atitle%3DAmantadine%2520inhibits%2520NMDA%2520receptors%2520by%2520accelerating%2520channel%2520closure%2520during%2520channel%2520block%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D3312%26epage%3D3322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Uitti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajput, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlskog, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offord, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajput, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basran, P.</span><span> </span><span class="NLM_article-title">Amantadine treatment is an independent predictor of improved survival in Parkinson’s disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1551</span><span class="NLM_x">–</span> <span class="NLM_lpage">1556</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1996&pages=1551-1556&author=R.+Uittiauthor=A.+Rajputauthor=J.+Ahlskogauthor=K.+Offordauthor=D.+Schroederauthor=M.+Hoauthor=M.+Prasadauthor=A.+Rajputauthor=P.+Basran&title=Amantadine+treatment+is+an+independent+predictor+of+improved+survival+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUitti%26aufirst%3DR.%26aulast%3DRajput%26aufirst%3DA.%26aulast%3DAhlskog%26aufirst%3DJ.%26aulast%3DOfford%26aufirst%3DK.%26aulast%3DSchroeder%26aufirst%3DD.%26aulast%3DHo%26aufirst%3DM.%26aulast%3DPrasad%26aufirst%3DM.%26aulast%3DRajput%26aufirst%3DA.%26aulast%3DBasran%26aufirst%3DP.%26atitle%3DAmantadine%2520treatment%2520is%2520an%2520independent%2520predictor%2520of%2520improved%2520survival%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D1996%26volume%3D46%26spage%3D1551%26epage%3D1556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Metman, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotto, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natte, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Munckhof, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, T.</span><span> </span><span class="NLM_article-title">Dextromethorphan improves levodopa-induced dyskinesias in Parkinson’s disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1998&pages=203-206&author=V.+L.+Metmanauthor=D.+P.+Dottoauthor=R.+Natteauthor=P.+Van+den+Munckhofauthor=T.+Chase&title=Dextromethorphan+improves+levodopa-induced+dyskinesias+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMetman%26aufirst%3DV.%2BL.%26aulast%3DDotto%26aufirst%3DD.%2BP.%26aulast%3DNatte%26aufirst%3DR.%26aulast%3DVan%2Bden%2BMunckhof%26aufirst%3DP.%26aulast%3DChase%26aufirst%3DT.%26atitle%3DDextromethorphan%2520improves%2520levodopa-induced%2520dyskinesias%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D1998%26volume%3D51%26spage%3D203%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Metman, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Dotto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LePoole, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konitsiotis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, T. N.</span><span> </span><span class="NLM_article-title">Amantadine for levodopa-induced dyskinesias: a 1-year follow-up study</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1383</span><span class="NLM_x">–</span> <span class="NLM_lpage">1386</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1001%2Farchneur.56.11.1383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=10555659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD3c%252Fit1Grtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1999&pages=1383-1386&author=L.+V.+Metmanauthor=P.+Del+Dottoauthor=K.+LePooleauthor=S.+Konitsiotisauthor=J.+Fangauthor=T.+N.+Chase&title=Amantadine+for+levodopa-induced+dyskinesias%3A+a+1-year+follow-up+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Amantadine for levodopa-induced dyskinesias: a 1-year follow-up study</span></div><div class="casAuthors">Metman L V; Del Dotto P; LePoole K; Konitsiotis S; Fang J; Chase T N</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1383-6</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">BACKGROUND:  In a recent acute study, amantadine was found to have antidyskinetic effect against levodopa-induced motor complications in patients with Parkinson disease.  The longevity of this effect was not addressed but is of interest in light of the controversy in the literature regarding the duration of amantadine's well-established antiparkinsonian action.  OBJECTIVE:  To determine the duration of the antidyskinetic effect of amantadine in advanced Parkinson disease.  DESIGN:  One year after completion of an acute, double-blind, placebo-controlled, crossover study, patients returned for re-evaluation of motor symptoms and dyskinesias using a nonrandomized, double-blind, placebo-controlled follow-up paradigm.  SETTING:  National Institutes of Health Clinical Center.  PATIENTS:  Seventeen of the original 18 patients with advanced Parkinson disease complicated by dyskinesias and motor fluctuations participated in this study; 1 was lost to follow-up.  Thirteen of the 17 individuals had remained on amantadine therapy for the entire year.  INTERVENTIONS:  Ten days prior to the follow-up assessment, amantadine was replaced with identical capsules containing either amantadine or placebo.  MAIN OUTCOME MEASURES:  Parkinsonian symptoms and dyskinesia severity were scored using standard rating scales, while subjects received steady-state intravenous levodopa infusions at the same rate as 1 year earlier.  RESULTS:  One year after initiation of amantadine cotherapy, its antidyskinetic effect was similar in magnitude (56% reduction in dyskinesia compared with 60% 1 year earlier).  Motor complications occurring with the patients' regular oral levodopa regimen also remained improved according to the Unified Parkinson's Disease Rating Scale (UPDRS-IV).  CONCLUSION:  The beneficial effects of amantadine on motor response complications are maintained for at least 1 year after treatment initiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgPRDOnNPw9wpJitSxOdIlfW6udTcc2eYj__Z-hxKdiLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c%252Fit1Grtw%253D%253D&md5=1de1d65f8e90f9e5fdc70b2c8c2020e2</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1001%2Farchneur.56.11.1383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.56.11.1383%26sid%3Dliteratum%253Aachs%26aulast%3DMetman%26aufirst%3DL.%2BV.%26aulast%3DDel%2BDotto%26aufirst%3DP.%26aulast%3DLePoole%26aufirst%3DK.%26aulast%3DKonitsiotis%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DChase%26aufirst%3DT.%2BN.%26atitle%3DAmantadine%2520for%2520levodopa-induced%2520dyskinesias%253A%2520a%25201-year%2520follow-up%2520study%26jtitle%3DArch.%2520Neurol.%26date%3D1999%26volume%3D56%26spage%3D1383%26epage%3D1386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Crosby, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deane, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, C.</span><span> </span><span class="NLM_article-title">Amantadine for dyskinesia in Parkinson’s disease</span> <span class="citation_source-journal">Cochrane Database Syst. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=1-14&author=N.+Crosbyauthor=K.+Deaneauthor=C.+Clarke&title=Amantadine+for+dyskinesia+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrosby%26aufirst%3DN.%26aulast%3DDeane%26aufirst%3DK.%26aulast%3DClarke%26aufirst%3DC.%26atitle%3DAmantadine%2520for%2520dyskinesia%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2003%26volume%3D2%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Shoulson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwid, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenamyre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siderowf, A.</span><span> </span><span class="NLM_article-title">A randomized, controlled trial of remacemide for motor fluctuations in Parkinson’s disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2001&pages=455-462&author=I.+Shoulsonauthor=J.+Penneyauthor=M.+McDermottauthor=S.+Schwidauthor=E.+Kaysonauthor=T.+Chaseauthor=S.+Fahnauthor=J.+Greenamyreauthor=A.+Langauthor=A.+Siderowf&title=A+randomized%2C+controlled+trial+of+remacemide+for+motor+fluctuations+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShoulson%26aufirst%3DI.%26aulast%3DPenney%26aufirst%3DJ.%26aulast%3DMcDermott%26aufirst%3DM.%26aulast%3DSchwid%26aufirst%3DS.%26aulast%3DKayson%26aufirst%3DE.%26aulast%3DChase%26aufirst%3DT.%26aulast%3DFahn%26aufirst%3DS.%26aulast%3DGreenamyre%26aufirst%3DJ.%26aulast%3DLang%26aufirst%3DA.%26aulast%3DSiderowf%26aufirst%3DA.%26atitle%3DA%2520randomized%252C%2520controlled%2520trial%2520of%2520remacemide%2520for%2520motor%2520fluctuations%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D2001%26volume%3D56%26spage%3D455%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Lipton, S. A.</span><span> </span><span class="NLM_article-title">Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">160</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnrd1958" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=16424917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslaquro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=160-170&author=S.+A.+Lipton&title=Paradigm+shift+in+neuroprotection+by+NMDA+receptor+blockade%3A+memantine+and+beyond"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond</span></div><div class="casAuthors">Lipton, Stuart A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">160-170</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Neuroprotective drugs tested in clin. trials, particularly those that block N-methyl-D-aspartate-sensitive glutamate receptors (NMDARs), have failed miserably in large part because of intolerable side effects.  However, one such drug, memantine, was recently approved by the European Union and the US FDA for the treatment of dementia following our group's discovery of its clin. tolerated mechanism of action.  Here, we review the mol. basis for memantine efficacy in neurol. diseases that are mediated, at least in part, by overactivation of NMDARs, producing excessive Ca2+ influx through the receptor's assocd. ion channel and consequent free-radical formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDq-DUijWIWbVg90H21EOLACvtfcHk0lgY3u6V2RoDFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslaquro%253D&md5=14bc9411b6a2b539aaef36aed789eaf8</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fnrd1958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1958%26sid%3Dliteratum%253Aachs%26aulast%3DLipton%26aufirst%3DS.%2BA.%26atitle%3DParadigm%2520shift%2520in%2520neuroprotection%2520by%2520NMDA%2520receptor%2520blockade%253A%2520memantine%2520and%2520beyond%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D160%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Ferris, S. H.</span><span> </span><span class="NLM_article-title">Evaluation of memantine for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2305</span><span class="NLM_x">–</span> <span class="NLM_lpage">2313</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1517%2F14656566.4.12.2305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=14640929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlemu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=2305-2313&author=S.+H.+Ferris&title=Evaluation+of+memantine+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of memantine for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Ferris, Steven H.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2305-2313</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Increasing evidence suggests that disturbances in glutamatergic activity play an important role in Alzheimer's disease (AD).  Excessive glutamate-mediated activation of NMDA receptors, for example, may contribute to the neuronal death that characterizes AD.  On the other hand, physiol. activation of the NMDA receptor appears necessary for normal cognitive function.  Therefore, compds. that finely modulate NMDA receptor activity hold promise as treatments for AD.  Memantine is a low-moderate affinity, uncompetitive NMDA-receptor antagonist that appears to block pathol., but not physiol., activation of the NMDA receptor.  Consequently, therapeutic doses of the drug are well-tolerated and do not seem to interfere with the acquisition or processing of cognitive information.  Memantine has been shown to improve symptoms and reduce the rate of clin. deterioration among patients with moderate-to-severe AD and was approved in the US for this indication in Oct. 2003.  This review provides a brief rationale for the development of memantine as a therapy for AD, as well as an overview of the pharmacol., clin. efficacy, safety and tolerability of this novel therapeutic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNYUSq0TIr0bVg90H21EOLACvtfcHk0lgY3u6V2RoDFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlemu78%253D&md5=495fec335eb670f61900aa37b0b7707d</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1517%2F14656566.4.12.2305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.4.12.2305%26sid%3Dliteratum%253Aachs%26aulast%3DFerris%26aufirst%3DS.%2BH.%26atitle%3DEvaluation%2520of%2520memantine%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2003%26volume%3D4%26spage%3D2305%26epage%3D2313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Herrmann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanctoot, K.</span><span> </span><span class="NLM_article-title">Memantine in dementia: a review of the current evidence</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">800</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1517%2F14656566.2011.558006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=21385152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivFWitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=787-800&author=N.+Herrmannauthor=A.+Liauthor=K.+Lanctoot&title=Memantine+in+dementia%3A+a+review+of+the+current+evidence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Memantine in dementia: a review of the current evidence</span></div><div class="casAuthors">Herrmann, Nathan; Li, Abby; Lanctoot, Krista</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">787-800</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  As the world's population ages, the incidence of Alzheimer's disease (AD) is projected to double every 20 years.  Understanding the pathogenesis of AD and developing effective treatments is a public health imperative.  Memantine is a low- to moderate-affinity, non-competitive NMDA receptor antagonist that is currently approved for the treatment of moderate to severe AD.  We discuss the current evidence, emphasizing more recent studies examg. the effects of memantine in AD.  We also look at the gaps in the current knowledge; the studies that will be required to fill these gaps are also discussed.  The present paper reviews: the pharmacol. of memantine; evidence for its use in moderate to severe AD, as well as in mild to moderate AD; adverse events related to memantine use; its effects specifically on behaviors including aggression and agitation; the pharmacoeconomics of memantine; and the use of memantine in other dementias.  Memantine has shown modest benefits in cognition, function, global and behavioral measures, and has shown little potential for drug-drug interactions.  For the treatment of moderate to severe AD, memantine should be offered as a therapeutic option, either on its own, or in combination with a cholinesterase inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryDfWm9U4acLVg90H21EOLACvtfcHk0lgY3u6V2RoDFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivFWitrc%253D&md5=e333d89fd45b6c8fad73d7998e186a63</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1517%2F14656566.2011.558006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2011.558006%26sid%3Dliteratum%253Aachs%26aulast%3DHerrmann%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DLanctoot%26aufirst%3DK.%26atitle%3DMemantine%2520in%2520dementia%253A%2520a%2520review%2520of%2520the%2520current%2520evidence%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2011%26volume%3D12%26spage%3D787%26epage%3D800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Lipton, S. A.</span><span> </span><span class="NLM_article-title">Pathologically activated therapeutics for neuroprotection</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">803</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnrn2229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=17882256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKht77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=803-808&author=S.+A.+Lipton&title=Pathologically+activated+therapeutics+for+neuroprotection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Pathologically activated therapeutics for neuroprotection</span></div><div class="casAuthors">Lipton, Stuart A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">803-808</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Many drugs that have been developed to treat neurodegenerative diseases fail to gain approval for clin. use because they are not well tolerated in humans.  In this article, I describe a series of strategies for the development of neuroprotective therapeutics that are both effective and well tolerated.  These strategies are based on the principle that drugs should be activated by the pathol. state that they are intended to inhibit.  This approach has already met with success, and has led to the development of the potentially neuroprotective drug memantine, an N-methyl-D-aspartate (NMDA)-type and glutamate receptor antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-chT-qiedELVg90H21EOLACvtfcHk0lgY3u6V2RoDFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKht77N&md5=07391644bbd0a7ab6f8cf6f2803fd97f</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1038%2Fnrn2229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2229%26sid%3Dliteratum%253Aachs%26aulast%3DLipton%26aufirst%3DS.%2BA.%26atitle%3DPathologically%2520activated%2520therapeutics%2520for%2520neuroprotection%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2007%26volume%3D8%26spage%3D803%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Williams, K.</span><span> </span><span class="NLM_article-title">Ifenprodil discriminates subtypes of the <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">851</span><span class="NLM_x">–</span> <span class="NLM_lpage">859</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=7901753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK2cXitlCnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1993&pages=851-859&author=K.+Williams&title=Ifenprodil+discriminates+subtypes+of+the+N-methyl-d-aspartate+receptor%3A+selectivity+and+mechanisms+at+recombinant+heteromeric+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: Selectivity and mechanisms at recombinant heteromeric receptors</span></div><div class="casAuthors">Williams, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">851-9</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">The effects of the atypical N-methyl-D-aspartate (NMDA) receptor antagonist ifenprodil were studied by voltage-clamp recording of Xenopus oocytes expressing heteromeric NMDA receptors from cloned NR1 and NR2 subunit RNAs.  In oocytes voltage-clamped at -70 mV, ifenprodil inhibited NMDA-induced currents at NR1A/NR2B receptors with high affinity (IC50 = 0.34 μM).  The affinity of NR1A/NR2A receptors for ifenprodil (IC50 = 146 μM) was 400-fold lower than that of NR1A/NR2B receptors.  The rate of onset of inhibition by low concns. of ifenprodil acting at NR1A/NR2B receptors was considerably slower than the onset of inhibition seen with high concns. of ifenprodil acting at NR1A/NR2A receptors.  The onset and recovery of blockade by ifenprodil at NR1A/NR2B receptors were not activity dependent.  The inhibitory effects of low concns. of ifenprodil at NR1A/NR2B receptors were not voltage dependent.  In contrast, the inhibitory effects of high concns. of ifenprodil at NR1A/NR2A receptors were partially voltage dependent, and a greater inhibition of NMDA-induced currents was seen at hyperpolarized membrane potentials than at depolarized membrane potentials.  The reversal potential of NMDA currents was not altered in the presence of ifenprodil.  Ifenprodil may act as a weak open-channel blocker of NR1A/NR2A receptors.  The degree of inhibition seen with 100 μM ifenprodil at NR1A/NR2A receptors was not altered by changes in the concn. of extracellular glycine.  However, the inhibitory effect of 1 μM ifenprodil at NR1A/NR2B receptors was reduced by increasing the concn. of glycine.  Thus, part of the mechanism of action of ifenprodil at NR1A/NR2B receptors may involve noncompetitive antagonism of the effects of glycine.  Apparently, the mechanism of action of ifenprodil, as well as the potency of this antagonist, is different at NR1A/NR2B and NR1A/NR2A receptors expressed in Xenopus oocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoffD1y7apqXrVg90H21EOLACvtfcHk0ljgAenJCA368Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlCnsw%253D%253D&md5=27f84915114a10b17c5f5c02740d84f8</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DK.%26atitle%3DIfenprodil%2520discriminates%2520subtypes%2520of%2520the%2520N-methyl-d-aspartate%2520receptor%253A%2520selectivity%2520and%2520mechanisms%2520at%2520recombinant%2520heteromeric%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D1993%26volume%3D44%26spage%3D851%26epage%3D859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Tahirovic, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geballe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruszecka-Kowalik, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyuboslavsky, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">French, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irier, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easterling, K.</span><span> </span><span class="NLM_article-title">Enantiomeric propanolamines as selective <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate 2B receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5506</span><span class="NLM_x">–</span> <span class="NLM_lpage">5521</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8002153" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5506-5521&author=Y.+A.+Tahirovicauthor=M.+Geballeauthor=E.+Gruszecka-Kowalikauthor=S.+J.+Myersauthor=P.+Lyuboslavskyauthor=P.+Leauthor=A.+Frenchauthor=H.+Irierauthor=W.+Choiauthor=K.+Easterling&title=Enantiomeric+propanolamines+as+selective+N-methyl-d-aspartate+2B+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm8002153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8002153%26sid%3Dliteratum%253Aachs%26aulast%3DTahirovic%26aufirst%3DY.%2BA.%26aulast%3DGeballe%26aufirst%3DM.%26aulast%3DGruszecka-Kowalik%26aufirst%3DE.%26aulast%3DMyers%26aufirst%3DS.%2BJ.%26aulast%3DLyuboslavsky%26aufirst%3DP.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DFrench%26aufirst%3DA.%26aulast%3DIrier%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DW.%26aulast%3DEasterling%26aufirst%3DK.%26atitle%3DEnantiomeric%2520propanolamines%2520as%2520selective%2520N-methyl-d-aspartate%25202B%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5506%26epage%3D5521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Mosley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santangelo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahirovic, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurtkaya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullasseril, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyuboslavsky, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P.</span><span> </span><span class="NLM_article-title">Synthesis, structural activity-relationships, and biological evaluation of novel amide-based allosteric binding site antagonists in NR1A/NR2B <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6463</span><span class="NLM_x">–</span> <span class="NLM_lpage">6480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=6463-6480&author=C.+A.+Mosleyauthor=S.+J.+Myersauthor=E.+E.+Murrayauthor=R.+Santangeloauthor=Y.+A.+Tahirovicauthor=N.+Kurtkayaauthor=P.+Mullasserilauthor=H.+Yuanauthor=P.+Lyuboslavskyauthor=P.+Le&title=Synthesis%2C+structural+activity-relationships%2C+and+biological+evaluation+of+novel+amide-based+allosteric+binding+site+antagonists+in+NR1A%2FNR2B+N-methyl-d-aspartate+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMosley%26aufirst%3DC.%2BA.%26aulast%3DMyers%26aufirst%3DS.%2BJ.%26aulast%3DMurray%26aufirst%3DE.%2BE.%26aulast%3DSantangelo%26aufirst%3DR.%26aulast%3DTahirovic%26aufirst%3DY.%2BA.%26aulast%3DKurtkaya%26aufirst%3DN.%26aulast%3DMullasseril%26aufirst%3DP.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DLyuboslavsky%26aufirst%3DP.%26aulast%3DLe%26aufirst%3DP.%26atitle%3DSynthesis%252C%2520structural%2520activity-relationships%252C%2520and%2520biological%2520evaluation%2520of%2520novel%2520amide-based%2520allosteric%2520binding%2520site%2520antagonists%2520in%2520NR1A%252FNR2B%2520N-methyl-d-aspartate%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D6463%26epage%3D6480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Fischer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trube, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malherbe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kew, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohacsi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, J.</span><span> </span><span class="NLM_article-title">Ro 25-6981, a highly potent and selective blocker of <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptors containing the NR2B subunit. Characterization in vitro</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">1285</span><span class="NLM_x">–</span> <span class="NLM_lpage">1292</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=9400004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1cXis1Giuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=1285-1292&author=G.+Fischerauthor=V.+Mutelauthor=G.+Trubeauthor=P.+Malherbeauthor=J.+Kewauthor=E.+Mohacsiauthor=M.+Heitzauthor=J.+Kemp&title=Ro+25-6981%2C+a+highly+potent+and+selective+blocker+of+N-methyl-d-aspartate+receptors+containing+the+NR2B+subunit.+Characterization+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro</span></div><div class="casAuthors">Fischer, G.; Mutel, V.; Trube, G.; Malherbe, P.; Kew, J. N. C.; Mohacsi, E.; Heitz, M. P.; Kemp, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1285-1292</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The interaction of Ro 25-6981 with N-methyl-D-aspartate (NMDA) receptors was characterized by a variety of different tests in vitro.  Ro 25-6981 inhibited 3H-MK-801 binding to rat forebrain membranes in a biphasic manner with IC50 values of 0.003 μM and 149 μM for high- (about 60%) and low-affinity sites, resp.  NMDA receptor subtypes expressed in Xenopus oocytes were blocked with IC50 values of 0.009 μM and 52 μM for the subunit combinations NR1C & NR2B and NR1C & NR2A, resp., which indicated a >5000-fold selectivity.  Like ifenprodil, Ro 25-6981 blocked NMDA receptor subtypes in an activity-dependent manner.  Ro 25-6981 protected cultured cortical neurons against glutamate toxicity (16 h exposure to 300 μM glutamate) and combined oxygen and glucose deprivation (60 min followed by 20 h recovery) with IC50 values of 0.4 μM and 0.04 μM, resp.  Ro 25-6981 was more potent than ifenprodil in all of these tests.  It showed no protection against kainate toxicity (exposure to 500 μM for 20 h) and only weak activity in blocking Na+ and Ca2+ channels, activated by exposure of cortical neurons to veratridine (10 μM) and potassium (50 mM), resp.  These findings demonstrate that Ro 25-6981 is a highly selective, activity-dependent blocker of NMDA receptors that contain the NR2B subunit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIOB0rLJv_oLVg90H21EOLACvtfcHk0ljgAenJCA368Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXis1Giuw%253D%253D&md5=42ab1bd4fa72ee96b25007a92ebce37a</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DMutel%26aufirst%3DV.%26aulast%3DTrube%26aufirst%3DG.%26aulast%3DMalherbe%26aufirst%3DP.%26aulast%3DKew%26aufirst%3DJ.%26aulast%3DMohacsi%26aufirst%3DE.%26aulast%3DHeitz%26aufirst%3DM.%26aulast%3DKemp%26aufirst%3DJ.%26atitle%3DRo%252025-6981%252C%2520a%2520highly%2520potent%2520and%2520selective%2520blocker%2520of%2520N-methyl-d-aspartate%2520receptors%2520containing%2520the%2520NR2B%2520subunit.%2520Characterization%2520in%2520vitro%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D1285%26epage%3D1292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Taniguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinjo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagahisa, A.</span><span> </span><span class="NLM_article-title">Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">812</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fsj.bjp.0701445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=9384494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK2sXnt1Sqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=1997&pages=809-812&author=K.+Taniguchiauthor=K.+Shinjoauthor=M.+Mizutaniauthor=K.+Shimadaauthor=T.+Ishikawaauthor=F.+S.+Mennitiauthor=A.+Nagahisa&title=Antinociceptive+activity+of+CP-101%2C606%2C+an+NMDA+receptor+NR2B+subunit+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist</span></div><div class="casAuthors">Taniguchi, Kana; Shinjo, Katsuhiro; Mizutani, Mayumi; Shimada, Kaoru; Ishikawa, Oshihisa; Menniti, Frank S.; Nagahisa, Atsushi</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">809-812</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">1. The analgesic activity of CP-101,606, an NR2B subunit-selective N-methyl-D-aspartate (NMDA) receptor antagonist, was examd. in carrageenan-induced hyperalgesia, capsaicin- and 4β-phorbol-12-myristate-13-acetate (PMA)-induced nociceptive tests in the rat.  2. CP-101,606 30 mg kg-1, s.c., at 0.5 and 2.5 h after carrageenan challenge suppressed mech. hyperalgesia without any apparent alternations in motor coordination or behavior in the rat.  3. CP-101,606 also inhibited capsaicin- and PMA-induced nociceptive responses (licking behavior) with ED50 values of 7.5 and 5.7 mg kg-1, s.c., resp.  4. These results suggest that inhibition of the NR2B subunit of the NMDA receptor is effective in vivo at modulating nociception and hyperalgesia responses without causing the behavioral side effects often obsd. with currently available NMDA receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN7dqi1JClaLVg90H21EOLACvtfcHk0lgptkcrqlD-pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnt1Sqtbc%253D&md5=9727650ebb93e9b63fa173ebd19305b3</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0701445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0701445%26sid%3Dliteratum%253Aachs%26aulast%3DTaniguchi%26aufirst%3DK.%26aulast%3DShinjo%26aufirst%3DK.%26aulast%3DMizutani%26aufirst%3DM.%26aulast%3DShimada%26aufirst%3DK.%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DNagahisa%26aufirst%3DA.%26atitle%3DAntinociceptive%2520activity%2520of%2520CP-101%252C606%252C%2520an%2520NMDA%2520receptor%2520NR2B%2520subunit%2520antagonist%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D122%26spage%3D809%26epage%3D812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Nutt, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzler, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirchhoff, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogarth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamerson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landen, J. W.</span><span> </span><span class="NLM_article-title">Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and parkinsonism</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1860</span><span class="NLM_x">–</span> <span class="NLM_lpage">1866</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1002%2Fmds.22169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=18759356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD1cjht1KnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=1860-1866&author=J.+G.+Nuttauthor=S.+A.+Gunzlerauthor=T.+Kirchhoffauthor=P.+Hogarthauthor=J.+L.+Weaverauthor=M.+Kramsauthor=B.+Jamersonauthor=F.+S.+Mennitiauthor=J.+W.+Landen&title=Effects+of+a+NR2B+selective+NMDA+glutamate+antagonist%2C+CP-101%2C606%2C+on+dyskinesia+and+parkinsonism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and Parkinsonism</span></div><div class="casAuthors">Nutt John G; Gunzler Steven A; Kirchhoff Trish; Hogarth Penelope; Weaver Jerry L; Krams Michael; Jamerson Brenda; Menniti Frank S; Landen Jaren W</div><div class="citationInfo"><span class="NLM_cas:title">Movement disorders : official journal of the Movement Disorder Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1860-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glutamate antagonists decrease dyskinesia and augment the antiparkinsonian effects of levodopa in animal models of Parkinson's disease (PD).  In a randomized, double-blind, placebo-controlled clinical trial, we investigated the acute effects of placebo and two doses of a NR2B subunit selective NMDA glutamate antagonist, CP-101,606, on the response to 2-hour levodopa infusions in 12 PD subjects with motor fluctuations and dyskinesia.  Both doses of CP-101,606 reduced the maximum severity of levodopa-induced dyskinesia approximately 30% but neither dose improved Parkinsonism.  CP-101,606 was associated with a dose-related dissociation and amnesia.  These results support the hypothesis that glutamate antagonists may be useful antidyskinetic agents.  However, future studies will have to determine if the benefits of dyskinesia suppression can be achieved without adverse cognitive effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRsgHo5QLhgm7YtC3U5jeOifW6udTcc2ebaVk-uOv4Zjbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjht1KnsA%253D%253D&md5=69a5fd96cd5ee1922ef79c530157d756</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1002%2Fmds.22169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.22169%26sid%3Dliteratum%253Aachs%26aulast%3DNutt%26aufirst%3DJ.%2BG.%26aulast%3DGunzler%26aufirst%3DS.%2BA.%26aulast%3DKirchhoff%26aufirst%3DT.%26aulast%3DHogarth%26aufirst%3DP.%26aulast%3DWeaver%26aufirst%3DJ.%2BL.%26aulast%3DKrams%26aufirst%3DM.%26aulast%3DJamerson%26aufirst%3DB.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DLanden%26aufirst%3DJ.%2BW.%26atitle%3DEffects%2520of%2520a%2520NR2B%2520selective%2520NMDA%2520glutamate%2520antagonist%252C%2520CP-101%252C606%252C%2520on%2520dyskinesia%2520and%2520parkinsonism%26jtitle%3DMov.%2520Disord.%26date%3D2008%26volume%3D23%26spage%3D1860%26epage%3D1866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Mosley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acker, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullasseril, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vellano, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bräuner-Osborne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span> </span><span class="NLM_article-title">Quinazolin-4-one derivatives: a novel class of noncompetitive NR2C/D subunit-selective <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_fpage">5476</span><span class="NLM_x">–</span> <span class="NLM_lpage">5490</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=5476-5490&author=C.+A.+Mosleyauthor=T.+M.+Ackerauthor=K.+B.+Hansenauthor=P.+Mullasserilauthor=K.+T.+Andersenauthor=P.+Leauthor=K.+M.+Vellanoauthor=H.+Br%C3%A4uner-Osborneauthor=D.+C.+Liottaauthor=S.+F.+Traynelis&title=Quinazolin-4-one+derivatives%3A+a+novel+class+of+noncompetitive+NR2C%2FD+subunit-selective+N-methyl-d-aspartate+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMosley%26aufirst%3DC.%2BA.%26aulast%3DAcker%26aufirst%3DT.%2BM.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DMullasseril%26aufirst%3DP.%26aulast%3DAndersen%26aufirst%3DK.%2BT.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DVellano%26aufirst%3DK.%2BM.%26aulast%3DBr%25C3%25A4uner-Osborne%26aufirst%3DH.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DQuinazolin-4-one%2520derivatives%253A%2520a%2520novel%2520class%2520of%2520noncompetitive%2520NR2C%252FD%2520subunit-selective%2520N-methyl-d-aspartate%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26spage%3D5476%26epage%3D5490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span> </span><span class="NLM_article-title">Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">3650</span><span class="NLM_x">–</span> <span class="NLM_lpage">3661</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1523%2FJNEUROSCI.5565-10.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=21389220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslGqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=3650-3661&author=K.+B.+Hansenauthor=S.+F.+Traynelis&title=Structural+and+mechanistic+determinants+of+a+novel+site+for+noncompetitive+inhibition+of+GluN2D-containing+NMDA+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors</span></div><div class="casAuthors">Hansen, Kasper B.; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3650-3661</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">NMDA receptors are ionotropic glutamate receptors that mediate excitatory synaptic transmission and have been implicated in several neurol. diseases.  We have evaluated the mechanism of action of a class of novel subunit-selective NMDA receptor antagonists, typified by (E)-4-(6-methoxy-2-(3-nitrostyryl)-4-oxoquinazolin-3(4H)-yl)-benzoic acid (QNZ46).  We found that QNZ46 inhibits NMDA receptor function in a noncompetitive and voltage-independent manner by an unconventional mechanism that requires binding of glutamate to the GluN2 subunit, but not glycine binding to the GluN1 subunit.  This dependency of antagonist assocn. on glutamate binding to GluN2 renders these compds. nominally use-dependent, since inhibition will rely on synaptic release of glutamate.  Evaluation of the structural determinants responsible for the subunit-selectivity of QNZ46 revealed that these compds. act at a new site that has not previously been described.  Residues residing in the part of the agonist binding domain immediately adjacent to the transmembrane helixes appear to control selectivity of QNZ46 for GluN2C- and GluN2D-contg. receptors.  These residues are well-positioned to sense glutamate binding to GluN2 and thus to mediate glutamate-dependent actions.  This new class of noncompetitive antagonists could provide an opportunity for the development of pharmacol. tools and therapeutic agents that target NMDA receptors at a new site and modulate function by a novel mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6tfEgKAb7trVg90H21EOLACvtfcHk0lgptkcrqlD-pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslGqt7w%253D&md5=ac8e6c3cd76ba67768f765926a66381c</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5565-10.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5565-10.2011%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DStructural%2520and%2520mechanistic%2520determinants%2520of%2520a%2520novel%2520site%2520for%2520noncompetitive%2520inhibition%2520of%2520GluN2D-containing%2520NMDA%2520receptors%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D3650%26epage%3D3661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Costa, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irvine, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaves, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayo-Martin, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skifter, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jane, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monaghan, D. T.</span><span> </span><span class="NLM_article-title">A novel family of negative and positive allosteric modulators of NMDA receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">614</span><span class="NLM_x">–</span> <span class="NLM_lpage">621</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1124%2Fjpet.110.174144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20858708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFOmsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2010&pages=614-621&author=B.+M.+Costaauthor=M.+W.+Irvineauthor=G.+Fangauthor=R.+J.+Eavesauthor=M.+B.+Mayo-Martinauthor=D.+A.+Skifterauthor=D.+E.+Janeauthor=D.+T.+Monaghan&title=A+novel+family+of+negative+and+positive+allosteric+modulators+of+NMDA+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">A novel family of negative and positive allosteric modulators of NMDA receptors</span></div><div class="casAuthors">Costa, Blaise Mathias; Irvine, Mark W.; Fang, Guangyu; Eaves, Richard J.; Mayo-Martin, Marie Belen; Skifter, Donald A.; Jane, David E.; Monaghan, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">614-621</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The N-methyl-D-aspartate (NMDA) receptor family regulates various central nervous system functions, such as synaptic plasticity.  However, hypo- or hyperactivation of NMDA receptors is critically involved in many neurol. and psychiatric conditions, such as pain, stroke, epilepsy, neurodegeneration, schizophrenia, and depression.  Consequently, subtype-selective pos. and neg. modulators of NMDA receptor function have many potential therapeutic applications not addressed by currently available compds.  We have identified allosteric modulators with several novel patterns of NMDA receptor subtype selectivity that have a novel mechanism of action.  In a series of carboxylated naphthalene and phenanthrene derivs., compds. were identified that selectively potentiate responses at GluN1/GluN2A [e.g., 9-iodophenanthrene-3-carboxylic acid (UBP512)]; GluN1/GluN2A and GluN1/GluN2B [9-cyclopropylphenanthrene-3-carboxylic acid (UBP710)]; GluN1/GluN2D [3,5-dihydroxynaphthalene-2-carboxylic acid (UBP551)]; or GluN1/GluN2C and GluN1/GluN2D receptors [6-, 7-, 8-, and 9-nitro isomers of naphth[1,2-c][1,2,5]oxadiazole-5-sulfonic acid (NSC339614)] and have no effect or inhibit responses at the other NMDA receptors.  Selective inhibition was also obsd.; UBP512 inhibits only GluN1/GluN2C and GluN1/GluN2D receptors, whereas 6-bromo-2-oxo-2H-chromene-3-carboxylic acid (UBP608) inhibits GluN1/GluN2A receptors with a 23-fold selectivity compared with GluN1/GluN2D receptors.  The actions of these compds. were not competitive with the agonists L-glutamate or glycine and were not voltage-dependent.  Whereas the N-terminal regulatory domain was not necessary for activity of either potentiators or inhibitors, segment 2 of the agonist ligand-binding domain was important for potentiating activity, whereas subtype-specific inhibitory activity was dependent upon segment 1.  In terms of chem. structure, activity profile, and mechanism of action, these modulators represent a new class of pharmacol. agents for the study of NMDA receptor subtype function and provide novel lead compds. for a variety of neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ9F9N6PVoh7Vg90H21EOLACvtfcHk0lh0i9PcWdy6zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFOmsrnI&md5=cefc65523d06856f6dd704274ecb6f22</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.174144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.174144%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DB.%2BM.%26aulast%3DIrvine%26aufirst%3DM.%2BW.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DEaves%26aufirst%3DR.%2BJ.%26aulast%3DMayo-Martin%26aufirst%3DM.%2BB.%26aulast%3DSkifter%26aufirst%3DD.%2BA.%26aulast%3DJane%26aufirst%3DD.%2BE.%26aulast%3DMonaghan%26aufirst%3DD.%2BT.%26atitle%3DA%2520novel%2520family%2520of%2520negative%2520and%2520positive%2520allosteric%2520modulators%2520of%2520NMDA%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D335%26spage%3D614%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Acker, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullasseril, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span> </span><span class="NLM_article-title">Mechanism for noncompetitive inhibition by novel GluN2C/D <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor subunit-selective modulators</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">782</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2011&pages=782-795&author=T.+M.+Ackerauthor=H.+Yuanauthor=K.+B.+Hansenauthor=K.+M.+Vanceauthor=K.+K.+Ogdenauthor=H.+S.+Jensenauthor=P.+B.+Burgerauthor=P.+Mullasserilauthor=J.+P.+Snyderauthor=D.+C.+Liotta&title=Mechanism+for+noncompetitive+inhibition+by+novel+GluN2C%2FD+N-methyl-d-aspartate+receptor+subunit-selective+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAcker%26aufirst%3DT.%2BM.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DJensen%26aufirst%3DH.%2BS.%26aulast%3DBurger%26aufirst%3DP.%2BB.%26aulast%3DMullasseril%26aufirst%3DP.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26atitle%3DMechanism%2520for%2520noncompetitive%2520inhibition%2520by%2520novel%2520GluN2C%252FD%2520N-methyl-d-aspartate%2520receptor%2520subunit-selective%2520modulators%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D80%26spage%3D782%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Bettini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffante, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carignani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelli, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreetta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senar-Sancho, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiral, L.</span><span> </span><span class="NLM_article-title">Identification and characterization of novel NMDA receptor antagonists selective for NR2A-over NR2B-containing receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">636</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1124%2Fjpet.110.172544" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20810618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFOmsrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2010&pages=636-644&author=E.+Bettiniauthor=A.+Savaauthor=C.+Griffanteauthor=C.+Carignaniauthor=A.+Busonauthor=A.+M.+Capelliauthor=M.+Negriauthor=F.+Andreettaauthor=S.+A.+Senar-Sanchoauthor=L.+Guiral&title=Identification+and+characterization+of+novel+NMDA+receptor+antagonists+selective+for+NR2A-over+NR2B-containing+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors</span></div><div class="casAuthors">Bettini, Ezio; Sava, Anna; Griffante, Cristiana; Carignani, Corrado; Buson, Alberto; Capelli, Anna Maria; Negri, Michele; Andreetta, Filippo; Senar-Sancho, Sergio A.; Guiral, Lorena; Cardullo, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">636-644</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">NR1/NR2A is a subtype of N-methyl-D-aspartate receptors (NMDARs), which are glutamate and glycine-gated Ca2+-permeable channels highly expressed in the central nervous system.  A high-throughput screening (HTS) campaign using human osteosarcoma (U-2 OS) cells transiently transduced with NR1/NR2A NMDAR subunits, tested in a specifically designed fluorometric imaging plate reader (FLIPR)/Ca2+ assay, identified sulfonamide deriv. series, exemplified by 3-chloro-4-fluoro-N-[(4-{[2-(phenylcarbonyl)hydrazino]carbonyl}phenyl)methyl]benzenesulfonamide (compd. 1) and thiodiazole deriv. N-(cyclohexylmethyl)-2-({5-[(phenylmethyl)amino]-1,3,4-thiadiazol-2-yl}thio)acetamide (compd. 13) as novel NR1/NR2A receptor antagonists.  Compds. 1 and 13 displayed submicromolar and micromolar potency at NR1/NR2A receptor, resp., although they did not show activity at NR2B-contg. receptor up to 50 μM concn.  Addn. of 1 mM glycine, but not 1 mM L-glutamate, was able to surmount compd. 1 and 13 inhibitory effects in FLIPR NR1/NR2A assay.  However, compds. 1 and 13 displaced a glutamate site antagonist [3H]D,L-(E)-2-amino-4-propyl-5-phosphono-3-pentenoic acid ([3H]CGP 39653) to a greater extent than the glycine site antagonist [3H]3-[(E)-2-carboxy-2-phenylethenyl]-4,6-dichloro-1H-indole-2-carboxylic acid ([3H]MDL 105,519), in rat brain cortex binding assay.  Results of FLIPR cell-based, electrophysiol., and biochem. binding assays suggest that compds. 1 and 13 are the prototypes of novel classes of NMDAR ligands, which to the best of our knowledge are the first selective antagonists at NR1/NR2A over NR1/NR2B receptor, and might constitute useful tools able to elucidate the relative role of the NR2A subunit in physiol. and pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFB-QKFiC9sLVg90H21EOLACvtfcHk0lh0i9PcWdy6zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFOmsrnK&md5=0bffd70be964ba27d17b9fbd877eaef0</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.172544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.172544%26sid%3Dliteratum%253Aachs%26aulast%3DBettini%26aufirst%3DE.%26aulast%3DSava%26aufirst%3DA.%26aulast%3DGriffante%26aufirst%3DC.%26aulast%3DCarignani%26aufirst%3DC.%26aulast%3DBuson%26aufirst%3DA.%26aulast%3DCapelli%26aufirst%3DA.%2BM.%26aulast%3DNegri%26aufirst%3DM.%26aulast%3DAndreetta%26aufirst%3DF.%26aulast%3DSenar-Sancho%26aufirst%3DS.%2BA.%26aulast%3DGuiral%26aufirst%3DL.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520novel%2520NMDA%2520receptor%2520antagonists%2520selective%2520for%2520NR2A-over%2520NR2B-containing%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D335%26spage%3D636%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Retchless, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. W.</span><span> </span><span class="NLM_article-title">A single GluN2 subunit residue controls NMDA receptor channel properties via intersubunit interaction</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">406</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnn.3025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=22246434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1Kktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=406-413&author=B.+S.+Retchlessauthor=W.+Gaoauthor=J.+W.+Johnson&title=A+single+GluN2+subunit+residue+controls+NMDA+receptor+channel+properties+via+intersubunit+interaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">A single GluN2 subunit residue controls NMDA receptor channel properties via intersubunit interaction</span></div><div class="casAuthors">Retchless, Beth Siegler; Gao, Wei; Johnson, Jon W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">406-413</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">NMDA receptors (NMDARs) are glutamate-gated ion channels that are present at most excitatory mammalian synapses.  The four GluN2 subunits (GluN2A-D) contribute to four diheteromeric NMDAR subtypes that have divergent physiol. and pathol. roles.  Channel properties that are fundamental to NMDAR function vary among subtypes.  We investigated the amino acid residues responsible for variations in channel properties by creating and examg. NMDARs contg. mutant GluN2 subunits.  We found that the NMDAR subtype specificity of three crucial channel properties, Mg2+ block, selective permeability to Ca2+ and single-channel conductance, were all controlled primarily by the residue at a single GluN2 site in the M3 transmembrane region.  Mutant cycle anal. guided by mol. modeling revealed that a GluN2-GluN1 subunit interaction mediates the site's effects.  We conclude that a single GluN2 subunit residue couples with the pore-forming loop of the GluN1 subunit to create naturally occurring variations in NMDAR properties that are crit. to synaptic plasticity and learning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzoTtIKoNyPbVg90H21EOLACvtfcHk0lh0i9PcWdy6zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1Kktw%253D%253D&md5=dec3943ae92b083656d1d9fa1dc9f58b</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1038%2Fnn.3025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3025%26sid%3Dliteratum%253Aachs%26aulast%3DRetchless%26aufirst%3DB.%2BS.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DJohnson%26aufirst%3DJ.%2BW.%26atitle%3DA%2520single%2520GluN2%2520subunit%2520residue%2520controls%2520NMDA%2520receptor%2520channel%2520properties%2520via%2520intersubunit%2520interaction%26jtitle%3DNat.%2520Neurosci.%26date%3D2012%26volume%3D15%26spage%3D406%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Neyton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paoletti, P.</span><span> </span><span class="NLM_article-title">Relating NMDA receptor function to receptor subunit composition: limitations of the pharmacological approach</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1331</span><span class="NLM_x">–</span> <span class="NLM_lpage">1333</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1523%2FJNEUROSCI.5242-05.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=16452656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFaitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=1331-1333&author=J.+Neytonauthor=P.+Paoletti&title=Relating+NMDA+receptor+function+to+receptor+subunit+composition%3A+limitations+of+the+pharmacological+approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Relating NMDA receptor function to receptor subunit composition: Limitations of the pharmacological approach</span></div><div class="casAuthors">Neyton, Jacques; Paoletti, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1331-1333</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A review.  Data showing that NVP-AAM077 displays much less subunit selectivity than originally described is presented.  Then, in a more general perspective, several limitations of the available selective drugs against NMDA receptors are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIcnczNhYgM7Vg90H21EOLACvtfcHk0lgfRLXpDLzbyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFaitr0%253D&md5=a04021d6cd5767e5a0f9652850469d7f</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5242-05.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5242-05.2006%26sid%3Dliteratum%253Aachs%26aulast%3DNeyton%26aufirst%3DJ.%26aulast%3DPaoletti%26aufirst%3DP.%26atitle%3DRelating%2520NMDA%2520receptor%2520function%2520to%2520receptor%2520subunit%2520composition%253A%2520limitations%2520of%2520the%2520pharmacological%2520approach%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D1331%26epage%3D1333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Hatton, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paoletti, P.</span><span> </span><span class="NLM_article-title">Modulation of triheteromeric NMDA receptors by N-terminal domain ligands</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=261-274&author=C.+J.+Hattonauthor=P.+Paoletti&title=Modulation+of+triheteromeric+NMDA+receptors+by+N-terminal+domain+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHatton%26aufirst%3DC.%2BJ.%26aulast%3DPaoletti%26aufirst%3DP.%26atitle%3DModulation%2520of%2520triheteromeric%2520NMDA%2520receptors%2520by%2520N-terminal%2520domain%2520ligands%26jtitle%3DNeuron%26date%3D2005%26volume%3D46%26spage%3D261%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Xia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, S. A.</span><span> </span><span class="NLM_article-title">Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">11246</span><span class="NLM_x">–</span> <span class="NLM_lpage">11250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1523%2FJNEUROSCI.2488-10.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20720132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWms7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=11246-11250&author=P.+Xiaauthor=H.+V.+Chenauthor=D.+Zhangauthor=S.+A.+Lipton&title=Memantine+preferentially+blocks+extrasynaptic+over+synaptic+NMDA+receptor+currents+in+hippocampal+autapses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses</span></div><div class="casAuthors">Xia, Peng; Chen, Huei-sheng Vincent; Zhang, Dongxian; Lipton, Stuart A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">11246-11250</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Glutamate is the major excitatory neurotransmitter in the brain.  The NMDA subtype of glutamate receptors (NMDAR) is known to mediate many physiol. neural functions.  However, excessive activation of NMDARs contributes to neuronal damage in various acute and chronic neurol. disorders.  To avoid unwanted adverse side effects, blockade of excessive NMDAR activity must therefore be achieved without affecting its physiol. function.  Memantine, an adamantane deriv., was used for the treatment of Alzheimer's disease with an excellent clin. safety profile.  We previously showed that memantine preferentially blocked neurotoxicity mediated by excessive NMDAR activity while relatively sparing normal neurotransmission, in part because of its uncompetitive antagonism with a fast off-rate.  Here, using rat autaptic hippocampal microcultures, we show that memantine at therapeutic concns. (1-10 μM) preferentially blocks extrasynaptic rather than synaptic currents mediated by NMDARs in the same neuron.  We found that memantine blocks extrasynaptic NMDAR-mediated currents induced by bath application of 100 μM NMDA/10 μM glycine with a twofold higher potency than its blockade of the NMDAR component of evoked EPSCs (EPSCsNMDAR); this effect persists under conditions of pathol. depolarization in the presence of 1 mM extracellular Mg2+.  Thus,these findings provide the first unequivocal evidence to explain the tolerability of memantine based on differential extrasynaptic/synaptic receptor blockade.  At therapeutic concns., memantine effectively blocks excessive extrasynaptic NMDAR-mediated currents, while relatively sparing normal synaptic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoBl6KMNuQ_bVg90H21EOLACvtfcHk0lgfRLXpDLzbyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWms7rL&md5=5cc09de23ce4e996cfa637937911de1f</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2488-10.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2488-10.2010%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DH.%2BV.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DLipton%26aufirst%3DS.%2BA.%26atitle%3DMemantine%2520preferentially%2520blocks%2520extrasynaptic%2520over%2520synaptic%2520NMDA%2520receptor%2520currents%2520in%2520hippocampal%2520autapses%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D11246%26epage%3D11250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Okamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouladi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talantova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrnhoefer, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaidi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemente, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. K.</span><span> </span><span class="NLM_article-title">Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1407</span><span class="NLM_x">–</span> <span class="NLM_lpage">1413</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnm.2056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=19915593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWksbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=1407-1413&author=S.+Okamotoauthor=M.+A.+Pouladiauthor=M.+Talantovaauthor=D.+Yaoauthor=P.+Xiaauthor=D.+E.+Ehrnhoeferauthor=R.+Zaidiauthor=A.+Clementeauthor=M.+Kaulauthor=R.+K.+Graham&title=Balance+between+synaptic+versus+extrasynaptic+NMDA+receptor+activity+influences+inclusions+and+neurotoxicity+of+mutant+huntingtin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin</span></div><div class="casAuthors">Okamoto, Shu-Ichi; Pouladi, Mahmoud A.; Talantova, Maria; Yao, Dong-Dong; Xia, Peng; Ehrnhoefer, Dagmar E.; Zaidi, Rameez; Clemente, Arjay; Kaul, Marcus; Graham, Rona K.; Zhang, Dong-Xian; Chen, H.-S. Vincent; Tong, Gary; Hayden, Michael R.; Lipton, Stuart A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1407-1413</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Huntington's disease is caused by an expanded CAG repeat in the gene encoding huntingtin (HTT), resulting in loss of striatal and cortical neurons.  Given that the gene product is widely expressed, it remains unclear why neurons are selectively targeted.  Here we show the relationship between synaptic and extrasynaptic activity, inclusion formation of mutant huntingtin protein (mtHtt) and neuronal survival.  Synaptic N-methyl-D-aspartate-type glutamate receptor (NMDAR) activity induces mtHtt inclusions via a T complex-1 (TCP-1) ring complex (TRiC)-dependent mechanism, rendering neurons more resistant to mtHtt-mediated cell death.  In contrast, stimulation of extrasynaptic NMDARs increases the vulnerability of mtHtt-contg. neurons to cell death by impairing the neuroprotective cAMP response element-binding protein (CREB)-peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) cascade and increasing the level of the small guanine nucleotide-binding protein Rhes, which is known to sumoylate and disaggregate mtHtt.  Treatment of transgenic mice expressing a yeast artificial chromosome contg. 128 CAG repeats (YAC128) with low-dose memantine blocks extrasynaptic (but not synaptic) NMDARs and ameliorates neuropathol. and behavioral manifestations.  By contrast, high-dose memantine, which blocks both extrasynaptic and synaptic NMDAR activity, decreases neuronal inclusions and worsens these outcomes.  Our findings offer a rational therapeutic approach for protecting susceptible neurons in Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo918WjH9XorLVg90H21EOLACvtfcHk0lgfRLXpDLzbyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWksbrM&md5=58746cbedeb2e252c51ef74c368cf3e9</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1038%2Fnm.2056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2056%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DS.%26aulast%3DPouladi%26aufirst%3DM.%2BA.%26aulast%3DTalantova%26aufirst%3DM.%26aulast%3DYao%26aufirst%3DD.%26aulast%3DXia%26aufirst%3DP.%26aulast%3DEhrnhoefer%26aufirst%3DD.%2BE.%26aulast%3DZaidi%26aufirst%3DR.%26aulast%3DClemente%26aufirst%3DA.%26aulast%3DKaul%26aufirst%3DM.%26aulast%3DGraham%26aufirst%3DR.%2BK.%26atitle%3DBalance%2520between%2520synaptic%2520versus%2520extrasynaptic%2520NMDA%2520receptor%2520activity%2520influences%2520inclusions%2520and%2520neurotoxicity%2520of%2520mutant%2520huntingtin%26jtitle%3DNat.%2520Med.%26date%3D2009%26volume%3D15%26spage%3D1407%26epage%3D1413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Hardingham, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bading, H.</span><span> </span><span class="NLM_article-title">Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">682</span><span class="NLM_x">–</span> <span class="NLM_lpage">696</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnrn2911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20842175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGntL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=682-696&author=G.+E.+Hardinghamauthor=H.+Bading&title=Synaptic+versus+extrasynaptic+NMDA+receptor+signalling%3A+implications+for+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders</span></div><div class="casAuthors">Hardingham, Giles E.; Bading, Hilmar</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">682-696</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is a long-standing paradox that NMDA (N-methyl-D-aspartate) receptors (NMDARs) can both promote neuronal health and kill neurons.  Recent studies show that NMDAR-induced responses depend on the receptor location: stimulation of synaptic NMDARs, acting primarily through nuclear Ca2+ signalling, leads to the build-up of a neuroprotective 'shield', whereas stimulation of extrasynaptic NMDARs promotes cell death.  These differences result from the activation of distinct genomic programs and from opposing actions on intracellular signalling pathways.  Perturbations in the balance between synaptic and extrasynaptic NMDAR activity contribute to neuronal dysfunction in acute ischemia and Huntington's disease, and could be a common theme in the etiol. of neurodegenerative diseases.  Neuroprotective therapies should aim to both enhance the effect of synaptic activity and disrupt extrasynaptic NMDAR-dependent death signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9AZO8mCvsT7Vg90H21EOLACvtfcHk0lhglpov6ssYFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGntL7P&md5=7884f06024ff58f8a72d94768d4e379f</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1038%2Fnrn2911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2911%26sid%3Dliteratum%253Aachs%26aulast%3DHardingham%26aufirst%3DG.%2BE.%26aulast%3DBading%26aufirst%3DH.%26atitle%3DSynaptic%2520versus%2520extrasynaptic%2520NMDA%2520receptor%2520signalling%253A%2520implications%2520for%2520neurodegenerative%2520disorders%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2010%26volume%3D11%26spage%3D682%26epage%3D696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Levine, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cepeda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">André, V. M.</span><span> </span><span class="NLM_article-title">Location, location, location: contrasting roles of synaptic and extrasynaptic NMDA receptors in Huntington’s disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2010&pages=145-147&author=M.+S.+Levineauthor=C.+Cepedaauthor=V.+M.+Andr%C3%A9&title=Location%2C+location%2C+location%3A+contrasting+roles+of+synaptic+and+extrasynaptic+NMDA+receptors+in+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DM.%2BS.%26aulast%3DCepeda%26aufirst%3DC.%26aulast%3DAndr%25C3%25A9%26aufirst%3DV.%2BM.%26atitle%3DLocation%252C%2520location%252C%2520location%253A%2520contrasting%2520roles%2520of%2520synaptic%2520and%2520extrasynaptic%2520NMDA%2520receptors%2520in%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D2010%26volume%3D65%26spage%3D145%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Surmeier, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Padilla, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, J. A.</span><span> </span><span class="NLM_article-title">The origins of oxidant stress in Parkinson’s disease and therapeutic strategies</span> <span class="citation_source-journal">Antioxid. Redox Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1289</span><span class="NLM_x">–</span> <span class="NLM_lpage">1301</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1089%2Fars.2010.3521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20712409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVGjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=1289-1301&author=D.+J.+Surmeierauthor=J.+N.+Guzmanauthor=J.+Sanchez-Padillaauthor=J.+A.+Goldberg&title=The+origins+of+oxidant+stress+in+Parkinson%E2%80%99s+disease+and+therapeutic+strategies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">The Origins of Oxidant Stress in Parkinson's Disease and Therapeutic Strategies</span></div><div class="casAuthors">Surmeier, Dalton James; Guzman, Jaime N.; Sanchez-Padilla, Javier; Goldberg, Joshua A.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1289-1301</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is a major world-wide health problem afflicting millions of the aged population.  Factors that act on most or all cell types (pan-cellular factors), particularly genetic mutations and environmental toxins, have dominated public discussions of disease etiol.  Although there is compelling evidence supporting an assocn. between disease risk and these factors, the pattern of neuronal pathol. and cell loss is difficult to explain without cell-specific factors.  This article focuses on recent studies showing that the neurons at greatest risk in PD-substantia nigra pars compacta dopamine neurons-have a distinctive physiol. phenotype that could contribute to their vulnerability.  The opening of L-type calcium channels during autonomous pacemaking results in sustained calcium entry into the cytoplasm of substantia nigra pars compacta dopamine neurons, resulting in elevated mitochondrial oxidant stress and susceptibility to toxins used to create animal models of PD. This cell-specific stress could increase the neg. consequences of pan-cellular factors that broadly challenge either mitochondrial or proteostatic competence. The availability of well-tolerated, orally deliverable antagonists for L-type calcium channels points to a novel neuroprotective strategy that could complement current attempts to boost mitochondrial function in the early stages of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot21d7HjTbW7Vg90H21EOLACvtfcHk0lhglpov6ssYFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVGjtrY%253D&md5=7d17c52dd9f5e13e548a314403091599</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1089%2Fars.2010.3521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2010.3521%26sid%3Dliteratum%253Aachs%26aulast%3DSurmeier%26aufirst%3DD.%2BJ.%26aulast%3DGuzman%26aufirst%3DJ.%2BN.%26aulast%3DSanchez-Padilla%26aufirst%3DJ.%26aulast%3DGoldberg%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520origins%2520of%2520oxidant%2520stress%2520in%2520Parkinson%25E2%2580%2599s%2520disease%2520and%2520therapeutic%2520strategies%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2011%26volume%3D14%26spage%3D1289%26epage%3D1301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Youdim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J.</span><span> </span><span class="NLM_article-title">CNS targets for multi-functional drugs in the treatment of Alzheimer’s and Parkinson’s diseases</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2005&pages=519-537&author=M.+Youdimauthor=J.+Buccafusco&title=CNS+targets+for+multi-functional+drugs+in+the+treatment+of+Alzheimer%E2%80%99s+and+Parkinson%E2%80%99s+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%26aulast%3DBuccafusco%26aufirst%3DJ.%26atitle%3DCNS%2520targets%2520for%2520multi-functional%2520drugs%2520in%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520and%2520Parkinson%25E2%2580%2599s%2520diseases%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2005%26volume%3D112%26spage%3D519%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geldenhuys, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Schyf, C. J.</span><span> </span><span class="NLM_article-title">Why should we use multifunctional neuroprotective and neurorestorative drugs for Parkinson’s disease?</span> <span class="citation_source-journal">Parkinsonism Relat. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">S281</span><span class="NLM_x">–</span> <span class="NLM_lpage">S291</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=S281-S291&author=M.+B.+H.+Youdimauthor=W.+J.+Geldenhuysauthor=C.+J.+Van+der+Schyf&title=Why+should+we+use+multifunctional+neuroprotective+and+neurorestorative+drugs+for+Parkinson%E2%80%99s+disease%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DGeldenhuys%26aufirst%3DW.%2BJ.%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26atitle%3DWhy%2520should%2520we%2520use%2520multifunctional%2520neuroprotective%2520and%2520neurorestorative%2520drugs%2520for%2520Parkinson%25E2%2580%2599s%2520disease%253F%26jtitle%3DParkinsonism%2520Relat.%2520Disord.%26date%3D2007%26volume%3D13%26spage%3DS281%26epage%3DS291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Geldenhuys, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Schyf, C. J.</span><span> </span><span class="NLM_article-title">The emergence of designed multiple ligands for neurodegenerative disorders</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.pneurobio.2011.04.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=21536094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=347-359&author=W.+J.+Geldenhuysauthor=M.+B.+H.+Youdimauthor=R.+T.+Carrollauthor=C.+J.+Van+der+Schyf&title=The+emergence+of+designed+multiple+ligands+for+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">The emergence of designed multiple ligands for neurodegenerative disorders</span></div><div class="casAuthors">Geldenhuys, Werner J.; Youdim, Moussa B. H.; Carroll, Richard T.; Van der Schyf, Cornelis J.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">347-359</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The incidence of neurodegenerative diseases has seen a const. increase in the global population, and is likely to be the result of extended life expectancy brought about by better health care.  Despite this increase in the incidence of neurodegenerative diseases, there has been a dearth in the introduction of new disease-modifying therapies that are approved to prevent or delay the onset of these diseases, or reverse the degenerative processes in brain.  Mounting evidence in the peer-reviewed literature shows that the etiopathol. of these diseases is extremely complex and heterogeneous, resulting in significant comorbidity and therefore unlikely to be mitigated by any drug acting on a single pathway or target.  A recent trend in drug design and discovery is the rational design or serendipitous discovery of novel drug entities with the ability to address multiple drug targets that form part of the complex pathophysiol. of a particular disease state.  In this review we discuss the rationale for developing such multifunctional drugs (also called designed multiple ligands or DMLs), and why these drug candidates seem to offer better outcomes in many cases compared to single-targeted drugs in pre-clin. studies for neurodegenerative diseases such as Alzheimer's and Parkinson's disease.  Examples are drawn from the literature of drug candidates that have already reached the market, some unsuccessful attempts, and others that are still in the drug development pipeline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvmaYriBnlW7Vg90H21EOLACvtfcHk0lhglpov6ssYFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL7E&md5=9a59fe2d3dd4c10cb14ab973090b7975</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2011.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2011.04.010%26sid%3Dliteratum%253Aachs%26aulast%3DGeldenhuys%26aufirst%3DW.%2BJ.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DCarroll%26aufirst%3DR.%2BT.%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520emergence%2520of%2520designed%2520multiple%2520ligands%2520for%2520neurodegenerative%2520disorders%26jtitle%3DProg.%2520Neurobiol.%26date%3D2011%26spage%3D347%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezprozvanny, I.</span><span> </span><span class="NLM_article-title">Evaluation of Dimebon in cellular model of Huntington’s disease</span> <span class="citation_source-journal">Mol. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1186%2F1750-1326-3-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=18939977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD1cjhtlagtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=15&author=J.+Wuauthor=Q.+Liauthor=I.+Bezprozvanny&title=Evaluation+of+Dimebon+in+cellular+model+of+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Dimebon in cellular model of Huntington's disease</span></div><div class="casAuthors">Wu Jun; Li Qin; Bezprozvanny Ilya</div><div class="citationInfo"><span class="NLM_cas:title">Molecular neurodegeneration</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Dimebon is an antihistamine compound with a long history of clinical use in Russia.  Recently, Dimebon has been proposed to be useful for treating neurodegenerative disorders.  It has demonstrated efficacy in phase II Alzheimer's disease (AD) and Huntington's disease (HD) clinical trials.  The mechanisms responsible for the beneficial actions of Dimebon in AD and HD remain unclear.  It has been suggested that Dimebon may act by blocking NMDA receptors or voltage-gated Ca2+ channels and by preventing mitochondrial permeability pore transition.  RESULTS:  We evaluated the effects of Dimebon in experiments with primary striatal neuronal cultures (MSN) from wild type (WT) mice and YAC128 HD transgenic mice.  We found that Dimebon acts as an inhibitor of NMDA receptors (IC50 = 10 muM) and voltage-gated calcium channels (IC50 = 50 muM) in WT and YAC128 MSN.  We further found that application of 50 muM Dimebon stabilized glutamate-induced Ca2+ signals in YAC128 MSN and protected cultured YAC128 MSN from glutamate-induced apoptosis.  Lower concentrations of Dimebon (5 muM and 10 muM) did not stabilize glutamate-induced Ca2+ signals and did not exert neuroprotective effects in experiments with YAC128 MSN.  Evaluation of Dimebon against a set of biochemical targets indicated that Dimebon inhibits alpha-Adrenergic receptors (alpha1A, alpha1B, alpha1D, and alpha2A), Histamine H1 and H2 receptors and Serotonin 5-HT2c, 5-HT5A, 5-HT6 receptors with high affinity.  Dimebon also had significant effect on a number of additional receptors.  CONCLUSION:  Our results suggest that Ca2+ and mitochondria stabilizing effects may, in part, be responsible for beneficial clinical effects of Dimebon.  However, the high concentrations of Dimebon required to achieve Ca2+ stabilizing and neuroprotective effects in our in vitro studies (50 muM) indicate that properties of Dimebon as cognitive enhancer are most likely due to potent inhibition of H1 histamine receptors.  It is also possible that Dimebon acts on novel high affinity targets not present in cultured MSN preparation.  Unbiased evaluation of Dimebon against a set of biochemical targets indicated that Dimebon efficiently inhibited a number of additional receptors.  Potential interactions with these receptors need to be considered in interpretation of results obtained with Dimebon in clinical trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTDH3auL-ya7WGmni0r9GoKfW6udTcc2eZ3ADCc1yGmabntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjhtlagtg%253D%253D&md5=82d7be080f7d6aaedae4a36c3f64ecff</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-3-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-3-15%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DBezprozvanny%26aufirst%3DI.%26atitle%3DEvaluation%2520of%2520Dimebon%2520in%2520cellular%2520model%2520of%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DMol.%2520Neurodegener.%26date%3D2008%26volume%3D3%26spage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Jones, R. W.</span><span> </span><span class="NLM_article-title">Dimebon disappointment</span> <span class="citation_source-journal">Alzheimer’s Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1186%2Falzrt49" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20836898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BC3cbnsVKksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=25&author=R.+W.+Jones&title=Dimebon+disappointment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Dimebon disappointment</span></div><div class="casAuthors">Jones Roy W</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's research & therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">25</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dimebon (latrepirdine) has received widespread publicity as a potential therapy for Alzheimer's disease following a very positive phase 2 study carried out in Russia and published in the Lancet in 2008.  In this study there were improvements over 6 months in all endpoints (cognitive, global, daily function and behaviour), with continuing improvement at 12 months in cognition and daily function.  A more recent multinational phase 3 study, however, showed no improvements whatsoever and no difference between the two drug-treated groups and the placebo group.  Of note, there was little deterioration in any of the groups after 6 months in contrast to the placebo group in the phase 2 study.  The potential reasons for these disappointing results are discussed, as well as the implication for dimebon and drug treatment in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQF38Y8DmqCPX6oPH0mYWL1fW6udTcc2eZ3ADCc1yGmabntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbnsVKksw%253D%253D&md5=d6b4e50451bbdb83da41e90e4d030a21</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1186%2Falzrt49&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt49%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BW.%26atitle%3DDimebon%2520disappointment%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Res.%2520Ther.%26date%3D2010%26volume%3D2%26spage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Lermontova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redkozubov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shevtsova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serkova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kireeva, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachurin, S.</span><span> </span><span class="NLM_article-title">Dimebon and tacrine inhibit neurotoxic action of β-amyloid in culture and block L-type Ca<sup>2+</sup> channels</span> <span class="citation_source-journal">Bull. Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">1079</span><span class="NLM_x">–</span> <span class="NLM_lpage">1083</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1023%2FA%3A1017972709652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11865327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtFOhtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2001&pages=1079-1083&author=N.+Lermontovaauthor=A.+Redkozubovauthor=E.+Shevtsovaauthor=T.+Serkovaauthor=E.+Kireevaauthor=S.+Bachurin&title=Dimebon+and+tacrine+inhibit+neurotoxic+action+of+%CE%B2-amyloid+in+culture+and+block+L-type+Ca2%2B+channels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Dimebon and tacrine inhibit neurotoxic action of β-amyloid in culture and block L-type Ca2+ channels</span></div><div class="casAuthors">Lermontova, N. N.; Redkozubov, A. E.; Shevtsova, E. F.; Serkova, T. P.; Kireeva, E. G.; Bachurin, S. O.</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of Experimental Biology and Medicine (Translation of Byulleten Eksperimental'noi Biologii i Meditsiny)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1079-1083</span>CODEN:
                <span class="NLM_cas:coden">BEXBAN</span>;
        ISSN:<span class="NLM_cas:issn">0007-4888</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Consultants Bureau</span>)
        </div><div class="casAbstract">Dimebon, a Russian-made drug, inhibited toxic effects of β-amyloid on cultured neurons.  Excessive accumulation of β-amyloid in the brain is characteristic of Alzheimer dementias.  Anti-Alzheimer prepns. tacrine and dimebon improve survival of cerebellar granule cells during long-term incubation with Aβ25-35, the neurotoxic fragment of β-amyloid.  Both prepns. can block potential-dependent Ca2+ entry into neurons by about 20%, which is explained by their selective action on L-type Ca2+ channels.  It was assumed that the neuroprotective effect of dimebon and tacrine against Aβ25-35 partially depends on inhibition of potential-dependent Ca2+ entry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGST_I29hTtbVg90H21EOLACvtfcHk0lgKsF1bCxPL6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtFOhtbk%253D&md5=da716770f509333da85cab7e45988edf</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1023%2FA%3A1017972709652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1017972709652%26sid%3Dliteratum%253Aachs%26aulast%3DLermontova%26aufirst%3DN.%26aulast%3DRedkozubov%26aufirst%3DA.%26aulast%3DShevtsova%26aufirst%3DE.%26aulast%3DSerkova%26aufirst%3DT.%26aulast%3DKireeva%26aufirst%3DE.%26aulast%3DBachurin%26aufirst%3DS.%26atitle%3DDimebon%2520and%2520tacrine%2520inhibit%2520neurotoxic%2520action%2520of%2520%25CE%25B2-amyloid%2520in%2520culture%2520and%2520block%2520L-type%2520Ca2%252B%2520channels%26jtitle%3DBull.%2520Exp.%2520Biol.%2520Med.%26date%3D2001%26volume%3D132%26spage%3D1079%26epage%3D1083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Grigor’ev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dranyi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachurin, S.</span><span> </span><span class="NLM_article-title">Comparative study of action mechanisms of dimebon and memantine on AMPA-and NMDA-subtypes glutamate receptors in rat cerebral neurons</span> <span class="citation_source-journal">Bull. Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">474</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1023%2FB%3ABEBM.0000017097.75818.14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=14968164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFSjt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2003&pages=474-477&author=V.+Grigor%E2%80%99evauthor=O.+Dranyiauthor=S.+Bachurin&title=Comparative+study+of+action+mechanisms+of+dimebon+and+memantine+on+AMPA-and+NMDA-subtypes+glutamate+receptors+in+rat+cerebral+neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative Study of Action Mechanisms of Dimebon and Memantine on AMPA- and NMDA-Subtypes Glutamate Receptors in Rat Cerebral Neurons</span></div><div class="casAuthors">Grigor'ev, V. V.; Dranyi, O. A.; Bachurin, S. O.</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of Experimental Biology and Medicine (Translation of Byulleten Eksperimental'noi Biologii i Meditsiny)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">474-477</span>CODEN:
                <span class="NLM_cas:coden">BEXBAN</span>;
        ISSN:<span class="NLM_cas:issn">0007-4888</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Consultants Bureau</span>)
        </div><div class="casAbstract">Dimebon in low concns. potentiated activity of AMPA-receptors in rat cerebellar Purkinje neurons, while memantine produced only an insignificant potentiation in a small group of these cells.  In cortical neurons of rat brain memantine efficiently blocked NMDA-induced currents in dimebon-insensitive neurons.  By contrast, its effect was far weaker in neurons, where the blocking action of dimebon on NMDA-receptors was most pronounced.  It was hypothesized that the differences in the effects of memantine and dimebon are detd. by their interaction with different sites of NMDA-receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIv2F-BnImHbVg90H21EOLACvtfcHk0liLaTo2UH29pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFSjt78%253D&md5=6b5f2bc89c8b38b5b973db1fe866e292</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1023%2FB%3ABEBM.0000017097.75818.14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FB%253ABEBM.0000017097.75818.14%26sid%3Dliteratum%253Aachs%26aulast%3DGrigor%25E2%2580%2599ev%26aufirst%3DV.%26aulast%3DDranyi%26aufirst%3DO.%26aulast%3DBachurin%26aufirst%3DS.%26atitle%3DComparative%2520study%2520of%2520action%2520mechanisms%2520of%2520dimebon%2520and%2520memantine%2520on%2520AMPA-and%2520NMDA-subtypes%2520glutamate%2520receptors%2520in%2520rat%2520cerebral%2520neurons%26jtitle%3DBull.%2520Exp.%2520Biol.%2520Med.%26date%3D2003%26volume%3D136%26spage%3D474%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Blandini, F.</span><span> </span><span class="NLM_article-title">An update on the potential role of excitotoxicity in the pathogenesis of Parkinson’s disease</span> <span class="citation_source-journal">Funct. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0213-4853%2810%2970027-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20923603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BC3cfnsV2ntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2010&pages=65-71&author=F.+Blandini&title=An+update+on+the+potential+role+of+excitotoxicity+in+the+pathogenesis+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">An update on the potential role of excitotoxicity in the pathogenesis of Parkinson's disease</span></div><div class="casAuthors">Blandini Fabio</div><div class="citationInfo"><span class="NLM_cas:title">Functional neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">65-71</span>
        ISSN:<span class="NLM_cas:issn">0393-5264</span>.
    </div><div class="casAbstract">The primary cause of the neurodegenerative process that underlies Parkinson's disease (PD) is still unknown.  Different mechanisms probably contribute to triggering neuronal death in the nigrostriatal pathway, including mitochondrial defects, oxidative stress and proteolytic stress.  Glutamate-mediated excitotoxicity may be a further contributor.  Glutamate is the predominant fast excitatory neurotransmitter in the central nervous system and, in the presence of specific conditions, a potential neurotoxin.  Although excitotoxicity per se is unlikely to act as a major causative agent in PD pathogenesis, glutamate-mediated intracellular changes may contribute, in a more subtle way, to the mechanisms that trigger the neurodegenerative process in the substantia nigra pars compacta (SNc).  It is, therefore, likely that synergistic interactions between mitochondrial defects, oxidative stress and glutamatergic stimulation take place at the SNc level.  These interactions may create the conditions for the development of the nigrostriatal damage that characterizes PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXyPa3iKu727mQt-ICR3qNfW6udTcc2ebJSHY8Ni0DS7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfnsV2ntw%253D%253D&md5=dfda83f139e1e458e8386cd7fdea7311</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2FS0213-4853%2810%2970027-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0213-4853%252810%252970027-X%26sid%3Dliteratum%253Aachs%26aulast%3DBlandini%26aufirst%3DF.%26atitle%3DAn%2520update%2520on%2520the%2520potential%2520role%2520of%2520excitotoxicity%2520in%2520the%2520pathogenesis%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DFunct.%2520Neurol.%26date%3D2010%26volume%3D25%26spage%3D65%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Waldmeier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bozyczko-Coyne, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaught, J. L.</span><span> </span><span class="NLM_article-title">Recent clinical failures in Parkinson’s disease with apoptosis inhibitors underline the need for a paradigm shift in drug discovery for neurodegenerative diseases</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">1197</span><span class="NLM_x">–</span> <span class="NLM_lpage">1206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2006&pages=1197-1206&author=P.+Waldmeierauthor=D.+Bozyczko-Coyneauthor=M.+Williamsauthor=J.+L.+Vaught&title=Recent+clinical+failures+in+Parkinson%E2%80%99s+disease+with+apoptosis+inhibitors+underline+the+need+for+a+paradigm+shift+in+drug+discovery+for+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWaldmeier%26aufirst%3DP.%26aulast%3DBozyczko-Coyne%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DVaught%26aufirst%3DJ.%2BL.%26atitle%3DRecent%2520clinical%2520failures%2520in%2520Parkinson%25E2%2580%2599s%2520disease%2520with%2520apoptosis%2520inhibitors%2520underline%2520the%2520need%2520for%2520a%2520paradigm%2520shift%2520in%2520drug%2520discovery%2520for%2520neurodegenerative%2520diseases%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2006%26volume%3D72%26spage%3D1197%26epage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Kim, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, Y. H.</span><span> </span><span class="NLM_article-title">Minocycline and neurodegenerative diseases</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">196</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2009&pages=168-179&author=H.+S.+Kimauthor=Y.+H.+Suh&title=Minocycline+and+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DSuh%26aufirst%3DY.%2BH.%26atitle%3DMinocycline%2520and%2520neurodegenerative%2520diseases%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2009%26volume%3D196%26spage%3D168%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">X Sureda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junyent, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdaguer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auladell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelegri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilaplana, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maria Canudas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beas Zarate, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallas, M.</span><span> </span><span class="NLM_article-title">Antiapoptotic drugs: a therapeutic strategy for the prevention of neurodegenerative diseases</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.2174%2F138161211795049732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=21348832" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=230-245&author=F.+X+Suredaauthor=F.+Junyentauthor=E.+Verdaguerauthor=C.+Auladellauthor=C.+Pelegriauthor=J.+Vilaplanaauthor=J.+Folchauthor=A.+Maria+Canudasauthor=C.+Beas+Zarateauthor=M.+Pallas&title=Antiapoptotic+drugs%3A+a+therapeutic+strategy+for+the+prevention+of+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.2174%2F138161211795049732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161211795049732%26sid%3Dliteratum%253Aachs%26aulast%3DX%2BSureda%26aufirst%3DF.%26aulast%3DJunyent%26aufirst%3DF.%26aulast%3DVerdaguer%26aufirst%3DE.%26aulast%3DAuladell%26aufirst%3DC.%26aulast%3DPelegri%26aufirst%3DC.%26aulast%3DVilaplana%26aufirst%3DJ.%26aulast%3DFolch%26aufirst%3DJ.%26aulast%3DMaria%2BCanudas%26aufirst%3DA.%26aulast%3DBeas%2BZarate%26aufirst%3DC.%26aulast%3DPallas%26aufirst%3DM.%26atitle%3DAntiapoptotic%2520drugs%253A%2520a%2520therapeutic%2520strategy%2520for%2520the%2520prevention%2520of%2520neurodegenerative%2520diseases%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2011%26volume%3D17%26spage%3D230%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Malgouris, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doble, A.</span><span> </span><span class="NLM_article-title">Neuroprotective effects of riluzole on <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate- or veratridine-induced neurotoxicity in rat hippocampal slices</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">177</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=1994&pages=95-99&author=C.+Malgourisauthor=M.+Danielauthor=A.+Doble&title=Neuroprotective+effects+of+riluzole+on+N-methyl-d-aspartate-+or+veratridine-induced+neurotoxicity+in+rat+hippocampal+slices"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalgouris%26aufirst%3DC.%26aulast%3DDaniel%26aufirst%3DM.%26aulast%3DDoble%26aufirst%3DA.%26atitle%3DNeuroprotective%2520effects%2520of%2520riluzole%2520on%2520N-methyl-d-aspartate-%2520or%2520veratridine-induced%2520neurotoxicity%2520in%2520rat%2520hippocampal%2520slices%26jtitle%3DNeurosci.%2520Lett.%26date%3D1994%26volume%3D177%26spage%3D95%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Doble, A.</span><span> </span><span class="NLM_article-title">The pharmacology and mechanism of action of riluzole</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">233S</span><span class="NLM_x">–</span> <span class="NLM_lpage">241S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1996&pages=233S-241S&author=A.+Doble&title=The+pharmacology+and+mechanism+of+action+of+riluzole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoble%26aufirst%3DA.%26atitle%3DThe%2520pharmacology%2520and%2520mechanism%2520of%2520action%2520of%2520riluzole%26jtitle%3DNeurology%26date%3D1996%26volume%3D47%26spage%3D233S%26epage%3D241S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Bryson, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benfield, P.</span><span> </span><span class="NLM_article-title">Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">549</span><span class="NLM_x">–</span> <span class="NLM_lpage">563</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1996&pages=549-563&author=H.+M.+Brysonauthor=B.+Fultonauthor=P.+Benfield&title=Riluzole.+A+review+of+its+pharmacodynamic+and+pharmacokinetic+properties+and+therapeutic+potential+in+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBryson%26aufirst%3DH.%2BM.%26aulast%3DFulton%26aufirst%3DB.%26aulast%3DBenfield%26aufirst%3DP.%26atitle%3DRiluzole.%2520A%2520review%2520of%2520its%2520pharmacodynamic%2520and%2520pharmacokinetic%2520properties%2520and%2520therapeutic%2520potential%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DDrugs%26date%3D1996%26volume%3D52%26spage%3D549%26epage%3D563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Jankovic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, C.</span><span> </span><span class="NLM_article-title">A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson’s disease</span> <span class="citation_source-journal">Parkinsonism Relat. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS1353-8020%2801%2900040-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12039422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD383pvFeltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=271-276&author=J.+Jankovicauthor=C.+Hunter&title=A+double-blind%2C+placebo-controlled+and+longitudinal+study+of+riluzole+in+early+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson's disease</span></div><div class="casAuthors">Jankovic J; Hunter C</div><div class="citationInfo"><span class="NLM_cas:title">Parkinsonism & related disorders</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">271-6</span>
        ISSN:<span class="NLM_cas:issn">1353-8020</span>.
    </div><div class="casAbstract">BACKGROUND:  To the extent that excitotoxicity may play a role in the pathogenesis of certain neurodegenerative disorders, antagonists of glutamate, an excitatory neurotransmitter, should exert neuroprotective effects in these disorders, including Parkinson's disease (PD).  METHODS:  Patients in early stages of PD, not previously treated with levodopa, were randomized to receive riluzole 50mg capsules orally, taken twice daily or a matching placebo.  All subjects were evaluated at baseline (pre-treatment), at 1, 3 and 6 months (post-treatment), and following a 6-week washout.  After the washout, all subjects were offered an enrollment in an open label, 1-year, extension study.  The principal investigator (JJ), however, remained blinded to the original assignment during the entire study.  The patients were assessed by the Unified Parkinson's Disease Rating Scale (UPDRS), Activities of Daily Living (ADL), Hoehn & Yahr (HY) stage, and Schwab and England (SE) ADL scale.  The quantitative assessments included Movement Time (MT) and Reaction Time (RT).  Additionally, the time to initiate dopaminergic therapy was assessed.  Safety was determined at each visit by clinical history and examination, a panel of blood safety laboratory tests including complete blood count, chemistry profile, and liver function studies.  RESULTS:  Twenty patients with a mean age of 62+/-9.02 (range: 46-73) years and mean duration of symptoms of 18+/-9.53 (range: 6-36) months were enrolled.  One patient withdrew from the study because he needed more aggressive treatment of his symptoms.  Analysis of the efficacy variables showed no meaningful symptomatic effect of riluzole on UPDRS score.  Likewise, there was no significant change in the median HY stage, SE ADL rating, or the MT/RT.  Seventeen patients (mean age 62+/-9.26) elected to continue in the open label extension study.  Although the observed deterioration in UPDRS scores seemed to be more pronounced in the placebo group than in the riluzole group, the difference did not reach statistical significance.  There was no statistically significant difference in the latency between enrollment and start of symptomatic therapy when patients initially treated with riluzole were compared to those initially treated with placebo (8.3 vs 9 months).  CONCLUSIONS:  This pilot and extension study showed that riluzole, 100mg/day, was well tolerated in patients with early PD.  No evidence of symptomatic effect of riluzole was observed.  Because of the exploratory nature of the design and small size of the study, it was not possible to determine whether riluzole affected the natural history of PD.  The encouraging results from our study, however, suggest that larger, longitudinal studies are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwgbyGZno1elMGsG_HTXYFfW6udTcc2ebIQ9O9GvVCgLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD383pvFeltA%253D%253D&md5=80f43b00c7d61590045e4dcaeb9843ca</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2FS1353-8020%2801%2900040-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1353-8020%252801%252900040-2%26sid%3Dliteratum%253Aachs%26aulast%3DJankovic%26aufirst%3DJ.%26aulast%3DHunter%26aufirst%3DC.%26atitle%3DA%2520double-blind%252C%2520placebo-controlled%2520and%2520longitudinal%2520study%2520of%2520riluzole%2520in%2520early%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DParkinsonism%2520Relat.%2520Disord.%26date%3D2002%26volume%3D8%26spage%3D271%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Landwehrmeyer, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Yébenes, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaus, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przuntek, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dib, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doble, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, W.</span><span> </span><span class="NLM_article-title">Riluzole in Huntington’s disease: a 3-year, randomized controlled study</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1002%2Fana.21181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=17702031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1CntrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2007&pages=262-272&author=G.+B.+Landwehrmeyerauthor=B.+Duboisauthor=J.+G.+de+Y%C3%A9benesauthor=B.+Kremerauthor=W.+Gausauthor=P.+H.+Krausauthor=H.+Przuntekauthor=M.+Dibauthor=A.+Dobleauthor=W.+Fischer&title=Riluzole+in+Huntington%E2%80%99s+disease%3A+a+3-year%2C+randomized+controlled+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Riluzole in Huntington's disease: a 3-year, randomized controlled study</span></div><div class="casAuthors">Landwehrmeyer, G. Bernhard; Dubois, Bruno; Garcia de Yebenes, Justo; Kremer, Berry; Gaus, Wilhelm; Kraus, Peter H.; Przuntek, Horst; Dib, Michel; Doble, Adam; Fischer, Wilhelm; Ludolph, Albert C.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">262-272</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Objective: We conducted a randomized double-blind trial of riluzole in Huntington's disease to investigate the efficacy of this antiexcitotoxic drug in slowing disease progression.  Methods: The study included 537 adult patients with a clin. diagnosis of Huntington's disease confirmed by genotyping.  Patients were randomized (2:1) to treatment with riluzole (50mg twice daily) or placebo for 3 years.  Concomitant use of antichoreic medication was forbidden, and introduction of such medication was a predefined end point.  The primary outcome measure was change in a combined score derived from the motor and total functional capacity subscores of the Unified Huntington's Disease Rating Scale.  Safety was also evaluated.  Results: A total of 379 patients completed the study (mean age, 47 [std. deviation, 9.5] years; 50% female patients).  The principal reason for discontinuation was introduction of antichoreic medication.  The median change from baseline in the combined score (primary outcome) for the "per protocol" population was 13.7 (95% confidence interval, 11.1-17.2) in the placebo group and 14.3 (95% confidence interval, 11.7-16.6) in the riluzole group.  No intergroup difference in outcome could thus be demonstrated (p = 0.93, Mann-Whitney U test).  No differences in secondary efficacy outcome variables were obsd. except for more frequent recourse to antichoreic medication in the placebo group.  No unexpected adverse events were reported, and tolerability was acceptable.  Interpretation: No neuroprotective or beneficial symptomatic effects of riluzole in Huntington's disease were demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE8dqPKeW6FLVg90H21EOLACvtfcHk0ljfCexlTj9SOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1CntrvO&md5=d1c4e80b7e583fb63b1b5f73501aeece</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1002%2Fana.21181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.21181%26sid%3Dliteratum%253Aachs%26aulast%3DLandwehrmeyer%26aufirst%3DG.%2BB.%26aulast%3DDubois%26aufirst%3DB.%26aulast%3Dde%2BY%25C3%25A9benes%26aufirst%3DJ.%2BG.%26aulast%3DKremer%26aufirst%3DB.%26aulast%3DGaus%26aufirst%3DW.%26aulast%3DKraus%26aufirst%3DP.%2BH.%26aulast%3DPrzuntek%26aufirst%3DH.%26aulast%3DDib%26aufirst%3DM.%26aulast%3DDoble%26aufirst%3DA.%26aulast%3DFischer%26aufirst%3DW.%26atitle%3DRiluzole%2520in%2520Huntington%25E2%2580%2599s%2520disease%253A%2520a%25203-year%252C%2520randomized%2520controlled%2520study%26jtitle%3DAnn.%2520Neurol.%26date%3D2007%26volume%3D62%26spage%3D262%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Lee, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Z. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emdad, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borjabad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volsky, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, P. B.</span><span> </span><span class="NLM_article-title">Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">13116</span><span class="NLM_x">–</span> <span class="NLM_lpage">13123</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=13116-13123&author=S.+G.+Leeauthor=Z.+Z.+Suauthor=L.+Emdadauthor=P.+Guptaauthor=D.+Sarkarauthor=A.+Borjabadauthor=D.+J.+Volskyauthor=P.+B.+Fisher&title=Mechanism+of+ceftriaxone+induction+of+excitatory+amino+acid+transporter-2+expression+and+glutamate+uptake+in+primary+human+astrocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BG.%26aulast%3DSu%26aufirst%3DZ.%2BZ.%26aulast%3DEmdad%26aufirst%3DL.%26aulast%3DGupta%26aufirst%3DP.%26aulast%3DSarkar%26aufirst%3DD.%26aulast%3DBorjabad%26aufirst%3DA.%26aulast%3DVolsky%26aufirst%3DD.%2BJ.%26aulast%3DFisher%26aufirst%3DP.%2BB.%26atitle%3DMechanism%2520of%2520ceftriaxone%2520induction%2520of%2520excitatory%2520amino%2520acid%2520transporter-2%2520expression%2520and%2520glutamate%2520uptake%2520in%2520primary%2520human%2520astrocytes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D13116%26epage%3D13123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Nicoletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casabona, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knöpfel, T.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders?</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1996&pages=267-271&author=F.+Nicolettiauthor=V.+Brunoauthor=A.+Copaniauthor=G.+Casabonaauthor=T.+Kn%C3%B6pfel&title=Metabotropic+glutamate+receptors%3A+a+new+target+for+the+therapy+of+neurodegenerative+disorders%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNicoletti%26aufirst%3DF.%26aulast%3DBruno%26aufirst%3DV.%26aulast%3DCopani%26aufirst%3DA.%26aulast%3DCasabona%26aufirst%3DG.%26aulast%3DKn%25C3%25B6pfel%26aufirst%3DT.%26atitle%3DMetabotropic%2520glutamate%2520receptors%253A%2520a%2520new%2520target%2520for%2520the%2520therapy%2520of%2520neurodegenerative%2520disorders%253F%26jtitle%3DTrends%2520Neurosci.%26date%3D1996%26volume%3D19%26spage%3D267%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Caraci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battaglia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sortino, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spampinato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, V.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptors in neurodegeneration/neuroprotection: Still a hot topic?</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">565</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.neuint.2012.01.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=22306345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvFGiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=559-565&author=F.+Caraciauthor=G.+Battagliaauthor=M.+A.+Sortinoauthor=S.+Spampinatoauthor=G.+Molinaroauthor=A.+Copaniauthor=F.+Nicolettiauthor=V.+Bruno&title=Metabotropic+glutamate+receptors+in+neurodegeneration%2Fneuroprotection%3A+Still+a+hot+topic%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Metabotropic glutamate receptors in neurodegeneration/neuroprotection: Still a hot topic?</span></div><div class="casAuthors">Caraci, Filippo; Battaglia, Giuseppe; Sortino, Maria Angela; Spampinato, Simona; Molinaro, Gemma; Copani, Agata; Nicoletti, Ferdinando; Bruno, Valeria</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">559-565</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Moving from early studies, we here review the most recent evidence linking metabotropic glutamate (mGlu) receptors to processes of neurodegeneration/neuroprotection.  The use of knockout mice and subtype-selective drugs has increased our knowledge of the precise role played by individual mGlu receptor subtypes in these processes.  Activation of mGlu1 and mGlu5 receptors may either amplify or reduce neuronal damage depending on the context and the nature of the toxic insults.  In contrast, mGlu1 and mGlu5 receptors antagonists are consistently protective in in vitro and in vivo models of neuronal death.  A series of studies suggest that mGlu1 receptor antagonists or neg. allosteric modulators (NAMs) are promising candidates for the treatment of ischemic brain damage, whereas mGlu5 receptor NAMs, which have been clin. developed for the treatment of Parkinson's disease (PD) and l-DOPA-induced dyskinesias, protect nigro-striatal dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity in mice and monkeys.  Activation of glial mGlu3 receptors promotes the formation of various neurotrophic factors, such as transforming growth factor-β (TGF-β), glial-derived neurotrophic factor (GDNF), nerve growth factor (NGF), and brain-derived neurotrophic factor (BDNF).  Hence, selective mGlu3 receptor agonists or pos. allosteric modulators (PAMs) (not yet available) are potentially helpful in the treatment of chronic neurodegenerative disorders such as PD, Alzheimer's disease (AD), and amyotrophic lateral sclerosis.  Selective mGlu2 receptor PAMs should be used with caution in AD patients because these drugs are shown to amplify β-amyloid neurotoxicity.  Finally, mGlu4 receptor agonists/PAMs share with mGlu5 receptor NAMs the ability to improve motor symptoms assocd. with PD and attenuate nigro-striatal degeneration at the same time.  No data are yet available on the role of mGlu7 and mGlu8 receptors in neurodegeneration/neuroprotection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfeMJzXS3HjrVg90H21EOLACvtfcHk0lj9R-a0uzDAVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvFGiurs%253D&md5=9ba8e6da902ee0e7063fbe4fe7a9d529</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2012.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2012.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DCaraci%26aufirst%3DF.%26aulast%3DBattaglia%26aufirst%3DG.%26aulast%3DSortino%26aufirst%3DM.%2BA.%26aulast%3DSpampinato%26aufirst%3DS.%26aulast%3DMolinaro%26aufirst%3DG.%26aulast%3DCopani%26aufirst%3DA.%26aulast%3DNicoletti%26aufirst%3DF.%26aulast%3DBruno%26aufirst%3DV.%26atitle%3DMetabotropic%2520glutamate%2520receptors%2520in%2520neurodegeneration%252Fneuroprotection%253A%2520Still%2520a%2520hot%2520topic%253F%26jtitle%3DNeurochem.%2520Int.%26date%3D2012%26volume%3D61%26spage%3D559%26epage%3D565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Gregory, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meiler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Allosteric modulation of metabotropic glutamate receptors: structural insights and therapeutic potential</span> <span class="citation_source-journal">Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.neuropharm.2010.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20637216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVaitLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=66-81&author=K.+J.+Gregoryauthor=E.+N.+Dongauthor=J.+Meilerauthor=P.+J.+Conn&title=Allosteric+modulation+of+metabotropic+glutamate+receptors%3A+structural+insights+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulation of metabotropic glutamate receptors: Structural insights and therapeutic potential</span></div><div class="casAuthors">Gregory, Karen J.; Dong, Elizabeth N.; Meiler, Jens; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-81</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Allosteric modulation of G protein-coupled receptors (GPCRs) represents a novel approach to the development of probes and therapeutics that is expected to enable subtype-specific regulation of central nervous system target receptors.  The metabotropic glutamate receptors (mGlus) are class C GPCRs that play important neuromodulatory roles throughout the brain, as such they are attractive targets for therapeutic intervention for a no. of psychiatric and neurol. disorders including anxiety, depression, Fragile X Syndrome, Parkinson's disease and schizophrenia.  Over the last fifteen years, selective allosteric modulators have been identified for many members of the mGlu family.  The vast majority of these allosteric modulators are thought to bind within the transmembrane-spanning domains of the receptors to enhance or inhibit functional responses.  A combination of mutagenesis-based studies and pharmacol. approaches are beginning to provide a better understanding of mGlu allosteric sites.  Collectively, when mapped onto a homol. model of the different mGlu subtypes based on the β2-adrenergic receptor, the previous mutagenesis studies suggest commonalities in the location of allosteric sites across different members of the mGlu family.  In addn., there is evidence for multiple allosteric binding pockets within the transmembrane region that can interact to modulate one another.  In the absence of a class C GPCR crystal structure, this approach has shown promise with respect to the interpretation of mutagenesis data and understanding structure-activity relationships of allosteric modulator pharmacophores.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMx_dBAbcb-7Vg90H21EOLACvtfcHk0lj9R-a0uzDAVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVaitLzE&md5=18c401c0442d322a116e6f3ff871c096</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2010.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2010.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DGregory%26aufirst%3DK.%2BJ.%26aulast%3DDong%26aufirst%3DE.%2BN.%26aulast%3DMeiler%26aufirst%3DJ.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DAllosteric%2520modulation%2520of%2520metabotropic%2520glutamate%2520receptors%253A%2520structural%2520insights%2520and%2520therapeutic%2520potential%26jtitle%3DNeuropharmacol.%26date%3D2011%26volume%3D60%26spage%3D66%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Striggow, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrlich, B. E.</span><span> </span><span class="NLM_article-title">Ligand-gated calcium channels inside and out</span> <span class="citation_source-journal">Curr. Opin. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">495</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0955-0674%2896%2980025-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=8791458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK28Xks1Gqtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1996&pages=490-495&author=F.+Striggowauthor=B.+E.+Ehrlich&title=Ligand-gated+calcium+channels+inside+and+out"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand-gated calcium channels inside and out</span></div><div class="casAuthors">Striggow, Frank; Ehrlich, Barbara E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">490-495</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">A review with 57 refs.  Calcium release from intracellular stores occurs through two types of channels assocd. with intracellular membranes, namely, the ryanodine receptor and the inositol 1,4,5-trisphosphate receptor.  Recently, it has been shown that these channels are regulated by allosteric mechanisms and assocd. proteins.  Release of intracellular calcium induces the opening of calcium-permeable channels on the plasma membrane.  Current work has focused on the mol. and functional characterization of these channels which have been identified as store-operated channels or calcium release activated channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJHAyoeCJshLVg90H21EOLACvtfcHk0lj9R-a0uzDAVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xks1Gqtbg%253D&md5=b7cae19ec73d798958ff79d73f65c7ad</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2FS0955-0674%2896%2980025-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0955-0674%252896%252980025-1%26sid%3Dliteratum%253Aachs%26aulast%3DStriggow%26aufirst%3DF.%26aulast%3DEhrlich%26aufirst%3DB.%2BE.%26atitle%3DLigand-gated%2520calcium%2520channels%2520inside%2520and%2520out%26jtitle%3DCurr.%2520Opin.%2520Cell.%2520Biol.%26date%3D1996%26volume%3D8%26spage%3D490%26epage%3D495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Zamponi, G. W.</span> <span class="citation_source-book">Voltage-Gated Calcium Channels</span>; <span class="NLM_publisher-name">Kluwer Academic</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=G.+W.+Zamponi&title=Voltage-Gated+Calcium+Channels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DZamponi%26aufirst%3DG.%2BW.%26btitle%3DVoltage-Gated%2520Calcium%2520Channels%26pub%3DKluwer%2520Academic%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Berridge, M. J.</span><span> </span><span class="NLM_article-title">Neuronal calcium signaling</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0896-6273%2800%2980510-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=9697848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1cXltFyiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1998&pages=13-26&author=M.+J.+Berridge&title=Neuronal+calcium+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal calcium signaling</span></div><div class="casAuthors">Berridge, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-26</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review, with ∼140 refs., on the idea that the endoplasmic reticulum and the plasma membrane form a binary membrane system that functions to regulate a variety of neuronal processes including excitability, associativity, neurotransmitter release, synaptic plasticity, and gene transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyPCiryD0p87Vg90H21EOLACvtfcHk0lj9R-a0uzDAVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltFyiu7s%253D&md5=281b01e305302373a2b92a86d709eedc</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2800%2980510-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252800%252980510-3%26sid%3Dliteratum%253Aachs%26aulast%3DBerridge%26aufirst%3DM.%2BJ.%26atitle%3DNeuronal%2520calcium%2520signaling%26jtitle%3DNeuron%26date%3D1998%26volume%3D21%26spage%3D13%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Catterall, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Striessnig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snutch, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Reyes, E.</span><span> </span><span class="NLM_article-title">International Union of Pharmacology. XL. Compendium of voltage-gated ion channels: calcium channels</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">581</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2003&pages=579-581&author=W.+A.+Catterallauthor=J.+Striessnigauthor=T.+P.+Snutchauthor=E.+Perez-Reyes&title=International+Union+of+Pharmacology.+XL.+Compendium+of+voltage-gated+ion+channels%3A+calcium+channels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCatterall%26aufirst%3DW.%2BA.%26aulast%3DStriessnig%26aufirst%3DJ.%26aulast%3DSnutch%26aufirst%3DT.%2BP.%26aulast%3DPerez-Reyes%26aufirst%3DE.%26atitle%3DInternational%2520Union%2520of%2520Pharmacology.%2520XL.%2520Compendium%2520of%2520voltage-gated%2520ion%2520channels%253A%2520calcium%2520channels%26jtitle%3DPharmacol.%2520Rev.%26date%3D2003%26volume%3D55%26spage%3D579%26epage%3D581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Eisenberg, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brox, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bestawros, A. N.</span><span> </span><span class="NLM_article-title">Calcium channel blockers: an update</span> <span class="citation_source-journal">Am. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.amjmed.2003.08.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=14706664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptVar" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2004&pages=35-43&author=M.+J.+Eisenbergauthor=A.+Broxauthor=A.+N.+Bestawros&title=Calcium+channel+blockers%3A+an+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium channel blockers: an update</span></div><div class="casAuthors">Eisenberg, Mark J.; Brox, Anya; Bestawros, Alain N.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-43</span>CODEN:
                <span class="NLM_cas:coden">AJMEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0002-9343</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  This paper reviews the current literature pertaining to calcium channel blockers, including their classification, properties, and therapeutic indications, in light of several recent trials that have addressed their safety.  Calcium channel blockers are a structurally and functionally heterogeneous group of medications that are used widely to control blood pressure and manage symptoms of angina.  They are classified as dihydropyridines or nondihydropyridines.  As a class, they are well tolerated and are assocd. with few side effects.  The question of whether they may ppt. cardiovascular events has been largely settled by recent trials, such as the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), the International Verapamil Slow-Release/Trandolapril Study (INVEST), and the Controlled Onset Verapamil Investigation of Cardiovascular Endpoints (CONVINCE) study, in which no such assocn. was found.  Even so, the use of these agents has been linked with an increased risk of heart failure.  Thus, long-acting calcium channel blockers may be safely used in the management of hypertension and angina.  However, as a class, they are not as protective as other antihypertensive agents against heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5AKwsyK8bMbVg90H21EOLACvtfcHk0lh7YwcUBMMLow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptVar&md5=32fe50b365109ee5efb0694e7d368d0f</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.amjmed.2003.08.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjmed.2003.08.027%26sid%3Dliteratum%253Aachs%26aulast%3DEisenberg%26aufirst%3DM.%2BJ.%26aulast%3DBrox%26aufirst%3DA.%26aulast%3DBestawros%26aufirst%3DA.%2BN.%26atitle%3DCalcium%2520channel%2520blockers%253A%2520an%2520update%26jtitle%3DAm.%2520J.%2520Med.%26date%3D2004%26volume%3D116%26spage%3D35%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Striessnig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koschak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinnegger-Brauns, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hetzenauer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busquet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelster, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singewald, N.</span><span> </span><span class="NLM_article-title">Role of voltage-gated L-type Ca<sup>2+</sup> channel isoforms for brain function</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">903</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1042%2FBST0340903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=17052224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWnsb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=903-909&author=J.+Striessnigauthor=A.+Koschakauthor=M.+J.+Sinnegger-Braunsauthor=A.+Hetzenauerauthor=N.+K.+Nguyenauthor=P.+Busquetauthor=G.+Pelsterauthor=N.+Singewald&title=Role+of+voltage-gated+L-type+Ca2%2B+channel+isoforms+for+brain+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Role of voltage-gated L-type Ca2+ channel isoforms for brain function</span></div><div class="casAuthors">Striessnig, J.; Koschak, A.; Sinnegger-brauns, M. J.; Hetzenauer, A.; Nguyen, N. K.; Busquet, P.; Pelster, G.; Singewald, N.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">903-909</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Voltage-gated L-type Ca2+ channels (LTCCs) are established drug targets for the treatment of cardiovascular diseases.  LTCCs are also expressed outside the cardiovascular system.  In the brain, LTCCs control synaptic plasticity in neurons, and dihydropyridine (DHP) LTCC blockers such as nifedipine modulate brain function (such as fear memory extinction and depression-like behavior).  Voltage-sensitive Ca2+ channels Cav1.2 and Cav1.3 are the predominant brain LTCCs.  As DHPs and other classes of org. LTCC blockers inhibit both isoforms, their pharmacol. distinction is impossible and their individual contributions to defined brain functions remain largely unknown.  Here, the authors summarize their recent expts. with 2 genetically modified mouse strains, which they generated to explore the individual biophys. features of Cav1.2 and Cav1.3 LTCCs and to det. their relative contributions to various physiol. peripheral and neuronal functions.  The results described here also allow predictions about the pharmacotherapeutic potential of isoform-selective LTCC modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLb1-8LxXKC7Vg90H21EOLACvtfcHk0lh7YwcUBMMLow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWnsb%252FM&md5=8ed33de666e79a9946a835ee2ecbcdda</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1042%2FBST0340903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0340903%26sid%3Dliteratum%253Aachs%26aulast%3DStriessnig%26aufirst%3DJ.%26aulast%3DKoschak%26aufirst%3DA.%26aulast%3DSinnegger-Brauns%26aufirst%3DM.%2BJ.%26aulast%3DHetzenauer%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DN.%2BK.%26aulast%3DBusquet%26aufirst%3DP.%26aulast%3DPelster%26aufirst%3DG.%26aulast%3DSingewald%26aufirst%3DN.%26atitle%3DRole%2520of%2520voltage-gated%2520L-type%2520Ca2%252B%2520channel%2520isoforms%2520for%2520brain%2520function%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2006%26volume%3D34%26spage%3D903%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Helton, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipscombe, D.</span><span> </span><span class="NLM_article-title">Neuronal L-type calcium channels open quickly and are inhibited slowly</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">10247</span><span class="NLM_x">–</span> <span class="NLM_lpage">10251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1523%2FJNEUROSCI.1089-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=16267232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Wqt7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=10247-10251&author=T.+D.+Heltonauthor=W.+Xuauthor=D.+Lipscombe&title=Neuronal+L-type+calcium+channels+open+quickly+and+are+inhibited+slowly"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal L-type calcium channels open quickly and are inhibited slowly</span></div><div class="casAuthors">Helton, Thomas D.; Xu, Weifeng; Lipscombe, Diane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">10247-10251</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Neuronal L-type calcium channels are essential for regulating activity-dependent gene expression, but they are thought to open too slowly to contribute to action potential-dependent calcium entry.  A complication of studying native L-type channels is that they represent a minor fraction of the whole-cell calcium current in most neurons.  Dihydropyridine antagonists are therefore widely used to establish the contribution of L-type channels to various neuronal processes and to study their underlying biophys. properties.  The effectiveness of these antagonists on L-type channels, however, varies with stimulus and channel subtype.  Here, we study recombinant neuronal L-type calcium channels, Cav1.2 and Cav1.3.  We show that these channels open with fast kinetics and carry substantial calcium entry in response to individual action potential waveforms, contrary to most studies of native L-type currents.  Neuronal Cav1.3 L-type channels were as efficient as Cav2.2 N-type channels at supporting calcium entry during action potential-like stimuli.  We conclude that the apparent slow activation of native L-type currents and their lack of contribution to single action potentials reflect the state-dependent nature of the dihydropyridine antagonists used to study them, not the underlying properties of L-type channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIqLsXeUuipLVg90H21EOLACvtfcHk0ljGOkKTJOoHPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Wqt7%252FN&md5=30ece670e34eba79670085f3b81c9e67</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1089-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1089-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DHelton%26aufirst%3DT.%2BD.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DLipscombe%26aufirst%3DD.%26atitle%3DNeuronal%2520L-type%2520calcium%2520channels%2520open%2520quickly%2520and%2520are%2520inhibited%2520slowly%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D10247%26epage%3D10251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Epstein, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, B. F.</span><span> </span><span class="NLM_article-title">Dihydropyridine calcium channel antagonists in the management of hypertension</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1309</span><span class="NLM_x">–</span> <span class="NLM_lpage">1327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=1309-1327&author=B.+J.+Epsteinauthor=K.+Vogelauthor=B.+F.+Palmer&title=Dihydropyridine+calcium+channel+antagonists+in+the+management+of+hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEpstein%26aufirst%3DB.%2BJ.%26aulast%3DVogel%26aufirst%3DK.%26aulast%3DPalmer%26aufirst%3DB.%2BF.%26atitle%3DDihydropyridine%2520calcium%2520channel%2520antagonists%2520in%2520the%2520management%2520of%2520hypertension%26jtitle%3DDrugs%26date%3D2007%26volume%3D67%26spage%3D1309%26epage%3D1327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Chan, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilijic, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rick, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tkatch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surmeier, D. J.</span><span> </span><span class="NLM_article-title">“Rejuvenation” protects neurons in mouse models of Parkinson’s disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">447</span><span class="NLM_x">, </span> <span class="NLM_fpage">1081</span><span class="NLM_x">–</span> <span class="NLM_lpage">1086</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2007&pages=1081-1086&author=C.+S.+Chanauthor=J.+N.+Guzmanauthor=E.+Ilijicauthor=J.+N.+Mercerauthor=C.+Rickauthor=T.+Tkatchauthor=G.+E.+Meredithauthor=D.+J.+Surmeier&title=%E2%80%9CRejuvenation%E2%80%9D+protects+neurons+in+mouse+models+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DC.%2BS.%26aulast%3DGuzman%26aufirst%3DJ.%2BN.%26aulast%3DIlijic%26aufirst%3DE.%26aulast%3DMercer%26aufirst%3DJ.%2BN.%26aulast%3DRick%26aufirst%3DC.%26aulast%3DTkatch%26aufirst%3DT.%26aulast%3DMeredith%26aufirst%3DG.%2BE.%26aulast%3DSurmeier%26aufirst%3DD.%2BJ.%26atitle%3D%25E2%2580%259CRejuvenation%25E2%2580%259D%2520protects%2520neurons%2520in%2520mouse%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D2007%26volume%3D447%26spage%3D1081%26epage%3D1086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Brevetti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaduce, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breglio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perna, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marconi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campanella, G.</span><span> </span><span class="NLM_article-title">Parkinson’s disease and hypotension: 24-hour blood pressure recording in ambulant patients</span> <span class="citation_source-journal">Clin. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">474</span><span class="NLM_x">–</span> <span class="NLM_lpage">478</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1002%2Fclc.4960130709" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=2364581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADyaK3czgsFahtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1990&pages=474-478&author=G.+Brevettiauthor=D.+Bonaduceauthor=R.+Breglioauthor=S.+Pernaauthor=P.+Simonelliauthor=R.+Marconiauthor=G.+Campanella&title=Parkinson%E2%80%99s+disease+and+hypotension%3A+24-hour+blood+pressure+recording+in+ambulant+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Parkinson's disease and hypotension: 24-hour blood pressure recording in ambulant patients</span></div><div class="casAuthors">Brevetti G; Bonaduce D; Breglio R; Perna S; Simonelli P; Marconi R; Campanella G</div><div class="citationInfo"><span class="NLM_cas:title">Clinical cardiology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">474-8</span>
        ISSN:<span class="NLM_cas:issn">0160-9289</span>.
    </div><div class="casAbstract">Continuous intra-arterial blood pressure was recorded in 5 ambulatory patients with Parkinson's disease and in 5 control subjects.  The 24-h mean systolic blood pressure was 135 +/- 7.6 mmHg in controls and 123.8 +/- 8.1 mmHg (p less than 0.01) in the parkinsonian group.  Similarly, diastolic blood pressure was 89 +/- 8.1 mmHg in the control group while in the parkinsonian patients it was lower, 69.4 +/- 5.8 (p less than 0.01).  Averages were also calculated for 8-h periods, the results of which indicate that both systolic and diastolic blood pressure were significantly lower in patients than in controls in all three 8-h periods of the day.  We normalized the blood pressure curve to mealtimes and arousal times and did not observe any difference between parkinsonian patients and controls.  This first study reporting continuous intra-arterial blood pressure measurements in ambulant parkinsonian patients demonstrates that blood pressure in such patients is lower than the mean for their age group.  This finding may be of direct relevance in the management of idiopathic parkinsonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQhFUz3M74nee3MPKNEWB5RfW6udTcc2ea4TJRP2QMrWbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3czgsFahtw%253D%253D&md5=f8717c427d26d2d3b167ab198e5e48bb</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1002%2Fclc.4960130709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fclc.4960130709%26sid%3Dliteratum%253Aachs%26aulast%3DBrevetti%26aufirst%3DG.%26aulast%3DBonaduce%26aufirst%3DD.%26aulast%3DBreglio%26aufirst%3DR.%26aulast%3DPerna%26aufirst%3DS.%26aulast%3DSimonelli%26aufirst%3DP.%26aulast%3DMarconi%26aufirst%3DR.%26aulast%3DCampanella%26aufirst%3DG.%26atitle%3DParkinson%25E2%2580%2599s%2520disease%2520and%2520hypotension%253A%252024-hour%2520blood%2520pressure%2520recording%2520in%2520ambulant%2520patients%26jtitle%3DClin.%2520Cardiol.%26date%3D1990%26volume%3D13%26spage%3D474%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Sinnegger-Brauns, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koschak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wild, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obermair, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einzinger, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoda, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartori, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Striessnig, J.</span><span> </span><span class="NLM_article-title">Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">414</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2009&pages=407-414&author=M.+J.+Sinnegger-Braunsauthor=I.+G.+Huberauthor=A.+Koschakauthor=C.+Wildauthor=G.+J.+Obermairauthor=U.+Einzingerauthor=J.+C.+Hodaauthor=S.+B.+Sartoriauthor=J.+Striessnig&title=Expression+and+1%2C4-dihydropyridine-binding+properties+of+brain+L-type+calcium+channel+isoforms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSinnegger-Brauns%26aufirst%3DM.%2BJ.%26aulast%3DHuber%26aufirst%3DI.%2BG.%26aulast%3DKoschak%26aufirst%3DA.%26aulast%3DWild%26aufirst%3DC.%26aulast%3DObermair%26aufirst%3DG.%2BJ.%26aulast%3DEinzinger%26aufirst%3DU.%26aulast%3DHoda%26aufirst%3DJ.%2BC.%26aulast%3DSartori%26aufirst%3DS.%2BB.%26aulast%3DStriessnig%26aufirst%3DJ.%26atitle%3DExpression%2520and%25201%252C4-dihydropyridine-binding%2520properties%2520of%2520brain%2520L-type%2520calcium%2520channel%2520isoforms%26jtitle%3DMol.%2520Pharmacol.%26date%3D2009%26volume%3D75%26spage%3D407%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipscombe, D.</span><span> </span><span class="NLM_article-title">Neuronal Ca(V)1.3alpha(1) L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5944</span><span class="NLM_x">–</span> <span class="NLM_lpage">5951</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11487617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvFKms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=5944-5951&author=W.+Xuauthor=D.+Lipscombe&title=Neuronal+Ca%28V%291.3alpha%281%29+L-type+channels+activate+at+relatively+hyperpolarized+membrane+potentials+and+are+incompletely+inhibited+by+dihydropyridines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal CaV1.3α1 L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines</span></div><div class="casAuthors">Xu, Weifeng; Lipscombe, Diane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5944-5951</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">L-type calcium channels regulate a diverse array of cellular functions within excitable cells.  Of the 4 molecularly defined subclasses of L-type Ca channels, 2 are expressed ubiquitously in the mammalian nervous system (CaV1.2α1 and CaV1.3α1).  Despite diversity at the mol. level, neuronal L-type channels are generally assumed to be functionally and pharmacol. similar, i.e., high-voltage activated and highly sensitive to dihydropyridines.  We now show that CaV1.3α1 L-type channels activate at membrane potentials ∼25 mV more hyperpolarized, compared with CaV1.2α1.  This unusually neg. activation threshold for CaV1.3α1 channels is independent of the specific auxiliary subunits coexpressed, of alternative splicing in domains I-II, IVS3-IVS4, and the C terminus, and of the expression system.  The use of high concns. of extracellular divalent cations has possibly obscured the unique voltage-dependent properties of CaV1.3α1 in certain previous studies.  We also demonstrate that CaV1.3α1 channels are pharmacol. distinct from CaV1.2α1.  The IC50 for nimodipine block of CaV1.3α1 L-type calcium channel currents is 2.7 μM, a value 20-fold higher than the concn. required to block CaV1.2α1.  The relatively low sensitivity of the CaV1.3α1 subunit to inhibition by dihydropyridine is unaffected by alternative splicing in the IVS3-IVS4 linker.  Our results suggest that functional and pharmacol. criteria used commonly to distinguish among different Ca currents greatly underestimate the biol. importance of L-type channels in cells expressing CaV1.3α1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRRfO-OII9w7Vg90H21EOLACvtfcHk0lj3GIf-drWrwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvFKms7o%253D&md5=6d9b9f0cba3dd45cbdc3b6a9e7d4011d</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DW.%26aulast%3DLipscombe%26aufirst%3DD.%26atitle%3DNeuronal%2520Ca%2528V%25291.3alpha%25281%2529%2520L-type%2520channels%2520activate%2520at%2520relatively%2520hyperpolarized%2520membrane%2520potentials%2520and%2520are%2520incompletely%2520inhibited%2520by%2520dihydropyridines%26jtitle%3DJ.%2520Neurosci.%26date%3D2001%26volume%3D21%26spage%3D5944%26epage%3D5951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Chang, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunne, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luan, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surmeier, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Antagonism of 4-substituted 1,4-dihydropyridine-3,5-dicarboxylates toward voltage-dependent L-type Ca<sup>2+</sup> channels Ca V 1.3 and Ca V 1.2</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3147</span><span class="NLM_x">–</span> <span class="NLM_lpage">3158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=3147-3158&author=C.+C.+Changauthor=S.+Caoauthor=S.+Kangauthor=L.+Kaiauthor=X.+Tianauthor=P.+Pandeyauthor=S.+F.+Dunneauthor=C.+H.+Luanauthor=D.+J.+Surmeierauthor=R.+B.+Silverman&title=Antagonism+of+4-substituted+1%2C4-dihydropyridine-3%2C5-dicarboxylates+toward+voltage-dependent+L-type+Ca2%2B+channels+Ca+V+1.3+and+Ca+V+1.2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DC.%2BC.%26aulast%3DCao%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DKai%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DPandey%26aufirst%3DP.%26aulast%3DDunne%26aufirst%3DS.%2BF.%26aulast%3DLuan%26aufirst%3DC.%2BH.%26aulast%3DSurmeier%26aufirst%3DD.%2BJ.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DAntagonism%2520of%25204-substituted%25201%252C4-dihydropyridine-3%252C5-dicarboxylates%2520toward%2520voltage-dependent%2520L-type%2520Ca2%252B%2520channels%2520Ca%2520V%25201.3%2520and%2520Ca%2520V%25201.2%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D3147%26epage%3D3158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Sorkin, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clissold, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogden, R. N.</span><span> </span><span class="NLM_article-title">Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1985&pages=182-274&author=E.+M.+Sorkinauthor=S.+P.+Clissoldauthor=R.+N.+Brogden&title=Nifedipine.+A+review+of+its+pharmacodynamic+and+pharmacokinetic+properties%2C+and+therapeutic+efficacy%2C+in+ischaemic+heart+disease%2C+hypertension+and+related+cardiovascular+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSorkin%26aufirst%3DE.%2BM.%26aulast%3DClissold%26aufirst%3DS.%2BP.%26aulast%3DBrogden%26aufirst%3DR.%2BN.%26atitle%3DNifedipine.%2520A%2520review%2520of%2520its%2520pharmacodynamic%2520and%2520pharmacokinetic%2520properties%252C%2520and%2520therapeutic%2520efficacy%252C%2520in%2520ischaemic%2520heart%2520disease%252C%2520hypertension%2520and%2520related%2520cardiovascular%2520disorders%26jtitle%3DDrugs%26date%3D1985%26volume%3D30%26spage%3D182%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Xia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benmohamed, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arvanites, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morimoto, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrante, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirsch, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Pyrimidine-2,4,6-trione derivatives and their inhibition of mutant SOD1-dependent protein aggregation. Toward a treatment for amyotrophic lateral sclerosis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2409</span><span class="NLM_x">–</span> <span class="NLM_lpage">2421</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101549k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2409-2421&author=G.+Xiaauthor=R.+Benmohamedauthor=J.+Kimauthor=A.+C.+Arvanitesauthor=R.+I.+Morimotoauthor=R.+J.+Ferranteauthor=D.+R.+Kirschauthor=R.+B.+Silverman&title=Pyrimidine-2%2C4%2C6-trione+derivatives+and+their+inhibition+of+mutant+SOD1-dependent+protein+aggregation.+Toward+a+treatment+for+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Fjm101549k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101549k%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DG.%26aulast%3DBenmohamed%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DArvanites%26aufirst%3DA.%2BC.%26aulast%3DMorimoto%26aufirst%3DR.%2BI.%26aulast%3DFerrante%26aufirst%3DR.%2BJ.%26aulast%3DKirsch%26aufirst%3DD.%2BR.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DPyrimidine-2%252C4%252C6-trione%2520derivatives%2520and%2520their%2520inhibition%2520of%2520mutant%2520SOD1-dependent%2520protein%2520aggregation.%2520Toward%2520a%2520treatment%2520for%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2409%26epage%3D2421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunne, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dusel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luan, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surmeier, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Ca(V)1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson’s disease</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fncomms2149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252Fns1Gnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1146&author=S.+Kangauthor=G.+Cooperauthor=S.+F.+Dunneauthor=B.+Duselauthor=C.+H.+Luanauthor=D.+J.+Surmeierauthor=R.+B.+Silverman&title=Ca%28V%291.3-selective+L-type+calcium+channel+antagonists+as+potential+new+therapeutics+for+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease</span></div><div class="casAuthors">Kang Soosung; Cooper Garry; Dunne Sara F; Dusel Brendon; Luan Chi-Hao; Surmeier D James; Silverman Richard B</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1146</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">L-type calcium channels expressed in the brain are heterogeneous.  The predominant class of L-type calcium channels has a Ca(V)1.2 pore-forming subunit.  L-type calcium channels with a Ca(V)1.3 pore-forming subunit are much less abundant, but have been implicated in the generation of mitochondrial oxidant stress underlying pathogenesis in Parkinson's disease.  Thus, selectively antagonizing Ca(V)1.3 L-type calcium channels could provide a means of diminishing cell loss in Parkinson's disease without producing side effects accompanying general antagonism of L-type calcium channels.  However, there are no known selective antagonists of Ca(V)1.3 L-type calcium channel.  Here we report high-throughput screening of commercial and 'in-house' chemical libraries and modification of promising hits.  Pyrimidine-2,4,6-triones were identified as a potential scaffold; structure-activity relationship-based modification of this scaffold led to 1-(3-chlorophenethyl)-3-cyclopentylpyrimidine-2,4,6-(1H,3H,5H)-trione (8), a potent and highly selective Ca(V)1.3 L-type calcium channel antagonist.  The biological relevance was confirmed by whole-cell patch-clamp electrophysiology.  These studies describe the first highly selective Ca(V)1.3 L-type calcium channel antagonist and point to a novel therapeutic strategy for Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIlgKYfUH9FVWTCLT8lX9SfW6udTcc2eYxgPIZZxTBCrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252Fns1Gnuw%253D%253D&md5=a55b56a37686004d5f9852e4f0c2b53a</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1038%2Fncomms2149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms2149%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DS.%26aulast%3DCooper%26aufirst%3DG.%26aulast%3DDunne%26aufirst%3DS.%2BF.%26aulast%3DDusel%26aufirst%3DB.%26aulast%3DLuan%26aufirst%3DC.%2BH.%26aulast%3DSurmeier%26aufirst%3DD.%2BJ.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DCa%2528V%25291.3-selective%2520L-type%2520calcium%2520channel%2520antagonists%2520as%2520potential%2520new%2520therapeutics%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Commun.%26date%3D2012%26volume%3D3%26spage%3D1146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, S. A.</span><span> </span><span class="NLM_article-title">Cell death: protein misfolding and neurodegenerative diseases</span> <span class="citation_source-journal">Apoptosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=455-468&author=T.+Nakamuraauthor=S.+A.+Lipton&title=Cell+death%3A+protein+misfolding+and+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DLipton%26aufirst%3DS.%2BA.%26atitle%3DCell%2520death%253A%2520protein%2520misfolding%2520and%2520neurodegenerative%2520diseases%26jtitle%3DApoptosis%26date%3D2009%26volume%3D14%26spage%3D455%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Chung, K. K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, K. K.</span><span> </span><span class="NLM_article-title">Emerging roles of nitric oxide in neurodegeneration</span> <span class="citation_source-journal">Nitric Oxide</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">290</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2010&pages=290-295&author=K.+K.+K.+Chungauthor=K.+K.+David&title=Emerging+roles+of+nitric+oxide+in+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DK.%2BK.%2BK.%26aulast%3DDavid%26aufirst%3DK.%2BK.%26atitle%3DEmerging%2520roles%2520of%2520nitric%2520oxide%2520in%2520neurodegeneration%26jtitle%3DNitric%2520Oxide%26date%3D2010%26volume%3D22%26spage%3D290%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Giasson, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duda, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souza, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurtig, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ischiropoulos, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span> </span><span class="NLM_article-title">Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">985</span><span class="NLM_x">–</span> <span class="NLM_lpage">989</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1126%2Fscience.290.5493.985" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11062131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvVWkurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2000&pages=985-989&author=B.+I.+Giassonauthor=J.+E.+Dudaauthor=I.+V.+Murrayauthor=Q.+Chenauthor=J.+M.+Souzaauthor=H.+I.+Hurtigauthor=H.+Ischiropoulosauthor=J.+Q.+Trojanowskiauthor=V.+M.+Lee&title=Oxidative+damage+linked+to+neurodegeneration+by+selective+alpha-synuclein+nitration+in+synucleinopathy+lesions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions</span></div><div class="casAuthors">Giasson, Benoit I.; Duda, John E.; Murray, Ian V. J.; Chen, Qiping; Souza, Jose M.; Hurtig, Howard I.; Ischiropoulos, Harry; Trojanowski, John Q.; Lee, Virginia M.-Y.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">5493</span>),
    <span class="NLM_cas:pages">985-989</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Aggregated α-synuclein proteins form brain lesions that are hallmarks of neurodegenerative synucleinopathies, and oxidative stress has been implicated in the pathogenesis of some of these disorders.  Using antibodies to specific nitrated tyrosine residues in α-synuclein, the authors demonstrate extensive and wide-spread accumulations of nitrated α-synuclein in the signature inclusions of Parkinson's disease, dementia with Lewy bodies, the Lewy body variant of Alzheimer's disease, and multiple system atrophy brains.  The authors also show that nitrated α-synuclein is present in the major filamentous building blocks of these inclusions, as well as in the insol. fractions of affected brain regions of synucleinopathies.  The selective and specific nitration of α-synuclein in these disorders provides evidence to directly link oxidative and nitrative damage to the onset and progression of neurodegenerative synucleinopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0c019GCOzeLVg90H21EOLACvtfcHk0lh1Xl1esU0caw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvVWkurY%253D&md5=2b1934a77639403caf4285764d6228c1</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1126%2Fscience.290.5493.985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.290.5493.985%26sid%3Dliteratum%253Aachs%26aulast%3DGiasson%26aufirst%3DB.%2BI.%26aulast%3DDuda%26aufirst%3DJ.%2BE.%26aulast%3DMurray%26aufirst%3DI.%2BV.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DSouza%26aufirst%3DJ.%2BM.%26aulast%3DHurtig%26aufirst%3DH.%2BI.%26aulast%3DIschiropoulos%26aufirst%3DH.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DOxidative%2520damage%2520linked%2520to%2520neurodegeneration%2520by%2520selective%2520alpha-synuclein%2520nitration%2520in%2520synucleinopathy%2520lesions%26jtitle%3DScience%26date%3D2000%26volume%3D290%26spage%3D985%26epage%3D989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Chung, K. K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pletnikova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troncoso, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span> </span><span class="NLM_article-title">S-Nitrosylation of parkin regulates ubiquitination and compromises parkin’s protective function</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">1328</span><span class="NLM_x">–</span> <span class="NLM_lpage">1331</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2004&pages=1328-1331&author=K.+K.+K.+Chungauthor=B.+Thomasauthor=X.+Liauthor=O.+Pletnikovaauthor=J.+C.+Troncosoauthor=L.+Marshauthor=V.+L.+Dawsonauthor=T.+M.+Dawson&title=S-Nitrosylation+of+parkin+regulates+ubiquitination+and+compromises+parkin%E2%80%99s+protective+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DK.%2BK.%2BK.%26aulast%3DThomas%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DPletnikova%26aufirst%3DO.%26aulast%3DTroncoso%26aufirst%3DJ.%2BC.%26aulast%3DMarsh%26aufirst%3DL.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26atitle%3DS-Nitrosylation%2520of%2520parkin%2520regulates%2520ubiquitination%2520and%2520compromises%2520parkin%25E2%2580%2599s%2520protective%2520function%26jtitle%3DScience%26date%3D2004%26volume%3D304%26spage%3D1328%26epage%3D1331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Yao, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Z. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Z.-Q. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaston, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, L. A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockenstein, E. M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masliah, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uehara, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, S. A. S.</span><span> </span><span class="NLM_article-title">Nitrosative stress linked to sporadic Parkinson’s disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">10810</span><span class="NLM_x">–</span> <span class="NLM_lpage">10814</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=10810-10814&author=D.+D.+Yaoauthor=Z.+Z.+Guauthor=T.+T.+Nakamuraauthor=Z.-Q.+Z.+Shiauthor=Y.+Y.+Maauthor=B.+B.+Gastonauthor=L.+A.+L.+Palmerauthor=E.+M.+E.+Rockensteinauthor=Z.+Z.+Zhangauthor=E.+E.+Masliahauthor=T.+T.+Ueharaauthor=S.+A.+S.+Lipton&title=Nitrosative+stress+linked+to+sporadic+Parkinson%E2%80%99s+disease%3A+S-nitrosylation+of+parkin+regulates+its+E3+ubiquitin+ligase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DD.%2BD.%26aulast%3DGu%26aufirst%3DZ.%2BZ.%26aulast%3DNakamura%26aufirst%3DT.%2BT.%26aulast%3DShi%26aufirst%3DZ.-Q.%2BZ.%26aulast%3DMa%26aufirst%3DY.%2BY.%26aulast%3DGaston%26aufirst%3DB.%2BB.%26aulast%3DPalmer%26aufirst%3DL.%2BA.%2BL.%26aulast%3DRockenstein%26aufirst%3DE.%2BM.%2BE.%26aulast%3DZhang%26aufirst%3DZ.%2BZ.%26aulast%3DMasliah%26aufirst%3DE.%2BE.%26aulast%3DUehara%26aufirst%3DT.%2BT.%26aulast%3DLipton%26aufirst%3DS.%2BA.%2BS.%26atitle%3DNitrosative%2520stress%2520linked%2520to%2520sporadic%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520S-nitrosylation%2520of%2520parkin%2520regulates%2520its%2520E3%2520ubiquitin%2520ligase%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D10810%26epage%3D10814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span> </span><span class="NLM_article-title">Nitric oxide in neurodegeneration</span> <span class="citation_source-journal">Prog. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0079-6123%2808%2963210-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=9932444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1cXnvFynsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1998&pages=215-229&author=V.+L.+Dawsonauthor=T.+M.+Dawson&title=Nitric+oxide+in+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide in neurodegeneration</span></div><div class="casAuthors">Dawson, Valina L.; Dawson, Ted M.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Brain Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">Nitric Oxide in Brain Development, Plasticity, and Disease</span>),
    <span class="NLM_cas:pages">215-229</span>CODEN:
                <span class="NLM_cas:coden">PBRRA4</span>;
        ISSN:<span class="NLM_cas:issn">0079-6123</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with 142 refs.  Nitric oxide (NO) is a unique biol. messenger mol. which mediates diverse physiol. roles.  NO mediates blood vessel relaxation by endothelium, immune activity of macrophages and neurotransmission of central and peripheral neurons.  NO is produced from three NO synthase (NOS) isoforms: neuronal NOS (nNOS), endothelial NOS, and inducible NOS (iNOS).  In the central nervous system, NO may play important roles in neurotransmitter release, neurotransmitter reuptake, neurodevelopment, synaptic plasticity, and regulation of gene expression.  However, excessive prodn. of NO following a pathol. insult can lead to neurotoxicity.  NO plays a role in mediating neurotoxicity assocd. with a variety of neurol. disorders, including stroke, Parkinson's disease, and HIV dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFnKDg2Zofr7Vg90H21EOLACvtfcHk0lhvq_hsz9VqeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvFynsbY%253D&md5=93866cb93206194ca52b37929410d2f3</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2FS0079-6123%2808%2963210-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6123%252808%252963210-0%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26atitle%3DNitric%2520oxide%2520in%2520neurodegeneration%26jtitle%3DProg.%2520Brain%2520Res.%26date%3D1998%26volume%3D118%26spage%3D215%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Martínez-Ruiz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villanueva, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González de Orduña, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Ferrer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higueras, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarín, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Crespo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vázquez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamas, S.</span><span> </span><span class="NLM_article-title">S-Nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">8525</span><span class="NLM_x">–</span> <span class="NLM_lpage">8530</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=8525-8530&author=A.+Mart%C3%ADnez-Ruizauthor=L.+Villanuevaauthor=C.+Gonz%C3%A1lez+de+Ordu%C3%B1aauthor=D.+L%C3%B3pez-Ferrerauthor=M.+A.+Higuerasauthor=C.+Tar%C3%ADnauthor=I.+Rodr%C3%ADguez-Crespoauthor=J.+V%C3%A1zquezauthor=S.+Lamas&title=S-Nitrosylation+of+Hsp90+promotes+the+inhibition+of+its+ATPase+and+endothelial+nitric+oxide+synthase+regulatory+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMart%25C3%25ADnez-Ruiz%26aufirst%3DA.%26aulast%3DVillanueva%26aufirst%3DL.%26aulast%3DGonz%25C3%25A1lez%2Bde%2BOrdu%25C3%25B1a%26aufirst%3DC.%26aulast%3DL%25C3%25B3pez-Ferrer%26aufirst%3DD.%26aulast%3DHigueras%26aufirst%3DM.%2BA.%26aulast%3DTar%25C3%25ADn%26aufirst%3DC.%26aulast%3DRodr%25C3%25ADguez-Crespo%26aufirst%3DI.%26aulast%3DV%25C3%25A1zquez%26aufirst%3DJ.%26aulast%3DLamas%26aufirst%3DS.%26atitle%3DS-Nitrosylation%2520of%2520Hsp90%2520promotes%2520the%2520inhibition%2520of%2520its%2520ATPase%2520and%2520endothelial%2520nitric%2520oxide%2520synthase%2520regulatory%2520activities%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D8525%26epage%3D8530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Tsang, A. H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, K. K. K.</span><span> </span><span class="NLM_article-title">Oxidative and nitrosative stress in Parkinson’s disease</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1792</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">650</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1792&publication_year=2009&pages=643-650&author=A.+H.+K.+Tsangauthor=K.+K.+K.+Chung&title=Oxidative+and+nitrosative+stress+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsang%26aufirst%3DA.%2BH.%2BK.%26aulast%3DChung%26aufirst%3DK.%2BK.%2BK.%26atitle%3DOxidative%2520and%2520nitrosative%2520stress%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2009%26volume%3D1792%26spage%3D643%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Daff, S.</span><span> </span><span class="NLM_article-title">NO synthase: structures and mechanisms</span> <span class="citation_source-journal">Nitric Oxide</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.niox.2010.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20303412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFCgu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=1-11&author=S.+Daff&title=NO+synthase%3A+structures+and+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">NO synthase: Structures and mechanisms</span></div><div class="casAuthors">Daff, Simon</div><div class="citationInfo"><span class="NLM_cas:title">Nitric Oxide</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">NIOXF5</span>;
        ISSN:<span class="NLM_cas:issn">1089-8603</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Prodn. of NO from arginine and mol. oxygen is a complex chem. reaction unique to biol.  Our understanding of the chem. and regulation mechanisms of the NO synthases has developed over the past two decades, uncovering some extraordinary features.  This article reviews recent progress and highlights current issues and controversies.  The structure of the enzyme has now been detd. almost in entirety, although it is as a selection of fragments, which are difficult to assemble unambiguously.  NO synthesis is driven by electron transfer through FAD and FMN cofactors, which is controlled by calmodulin binding in the constitutive mammalian enzymes.  Many of the unique structural features involved have been characterized, but the mechanics of calmodulin-dependent activation are largely unresolved.  Ultimately, NO is produced in the active site by the reaction of arginine with activated heme-bound oxygen in two distinct cycles.  The unique role of the tetrahydrobiopterin cofactor as an electron donor in this process has now been established, but the subsequent chem. events are currently a matter of intense speculation and debate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr3kdAXwpBLrVg90H21EOLACvtfcHk0lihdGahCm2o8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFCgu7s%253D&md5=eb3d07f5dade81e6f5ea3d6ec8ea657f</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.niox.2010.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.niox.2010.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DDaff%26aufirst%3DS.%26atitle%3DNO%2520synthase%253A%2520structures%2520and%2520mechanisms%26jtitle%3DNitric%2520Oxide%26date%3D2010%26volume%3D23%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Erdal, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litzinger, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Selective neuronal nitric oxide synthase inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.2174%2F1568026054679317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=16101423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFGhtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=603-624&author=E.+P.+Erdalauthor=E.+A.+Litzingerauthor=J.+Seoauthor=Y.+Zhuauthor=H.+Jiauthor=R.+B.+Silverman&title=Selective+neuronal+nitric+oxide+synthase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Selective neuronal nitric oxide synthase inhibitors</span></div><div class="casAuthors">Erdal, Erik P.; Litzinger, Elizabeth A.; Seo, Jiwon; Zhu, Yaoqiu; Ji, Haitao; Silverman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">603-624</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This review includes the non-patent literature up to Oct. 2004 that deals with selective neuronal nitric oxide synthase inhibitors (highest potency is for the neuronal isoenzyme).  Some non-selective inhibitors or selective inducible nitric oxide synthase inhibitors are mentioned if they are related to compds. that are discussed; structures of these compds. generally are not given.  In vitro inhibition consts. are given either as IC50 values or as Ki values.  An IC50 value, the inhibitor concn. that produces 50% inhibition in the presence of a const. concn. of substrate, is obtained by extrapolation of several rate data points to 50% inhibition.  Ki values are derived from several types of plots that relate the concn. of inhibitor with enzyme velocity in the presence of a variety of substrate concns.  The Ki value can be estd. from the IC50 value.  Although the two inhibition consts. are related, they are not the same; generally, the reported Ki values tend to be lower than the IC50 values.  If specifics are desired about how the data were collected, then the reader will have to look in the literature cited.  No attempt was made to be exhaustive in citing all refs. related to specific inhibitors; rather, examples of literature refs. are given for each inhibitor described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD4wFCjsRzF7Vg90H21EOLACvtfcHk0lhDy7tP0xsFoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFGhtr4%253D&md5=c338f82141c7af37470fd1cf9afecc75</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.2174%2F1568026054679317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054679317%26sid%3Dliteratum%253Aachs%26aulast%3DErdal%26aufirst%3DE.%2BP.%26aulast%3DLitzinger%26aufirst%3DE.%2BA.%26aulast%3DSeo%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DSelective%2520neuronal%2520nitric%2520oxide%2520synthase%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D603%26epage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Furfine, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paith, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, E. P.</span><span> </span><span class="NLM_article-title">Selective inhibition of constitutive nitric oxide synthase by L-NG-nitroarginine</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">8512</span><span class="NLM_x">–</span> <span class="NLM_lpage">8517</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00084a017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK3sXltFWqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1993&pages=8512-8517&author=E.+S.+Furfineauthor=M.+F.+Harmonauthor=J.+E.+Paithauthor=E.+P.+Garvey&title=Selective+inhibition+of+constitutive+nitric+oxide+synthase+by+L-NG-nitroarginine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of constitutive nitric oxide synthase by L-NG-nitroarginine</span></div><div class="casAuthors">Furfine, Eric S.; Harmon, Marilyn F.; Paith, Jerilin E.; Garvey, Edward P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">8512-17</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">L-NG-nitroarginine (NA) inhibited both the L-arginine oxidn. and the L-arginine-independent NADPH oxidn. reactions catalyzed by the calcium/calmodulin-dependent constitutive nitric oxide synthase (cNOS) from bovine brain.  NA binding did not require calmodulin, calcium, or NADPH.  The onset of inhibition was slow with a second-order assocn. rate const. (kon) of 4.4 x 104 M-1 s-1.  The dissocn. rate const. (koff) was 6.5 x 10-4 s-1.  The Kd value (koff/kon) of bovine brain cNOS for NA was 15 ± 2 nM.  L-Arginine was a competitive inhibitor of NA binding with a Ks value of 0.8 μM.  The Km for L-arginine in the cNOS reaction was 1.2 μM.  The NA binding sites of cNOS were titrated with NA, which enabled a kcat of 0.7 s-1, for the oxidn. of L-arginine, to be calcd.  Finally, a brain cNOS-(3H)NA complex was isolated.  In contrast to the potent and slow onset of NA inhibition of brain cNOS, NA inhibition of inducible mouse macrophage NOS (iNOS) was weaker (Ki = 4.4 μM) and rapidly reversible.  Thus, NA was a 300-fold more potent inhibitor of bovine brain cNOS than mouse macrophage iNOS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLhA06x44BabVg90H21EOLACvtfcHk0lhDy7tP0xsFoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltFWqu78%253D&md5=2f9a5c60f0f09c327e2e6db59d1d1026</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1021%2Fbi00084a017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00084a017%26sid%3Dliteratum%253Aachs%26aulast%3DFurfine%26aufirst%3DE.%2BS.%26aulast%3DHarmon%26aufirst%3DM.%2BF.%26aulast%3DPaith%26aufirst%3DJ.%2BE.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26atitle%3DSelective%2520inhibition%2520of%2520constitutive%2520nitric%2520oxide%2520synthase%2520by%2520L-NG-nitroarginine%26jtitle%3DBiochemistry%26date%3D1993%26volume%3D32%26spage%3D8512%26epage%3D8517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Yamamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekiguchi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunano, S.</span><span> </span><span class="NLM_article-title">Effects of NG-nitro-<span class="smallcaps smallerCapital">l</span>-arginine on the blood pressure of spontaneously hypertensive rats with different degrees of hypertension</span> <span class="citation_source-journal">Clin. Exper. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">544</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1081%2FCEH-100106824" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11710755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotlylurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2001&pages=533-544&author=K.+Yamamotoauthor=K.+Shimamuraauthor=F.+Sekiguchiauthor=S.+Sunano&title=Effects+of+NG-nitro-l-arginine+on+the+blood+pressure+of+spontaneously+hypertensive+rats+with+different+degrees+of+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of NG-nitro-L-arginine on the blood pressure of spontaneously hypertensive rats with different degrees of hypertension</span></div><div class="casAuthors">Yamamoto, Kazuo; Shimamura, Keiichi; Sekiguchi, Fumiko; Sunano, Satoru</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Hypertension</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">533-544</span>CODEN:
                <span class="NLM_cas:coden">CEHYER</span>;
        ISSN:<span class="NLM_cas:issn">1064-1963</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">The effects of NG-nitro-L-arginine (L-NNA) on blood pressure of various strains of spontaneously hypertensive rats were studied.  Blood pressure of the rats was higher in the order of WKY, SHR, SHRSP, M-SHRSP.  L-NNA caused an elevation of the blood pressure, which was greatest in SHR and smallest in WKY and M-SHRSP.  Endothelium-dependent relaxation of aortae by acetylcholine was greatest in prepns. from WKY and it decreased as the blood pressure of rats increased.  Phenylephrine (higher than 10-6 mg/kg) caused an elevation of the blood pressure, which was greatest in SHR and smallest in M-SHRSP.  It was suggested that L-NNA elevated blood pressure by inhibiting the basal or flow-induced release of nitric oxide from the endothelium that is causing a redn. in vascular smooth muscle tone.  The smaller effect of L-NNA in WKY was due to weak smooth muscle tone, while the smaller effect in SHRSP and M-SHRSP is due to impaired function of endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO4kZnjKxOOrVg90H21EOLACvtfcHk0liavLVH7aPatQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotlylurg%253D&md5=d1968a8647aa5a652e7a8ff815d5665e</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1081%2FCEH-100106824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FCEH-100106824%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DShimamura%26aufirst%3DK.%26aulast%3DSekiguchi%26aufirst%3DF.%26aulast%3DSunano%26aufirst%3DS.%26atitle%3DEffects%2520of%2520NG-nitro-l-arginine%2520on%2520the%2520blood%2520pressure%2520of%2520spontaneously%2520hypertensive%2520rats%2520with%2520different%2520degrees%2520of%2520hypertension%26jtitle%3DClin.%2520Exper.%2520Hypertens.%26date%3D2001%26volume%3D23%26spage%3D533%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Silverman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marletta, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span> </span><span class="NLM_article-title">Selective inhibition of neuronal nitric oxide synthase by <i>N</i><sup>ω</sup>-nitroarginine- and phenylalanine-containing dipeptides and dipeptide esters</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2813</span><span class="NLM_x">–</span> <span class="NLM_lpage">2817</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970200u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=2813-2817&author=R.+B.+Silvermanauthor=H.+Huangauthor=M.+A.+Marlettaauthor=P.+Mart%C3%A1sek&title=Selective+inhibition+of+neuronal+nitric+oxide+synthase+by+N%CF%89-nitroarginine-+and+phenylalanine-containing+dipeptides+and+dipeptide+esters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Fjm970200u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970200u%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DMarletta%26aufirst%3DM.%2BA.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26atitle%3DSelective%2520inhibition%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%2520by%2520N%25CF%2589-nitroarginine-%2520and%2520phenylalanine-containing%2520dipeptides%2520and%2520dipeptide%2520esters%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D2813%26epage%3D2817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, B. S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>ω</sup>-Nitroarginine-containing dipeptide amides. Potent and highly selective inhibitors of neuronal nitric oxide synthase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3147</span><span class="NLM_x">–</span> <span class="NLM_lpage">3153</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990111c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=3147-3153&author=H.+Huangauthor=P.+Mart%C3%A1sekauthor=L.+J.+Romanauthor=B.+S.+S.+Mastersauthor=R.+B.+Silverman&title=N%CF%89-Nitroarginine-containing+dipeptide+amides.+Potent+and+highly+selective+inhibitors+of+neuronal+nitric+oxide+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Fjm990111c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990111c%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DMasters%26aufirst%3DB.%2BS.%2BS.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DN%25CF%2589-Nitroarginine-containing%2520dipeptide%2520amides.%2520Potent%2520and%2520highly%2520selective%2520inhibitors%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D3147%26epage%3D3153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of peptidomimetics as selective inhibitors and active site probes of nitric oxide synthases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2938</span><span class="NLM_x">–</span> <span class="NLM_lpage">2945</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000127z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2938-2945&author=H.+Huangauthor=P.+Mart%C3%A1sekauthor=L.+J.+Romanauthor=R.+B.+Silverman&title=Synthesis+and+evaluation+of+peptidomimetics+as+selective+inhibitors+and+active+site+probes+of+nitric+oxide+synthases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1021%2Fjm000127z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000127z%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520peptidomimetics%2520as%2520selective%2520inhibitors%2520and%2520active%2520site%2520probes%2520of%2520nitric%2520oxide%2520synthases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2938%26epage%3D2945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Gómez-Vidal, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Potent and selective conformationally restricted neuronal nitric oxide synthase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030297m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=703-710&author=J.+A.+G%C3%B3mez-Vidalauthor=P.+Mart%C3%A1sekauthor=L.+J.+Romanauthor=R.+B.+Silverman&title=Potent+and+selective+conformationally+restricted+neuronal+nitric+oxide+synthase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Fjm030297m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030297m%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B3mez-Vidal%26aufirst%3DJ.%2BA.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DPotent%2520and%2520selective%2520conformationally%2520restricted%2520neuronal%2520nitric%2520oxide%2520synthase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D703%26epage%3D710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Hah, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Reduced amide bond peptidomimetics. (4<i>S</i>)-<i>N</i>-(4-Amino-5-[aminoakyl]aminopentyl)-<i>N</i>′-nitroguanidines, potent and highly selective inhibitors of neuronal nitric oxide synthase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2667</span><span class="NLM_x">–</span> <span class="NLM_lpage">2670</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0101491" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2667-2670&author=J.-M.+Hahauthor=L.+J.+Romanauthor=P.+Mart%C3%A1sekauthor=R.+B.+Silverman&title=Reduced+amide+bond+peptidomimetics.+%284S%29-N-%284-Amino-5-%5Baminoakyl%5Daminopentyl%29-N%E2%80%B2-nitroguanidines%2C+potent+and+highly+selective+inhibitors+of+neuronal+nitric+oxide+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1021%2Fjm0101491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0101491%26sid%3Dliteratum%253Aachs%26aulast%3DHah%26aufirst%3DJ.-M.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DReduced%2520amide%2520bond%2520peptidomimetics.%2520%25284S%2529-N-%25284-Amino-5-%255Baminoakyl%255Daminopentyl%2529-N%25E2%2580%25B2-nitroguanidines%252C%2520potent%2520and%2520highly%2520selective%2520inhibitors%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2667%26epage%3D2670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Hah, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1661</span><span class="NLM_x">–</span> <span class="NLM_lpage">1669</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0202932" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1661-1669&author=J.-M.+Hahauthor=P.+Mart%C3%A1sekauthor=L.+J.+Romanauthor=R.+B.+Silverman&title=Aromatic+reduced+amide+bond+peptidomimetics+as+selective+inhibitors+of+neuronal+nitric+oxide+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1021%2Fjm0202932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0202932%26sid%3Dliteratum%253Aachs%26aulast%3DHah%26aufirst%3DJ.-M.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DAromatic%2520reduced%2520amide%2520bond%2520peptidomimetics%2520as%2520selective%2520inhibitors%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1661%26epage%3D1669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Crane, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arvai, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gachhui, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getzoff, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuehr, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tainer, J. A.</span><span> </span><span class="NLM_article-title">The structure of nitric oxide synthase oxygenase domain and inhibitor complexes</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=1997&pages=425-431&author=B.+R.+Craneauthor=A.+S.+Arvaiauthor=R.+Gachhuiauthor=C.+Wuauthor=D.+K.+Ghoshauthor=E.+D.+Getzoffauthor=D.+J.+Stuehrauthor=J.+A.+Tainer&title=The+structure+of+nitric+oxide+synthase+oxygenase+domain+and+inhibitor+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrane%26aufirst%3DB.%2BR.%26aulast%3DArvai%26aufirst%3DA.%2BS.%26aulast%3DGachhui%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DGhosh%26aufirst%3DD.%2BK.%26aulast%3DGetzoff%26aufirst%3DE.%2BD.%26aulast%3DStuehr%26aufirst%3DD.%2BJ.%26aulast%3DTainer%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520structure%2520of%2520nitric%2520oxide%2520synthase%2520oxygenase%2520domain%2520and%2520inhibitor%2520complexes%26jtitle%3DScience%26date%3D1997%26volume%3D278%26spage%3D425%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Raman, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Král, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, B. S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulos, T. L.</span><span> </span><span class="NLM_article-title">Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">939</span><span class="NLM_x">–</span> <span class="NLM_lpage">950</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0092-8674%2800%2981718-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=9875848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1MXjslylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=939-950&author=C.+S.+Ramanauthor=H.+Liauthor=P.+Mart%C3%A1sekauthor=V.+Kr%C3%A1lauthor=B.+S.+S.+Mastersauthor=T.+L.+Poulos&title=Crystal+structure+of+constitutive+endothelial+nitric+oxide+synthase%3A+a+paradigm+for+pterin+function+involving+a+novel+metal+center"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center</span></div><div class="casAuthors">Raman, C. S.; Li, Huiying; Martasek, Pavel; Kral, Vladimir; Masters, Bettie Sue S.; Poulos, Thomas L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">939-950</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Nitric oxide, a key signaling mol., is produced by a family of enzymes collectively called nitric oxide synthases (NOS).  Here, we report the crystal structure of the heme domain of endothelial NOS in tetrahydrobiopterin (H4B)-free and -bound forms at 1.95 Å and 1.9 Å resoln., resp.  In both structures a zinc ion is tetrahedrally coordinated to pairs of symmetry-related cysteine residues at the dimer interface.  The phylogenetically conserved Cys-(X)4-Cys motif and its strategic location establish a structural role for the metal center in maintaining the integrity of the H4B-binding site.  The unexpected recognition of the substrate, L-arginine, at the H4B site indicates that this site is poised to stabilize a pos. charged pterin ring and suggests a model involving a cationic pterin radical in the catalytic cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJtFVAWnJlS7Vg90H21EOLACvtfcHk0lhCwRnMJVWTew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjslylug%253D%253D&md5=be75ef6125b6a5a8db8621b1e1735bc9</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981718-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981718-3%26sid%3Dliteratum%253Aachs%26aulast%3DRaman%26aufirst%3DC.%2BS.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DKr%25C3%25A1l%26aufirst%3DV.%26aulast%3DMasters%26aufirst%3DB.%2BS.%2BS.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26atitle%3DCrystal%2520structure%2520of%2520constitutive%2520endothelial%2520nitric%2520oxide%2520synthase%253A%2520a%2520paradigm%2520for%2520pterin%2520function%2520involving%2520a%2520novel%2520metal%2520center%26jtitle%3DCell%26date%3D1998%26volume%3D95%26spage%3D939%26epage%3D950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulos, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Discovery of highly potent and selective inhibitors of neuronal nitric oxide synthase by fragment hopping</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">797</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801220a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=779-797&author=H.+Jiauthor=H.+Liauthor=P.+Mart%C3%A1sekauthor=L.+J.+Romanauthor=T.+L.+Poulosauthor=R.+B.+Silverman&title=Discovery+of+highly+potent+and+selective+inhibitors+of+neuronal+nitric+oxide+synthase+by+fragment+hopping"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1021%2Fjm801220a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801220a%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DDiscovery%2520of%2520highly%2520potent%2520and%2520selective%2520inhibitors%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%2520by%2520fragment%2520hopping%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D779%26epage%3D797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, B. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulos, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Minimal pharmacophoric elements and fragment hopping, an approach directed at molecular diversity and isozyme selectivity. Design of selective neuronal nitric oxide synthase inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">3900</span><span class="NLM_x">–</span> <span class="NLM_lpage">3914</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0772041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=3900-3914&author=H.+Jiauthor=B.+Z.+Stantonauthor=J.+Igarashiauthor=H.+Liauthor=P.+Mart%C3%A1sekauthor=L.+J.+Romanauthor=T.+L.+Poulosauthor=R.+B.+Silverman&title=Minimal+pharmacophoric+elements+and+fragment+hopping%2C+an+approach+directed+at+molecular+diversity+and+isozyme+selectivity.+Design+of+selective+neuronal+nitric+oxide+synthase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Fja0772041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0772041%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DH.%26aulast%3DStanton%26aufirst%3DB.%2BZ.%26aulast%3DIgarashi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DMinimal%2520pharmacophoric%2520elements%2520and%2520fragment%2520hopping%252C%2520an%2520approach%2520directed%2520at%2520molecular%2520diversity%2520and%2520isozyme%2520selectivity.%2520Design%2520of%2520selective%2520neuronal%2520nitric%2520oxide%2520synthase%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D3900%26epage%3D3914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derrick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vásquez-Vivar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulos, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsy</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1002%2Fana.21555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=19235180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVynu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=209-217&author=H.+Jiauthor=S.+Tanauthor=J.+Igarashiauthor=H.+Liauthor=M.+Derrickauthor=P.+Mart%C3%A1sekauthor=L.+J.+Romanauthor=J.+V%C3%A1squez-Vivarauthor=T.+L.+Poulosauthor=R.+B.+Silverman&title=Selective+neuronal+nitric+oxide+synthase+inhibitors+and+the+prevention+of+cerebral+palsy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsy</span></div><div class="casAuthors">Ji, Haitao; Tan, Sidhartha; Igarashi, Jotaro; Li, Huiying; Derrick, Matthew; Martasek, Pavel; Roman, Linda J.; Vasquez-Vivar, Jeannette; Poulos, Thomas L.; Silverman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">209-217</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">To design a new class of selective neuronal nitric oxide synthase (NOS) inhibitors, and demonstrate that administration in a rabbit model for cerebral palsy (CP) prevents hypoxia-ischemia-induced deaths and reduces the no. of newborn kits exhibiting signs of CP.  We used a novel computer-based drug design method called fragment hopping to identify new chem. entities, synthesized them, and conducted in vitro enzyme inhibition studies with the three isoenzymes of NOS and in vivo expts. to monitor cardiovascular effects on pregnant rabbit dams, NOS activity, and NOx (NO and NO2) concn. in fetal brain, and assess neurobehavioral effects on kits born to saline- and compd. treated dams.  The computer-based design led to the development of powerful and highly selective compds. for inhibition of neuronal NOS over the other isoenzymes.  After maternal administration in a rabbit model of CP, these compds. were found to distribute to fetal brain, to be nontoxic, without cardiovascular effects, inhibit fetal brain NOS activity in vivo, reduce NO concn. in fetal brain, and dramatically ameliorate deaths and no. of newborn kits exhibiting signs of CP.  This approach may lead to new preventive strategies for CP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRq8EX0vjbkbVg90H21EOLACvtfcHk0lhCwRnMJVWTew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVynu78%253D&md5=d2d866c273450dc8169b6aefec8aa092</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1002%2Fana.21555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.21555%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DS.%26aulast%3DIgarashi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DDerrick%26aufirst%3DM.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DV%25C3%25A1squez-Vivar%26aufirst%3DJ.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DSelective%2520neuronal%2520nitric%2520oxide%2520synthase%2520inhibitors%2520and%2520the%2520prevention%2520of%2520cerebral%2520palsy%26jtitle%3DAnn.%2520Neurol.%26date%3D2009%26volume%3D65%26spage%3D209%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Delker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulos, T. L.</span><span> </span><span class="NLM_article-title">Unexpected binding modes of nitric oxide synthase inhibitors effective in the prevention of a cerebral palsy phenotype in an animal model</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">5437</span><span class="NLM_x">–</span> <span class="NLM_lpage">5442</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja910228a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=5437-5442&author=S.+L.+Delkerauthor=H.+Jiauthor=H.+Liauthor=J.+Jamalauthor=J.+Fangauthor=F.+Xueauthor=R.+B.+Silvermanauthor=T.+L.+Poulos&title=Unexpected+binding+modes+of+nitric+oxide+synthase+inhibitors+effective+in+the+prevention+of+a+cerebral+palsy+phenotype+in+an+animal+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Unexpected Binding Modes of Nitric Oxide Synthase Inhibitors Effective in the Prevention of a Cerebral Palsy Phenotype in an Animal Model</span></div><div class="casAuthors">Delker, Silvia L.; Ji, Haitao; Li, Huiying; Jamal, Joumana; Fang, Jianguo; Xue, Fengtian; Silverman, Richard B.; Poulos, Thomas L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5437-5442</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective inhibition of the neuronal isoform of nitric oxide synthase NOS (nNOS) has been shown to prevent brain injury and is important for the treatment of various neurodegenerative disorders.  However, given the high active site conservation among all three NOS isoforms, the design of selective inhibitors is an extremely challenging problem.  Here we present the structural basis for why novel and potent nNOS inhibitors exhibit the highest level of selectivity over eNOS reported so far (∼3,800-fold).  By using a combination of crystallog., computational methods, and site-directed mutagenesis, we found that inhibitor chirality and an unanticipated structural change of the target enzyme control both the orientation and selectivity of these novel nNOS inhibitors.  A new hot spot generated as a result of enzyme elasticity provides important information for the future fragment-based design of selective NOS inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvsA-51wZgRLVg90H21EOLACvtfcHk0lg5xtHanQNIOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtLw%253D&md5=77f308ca289c6c599f683fe601240cad</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fja910228a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja910228a%26sid%3Dliteratum%253Aachs%26aulast%3DDelker%26aufirst%3DS.%2BL.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DJamal%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DXue%26aufirst%3DF.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26atitle%3DUnexpected%2520binding%2520modes%2520of%2520nitric%2520oxide%2520synthase%2520inhibitors%2520effective%2520in%2520the%2520prevention%2520of%2520a%2520cerebral%2520palsy%2520phenotype%2520in%2520an%2520animal%2520model%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D5437%26epage%3D5442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulos, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Exploration of the active site of neuronal nitric oxide synthase by the design and synthesis of pyrrolidinomethyl 2-aminopyridine derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7804</span><span class="NLM_x">–</span> <span class="NLM_lpage">7824</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100947x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7804-7824&author=H.+Jiauthor=S.+L.+Delkerauthor=H.+Liauthor=P.+Mart%C3%A1sekauthor=L.+J.+Romanauthor=T.+L.+Poulosauthor=R.+B.+Silverman&title=Exploration+of+the+active+site+of+neuronal+nitric+oxide+synthase+by+the+design+and+synthesis+of+pyrrolidinomethyl+2-aminopyridine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1021%2Fjm100947x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100947x%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DH.%26aulast%3DDelker%26aufirst%3DS.%2BL.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DExploration%2520of%2520the%2520active%2520site%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%2520by%2520the%2520design%2520and%2520synthesis%2520of%2520pyrrolidinomethyl%25202-aminopyridine%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7804%26epage%3D7824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Xue, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulos, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Symmetric double-headed aminopyridines, a novel strategy for potent and membrane-permeable inhibitors of neuronal nitric oxide synthase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2039</span><span class="NLM_x">–</span> <span class="NLM_lpage">2048</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101071n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2039-2048&author=F.+Xueauthor=J.+Fangauthor=S.+L.+Delkerauthor=H.+Liauthor=P.+Mart%C3%A1sekauthor=L.+J.+Romanauthor=T.+L.+Poulosauthor=R.+B.+Silverman&title=Symmetric+double-headed+aminopyridines%2C+a+novel+strategy+for+potent+and+membrane-permeable+inhibitors+of+neuronal+nitric+oxide+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1021%2Fjm101071n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101071n%26sid%3Dliteratum%253Aachs%26aulast%3DXue%26aufirst%3DF.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DDelker%26aufirst%3DS.%2BL.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DSymmetric%2520double-headed%2520aminopyridines%252C%2520a%2520novel%2520strategy%2520for%2520potent%2520and%2520membrane-permeable%2520inhibitors%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2039%26epage%3D2048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Faraci, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagel, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdries, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labasi, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettipher, E. R.</span><span> </span><span class="NLM_article-title">2-Amino-4-methylpyridine as a potent inhibitor of inducible NO synthase activity in vitro and in vivo</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">1101</span><span class="NLM_x">–</span> <span class="NLM_lpage">1108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1111%2Fj.1476-5381.1996.tb16010.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=8937711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK28Xntlent70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1996&pages=1101-1108&author=W.+S.+Faraciauthor=A.+A.+Nagelauthor=K.+A.+Verdriesauthor=L.+A.+Vincentauthor=H.+Xuauthor=L.+E.+Nicholsauthor=J.+M.+Labasiauthor=E.+D.+Salterauthor=E.+R.+Pettipher&title=2-Amino-4-methylpyridine+as+a+potent+inhibitor+of+inducible+NO+synthase+activity+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">2-Amino-4-methylpyridine as a potent inhibitor of inducible NO synthase activity in vitro and in vivo</span></div><div class="casAuthors">Faraci, W. Stephen; Nagel, Arthur A.; Verdries, Kimberly A.; Vincent, Lawrence A.; Xu, Hong; Nichols, Lois E.; Labasi, Jeffrey M.; Salter, Eben D.; Pettipher, E. Roy</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1101-1108</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">The ability of 2-amino-4-methylpyridine to inhibit the catalytic activity of the inducible NO synthase (NOS II) enzyme was characterized in vitro and in vivo.  In vitro, 2-amino-4-methylpyridine inhibited NOS II activity derived from mouse RAW 264.7 cells with an IC50 of 6 nM.  Enzyme kinetic studies indicated that inhibition is competitive with respect to arginine.  2-Amino-4-methylpyridine was less potent on human recombinant NOS II (IC50=40 nM) and was still less potent on human recombinant NOS I and NOS III (IC50=100 nM).  NG-monomethyl-L-arginine (L-NMMA), N6-iminoethyl-L-lysine (L-NIL) and aminoguanidine were much weaker inhibitors of murine NOS II than 2-amino-4-methylpyridine but, unlike 2-amino-4-methylpyridine, retained similar activity on human recombinant NOS II.  L-NMMA inhibited all three NOS isoforms with similar potency (IC50s 3-7 μM).  In contrast, compared to activity on human recombinant NOS III, L-NIL displayed 10 × selectivity for murine NOS II and 11 × selectivity for human recombinant NOS II while aminoguanidine displayed 7.3× selectivity for murine NOS II and 3.7× selectivity for human recombinant NOS II.  Mouse RAW 264.7 macrophages produced high levels of nitrite when cultured overnight in the presence of lipopolysaccharide (LPS) and interferon-γ.  Addn. of 2-amino-4-methylpyridine at the same time as the LPS and IFN-γ, dose-dependently reduced the levels of nitrite (IC50=1.5 μM) without affecting the induction of NOS II protein.  Increasing the extracellular concn. of arginine decreased the potency of 2-amino-4-methylpyridine but at concns. up to 10 μM, 2-amino-4-methylpyridine did not inhibit the uptake of [3H]-arginine into the cell.  Addn. of 2-amino-4-methylpyridine after the enzyme was induced also dose-dependently inhibited nitrite prodn.  Together, these data suggest that 2-amino-4-methylpyridine reduces cellular prodn. of NO by competitive inhibition of the catalytic activity of NOS II, in agreement with results obtained from in vitro enzyme kinetic studies.  When infused i.v. in conscious unrestrained rats, 2-amino-4-methylpyridine inhibited the rise in plasma nitrate produced in response to i.p. injection of LPS (ID50-0.009 mg kg-1 min-1).  Larger doses of 2-amino-4-methylpyridine were required to raise mean arterial pressure in untreated conscious rats (ED50=0.060 mg kg-1 min-1) indicating 6.9 × selectivity for NOS II over NOS III in vivo.  Under the same conditions, L-NMMA was nonselective while L-NIL and aminoguanidine displayed 5.2 × and 8.6 × selectivity, resp.  All of these compds. caused significant increases in mean arterial pressure at doses above the ID50 for inhibition of NOS II activity in vivo.  2-Amino-4-methylpyridine also inhibited LPS-induced elevation in plasma nitrate after either s.c. (ID50=0.3 mg kg-1) or oral (ID50=20.8 mg kg-1) administration.  These data indicate that 2-amino-4-methylpyridine is a potent inhibitor of NOS II activity in vitro and in vivo with a similar degree of isoenzyme selectivity to that of L-NIL and aminoguanidine in rodents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEBa3UdtL3ILVg90H21EOLACvtfcHk0lj3LpVsAOj_vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xntlent70%253D&md5=199acaee16943d816a72e2322c5b352a</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1996.tb16010.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1996.tb16010.x%26sid%3Dliteratum%253Aachs%26aulast%3DFaraci%26aufirst%3DW.%2BS.%26aulast%3DNagel%26aufirst%3DA.%2BA.%26aulast%3DVerdries%26aufirst%3DK.%2BA.%26aulast%3DVincent%26aufirst%3DL.%2BA.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DNichols%26aufirst%3DL.%2BE.%26aulast%3DLabasi%26aufirst%3DJ.%2BM.%26aulast%3DSalter%26aufirst%3DE.%2BD.%26aulast%3DPettipher%26aufirst%3DE.%2BR.%26atitle%3D2-Amino-4-methylpyridine%2520as%2520a%2520potent%2520inhibitor%2520of%2520inducible%2520NO%2520synthase%2520activity%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D119%26spage%3D1101%26epage%3D1108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Hagmann, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durette, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esser, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanza, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopka, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guthikonda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabin, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humes, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meurer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacholok, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavia, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. K.</span><span> </span><span class="NLM_article-title">Substituted 2-aminopyridines as inhibitors of nitric oxide synthases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1975</span><span class="NLM_x">–</span> <span class="NLM_lpage">1978</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1975-1978&author=W.+K.+Hagmannauthor=C.+G.+Caldwellauthor=P.+Chenauthor=P.+L.+Duretteauthor=C.+K.+Esserauthor=T.+J.+Lanzaauthor=I.+E.+Kopkaauthor=R.+Guthikondaauthor=S.+K.+Shahauthor=M.+MacCossauthor=R.+M.+Chabinauthor=D.+Fletcherauthor=S.+K.+Grantauthor=B.+G.+Greenauthor=J.+L.+Humesauthor=T.+M.+Kellyauthor=S.+Luellauthor=R.+Meurerauthor=V.+Mooreauthor=S.+G.+Pacholokauthor=T.+Paviaauthor=H.+R.+Williamsauthor=K.+K.+Wong&title=Substituted+2-aminopyridines+as+inhibitors+of+nitric+oxide+synthases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHagmann%26aufirst%3DW.%2BK.%26aulast%3DCaldwell%26aufirst%3DC.%2BG.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DDurette%26aufirst%3DP.%2BL.%26aulast%3DEsser%26aufirst%3DC.%2BK.%26aulast%3DLanza%26aufirst%3DT.%2BJ.%26aulast%3DKopka%26aufirst%3DI.%2BE.%26aulast%3DGuthikonda%26aufirst%3DR.%26aulast%3DShah%26aufirst%3DS.%2BK.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DChabin%26aufirst%3DR.%2BM.%26aulast%3DFletcher%26aufirst%3DD.%26aulast%3DGrant%26aufirst%3DS.%2BK.%26aulast%3DGreen%26aufirst%3DB.%2BG.%26aulast%3DHumes%26aufirst%3DJ.%2BL.%26aulast%3DKelly%26aufirst%3DT.%2BM.%26aulast%3DLuell%26aufirst%3DS.%26aulast%3DMeurer%26aufirst%3DR.%26aulast%3DMoore%26aufirst%3DV.%26aulast%3DPacholok%26aufirst%3DS.%2BG.%26aulast%3DPavia%26aufirst%3DT.%26aulast%3DWilliams%26aufirst%3DH.%2BR.%26aulast%3DWong%26aufirst%3DK.%2BK.%26atitle%3DSubstituted%25202-aminopyridines%2520as%2520inhibitors%2520of%2520nitric%2520oxide%2520synthases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D1975%26epage%3D1978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Lowe, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkmann, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowakowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanase, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraci, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdries, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittle, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefaniak, M.</span><span> </span><span class="NLM_article-title">A new class of selective and potent inhibitors of neuronal nitric oxide synthase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2569</span><span class="NLM_x">–</span> <span class="NLM_lpage">2572</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=2569-2572&author=J.+A.+Loweauthor=W.+Qianauthor=R.+A.+Volkmannauthor=S.+Heckauthor=J.+Nowakowskiauthor=R.+Nelsonauthor=C.+Nolanauthor=D.+Listonauthor=K.+Wardauthor=S.+Zornauthor=C.+Johnsonauthor=M.+Vanaseauthor=W.+S.+Faraciauthor=K.+A.+Verdriesauthor=J.+Baxterauthor=S.+Doranauthor=M.+Sandersauthor=M.+Ashtonauthor=P.+Whittleauthor=M.+Stefaniak&title=A+new+class+of+selective+and+potent+inhibitors+of+neuronal+nitric+oxide+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLowe%26aufirst%3DJ.%2BA.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DVolkmann%26aufirst%3DR.%2BA.%26aulast%3DHeck%26aufirst%3DS.%26aulast%3DNowakowski%26aufirst%3DJ.%26aulast%3DNelson%26aufirst%3DR.%26aulast%3DNolan%26aufirst%3DC.%26aulast%3DListon%26aufirst%3DD.%26aulast%3DWard%26aufirst%3DK.%26aulast%3DZorn%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DC.%26aulast%3DVanase%26aufirst%3DM.%26aulast%3DFaraci%26aufirst%3DW.%2BS.%26aulast%3DVerdries%26aufirst%3DK.%2BA.%26aulast%3DBaxter%26aufirst%3DJ.%26aulast%3DDoran%26aufirst%3DS.%26aulast%3DSanders%26aufirst%3DM.%26aulast%3DAshton%26aufirst%3DM.%26aulast%3DWhittle%26aufirst%3DP.%26aulast%3DStefaniak%26aufirst%3DM.%26atitle%3DA%2520new%2520class%2520of%2520selective%2520and%2520potent%2520inhibitors%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D2569%26epage%3D2572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Lowe, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drozda, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkmann, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nason, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdries, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majchrzak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, W. F.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of potent, selective inhibitors of neuronal nitric oxide synthase based on the 6-phenyl-2-aminopyridine structure</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1575</span><span class="NLM_x">–</span> <span class="NLM_lpage">1586</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030519g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1575-1586&author=J.+A.+Loweauthor=W.+Qianauthor=S.+E.+Drozdaauthor=R.+A.+Volkmannauthor=D.+Nasonauthor=R.+B.+Nelsonauthor=C.+Nolanauthor=D.+Listonauthor=K.+Wardauthor=S.+Faraciauthor=K.+Verdriesauthor=P.+Seymourauthor=M.+Majchrzakauthor=A.+Villalobosauthor=W.+F.+White&title=Structure%E2%80%93activity+relationships+of+potent%2C+selective+inhibitors+of+neuronal+nitric+oxide+synthase+based+on+the+6-phenyl-2-aminopyridine+structure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1021%2Fjm030519g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030519g%26sid%3Dliteratum%253Aachs%26aulast%3DLowe%26aufirst%3DJ.%2BA.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DDrozda%26aufirst%3DS.%2BE.%26aulast%3DVolkmann%26aufirst%3DR.%2BA.%26aulast%3DNason%26aufirst%3DD.%26aulast%3DNelson%26aufirst%3DR.%2BB.%26aulast%3DNolan%26aufirst%3DC.%26aulast%3DListon%26aufirst%3DD.%26aulast%3DWard%26aufirst%3DK.%26aulast%3DFaraci%26aufirst%3DS.%26aulast%3DVerdries%26aufirst%3DK.%26aulast%3DSeymour%26aufirst%3DP.%26aulast%3DMajchrzak%26aufirst%3DM.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWhite%26aufirst%3DW.%2BF.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520potent%252C%2520selective%2520inhibitors%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%2520based%2520on%2520the%25206-phenyl-2-aminopyridine%2520structure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1575%26epage%3D1586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">McCall, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feelisch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moncada, S.</span><span> </span><span class="NLM_article-title">Identification of <i>N</i>-iminoethyl-<span class="smallcaps smallerCapital">l</span>-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">234</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1111%2Fj.1476-5381.1991.tb12159.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=1710525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK3MXpvFyhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1991&pages=234-238&author=T.+B.+McCallauthor=M.+Feelischauthor=R.+M.+Palmerauthor=S.+Moncada&title=Identification+of+N-iminoethyl-l-ornithine+as+an+irreversible+inhibitor+of+nitric+oxide+synthase+in+phagocytic+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells</span></div><div class="casAuthors">McCall, T. B.; Feelisch, M.; Palmer, R. M. J.; Moncada, S.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">234-8</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">The synthesis of nitric oxide (NO) from L-arginine by rat peritoneal neutrophils (PMN) and the murine macrophage cell-line J774 and the inhibition of this synthesis by N-iminoethyl-L-ornithine (L-NIO), NG-monomethyl-L-arginine (L-NMMA), NG-nitro-L-arginine (L-NNA) and its Me ester (L-NAME) was investigated.  L-NIO was the most potent inhibitor in both types of cells while L-NMMA was less active.  L-NNA and L-NAME had no significant effect in PMN and L-NNA produced only approx. 40% inhibition of the generation of NO in J774 cells at the highest concn. tested (300 μM).  The inhibitor effect of L-NIO was rapid in onset, requiring 10 min pre-incubation to achieve its full inhibitory activity, while the other compds. required 20-60 min pre-incubation to achieve their full effect.  The inhibitory effect of L-NIO (10 μM) on intact cells could not be reversed by L-arginine (300 μM) but could be prevented by concomitant incubation with this compd. (300 μM), while the effect of the other inhibitors could be reversed by a 3-5 fold molar excess of L-arginine.  The NO synthase from both PMN and J774 cells was cytosolic and NADPH- but not Ca2+-dependent, with Km values for L-arginine of 3.3 and 4.2 μM resp.  L-NIO was the most potent inhibitor of the neutrophil and J774 enzymes with IC50 values of 0.8 and 3 μM resp.  Furthermore, the effect of L-NIO was irreversible.  The other 3 compds. were less potent, reversible inhibitors.  The inhibitory effects of all these compds. were enantiomerically specific.  These data indicate that L-NIO is a novel, potent, rapid in onset and irreversible inhibitor of NO synthase in phagocytic cells.  The rapid uptake of L-NIO compared with the other compds. indicates that phagocytic cells have different uptake mechanisms for L-arginine and analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOfoSEiO1AYrVg90H21EOLACvtfcHk0lgikujgW4d7DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXpvFyhtA%253D%253D&md5=334f61786b58ce73a3e2b5fcf2fc76cc</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1991.tb12159.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1991.tb12159.x%26sid%3Dliteratum%253Aachs%26aulast%3DMcCall%26aufirst%3DT.%2BB.%26aulast%3DFeelisch%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DR.%2BM.%26aulast%3DMoncada%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520N-iminoethyl-l-ornithine%2520as%2520an%2520irreversible%2520inhibitor%2520of%2520nitric%2520oxide%2520synthase%2520in%2520phagocytic%2520cells%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1991%26volume%3D102%26spage%3D234%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Collins, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearer, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oplinger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnette, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furfine, E. S.</span><span> </span><span class="NLM_article-title"><i>N</i>-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: structure–activity studies and demonstration of in vivo activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2858</span><span class="NLM_x">–</span> <span class="NLM_lpage">2871</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980072p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2858-2871&author=J.+L.+Collinsauthor=B.+G.+Shearerauthor=J.+A.+Oplingerauthor=S.+Leeauthor=E.+P.+Garveyauthor=M.+Salterauthor=C.+Duffyauthor=T.+C.+Burnetteauthor=E.+S.+Furfine&title=N-Phenylamidines+as+selective+inhibitors+of+human+neuronal+nitric+oxide+synthase%3A+structure%E2%80%93activity+studies+and+demonstration+of+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1021%2Fjm980072p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980072p%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DJ.%2BL.%26aulast%3DShearer%26aufirst%3DB.%2BG.%26aulast%3DOplinger%26aufirst%3DJ.%2BA.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DSalter%26aufirst%3DM.%26aulast%3DDuffy%26aufirst%3DC.%26aulast%3DBurnette%26aufirst%3DT.%2BC.%26aulast%3DFurfine%26aufirst%3DE.%2BS.%26atitle%3DN-Phenylamidines%2520as%2520selective%2520inhibitors%2520of%2520human%2520neuronal%2520nitric%2520oxide%2520synthase%253A%2520structure%25E2%2580%2593activity%2520studies%2520and%2520demonstration%2520of%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D2858%26epage%3D2871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Garvey, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oplinger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furfine, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiff, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laszlo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittle, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knowles, R. G.</span><span> </span><span class="NLM_article-title">1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">4959</span><span class="NLM_x">–</span> <span class="NLM_lpage">4963</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=4959-4963&author=E.+P.+Garveyauthor=J.+A.+Oplingerauthor=E.+S.+Furfineauthor=R.+J.+Kiffauthor=F.+Laszloauthor=B.+J.+Whittleauthor=R.+G.+Knowles&title=1400W+is+a+slow%2C+tight+binding%2C+and+highly+selective+inhibitor+of+inducible+nitric-oxide+synthase+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DOplinger%26aufirst%3DJ.%2BA.%26aulast%3DFurfine%26aufirst%3DE.%2BS.%26aulast%3DKiff%26aufirst%3DR.%2BJ.%26aulast%3DLaszlo%26aufirst%3DF.%26aulast%3DWhittle%26aufirst%3DB.%2BJ.%26aulast%3DKnowles%26aufirst%3DR.%2BG.%26atitle%3D1400W%2520is%2520a%2520slow%252C%2520tight%2520binding%252C%2520and%2520highly%2520selective%2520inhibitor%2520of%2520inducible%2520nitric-oxide%2520synthase%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D4959%26epage%3D4963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Maccallini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patruno, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lannutti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammazzalorso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Filippis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantacuzzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franceschelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giampietro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masella, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felaco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Re, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amoroso, R.</span><span> </span><span class="NLM_article-title">N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6495</span><span class="NLM_x">–</span> <span class="NLM_lpage">6499</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6495-6499&author=C.+Maccalliniauthor=A.+Patrunoauthor=F.+Lannuttiauthor=A.+Ammazzalorsoauthor=B.+De+Filippisauthor=M.+Fantacuzziauthor=S.+Franceschelliauthor=L.+Giampietroauthor=S.+Masellaauthor=M.+Felacoauthor=N.+Reauthor=R.+Amoroso&title=N-Substituted+acetamidines+and+2-methylimidazole+derivatives+as+selective+inhibitors+of+neuronal+nitric+oxide+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaccallini%26aufirst%3DC.%26aulast%3DPatruno%26aufirst%3DA.%26aulast%3DLannutti%26aufirst%3DF.%26aulast%3DAmmazzalorso%26aufirst%3DA.%26aulast%3DDe%2BFilippis%26aufirst%3DB.%26aulast%3DFantacuzzi%26aufirst%3DM.%26aulast%3DFranceschelli%26aufirst%3DS.%26aulast%3DGiampietro%26aufirst%3DL.%26aulast%3DMasella%26aufirst%3DS.%26aulast%3DFelaco%26aufirst%3DM.%26aulast%3DRe%26aufirst%3DN.%26aulast%3DAmoroso%26aufirst%3DR.%26atitle%3DN-Substituted%2520acetamidines%2520and%25202-methylimidazole%2520derivatives%2520as%2520selective%2520inhibitors%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6495%26epage%3D6499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group">Reif, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cregan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, J. E.</span><span> </span><span class="NLM_article-title">Discovery and development of neuronal nitric oxide synthase inhibitors</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1470</span><span class="NLM_x">–</span> <span class="NLM_lpage">1477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0891-5849%2800%2900250-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=10927171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltlWgurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=1470-1477&author=D.+W.+Reifauthor=D.+J.+McCarthyauthor=E.+Creganauthor=J.+E.+Macdonald&title=Discovery+and+development+of+neuronal+nitric+oxide+synthase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of neuronal nitric oxide synthase inhibitors</span></div><div class="casAuthors">Reif, D. W.; McCarthy, D. J.; Cregan, E.; Macdonald, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1470-1477</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The role of neuronally derived nitric oxide (NO) in neurotransmission and neural injury remains an area of active investigation.  NO generation has been postulated to be involved in the deleterious events surrounding ischemia/reperfusion injury either directly or via the prodn. of more reactive oxidants such as peroxynitrite.  In our search for novel therapeutics for the treatment of a variety of neurol. diseases including stroke, we have discovered novel, potent, and selective inhibitors of the neuronal nitric oxide synthase (nNOS) isoform.  These compds. have proven to be effective in models of ischemia/reperfusion supporting the role of nNOS in these processes.  The effects of these compds. as well as addnl. aspects crit. to their development will be presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzomMpZL9Od7Vg90H21EOLACvtfcHk0lgNzuyyYq9JDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltlWgurw%253D&md5=4f9b80de4e010baec016f96d66578628</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2800%2900250-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252800%252900250-1%26sid%3Dliteratum%253Aachs%26aulast%3DReif%26aufirst%3DD.%2BW.%26aulast%3DMcCarthy%26aufirst%3DD.%2BJ.%26aulast%3DCregan%26aufirst%3DE.%26aulast%3DMacdonald%26aufirst%3DJ.%2BE.%26atitle%3DDiscovery%2520and%2520development%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%2520inhibitors%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2000%26volume%3D28%26spage%3D1470%26epage%3D1477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group">O’Neill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarty, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicks, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dell, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiernicki, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleisch, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span> </span><span class="NLM_article-title">ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemia</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">871</span><span class="NLM_x">, </span> <span class="NLM_fpage">234</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0006-8993%2800%2902471-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=10899290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFSgt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=871&publication_year=2000&pages=234-244&author=M.+J.+O%E2%80%99Neillauthor=T.+K.+Murrayauthor=D.+R.+McCartyauthor=C.+A.+Hicksauthor=C.+P.+Dellauthor=K.+E.+Patrickauthor=M.+A.+Wardauthor=D.+J.+Osborneauthor=T.+R.+Wiernickiauthor=C.+R.+Romanauthor=D.+Lodgeauthor=J.+H.+Fleischauthor=J.+Singh&title=ARL+17477%2C+a+selective+nitric+oxide+synthase+inhibitor%2C+with+neuroprotective+effects+in+animal+models+of+global+and+focal+cerebral+ischaemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischemia</span></div><div class="casAuthors">O'Neill, M. J.; Murray, T. K.; McCarty, D. R.; Hicks, C. A.; Dell, C. P.; Patrick, K. E.; Ward, M. A.; Osborne, D. J.; Wiernicki, T. R.; Roman, C. R.; Lodge, D.; Fleisch, J. H.; Singh, J.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">871</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">234-244</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">In the present studies, we have evaluated the effects of N-[4-(2-{[(3-Chlorophenyl)methyl]amino}ethyl)phenyl]-2-thiophenecarboximidamide dihydrochloride (ARL 17477) on recombinant human neuronal NOS (nNOS) and endothelial NOS (eNOS).  We then carried out pharmacokinetic studies and measured cortical nitric oxide synthase (NOS) inhibition to det. that the compd. crossed the blood brain barrier.  Finally, the compd. was evaluated in a model of global ischemia in the gerbil and two models of transient focal ischemia in the rat.  The IC50 values for ARL 17477 on human recombinant human nNOS and eNOS were 1 and 17 μM, resp.  ARL 17477 (50 mg/kg i.p.) produced a significant redn. in the ischemia-induced hippocampal damage following global ischemia when administered immediately post-occlusion, but failed to protect when administration was delayed until 30 min post-occlusion.  In the endothelin-1 model of focal ischemia, ARL 17477 (1 mg/kg i.v.) significantly attenuated the infarct vol. when administered at either 0, 1 or 2 h post-endothelin-1 (P<0.05).  In the intraluminal suture model, ARL 17477 at both 1 and 3 mg/kg i.v. failed to reduce the infarct vol. measured at 1, 3 or 7 days post-occlusion.  These results demonstrate that ARL 17477 protects against global ischemia in gerbils and provides some redn. in infarct vol. following transient middle cerebral artery occlusion in rats, indicating that nNOS inhibition may be a useful treatment of ischemic conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSnwwa_fNHhLVg90H21EOLACvtfcHk0lgNzuyyYq9JDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFSgt7Y%253D&md5=1fc64ac43699e9bc54747a3a1a35eef5</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2800%2902471-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252800%252902471-9%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DM.%2BJ.%26aulast%3DMurray%26aufirst%3DT.%2BK.%26aulast%3DMcCarty%26aufirst%3DD.%2BR.%26aulast%3DHicks%26aufirst%3DC.%2BA.%26aulast%3DDell%26aufirst%3DC.%2BP.%26aulast%3DPatrick%26aufirst%3DK.%2BE.%26aulast%3DWard%26aufirst%3DM.%2BA.%26aulast%3DOsborne%26aufirst%3DD.%2BJ.%26aulast%3DWiernicki%26aufirst%3DT.%2BR.%26aulast%3DRoman%26aufirst%3DC.%2BR.%26aulast%3DLodge%26aufirst%3DD.%26aulast%3DFleisch%26aufirst%3DJ.%2BH.%26aulast%3DSingh%26aufirst%3DJ.%26atitle%3DARL%252017477%252C%2520a%2520selective%2520nitric%2520oxide%2520synthase%2520inhibitor%252C%2520with%2520neuroprotective%2520effects%2520in%2520animal%2520models%2520of%2520global%2520and%2520focal%2520cerebral%2520ischaemia%26jtitle%3DBrain%2520Res.%26date%3D2000%26volume%3D871%26spage%3D234%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Fedorov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlichting, I.</span><span> </span><span class="NLM_article-title">Structures of nitric oxide synthase isoforms complexed with the inhibitor AR-R17477 suggest a rational basis for specificity and inhibitor design</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">5892</span><span class="NLM_x">–</span> <span class="NLM_lpage">5897</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=5892-5897&author=R.+Fedorovauthor=R.+Vasanauthor=D.+K.+Ghoshauthor=I.+Schlichting&title=Structures+of+nitric+oxide+synthase+isoforms+complexed+with+the+inhibitor+AR-R17477+suggest+a+rational+basis+for+specificity+and+inhibitor+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFedorov%26aufirst%3DR.%26aulast%3DVasan%26aufirst%3DR.%26aulast%3DGhosh%26aufirst%3DD.%2BK.%26aulast%3DSchlichting%26aufirst%3DI.%26atitle%3DStructures%2520of%2520nitric%2520oxide%2520synthase%2520isoforms%2520complexed%2520with%2520the%2520inhibitor%2520AR-R17477%2520suggest%2520a%2520rational%2520basis%2520for%2520specificity%2520and%2520inhibitor%2520design%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D5892%26epage%3D5897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group">Renton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddaford, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakhit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, J. S.</span><span> </span><span class="NLM_article-title">Novel dual action neuronal nitric oxide synthase inhibitors with μ-opioid agonist activity</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml200268w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=227-231&author=P.+Rentonauthor=B.+Greenauthor=S.+P.+Maddafordauthor=S.+Rakhitauthor=J.+S.+Andrews&title=Novel+dual+action+neuronal+nitric+oxide+synthase+inhibitors+with+%CE%BC-opioid+agonist+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1021%2Fml200268w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200268w%26sid%3Dliteratum%253Aachs%26aulast%3DRenton%26aufirst%3DP.%26aulast%3DGreen%26aufirst%3DB.%26aulast%3DMaddaford%26aufirst%3DS.%2BP.%26aulast%3DRakhit%26aufirst%3DS.%26aulast%3DAndrews%26aufirst%3DJ.%2BS.%26atitle%3DNovel%2520dual%2520action%2520neuronal%2520nitric%2520oxide%2520synthase%2520inhibitors%2520with%2520%25CE%25BC-opioid%2520agonist%2520activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D227%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group">Annedi, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramnauth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddaford, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakhit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mladenova, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dove, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felice, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span> </span><span class="NLM_article-title">Discovery of <i>cis</i>-<i>N</i>-(1-(4-(methylamino)cyclohexyl)indolin-6-yl)thiophene-2-carboximidamide: a 1,6-disubstituted indoline derivative as a highly selective inhibitor of human neuronal nitric oxide synthase (nNOS) without any cardiovascular liabilities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">943</span><span class="NLM_x">–</span> <span class="NLM_lpage">955</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201564u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=943-955&author=S.+C.+Annediauthor=J.+Ramnauthauthor=S.+P.+Maddafordauthor=P.+Rentonauthor=S.+Rakhitauthor=G.+Mladenovaauthor=P.+Doveauthor=S.+Silvermanauthor=J.+S.+Andrewsauthor=M.+D.+Feliceauthor=F.+Porreca&title=Discovery+of+cis-N-%281-%284-%28methylamino%29cyclohexyl%29indolin-6-yl%29thiophene-2-carboximidamide%3A+a+1%2C6-disubstituted+indoline+derivative+as+a+highly+selective+inhibitor+of+human+neuronal+nitric+oxide+synthase+%28nNOS%29+without+any+cardiovascular+liabilities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1021%2Fjm201564u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201564u%26sid%3Dliteratum%253Aachs%26aulast%3DAnnedi%26aufirst%3DS.%2BC.%26aulast%3DRamnauth%26aufirst%3DJ.%26aulast%3DMaddaford%26aufirst%3DS.%2BP.%26aulast%3DRenton%26aufirst%3DP.%26aulast%3DRakhit%26aufirst%3DS.%26aulast%3DMladenova%26aufirst%3DG.%26aulast%3DDove%26aufirst%3DP.%26aulast%3DSilverman%26aufirst%3DS.%26aulast%3DAndrews%26aufirst%3DJ.%2BS.%26aulast%3DFelice%26aufirst%3DM.%2BD.%26aulast%3DPorreca%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520cis-N-%25281-%25284-%2528methylamino%2529cyclohexyl%2529indolin-6-yl%2529thiophene-2-carboximidamide%253A%2520a%25201%252C6-disubstituted%2520indoline%2520derivative%2520as%2520a%2520highly%2520selective%2520inhibitor%2520of%2520human%2520neuronal%2520nitric%2520oxide%2520synthase%2520%2528nNOS%2529%2520without%2520any%2520cardiovascular%2520liabilities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D943%26epage%3D955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group">Maddaford, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annedi, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramnauth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakhit, S.</span><span> </span><span class="NLM_article-title">Advancements in the development of nitric oxide synthase inhibitors</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=27-50&author=S.+Maddafordauthor=S.+C.+Annediauthor=J.+Ramnauthauthor=S.+Rakhit&title=Advancements+in+the+development+of+nitric+oxide+synthase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaddaford%26aufirst%3DS.%26aulast%3DAnnedi%26aufirst%3DS.%2BC.%26aulast%3DRamnauth%26aufirst%3DJ.%26aulast%3DRakhit%26aufirst%3DS.%26atitle%3DAdvancements%2520in%2520the%2520development%2520of%2520nitric%2520oxide%2520synthase%2520inhibitors%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D27%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group">Serafim, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Primi, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trossini, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, E. I.</span><span> </span><span class="NLM_article-title">Nitric oxide: state of the art in drug design</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">386</span><span class="NLM_x">–</span> <span class="NLM_lpage">405</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.2174%2F092986712803414321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=22335514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=386-405&author=R.+A.+Serafimauthor=M.+C.+Primiauthor=G.+H.+Trossiniauthor=E.+I.+Ferreira&title=Nitric+oxide%3A+state+of+the+art+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide: state of the art in drug design</span></div><div class="casAuthors">Serafim, R. A. M.; Primi, M. C.; Trossini, G. H. G.; Ferreira, E. I.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">386-405</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Since the great discovery of Furchgott, Ignarro and Murad in the late 90's, nitric oxide (NO) is considered one of the most versatile endogenous mols., which is involved in important signaling biochem. pathways of the human body.  Thus, it is directly related to pathol. processes and its over- or low-prodn. is able to cause damage in systems that are involved.  By using certain functional groups present in mols. that already have potential therapeutic value, hybrid compds., by means of inclusion of NO-donors (e.g., ester nitrates, furoxans, benzofuroxans, NONOates, S-nitrosothiols, metal complexes), can be generated that have a NO release benefit along with maintaining the activity of the native drug.  This approach has proved to be useful in many spheres of Medicinal Chem., such as cardiovascular, inflammatory, bacterial, fungal, viral, parasitic, ocular diseases and cancer.  Potent and selective nitric oxide synthase inhibitors are being designed, mainly through enzyme structure based process, however, due to high homol. between the isoforms, these studies have proved to be very difficult.  The objective of the research is to achieve a balance between the release of therapeutic amts. of NO, esp. in specific site of action, and maintaining the native drug activity.  The search for new and effective NO-donor hybrid drugs, as well as selective nitric oxide synthase inhibitors, is an important focus in modern drug design in order to manipulate biochem. pathways involving NO that influence many dysfunctions of the human organism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3_yT_6c0DALVg90H21EOLACvtfcHk0ljLMoTlqiKAKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqtro%253D&md5=67e1c78173020957b89e009e5e605860</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.2174%2F092986712803414321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712803414321%26sid%3Dliteratum%253Aachs%26aulast%3DSerafim%26aufirst%3DR.%2BA.%26aulast%3DPrimi%26aufirst%3DM.%2BC.%26aulast%3DTrossini%26aufirst%3DG.%2BH.%26aulast%3DFerreira%26aufirst%3DE.%2BI.%26atitle%3DNitric%2520oxide%253A%2520state%2520of%2520the%2520art%2520in%2520drug%2520design%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D386%26epage%3D405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group">Payne, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnefous, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sablad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rozenkrants, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yazdani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiau, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rix, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassig, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, N. D.</span><span> </span><span class="NLM_article-title">Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-(2-cyclobutyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1<i>H</i>)-one (KD7332). Part 2: Identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS dimerization inhibitors that are orally active in pain models</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7739</span><span class="NLM_x">–</span> <span class="NLM_lpage">7755</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100828n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7739-7755&author=J.+E.+Payneauthor=C.+Bonnefousauthor=K.+T.+Symonsauthor=P.+M.+Nguyenauthor=M.+Sabladauthor=N.+Rozenkrantsauthor=Y.+Zhangauthor=L.+Wangauthor=N.+Yazdaniauthor=A.+K.+Shiauauthor=S.+A.+Nobleauthor=P.+Rixauthor=T.+S.+Raoauthor=C.+A.+Hassigauthor=N.+D.+Smith&title=Discovery+of+dual+inducible%2Fneuronal+nitric+oxide+synthase+%28iNOS%2FnNOS%29+inhibitor+development+candidate+4-%282-cyclobutyl-1H-imidazo%5B4%2C5-b%5Dpyrazin-1-yl%29methyl%29-7%2C8-difluoroquinolin-2%281H%29-one+%28KD7332%29.+Part+2%3A+Identification+of+a+novel%2C+potent%2C+and+selective+series+of+benzimidazole-quinolinone+iNOS%2FnNOS+dimerization+inhibitors+that+are+orally+active+in+pain+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1021%2Fjm100828n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100828n%26sid%3Dliteratum%253Aachs%26aulast%3DPayne%26aufirst%3DJ.%2BE.%26aulast%3DBonnefous%26aufirst%3DC.%26aulast%3DSymons%26aufirst%3DK.%2BT.%26aulast%3DNguyen%26aufirst%3DP.%2BM.%26aulast%3DSablad%26aufirst%3DM.%26aulast%3DRozenkrants%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYazdani%26aufirst%3DN.%26aulast%3DShiau%26aufirst%3DA.%2BK.%26aulast%3DNoble%26aufirst%3DS.%2BA.%26aulast%3DRix%26aufirst%3DP.%26aulast%3DRao%26aufirst%3DT.%2BS.%26aulast%3DHassig%26aufirst%3DC.%2BA.%26aulast%3DSmith%26aufirst%3DN.%2BD.%26atitle%3DDiscovery%2520of%2520dual%2520inducible%252Fneuronal%2520nitric%2520oxide%2520synthase%2520%2528iNOS%252FnNOS%2529%2520inhibitor%2520development%2520candidate%25204-%25282-cyclobutyl-1H-imidazo%255B4%252C5-b%255Dpyrazin-1-yl%2529methyl%2529-7%252C8-difluoroquinolin-2%25281H%2529-one%2520%2528KD7332%2529.%2520Part%25202%253A%2520Identification%2520of%2520a%2520novel%252C%2520potent%252C%2520and%2520selective%2520series%2520of%2520benzimidazole-quinolinone%2520iNOS%252FnNOS%2520dimerization%2520inhibitors%2520that%2520are%2520orally%2520active%2520in%2520pain%2520models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7739%26epage%3D7755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group">Matter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, H. S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotsonis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fröhlich, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reif, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfleiderer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheurer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlichting, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, H. H. H. W.</span><span> </span><span class="NLM_article-title">Structural analysis of isoform-specific inhibitors targeting the tetrahydrobiopterin binding site of human nitric oxide synthases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4783</span><span class="NLM_x">–</span> <span class="NLM_lpage">4792</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4783-4792&author=H.+Matterauthor=H.+S.+A.+Kumarauthor=R.+Fedorovauthor=A.+Freyauthor=P.+Kotsonisauthor=E.+Hartmannauthor=L.+G.+Fr%C3%B6hlichauthor=A.+Reifauthor=W.+Pfleidererauthor=P.+Scheurerauthor=D.+K.+Ghoshauthor=I.+Schlichtingauthor=H.+H.+H.+W.+Schmidt&title=Structural+analysis+of+isoform-specific+inhibitors+targeting+the+tetrahydrobiopterin+binding+site+of+human+nitric+oxide+synthases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1021%2Fjm050007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050007x%26sid%3Dliteratum%253Aachs%26aulast%3DMatter%26aufirst%3DH.%26aulast%3DKumar%26aufirst%3DH.%2BS.%2BA.%26aulast%3DFedorov%26aufirst%3DR.%26aulast%3DFrey%26aufirst%3DA.%26aulast%3DKotsonis%26aufirst%3DP.%26aulast%3DHartmann%26aufirst%3DE.%26aulast%3DFr%25C3%25B6hlich%26aufirst%3DL.%2BG.%26aulast%3DReif%26aufirst%3DA.%26aulast%3DPfleiderer%26aufirst%3DW.%26aulast%3DScheurer%26aufirst%3DP.%26aulast%3DGhosh%26aufirst%3DD.%2BK.%26aulast%3DSchlichting%26aufirst%3DI.%26aulast%3DSchmidt%26aufirst%3DH.%2BH.%2BH.%2BW.%26atitle%3DStructural%2520analysis%2520of%2520isoform-specific%2520inhibitors%2520targeting%2520the%2520tetrahydrobiopterin%2520binding%2520site%2520of%2520human%2520nitric%2520oxide%2520synthases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4783%26epage%3D4792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group">Behl, C.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease and oxidative stress: implications for novel therapeutic approaches</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0301-0082%2898%2900055-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=10096843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1MXkslyltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1999&pages=301-323&author=C.+Behl&title=Alzheimer%E2%80%99s+disease+and+oxidative+stress%3A+implications+for+novel+therapeutic+approaches"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease and oxidative stress: Implications for novel therapeutic approaches</span></div><div class="casAuthors">Behl, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">301-323</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 293 refs.  Alzheimer's disease (AD) is a progressive neurodegenerative disorder with a deadly outcome.  AD is the leading cause of senile dementia and although the pathogenesis of this disorder is not known, various hypotheses have been developed based on exptl. data accumulated since the initial description of this disease by Alois Alzheimer about 90 yr ago.  Most approaches to explain the pathogenesis of AD focus on its two histopathol. hallmarks, the amyloid β protein- (Aβ-) loaded senile plaques and the neurofibrillary tangles, which consist of the filament protein tau.  Various lines of genetic evidence support a central role of Aβ in the pathogenesis of AD and an increasing no. of studies show that oxidn. reactions occur in AD and that Aβ may be one mol. link between oxidative stress and AD-assocd. neuronal cell death.  Aβ itself can be neurotoxic and can induce oxidative stress in cultivated neurons.  Aβ is, therefore, one player in the concert of oxidative reactions that challenge neurons besides inflammatory reactions which are also assocd. with the AD pathol.  Consequently, antioxidant approaches for the prevention and therapy of AD are of central interest.  Exptl. as well as clin. data show that lipophilic antioxidants, such as vitamin E and estrogens, are neuroprotective and may help patients suffering from AD.  While an addnl. intensive elucidation of the cellular and mol. events of neuronal cell death in AD will, ultimately, lead to novel drug targets, various antioxidants are already available for a further exploitation of their preventive and therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN-ulfiWkcxLVg90H21EOLACvtfcHk0liRvqATx4M3gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkslyltQ%253D%253D&md5=10be10b699e72402337e4dc8c4635d5f</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1016%2FS0301-0082%2898%2900055-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-0082%252898%252900055-0%26sid%3Dliteratum%253Aachs%26aulast%3DBehl%26aufirst%3DC.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520and%2520oxidative%2520stress%253A%2520implications%2520for%2520novel%2520therapeutic%2520approaches%26jtitle%3DProg.%2520Neurobiol.%26date%3D1999%26volume%3D57%26spage%3D301%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group">Christen, Y.</span><span> </span><span class="NLM_article-title">Oxidative stress and Alzheimer disease</span> <span class="citation_source-journal">Am. J. Clin. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">621S</span><span class="NLM_x">–</span> <span class="NLM_lpage">629S</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1093%2Fajcn%2F71.2.621s" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=10681270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD3c7kt1Oguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2000&pages=621S-629S&author=Y.+Christen&title=Oxidative+stress+and+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress and Alzheimer disease</span></div><div class="casAuthors">Christen Y</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of clinical nutrition</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">621S-629S</span>
        ISSN:<span class="NLM_cas:issn">0002-9165</span>.
    </div><div class="casAbstract">Research in the field of molecular biology has helped to provide a better understanding of both the cascade of biochemical events that occurs with Alzheimer disease (AD) and the heterogeneous nature of the disease.  One hypothesis that accounts for both the heterogeneous nature of AD and the fact that aging is the most obvious risk factor is that free radicals are involved.  The probability of this involvement is supported by the fact that neurons are extremely sensitive to attacks by destructive free radicals.  Furthermore, lesions are present in the brains of AD patients that are typically associated with attacks by free radicals (eg, damage to DNA, protein oxidation, lipid peroxidation, and advanced glycosylation end products), and metals (eg, iron, copper, zinc, and aluminum) are present that have catalytic activity that produce free radicals. beta-Amyloid is aggregated and produces more free radicals in the presence of free radicals; beta-amyloid toxicity is eliminated by free radical scavengers.  Apolipoprotein E is subject to attacks by free radicals, and apolipoprotein E peroxidation has been correlated with AD.  In contrast, apolipoprotein E can act as a free radical scavenger and this behavior is isoform dependent.  AD has been linked to mitochondrial anomalies affecting cytochrome-c oxidase, and these anomalies may contribute to the abnormal production of free radicals.  Finally, many free radical scavengers (eg, vitamin E, selegeline, and Ginkgo biloba extract EGb 761) have produced promising results in relation to AD, as has desferrioxamine-an iron-chelating agent-and antiinflammatory drugs and estrogens, which also have an antioxidant effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRjZRhxHc0mgYFEOhA_Im3cfW6udTcc2ebiadWlNGJZobntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7kt1Oguw%253D%253D&md5=e47395137b1aa3c380f1190ff3f5d29c</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1093%2Fajcn%2F71.2.621s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fajcn%252F71.2.621s%26sid%3Dliteratum%253Aachs%26aulast%3DChristen%26aufirst%3DY.%26atitle%3DOxidative%2520stress%2520and%2520Alzheimer%2520disease%26jtitle%3DAm.%2520J.%2520Clin.%2520Nutr.%26date%3D2000%26volume%3D71%26spage%3D621S%26epage%3D629S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group">Harman, D.</span><span> </span><span class="NLM_article-title">A hypothesis on the pathogenesis of Alzheimer’s disease</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">786</span><span class="NLM_x">, </span> <span class="NLM_fpage">152</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=786&publication_year=1996&pages=152-168&author=D.+Harman&title=A+hypothesis+on+the+pathogenesis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarman%26aufirst%3DD.%26atitle%3DA%2520hypothesis%2520on%2520the%2520pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D1996%26volume%3D786%26spage%3D152%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group">Joseph, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukitt-Hale, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denisova, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. A.</span><span> </span><span class="NLM_article-title">Copernicus revisited: amyloid beta in Alzheimer’s disease</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0197-4580%2800%2900211-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11164287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD3MzgtVGntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2001&pages=131-146&author=J.+Josephauthor=B.+Shukitt-Haleauthor=N.+A.+Denisovaauthor=A.+Martinauthor=G.+Perryauthor=M.+A.+Smith&title=Copernicus+revisited%3A+amyloid+beta+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Copernicus revisited: amyloid beta in Alzheimer's disease</span></div><div class="casAuthors">Joseph J; Shukitt-Hale B; Denisova N A; Martin A; Perry G; Smith M A</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of aging</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">131-46</span>
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    </div><div class="casAbstract">The beta-amyloid hypothesis of Alzheimer's Disease (AD) has dominated the thinking and research in this area for over a decade and a half.  While there has been a great deal of effort in attempting to prove its centrality in this devastating disease, and while an enormous amount has been learned about its properties (e.g., putative toxicity, processing and signaling), Abeta has not proven to be both necessary and sufficient for the development, neurotoxicity, and cognitive deficits associated with this disease.  Instead, the few treatments that are available have emerged from aging research and are primarily directed toward modification of acetylcholine levels.  Clearly, it is time to rethink this position and to propose instead that future approaches should focus upon altering the age-related sensitivity of the neuronal environment to insults involving such factors as inflammation and oxidative stress.  In other words "solve the problems of aging and by extension those of AD will also be reduced." This review is being submitted as a rather Lutherian attempt to "nail an alternative thesis" to the gate of the Church of the Holy Amyloid to open its doors to the idea that aging is the most pervasive element in this disease and Abeta is merely one of the planets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTLOmhNe5JnPZZoeNcnHOQ9fW6udTcc2eYcExgFJ1pugrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MzgtVGntg%253D%253D&md5=bfae663fb0e1c8d41ce28196a5eb5109</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1016%2FS0197-4580%2800%2900211-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-4580%252800%252900211-6%26sid%3Dliteratum%253Aachs%26aulast%3DJoseph%26aufirst%3DJ.%26aulast%3DShukitt-Hale%26aufirst%3DB.%26aulast%3DDenisova%26aufirst%3DN.%2BA.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DPerry%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26atitle%3DCopernicus%2520revisited%253A%2520amyloid%2520beta%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2001%26volume%3D22%26spage%3D131%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group">Markesbery, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carney, J. M.</span><span> </span><span class="NLM_article-title">Oxidative alterations in Alzheimer’s disease</span> <span class="citation_source-journal">Brain Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1111%2Fj.1750-3639.1999.tb00215.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=9989456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1MXht1Cmsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=133-146&author=W.+R.+Markesberyauthor=J.+M.+Carney&title=Oxidative+alterations+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative alterations in Alzheimer's disease</span></div><div class="casAuthors">Markesbery, William R.; Carney, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Pathology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">133-146</span>CODEN:
                <span class="NLM_cas:coden">BRPAE7</span>;
        ISSN:<span class="NLM_cas:issn">1015-6305</span>.
    
            (<span class="NLM_cas:orgname">International Society of Neuropathology</span>)
        </div><div class="casAbstract">A review with 136 refs.  There is increasing evidence that free radical damage to brain lipids, carbohydrates, proteins, and DNA is involved in neuron death in neurodegenerative disorders.  The largest no. of studies have been performed in Alzheimer's disease (AD) where there is considerable support for the oxidative stress hypothesis in the pathogenesis of neuron degeneration.  In autopsied brain there is an increase in lipid peroxidn., a decline in polyunsatd. fatty acids (PUFA) and an increase in 4-hydroxynonenal (HNE), a neurotoxic aldehyde product of PUFA oxidn.  Increased protein oxidn. and a marked decline in oxidative-sensitive enzymes, glutamine synthetase and creatinine kinase, are found in the brain in AD.  Increased DNA oxidn., esp. 8-hydroxy-2'-deoxyguanosine (8-OHdG) is present in the brain in AD.  Immunohistochem. studies show the presence of oxidative stress products in neurofibrillary tangles and senile plaques in AD.  Markers of lipid peroxidn. (HNE, isoprostanes) and DNA (8-OHdG) are increased in CSF in AD.  In addn., inflammatory response markers (the complement cascade, cytokines, acute phase reactants and proteases) are present in the brain in AD.  These findings, coupled with epidemiol. studies showing that anti-inflammatory agents slow the progression or delay the onset of AD, suggest that inflammation plays a role in AD.  Overall these studies indicate that oxidative stress and the inflammatory cascade, working in concert, are important in the pathogenetic cascade of neurodegeneration in AD, suggesting that therapeutic efforts aimed at both of these mechanisms may be beneficial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQLMrceQruxrVg90H21EOLACvtfcHk0lhFCETehFZtyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXht1Cmsbw%253D&md5=e79d14e67f9ae9f1c00ca6a667dc8c6c</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1111%2Fj.1750-3639.1999.tb00215.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1750-3639.1999.tb00215.x%26sid%3Dliteratum%253Aachs%26aulast%3DMarkesbery%26aufirst%3DW.%2BR.%26aulast%3DCarney%26aufirst%3DJ.%2BM.%26atitle%3DOxidative%2520alterations%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBrain%2520Pathol.%26date%3D1999%26volume%3D9%26spage%3D133%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group">Prasad, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hovland, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nahreini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards-Prasad, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreatta, C. P.</span><span> </span><span class="NLM_article-title">Multiple antioxidants in the prevention and treatment of Alzheimer disease: analysis of biologic rationale</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2000&pages=2-13&author=K.+N.+Prasadauthor=A.+R.+Hovlandauthor=W.+C.+Coleauthor=K.+C.+Prasadauthor=P.+Nahreiniauthor=J.+Edwards-Prasadauthor=C.+P.+Andreatta&title=Multiple+antioxidants+in+the+prevention+and+treatment+of+Alzheimer+disease%3A+analysis+of+biologic+rationale"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrasad%26aufirst%3DK.%2BN.%26aulast%3DHovland%26aufirst%3DA.%2BR.%26aulast%3DCole%26aufirst%3DW.%2BC.%26aulast%3DPrasad%26aufirst%3DK.%2BC.%26aulast%3DNahreini%26aufirst%3DP.%26aulast%3DEdwards-Prasad%26aufirst%3DJ.%26aulast%3DAndreatta%26aufirst%3DC.%2BP.%26atitle%3DMultiple%2520antioxidants%2520in%2520the%2520prevention%2520and%2520treatment%2520of%2520Alzheimer%2520disease%253A%2520analysis%2520of%2520biologic%2520rationale%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2000%26volume%3D23%26spage%3D2%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group">Beal, M. F.</span><span> </span><span class="NLM_article-title">Experimental models of Parkinson’s disease</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2F35072550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11331916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjs1Ogtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=325-334&author=M.+F.+Beal&title=Experimental+models+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental models of Parkinson's disease</span></div><div class="casAuthors">Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">325-332</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review, with 105 refs.  Research into the pathogenesis of Parkinson's disease has been rapidly advanced by the development of animal models.  Initial models were developed by using toxins that specifically targeted dopamine neurons, the most successful of which used 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a toxin that causes parkinsonism in man.  More recently, the identification of α-synuclein mutations as a rare cause of Parkinson's disease has led to the development of α-synuclein transgenic mice and Drosophila.  Here, I discuss the merits and limitations of these different animal models in our attempts to understand the physiol. of parkinson's disease and to develop new therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1Lsui9cNvDbVg90H21EOLACvtfcHk0lhFCETehFZtyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjs1Ogtrs%253D&md5=cf528476d8ad3bbf95b9bd8ed3701c6e</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1038%2F35072550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35072550%26sid%3Dliteratum%253Aachs%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DExperimental%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2001%26volume%3D2%26spage%3D325%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group">Blum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nissou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benabid, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadoul, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verna, J. M.</span><span> </span><span class="NLM_article-title">Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson’s disease</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0301-0082%2801%2900003-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11403877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkt1Kitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2001&pages=135-172&author=D.+Blumauthor=S.+Torchauthor=N.+Lambengauthor=M.+Nissouauthor=A.+L.+Benabidauthor=R.+Sadoulauthor=J.+M.+Verna&title=Molecular+pathways+involved+in+the+neurotoxicity+of+6-OHDA%2C+dopamine+and+MPTP%3A+contribution+to+the+apoptotic+theory+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease</span></div><div class="casAuthors">Blum, D.; Torch, S.; Lambeng, N.; Nissou, M.-F.; Benabid, A.-L.; Sadoul, R.; Verna, J.-M.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-172</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is a neurodegenerative disorder characterized by a preferential loss of the dopaminergic neurons of the substantia nigra pars compacta.  Although the etiol. of PD is unknown, major biochem. processes such as oxidative stress and mitochondrial inhibition are largely described.  However, despite these findings, the actual therapeutics are essentially symptomatical and are not able to block the degenerative process.  Recent histol. studies performed on brains from PD patients suggest that nigral cell death could be apoptotic.  However, since post-mortem studies do not allow precise detn. of the sequence of events leading to this apoptotic cell death, the mol. pathways involved in this process have been essentially studied on exptl. models reproducing the human disease.  These latter are created by using neurotoxic compds. such as 6-hydroxydopamine (6-OHDA), 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or dopamine (DA).  Extensive study of these models have shown that they mimic, in vitro and in vivo, the histol. and/or the biochem. characteristics of PD and thus help to define important cellular actors of cell death presumably crit. for the nigral degeneration.  This review reports recent data concerning the biochem. and mol. apoptotic mechanisms underlying the exptl. models of PD and correlates them to the phenomena occurring in human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp06yzzR3ObwbVg90H21EOLACvtfcHk0lhFCETehFZtyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkt1Kitbo%253D&md5=61afe1d88da62953d6b34b1f87482e5f</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1016%2FS0301-0082%2801%2900003-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-0082%252801%252900003-X%26sid%3Dliteratum%253Aachs%26aulast%3DBlum%26aufirst%3DD.%26aulast%3DTorch%26aufirst%3DS.%26aulast%3DLambeng%26aufirst%3DN.%26aulast%3DNissou%26aufirst%3DM.%26aulast%3DBenabid%26aufirst%3DA.%2BL.%26aulast%3DSadoul%26aufirst%3DR.%26aulast%3DVerna%26aufirst%3DJ.%2BM.%26atitle%3DMolecular%2520pathways%2520involved%2520in%2520the%2520neurotoxicity%2520of%25206-OHDA%252C%2520dopamine%2520and%2520MPTP%253A%2520contribution%2520to%2520the%2520apoptotic%2520theory%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DProg.%2520Neurobiol.%26date%3D2001%26volume%3D65%26spage%3D135%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group">Foley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, P.</span><span> </span><span class="NLM_article-title">Influence of neurotoxins and oxidative stress on the onset and progression of Parkinson’s disease</span> <span class="citation_source-journal">J. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">247</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">II82</span><span class="NLM_x">–</span> <span class="NLM_lpage">II94</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=247&publication_year=2000&pages=II82-II94&issue=Suppl.+2&author=P.+Foleyauthor=P.+Riederer&title=Influence+of+neurotoxins+and+oxidative+stress+on+the+onset+and+progression+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoley%26aufirst%3DP.%26aulast%3DRiederer%26aufirst%3DP.%26atitle%3DInfluence%2520of%2520neurotoxins%2520and%2520oxidative%2520stress%2520on%2520the%2520onset%2520and%2520progression%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurol.%26date%3D2000%26volume%3D247%26issue%3DSuppl.%25202%26spage%3DII82%26epage%3DII94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group">Gerlach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, P.</span><span> </span><span class="NLM_article-title">Animal models of Parkinson’s disease: an empirical comparison with the phenomenology of the disease in man</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">1041</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1996&pages=987-1041&author=M.+Gerlachauthor=P.+Riederer&title=Animal+models+of+Parkinson%E2%80%99s+disease%3A+an+empirical+comparison+with+the+phenomenology+of+the+disease+in+man"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGerlach%26aufirst%3DM.%26aulast%3DRiederer%26aufirst%3DP.%26atitle%3DAnimal%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520an%2520empirical%2520comparison%2520with%2520the%2520phenomenology%2520of%2520the%2520disease%2520in%2520man%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D1996%26volume%3D103%26spage%3D987%26epage%3D1041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group">Browne, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrante, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, M. F.</span><span> </span><span class="NLM_article-title">Oxidative stress in Huntington’s disease</span> <span class="citation_source-journal">Brain Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1111%2Fj.1750-3639.1999.tb00216.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=9989457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1MXht1Cmsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=147-163&author=S.+E.+Browneauthor=R.+J.+Ferranteauthor=M.+F.+Beal&title=Oxidative+stress+in+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress in Huntington's disease</span></div><div class="casAuthors">Browne, Susan E.; Ferrante, Robert J.; Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Brain Pathology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">147-163</span>CODEN:
                <span class="NLM_cas:coden">BRPAE7</span>;
        ISSN:<span class="NLM_cas:issn">1015-6305</span>.
    
            (<span class="NLM_cas:orgname">International Society of Neuropathology</span>)
        </div><div class="casAbstract">A review with 105 refs.  It has been five years since the elucidation of the genetic mutation underlying the pathogenesis of Huntington's disease (HD) (97), however the precise mechanism of the selective neuronal death it propagates still remains an enigma.  Several different etiol. processes may play roles, and strong evidence from studies in both humans and animal models suggests the involvement of energy metab. dysfunction, excitotoxic processes, and oxidative stress.  Importantly, the recent development of transgenic mouse models of HD led to the identification of neuronal intranuclear inclusion bodies in affected brain regions in both mouse models and in HD brain, consisting of protein aggregates contg. fragments of mutant huntingtin protein.  These observations opened new avenues of investigation into possible huntingtin protein interactions and their putative pathogenetic sequelae.  Amongst these studies, findings of elevated levels of oxidative damage products such as malondialdehyde, 8-hydroxy-deoxyguanosine, 3-nitrotyrosine and heme oxygenase in areas of degeneration in HD brain, and of increased free radical prodn. in animal models, indicate the involvement of oxidative stress either as a causative event, or as a secondary constituent of the cell death cascade in the disease.  Here the authors review the evidence for oxidative damage and potential mechanisms of neuronal death in HD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdG6l3odjA7LVg90H21EOLACvtfcHk0liJp5Rs3xP-Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXht1Cmsb0%253D&md5=7d5f3ea8cef42c6bb3f102554889aefe</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1111%2Fj.1750-3639.1999.tb00216.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1750-3639.1999.tb00216.x%26sid%3Dliteratum%253Aachs%26aulast%3DBrowne%26aufirst%3DS.%2BE.%26aulast%3DFerrante%26aufirst%3DR.%2BJ.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DOxidative%2520stress%2520in%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DBrain%2520Pathol.%26date%3D1999%26volume%3D9%26spage%3D147%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group">Pedersen, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markesbery, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasarskis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, M. P.</span><span> </span><span class="NLM_article-title">Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">819</span><span class="NLM_x">–</span> <span class="NLM_lpage">824</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1002%2Fana.410440518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=9818940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1cXnsFChtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1998&pages=819-824&author=W.+A.+Pedersenauthor=W.+Fuauthor=J.+N.+Kellerauthor=W.+R.+Markesberyauthor=S.+Appelauthor=R.+G.+Smithauthor=E.+Kasarskisauthor=M.+P.+Mattson&title=Protein+modification+by+the+lipid+peroxidation+product+4-hydroxynonenal+in+the+spinal+cords+of+amyotrophic+lateral+sclerosis+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients</span></div><div class="casAuthors">Pedersen, Ward A.; Fu, Weiming; Keller, Jeffrey N.; Markesbery, William R.; Appel, Stanley; Smith, Glenn; Kasarskis, Edward; Mattson, Mark P.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">819-824</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">We report increased modification of proteins by 4-hydroxynonenal (HNE), a product of membrane lipid peroxidn., in the lumbar spinal cord of sporadic amyotrophic lateral sclerosis (ALS) patients vs. that of neurol. normal controls.  By immunohistochem., HNE-protein modification was detected in ventral horn motor neurons, and immunopptn. anal. revealed that one of the proteins modified by HNE was the astrocytic glutamate transporter EAAT2.  Given that the function of proteins modified by HNE can be severely compromised as previously demonstrated for glutamate transporters in cortical synaptosome prepns., our findings suggest a scenario in which oxidative stress leads to the prodn. of HNE, impairment of glutamate transport, and excitotoxic motor neuron degeneration in ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIlWrEwLxZALVg90H21EOLACvtfcHk0liJp5Rs3xP-Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnsFChtr8%253D&md5=253cc45834141872113db1f5b22ff392</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1002%2Fana.410440518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410440518%26sid%3Dliteratum%253Aachs%26aulast%3DPedersen%26aufirst%3DW.%2BA.%26aulast%3DFu%26aufirst%3DW.%26aulast%3DKeller%26aufirst%3DJ.%2BN.%26aulast%3DMarkesbery%26aufirst%3DW.%2BR.%26aulast%3DAppel%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DKasarskis%26aufirst%3DE.%26aulast%3DMattson%26aufirst%3DM.%2BP.%26atitle%3DProtein%2520modification%2520by%2520the%2520lipid%2520peroxidation%2520product%25204-hydroxynonenal%2520in%2520the%2520spinal%2520cords%2520of%2520amyotrophic%2520lateral%2520sclerosis%2520patients%26jtitle%3DAnn.%2520Neurol.%26date%3D1998%26volume%3D44%26spage%3D819%26epage%3D824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group">Sayre, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, G.</span><span> </span><span class="NLM_article-title">Chemistry and biochemistry of oxidative stress in neurodegenerative disease</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.2174%2F0929867013372922" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11375746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsVChtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=721-738&author=L.+M.+Sayreauthor=M.+A.+Smithauthor=G.+Perry&title=Chemistry+and+biochemistry+of+oxidative+stress+in+neurodegenerative+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry and biochemistry of oxidative stress in neurodegenerative disease</span></div><div class="casAuthors">Sayre, Lawrence M.; Smith, Mark A.; Perry, George</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">721-738</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with 234 refs.  The age-related neurodegenerative diseases exemplified by Alzheimer's disease (AD), Lewy body diseases such as Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington's disease are characterized by the deposition of abnormal forms of specific proteins in the brain.  Although several factors appear to underlie the pathol. depositions, the cause of neuronal death in each disease appears to be multifactorial.  In this regard, evidence in each case for a role of oxidative stress is provided by the finding that the pathol. deposits are immunoreactive to antibodies recognizing protein side-chains modified either directly by reactive oxygen or nitrogen species, or by products of lipid peroxidn. or glycoxidn.  Although the source(s) of increased oxidative damage are not entirely clear, the findings of increased localization of redox-active transition metals in the brain regions most affected is consistent with their contribution to oxidative stress.  It is tempting to speculate that free radical oxygen chem. plays a pathogenetic role in all these neurodegenerative conditions, though it is as yet undetd. what types of oxidative damage occur early in pathogenesis, and what types are secondary manifestations of dying neurons.  Delineation of the profile of oxidative damage in each disease will provide clues to how the specific neuronal populations are differentially affected by the individual disease conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9DAa0j4fYwbVg90H21EOLACvtfcHk0liJp5Rs3xP-Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsVChtbs%253D&md5=ff9d8a618f96b8fc7b6994e88e07191c</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.2174%2F0929867013372922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867013372922%26sid%3Dliteratum%253Aachs%26aulast%3DSayre%26aufirst%3DL.%2BM.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26aulast%3DPerry%26aufirst%3DG.%26atitle%3DChemistry%2520and%2520biochemistry%2520of%2520oxidative%2520stress%2520in%2520neurodegenerative%2520disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2001%26volume%3D8%26spage%3D721%26epage%3D738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group">Grodstein, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, W. C.</span><span> </span><span class="NLM_article-title">High-dose antioxidant supplements and cognitive function in community-dwelling elderly women</span> <span class="citation_source-journal">Am. J. Clin. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">984</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12663300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsVSrt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2003&pages=975-984&author=F.+Grodsteinauthor=J.+Chenauthor=W.+C.+Willett&title=High-dose+antioxidant+supplements+and+cognitive+function+in+community-dwelling+elderly+women"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">High-dose antioxidant supplements and cognitive function in community-dwelling elderly women</span></div><div class="casAuthors">Grodstein, Francine; Chen, Jennifer; Willett, Walter C.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Clinical Nutrition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">975-984</span>CODEN:
                <span class="NLM_cas:coden">AJCNAC</span>;
        ISSN:<span class="NLM_cas:issn">0002-9165</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Nutrition</span>)
        </div><div class="casAbstract">Exptl. data suggest that oxygen free radicals may be involved in the deterioration of cognitive processes.  The relations of high-dose dietary antioxidant supplementation to cognition were studied.  Information on the use of specific supplements contg. vitamins E and C was collected biennially via mailed questionnaires beginning in 1980 from 14968 community-dwelling women participating in the Nurses' Health Study.  From 1995 to 2000, telephone tests of cognitive function [Telephone Interview of Cognitive Status (TICS), delayed recall of the TICS 10-word list, immediate and delayed recall of a short paragraph, test of verbal fluency, digit span backwards test] were administered to the women 70-79 yr old at that time.  Linear and logistic regression models were used to calc. multivariate-adjusted mean differences in test scores and relative risks of a low score for specific supplement users compared with nonusers.  Long-term current users of vitamin E with vitamin C had better mean performance, as judged by a global score that combined individual test scores, than did women who had never used vitamin E or C; there was a trend for increasingly higher mean scores with increasing duration of supplement use.  These assocns. were strongest in women with low dietary intakes of α-tocopherol.  Benefits were less consistent in women taking vitamin E alone, with no evidence of higher scores with longer durations of use.  Use of specific vitamin C supplements alone had little relation to performance in the cognitive tests used.  Thus, the use of specific vitamin E supplements, but not specific vitamin C supplements, may be related to modest cognitive benefits in older women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTwoPqvdVtl7Vg90H21EOLACvtfcHk0ljOrREmkWU-vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsVSrt7g%253D&md5=7811b0796cb34ae25316a25b9f15c1c0</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrodstein%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWillett%26aufirst%3DW.%2BC.%26atitle%3DHigh-dose%2520antioxidant%2520supplements%2520and%2520cognitive%2520function%2520in%2520community-dwelling%2520elderly%2520women%26jtitle%3DAm.%2520J.%2520Clin.%2520Nutr.%26date%3D2003%26volume%3D77%26spage%3D975%26epage%3D984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group">Laurin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masaki, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Launer, L. J.</span><span> </span><span class="NLM_article-title">Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia aging study</span> <span class="citation_source-journal">Am. J. Epidemiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">959</span><span class="NLM_x">–</span> <span class="NLM_lpage">967</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1093%2Faje%2Fkwh124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=15128608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ivFCrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2004&pages=959-967&author=D.+Laurinauthor=K.+H.+Masakiauthor=D.+J.+Foleyauthor=L.+R.+Whiteauthor=L.+J.+Launer&title=Midlife+dietary+intake+of+antioxidants+and+risk+of+late-life+incident+dementia%3A+the+Honolulu-Asia+aging+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study</span></div><div class="casAuthors">Laurin Danielle; Masaki Kamal H; Foley Daniel J; White Lon R; Launer Lenore J</div><div class="citationInfo"><span class="NLM_cas:title">American journal of epidemiology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">959-67</span>
        ISSN:<span class="NLM_cas:issn">0002-9262</span>.
    </div><div class="casAbstract">Antioxidants have been hypothesized to protect against Alzheimer's disease, but studies conducted in late life have been inconsistent.  Risk factors measured in midlife may better predict dementia in late life because they are less affected by the disease process.  The authors examined the association of midlife dietary intake of antioxidants to late-life dementia and its subtypes.  Data were obtained from the Honolulu-Asia Aging Study, a prospective community-based study of Japanese-American men who were aged 45-68 years in 1965-1968, when a 24-hour dietary recall was administered.  The analysis included 2,459 men with complete dietary data who were dementia-free at the first assessment in 1991-1993 and were examined up to two times for dementia between 1991 and 1999.  The sample included 235 incident cases of dementia (102 cases of Alzheimer's disease, 38 cases of Alzheimer's disease with contributing cerebrovascular disease, and 44 cases of vascular dementia).  Relative risks by quartile of intake were calculated using Cox proportional hazards models with age as the time scale, after adjustment for sociodemographic and lifestyle factors, cardiovascular risk factors, other dietary constituents, and apolipoprotein E e4.  Intakes of beta-carotene, flavonoids, and vitamins E and C were not associated with the risk of dementia or its subtypes.  This analysis suggests that midlife dietary intake of antioxidants does not modify the risk of late-life dementia or its most prevalent subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR-PI_JCgD5aZ0d-O_J5C0AfW6udTcc2ebdvdNzcukXVLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ivFCrsg%253D%253D&md5=8c3ab79a313897b5ebfe7c12c4943075</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1093%2Faje%2Fkwh124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Faje%252Fkwh124%26sid%3Dliteratum%253Aachs%26aulast%3DLaurin%26aufirst%3DD.%26aulast%3DMasaki%26aufirst%3DK.%2BH.%26aulast%3DFoley%26aufirst%3DD.%2BJ.%26aulast%3DWhite%26aufirst%3DL.%2BR.%26aulast%3DLauner%26aufirst%3DL.%2BJ.%26atitle%3DMidlife%2520dietary%2520intake%2520of%2520antioxidants%2520and%2520risk%2520of%2520late-life%2520incident%2520dementia%253A%2520the%2520Honolulu-Asia%2520aging%2520study%26jtitle%3DAm.%2520J.%2520Epidemiol.%26date%3D2004%26volume%3D159%26spage%3D959%26epage%3D967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group">Petersen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doody, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galasko, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dyck, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thal, L. J.</span><span> </span><span class="NLM_article-title">Vitamin E and donepezil for the treatment of mild cognitive impairment</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">2379</span><span class="NLM_x">–</span> <span class="NLM_lpage">2388</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1056%2FNEJMoa050151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=15829527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVCjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=2379-2388&author=R.+C.+Petersenauthor=R.+G.+Thomasauthor=M.+Grundmanauthor=D.+Bennettauthor=R.+Doodyauthor=S.+Ferrisauthor=D.+Galaskoauthor=S.+Jinauthor=J.+Kayeauthor=A.+Leveyauthor=E.+Pfeifferauthor=M.+Sanoauthor=C.+H.+van+Dyckauthor=L.+J.+Thal&title=Vitamin+E+and+donepezil+for+the+treatment+of+mild+cognitive+impairment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">Vitamin E and Donepezil for the treatment of mild cognitive impairment</span></div><div class="casAuthors">Petersen, Ronald C.; Thomas, Ronald G.; Grundman, Michael; Bennett, David; Doody, Rachelle; Ferris, Steven; Galasko, Douglas; Jin, Shelia; Kaye, Jeffrey; Levey, Allan; Pfeiffer, Eric; Sano, Mary; van Dyck, Christopher H.; Thal, Leon J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2379-2388</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Mild cognitive impairment is a transitional state between the cognitive changes of normal aging and early Alzheimer's disease.  Methods: In a double-blind study, we evaluated subjects with the amnestic subtype of mild cognitive impairment.  Subjects were randomly assigned to receive 2000 IU of vitamin E daily, 10 mg of donepezil daily, or placebo for three years.  The primary outcome was clin. possible or probable Alzheimer's disease; secondary outcomes were cognition and function.  Results: A total of 769 subjects were enrolled, and possible or probable Alzheimer's disease developed in 212.  The overall rate of progression from mild cognitive impairment to Alzheimer's disease was 16 % per yr.  As compared with the placebo group, there were no significant differences in the probability of progression to Alzheimer's disease in the vitamin E group (hazard ratio, 1.02; 95 % confidence interval, 0.74 to 1.41; P = 0.91) or the donepezil group (hazard ratio, 0.80; 95 % confidence interval, 0.57 to 1.13; P = 0.42) during the three years of treatment.  Prespecified analyses of the treatment effects at 6-mo intervals showed that as compared with the placebo group, the donepezil group had a reduced likelihood of progression to Alzheimer's disease during the first 12 mo of the study (P = 0.04), a finding supported by the secondary outcome measures.  Among carriers of one or more apolipoprotein E ε4 alleles, the benefit of donepezil was evident throughout the three-year follow-up.  There were no significant differences in the rate of progression to Alzheimer's disease between the vitamin E and placebo groups at any point, either among all patients or among apolipoprotein E ε4 carriers.  Conclusions: Vitamin E had no benefit in patients with mild cognitive impairment.  Although donepezil therapy was assocd. with a lower rate of progression to Alzheimer's disease during the first 12 mo of treatment, the rate of progression to Alzheimer's disease after three years was not lower among patients treated with donepezil than among those given placebo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXAHw4M6-5u7Vg90H21EOLACvtfcHk0ljOrREmkWU-vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVCjsbg%253D&md5=af3c48d4cfaa74b18828b4ea143eae68</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa050151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa050151%26sid%3Dliteratum%253Aachs%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DThomas%26aufirst%3DR.%2BG.%26aulast%3DGrundman%26aufirst%3DM.%26aulast%3DBennett%26aufirst%3DD.%26aulast%3DDoody%26aufirst%3DR.%26aulast%3DFerris%26aufirst%3DS.%26aulast%3DGalasko%26aufirst%3DD.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKaye%26aufirst%3DJ.%26aulast%3DLevey%26aufirst%3DA.%26aulast%3DPfeiffer%26aufirst%3DE.%26aulast%3DSano%26aufirst%3DM.%26aulast%3Dvan%2BDyck%26aufirst%3DC.%2BH.%26aulast%3DThal%26aufirst%3DL.%2BJ.%26atitle%3DVitamin%2520E%2520and%2520donepezil%2520for%2520the%2520treatment%2520of%2520mild%2520cognitive%2520impairment%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D2379%26epage%3D2388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group">Hayden, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsh-Bohmer, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wengreen, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zandi, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyketsos, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitner, J. C.</span><span> </span><span class="NLM_article-title">Risk of mortality with vitamin E supplements: the Cache County study</span> <span class="citation_source-journal">Am. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">180</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.amjmed.2006.03.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=17275460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlSqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2007&pages=180-184&author=K.+M.+Haydenauthor=K.+A.+Welsh-Bohmerauthor=H.+J.+Wengreenauthor=P.+P.+Zandiauthor=C.+G.+Lyketsosauthor=J.+C.+Breitner&title=Risk+of+mortality+with+vitamin+E+supplements%3A+the+Cache+County+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Risk of Mortality with Vitamin E Supplements: The Cache County Study</span></div><div class="casAuthors">Hayden, Kathleen M.; Welsh-Bohmer, Kathleen A.; Wengreen, Heidi J.; Zandi, Peter P.; Lyketsos, Constantine G.; Breitner, John C. S.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">180-184</span>CODEN:
                <span class="NLM_cas:coden">AJMEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0002-9343</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Purpose: A recent meta-anal. reported increased mortality in clin. trial participants randomized to high-dose vitamin E. We sought to det. whether these mortality risks with vitamin E reflect adverse consequences of its use in the presence of cardiovascular disease.  Methods: In a defined population aged 65 years or older, baseline interviews captured self- or proxy-reported history of cardiovascular illness.  A medicine cabinet inventory verified nutritional supplement and medication use.  Three sources identified subsequent deaths.  Cox proportional hazards methods examd. the assocn. between vitamin E use and mortality.  Results: After adjustment for age and sex, there was no assocn. in this population between vitamin E use and mortality (adjusted hazard ratio [aHR] 0.93; 95% confidence interval [CI], 0.74-1.15).  Predictably, deaths were more frequent with a history of diabetes, stroke, coronary artery bypass graft surgery, or myocardial infarction, and with the use of warfarin, nitrates, or diuretics.  None of these conditions or treatments altered the null main effect with vitamin E, but mortality was increased in vitamin E users who had a history of stroke (aHR 3.64; CI, 1.73-7.68), coronary bypass graft surgery (aHR 4.40; CI, 2.83-6.83), or myocardial infarction (aHR 1.95; CI, 1.29-2.95) and, independently, in those taking nitrates (aHR 3.95; CI, 2.04-7.65), warfarin (aHR 3.71; CI, 2.22-6.21), or diuretics (aHR 1.83; CI, 1.35-2.49).  Although not definitive, a consistent trend toward reduced mortality was seen in vitamin E users without these conditions or treatments.  Conclusions: In this population-based study, vitamin E use was unrelated to mortality, but this apparently null finding seems to represent a combination of increased mortality in those with severe cardiovascular disease and a possible protective effect in those without.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq55TOu2Y2lGrVg90H21EOLACvtfcHk0lgiB5DpkyxQeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlSqtr4%253D&md5=ffef9e596815036b6d1e0538a4c8c1b3</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1016%2Fj.amjmed.2006.03.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjmed.2006.03.039%26sid%3Dliteratum%253Aachs%26aulast%3DHayden%26aufirst%3DK.%2BM.%26aulast%3DWelsh-Bohmer%26aufirst%3DK.%2BA.%26aulast%3DWengreen%26aufirst%3DH.%2BJ.%26aulast%3DZandi%26aufirst%3DP.%2BP.%26aulast%3DLyketsos%26aufirst%3DC.%2BG.%26aulast%3DBreitner%26aufirst%3DJ.%2BC.%26atitle%3DRisk%2520of%2520mortality%2520with%2520vitamin%2520E%2520supplements%253A%2520the%2520Cache%2520County%2520study%26jtitle%3DAm.%2520J.%2520Med.%26date%3D2007%26volume%3D120%26spage%3D180%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group">Luchsinger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, M. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shea, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayeux, R.</span><span> </span><span class="NLM_article-title">Antioxidant vitamin intake and risk of Alzheimer disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1001%2Farchneur.60.2.203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12580704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD3s%252FntVyltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2003&pages=203-208&author=J.+A.+Luchsingerauthor=M.+X.+Tangauthor=S.+Sheaauthor=R.+Mayeux&title=Antioxidant+vitamin+intake+and+risk+of+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant vitamin intake and risk of Alzheimer disease</span></div><div class="casAuthors">Luchsinger Jose A; Tang Ming-Xin; Shea Steven; Mayeux Richard</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">203-8</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">BACKGROUND:  The generation of oxygen free radicals is involved in the pathogenesis of Alzheimer disease (AD).  OBJECTIVE:  To determine whether the intake of antioxidant vitamins decreases the risk of AD.  METHODS:  We investigated the relationship between AD and the intake of carotenes, vitamin C, and vitamin E in 980 elderly subjects in the Washington Heights-Inwood Columbia Aging Project who were free of dementia at baseline and were followed for a mean time of 4 years.  Semiquantitative food frequency questionnaires were administered between baseline and the first follow-up visit.  Cox proportional hazards regression models were conducted with quartiles of each vitamin intake as the exposure of interest and incident AD as the outcome, adjusted for age, level of education, sex, APOE epsilon4 status, ethnicity, and smoking.  RESULTS:  There were 242 incident cases of AD in 4,023 person-years of follow-up (6 per 100 person-years).  Intake of carotenes and vitamin C, or vitamin E in supplemental or dietary (nonsupplemental) form or in both forms, was not related to a decreased risk of AD.  Trend tests for the association between quartiles of total intake of vitamins C and E also were not significant.  CONCLUSION:  Neither dietary, supplemental, nor total intake of carotenes and vitamins C and E was associated with a decreased risk of AD in this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRyvow083js2C6Ufuk_1xoTfW6udTcc2ea1x9NI-wkodLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s%252FntVyltg%253D%253D&md5=cd5f302276eda558d29c8322c8b5cd58</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1001%2Farchneur.60.2.203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.60.2.203%26sid%3Dliteratum%253Aachs%26aulast%3DLuchsinger%26aufirst%3DJ.%2BA.%26aulast%3DTang%26aufirst%3DM.%2BX.%26aulast%3DShea%26aufirst%3DS.%26aulast%3DMayeux%26aufirst%3DR.%26atitle%3DAntioxidant%2520vitamin%2520intake%2520and%2520risk%2520of%2520Alzheimer%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D2003%26volume%3D60%26spage%3D203%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group">Sinha, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhary, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, Y. K.</span><span> </span><span class="NLM_article-title">Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">665</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2002&pages=655-665&author=K.+Sinhaauthor=G.+Chaudharyauthor=Y.+K.+Gupta&title=Protective+effect+of+resveratrol+against+oxidative+stress+in+middle+cerebral+artery+occlusion+model+of+stroke+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DK.%26aulast%3DChaudhary%26aufirst%3DG.%26aulast%3DGupta%26aufirst%3DY.%2BK.%26atitle%3DProtective%2520effect%2520of%2520resveratrol%2520against%2520oxidative%2520stress%2520in%2520middle%2520cerebral%2520artery%2520occlusion%2520model%2520of%2520stroke%2520in%2520rats%26jtitle%3DLife%2520Sci.%26date%3D2002%26volume%3D71%26spage%3D655%26epage%3D665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group">The Parkinson Study Group</span><span> </span><span class="NLM_article-title">Effects of tocopherol and deprenyl on the progression of disability in early Parkinson’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">176</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1056%2FNEJM199301213280305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=8417384" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=1993&pages=176-183&author=The+Parkinson+Study+Group&title=Effects+of+tocopherol+and+deprenyl+on+the+progression+of+disability+in+early+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1056%2FNEJM199301213280305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199301213280305%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DEffects%2520of%2520tocopherol%2520and%2520deprenyl%2520on%2520the%2520progression%2520of%2520disability%2520in%2520early%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1993%26volume%3D328%26spage%3D176%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group">Kieburtz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Como, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Growdon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanigan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saint-Cyr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tennis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thelen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoulson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkinson Study Group</span><span> </span><span class="NLM_article-title">The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson’s disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1756</span><span class="NLM_x">–</span> <span class="NLM_lpage">1759</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1994&pages=1756-1759&author=K.+Kieburtzauthor=M.+McDermottauthor=P.+Comoauthor=J.+Growdonauthor=J.+Bradyauthor=J.+Carterauthor=S.+Huberauthor=B.+Kaniganauthor=E.+Landowauthor=A.+Rudolphauthor=J.+Saint-Cyrauthor=Y.+Sternauthor=M.+Tennisauthor=J.+Thelenauthor=I.+Shoulsonauthor=Parkinson+Study+Group&title=The+effect+of+deprenyl+and+tocopherol+on+cognitive+performance+in+early+untreated+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKieburtz%26aufirst%3DK.%26aulast%3DMcDermott%26aufirst%3DM.%26aulast%3DComo%26aufirst%3DP.%26aulast%3DGrowdon%26aufirst%3DJ.%26aulast%3DBrady%26aufirst%3DJ.%26aulast%3DCarter%26aufirst%3DJ.%26aulast%3DHuber%26aufirst%3DS.%26aulast%3DKanigan%26aufirst%3DB.%26aulast%3DLandow%26aufirst%3DE.%26aulast%3DRudolph%26aufirst%3DA.%26aulast%3DSaint-Cyr%26aufirst%3DJ.%26aulast%3DStern%26aufirst%3DY.%26aulast%3DTennis%26aufirst%3DM.%26aulast%3DThelen%26aufirst%3DJ.%26aulast%3DShoulson%26aufirst%3DI.%26aulast%3D%26atitle%3DThe%2520effect%2520of%2520deprenyl%2520and%2520tocopherol%2520on%2520cognitive%2520performance%2520in%2520early%2520untreated%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D1994%26volume%3D44%26spage%3D1756%26epage%3D1759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group">Mihatsch, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russ, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przuntek, H.</span><span> </span><span class="NLM_article-title">Treatment with antioxidants does not prevent loss of dopamine in the striatum of MPTP-treated common marmosets: preliminary observations</span> <span class="citation_source-journal">J. Neural Transm.: Parkinson’s Dis. Dementia Sect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1007%2FBF02251138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=1905937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK3sXltlWntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1991&pages=73-78&author=W.+Mihatschauthor=H.+Russauthor=M.+Gerlachauthor=P.+Riedererauthor=H.+Przuntek&title=Treatment+with+antioxidants+does+not+prevent+loss+of+dopamine+in+the+striatum+of+MPTP-treated+common+marmosets%3A+preliminary+observations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment with antioxidants does not prevent loss of dopamine in the striatum of MPTP-treated common marmosets: preliminary observations</span></div><div class="casAuthors">Mihatsch, W.; Russ, H.; Gerlach, M.; Riederer, P.; Przuntek, H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neural Transmission:  Parkinson's Disease and Dementia Section</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-8</span>CODEN:
                <span class="NLM_cas:coden">JNPSEJ</span>;
        ISSN:<span class="NLM_cas:issn">0936-3076</span>.
    </div><div class="casAbstract">Administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to common marmosets causes a profound loss of dopamine and serotonin in the striatum.  Addnl. daily systemic treatment of monkeys with the antioxidants ascorbic acid (100 mg/kg) and α-tocopherol (2,350 mg/kg) prior to, during and following administration of MPTP does not prevent the loss of dopamine and serotonin in the striatum, suggesting that these antioxidants are unable to protect dopaminergic neurons against neurotoxicity of MPTP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovr1XgkuMldrVg90H21EOLACvtfcHk0lihmEFIvHclSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltlWntbw%253D&md5=e5d66a3cf8ac0431f33052d4f5e1f290</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1007%2FBF02251138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02251138%26sid%3Dliteratum%253Aachs%26aulast%3DMihatsch%26aufirst%3DW.%26aulast%3DRuss%26aufirst%3DH.%26aulast%3DGerlach%26aufirst%3DM.%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DPrzuntek%26aufirst%3DH.%26atitle%3DTreatment%2520with%2520antioxidants%2520does%2520not%2520prevent%2520loss%2520of%2520dopamine%2520in%2520the%2520striatum%2520of%2520MPTP-treated%2520common%2520marmosets%253A%2520preliminary%2520observations%26jtitle%3DJ.%2520Neural%2520Transm.%253A%2520Parkinson%25E2%2580%2599s%2520Dis.%2520Dementia%2520Sect.%26date%3D1991%26volume%3D3%26spage%3D73%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group">Perry, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foulks, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J. M.</span><span> </span><span class="NLM_article-title">Alpha-tocopherol and beta-carotene do not protect marmosets against the dopaminergic neurotoxicity of <i>N</i>-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</span> <span class="citation_source-journal">J. Neurol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2F0022-510X%2887%2990106-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=3121800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaL1cXhslyi" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1987&pages=321-331&author=T.+L.+Perryauthor=V.+W.+Yongauthor=S.+Hansenauthor=K.+Jonesauthor=C.+Bergeronauthor=J.+G.+Foulksauthor=J.+M.+Wright&title=Alpha-tocopherol+and+beta-carotene+do+not+protect+marmosets+against+the+dopaminergic+neurotoxicity+of+N-methyl-4-phenyl-1%2C2%2C3%2C6-tetrahydropyridine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">α-Tocopherol and β-carotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</span></div><div class="casAuthors">Perry, Thomas L.; Yong, Voon Wee; Hansen, Shirley; Jones, Karen; Bergeron, Catherine; Foulks, James G.; Wright, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Neurological Sciences</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">321-31</span>CODEN:
                <span class="NLM_cas:coden">JNSCAG</span>;
        ISSN:<span class="NLM_cas:issn">0022-510X</span>.
    </div><div class="casAbstract">MPTP (I) is an exptl. neurotoxin which produces biochem. and neuropathol. changes in humans, lower primates, and mice that closely resemble those found in Parkinson's disease (PD).  Because the mechanisms of neuronal damage in both idiopathic PD and in the I model of PD may involve free radical formation in the substantia nigra, antioxidants might protect dopaminergic neurons.  Neither α-tocopherol nor β-carotene, each administered in massive doses, had any demonstrable protective effect for dopaminergic nigrostriatal neurons in marmosets injected with low doses of I.  Whether these 2 antioxidants might be clin. useful in preventing or ameliorating PD was discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTXn6WsBIq67Vg90H21EOLACvtfcHk0lihmEFIvHclSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhslyi&md5=39eca82f8824aa369e2b60b51c1471ea</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1016%2F0022-510X%2887%2990106-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-510X%252887%252990106-7%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DT.%2BL.%26aulast%3DYong%26aufirst%3DV.%2BW.%26aulast%3DHansen%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DBergeron%26aufirst%3DC.%26aulast%3DFoulks%26aufirst%3DJ.%2BG.%26aulast%3DWright%26aufirst%3DJ.%2BM.%26atitle%3DAlpha-tocopherol%2520and%2520beta-carotene%2520do%2520not%2520protect%2520marmosets%2520against%2520the%2520dopaminergic%2520neurotoxicity%2520of%2520N-methyl-4-phenyl-1%252C2%252C3%252C6-tetrahydropyridine%26jtitle%3DJ.%2520Neurol.%2520Sci.%26date%3D1987%26volume%3D81%26spage%3D321%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group">Peyser, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starkstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockrell, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bylsma, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyle, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folstein, S. E.</span><span> </span><span class="NLM_article-title">Trial of <span class="smallcaps smallerCapital">d</span>-alpha-tocopherol in Huntington’s disease</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">1771</span><span class="NLM_x">–</span> <span class="NLM_lpage">1775</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=8526244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADyaK28%252FotVSisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=1995&pages=1771-1775&author=C.+E.+Peyserauthor=M.+Folsteinauthor=G.+A.+Chaseauthor=S.+Starksteinauthor=J.+Brandtauthor=J.+R.+Cockrellauthor=F.+Bylsmaauthor=J.+T.+Coyleauthor=P.+R.+McHughauthor=S.+E.+Folstein&title=Trial+of+d-alpha-tocopherol+in+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Trial of d-alpha-tocopherol in Huntington's disease</span></div><div class="casAuthors">Peyser C E; Folstein M; Chase G A; Starkstein S; Brandt J; Cockrell J R; Bylsma F; Coyle J T; McHugh P R; Folstein S E</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1771-5</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Evidence suggests that the neuropathology of Huntington's disease, a neuropsychiatric disorder due to a mutation on chromosome 4, results from excessive activation of glutamate-gated ion channels, which kills neurons by oxidative stress.  Therefore, the authors hypothesized that alpha-tocopherol, which reduces oxyradical damage to cell membranes, might slow the course of Huntington's disease.  METHOD:  A prospective, double-blind; placebo-controlled study of high-dose d-alpha-tocopherol treatment was carried out with a cohort of 73 patients with Huntington's disease who were randomly assigned to either d-alpha-tocopherol or placebo.  Patients were monitored for changes in neurologic and neuropsychologic symptoms.  RESULTS:  Treatment with d-alpha-tocopherol had no effect on neurologic and neuropsychiatric symptoms in the treatment group overall.  However, post hoc analysis revealed a significant selective therapeutic effect on neurologic symptoms for patients early in the course of the disorder.  CONCLUSIONS:  Antioxidant therapy may slow the rate of motor decline early in the course of Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSkXXm882wPXIJKJbLTgsvCfW6udTcc2eaD65mHfBzBTLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28%252FotVSisQ%253D%253D&md5=180c5a035234968965ece270542d13c3</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeyser%26aufirst%3DC.%2BE.%26aulast%3DFolstein%26aufirst%3DM.%26aulast%3DChase%26aufirst%3DG.%2BA.%26aulast%3DStarkstein%26aufirst%3DS.%26aulast%3DBrandt%26aufirst%3DJ.%26aulast%3DCockrell%26aufirst%3DJ.%2BR.%26aulast%3DBylsma%26aufirst%3DF.%26aulast%3DCoyle%26aufirst%3DJ.%2BT.%26aulast%3DMcHugh%26aufirst%3DP.%2BR.%26aulast%3DFolstein%26aufirst%3DS.%2BE.%26atitle%3DTrial%2520of%2520d-alpha-tocopherol%2520in%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D1995%26volume%3D152%26spage%3D1771%26epage%3D1775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group">Desnuelle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dib, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favier, A.</span><span> </span><span class="NLM_article-title">A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS Riluzole-Tocopherol Study Group</span> <span class="citation_source-journal">Amyotrophic Lateral Scler. Other Mot. Neuron Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1080%2F146608201300079364" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11465936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktlCjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=9-18&author=C.+Desnuelleauthor=M.+Dibauthor=C.+Garrelauthor=A.+Favier&title=A+double-blind%2C+placebo-controlled+randomized+clinical+trial+of+alpha-tocopherol+%28vitamin+E%29+in+the+treatment+of+amyotrophic+lateral+sclerosis.+ALS+Riluzole-Tocopherol+Study+Group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">A double-blind, placebo-controlled randomized clinical trial of α-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis</span></div><div class="casAuthors">Desnuelle, Claude; Dib, Michel; Garrel, Catherine; Favier, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-18</span>CODEN:
                <span class="NLM_cas:coden">ALSCFA</span>;
        ISSN:<span class="NLM_cas:issn">1466-0822</span>.
    
            (<span class="NLM_cas:orgname">Martin Dunitz Ltd.</span>)
        </div><div class="casAbstract">Increasing evidence suggests that oxidative stress may be involved in the pathogenesis of amyotrophic lateral sclerosis (ALS).  The antioxidant vitamin E (α-tocopherol) has been shown to slow down the onset and progression of paralysis in transgenic mice expressing a mutation in superoxide dismutase found in certain forms of familial ALS.  The current study was designed to det. whether α-tocopherol (500 mg b.i.d.) may be efficacious in the treatment of ALS.  Two hundred and eighty-nine patients with ALS of less than 5 yr duration, treated with riluzole, were enrolled in this study, and were randomly assigned to receive either α-tocopherol or placebo daily for one year.  The primary outcome measure was the rate of deterioration of function assessed by the modified Norris limb scale.  Patients were assessed at entry, and every 3 mo thereafter during the study period.  Survival was also recorded.  Biochem. markers of oxidative stress were measured in a subset of patients on entry and after 3 mo of treatment.  After 12 mo of treatment, α-tocopherol had no effect on the primary outcome measure.  Survival was not influenced by treatment.  Among secondary outcome measures, patients given α-tocopherol were less likely to progress from the milder state A to the more severe state B (P = 0.046) of the ALS Health State scale.  After 3 mo treatment, anal. of oxidative stress markers showed an increase in glutathione peroxidase activity in plasma (P = 0.0389) and a decrease in plasma levels of thiobarbituric acid reactive species (P = 0.0055) in the group of patients given α-tocopherol in combination with riluzole.  Although α-tocopherol did not appear to affect the survival and motor function in ALS, patients receiving riluzole plus α-tocopherol remained longer in the milder states of the ALS Health State scale and showed, after 3 mo, changes in biochem. markers of oxidative stress.  Further studies are required to confirm the greater sensitivity of the ALS Health State scale over other clin. endpoints.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp3exQmY8SUbVg90H21EOLACvtfcHk0lihmEFIvHclSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktlCjt7g%253D&md5=645e48abad59fd982db3eda2d1ab0a77</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1080%2F146608201300079364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F146608201300079364%26sid%3Dliteratum%253Aachs%26aulast%3DDesnuelle%26aufirst%3DC.%26aulast%3DDib%26aufirst%3DM.%26aulast%3DGarrel%26aufirst%3DC.%26aulast%3DFavier%26aufirst%3DA.%26atitle%3DA%2520double-blind%252C%2520placebo-controlled%2520randomized%2520clinical%2520trial%2520of%2520alpha-tocopherol%2520%2528vitamin%2520E%2529%2520in%2520the%2520treatment%2520of%2520amyotrophic%2520lateral%2520sclerosis.%2520ALS%2520Riluzole-Tocopherol%2520Study%2520Group%26jtitle%3DAmyotrophic%2520Lateral%2520Scler.%2520Other%2520Mot.%2520Neuron%2520Disord.%26date%3D2001%26volume%3D2%26spage%3D9%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group">Gurney, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutting, F. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doble, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrus, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, E. D.</span><span> </span><span class="NLM_article-title">Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1002%2Fana.410390203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=8967745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK28XitlKktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=147-157&author=M.+E.+Gurneyauthor=F.+B.+Cuttingauthor=P.+Zhaiauthor=A.+Dobleauthor=C.+P.+Taylorauthor=P.+K.+Andrusauthor=E.+D.+Hall&title=Benefit+of+vitamin+E%2C+riluzole%2C+and+gabapentin+in+a+transgenic+model+of+familial+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis</span></div><div class="casAuthors">Gurney, Mark E.; Cutting, Frank B.; Zhai, Ping; Doble, Adam; Taylor, Charles P.; Andrus, Paula K.; Hall, Edward D.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-57</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Little, Brown</span>)
        </div><div class="casAbstract">Familial amyotrophic lateral sclerosis (FALS) has been linked in some families to dominant mutations of the SOD1 gene encoding Cu,Zn-superoxide dismutase (Cu,Zn SOD).  We have used a transgenic model of FALS based on expression of mutant human Cu,Zn SOD to explore the etiol. and therapy of the genetic disease.  Expression of mutant, but not wild-type, human Cu,Zn SOD in mice places the brain and spinal cord under oxidative stress.  This causes depletion of vitamin E, rather than the typical age-dependent increase in vitamin E content as occurs in nontransgenic mice and in mice expressing wild-type human Cu,Zn SOD.  Dietary supplementation with vitamin E delays onset of clin. disease and slows progression in the transgenic model but does not prolong survival.  In contrast, two putative inhibitors of the glutamatergic system, riluzole and gabapentin, prolong survival.  However, riluzole did not delay disease onset.  Thus, there was clear sepn. of effects on onset, progression, and survival by the three therapeutics tested.  This suggests the hypothesis that oxidative damage produced by the expression of mutant Cu,Zn SOD causes slow or weak excitotoxicity that can be inhibited in part by altering glutamate release or biosynthesis presynaptically.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW4p9cWtj_yLVg90H21EOLACvtfcHk0licuvg-8EFLWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitlKktLw%253D&md5=24a897326b265ac0188f8b1ee62ee5dc</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1002%2Fana.410390203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410390203%26sid%3Dliteratum%253Aachs%26aulast%3DGurney%26aufirst%3DM.%2BE.%26aulast%3DCutting%26aufirst%3DF.%2BB.%26aulast%3DZhai%26aufirst%3DP.%26aulast%3DDoble%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DC.%2BP.%26aulast%3DAndrus%26aufirst%3DP.%2BK.%26aulast%3DHall%26aufirst%3DE.%2BD.%26atitle%3DBenefit%2520of%2520vitamin%2520E%252C%2520riluzole%252C%2520and%2520gabapentin%2520in%2520a%2520transgenic%2520model%2520of%2520familial%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DAnn.%2520Neurol.%26date%3D1996%26volume%3D39%26spage%3D147%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group">Asthana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craft, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanczyk, F. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veith, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raskind, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plymate, S. R.</span><span> </span><span class="NLM_article-title">High-dose estradiol improves cognition for women with AD: results of a randomized study</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">–</span> <span class="NLM_lpage">612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2001&pages=605-612&author=S.+Asthanaauthor=L.+D.+Bakerauthor=S.+Craftauthor=F.+Z.+Stanczykauthor=R.+C.+Veithauthor=M.+A.+Raskindauthor=S.+R.+Plymate&title=High-dose+estradiol+improves+cognition+for+women+with+AD%3A+results+of+a+randomized+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAsthana%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DL.%2BD.%26aulast%3DCraft%26aufirst%3DS.%26aulast%3DStanczyk%26aufirst%3DF.%2BZ.%26aulast%3DVeith%26aufirst%3DR.%2BC.%26aulast%3DRaskind%26aufirst%3DM.%2BA.%26aulast%3DPlymate%26aufirst%3DS.%2BR.%26atitle%3DHigh-dose%2520estradiol%2520improves%2520cognition%2520for%2520women%2520with%2520AD%253A%2520results%2520of%2520a%2520randomized%2520study%26jtitle%3DNeurology%26date%3D2001%26volume%3D57%26spage%3D605%26epage%3D612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group">Carlson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zandi, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plassman, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschanz, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsh-Bohmer, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffens, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastian, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitner, J. C.</span><span> </span><span class="NLM_article-title">Hormone replacement therapy and reduced cognitive decline in older women: the Cache County study</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2210</span><span class="NLM_x">–</span> <span class="NLM_lpage">2216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2001&pages=2210-2216&author=M.+C.+Carlsonauthor=P.+P.+Zandiauthor=B.+L.+Plassmanauthor=J.+T.+Tschanzauthor=K.+A.+Welsh-Bohmerauthor=D.+C.+Steffensauthor=L.+A.+Bastianauthor=K.+M.+Mehtaauthor=J.+C.+Breitner&title=Hormone+replacement+therapy+and+reduced+cognitive+decline+in+older+women%3A+the+Cache+County+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarlson%26aufirst%3DM.%2BC.%26aulast%3DZandi%26aufirst%3DP.%2BP.%26aulast%3DPlassman%26aufirst%3DB.%2BL.%26aulast%3DTschanz%26aufirst%3DJ.%2BT.%26aulast%3DWelsh-Bohmer%26aufirst%3DK.%2BA.%26aulast%3DSteffens%26aufirst%3DD.%2BC.%26aulast%3DBastian%26aufirst%3DL.%2BA.%26aulast%3DMehta%26aufirst%3DK.%2BM.%26aulast%3DBreitner%26aufirst%3DJ.%2BC.%26atitle%3DHormone%2520replacement%2520therapy%2520and%2520reduced%2520cognitive%2520decline%2520in%2520older%2520women%253A%2520the%2520Cache%2520County%2520study%26jtitle%3DNeurology%26date%3D2001%26volume%3D57%26spage%3D2210%26epage%3D2216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group">Henderson, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paganini-Hill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elble, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyes, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoupe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCleary, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hake, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farlow, M. R.</span><span> </span><span class="NLM_article-title">Estrogen for Alzheimer’s disease in women: randomized, double-blind, placebo-controlled trial</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2000&pages=295-301&author=V.+W.+Hendersonauthor=A.+Paganini-Hillauthor=B.+L.+Millerauthor=R.+J.+Elbleauthor=P.+F.+Reyesauthor=D.+Shoupeauthor=C.+A.+McClearyauthor=R.+A.+Kleinauthor=A.+M.+Hakeauthor=M.+R.+Farlow&title=Estrogen+for+Alzheimer%E2%80%99s+disease+in+women%3A+randomized%2C+double-blind%2C+placebo-controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DV.%2BW.%26aulast%3DPaganini-Hill%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DB.%2BL.%26aulast%3DElble%26aufirst%3DR.%2BJ.%26aulast%3DReyes%26aufirst%3DP.%2BF.%26aulast%3DShoupe%26aufirst%3DD.%26aulast%3DMcCleary%26aufirst%3DC.%2BA.%26aulast%3DKlein%26aufirst%3DR.%2BA.%26aulast%3DHake%26aufirst%3DA.%2BM.%26aulast%3DFarlow%26aufirst%3DM.%2BR.%26atitle%3DEstrogen%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520in%2520women%253A%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520trial%26jtitle%3DNeurology%26date%3D2000%26volume%3D54%26spage%3D295%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group">Mulnard, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotman, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dyck, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doody, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koss, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamst, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thal, L. J.</span><span> </span><span class="NLM_article-title">Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer’s disease cooperative study</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2000&pages=1007-1015&author=R.+A.+Mulnardauthor=C.+W.+Cotmanauthor=C.+Kawasauthor=C.+H.+van+Dyckauthor=M.+Sanoauthor=R.+Doodyauthor=E.+Kossauthor=E.+Pfeifferauthor=S.+Jinauthor=A.+Gamstauthor=M.+Grundmanauthor=R.+Thomasauthor=L.+J.+Thal&title=Estrogen+replacement+therapy+for+treatment+of+mild+to+moderate+Alzheimer+disease%3A+a+randomized+controlled+trial.+Alzheimer%E2%80%99s+disease+cooperative+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMulnard%26aufirst%3DR.%2BA.%26aulast%3DCotman%26aufirst%3DC.%2BW.%26aulast%3DKawas%26aufirst%3DC.%26aulast%3Dvan%2BDyck%26aufirst%3DC.%2BH.%26aulast%3DSano%26aufirst%3DM.%26aulast%3DDoody%26aufirst%3DR.%26aulast%3DKoss%26aufirst%3DE.%26aulast%3DPfeiffer%26aufirst%3DE.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DGamst%26aufirst%3DA.%26aulast%3DGrundman%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DR.%26aulast%3DThal%26aufirst%3DL.%2BJ.%26atitle%3DEstrogen%2520replacement%2520therapy%2520for%2520treatment%2520of%2520mild%2520to%2520moderate%2520Alzheimer%2520disease%253A%2520a%2520randomized%2520controlled%2520trial.%2520Alzheimer%25E2%2580%2599s%2520disease%2520cooperative%2520study%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2000%26volume%3D283%26spage%3D1007%26epage%3D1015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group">Wang, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, S. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H. C.</span><span> </span><span class="NLM_article-title">Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2061</span><span class="NLM_x">–</span> <span class="NLM_lpage">2066</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2000&pages=2061-2066&author=P.+N.+Wangauthor=S.+Q.+Liaoauthor=R.+S.+Liuauthor=C.+Y.+Liuauthor=H.+T.+Chaoauthor=S.+R.+Luauthor=H.+Y.+Yuauthor=S.+J.+Wangauthor=H.+C.+Liu&title=Effects+of+estrogen+on+cognition%2C+mood%2C+and+cerebral+blood+flow+in+AD%3A+a+controlled+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%2BN.%26aulast%3DLiao%26aufirst%3DS.%2BQ.%26aulast%3DLiu%26aufirst%3DR.%2BS.%26aulast%3DLiu%26aufirst%3DC.%2BY.%26aulast%3DChao%26aufirst%3DH.%2BT.%26aulast%3DLu%26aufirst%3DS.%2BR.%26aulast%3DYu%26aufirst%3DH.%2BY.%26aulast%3DWang%26aufirst%3DS.%2BJ.%26aulast%3DLiu%26aufirst%3DH.%2BC.%26atitle%3DEffects%2520of%2520estrogen%2520on%2520cognition%252C%2520mood%252C%2520and%2520cerebral%2520blood%2520flow%2520in%2520AD%253A%2520a%2520controlled%2520study%26jtitle%3DNeurology%26date%3D2000%26volume%3D54%26spage%3D2061%26epage%3D2066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group">Blanchet, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyland, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouradian, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, T. N.</span><span> </span><span class="NLM_article-title">Short-term effects of high-dose 17beta-estradiol in postmenopausal PD patients: a crossover study</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1999&pages=91-95&author=P.+J.+Blanchetauthor=J.+Fangauthor=K.+Hylandauthor=L.+A.+Arnoldauthor=M.+M.+Mouradianauthor=T.+N.+Chase&title=Short-term+effects+of+high-dose+17beta-estradiol+in+postmenopausal+PD+patients%3A+a+crossover+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlanchet%26aufirst%3DP.%2BJ.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DHyland%26aufirst%3DK.%26aulast%3DArnold%26aufirst%3DL.%2BA.%26aulast%3DMouradian%26aufirst%3DM.%2BM.%26aulast%3DChase%26aufirst%3DT.%2BN.%26atitle%3DShort-term%2520effects%2520of%2520high-dose%252017beta-estradiol%2520in%2520postmenopausal%2520PD%2520patients%253A%2520a%2520crossover%2520study%26jtitle%3DNeurology%26date%3D1999%26volume%3D53%26spage%3D91%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group">Fernandez, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapane, K. L.</span><span> </span><span class="NLM_article-title">Estrogen use among nursing home residents with a diagnosis of Parkinson’s disease</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1119</span><span class="NLM_x">–</span> <span class="NLM_lpage">1124</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2000&pages=1119-1124&author=H.+H.+Fernandezauthor=K.+L.+Lapane&title=Estrogen+use+among+nursing+home+residents+with+a+diagnosis+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez%26aufirst%3DH.%2BH.%26aulast%3DLapane%26aufirst%3DK.%2BL.%26atitle%3DEstrogen%2520use%2520among%2520nursing%2520home%2520residents%2520with%2520a%2520diagnosis%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DMov.%2520Disord.%26date%3D2000%26volume%3D15%26spage%3D1119%26epage%3D1124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group">Tsang, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, S. K.</span><span> </span><span class="NLM_article-title">Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2292</span><span class="NLM_x">–</span> <span class="NLM_lpage">2298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2000&pages=2292-2298&author=K.+L.+Tsangauthor=S.+L.+Hoauthor=S.+K.+Lo&title=Estrogen+improves+motor+disability+in+parkinsonian+postmenopausal+women+with+motor+fluctuations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsang%26aufirst%3DK.%2BL.%26aulast%3DHo%26aufirst%3DS.%2BL.%26aulast%3DLo%26aufirst%3DS.%2BK.%26atitle%3DEstrogen%2520improves%2520motor%2520disability%2520in%2520parkinsonian%2520postmenopausal%2520women%2520with%2520motor%2520fluctuations%26jtitle%3DNeurology%26date%3D2000%26volume%3D54%26spage%3D2292%26epage%3D2298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group">Baldereschi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Carlo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocca, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perissinotto, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grigoletto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaducci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inzitari, D.</span><span> </span><span class="NLM_article-title">Parkinson’s disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian longitudinal study on aging</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1358</span><span class="NLM_x">–</span> <span class="NLM_lpage">1363</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2000&pages=1358-1363&author=M.+Baldereschiauthor=A.+Di+Carloauthor=W.+A.+Roccaauthor=P.+Vanniauthor=S.+Maggiauthor=E.+Perissinottoauthor=F.+Grigolettoauthor=L.+Amaducciauthor=D.+Inzitari&title=Parkinson%E2%80%99s+disease+and+parkinsonism+in+a+longitudinal+study%3A+two-fold+higher+incidence+in+men.+ILSA+Working+Group.+Italian+longitudinal+study+on+aging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaldereschi%26aufirst%3DM.%26aulast%3DDi%2BCarlo%26aufirst%3DA.%26aulast%3DRocca%26aufirst%3DW.%2BA.%26aulast%3DVanni%26aufirst%3DP.%26aulast%3DMaggi%26aufirst%3DS.%26aulast%3DPerissinotto%26aufirst%3DE.%26aulast%3DGrigoletto%26aufirst%3DF.%26aulast%3DAmaducci%26aufirst%3DL.%26aulast%3DInzitari%26aufirst%3DD.%26atitle%3DParkinson%25E2%2580%2599s%2520disease%2520and%2520parkinsonism%2520in%2520a%2520longitudinal%2520study%253A%2520two-fold%2520higher%2520incidence%2520in%2520men.%2520ILSA%2520Working%2520Group.%2520Italian%2520longitudinal%2520study%2520on%2520aging%26jtitle%3DNeurology%26date%3D2000%26volume%3D55%26spage%3D1358%26epage%3D1363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group">Mayeux, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marder, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cote, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denaro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemenegildo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mejia, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, M. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lantigua, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilder, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurland, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, A.</span><span> </span><span class="NLM_article-title">The frequency of idiopathic Parkinson’s disease by age, ethnic group, and sex in northern Manhattan, 1988–1993</span> <span class="citation_source-journal">Am. J. Epidemiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">820</span><span class="NLM_x">–</span> <span class="NLM_lpage">827</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=7572958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADyaK28%252FhslCjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=1995&pages=820-827&author=R.+Mayeuxauthor=K.+Marderauthor=L.+J.+Coteauthor=J.+Denaroauthor=N.+Hemenegildoauthor=H.+Mejiaauthor=M.+X.+Tangauthor=R.+Lantiguaauthor=D.+Wilderauthor=B.+Gurlandauthor=A.+Hauser&title=The+frequency+of+idiopathic+Parkinson%E2%80%99s+disease+by+age%2C+ethnic+group%2C+and+sex+in+northern+Manhattan%2C+1988%E2%80%931993"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993</span></div><div class="casAuthors">Mayeux R; Marder K; Cote L J; Denaro J; Hemenegildo N; Mejia H; Tang M X; Lantigua R; Wilder D; Gurland B; et al</div><div class="citationInfo"><span class="NLM_cas:title">American journal of epidemiology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">820-7</span>
        ISSN:<span class="NLM_cas:issn">0002-9262</span>.
    </div><div class="casAbstract">Sex and ethnic differences in the frequency of Parkinson's disease have become increasingly important, because putative genetic and environmental risk factors have been identified.  The authors estimated the prevalence and incidence of Parkinson's disease in a culturally diverse community in New York City over a 4-year period (January 1, 1988-December 31, 1991) using a disease registry substantiated, for older individuals, by a subsequent survey of a random sample of Medicare recipients between January 1, 1992, and December 31, 1993.  The prevalence rate was 107 per 100,000 persons, and over a 3-year period the average incidence rate was 13 per 100,000 person-years.  Age-adjusted prevalence rates were lower for women than for men in each ethnic group and were lower for blacks than for whites and Hispanics.  Incidence rates were highest among black men, but they were otherwise comparable across the sex and ethnic groups.  The estimated cumulative incidence of Parkinson's disease up to age 90 years was lower for women than for men, which could partially explain the lower prevalence rate.  By ethnic group, the cumulative incidence was higher for blacks than for whites and Hispanics, but more deaths occurred among incident black cases.  Discrepant prevalence and incidence rates of Parkinson's disease among blacks and women warrant further investigation.  While selective mortality could partially account for this paradox, it is also possible that a delay in diagnosis due to limited access to appropriate health services among these individuals could have resulted in the observed discordant rates of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAmRjLvYKK2T0SWnHPWbmmfW6udTcc2eZYKOI4J4NO7rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28%252FhslCjtw%253D%253D&md5=4c96dd0406b55685875a9d760b150d8d</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMayeux%26aufirst%3DR.%26aulast%3DMarder%26aufirst%3DK.%26aulast%3DCote%26aufirst%3DL.%2BJ.%26aulast%3DDenaro%26aufirst%3DJ.%26aulast%3DHemenegildo%26aufirst%3DN.%26aulast%3DMejia%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DM.%2BX.%26aulast%3DLantigua%26aufirst%3DR.%26aulast%3DWilder%26aufirst%3DD.%26aulast%3DGurland%26aufirst%3DB.%26aulast%3DHauser%26aufirst%3DA.%26atitle%3DThe%2520frequency%2520of%2520idiopathic%2520Parkinson%25E2%2580%2599s%2520disease%2520by%2520age%252C%2520ethnic%2520group%252C%2520and%2520sex%2520in%2520northern%2520Manhattan%252C%25201988%25E2%2580%25931993%26jtitle%3DAm.%2520J.%2520Epidemiol.%26date%3D1995%26volume%3D142%26spage%3D820%26epage%3D827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group">Aggarwal, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harikumar, K. B.</span><span> </span><span class="NLM_article-title">Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.biocel.2008.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=18662800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWnu73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=40-59&author=B.+B.+Aggarwalauthor=K.+B.+Harikumar&title=Potential+therapeutic+effects+of+curcumin%2C+the+anti-inflammatory+agent%2C+against+neurodegenerative%2C+cardiovascular%2C+pulmonary%2C+metabolic%2C+autoimmune+and+neoplastic+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune, and neoplastic diseases</span></div><div class="casAuthors">Aggarwal, Bharat B.; Harikumar, Kuzhuvelil B.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-59</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Although safe in most cases, ancient treatments are ignored because neither their active component nor their mol. targets are well defined.  This is not the case, however, with curcumin, a yellow-pigment substance and component of turmeric (Curcuma longa), which was identified more than a century ago.  For centuries it was known that turmeric exhibits anti-inflammatory activity, but extensive research performed within the past 2 decades has shown that this activity of turmeric is due to curcumin (diferuloylmethane).  This agent was shown to regulate numerous transcription factors, cytokines, protein kinases, adhesion mols., redox status, and enzymes that were linked to inflammation.  The process of inflammation was shown to play a major role in most chronic illnesses, including neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune, and neoplastic diseases.  In the current review, we provide evidence for the potential role of curcumin in the prevention and treatment of various proinflammatory chronic diseases.  These features, combined with the pharmacol. safety and negligible cost, render curcumin an attractive agent to explore further.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6QcBf26uTvrVg90H21EOLACvtfcHk0liQe_71XUCWxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWnu73P&md5=258bcc5b059184d67211b805b2d5303d</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2008.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2008.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26aulast%3DHarikumar%26aufirst%3DK.%2BB.%26atitle%3DPotential%2520therapeutic%2520effects%2520of%2520curcumin%252C%2520the%2520anti-inflammatory%2520agent%252C%2520against%2520neurodegenerative%252C%2520cardiovascular%252C%2520pulmonary%252C%2520metabolic%252C%2520autoimmune%2520and%2520neoplastic%2520diseases%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2009%26volume%3D41%26spage%3D40%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group">Richard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlus, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iglesias, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedrot, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waffo-Teguo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merillon, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, J. P.</span><span> </span><span class="NLM_article-title">Neuroprotective properties of resveratrol and derivatives</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1215</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1215&publication_year=2011&pages=103-108&author=T.+Richardauthor=A.+D.+Pawlusauthor=M.+L.+Iglesiasauthor=E.+Pedrotauthor=P.+Waffo-Teguoauthor=J.+M.+Merillonauthor=J.+P.+Monti&title=Neuroprotective+properties+of+resveratrol+and+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichard%26aufirst%3DT.%26aulast%3DPawlus%26aufirst%3DA.%2BD.%26aulast%3DIglesias%26aufirst%3DM.%2BL.%26aulast%3DPedrot%26aufirst%3DE.%26aulast%3DWaffo-Teguo%26aufirst%3DP.%26aulast%3DMerillon%26aufirst%3DJ.%2BM.%26aulast%3DMonti%26aufirst%3DJ.%2BP.%26atitle%3DNeuroprotective%2520properties%2520of%2520resveratrol%2520and%2520derivatives%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2011%26volume%3D1215%26spage%3D103%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group">Heim, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagliaferro, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobilya, D. J.</span><span> </span><span class="NLM_article-title">Flavonoid antioxidants: chemistry, metabolism and structure–activity relationships</span> <span class="citation_source-journal">J. Nutr. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">572</span><span class="NLM_x">–</span> <span class="NLM_lpage">584</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0955-2863%2802%2900208-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12550068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVeqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=572-584&author=K.+E.+Heimauthor=A.+R.+Tagliaferroauthor=D.+J.+Bobilya&title=Flavonoid+antioxidants%3A+chemistry%2C+metabolism+and+structure%E2%80%93activity+relationships"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships</span></div><div class="casAuthors">Heim, Kelly E.; Tagliaferro, Anthony R.; Bobilya, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nutritional Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">572-584</span>CODEN:
                <span class="NLM_cas:coden">JNBIEL</span>;
        ISSN:<span class="NLM_cas:issn">0955-2863</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  Flavonoids are a class of secondary plant phenolics with significant antioxidant and chelating properties.  In the human diet, they are most concd. in fruits, vegetables, wines, teas and cocoa.  Their cardioprotective effects stem from the ability to inhibit lipid peroxidn., chelate redox-active metals, and attenuate other processes involving reactive oxygen species.  Flavonoids occur in foods primarily as glycosides and polymers that are degraded to variable extents in the digestive tract.  Although metab. of these compds. remains elusive, enteric absorption occurs sufficiently to reduce plasma indexes of oxidant status.  The propensity of a flavonoid to inhibit free-radical mediated events is governed by its chem. structure.  Since these compds. are based on the flavan nucleus, the no., positions, and types of substitutions influence radical scavenging and chelating activity.  The diversity and multiple mechanisms of flavonoid action, together with the numerous methods of initiation, detection and measurement of oxidative processes in vitro and in vivo offer plausible explanations for existing discrepancies in structure-activity relationships.  Despite some inconsistent lines of evidence, several structure-activity relationships are well established in vitro.  Multiple hydroxyl groups confer upon the mol. substantial antioxidant, chelating and prooxidant activity.  Methoxy groups introduce unfavorable steric effects and increase lipophilicity and membrane partitioning.  A double bond and carbonyl function in the heterocycle or polymn. of the nuclear structure increases activity by affording a more stable flavonoid radical through conjugation and electron delocalization.  Further investigation of the metab. of these phytochems. is justified to extend structure-activity relationships (SAR) to preventive and therapeutic nutritional strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbPogyXeMwNrVg90H21EOLACvtfcHk0liQe_71XUCWxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVeqs7s%253D&md5=ee7b9144f4f578b0ee7cd09e6b26ec04</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1016%2FS0955-2863%2802%2900208-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0955-2863%252802%252900208-5%26sid%3Dliteratum%253Aachs%26aulast%3DHeim%26aufirst%3DK.%2BE.%26aulast%3DTagliaferro%26aufirst%3DA.%2BR.%26aulast%3DBobilya%26aufirst%3DD.%2BJ.%26atitle%3DFlavonoid%2520antioxidants%253A%2520chemistry%252C%2520metabolism%2520and%2520structure%25E2%2580%2593activity%2520relationships%26jtitle%3DJ.%2520Nutr.%2520Biochem.%26date%3D2002%26volume%3D13%26spage%3D572%26epage%3D584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref207"><div class="reference"><strong class="refLabel"><a href="#ref207" class="rightTabRefNumLink">207</a></strong><div class="NLM_citation" id="rightTab-cit207"><span><span class="NLM_contrib-group">Pietta, P. G.</span><span> </span><span class="NLM_article-title">Flavonoids as antioxidants</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1042</span></span><div class="citationLinks">[<a href="/doi/10.1021/np9904509" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjsFOrsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2000&pages=1035-1042&author=P.+G.+Pietta&title=Flavonoids+as+antioxidants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Flavonoids as Antioxidants</span></div><div class="casAuthors">Pietta, Pier-Giorgio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1035-1042</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The natural occurrence and antioxidant activity of flavonoids were reviewed with 91 refs.  Flavonoids are phenolic substances isolated from a wide range of vascular plants, with over 8000 individual compds. known.  They act in plants as antioxidants, antimicrobials, photoreceptors, visual attractors, feeding repellents, and for light screening.  Many studies have suggested that flavonoids exhibit biol. activities, including antiallergenic, antiviral, antiinflammatory, and vasodilating actions. However, most interest has been devoted to the antioxidant activity of flavonoids, which is due to their ability to reduce free radical formation and to scavenge free radicals.  The capacity of flavonoids to act as antioxidants in vitro has been the subject of several studies in the past years, and important structure-activity relationships of the antioxidant activity have been established.  The antioxidant efficacy of flavonoids in vivo is less documented, presumably because of the limited knowledge on their uptake in humans.  Most ingested flavonoids are extensively degraded to various phenolic acids, some of which still possess a radical-scavenging ability.  Both the absorbed flavonoids and their metabolites may display an in vivo antioxidant activity, which is evidenced exptl. by the increase of the plasma antioxidant status, the sparing effect on vitamin E of erythrocyte membranes and low-d. lipoproteins, and the preservation of erythrocyte membrane polyunsatd. fatty acids.  This review presents the current knowledge on structural aspects and in vitro antioxidant capacity of most common flavonoids as well as in vivo antioxidant activity and effects on endogenous antioxidants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGR_upjsM_DLVg90H21EOLACvtfcHk0liQe_71XUCWxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjsFOrsrY%253D&md5=5dbcbd974984fbb92075e556232f6f83</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1021%2Fnp9904509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp9904509%26sid%3Dliteratum%253Aachs%26aulast%3DPietta%26aufirst%3DP.%2BG.%26atitle%3DFlavonoids%2520as%2520antioxidants%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2000%26volume%3D63%26spage%3D1035%26epage%3D1042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref208"><div class="reference"><strong class="refLabel"><a href="#ref208" class="rightTabRefNumLink">208</a></strong><div class="NLM_citation" id="rightTab-cit208"><span><span class="NLM_contrib-group">Dickinson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forman, H. J.</span><span> </span><span class="NLM_article-title">Cellular glutathione and thiols metabolism</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1019</span><span class="NLM_x">–</span> <span class="NLM_lpage">1026</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0006-2952%2802%2901172-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12213601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1ymsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2002&pages=1019-1026&author=D.+A.+Dickinsonauthor=H.+J.+Forman&title=Cellular+glutathione+and+thiols+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular glutathione and thiols metabolism</span></div><div class="casAuthors">Dickinson, Dale A.; Forman, Henry Jay</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">1019-1026</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  Low-mol.-wt. thiol-contg. compds. have an essential role in many biochem. and pharmacol. reactions due to the ease with which they are oxidized, and the rapidity with which they can be regenerated.  Thioredoxin and glutathione (GSH) are 2 of the major small-mol.-wt. thiol-contg. compds. synthesized de novo in mammalian cells that participate in those functions.  Understanding the mechanisms of thiol metab. has special relevance to understanding the cell's defense against toxicant exposure and as the focal point in redox signaling.  This commentary will, however, focus on GSH consumption and synthesis, and the role of thiols in signaling.  The chem. reactions of GSH, including conjugation reactions mediated by glutathione S-transferases (GST) and oxidn. reactions mediated by glutathione peroxidases, will be described.  The regulation of GSH synthesis will be illustrated from a compilation of studies designed to understand the various levels at which enzymic GSH biosynthesis is controlled, and the signaling pathways that mediate them.  The response of the cell to 4-hydroxynonenal (4HNE), a reactive aldehyde produced physiol. in response to inflammation and various air pollutants, will be explored in detail.  Finally, the direct role of thiols as signaling mols. will be addressed, with particular attention given to redox state.  It is the aim that this commentary will lead the reader to appreciate that studies investigating the signaling for and regulation of thiol metab. must never be generalized, and that perturbations in any one step of thiol metab. may have etiol. roles in genetically, virally, and environmentally borne pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMxQAnLLSLzbVg90H21EOLACvtfcHk0libDaISzDrDlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1ymsb4%253D&md5=7859b19b7c1434237f00d79154389c93</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2802%2901172-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252802%252901172-3%26sid%3Dliteratum%253Aachs%26aulast%3DDickinson%26aufirst%3DD.%2BA.%26aulast%3DForman%26aufirst%3DH.%2BJ.%26atitle%3DCellular%2520glutathione%2520and%2520thiols%2520metabolism%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2002%26volume%3D64%26spage%3D1019%26epage%3D1026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref209"><div class="reference"><strong class="refLabel"><a href="#ref209" class="rightTabRefNumLink">209</a></strong><div class="NLM_citation" id="rightTab-cit209"><span><span class="NLM_contrib-group">Owuor, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, A. N.</span><span> </span><span class="NLM_article-title">Antioxidants and oxidants regulated signal transduction pathways</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">765</span><span class="NLM_x">–</span> <span class="NLM_lpage">770</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2002&pages=765-770&author=E.+D.+Owuorauthor=A.+N.+Kong&title=Antioxidants+and+oxidants+regulated+signal+transduction+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOwuor%26aufirst%3DE.%2BD.%26aulast%3DKong%26aufirst%3DA.%2BN.%26atitle%3DAntioxidants%2520and%2520oxidants%2520regulated%2520signal%2520transduction%2520pathways%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2002%26volume%3D64%26spage%3D765%26epage%3D770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref210"><div class="reference"><strong class="refLabel"><a href="#ref210" class="rightTabRefNumLink">210</a></strong><div class="NLM_citation" id="rightTab-cit210"><span><span class="NLM_contrib-group">Filomeni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotilio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciriolo, M. R.</span><span> </span><span class="NLM_article-title">Cell signalling and the glutathione redox system</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1057</span><span class="NLM_x">–</span> <span class="NLM_lpage">1064</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2002&pages=1057-1064&author=G.+Filomeniauthor=G.+Rotilioauthor=M.+R.+Ciriolo&title=Cell+signalling+and+the+glutathione+redox+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFilomeni%26aufirst%3DG.%26aulast%3DRotilio%26aufirst%3DG.%26aulast%3DCiriolo%26aufirst%3DM.%2BR.%26atitle%3DCell%2520signalling%2520and%2520the%2520glutathione%2520redox%2520system%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2002%26volume%3D64%26spage%3D1057%26epage%3D1064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref211"><div class="reference"><strong class="refLabel"><a href="#ref211" class="rightTabRefNumLink">211</a></strong><div class="NLM_citation" id="rightTab-cit211"><span><span class="NLM_contrib-group">Paolicchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominici, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maellaro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompella, A.</span><span> </span><span class="NLM_article-title">Glutathione catabolism as a signaling mechanism</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1035</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2002&pages=1027-1035&author=A.+Paolicchiauthor=S.+Dominiciauthor=L.+Pieriauthor=E.+Maellaroauthor=A.+Pompella&title=Glutathione+catabolism+as+a+signaling+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaolicchi%26aufirst%3DA.%26aulast%3DDominici%26aufirst%3DS.%26aulast%3DPieri%26aufirst%3DL.%26aulast%3DMaellaro%26aufirst%3DE.%26aulast%3DPompella%26aufirst%3DA.%26atitle%3DGlutathione%2520catabolism%2520as%2520a%2520signaling%2520mechanism%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2002%26volume%3D64%26spage%3D1027%26epage%3D1035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref212"><div class="reference"><strong class="refLabel"><a href="#ref212" class="rightTabRefNumLink">212</a></strong><div class="NLM_citation" id="rightTab-cit212"><span><span class="NLM_contrib-group">Fridovich, I.</span><span> </span><span class="NLM_article-title">Superoxide anion radical (O<sub>2</sub><sup>–•</sup>), superoxide dismutases, and related matters</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">18515</span><span class="NLM_x">–</span> <span class="NLM_lpage">18517</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=18515-18517&author=I.+Fridovich&title=Superoxide+anion+radical+%28O2%E2%80%93%E2%80%A2%29%2C+superoxide+dismutases%2C+and+related+matters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFridovich%26aufirst%3DI.%26atitle%3DSuperoxide%2520anion%2520radical%2520%2528O2%25E2%2580%2593%25E2%2580%25A2%2529%252C%2520superoxide%2520dismutases%252C%2520and%2520related%2520matters%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D18515%26epage%3D18517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref213"><div class="reference"><strong class="refLabel"><a href="#ref213" class="rightTabRefNumLink">213</a></strong><div class="NLM_citation" id="rightTab-cit213"><span><span class="NLM_contrib-group">Masumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sies, H.</span><span> </span><span class="NLM_article-title">The reaction of 2-(methylseleno)benzanilide with peroxynitrite</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1057</span><span class="NLM_x">–</span> <span class="NLM_lpage">1062</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx9600560" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1996&pages=1057-1062&author=H.+Masumotoauthor=H.+Sies&title=The+reaction+of+2-%28methylseleno%29benzanilide+with+peroxynitrite"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1021%2Ftx9600560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx9600560%26sid%3Dliteratum%253Aachs%26aulast%3DMasumoto%26aufirst%3DH.%26aulast%3DSies%26aufirst%3DH.%26atitle%3DThe%2520reaction%2520of%25202-%2528methylseleno%2529benzanilide%2520with%2520peroxynitrite%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D1996%26volume%3D9%26spage%3D1057%26epage%3D1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref214"><div class="reference"><strong class="refLabel"><a href="#ref214" class="rightTabRefNumLink">214</a></strong><div class="NLM_citation" id="rightTab-cit214"><span><span class="NLM_contrib-group">Parnham, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sies, H.</span><span> </span><span class="NLM_article-title">Ebselen: prospective therapy for cerebral ischaemia</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1517%2F13543784.9.3.607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11060699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhslKnsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=607-619&author=M.+Parnhamauthor=H.+Sies&title=Ebselen%3A+prospective+therapy+for+cerebral+ischaemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Ebselen: prospective therapy for cerebral ischaemia</span></div><div class="casAuthors">Parnham, Michael; Sies, Helmut</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">607-619</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications</span>)
        </div><div class="casAbstract">A review with 82 refs.  Stroke occurs due to hemorrhage or occlusive injury and results in ischemia and reperfusion injury.  A variety of destructive mechanisms are involved including oxygen radical generation, calcium overload, cytotoxicity and apoptosis as well as the generation of inflammatory mediators.  Ebselen, 2-phenyl-1,2-benzisoselenazol-3(2H)-one (PZ 51, DR3305), is a mimic of GSH peroxidase which also reacts with peroxynitrite and can inhibit enzymes such as lipoxygenases, NO synthases, NADPH oxidase, protein kinase C and H+/K+-ATPase.  Ebselen is in a late stage of development for the treatment of stroke.  The mol. actions of ebselen contribute to its anti-inflammatory and anti-oxidant properties, which have been demonstrated in a variety of in vivo models.  Numerous in vitro expts. using isolated LDL, liposomes, microsomes, isolated cells and organs have established that ebselen protects against oxidative challenge.  Unlike many inorg. and aliph. selenium compds., ebselen has low toxicity as metab. of the compd. does not liberate the selenium moiety, which remains within the ring structure.  Subsequent metab. involves methylation, glucuronidation and hydroxylation.  Exptl. studies in rats and dogs have revealed that ebselen is able to inhibit both vasospasm and tissue damage in stroke models, which correlates with its inhibitory effects on oxidative processes.  Results from randomized, placebo-controlled, double-blind clin. studies on the neurol. consequences of acute ischemic stroke, subarachnoid hemorrhage and acute middle cerebral artery occlusion, have revealed that ebselen significantly enhances outcome in patients who have experienced occlusive cerebral ischemia of limited duration.  The benefit achieved with ebselen is closely related to the rapidity with which the treatment is initiated, following the onset of the stroke attack.  Safety and tolerability are good and no adverse effects have become apparent.  Ebselen is currently at the pre-registration stage for subarachnoid hemorrhage and stroke in Japan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGRNMF1u9z8rVg90H21EOLACvtfcHk0libDaISzDrDlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhslKnsbs%253D&md5=4f5cd68b3073784362ce3b43ce474a7d</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1517%2F13543784.9.3.607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.9.3.607%26sid%3Dliteratum%253Aachs%26aulast%3DParnham%26aufirst%3DM.%26aulast%3DSies%26aufirst%3DH.%26atitle%3DEbselen%253A%2520prospective%2520therapy%2520for%2520cerebral%2520ischaemia%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs.%26date%3D2000%26volume%3D9%26spage%3D607%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref215"><div class="reference"><strong class="refLabel"><a href="#ref215" class="rightTabRefNumLink">215</a></strong><div class="NLM_citation" id="rightTab-cit215"><span><span class="NLM_contrib-group">Moussaoui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obinu, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reibaud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imperato, A.</span><span> </span><span class="NLM_article-title">The antioxidant ebselen prevents neurotoxicity and clinical symptoms in a primate model of Parkinson’s disease</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1006%2Fexnr.2000.7516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11085889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotFCrsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2000&pages=235-245&author=S.+Moussaouiauthor=M.+C.+Obinuauthor=N.+Danielauthor=M.+Reibaudauthor=V.+Blanchardauthor=A.+Imperato&title=The+antioxidant+ebselen+prevents+neurotoxicity+and+clinical+symptoms+in+a+primate+model+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">The Antioxidant Ebselen Prevents Neurotoxicity and Clinical Symptoms in a Primate Model of Parkinson's Disease</span></div><div class="casAuthors">Moussaoui, Saliha; Obinu, Maria-Carmen; Daniel, Nadine; Reibaud, Michel; Blanchard, Veronique; Imperato, Assunta</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">235-245</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), via its major metabolite 1-methyl-4-phenylpyridinium (MPP+), produces in primates including humans clin., biochem., and neuropathol. changes similar to those which occur in idiopathic Parkinson's disease.  Ebselen is an antioxidant drug with glutathione peroxidase-like activity and a proven neuroprotective action in stroke patients.  Here we show that Ebselen, when administered before, during, and after MPTP injections, prevents both neuronal loss and clin. symptoms in a primate MPTP model of Parkinson's disease.  Ebselen also prevents peroxide radical overprodn. induced by serum withdrawal in cultured PC12 cells and hydroxyl radical generation induced by the mitochondrial toxin, MPP+, in vivo in rat brain.  Moreover, Ebselen inhibits MPP+-induced toxicity in PC12 cells, without interacting with the dopamine uptake system.  Our results demonstrate that compds. which prevent mitochondrial dysfunction and free radical prodn. may be useful as preventive treatment of Parkinson's disease.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCwoSO7nWsBrVg90H21EOLACvtfcHk0lhbqSYqcFYHTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotFCrsLY%253D&md5=3fc30382959d83231a314b4bfe66d350</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1006%2Fexnr.2000.7516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexnr.2000.7516%26sid%3Dliteratum%253Aachs%26aulast%3DMoussaoui%26aufirst%3DS.%26aulast%3DObinu%26aufirst%3DM.%2BC.%26aulast%3DDaniel%26aufirst%3DN.%26aulast%3DReibaud%26aufirst%3DM.%26aulast%3DBlanchard%26aufirst%3DV.%26aulast%3DImperato%26aufirst%3DA.%26atitle%3DThe%2520antioxidant%2520ebselen%2520prevents%2520neurotoxicity%2520and%2520clinical%2520symptoms%2520in%2520a%2520primate%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DExp.%2520Neurol.%26date%3D2000%26volume%3D166%26spage%3D235%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref216"><div class="reference"><strong class="refLabel"><a href="#ref216" class="rightTabRefNumLink">216</a></strong><div class="NLM_citation" id="rightTab-cit216"><span><span class="NLM_contrib-group">Aitken, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lay, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witting, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, G. I.</span><span> </span><span class="NLM_article-title">Synchrotron radiation induced X-ray emission studies of the antioxidant mechanism of the organoselenium drug ebselen</span> <span class="citation_source-journal">J. Biol. Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="NLM_x">–</span> <span class="NLM_lpage">598</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1007%2Fs00775-012-0879-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=22327627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38XitFaksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=589-598&author=J.+B.+Aitkenauthor=P.+A.+Layauthor=T.+T.+Duongauthor=R.+Aranauthor=P.+K.+Wittingauthor=H.+H.+Harrisauthor=B.+Laiauthor=S.+Vogtauthor=G.+I.+Giles&title=Synchrotron+radiation+induced+X-ray+emission+studies+of+the+antioxidant+mechanism+of+the+organoselenium+drug+ebselen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Synchrotron radiation induced X-ray emission studies of the antioxidant mechanism of the organoselenium drug ebselen</span></div><div class="casAuthors">Aitken, Jade B.; Lay, Peter A.; Duong, T. T. Hong; Aran, Roshanak; Witting, Paul K.; Harris, Hugh H.; Lai, Barry; Vogt, Stefan; Giles, Gregory I.</div><div class="citationInfo"><span class="NLM_cas:title">JBIC, Journal of Biological Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">589-598</span>CODEN:
                <span class="NLM_cas:coden">JJBCFA</span>;
        ISSN:<span class="NLM_cas:issn">0949-8257</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Synchrotron radiation induced X-ray emission (SRIXE) spectroscopy was used to map the cellular uptake of the organoselenium-based antioxidant drug ebselen using differentiated ND15 cells as a neuronal model.  The cellular SRIXE spectra, acquired using a hard X-ray microprobe beam (12.8-keV), showed a large enhancement of fluorescence at the Kα line for Se (11.2-keV) following treatment with ebselen (10 μM) at time periods from 60 to 240 min.  Drug uptake was quantified and ebselen was shown to induce time-dependent changes in cellular elemental content that were characteristic of oxidative stress with the efflux of K, Cl, and Ca species.  The SRIXE cellular Se distribution map revealed that ebselen was predominantly localized to a discreet region of the cell which, by comparison with the K and P elemental maps, is postulated to correspond to the endoplasmic reticulum.  On the basis of these findings, it is hypothesized that a major outcome of ebselen redox catalysis is the induction of cellular stress.  A mechanism of action of ebselen is proposed that involves the cell responding to drug-induced stress by increasing the expression of antioxidant genes.  This hypothesis is supported by the observation that ebselen also regulated the homeostasis of the transition metals Mn, Cu, Fe, and Zn, with increases in transition metal uptake paralleling known induction times for the expression of antioxidant metalloenzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK4qZe0bds6rVg90H21EOLACvtfcHk0lhbqSYqcFYHTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitFaksLs%253D&md5=d11c1780c730712cce8a8c55aafa0472</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1007%2Fs00775-012-0879-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00775-012-0879-y%26sid%3Dliteratum%253Aachs%26aulast%3DAitken%26aufirst%3DJ.%2BB.%26aulast%3DLay%26aufirst%3DP.%2BA.%26aulast%3DDuong%26aufirst%3DT.%2BT.%26aulast%3DAran%26aufirst%3DR.%26aulast%3DWitting%26aufirst%3DP.%2BK.%26aulast%3DHarris%26aufirst%3DH.%2BH.%26aulast%3DLai%26aufirst%3DB.%26aulast%3DVogt%26aufirst%3DS.%26aulast%3DGiles%26aufirst%3DG.%2BI.%26atitle%3DSynchrotron%2520radiation%2520induced%2520X-ray%2520emission%2520studies%2520of%2520the%2520antioxidant%2520mechanism%2520of%2520the%2520organoselenium%2520drug%2520ebselen%26jtitle%3DJ.%2520Biol.%2520Inorg.%2520Chem.%26date%3D2012%26volume%3D17%26spage%3D589%26epage%3D598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref217"><div class="reference"><strong class="refLabel"><a href="#ref217" class="rightTabRefNumLink">217</a></strong><div class="NLM_citation" id="rightTab-cit217"><span><span class="NLM_contrib-group">d’Alessio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moutet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coudrier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darquenne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudiere, J.</span><span> </span><span class="NLM_article-title">ICAM-1 and VCAM-1 expression induced by TNF-alpha are inhibited by a glutathione peroxidase mimic</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">987</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0891-5849%2897%2900396-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=9607608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1cXjtVWkurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1998&pages=979-987&author=P.+d%E2%80%99Alessioauthor=M.+Moutetauthor=E.+Coudrierauthor=S.+Darquenneauthor=J.+Chaudiere&title=ICAM-1+and+VCAM-1+expression+induced+by+TNF-alpha+are+inhibited+by+a+glutathione+peroxidase+mimic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit217R"><div class="casContent"><span class="casTitleNuber">217</span><div class="casTitle"><span class="NLM_cas:atitle">ICAM-1 and VCAM-1 expression induced by TNF-α are inhibited by a glutathione peroxidase mimic</span></div><div class="casAuthors">D'Alessio, Patrizia; Moutet, Marc; Coudrier, Evelyne; Darquenne, Sophie; Chaudiere, Jean</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">979-987</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Intercellular adhesion mol.-1 (ICAM-1) and vascular cell adhesion mol.-1 (VCAM-1) are resp. involved in the endothelial recruitment of neutrophils, and in that of lymphocytes or tumor cells, in response to specific signals.  We have used the glutathione peroxidase (GPx) mimic BXT-51072 to assess the possibility that endogenous hydroperoxides play a role in the tumor necrosis factor-α (TNFα)-induced expression of ICAM-1 and VCAM-1 by monolayers of human endothelial cells.  The GPx mimic BXT-51072 strongly inhibits the TNFα-induced and cycloheximide-sensitive expression of ICAM-1 and VCAM-1.  It also inhibits the TNFa-induced reorganization of the actin network and the assocd. formation of stress fibers.  Actin reorganization induced by cytochalasin D treatment did not inhibit ICAM-1 expression.  Our results are compatible with specific and synergistic effects of endogenous hydroperoxides on the biosynthesis and processing of cell adhesion mols. and cytoskeleton components.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDMA_6aTavXrVg90H21EOLACvtfcHk0lhbqSYqcFYHTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtVWkurs%253D&md5=741c12f7fecd934c9a9e9e9563c8cc21</span></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2897%2900396-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252897%252900396-1%26sid%3Dliteratum%253Aachs%26aulast%3Dd%25E2%2580%2599Alessio%26aufirst%3DP.%26aulast%3DMoutet%26aufirst%3DM.%26aulast%3DCoudrier%26aufirst%3DE.%26aulast%3DDarquenne%26aufirst%3DS.%26aulast%3DChaudiere%26aufirst%3DJ.%26atitle%3DICAM-1%2520and%2520VCAM-1%2520expression%2520induced%2520by%2520TNF-alpha%2520are%2520inhibited%2520by%2520a%2520glutathione%2520peroxidase%2520mimic%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D1998%26volume%3D24%26spage%3D979%26epage%3D987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref218"><div class="reference"><strong class="refLabel"><a href="#ref218" class="rightTabRefNumLink">218</a></strong><div class="NLM_citation" id="rightTab-cit218"><span><span class="NLM_contrib-group">Moutet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">d’Alessio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malette, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devaux, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudiere, J.</span><span> </span><span class="NLM_article-title">Glutathione peroxidase mimics prevent TNFalpha- and neutrophil-induced endothelial alterations</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0891-5849%2898%2900038-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=9680172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1cXks1Chtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1998&pages=270-281&author=M.+Moutetauthor=P.+d%E2%80%99Alessioauthor=P.+Maletteauthor=V.+Devauxauthor=J.+Chaudiere&title=Glutathione+peroxidase+mimics+prevent+TNFalpha-+and+neutrophil-induced+endothelial+alterations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">Glutathione peroxidase mimics prevent TNFα- and neutrophil-induced endothelial alterations</span></div><div class="casAuthors">Moutet, Marc; D'alessio, Patrizia; Malette, Patricia; Devaux, Veronique; Chaudiere, Jean</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">270-281</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Based on the assumption that glutathione peroxidase (GPx) activity might be limiting in preventing peroxide-induced impairment of endothelial regulatory functions, we studied the effect of a series of new selenium-contg. GPx mimics on endothelial cells exposed to an inflammatory stress.  The two compds. that have the highest GPx activity, BXT-51072 and BXT-51077, were shown to be the most efficient inhibitors of leukocyte recruitment by human umbilical vein endothelial cells (HUVEC), upon incubation with neutrophils (10-fold excess over HUVEC) and with 1 ng/mL TNF-α for 1 or 3.5 h.  When HUVEC were pre- and cotreated with 10 μM of either compd., neutrophil adhesion and endothelial alteration were markedly inhibited, as assessed by immunoassays of myeloperoxidase and von Willebrand factor, resp.  These two GPx mimics were also found to be the most efficient inhibitors of the TNFα-induced endothelial expression of P- and E-selectin and of the TNFα- or interleukin-1-induced endothelial release of interleukin-8.  Our results demonstrate that GPx mimics such as BXT-51072 behave as potent antagonists of TNF-α and interleukin-1 through the downregulation of endothelial proinflammatory responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPIFsCDDD2IbVg90H21EOLACvtfcHk0lhbqSYqcFYHTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXks1Chtb8%253D&md5=91b9045691ccaaedb8f6ff7f30f058ec</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2898%2900038-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252898%252900038-0%26sid%3Dliteratum%253Aachs%26aulast%3DMoutet%26aufirst%3DM.%26aulast%3Dd%25E2%2580%2599Alessio%26aufirst%3DP.%26aulast%3DMalette%26aufirst%3DP.%26aulast%3DDevaux%26aufirst%3DV.%26aulast%3DChaudiere%26aufirst%3DJ.%26atitle%3DGlutathione%2520peroxidase%2520mimics%2520prevent%2520TNFalpha-%2520and%2520neutrophil-induced%2520endothelial%2520alterations%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D1998%26volume%3D25%26spage%3D270%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref219"><div class="reference"><strong class="refLabel"><a href="#ref219" class="rightTabRefNumLink">219</a></strong><div class="NLM_citation" id="rightTab-cit219"><span><span class="NLM_contrib-group">Batinic-Haberle, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benov, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spasojevic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridovich, I.</span><span> </span><span class="NLM_article-title">The ortho effect makes manganese(III) meso-tetrakis(<i>N</i>-methylpyridinium-2-yl)porphyrin a powerful and potentially useful superoxide dismutase mimic</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">24521</span><span class="NLM_x">–</span> <span class="NLM_lpage">24528</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=24521-24528&author=I.+Batinic-Haberleauthor=L.+Benovauthor=I.+Spasojevicauthor=I.+Fridovich&title=The+ortho+effect+makes+manganese%28III%29+meso-tetrakis%28N-methylpyridinium-2-yl%29porphyrin+a+powerful+and+potentially+useful+superoxide+dismutase+mimic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBatinic-Haberle%26aufirst%3DI.%26aulast%3DBenov%26aufirst%3DL.%26aulast%3DSpasojevic%26aufirst%3DI.%26aulast%3DFridovich%26aufirst%3DI.%26atitle%3DThe%2520ortho%2520effect%2520makes%2520manganese%2528III%2529%2520meso-tetrakis%2528N-methylpyridinium-2-yl%2529porphyrin%2520a%2520powerful%2520and%2520potentially%2520useful%2520superoxide%2520dismutase%2520mimic%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D24521%26epage%3D24528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref220"><div class="reference"><strong class="refLabel"><a href="#ref220" class="rightTabRefNumLink">220</a></strong><div class="NLM_citation" id="rightTab-cit220"><span><span class="NLM_contrib-group">Bowler, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enghild, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearlstein, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crapo, J. D.</span><span> </span><span class="NLM_article-title">A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1141</span><span class="NLM_x">–</span> <span class="NLM_lpage">1152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0891-5849%2802%2901008-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12374626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD38Xns1Sitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2002&pages=1141-1152&author=R.+P.+Bowlerauthor=H.+Shengauthor=J.+J.+Enghildauthor=R.+D.+Pearlsteinauthor=D.+S.+Warnerauthor=J.+D.+Crapo&title=A+catalytic+antioxidant+%28AEOL+10150%29+attenuates+expression+of+inflammatory+genes+in+stroke"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit220R"><div class="casContent"><span class="casTitleNuber">220</span><div class="casTitle"><span class="NLM_cas:atitle">A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke</span></div><div class="casAuthors">Bowler, Russell P.; Sheng, Huaxin; Enghild, Jan J.; Pearlstein, Robert D.; Warner, David S.; Crapo, James D.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1141-1152</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Oxidative stress is a major source of injury from cerebral ischemia and reperfusion.  We hypothesized that a catalytic antioxidant AEOL 10150 [manganese (III) meso-tetrakis (di-N-ethylimidazole) porphyrin] would attenuate changes in brain gene expression in a mouse model of transient middle cerebral artery occlusion (MCAO).  C57BL/6J mice were subjected to either sham surgery or 60 min of right MCAO.  AEOL 10150 or phosphate-buffered saline was given i.v. 5 min after onset of reperfusion (n = 6 per group).  Six hours later, parenchyma within the MCA distribution was harvested.  RNA from the six brains in each group was pooled and mRNA expression detd. using an Affymetrix murine MG_74A v. 2.0 expression microarray.  Each expt. was performed three times.  The largest changes in expression occurred in stress response and inflammatory genes such as heat shock protein, interleukin-6, and macrophage inflammatory protein-2.  Treatment with AEOL 10150 attenuated only the increase in expression of inflammatory genes.  This suggests that AEOL 10150 protects brain by attenuating the immune response to ischemia and reperfusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9YVEXTO_hSbVg90H21EOLACvtfcHk0ljqA1_ozWsVMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xns1Sitro%253D&md5=2bfefa35475b6857221a35d432a2c4e6</span></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2802%2901008-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252802%252901008-0%26sid%3Dliteratum%253Aachs%26aulast%3DBowler%26aufirst%3DR.%2BP.%26aulast%3DSheng%26aufirst%3DH.%26aulast%3DEnghild%26aufirst%3DJ.%2BJ.%26aulast%3DPearlstein%26aufirst%3DR.%2BD.%26aulast%3DWarner%26aufirst%3DD.%2BS.%26aulast%3DCrapo%26aufirst%3DJ.%2BD.%26atitle%3DA%2520catalytic%2520antioxidant%2520%2528AEOL%252010150%2529%2520attenuates%2520expression%2520of%2520inflammatory%2520genes%2520in%2520stroke%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2002%26volume%3D33%26spage%3D1141%26epage%3D1152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref221"><div class="reference"><strong class="refLabel"><a href="#ref221" class="rightTabRefNumLink">221</a></strong><div class="NLM_citation" id="rightTab-cit221"><span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, B. J.</span><span> </span><span class="NLM_article-title">Metalloporphyrin class of therapeutic catalytic antioxidants</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=359-364&author=M.+Patelauthor=B.+J.+Day&title=Metalloporphyrin+class+of+therapeutic+catalytic+antioxidants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DDay%26aufirst%3DB.%2BJ.%26atitle%3DMetalloporphyrin%2520class%2520of%2520therapeutic%2520catalytic%2520antioxidants%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1999%26volume%3D20%26spage%3D359%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref222"><div class="reference"><strong class="refLabel"><a href="#ref222" class="rightTabRefNumLink">222</a></strong><div class="NLM_citation" id="rightTab-cit222"><span><span class="NLM_contrib-group">Peng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, X. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, J. K.</span><span> </span><span class="NLM_article-title">The herbicide paraquat induces dopaminergic nigral apoptosis through sustained activation of the JNK pathway</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">32626</span><span class="NLM_x">–</span> <span class="NLM_lpage">32632</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=32626-32632&author=J.+Pengauthor=X.+O.+Maoauthor=F.+F.+Stevensonauthor=M.+Hsuauthor=J.+K.+Andersen&title=The+herbicide+paraquat+induces+dopaminergic+nigral+apoptosis+through+sustained+activation+of+the+JNK+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit222&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DX.%2BO.%26aulast%3DStevenson%26aufirst%3DF.%2BF.%26aulast%3DHsu%26aufirst%3DM.%26aulast%3DAndersen%26aufirst%3DJ.%2BK.%26atitle%3DThe%2520herbicide%2520paraquat%2520induces%2520dopaminergic%2520nigral%2520apoptosis%2520through%2520sustained%2520activation%2520of%2520the%2520JNK%2520pathway%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D32626%26epage%3D32632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref223"><div class="reference"><strong class="refLabel"><a href="#ref223" class="rightTabRefNumLink">223</a></strong><div class="NLM_citation" id="rightTab-cit223"><span><span class="NLM_contrib-group">Peng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doctrow, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, J. K.</span><span> </span><span class="NLM_article-title">Superoxide dismutase/catalase mimetics are neuroprotective against selective paraquat-mediated dopaminergic neuron death in the substantial nigra: implications for Parkinson disease</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">29194</span><span class="NLM_x">–</span> <span class="NLM_lpage">29198</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=29194-29198&author=J.+Pengauthor=F.+F.+Stevensonauthor=S.+R.+Doctrowauthor=J.+K.+Andersen&title=Superoxide+dismutase%2Fcatalase+mimetics+are+neuroprotective+against+selective+paraquat-mediated+dopaminergic+neuron+death+in+the+substantial+nigra%3A+implications+for+Parkinson+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DStevenson%26aufirst%3DF.%2BF.%26aulast%3DDoctrow%26aufirst%3DS.%2BR.%26aulast%3DAndersen%26aufirst%3DJ.%2BK.%26atitle%3DSuperoxide%2520dismutase%252Fcatalase%2520mimetics%2520are%2520neuroprotective%2520against%2520selective%2520paraquat-mediated%2520dopaminergic%2520neuron%2520death%2520in%2520the%2520substantial%2520nigra%253A%2520implications%2520for%2520Parkinson%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D29194%26epage%3D29198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref224"><div class="reference"><strong class="refLabel"><a href="#ref224" class="rightTabRefNumLink">224</a></strong><div class="NLM_citation" id="rightTab-cit224"><span><span class="NLM_contrib-group">Young, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, G. M.</span><span> </span><span class="NLM_article-title">Antioxidant and prooxidant properties of carotenoids</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">385</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1006%2Fabbi.2000.2149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11361018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovFyjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=2001&pages=20-27&author=A.+J.+Youngauthor=G.+M.+Lowe&title=Antioxidant+and+prooxidant+properties+of+carotenoids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit224R"><div class="casContent"><span class="casTitleNuber">224</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant and Prooxidant properties of Carotenoids</span></div><div class="casAuthors">Young, Andrew J.; Lowe, Gordon M.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">385</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-27</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review with 62 refs.  The ability of dietary carotenoids such as β-carotene and lycopene to act as antioxidants in biol. systems is dependent upon a no. of factors.  While the structure of carotenoids, esp. the conjugated double bond system, gives rise to many of the fundamental properties of these mols., it also affects how these mols. are incorporated into biol. membranes.  This, in turn, alters the way these mols. interact with reactive oxygen species, so that the in vivo behavior may be quite different from that seen in soln.  The effectiveness of carotenoids as antioxidants is also dependent upon their interaction with other coantioxidants, esp. vitamins E and C. Carotenoids may, however, lose their effectiveness as antioxidants at high concns. or at high partial pressures of oxygen.  It is unlikely that carotenoids actually act as prooxidants in biol. systems; rather they exhibit a tendency to lose their effectiveness as antioxidants.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvMKoZA8g1lbVg90H21EOLACvtfcHk0ljqA1_ozWsVMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovFyjs7g%253D&md5=dbc4956f7e18a2a1639c5c427c536bbf</span></div><a href="/servlet/linkout?suffix=cit224&amp;dbid=16384&amp;doi=10.1006%2Fabbi.2000.2149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.2000.2149%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DA.%2BJ.%26aulast%3DLowe%26aufirst%3DG.%2BM.%26atitle%3DAntioxidant%2520and%2520prooxidant%2520properties%2520of%2520carotenoids%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2001%26volume%3D385%26spage%3D20%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref225"><div class="reference"><strong class="refLabel"><a href="#ref225" class="rightTabRefNumLink">225</a></strong><div class="NLM_citation" id="rightTab-cit225"><span><span class="NLM_contrib-group">Di Mascio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sies, H.</span><span> </span><span class="NLM_article-title">Lycopene as the most efficient biological carotenoid singlet oxygen quencher</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">532</span><span class="NLM_x">–</span> <span class="NLM_lpage">538</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2F0003-9861%2889%2990467-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=2802626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaL1MXlvVOjt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1989&pages=532-538&author=P.+Di+Mascioauthor=S.+Kaiserauthor=H.+Sies&title=Lycopene+as+the+most+efficient+biological+carotenoid+singlet+oxygen+quencher"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit225R"><div class="casContent"><span class="casTitleNuber">225</span><div class="casTitle"><span class="NLM_cas:atitle">Lycopene as the most efficient biological carotenoid singlet oxygen quencher</span></div><div class="casAuthors">Di Mascio, Paolo; Kaiser, Stephan; Sies, Helmut</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">532-8</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    </div><div class="casAbstract">Of a no. of carotenoids and related compds. tested, lycopene, a biol. occurring carotenoid, exhibited the highest phys. quenching rate const. with singlet O (kq = 31 × 109 M-1 s-1); its plasma levels in humans is slightly higher than that of β-carotene (kq = 14 × 109 M-1 s-1).  This is of considerable general interest, since nutritional carotenoids, particularly β-carotene, and other antioxidants such as α-tocopherol (kq = 0.3 × 109 M-1 s-1) have been implicated in the defense against prooxidant states; epidemiol. evidence reveals that such compds. exert a protective action against certain types of cancer.  Also, albumin-bound bilirubin is a known singlet O quencher (kq = 3.2 × 109 M-1 s-1).  Interestingly, those compds. with low kq values occur at relatively high plasma levels.  When these differences are taken into account, the singlet O-quenching capacities of lycopene (0.7 μM in plasm), β-carotene (0.5 μM in plasma), albumin-bound bilirubin (15 μM in plasma), and α-tocopherol (22 μM in plasma) are of comparable magnitude.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJjfCKpLEnnbVg90H21EOLACvtfcHk0ljitEWiqazIXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXlvVOjt7c%253D&md5=f3fe1399c994331ab8f44a5ff1c5fbdd</span></div><a href="/servlet/linkout?suffix=cit225&amp;dbid=16384&amp;doi=10.1016%2F0003-9861%2889%2990467-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-9861%252889%252990467-0%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMascio%26aufirst%3DP.%26aulast%3DKaiser%26aufirst%3DS.%26aulast%3DSies%26aufirst%3DH.%26atitle%3DLycopene%2520as%2520the%2520most%2520efficient%2520biological%2520carotenoid%2520singlet%2520oxygen%2520quencher%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1989%26volume%3D274%26spage%3D532%26epage%3D538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref226"><div class="reference"><strong class="refLabel"><a href="#ref226" class="rightTabRefNumLink">226</a></strong><div class="NLM_citation" id="rightTab-cit226"><span><span class="NLM_contrib-group">Burton, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingold, K. U.</span><span> </span><span class="NLM_article-title">beta-Carotene: an unusual type of lipid antioxidant</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">224</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">573</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=224&publication_year=1984&pages=569-573&author=G.+W.+Burtonauthor=K.+U.+Ingold&title=beta-Carotene%3A+an+unusual+type+of+lipid+antioxidant"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit226&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurton%26aufirst%3DG.%2BW.%26aulast%3DIngold%26aufirst%3DK.%2BU.%26atitle%3Dbeta-Carotene%253A%2520an%2520unusual%2520type%2520of%2520lipid%2520antioxidant%26jtitle%3DScience%26date%3D1984%26volume%3D224%26spage%3D569%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref227"><div class="reference"><strong class="refLabel"><a href="#ref227" class="rightTabRefNumLink">227</a></strong><div class="NLM_citation" id="rightTab-cit227"><span><span class="NLM_contrib-group">Goodman, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardee, A. B.</span><span> </span><span class="NLM_article-title">Evidence for defective retinoid transport and function in late onset Alzheimer’s disease</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">2901</span><span class="NLM_x">–</span> <span class="NLM_lpage">2905</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=2901-2905&author=A.+B.+Goodmanauthor=A.+B.+Pardee&title=Evidence+for+defective+retinoid+transport+and+function+in+late+onset+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit227&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoodman%26aufirst%3DA.%2BB.%26aulast%3DPardee%26aufirst%3DA.%2BB.%26atitle%3DEvidence%2520for%2520defective%2520retinoid%2520transport%2520and%2520function%2520in%2520late%2520onset%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2003%26volume%3D100%26spage%3D2901%26epage%3D2905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref228"><div class="reference"><strong class="refLabel"><a href="#ref228" class="rightTabRefNumLink">228</a></strong><div class="NLM_citation" id="rightTab-cit228"><span><span class="NLM_contrib-group">Goodman, A. B.</span><span> </span><span class="NLM_article-title">Retinoid receptors, transporters, and metabolizers as therapeutic targets in late onset Alzheimer disease</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">209</span><span class="NLM_x">, </span> <span class="NLM_fpage">598</span><span class="NLM_x">–</span> <span class="NLM_lpage">603</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1002%2Fjcp.20784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=17001693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOktLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=209&publication_year=2006&pages=598-603&author=A.+B.+Goodman&title=Retinoid+receptors%2C+transporters%2C+and+metabolizers+as+therapeutic+targets+in+late+onset+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit228R"><div class="casContent"><span class="casTitleNuber">228</span><div class="casTitle"><span class="NLM_cas:atitle">Retinoid receptors, transporters, and metabolizers as therapeutic targets in late onset Alzheimer disease</span></div><div class="casAuthors">Goodman, Ann B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">209</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">598-603</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Vitamin A (retinoid) is required in the adult brain to enable cognition, learning, and memory.  While brain levels of retinoid diminish over the course of normal aging, retinoid deficit is greater in late onset Alzheimer disease (LOAD) brains than in normal-aged controls.  This paper reviews recent evidence supporting these statements and further suggests that genes necessary for the synthesis, transport and function of retinoid to and within the aging brain are appropriate targets for treatment of LOAD.  These genes tend to be clustered with genes that have been proposed as candidates in LOAD, are found at chromosomal regions linked to LOAD, and suggest the possibility of an overall coordinated regulation.  This phenomenon is termed Chromeron and is analogous to the operon mechanism obsd. in prokaryotes.  Suggested treatment targets are the retinoic-acid inactivating enzymes (CYP26)s, the retinol binding and transport proteins, retinol-binding protein (RBP)4 and transthyretin (TTR), and the retinoid receptors.  TTR as a LOAD target is the subject of active investigation.  The retinoid receptors and the retinoid-inactivating enzymes have previously been proposed as targets.  This is the first report to suggest that RBP4 is an amenable treatment target in LOAD.  RBP4 is elevated in type-2 diabetes and obesity, conditions assocd. with increased risk for LOAD.  Fenretinide, a novel synthetic retinoic acid (RA) analog lowers RBP4 in glucose intolerant obese mice.  The feasibility of using fenretinide either as an adjunct to present LOAD therapies, or on its own as an early prevention strategy should be detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpivWzk2D77hrVg90H21EOLACvtfcHk0ljitEWiqazIXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOktLzL&md5=def975d68db7ecae2277e93e7a6f09a9</span></div><a href="/servlet/linkout?suffix=cit228&amp;dbid=16384&amp;doi=10.1002%2Fjcp.20784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.20784%26sid%3Dliteratum%253Aachs%26aulast%3DGoodman%26aufirst%3DA.%2BB.%26atitle%3DRetinoid%2520receptors%252C%2520transporters%252C%2520and%2520metabolizers%2520as%2520therapeutic%2520targets%2520in%2520late%2520onset%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2006%26volume%3D209%26spage%3D598%26epage%3D603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref229"><div class="reference"><strong class="refLabel"><a href="#ref229" class="rightTabRefNumLink">229</a></strong><div class="NLM_citation" id="rightTab-cit229"><span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodwin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allsbrook, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, G. H.</span><span> </span><span class="NLM_article-title">Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer’s disease transgenic mouse model</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">11622</span><span class="NLM_x">–</span> <span class="NLM_lpage">11634</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1523%2FJNEUROSCI.3153-08.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=18987198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOgt7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=11622-11634&author=Y.+Dingauthor=A.+Qiaoauthor=Z.+Wangauthor=J.+S.+Goodwinauthor=E.+S.+Leeauthor=M.+L.+Blockauthor=M.+Allsbrookauthor=M.+P.+McDonaldauthor=G.+H.+Fan&title=Retinoic+acid+attenuates+beta-amyloid+deposition+and+rescues+memory+deficits+in+an+Alzheimer%E2%80%99s+disease+transgenic+mouse+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit229R"><div class="casContent"><span class="casTitleNuber">229</span><div class="casTitle"><span class="NLM_cas:atitle">Retinoic acid attenuates β-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model</span></div><div class="casAuthors">Ding, Yun; Qiao, Aimin; Wang, Ziqing; Goodwin, J. Shawn; Lee, Eun-Sook; Block, Michelle L.; Allsbrook, Matthew; McDonald, Michael P.; Fan, Guo-Huang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">11622-11634</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Recent studies have revealed that disruption of vitamin A signaling obsd. in Alzheimer's disease (AD) leads to β-amyloid (Aβ) accumulation and memory deficits in rodents.  The aim of the present study was to evaluate the therapeutic effect of all-trans retinoic acid (ATRA), an active metabolite of vitamin A, on the neuropathol. and deficits of spatial learning and memory in amyloid precursor protein (APP) and presenilin 1 (PS1) double-transgenic mice, a well established AD mouse model.  Here we report a robust decrease in brain Aβ deposition and tau phosphorylation in the blinded study of APP/PS1 transgenic mice treated i.p. for 8 wk with ATRA (20 mg/kg, three times weekly, initiated when the mice were 5 mo old).  This was accompanied by a significant decrease in the APP phosphorylation and processing.  The activity of cyclin-dependent kinase 5, a major kinase involved in both APP and tau phosphorylation, was markedly downregulated by ATRA treatment.  The ATRA-treated APP/PS1 mice showed decreased activation of microglia and astrocytes, attenuated neuronal degeneration, and improved spatial learning and memory compared with the vehicle-treated APP/PS1 mice.  These results support ATRA as an effective therapeutic agent for the prevention and treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeaBvX8Xo-vbVg90H21EOLACvtfcHk0ljitEWiqazIXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOgt7%252FP&md5=4e01293117a02d5516f64190ecb34eb4</span></div><a href="/servlet/linkout?suffix=cit229&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3153-08.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3153-08.2008%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DY.%26aulast%3DQiao%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DGoodwin%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DE.%2BS.%26aulast%3DBlock%26aufirst%3DM.%2BL.%26aulast%3DAllsbrook%26aufirst%3DM.%26aulast%3DMcDonald%26aufirst%3DM.%2BP.%26aulast%3DFan%26aufirst%3DG.%2BH.%26atitle%3DRetinoic%2520acid%2520attenuates%2520beta-amyloid%2520deposition%2520and%2520rescues%2520memory%2520deficits%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520transgenic%2520mouse%2520model%26jtitle%3DJ.%2520Neurosci.%26date%3D2008%26volume%3D28%26spage%3D11622%26epage%3D11634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref230"><div class="reference"><strong class="refLabel"><a href="#ref230" class="rightTabRefNumLink">230</a></strong><div class="NLM_citation" id="rightTab-cit230"><span><span class="NLM_contrib-group">Mann, K. G.</span><span> </span><span class="NLM_article-title">Biochemistry and physiology of blood coagulation</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1055%2Fs-0037-1615780" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=10605701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1MXnsVWnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1999&pages=165-174&author=K.+G.+Mann&title=Biochemistry+and+physiology+of+blood+coagulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit230R"><div class="casContent"><span class="casTitleNuber">230</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemistry and physiology of blood coagulation</span></div><div class="casAuthors">Mann, Kenneth G.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">165-174</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">F. K. Schattauer Verlagsgesellschaft mbH</span>)
        </div><div class="casAbstract">A review is given with 54 refs.  The accomplishments of many colleagues in the field of coagulation over the past 150 yr portens a bright future for advances in the intervention for hemorrhagic and thrombotic diseases in the 21st century.  The principal limitation will be the attraction of new basic and clin. scientists into the relevant fields of biochem., mol. genetics, hematol., cardiol., pathol., and surgery.  Future research will exploit existing advances in technol. in the pursuit of better techniques for diagnosis, prophylaxis, and intervention in cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPZK7SvwQDBbVg90H21EOLACvtfcHk0lid5eHdS7sdsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnsVWnur8%253D&md5=77570b86fe68de8e57cc14b0296cd5de</span></div><a href="/servlet/linkout?suffix=cit230&amp;dbid=16384&amp;doi=10.1055%2Fs-0037-1615780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0037-1615780%26sid%3Dliteratum%253Aachs%26aulast%3DMann%26aufirst%3DK.%2BG.%26atitle%3DBiochemistry%2520and%2520physiology%2520of%2520blood%2520coagulation%26jtitle%3DThromb.%2520Haemostasis%26date%3D1999%26volume%3D82%26spage%3D165%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref231"><div class="reference"><strong class="refLabel"><a href="#ref231" class="rightTabRefNumLink">231</a></strong><div class="NLM_citation" id="rightTab-cit231"><span><span class="NLM_contrib-group">Price, P. A.</span><span> </span><span class="NLM_article-title">Role of vitamin-K-dependent proteins in bone metabolism</span> <span class="citation_source-journal">Annu. Rev. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1988&pages=565-583&author=P.+A.+Price&title=Role+of+vitamin-K-dependent+proteins+in+bone+metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit231&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DP.%2BA.%26atitle%3DRole%2520of%2520vitamin-K-dependent%2520proteins%2520in%2520bone%2520metabolism%26jtitle%3DAnnu.%2520Rev.%2520Nutr.%26date%3D1988%26volume%3D8%26spage%3D565%26epage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref232"><div class="reference"><strong class="refLabel"><a href="#ref232" class="rightTabRefNumLink">232</a></strong><div class="NLM_citation" id="rightTab-cit232"><span><span class="NLM_contrib-group">Allison, A. C.</span><span> </span><span class="NLM_article-title">The possible role of vitamin K deficiency in the pathogenesis of Alzheimer’s disease and in augmenting brain damage associated with cardiovascular disease</span> <span class="citation_source-journal">Med. Hypotheses</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1054%2Fmehy.2001.1307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11461163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtVymt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2001&pages=151-155&author=A.+C.+Allison&title=The+possible+role+of+vitamin+K+deficiency+in+the+pathogenesis+of+Alzheimer%E2%80%99s+disease+and+in+augmenting+brain+damage+associated+with+cardiovascular+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit232R"><div class="casContent"><span class="casTitleNuber">232</span><div class="casTitle"><span class="NLM_cas:atitle">The possible role of vitamin K deficiency in the pathogenesis of Alzheimer's disease and in augmenting brain damage associated with cardiovascular disease</span></div><div class="casAuthors">Allison, A. C.</div><div class="citationInfo"><span class="NLM_cas:title">Medical Hypotheses</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-155</span>CODEN:
                <span class="NLM_cas:coden">MEHYDY</span>;
        ISSN:<span class="NLM_cas:issn">0306-9877</span>.
    
            (<span class="NLM_cas:orgname">Churchill Livingstone</span>)
        </div><div class="casAbstract">A review.  The incidence of Alzheimer's disease (AD) increases with age and in carriers of the apolipoprotein E4 genotype.  A relative deficiency of vitamin K, affecting the extrahepatic functions of the vitamin, is common in ageing men and women.  The concn. of vitamin K is lower in the circulating blood of APOE4 carriers than in that of persons with other APOE genotypes.  Evidence is accumulating that vitamin K has important functions in the brain, including the regulation of sulfotransferase activity and the activity of a growth factor/tyrosine kinase receptor (Gas 6/Axl).  The hypothesis is now proposed that vitamin K deficiency contributes to the pathogenesis of AD and that vitamin K supplementation may have a beneficial effect in preventing or treating the disease.  Vitamin K may also reduce neuronal damage assocd. with cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRHNf86TqCTLVg90H21EOLACvtfcHk0lid5eHdS7sdsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtVymt78%253D&md5=4bf44b2a7039ccbc513f9aebb460812e</span></div><a href="/servlet/linkout?suffix=cit232&amp;dbid=16384&amp;doi=10.1054%2Fmehy.2001.1307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1054%252Fmehy.2001.1307%26sid%3Dliteratum%253Aachs%26aulast%3DAllison%26aufirst%3DA.%2BC.%26atitle%3DThe%2520possible%2520role%2520of%2520vitamin%2520K%2520deficiency%2520in%2520the%2520pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520in%2520augmenting%2520brain%2520damage%2520associated%2520with%2520cardiovascular%2520disease%26jtitle%3DMed.%2520Hypotheses%26date%3D2001%26volume%3D57%26spage%3D151%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref233"><div class="reference"><strong class="refLabel"><a href="#ref233" class="rightTabRefNumLink">233</a></strong><div class="NLM_citation" id="rightTab-cit233"><span><span class="NLM_contrib-group">Beal, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shults, C. W.</span><span> </span><span class="NLM_article-title">Effects of coenzyme Q10 in Huntington’s disease and early Parkinson’s disease</span> <span class="citation_source-journal">BioFactors</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=153-161&author=M.+F.+Bealauthor=C.+W.+Shults&title=Effects+of+coenzyme+Q10+in+Huntington%E2%80%99s+disease+and+early+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit233&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeal%26aufirst%3DM.%2BF.%26aulast%3DShults%26aufirst%3DC.%2BW.%26atitle%3DEffects%2520of%2520coenzyme%2520Q10%2520in%2520Huntington%25E2%2580%2599s%2520disease%2520and%2520early%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DBioFactors%26date%3D2003%26volume%3D18%26spage%3D153%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref234"><div class="reference"><strong class="refLabel"><a href="#ref234" class="rightTabRefNumLink">234</a></strong><div class="NLM_citation" id="rightTab-cit234"><span><span class="NLM_contrib-group">Bhat, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, W. J.</span><span> </span><span class="NLM_article-title">Parkinson’s disease. Diagnosis and the initiation of therapy</span> <span class="citation_source-journal">Minerva Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=16175158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD2MrgtlSitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2005&pages=145-154&author=V.+Bhatauthor=W.+J.+Weiner&title=Parkinson%E2%80%99s+disease.+Diagnosis+and+the+initiation+of+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit234R"><div class="casContent"><span class="casTitleNuber">234</span><div class="casTitle"><span class="NLM_cas:atitle">Parkinson's disease. Diagnosis and the initiation of therapy</span></div><div class="casAuthors">Bhat V; Weiner W J</div><div class="citationInfo"><span class="NLM_cas:title">Minerva medica</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">145-54</span>
        ISSN:<span class="NLM_cas:issn">0026-4806</span>.
    </div><div class="casAbstract">Parkinson's disease (PD) is the most common cause of parkinsonism.  Parkinsonism is characterized by resting tremor, bradykinesia, rigidity and gait impairment.  There is no specific diagnostic test for PD and it is important for clinicians to understand the clinical signs which help to distinguish PD from parkinsonism.  It is equally important to be aware of the clinical signs which can be an indication that the diagnosis is not PD.  These so-called Parkinson-plus syndromes include progressive supranuclear palsy (PSP), multiple systems atrophy (MSA), corticobasal degeneration (CBD), vascular parkinsonism (VP) and parkinsonism with dementia (Lewy body dementia, LBD).  The differential diagnosis of parkinsonism will be discussed.  Initiating pharmacologic therapy for PD must take into consideration the degree of dysfunction the patient is experiencing, the question of neuroprotection, the degree of motor response required, and the potential complications of long-term treatment.  Neuropro-tective trials of coenzyme Q10 (CoQ), vitamin C, vitamin E, monoamine oxidase B inhibitors (MAO-I) and dopamine agonists do not support the use of any of these drugs for a neuroprotective effect.  There is recent supportive evidence that levodopa may have a neuroprotective effect.  Either dopamine agonists or levodopa may be initiated.  Dopamine agonists are associated with fewer motor fluctuations and dyskinesias, while levodopa is associated with better motor performance.  Initiation of therapy should be tailored to individual patients with the emphasis on symptom control, with the hope that new approaches to treatment of PD (including neuroprotection) will be forthcoming.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPK209odsbaQqdek-gHSrIfW6udTcc2eYBx-_3j1sbTrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MrgtlSitA%253D%253D&md5=0eebdb3d82f76300c857d310123f4aa1</span></div><a href="/servlet/linkout?suffix=cit234&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DV.%26aulast%3DWeiner%26aufirst%3DW.%2BJ.%26atitle%3DParkinson%25E2%2580%2599s%2520disease.%2520Diagnosis%2520and%2520the%2520initiation%2520of%2520therapy%26jtitle%3DMinerva%2520Med.%26date%3D2005%26volume%3D96%26spage%3D145%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref235"><div class="reference"><strong class="refLabel"><a href="#ref235" class="rightTabRefNumLink">235</a></strong><div class="NLM_citation" id="rightTab-cit235"><span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E. S.</span><span> </span><span class="NLM_article-title">Coenzyme Q10 attenuates beta-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation</span> <span class="citation_source-journal">J. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1007%2Fs12031-007-9033-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=18181031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFOhtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2008&pages=165-171&author=X.+Yangauthor=Y.+Yangauthor=G.+Liauthor=J.+Wangauthor=E.+S.+Yang&title=Coenzyme+Q10+attenuates+beta-amyloid+pathology+in+the+aged+transgenic+mice+with+Alzheimer+presenilin+1+mutation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit235R"><div class="casContent"><span class="casTitleNuber">235</span><div class="casTitle"><span class="NLM_cas:atitle">Coenzyme Q10 attenuates β-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation</span></div><div class="casAuthors">Yang, Xifei; Yang, Ying; Li, Geng; Wang, Jianzhi; Yang, Edward S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">165-171</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">One of the neuropathol. features of Alzheimer's disease (AD) is the deposition of senile plaques contg. β-amyloid (Aβ).  There is limited evidence for the treatment to arrest Aβ pathol. of AD.  In our present study, we tested the effect of coenzyme Q10 (CoQ10), an endogenous antioxidant and a powerful free radical scavenger, on Aβ in the aged transgenic mice overexpressing Alzheimer presenilin 1-L235P (leucine-to-proline mutation at codon 235, 16-17 mo old).  The treatment by feeding the transgenic mice with CoQ10 for 60 days (1,200 mg kg-1 day-1) partially attenuated Aβ overprodn. and intracellular Aβ deposit in the cortex of the transgenic mice compared with the age-matched untreated transgenic mice.  Meanwhile, an increased oxidative stress reaction was detected as evidenced by elevated level of malondialdehyde (MDA) and decreased activity of superoxide dismutase (SOD) in the transgenic mice relative to the wild-type mice, and supplementation of CoQ10 partially decreased MDA level and upregulated the activity of SOD.  The results indicate that oxidative stress is enhanced in the brain of the transgenic mice, that this enhancement may further promote Aβ42 overprodn. in a vicious formation, and that CoQ10 would be beneficial for the therapy of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3P840SlD4ULVg90H21EOLACvtfcHk0lioEPg4zEReBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFOhtLc%253D&md5=8f2cced90d89e0e8b8e5118f33b482df</span></div><a href="/servlet/linkout?suffix=cit235&amp;dbid=16384&amp;doi=10.1007%2Fs12031-007-9033-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12031-007-9033-7%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DE.%2BS.%26atitle%3DCoenzyme%2520Q10%2520attenuates%2520beta-amyloid%2520pathology%2520in%2520the%2520aged%2520transgenic%2520mice%2520with%2520Alzheimer%2520presenilin%25201%2520mutation%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2008%26volume%3D34%26spage%3D165%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref236"><div class="reference"><strong class="refLabel"><a href="#ref236" class="rightTabRefNumLink">236</a></strong><div class="NLM_citation" id="rightTab-cit236"><span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E. S.</span><span> </span><span class="NLM_article-title">Coenzyme Q10 reduces beta-amyloid plaque in an APP/PS1 transgenic mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">J. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1007%2Fs12031-009-9297-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=19834824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs1OgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2010&pages=110-113&author=X.+Yangauthor=G.+Daiauthor=G.+Liauthor=E.+S.+Yang&title=Coenzyme+Q10+reduces+beta-amyloid+plaque+in+an+APP%2FPS1+transgenic+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit236R"><div class="casContent"><span class="casTitleNuber">236</span><div class="casTitle"><span class="NLM_cas:atitle">Coenzyme Q10 Reduces β-Amyloid Plaque in an APP/PS1 Transgenic Mouse Model of Alzheimer's Disease</span></div><div class="casAuthors">Yang, Xifei; Dai, George; Li, Geng; Yang, Edward S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">110-113</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We previously reported that coenzyme Q10 (CoQ10) could reduce intracellular deposition in an aged transgenic mouse model.  Here, we further tested the effect of CoQ10 on amyloid plaque in an amyloid precursor protein/presenilin 1 transgenic mouse model of Alzheimer's disease (AD).  By using immunohistochem. and magnetic resonance imaging to det. the burden of amyloid plaque, we found that oral administration of CoQ10 can efficiently reduce the burden of the plaques in this mouse model.  These data demonstrate that in addn. to reducing intracellular deposition of Aβ, CoQ10 can also reduce plaque pathol.  Our study further supports the use of CoQ10 as a therapeutic candidate for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDZAa6xs0F2bVg90H21EOLACvtfcHk0lioEPg4zEReBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs1OgsLY%253D&md5=8a9458cf9d9758bf5f409e8f6767367c</span></div><a href="/servlet/linkout?suffix=cit236&amp;dbid=16384&amp;doi=10.1007%2Fs12031-009-9297-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12031-009-9297-1%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3DDai%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DE.%2BS.%26atitle%3DCoenzyme%2520Q10%2520reduces%2520beta-amyloid%2520plaque%2520in%2520an%2520APP%252FPS1%2520transgenic%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2010%26volume%3D41%26spage%3D110%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref237"><div class="reference"><strong class="refLabel"><a href="#ref237" class="rightTabRefNumLink">237</a></strong><div class="NLM_citation" id="rightTab-cit237"><span><span class="NLM_contrib-group">Skulachev, V. P.</span><span> </span><span class="NLM_article-title">Mitochondria-targeted antioxidants as promising drugs for treatment of age-related brain diseases</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=21987592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVerur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2012&pages=283-289&author=V.+P.+Skulachev&title=Mitochondria-targeted+antioxidants+as+promising+drugs+for+treatment+of+age-related+brain+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit237R"><div class="casContent"><span class="casTitleNuber">237</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria-Targeted Antioxidants as Promising Drugs for Treatment of Age-Related Brain Diseases</span></div><div class="casAuthors">Skulachev, Vladimir P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">283-289</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Much exptl. evidence suggests that age-related brain pathologies are most often mediated by reactive oxygen species primarily originating from mitochondria (mROS).  Two papers with such evidence have been recently published in the Journal of Alzheimer's Disease (Stefanova et al., J Alzheimers Dis 21, 476-491, 2010; Lloret et al., J Alzheimers Dis, doi: 10.3233/JAD-2011-110890).  In the first paper, it was shown that appearance of a typical behavioral trait of aging in rats (that old animals do not enter an open arm in a maze) was completely reversed by ten weeks treatment of the old rats with the mitochondria-targeted antioxidant SkQ1.  In the second article, the authors identified mol. mechanisms by which amyloid-β-induced mROS can mediate hyperphosphorylation of the tau protein, a key event in Alzheimer's disease.  Conventional antioxidants prevented such hyperphosphorylation.  In this article, I will summarize the present state of the art in this field.  I conclude that mitochondria-targeted rechargeable antioxidants are promising as tools to treat brain pathologies developing in elderly humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp10YLEATJJV7Vg90H21EOLACvtfcHk0lioEPg4zEReBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVerur0%253D&md5=e717a80140b4ad05752ca68cd6a71d6c</span></div><a href="/servlet/linkout?suffix=cit237&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkulachev%26aufirst%3DV.%2BP.%26atitle%3DMitochondria-targeted%2520antioxidants%2520as%2520promising%2520drugs%2520for%2520treatment%2520of%2520age-related%2520brain%2520diseases%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2012%26volume%3D28%26spage%3D283%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref238"><div class="reference"><strong class="refLabel"><a href="#ref238" class="rightTabRefNumLink">238</a></strong><div class="NLM_citation" id="rightTab-cit238"><span><span class="NLM_contrib-group">Szeto, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiller, P. W.</span><span> </span><span class="NLM_article-title">Novel therapies targeting inner mitochondrial membrane—from discovery to clinical development</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">2669</span><span class="NLM_x">–</span> <span class="NLM_lpage">2679</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2011&pages=2669-2679&author=H.+H.+Szetoauthor=P.+W.+Schiller&title=Novel+therapies+targeting+inner+mitochondrial+membrane%E2%80%94from+discovery+to+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit238&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSzeto%26aufirst%3DH.%2BH.%26aulast%3DSchiller%26aufirst%3DP.%2BW.%26atitle%3DNovel%2520therapies%2520targeting%2520inner%2520mitochondrial%2520membrane%25E2%2580%2594from%2520discovery%2520to%2520clinical%2520development%26jtitle%3DPharm.%2520Res.%26date%3D2011%26volume%3D28%26spage%3D2669%26epage%3D2679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref239"><div class="reference"><strong class="refLabel"><a href="#ref239" class="rightTabRefNumLink">239</a></strong><div class="NLM_citation" id="rightTab-cit239"><span><span class="NLM_contrib-group">Floyd, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensley, K.</span><span> </span><span class="NLM_article-title">Nitrone inhibition of age-associated oxidative damage</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">899</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=899&publication_year=2000&pages=222-237&author=R.+A.+Floydauthor=K.+Hensley&title=Nitrone+inhibition+of+age-associated+oxidative+damage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit239&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFloyd%26aufirst%3DR.%2BA.%26aulast%3DHensley%26aufirst%3DK.%26atitle%3DNitrone%2520inhibition%2520of%2520age-associated%2520oxidative%2520damage%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2000%26volume%3D899%26spage%3D222%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref240"><div class="reference"><strong class="refLabel"><a href="#ref240" class="rightTabRefNumLink">240</a></strong><div class="NLM_citation" id="rightTab-cit240"><span><span class="NLM_contrib-group">Floyd, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bing, G.</span><span> </span><span class="NLM_article-title">Evidence for enhanced neuro-inflammatory processes in neurodegenerative diseases and the action of nitrones as potential therapeutics</span> <span class="citation_source-journal">J. Neural Transm., Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">414</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=11205157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD3M3gt1Ohug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=387-414&author=R.+A.+Floydauthor=K.+Hensleyauthor=G.+Bing&title=Evidence+for+enhanced+neuro-inflammatory+processes+in+neurodegenerative+diseases+and+the+action+of+nitrones+as+potential+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit240R"><div class="casContent"><span class="casTitleNuber">240</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for enhanced neuro-inflammatory processes in neurodegenerative diseases and the action of nitrones as potential therapeutics</span></div><div class="casAuthors">Floyd R A; Hensley K; Bing G</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neural transmission. Supplementum</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">60</span>),
    <span class="NLM_cas:pages">387-414</span>
        ISSN:<span class="NLM_cas:issn">0303-6995</span>.
    </div><div class="casAbstract">A brief review is presented on observations leading to the current notions regarding neuro-inflammatory processes.  The greatest focus is on Alzheimer's disease (AD) since this is where the most convincing data has been obtained.  A brief summary of observations on the neuroprotective action of alpha-phenyl-tert-butyl-nitrone (PBN) as well as results of research designed to understand its mechanism of action is presented.  We hypothesize that the mechanism of action of PBN involves inhibition of signal transduction processes, which are involved in the upregulation of genes mediated by pro-inflammatory cytokines and H2O2 that cause formation of toxic gene products.  Results from recent experiments on Kainic acid (KA) mediated brain damage are provided to suggest the validity of the in vivo action of PBN to inhibit neuro-inflammatory processes.  The accumulating scientific facts are helping to provide concepts that may become the basis for novel therapeutic approaches to the treatment of several neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRj2Aw68nvLXQqdek-gHSrIfW6udTcc2eaHEKT6zJ4whrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M3gt1Ohug%253D%253D&md5=3101c65abe629bf48c7b4b994ba108b6</span></div><a href="/servlet/linkout?suffix=cit240&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFloyd%26aufirst%3DR.%2BA.%26aulast%3DHensley%26aufirst%3DK.%26aulast%3DBing%26aufirst%3DG.%26atitle%3DEvidence%2520for%2520enhanced%2520neuro-inflammatory%2520processes%2520in%2520neurodegenerative%2520diseases%2520and%2520the%2520action%2520of%2520nitrones%2520as%2520potential%2520therapeutics%26jtitle%3DJ.%2520Neural%2520Transm.%252C%2520Suppl.%26date%3D2000%26spage%3D387%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref241"><div class="reference"><strong class="refLabel"><a href="#ref241" class="rightTabRefNumLink">241</a></strong><div class="NLM_citation" id="rightTab-cit241"><span><span class="NLM_contrib-group">Das, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voss, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doseff, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villamena, F. A.</span><span> </span><span class="NLM_article-title">Inhibition of ROS-induced apoptosis in endothelial cells by nitrone spin traps via induction of phase II enzymes and suppression of mitochondria-dependent pro-apoptotic signaling</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=486-497&author=A.+Dasauthor=B.+Gopalakrishnanauthor=O.+H.+Vossauthor=A.+I.+Doseffauthor=F.+A.+Villamena&title=Inhibition+of+ROS-induced+apoptosis+in+endothelial+cells+by+nitrone+spin+traps+via+induction+of+phase+II+enzymes+and+suppression+of+mitochondria-dependent+pro-apoptotic+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit241&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DA.%26aulast%3DGopalakrishnan%26aufirst%3DB.%26aulast%3DVoss%26aufirst%3DO.%2BH.%26aulast%3DDoseff%26aufirst%3DA.%2BI.%26aulast%3DVillamena%26aufirst%3DF.%2BA.%26atitle%3DInhibition%2520of%2520ROS-induced%2520apoptosis%2520in%2520endothelial%2520cells%2520by%2520nitrone%2520spin%2520traps%2520via%2520induction%2520of%2520phase%2520II%2520enzymes%2520and%2520suppression%2520of%2520mitochondria-dependent%2520pro-apoptotic%2520signaling%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D84%26spage%3D486%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref242"><div class="reference"><strong class="refLabel"><a href="#ref242" class="rightTabRefNumLink">242</a></strong><div class="NLM_citation" id="rightTab-cit242"><span><span class="NLM_contrib-group">Floyd, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffery, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maidt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, C.</span><span> </span><span class="NLM_article-title">Increased oxidative stress brought on by pro-inflammatory cytokines in neurodegenerative processes and the protective role of nitrone-based free radical traps</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1893</span><span class="NLM_x">–</span> <span class="NLM_lpage">1899</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1999&pages=1893-1899&author=R.+A.+Floydauthor=K.+Hensleyauthor=F.+Jafferyauthor=L.+Maidtauthor=K.+Robinsonauthor=Q.+Pyeauthor=C.+Stewart&title=Increased+oxidative+stress+brought+on+by+pro-inflammatory+cytokines+in+neurodegenerative+processes+and+the+protective+role+of+nitrone-based+free+radical+traps"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit242&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFloyd%26aufirst%3DR.%2BA.%26aulast%3DHensley%26aufirst%3DK.%26aulast%3DJaffery%26aufirst%3DF.%26aulast%3DMaidt%26aufirst%3DL.%26aulast%3DRobinson%26aufirst%3DK.%26aulast%3DPye%26aufirst%3DQ.%26aulast%3DStewart%26aufirst%3DC.%26atitle%3DIncreased%2520oxidative%2520stress%2520brought%2520on%2520by%2520pro-inflammatory%2520cytokines%2520in%2520neurodegenerative%2520processes%2520and%2520the%2520protective%2520role%2520of%2520nitrone-based%2520free%2520radical%2520traps%26jtitle%3DLife%2520Sci.%26date%3D1999%26volume%3D65%26spage%3D1893%26epage%3D1899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref243"><div class="reference"><strong class="refLabel"><a href="#ref243" class="rightTabRefNumLink">243</a></strong><div class="NLM_citation" id="rightTab-cit243"><span><span class="NLM_contrib-group">Floyd, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forster, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelleher-Andersson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, P. L.</span><span> </span><span class="NLM_article-title">Nitrones, their value as therapeutics and probes to understand aging</span> <span class="citation_source-journal">Mech. Ageing Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1031</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS0047-6374%2801%2900385-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12044951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD38XktFOls7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2002&pages=1021-1031&author=R.+A.+Floydauthor=K.+Hensleyauthor=M.+J.+Forsterauthor=J.+A.+Kelleher-Anderssonauthor=P.+L.+Wood&title=Nitrones%2C+their+value+as+therapeutics+and+probes+to+understand+aging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit243R"><div class="casContent"><span class="casTitleNuber">243</span><div class="casTitle"><span class="NLM_cas:atitle">Nitrones, their value as therapeutics and probes to understand aging</span></div><div class="casAuthors">Floyd, Robert A.; Hensley, Kenneth; Forster, Michael J.; Kelleher-Andersson, Judith A.; Wood, Paul L.</div><div class="citationInfo"><span class="NLM_cas:title">Mechanisms of Ageing and Development</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1021-1031</span>CODEN:
                <span class="NLM_cas:coden">MAGDA3</span>;
        ISSN:<span class="NLM_cas:issn">0047-6374</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  The nitrone-based free radical traps have significant potential in the treatment of neurodegenerative diseases as well as in the prolongation of life span.  The mass action free radical trapping activity of these compds. is the property, which first brought them to the attention of the scientific community.  Nevertheless extensive research has demonstrated that these reactions are not responsible for their therapeutic mechanistic basis of activity.  Rather the mechanism of action in the case of their neuroprotective activity appears to involve the inhibition of enhanced signal transduction processes that mediate the upregulation of genes, which produce neurotoxic products.  The most widely used compd. in this series, α-phenyl-tert-butyl-nitrone (PBN), has been shown to extend life span in three published studies, i.e. two mouse models and one rat model.  Significant prolongation of life span was noted in all three studies.  We report the summary of a recent study with a novel nitrone, CPI-1429, which demonstrated the ability to extend life span even though administration of the compd. was begun in older animals.  Despite these promising studies, much more rigorous research examg. the anti-aging activity of the nitrones needs to be conducted.  It is not known exactly why the nitrones possess anti-aging activity.  They have been shown to quell enhanced signal transduction processes assocd. with enhanced pro-inflammatory cytokine mediated events.  The nitrones interfere in some unknown steps preventing receptor triggered MAP kinase phosphorylation cascades.  Stabilization of phosphorylation networks assocd. with checkpoint proteins could slow cell cycle processes and this could be the basis of the nitrones anti-senescent activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplDsHg8sWik7Vg90H21EOLACvtfcHk0liTFElyymJv9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktFOls7c%253D&md5=ced7eca28eafa53da1565d324a8ecc5d</span></div><a href="/servlet/linkout?suffix=cit243&amp;dbid=16384&amp;doi=10.1016%2FS0047-6374%2801%2900385-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0047-6374%252801%252900385-2%26sid%3Dliteratum%253Aachs%26aulast%3DFloyd%26aufirst%3DR.%2BA.%26aulast%3DHensley%26aufirst%3DK.%26aulast%3DForster%26aufirst%3DM.%2BJ.%26aulast%3DKelleher-Andersson%26aufirst%3DJ.%2BA.%26aulast%3DWood%26aufirst%3DP.%2BL.%26atitle%3DNitrones%252C%2520their%2520value%2520as%2520therapeutics%2520and%2520probes%2520to%2520understand%2520aging%26jtitle%3DMech.%2520Ageing%2520Dev.%26date%3D2002%26volume%3D123%26spage%3D1021%26epage%3D1031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref244"><div class="reference"><strong class="refLabel"><a href="#ref244" class="rightTabRefNumLink">244</a></strong><div class="NLM_citation" id="rightTab-cit244"><span><span class="NLM_contrib-group">Shuaib, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyden, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davalos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diener, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasiewski, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emeribe, U.</span><span> </span><span class="NLM_article-title">NXY-059 for the treatment of acute ischemic stroke</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">562</span><span class="NLM_x">–</span> <span class="NLM_lpage">571</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1056%2FNEJMoa070240" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=17687131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptVSjsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2007&pages=562-571&author=A.+Shuaibauthor=K.+R.+Leesauthor=P.+Lydenauthor=J.+Grottaauthor=A.+Davalosauthor=S.+M.+Davisauthor=H.+C.+Dienerauthor=T.+Ashwoodauthor=W.+W.+Wasiewskiauthor=U.+Emeribe&title=NXY-059+for+the+treatment+of+acute+ischemic+stroke"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit244R"><div class="casContent"><span class="casTitleNuber">244</span><div class="casTitle"><span class="NLM_cas:atitle">NXY-059 for the treatment of acute ischemic stroke</span></div><div class="casAuthors">Shuaib, Ashfaq; Lees, Kennedy R.; Lyden, Patrick; Grotta, James; Davalos, Antonio; Davis, Stephen M.; Diener, Hans-Christoph; Ashwood, Tim; Wasiewski, Warren W.; Emeribe, Ugochi</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">562-571</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: The free-radical-trapping agent NXY-059 showed promise as a neuroprotectant in the Stroke-Acute Ischemic NXY Treatment I (SAINT I) trial, reducing disability when given to patients who had acute ischemic stroke.  We sought confirmation of efficacy in a second, larger trial.  Methods: We enrolled 3306 patients with acute ischemic stroke in a randomized, double-blind trial to receive a 72-h infusion of i.v. NXY-059 or placebo within 6 h after the. onset of stroke symptoms.  Our primary end point was the distribution of disability scores on the modified Rankin scale at 90 days.  We examd. scores on neurol. and activities-of-daily-living scales as secondary end points.  We also tested the hypothesis that NXY-059 would reduce alteplase-related intracranial hemorrhages.  Results: The efficacy anal. was based on 3195 patients.  Prognostic factors were well balanced between the treatment groups.  Mortality was equal in the two groups, and adverse-event rates were similar.  The distribution of scores on the modified Rankin scale did not differ between the group treated with NXY-059 (1588 patients) and the placebo group (1607 patients; P = 0.33 by the Cochran-Mantel-Haenszel test; odds ratio for limiting disability, 0.94; 95% confidence interval [CI], 0.83 to 1.06).  Anal. of categorized scores on the modified Rankin scale confirmed the lack of benefit: the odds ratio for trichotomization into modified Rankin scale scores of 0 to 1 vs. 2 to 3 vs. 4 to 6 was 0.92 (95% CI, 0.80 to 1.06).  There was no evidence of efficacy for any of the secondary end points.  Among patients treated with alteplase, there was no difference between the NXY-059 group and the placebo group in the frequency of symptomatic or asymptomatic hemorrhage.  Conclusions: NXY-059 is ineffective for the treatment of acute ischemic stroke within 6 h after the onset of symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF9Lz8mJUaG7Vg90H21EOLACvtfcHk0ljYsPjSZC830Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptVSjsLc%253D&md5=4a249bb6f8aa45b485496c9c91bede82</span></div><a href="/servlet/linkout?suffix=cit244&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa070240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa070240%26sid%3Dliteratum%253Aachs%26aulast%3DShuaib%26aufirst%3DA.%26aulast%3DLees%26aufirst%3DK.%2BR.%26aulast%3DLyden%26aufirst%3DP.%26aulast%3DGrotta%26aufirst%3DJ.%26aulast%3DDavalos%26aufirst%3DA.%26aulast%3DDavis%26aufirst%3DS.%2BM.%26aulast%3DDiener%26aufirst%3DH.%2BC.%26aulast%3DAshwood%26aufirst%3DT.%26aulast%3DWasiewski%26aufirst%3DW.%2BW.%26aulast%3DEmeribe%26aufirst%3DU.%26atitle%3DNXY-059%2520for%2520the%2520treatment%2520of%2520acute%2520ischemic%2520stroke%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2007%26volume%3D357%26spage%3D562%26epage%3D571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref245"><div class="reference"><strong class="refLabel"><a href="#ref245" class="rightTabRefNumLink">245</a></strong><div class="NLM_citation" id="rightTab-cit245"><span><span class="NLM_contrib-group">Klivenyi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wermer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacGarvey, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, M. F.</span><span> </span><span class="NLM_article-title">Azulenyl nitrone spin traps protect against MPTP neurotoxicity</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1006%2Fexnr.1998.6824" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=9682023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1cXlsFKrsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=1998&pages=163-166&author=P.+Klivenyiauthor=R.+T.+Matthewsauthor=M.+Wermerauthor=L.+Yangauthor=U.+MacGarveyauthor=D.+A.+Beckerauthor=R.+Nateroauthor=M.+F.+Beal&title=Azulenyl+nitrone+spin+traps+protect+against+MPTP+neurotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit245R"><div class="casContent"><span class="casTitleNuber">245</span><div class="casTitle"><span class="NLM_cas:atitle">Azulenyl nitrone spin traps protect against MPTP neurotoxicity</span></div><div class="casAuthors">Klivenyi, Peter; Matthews, Russell T.; Wermer, Marieke; Yang, Lichuan; MacGarvey, Usha; Becker, David A.; Natero, Reina; Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">163-166</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Azulenyl nitrones are a unique class of free radical spin-trapping compds.  The authors administered both a water-sol. and a lipid-sol. azulenyl nitrone to mice prior to administration of MPTP.  Both compds. produced significant neuroprotection against depletions of dopamine and its metabolites measured 1 wk after MPTP administration.  There were no effects on MPP+ levels.  These findings provide further evidence that free radical scavengers can produce significant neuroprotection against MPTP neurotoxicity.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroLtahi2GDibVg90H21EOLACvtfcHk0ljYsPjSZC830Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsFKrsrY%253D&md5=e34ca7e6871b4ba6ebe2268c61e1a892</span></div><a href="/servlet/linkout?suffix=cit245&amp;dbid=16384&amp;doi=10.1006%2Fexnr.1998.6824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexnr.1998.6824%26sid%3Dliteratum%253Aachs%26aulast%3DKlivenyi%26aufirst%3DP.%26aulast%3DMatthews%26aufirst%3DR.%2BT.%26aulast%3DWermer%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DMacGarvey%26aufirst%3DU.%26aulast%3DBecker%26aufirst%3DD.%2BA.%26aulast%3DNatero%26aufirst%3DR.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DAzulenyl%2520nitrone%2520spin%2520traps%2520protect%2520against%2520MPTP%2520neurotoxicity%26jtitle%3DExp.%2520Neurol.%26date%3D1998%26volume%3D152%26spage%3D163%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref246"><div class="reference"><strong class="refLabel"><a href="#ref246" class="rightTabRefNumLink">246</a></strong><div class="NLM_citation" id="rightTab-cit246"><span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calingasan, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, M. F.</span><span> </span><span class="NLM_article-title">A novel azulenyl nitrone antioxidant protects against MPTP and 3-nitropropionic acid neurotoxicities</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.expneurol.2004.07.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=15589515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKltL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2005&pages=86-93&author=L.+Yangauthor=N.+Y.+Calingasanauthor=J.+Chenauthor=J.+J.+Leyauthor=D.+A.+Beckerauthor=M.+F.+Beal&title=A+novel+azulenyl+nitrone+antioxidant+protects+against+MPTP+and+3-nitropropionic+acid+neurotoxicities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit246R"><div class="casContent"><span class="casTitleNuber">246</span><div class="casTitle"><span class="NLM_cas:atitle">A novel azulenyl nitrone antioxidant protects against MPTP and 3-nitropropionic acid neurotoxicities</span></div><div class="casAuthors">Yang, Lichuan; Calingasan, Noel Y.; Chen, Junyu; Ley, James J.; Becker, David A.; Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">86-93</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Oxidative stress plays an important role in neuronal death in neurodegenerative disorders such as Parkinson's disease (PD) and Huntington's disease (HD).  Animal models of PD or HD, produced by administration of the mitochondrial toxins 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or 3-nitropropionic acid (3NP), resp., show increased free radical generation.  Free radicals generated in biol. systems can react with spin-trapping compds., such as nitrones, to form stable adducts.  In recent years, the utility of nitrones has moved beyond anal. applications and into the realm of neuroprotection as antioxidants in both brain ischemia and models of neurodegenerative diseases.  In the present study, we administered a new nitrone antioxidant, stilbazulenyl nitrone (STAZN), with either MPTP or 3NP.  STAZN attenuated MPTP-induced striatal dopamine depletion by 40% and showed a tendency to dose-dependent neuroprotection.  STAZN dose-dependently protected against loss of tyrosine hydroxylase immunoreactive neurons in the substantia nigra pars compacta.  STAZN reduced the striatal lesion vol. caused by systemic 3NP administration from 44 ± 9 to 20 ± 6 mm3.  The lipid peroxidn. marker, malondialdehyde(MDA), was significantly increased in the striatum, cortex, and cerebellum of rats after administration of 3NP.  These increases were blocked by co-injection of STAZN.  Our data provide further evidence that STAZN is a neuroprotective free radical spin trap, and suggest that the development of new antioxidants will broaden our therapeutic strategies for neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3f9FMQ2iaA7Vg90H21EOLACvtfcHk0ljYsPjSZC830Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKltL7M&md5=3e2db3bd5211d99799f3fc2464c68a10</span></div><a href="/servlet/linkout?suffix=cit246&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2004.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2004.07.012%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DCalingasan%26aufirst%3DN.%2BY.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLey%26aufirst%3DJ.%2BJ.%26aulast%3DBecker%26aufirst%3DD.%2BA.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DA%2520novel%2520azulenyl%2520nitrone%2520antioxidant%2520protects%2520against%2520MPTP%2520and%25203-nitropropionic%2520acid%2520neurotoxicities%26jtitle%3DExp.%2520Neurol.%26date%3D2005%26volume%3D191%26spage%3D86%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref247"><div class="reference"><strong class="refLabel"><a href="#ref247" class="rightTabRefNumLink">247</a></strong><div class="NLM_citation" id="rightTab-cit247"><span><span class="NLM_contrib-group">Padayatty, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corpe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, M.</span><span> </span><span class="NLM_article-title">Vitamin C as an antioxidant: evaluation of its role in disease prevention</span> <span class="citation_source-journal">J. Am. Coll. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1080%2F07315724.2003.10719272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12569111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhs12isL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=18-35&author=S.+J.+Padayattyauthor=A.+Katzauthor=Y.+Wangauthor=P.+Eckauthor=O.+Kwonauthor=J.+H.+Leeauthor=S.+Chenauthor=C.+Corpeauthor=A.+Duttaauthor=S.+K.+Duttaauthor=M.+Levine&title=Vitamin+C+as+an+antioxidant%3A+evaluation+of+its+role+in+disease+prevention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit247R"><div class="casContent"><span class="casTitleNuber">247</span><div class="casTitle"><span class="NLM_cas:atitle">Vitamin C as an antioxidant: evaluation of its role in disease prevention</span></div><div class="casAuthors">Padayatty, Sebastian J.; Katz, Arie; Wang, Yaohui; Eck, Peter; Kwon, Oran; Lee, Je-Hyuk; Chen, Shenglin; Corpe, Christopher; Dutta, Anand; Dutta, Sudhir K.; Levine, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Nutrition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-35</span>CODEN:
                <span class="NLM_cas:coden">JONUDL</span>;
        ISSN:<span class="NLM_cas:issn">0731-5724</span>.
    
            (<span class="NLM_cas:orgname">American College of Nutrition</span>)
        </div><div class="casAbstract">A review.  Vitamin C in humans must be ingested for survival.  Vitamin C is an electron donor, and this property accounts for all its known functions.  As an electron donor, vitamin C is a potent water-sol. antioxidant in humans.  Antioxidant effects of vitamin C were demonstrated in many expts. in vitro.  Human diseases such as atherosclerosis and cancer might occur in part from oxidant damage to tissues.  Oxidn. of lipids, proteins and DNA results in specific oxidn. products that can be measured in the lab.  While these biomarkers of oxidn. were measured in humans such assays have not yet been validated or standardized and the relationship of oxidant markers to human disease conditions is not clear.  Epidemiol. studies show that diets high in fruits and vegetables are assocd. with lower risk of cardiovascular disease, stroke and cancer, and with increased longevity.  Whether these protective effects are directly attributable to vitamin C is not known.  Intervention studies with vitamin C have shown no change in markers of oxidn. or clin. benefit.  Dose concn. studies of vitamin C in healthy people showed a sigmoidal relationship between oral dose and plasma and tissue vitamin C concns.  Hence, optimal dosing is crit. to intervention studies using vitamin C.  Ideally, future studies of antioxidant actions of vitamin C should target selected patient groups.  These groups should be known to have increased oxidative damage as assessed by a reliable biomarker or should have high morbidity and mortality due to diseases thought to be caused or exacerbated by oxidant damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk1Rk3zu39_bVg90H21EOLACvtfcHk0ljYsPjSZC830Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhs12isL0%253D&md5=d6022179b92e8eb38cbc96072db55298</span></div><a href="/servlet/linkout?suffix=cit247&amp;dbid=16384&amp;doi=10.1080%2F07315724.2003.10719272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07315724.2003.10719272%26sid%3Dliteratum%253Aachs%26aulast%3DPadayatty%26aufirst%3DS.%2BJ.%26aulast%3DKatz%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DEck%26aufirst%3DP.%26aulast%3DKwon%26aufirst%3DO.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DCorpe%26aufirst%3DC.%26aulast%3DDutta%26aufirst%3DA.%26aulast%3DDutta%26aufirst%3DS.%2BK.%26aulast%3DLevine%26aufirst%3DM.%26atitle%3DVitamin%2520C%2520as%2520an%2520antioxidant%253A%2520evaluation%2520of%2520its%2520role%2520in%2520disease%2520prevention%26jtitle%3DJ.%2520Am.%2520Coll.%2520Nutr.%26date%3D2003%26volume%3D22%26spage%3D18%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref248"><div class="reference"><strong class="refLabel"><a href="#ref248" class="rightTabRefNumLink">248</a></strong><div class="NLM_citation" id="rightTab-cit248"><span><span class="NLM_contrib-group">Dringen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamprecht, B.</span><span> </span><span class="NLM_article-title">Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">562</span><span class="NLM_x">–</span> <span class="NLM_lpage">569</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1523%2FJNEUROSCI.19-02-00562.1999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=9880576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK1MXltlagtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=562-569&author=R.+Dringenauthor=B.+Pfeifferauthor=B.+Hamprecht&title=Synthesis+of+the+antioxidant+glutathione+in+neurons%3A+supply+by+astrocytes+of+CysGly+as+precursor+for+neuronal+glutathione"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit248R"><div class="casContent"><span class="casTitleNuber">248</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione</span></div><div class="casAuthors">Dringen, Ralf; Pfeiffer, Brigitte; Hamprecht, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">562-569</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Deficiency of the antioxidant glutathione in brain appears to be connected with several diseases characterized by neuronal loss.  To study neuronal glutathione metab. and metabolic interactions between neurons and astrocytes in this respect, neuron-rich primary cultures and transient cocultures of neurons and astroglial cells were used.  Coincubation of neurons with astroglial cells resulted within 24 h of incubation in a neuronal glutathione content twice that of neurons incubated in the absence of astroglial cells.  In cultured neurons, the availability of cysteine limited the cellular level of glutathione.  During a 4 h incubation in a minimal medium lacking all amino acids except cysteine, the amt. of neuronal glutathione was doubled.  Besides cysteine, also the dipeptides CysGly and γGluCys were able to serve as glutathione precursors and caused a concn.-dependent increase in glutathione content.  Concns. giving half-maximal effects were 5, 5, and 200 μM for cysteine, CysGly, and γGluCys, resp.  In the transient cocultures, the astroglia-mediated increase in neuronal glutathione was suppressed by acivicin, an inhibitor of the astroglial ectoenzyme γ-glutamyl transpeptidase, which generates CysGly from glutathione.  These data suggest the following metabolic interaction in glutathione metab. of brain cells: the ectoenzyme γ-glutamyl transpeptidase uses as substrate the glutathione released by astrocytes to generate the dipeptide CysGly that is subsequently used by neurons as precursor for glutathione synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoroZ8fOfsF-bVg90H21EOLACvtfcHk0lgQJtXGouuapQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltlagtA%253D%253D&md5=7366ee20452ce0d555e27926a5b56729</span></div><a href="/servlet/linkout?suffix=cit248&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.19-02-00562.1999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.19-02-00562.1999%26sid%3Dliteratum%253Aachs%26aulast%3DDringen%26aufirst%3DR.%26aulast%3DPfeiffer%26aufirst%3DB.%26aulast%3DHamprecht%26aufirst%3DB.%26atitle%3DSynthesis%2520of%2520the%2520antioxidant%2520glutathione%2520in%2520neurons%253A%2520supply%2520by%2520astrocytes%2520of%2520CysGly%2520as%2520precursor%2520for%2520neuronal%2520glutathione%26jtitle%3DJ.%2520Neurosci.%26date%3D1999%26volume%3D19%26spage%3D562%26epage%3D569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref249"><div class="reference"><strong class="refLabel"><a href="#ref249" class="rightTabRefNumLink">249</a></strong><div class="NLM_citation" id="rightTab-cit249"><span><span class="NLM_contrib-group">Dringen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamprecht, B.</span><span> </span><span class="NLM_article-title"><i>N</i>-Acetylcysteine, but not methionine or 2-oxothiazolidine-4-carboxylate, serves as cysteine donor for the synthesis of glutathione in cultured neurons derived from embryonal rat brain</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">259</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=259&publication_year=1999&pages=79-82&author=R.+Dringenauthor=B.+Hamprecht&title=N-Acetylcysteine%2C+but+not+methionine+or+2-oxothiazolidine-4-carboxylate%2C+serves+as+cysteine+donor+for+the+synthesis+of+glutathione+in+cultured+neurons+derived+from+embryonal+rat+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit249&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDringen%26aufirst%3DR.%26aulast%3DHamprecht%26aufirst%3DB.%26atitle%3DN-Acetylcysteine%252C%2520but%2520not%2520methionine%2520or%25202-oxothiazolidine-4-carboxylate%252C%2520serves%2520as%2520cysteine%2520donor%2520for%2520the%2520synthesis%2520of%2520glutathione%2520in%2520cultured%2520neurons%2520derived%2520from%2520embryonal%2520rat%2520brain%26jtitle%3DNeurosci.%2520Lett.%26date%3D1999%26volume%3D259%26spage%3D79%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref250"><div class="reference"><strong class="refLabel"><a href="#ref250" class="rightTabRefNumLink">250</a></strong><div class="NLM_citation" id="rightTab-cit250"><span><span class="NLM_contrib-group">Cudkowicz, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayden, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwilt, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whalen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. H.,  Jr.</span><span> </span><span class="NLM_article-title">The pharmacokinetics and pharmaco-dynamics of procysteine in amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1492</span><span class="NLM_x">–</span> <span class="NLM_lpage">1494</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=1492-1494&author=M.+E.+Cudkowiczauthor=P.+M.+Sextonauthor=T.+Ellisauthor=D.+L.+Haydenauthor=P.+R.+Gwiltauthor=J.+Whalenauthor=R.+H.+Brown&title=The+pharmacokinetics+and+pharmaco-dynamics+of+procysteine+in+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit250&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCudkowicz%26aufirst%3DM.%2BE.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DEllis%26aufirst%3DT.%26aulast%3DHayden%26aufirst%3DD.%2BL.%26aulast%3DGwilt%26aufirst%3DP.%2BR.%26aulast%3DWhalen%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DR.%2BH.%26atitle%3DThe%2520pharmacokinetics%2520and%2520pharmaco-dynamics%2520of%2520procysteine%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DNeurology%26date%3D1999%26volume%3D52%26spage%3D1492%26epage%3D1494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref251"><div class="reference"><strong class="refLabel"><a href="#ref251" class="rightTabRefNumLink">251</a></strong><div class="NLM_citation" id="rightTab-cit251"><span><span class="NLM_contrib-group">Dinkova-Kostova, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtzclaw, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakabayashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talalay, P.</span><span> </span><span class="NLM_article-title">Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">11908</span><span class="NLM_x">–</span> <span class="NLM_lpage">11913</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1073%2Fpnas.172398899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12193649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD38XntFWqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=11908-11913&author=A.+T.+Dinkova-Kostovaauthor=W.+D.+Holtzclawauthor=R.+N.+Coleauthor=K.+Itohauthor=N.+Wakabayashiauthor=Y.+Katohauthor=M.+Yamamotoauthor=P.+Talalay&title=Direct+evidence+that+sulfhydryl+groups+of+Keap1+are+the+sensors+regulating+induction+of+phase+2+enzymes+that+protect+against+carcinogens+and+oxidants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit251R"><div class="casContent"><span class="casTitleNuber">251</span><div class="casTitle"><span class="NLM_cas:atitle">Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants</span></div><div class="casAuthors">Dinkova-Kostova, Albena T.; Holtzclaw, W. David; Cole, Robert N.; Itoh, Ken; Wakabayashi, Nobunao; Katoh, Yasutake; Yamamoto, Masayuki; Talalay, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">11908-11913</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Coordinate induction of phase 2 proteins and elevation of glutathione protect cells against the toxic and carcinogenic effects of electrophiles and oxidants.  All inducers react covalently with thiols at rates that are closely related to their potencies.  Inducers disrupt the cytoplasmic complex between the actin-bound protein Keap1 and the transcription factor Nrf2, thereby releasing Nrf2 to migrate to the nucleus where it activates the antioxidant response element (ARE) of phase 2 genes and accelerates their transcription.  We cloned, overexpressed, and purified murine Keap1 and demonstrated on native gels the formation of complexes of Keap1 with the Neh2 domain of Nrf2 and their concn.-dependent disruption by inducers such as sulforaphane and bis(2-hydroxybenzylidene)acetone.  The kinetics, stoichiometry, and order of reactivities of the most reactive of the 25 cysteine thiol groups of Keap1 have been detd. by tritium incorporation from [3H]dexamethasone mesylate (an inducer and irreversible modifier of thiols) and by UV spectroscopy with sulforaphane, 2,2'-dipyridyl disulfide and 4,4'-dipyridyl disulfide (titrants of thiol groups), and two closely related Michael reaction acceptors [bis(2- and 4-hydroxybenzylidene)acetones] that differ 100-fold in inducer potency and the UV spectra of which are bleached by thiol addn.  With large excesses of these reagents nearly all thiols of Keap1 react, but sequential reaction with three successive single equiv. (per cysteine residue) of dipyridyl disulfides revealed excellent agreement with pseudo-first order kinetics, rapid successive declines in reaction velocity, and the stoichiometric formation of two equiv. of thiopyridone per reacted cysteine.  This finding suggests that reaction of cysteine thiols is followed by rapid formation of protein disulfide linkages.  The most reactive residues of Keap1 (C257, C273, C288, and C297) were identified by mapping the dexamethasone-modified cysteines by mass spectrometry of tryptic peptides.  These residues are located in the intervening region between BTB and Kelch repeat domains of Keap1 and probably are the direct sensors of inducers of the phase 2 system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAg7V1wdZgxLVg90H21EOLACvtfcHk0lgQJtXGouuapQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntFWqtb0%253D&md5=83a3b1b0549cf21153805e9c04f36620</span></div><a href="/servlet/linkout?suffix=cit251&amp;dbid=16384&amp;doi=10.1073%2Fpnas.172398899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.172398899%26sid%3Dliteratum%253Aachs%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DHoltzclaw%26aufirst%3DW.%2BD.%26aulast%3DCole%26aufirst%3DR.%2BN.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DWakabayashi%26aufirst%3DN.%26aulast%3DKatoh%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DTalalay%26aufirst%3DP.%26atitle%3DDirect%2520evidence%2520that%2520sulfhydryl%2520groups%2520of%2520Keap1%2520are%2520the%2520sensors%2520regulating%2520induction%2520of%2520phase%25202%2520enzymes%2520that%2520protect%2520against%2520carcinogens%2520and%2520oxidants%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D11908%26epage%3D11913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref252"><div class="reference"><strong class="refLabel"><a href="#ref252" class="rightTabRefNumLink">252</a></strong><div class="NLM_citation" id="rightTab-cit252"><span><span class="NLM_contrib-group">Surh, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kundu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Na, H. K.</span><span> </span><span class="NLM_article-title">Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals</span> <span class="citation_source-journal">Planta Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1526</span><span class="NLM_x">–</span> <span class="NLM_lpage">1539</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2008&pages=1526-1539&author=Y.+J.+Surhauthor=J.+K.+Kunduauthor=H.+K.+Na&title=Nrf2+as+a+master+redox+switch+in+turning+on+the+cellular+signaling+involved+in+the+induction+of+cytoprotective+genes+by+some+chemopreventive+phytochemicals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit252&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSurh%26aufirst%3DY.%2BJ.%26aulast%3DKundu%26aufirst%3DJ.%2BK.%26aulast%3DNa%26aufirst%3DH.%2BK.%26atitle%3DNrf2%2520as%2520a%2520master%2520redox%2520switch%2520in%2520turning%2520on%2520the%2520cellular%2520signaling%2520involved%2520in%2520the%2520induction%2520of%2520cytoprotective%2520genes%2520by%2520some%2520chemopreventive%2520phytochemicals%26jtitle%3DPlanta%2520Med.%26date%3D2008%26volume%3D74%26spage%3D1526%26epage%3D1539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref253"><div class="reference"><strong class="refLabel"><a href="#ref253" class="rightTabRefNumLink">253</a></strong><div class="NLM_citation" id="rightTab-cit253"><span><span class="NLM_contrib-group">Magesh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L. Q.</span><span> </span><span class="NLM_article-title">Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1002%2Fmed.21257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=22549716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVegsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=687-726&author=S.+Mageshauthor=Y.+Chenauthor=L.+Q.+Hu&title=Small+molecule+modulators+of+Keap1-Nrf2-ARE+pathway+as+potential+preventive+and+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit253R"><div class="casContent"><span class="casTitleNuber">253</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Modulators of Keap1-Nrf2-ARE Pathway as Potential Preventive and Therapeutic Agents</span></div><div class="casAuthors">Magesh, Sadagopan; Chen, Yu; Hu, Longqin</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">687-726</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Kelch-like ECH-assocd. protein 1 (Keap1)-nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response elements (ARE) pathway represents one of the most important cellular defense mechanisms against oxidative stress and xenobiotic damage.  Activation of Nrf2 signaling induces the transcriptional regulation of ARE-dependent expression of various detoxifying and antioxidant defense enzymes and proteins.  Keap1-Nrf2-ARE signaling has become an attractive target for the prevention and treatment of oxidative stress-related diseases and conditions including cancer, neurodegenerative, cardiovascular, metabolic, and inflammatory diseases.  Over the last few decades, numerous Nrf2 inducers have been developed and some of them are currently undergoing clin. trials.  Recently, overactivation of Nrf2 has been implicated in cancer progression as well as in drug resistance to cancer chemotherapy.  Thus, Nrf2 inhibitors could potentially be used to improve the effectiveness of cancer therapy.  Herein, we review the signaling mechanism of Keap1-Nrf2-ARE pathway, its disease relevance, and currently known classes of small mol. modulators.  We also discuss several aspects of Keap1-Nrf2 interaction, Nrf2-based peptide inhibitor design, and the screening assays currently used for the discovery of direct inhibitors of Keap1-Nrf2 interaction. © 2012 Wiley Periodicals, Inc.  Med Res Rev., 32, No. 4, 687-726, 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhLmdkuTSh7Vg90H21EOLACvtfcHk0liJcgyIMlN6sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVegsrw%253D&md5=2104d731cb251e0d9b6d2ad73a735175</span></div><a href="/servlet/linkout?suffix=cit253&amp;dbid=16384&amp;doi=10.1002%2Fmed.21257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21257%26sid%3Dliteratum%253Aachs%26aulast%3DMagesh%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DL.%2BQ.%26atitle%3DSmall%2520molecule%2520modulators%2520of%2520Keap1-Nrf2-ARE%2520pathway%2520as%2520potential%2520preventive%2520and%2520therapeutic%2520agents%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2012%26volume%3D32%26spage%3D687%26epage%3D726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref254"><div class="reference"><strong class="refLabel"><a href="#ref254" class="rightTabRefNumLink">254</a></strong><div class="NLM_citation" id="rightTab-cit254"><span><span class="NLM_contrib-group">Calkins, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowell, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraft, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. A.</span><span> </span><span class="NLM_article-title">The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease</span> <span class="citation_source-journal">Antioxid. Redox Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">497</span><span class="NLM_x">–</span> <span class="NLM_lpage">508</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1089%2Fars.2008.2242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=18717629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=497-508&author=M.+J.+Calkinsauthor=D.+A.+Johnsonauthor=J.+A.+Townsendauthor=M.+R.+Vargasauthor=J.+A.+Dowellauthor=T.+P.+Williamsonauthor=A.+D.+Kraftauthor=J.+M.+Leeauthor=J.+Liauthor=J.+A.+Johnson&title=The+Nrf2%2FARE+pathway+as+a+potential+therapeutic+target+in+neurodegenerative+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit254R"><div class="casContent"><span class="casTitleNuber">254</span><div class="casTitle"><span class="NLM_cas:atitle">The Nrf2/ARE Pathway as a Potential Therapeutic Target in Neurodegenerative Disease</span></div><div class="casAuthors">Calkins, Marcus J.; Johnson, Delinda A.; Townsend, Jessica A.; Vargas, Marcelo R.; Dowell, James A.; Williamson, Tracy P.; Kraft, Andrew D.; Lee, Jong-Min; Li, Jiang; Johnson, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">497-508</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Nuclear factor E2-related factor 2 (Nrf2) is a transcription factor known to induce expression of a variety of cytoprotective and detoxification genes.  Several of the genes commonly regulated by Nrf2 have been implicated in protection from neurodegenerative conditions.  Work from several labs. has uncovered the potential for Nrf2-mediated transcription to protect from neurodegeneration resulting from mechanisms involving oxidative stress.  For this reason, Nrf2 may be considered a therapeutic target for conditions that are known to involve free radical damage.  Because common mechanisms of neurodegeneration, such as mitochondrial dysfunction and build-up of reactive oxygen species, are currently being uncovered, targeting Nrf2 may be valuable in combating conditions with variable causes and etiologies.  Most effectively to target this protein in neurodegenerative conditions, a description of the involvement of Nrf2 and potential for neuroprotection must come from lab. models.  Herein, we review the current literature that suggests that Nrf2 may be a valuable therapeutic target for neurodegenerative disease, as well as expts. that illustrate potential mechanisms of protection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR_DaElYFTArVg90H21EOLACvtfcHk0liJcgyIMlN6sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOrtLg%253D&md5=7d96372e6c308f88810c8b03bb9f3dd3</span></div><a href="/servlet/linkout?suffix=cit254&amp;dbid=16384&amp;doi=10.1089%2Fars.2008.2242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2008.2242%26sid%3Dliteratum%253Aachs%26aulast%3DCalkins%26aufirst%3DM.%2BJ.%26aulast%3DJohnson%26aufirst%3DD.%2BA.%26aulast%3DTownsend%26aufirst%3DJ.%2BA.%26aulast%3DVargas%26aufirst%3DM.%2BR.%26aulast%3DDowell%26aufirst%3DJ.%2BA.%26aulast%3DWilliamson%26aufirst%3DT.%2BP.%26aulast%3DKraft%26aufirst%3DA.%2BD.%26aulast%3DLee%26aufirst%3DJ.%2BM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520Nrf2%252FARE%2520pathway%2520as%2520a%2520potential%2520therapeutic%2520target%2520in%2520neurodegenerative%2520disease%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2009%26volume%3D11%26spage%3D497%26epage%3D508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref255"><div class="reference"><strong class="refLabel"><a href="#ref255" class="rightTabRefNumLink">255</a></strong><div class="NLM_citation" id="rightTab-cit255"><span><span class="NLM_contrib-group">Jung, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, M. K.</span><span> </span><span class="NLM_article-title">The Nrf2 system as a potential target for the development of indirect antioxidants</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">7266</span><span class="NLM_x">–</span> <span class="NLM_lpage">7291</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=7266-7291&author=K.+A.+Jungauthor=M.+K.+Kwak&title=The+Nrf2+system+as+a+potential+target+for+the+development+of+indirect+antioxidants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit255&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DK.%2BA.%26aulast%3DKwak%26aufirst%3DM.%2BK.%26atitle%3DThe%2520Nrf2%2520system%2520as%2520a%2520potential%2520target%2520for%2520the%2520development%2520of%2520indirect%2520antioxidants%26jtitle%3DMolecules%26date%3D2010%26volume%3D15%26spage%3D7266%26epage%3D7291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref256"><div class="reference"><strong class="refLabel"><a href="#ref256" class="rightTabRefNumLink">256</a></strong><div class="NLM_citation" id="rightTab-cit256"><span><span class="NLM_contrib-group">Vargas, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pehar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassina, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbeito, L.</span><span> </span><span class="NLM_article-title">Increased glutathione biosynthesis by Nrf2 activation in astrocytes prevents p75(NTR)-dependent motor neuron apoptosis</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">696</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1111%2Fj.1471-4159.2006.03742.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=16524372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslCjsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2006&pages=687-696&author=M.+R.+Vargasauthor=M.+Peharauthor=P.+Cassinaauthor=J.+S.+Beckmanauthor=L.+Barbeito&title=Increased+glutathione+biosynthesis+by+Nrf2+activation+in+astrocytes+prevents+p75%28NTR%29-dependent+motor+neuron+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit256R"><div class="casContent"><span class="casTitleNuber">256</span><div class="casTitle"><span class="NLM_cas:atitle">Increased glutathione biosynthesis by Nrf2 activation in astrocytes prevents p75NTR-dependent motor neuron apoptosis</span></div><div class="casAuthors">Vargas, Marcelo R.; Pehar, Mariana; Cassina, Patricia; Beckman, Joseph S.; Barbeito, Luis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">687-696</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Astrocytes may modulate the survival of motor neurons in amyotrophic lateral sclerosis (ALS).  We have previously shown that fibroblast growth factor-1 (FGF-1) activates astrocytes to increase secretion of nerve growth factor (NGF).  NGF in turn induces apoptosis in co-cultured motor neurons expressing the p75 neurotrophin receptor (p75NTR) by a mechanism involving nitric oxide (NO) and peroxynitrite formation.  We show here that FGF-1 increased the expression of inducible nitric oxide synthase and NO prodn. in astrocytes, making adjacent motor neurons vulnerable to NGF-induced apoptosis.  Spinal cord astrocytes isolated from transgenic SOD1G93A rats displayed increased NO prodn. and spontaneously induced apoptosis of co-cultured motor neurons.  FGF-1 also activates the redox-sensitive transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) in astrocytes.  Because Nrf2 increases glutathione (GSH) biosynthesis, we investigated the role of GSH prodn. by astrocytes on p75NTR-dependent motor neuron apoptosis.  The combined treatment of astrocytes with FGF-1 and t-butylhydroquinone (tBHQ) increased GSH prodn. and secretion, preventing motor neuron apoptosis.  Moreover, Nrf2 activation in SOD1G93A astrocytes abolished their apoptotic activity.  The protection exerted by increased Nrf2 activity was overcome by adding the NO donor DETA-NONOate to the co-cultures or by inhibiting GSH synthesis and release from astrocytes.  These results suggest that activation of Nrf2 in astrocytes can reduce NO-dependent toxicity to motor neurons by increasing GSH biosynthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI9qGU4JROsrVg90H21EOLACvtfcHk0liJcgyIMlN6sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslCjsrk%253D&md5=d3a252123e5b1823aa4bc518e8edd693</span></div><a href="/servlet/linkout?suffix=cit256&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.03742.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.03742.x%26sid%3Dliteratum%253Aachs%26aulast%3DVargas%26aufirst%3DM.%2BR.%26aulast%3DPehar%26aufirst%3DM.%26aulast%3DCassina%26aufirst%3DP.%26aulast%3DBeckman%26aufirst%3DJ.%2BS.%26aulast%3DBarbeito%26aufirst%3DL.%26atitle%3DIncreased%2520glutathione%2520biosynthesis%2520by%2520Nrf2%2520activation%2520in%2520astrocytes%2520prevents%2520p75%2528NTR%2529-dependent%2520motor%2520neuron%2520apoptosis%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D97%26spage%3D687%26epage%3D696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref257"><div class="reference"><strong class="refLabel"><a href="#ref257" class="rightTabRefNumLink">257</a></strong><div class="NLM_citation" id="rightTab-cit257"><span><span class="NLM_contrib-group">Kirby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halligan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baptista, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heath, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holden, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barber, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loynes, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood-Allum, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunec, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, P. J.</span><span> </span><span class="NLM_article-title">Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">1686</span><span class="NLM_x">–</span> <span class="NLM_lpage">1706</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2005&pages=1686-1706&author=J.+Kirbyauthor=E.+Halliganauthor=M.+J.+Baptistaauthor=S.+Allenauthor=P.+R.+Heathauthor=H.+Holdenauthor=S.+C.+Barberauthor=C.+A.+Loynesauthor=C.+A.+Wood-Allumauthor=J.+Lunecauthor=P.+J.+Shaw&title=Mutant+SOD1+alters+the+motor+neuronal+transcriptome%3A+implications+for+familial+ALS"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit257&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKirby%26aufirst%3DJ.%26aulast%3DHalligan%26aufirst%3DE.%26aulast%3DBaptista%26aufirst%3DM.%2BJ.%26aulast%3DAllen%26aufirst%3DS.%26aulast%3DHeath%26aufirst%3DP.%2BR.%26aulast%3DHolden%26aufirst%3DH.%26aulast%3DBarber%26aufirst%3DS.%2BC.%26aulast%3DLoynes%26aufirst%3DC.%2BA.%26aulast%3DWood-Allum%26aufirst%3DC.%2BA.%26aulast%3DLunec%26aufirst%3DJ.%26aulast%3DShaw%26aufirst%3DP.%2BJ.%26atitle%3DMutant%2520SOD1%2520alters%2520the%2520motor%2520neuronal%2520transcriptome%253A%2520implications%2520for%2520familial%2520ALS%26jtitle%3DBrain%26date%3D2005%26volume%3D128%26spage%3D1686%26epage%3D1706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref258"><div class="reference"><strong class="refLabel"><a href="#ref258" class="rightTabRefNumLink">258</a></strong><div class="NLM_citation" id="rightTab-cit258"><span><span class="NLM_contrib-group">Trinh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wes, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchowski, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallanck, L. J.</span><span> </span><span class="NLM_article-title">Induction of the phase II detoxification pathway suppresses neuron loss in <i>Drosophila</i> models of Parkinson’s disease</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1523%2FJNEUROSCI.4778-07.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=18184789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252Fit1Gksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=465-472&author=K.+Trinhauthor=K.+Mooreauthor=P.+D.+Wesauthor=P.+J.+Muchowskiauthor=J.+Deyauthor=L.+Andrewsauthor=L.+J.+Pallanck&title=Induction+of+the+phase+II+detoxification+pathway+suppresses+neuron+loss+in+Drosophila+models+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit258R"><div class="casContent"><span class="casTitleNuber">258</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of the phase II detoxification pathway suppresses neuron loss in Drosophila models of Parkinson's disease</span></div><div class="casAuthors">Trinh Kien; Moore Katherine; Wes Paul D; Muchowski Paul J; Dey Joyoti; Andrews Laurie; Pallanck Leo J</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of neuroscience : the official journal of the Society for Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">465-72</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alpha-synuclein aggregates are a common feature of sporadic Parkinson's disease (PD), and mutations that increase alpha-synuclein abundance confer rare heritable forms of PD.  Although these findings suggest that alpha-synuclein plays a central role in the pathogenesis of this disorder, little is known of the mechanism by which alpha-synuclein promotes neuron loss or the factors that regulate alpha-synuclein toxicity.  To address these matters, we tested candidate modifiers of alpha-synuclein toxicity using a Drosophila model of PD.  In the current work, we focused on phase II detoxification enzymes involved in glutathione metabolism.  We find that the neuronal death accompanying alpha-synuclein expression in Drosophila is enhanced by loss-of-function mutations in genes that promote glutathione synthesis and glutathione conjugation.  This neuronal loss can be overcome by genetic or pharmacological interventions that increase glutathione synthesis or glutathione conjugation activity.  Moreover, these same pharmacological agents suppress neuron loss in Drosophila parkin mutants, a loss-of-function model of PD.  Our results suggest that oxidative stress is a feature of alpha-synuclein toxicity and that induction of the phase II detoxification pathway represents a potential preventative therapy for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQif2_pEJNWVkEgZCMqtRBifW6udTcc2eYnCCyEXtvQLLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252Fit1Gksw%253D%253D&md5=1b31c42a2249f5bc433e546d5ce52c20</span></div><a href="/servlet/linkout?suffix=cit258&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4778-07.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4778-07.2008%26sid%3Dliteratum%253Aachs%26aulast%3DTrinh%26aufirst%3DK.%26aulast%3DMoore%26aufirst%3DK.%26aulast%3DWes%26aufirst%3DP.%2BD.%26aulast%3DMuchowski%26aufirst%3DP.%2BJ.%26aulast%3DDey%26aufirst%3DJ.%26aulast%3DAndrews%26aufirst%3DL.%26aulast%3DPallanck%26aufirst%3DL.%2BJ.%26atitle%3DInduction%2520of%2520the%2520phase%2520II%2520detoxification%2520pathway%2520suppresses%2520neuron%2520loss%2520in%2520Drosophila%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D2008%26volume%3D28%26spage%3D465%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref259"><div class="reference"><strong class="refLabel"><a href="#ref259" class="rightTabRefNumLink">259</a></strong><div class="NLM_citation" id="rightTab-cit259"><span><span class="NLM_contrib-group">Ramsey, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindl, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritson, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chia, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan-Sciutto, K. L.</span><span> </span><span class="NLM_article-title">Expression of Nrf2 in neurodegenerative diseases</span> <span class="citation_source-journal">J. Neuropathol. Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1097%2Fnen.0b013e31802d6da9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=17204939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsV2qtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2007&pages=75-85&author=C.+P.+Ramseyauthor=C.+A.+Glassauthor=M.+B.+Montgomeryauthor=K.+A.+Lindlauthor=G.+P.+Ritsonauthor=L.+A.+Chiaauthor=R.+L.+Hamiltonauthor=C.+T.+Chuauthor=K.+L.+Jordan-Sciutto&title=Expression+of+Nrf2+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit259R"><div class="casContent"><span class="casTitleNuber">259</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of Nrf2 in neurodegenerative diseases</span></div><div class="casAuthors">Ramsey, Chenere P.; Glass, Charles A.; Montgomery, Marshall B.; Lindl, Kathryn A.; Ritson, Gillian P.; Chia, Luis A.; Hamilton, Ronald L.; Chu, Charleen T.; Jordan-Sciutto, Kelly L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuropathology & Experimental Neurology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-85</span>CODEN:
                <span class="NLM_cas:coden">JNENAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">In response to oxidative stress, the nuclear factor E2-related factor 2 (Nrf2) transcription factor translocates from the cytoplasm into the nucleus and transactivates expression of genes with antioxidant activity.  Despite this cellular mechanism, oxidative damage is abundant in Alzheimer and Parkinson disease (AD and PD).  To investigate mechanisms by which Nrf2 activity may be aberrant or insufficient in neurodegenerative conditions, we assessed Nrf2 localization in affected brain regions of AD, Lewy body variant of AD (LBVAD), and PD.  By immunohistochem., Nrf2 is expressed in both the nucleus and the cytoplasm of neurons in normal hippocampi with predominant expression in the nucleus.  In AD and LBVAD, Nrf2 was predominantly cytoplasmic in hippocampal neurons and was not a major component of beta amyloid plaques or neurofibrillary tangles.  By immunoblotting, we obsd. a significant decrease in nuclear Nrf2 levels in AD cases.  In contrast, Nrf2 was strongly nuclear in PD nigral neurons but cytoplasmic in substantia nigra of normal, AD, and LBVAD cases.  These findings suggest that Nrf2-mediated transcription is not induced in neurons in AD despite the presence of oxidative stress.  In PD, nuclear localization of Nrf2 is strongly induced, but this response may be insufficient to protect neurons from degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxUT2O_7i7C7Vg90H21EOLACvtfcHk0ljPNlBNRYbbyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsV2qtb4%253D&md5=af62d8ddc814ca4272250cf815366674</span></div><a href="/servlet/linkout?suffix=cit259&amp;dbid=16384&amp;doi=10.1097%2Fnen.0b013e31802d6da9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252Fnen.0b013e31802d6da9%26sid%3Dliteratum%253Aachs%26aulast%3DRamsey%26aufirst%3DC.%2BP.%26aulast%3DGlass%26aufirst%3DC.%2BA.%26aulast%3DMontgomery%26aufirst%3DM.%2BB.%26aulast%3DLindl%26aufirst%3DK.%2BA.%26aulast%3DRitson%26aufirst%3DG.%2BP.%26aulast%3DChia%26aufirst%3DL.%2BA.%26aulast%3DHamilton%26aufirst%3DR.%2BL.%26aulast%3DChu%26aufirst%3DC.%2BT.%26aulast%3DJordan-Sciutto%26aufirst%3DK.%2BL.%26atitle%3DExpression%2520of%2520Nrf2%2520in%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D2007%26volume%3D66%26spage%3D75%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref260"><div class="reference"><strong class="refLabel"><a href="#ref260" class="rightTabRefNumLink">260</a></strong><div class="NLM_citation" id="rightTab-cit260"><span><span class="NLM_contrib-group">Stack, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wille, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calingasan, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liby, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sporn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumont, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, M. F.</span><span> </span><span class="NLM_article-title">Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington’s disease</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref260/cit260&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.freeradbiomed.2010.03.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref260/cit260&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20338236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref260/cit260&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntVOntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=147-158&author=C.+Stackauthor=D.+Hoauthor=E.+Willeauthor=N.+Y.+Calingasanauthor=C.+Williamsauthor=K.+Libyauthor=M.+Spornauthor=M.+Dumontauthor=M.+F.+Beal&title=Triterpenoids+CDDO-ethyl+amide+and+CDDO-trifluoroethyl+amide+improve+the+behavioral+phenotype+and+brain+pathology+in+a+transgenic+mouse+model+of+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit260R"><div class="casContent"><span class="casTitleNuber">260</span><div class="casTitle"><span class="NLM_cas:atitle">Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease</span></div><div class="casAuthors">Stack, Cliona; Ho, Daniel; Wille, Elizabeth; Calingasan, Noel Y.; Williams, Charlotte; Liby, Karen; Sporn, Michael; Dumont, Magali; Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-158</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Oxidative stress is a prominent feature of Huntington's disease (HD) due to mitochondrial dysfunction and the ensuing overprodn. of reactive oxygen species (ROS).  This phenomenon ultimately contributes to cognitive and motor impairment, as well as brain pathol., esp. in the striatum.  Targeting the transcription of the endogenous antioxidant machinery could be a promising therapeutic approach.  The NF-E2-related factor-2 (Nrf2)/antioxidant response element (ARE) signaling pathway is an important pathway involved in antioxidant and anti-inflammatory responses.  Synthetic triterpenoids, which are derived from 2-Cyano-3,12-Dioxooleana-1,9-Dien-28-Oic acid (CDDO) activate the Nrf2/ARE pathway and reduce oxidative stress in animal models of neurodegenerative diseases.  We investigated the effects of CDDO-Et amide (CDDO-EA) and CDDO-trifluoroethyl amide (CDDO-TFEA) in N171-82Q mice, a transgenic mouse model of HD.  CDDO-EA or CDDO-TFEA were administered in the diet at various concns., starting at 30 days of age.  CDDO-EA and CDDO-TFEA upregulated Nrf2/ARE induced genes in the brain and peripheral tissues, reduced oxidative stress, improved motor impairment and increased longevity.  They also rescued striatal atrophy in the brain and vacuolation in the brown adipose tissue.  Therefore compds. targeting the Nrf2/ARE pathway show great promise for the treatment of HD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnPF1FYjzbwLVg90H21EOLACvtfcHk0ljPNlBNRYbbyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntVOntrc%253D&md5=a717e61f8a636c33ec1d82237155f710</span></div><a href="/servlet/linkout?suffix=cit260&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2010.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2010.03.017%26sid%3Dliteratum%253Aachs%26aulast%3DStack%26aufirst%3DC.%26aulast%3DHo%26aufirst%3DD.%26aulast%3DWille%26aufirst%3DE.%26aulast%3DCalingasan%26aufirst%3DN.%2BY.%26aulast%3DWilliams%26aufirst%3DC.%26aulast%3DLiby%26aufirst%3DK.%26aulast%3DSporn%26aufirst%3DM.%26aulast%3DDumont%26aufirst%3DM.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DTriterpenoids%2520CDDO-ethyl%2520amide%2520and%2520CDDO-trifluoroethyl%2520amide%2520improve%2520the%2520behavioral%2520phenotype%2520and%2520brain%2520pathology%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2010%26volume%3D49%26spage%3D147%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref261"><div class="reference"><strong class="refLabel"><a href="#ref261" class="rightTabRefNumLink">261</a></strong><div class="NLM_citation" id="rightTab-cit261"><span><span class="NLM_contrib-group">Ross, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M. A.</span><span> </span><span class="NLM_article-title">Protein aggregation and neurodegenerative disease</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">S10</span><span class="NLM_x">–</span> <span class="NLM_lpage">S17</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=S10-S17&issue=Suppl.&author=C.+A.+Rossauthor=M.+A.+Poirier&title=Protein+aggregation+and+neurodegenerative+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit261&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DC.%2BA.%26aulast%3DPoirier%26aufirst%3DM.%2BA.%26atitle%3DProtein%2520aggregation%2520and%2520neurodegenerative%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26issue%3DSuppl%26spage%3DS10%26epage%3DS17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref262"><div class="reference"><strong class="refLabel"><a href="#ref262" class="rightTabRefNumLink">262</a></strong><div class="NLM_citation" id="rightTab-cit262"><span><span class="NLM_contrib-group">Aguzzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, T.</span><span> </span><span class="NLM_article-title">Protein aggregation diseases: pathogenicity and therapeutic perspectives</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnrd3050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20190788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFeksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=237-248&author=A.+Aguzziauthor=T.+O%E2%80%99Connor&title=Protein+aggregation+diseases%3A+pathogenicity+and+therapeutic+perspectives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit262R"><div class="casContent"><span class="casTitleNuber">262</span><div class="casTitle"><span class="NLM_cas:atitle">Protein aggregation diseases: pathogenicity and therapeutic perspectives</span></div><div class="casAuthors">Aguzzi, Adriano; O'Connor, Tracy</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">237-248</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A growing no. of diseases seem to be assocd. with inappropriate deposition of protein aggregates.  Some of these diseases - such as Alzheimer's disease and systemic amyloidoses - were recognized for a long time.  However, it is now clear that ordered aggregation of pathogenic proteins does not only occur in the extracellular space, but in the cytoplasm and nucleus as well, indicating that many other diseases may also qualify as amyloidoses.  The common structural and pathogenic features of these diverse protein aggregation diseases is only now being fully understood, and may provide novel opportunities for overarching therapeutic approaches such as depleting the monomeric precursor protein, inhibiting aggregation, enhancing aggregate clearance or blocking common aggregation-induced cellular toxicity pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZPeSFBYjDwLVg90H21EOLACvtfcHk0lhHhMGmaaR7PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFeksbo%253D&md5=6a70e6af3dd4cd4dcba8de1d7faa78f2</span></div><a href="/servlet/linkout?suffix=cit262&amp;dbid=16384&amp;doi=10.1038%2Fnrd3050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3050%26sid%3Dliteratum%253Aachs%26aulast%3DAguzzi%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DT.%26atitle%3DProtein%2520aggregation%2520diseases%253A%2520pathogenicity%2520and%2520therapeutic%2520perspectives%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D237%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref263"><div class="reference"><strong class="refLabel"><a href="#ref263" class="rightTabRefNumLink">263</a></strong><div class="NLM_citation" id="rightTab-cit263"><span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span> </span><span class="NLM_article-title">Strategies for the inhibition of protein aggregation in human diseases</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1018</span><span class="NLM_x">–</span> <span class="NLM_lpage">1035</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=1018-1035&author=M.+Bartoliniauthor=V.+Andrisano&title=Strategies+for+the+inhibition+of+protein+aggregation+in+human+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit263&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26atitle%3DStrategies%2520for%2520the%2520inhibition%2520of%2520protein%2520aggregation%2520in%2520human%2520diseases%26jtitle%3DChemBioChem%26date%3D2010%26volume%3D11%26spage%3D1018%26epage%3D1035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref264"><div class="reference"><strong class="refLabel"><a href="#ref264" class="rightTabRefNumLink">264</a></strong><div class="NLM_citation" id="rightTab-cit264"><span><span class="NLM_contrib-group">Schneider, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Tau based treatment strategies in neurodegenerative diseases</span> <span class="citation_source-journal">Neurotherapeutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">457</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=443-457&author=A.+Schneiderauthor=E.+Mandelkow&title=Tau+based+treatment+strategies+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit264&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DA.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DTau%2520based%2520treatment%2520strategies%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNeurotherapeutics%26date%3D2008%26volume%3D5%26spage%3D443%26epage%3D457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref265"><div class="reference"><strong class="refLabel"><a href="#ref265" class="rightTabRefNumLink">265</a></strong><div class="NLM_citation" id="rightTab-cit265"><span><span class="NLM_contrib-group">Shelton, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, G. V.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinase-5 in neurodegeneration</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">1313</span><span class="NLM_x">–</span> <span class="NLM_lpage">1326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref265/cit265&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1111%2Fj.1471-4159.2003.02328.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref265/cit265&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=15009631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref265/cit265&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivVCit7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2004&pages=1313-1326&author=S.+B.+Sheltonauthor=G.+V.+Johnson&title=Cyclin-dependent+kinase-5+in+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit265R"><div class="casContent"><span class="casTitleNuber">265</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-dependent kinase-5 in neurodegeneration</span></div><div class="casAuthors">Shelton, Shirley B.; Johnson, Gail V. W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1313-1326</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Cyclin-dependent kinase-5 (CDK5) is predominantly active in the nervous system and it is well established that CDK5 is essential in neuronal development.  In addn. to its recognized role in development, there is increasing evidence that CDK5 may be involved in the pathogenesis of several neurodegenerative disorders.  Although studies have shown that CDK5 can modulate cell death and survival, controversy still exists as to the exact role CDK5 may play in neurodegenerative processes.  This review will highlight recent data on the possible roles of CDK5 in neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFnp9yVi3hq7Vg90H21EOLACvtfcHk0lhHhMGmaaR7PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivVCit7w%253D&md5=6d306157d802a45c18bf480a3bb028ee</span></div><a href="/servlet/linkout?suffix=cit265&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2003.02328.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2003.02328.x%26sid%3Dliteratum%253Aachs%26aulast%3DShelton%26aufirst%3DS.%2BB.%26aulast%3DJohnson%26aufirst%3DG.%2BV.%26atitle%3DCyclin-dependent%2520kinase-5%2520in%2520neurodegeneration%26jtitle%3DJ.%2520Neurochem.%26date%3D2004%26volume%3D88%26spage%3D1313%26epage%3D1326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref266"><div class="reference"><strong class="refLabel"><a href="#ref266" class="rightTabRefNumLink">266</a></strong><div class="NLM_citation" id="rightTab-cit266"><span><span class="NLM_contrib-group">Hanger, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderton, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, W.</span><span> </span><span class="NLM_article-title">Tau phosphorylation: the therapeutic challenge for neurodegenerative disease</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">119</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.molmed.2009.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=19246243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjt1ahu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=112-119&author=D.+P.+Hangerauthor=B.+H.+Andertonauthor=W.+Noble&title=Tau+phosphorylation%3A+the+therapeutic+challenge+for+neurodegenerative+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit266R"><div class="casContent"><span class="casTitleNuber">266</span><div class="casTitle"><span class="NLM_cas:atitle">Tau phosphorylation: the therapeutic challenge for neurodegenerative disease</span></div><div class="casAuthors">Hanger, Diane P.; Anderton, Brian H.; Noble, Wendy</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">112-119</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The microtubule-assocd. protein tau is integral to the pathogenesis of Alzheimer's disease (AD), as well as several related disorders, termed tauopathies, in which tau is deposited in affected brain regions.  In the tauopathies, pathol. tau is in an elevated state of phosphorylation and is aberrantly cleaved.  It also exhibits abnormal conformations and becomes aggregated, resulting in neurofibrillary tau pathol.  Recent evidence suggests that relatively early disease-assocd. changes in sol. tau proteins, including phosphorylation, are involved in the induction of neuronal death.  Here, we summarize recent developments that suggest new therapeutic strategies to prevent or reduce the progression of pathol. in the tauopathies.  A list of tau phosphorylation sites identified in the tauopathies and in controls accompanies this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8l3EQ3bznVLVg90H21EOLACvtfcHk0liJlIxidPvZVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjt1ahu7w%253D&md5=116159eeaae25800a22b687f36df70e2</span></div><a href="/servlet/linkout?suffix=cit266&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2009.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2009.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DHanger%26aufirst%3DD.%2BP.%26aulast%3DAnderton%26aufirst%3DB.%2BH.%26aulast%3DNoble%26aufirst%3DW.%26atitle%3DTau%2520phosphorylation%253A%2520the%2520therapeutic%2520challenge%2520for%2520neurodegenerative%2520disease%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2009%26volume%3D15%26spage%3D112%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref267"><div class="reference"><strong class="refLabel"><a href="#ref267" class="rightTabRefNumLink">267</a></strong><div class="NLM_citation" id="rightTab-cit267"><span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thunnissen, A. M. W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleverley, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salinas, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettit, G. R.</span><span> </span><span class="NLM_article-title">Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2FS1074-5521%2800%2900063-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=10662688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotFertA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=51-63&author=L.+Meijerauthor=A.+M.+W.+H.+Thunnissenauthor=A.+W.+Whiteauthor=M.+Garnierauthor=M.+Nikolicauthor=L.+H.+Tsaiauthor=J.+Walterauthor=K.+E.+Cleverleyauthor=P.+C.+Salinasauthor=Y.+Z.+Wuauthor=J.+Biernatauthor=E.+Mandelkowauthor=S.+H.+Kimauthor=G.+R.+Pettit&title=Inhibition+of+cyclin-dependent+kinases%2C+GSK-3beta+and+CK1+by+hymenialdisine%2C+a+marine+sponge+constituent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit267R"><div class="casContent"><span class="casTitleNuber">267</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of cyclin-dependent kinases, GSK-3β and CK1 by hymenialdisine, a marine sponge constituent</span></div><div class="casAuthors">Meijer, L.; Thunnissen, A. M. W. H.; White, A. W.; Garnier, M.; Nikolic, M.; Tsai, L. H.; Walter, J.; Cleverley, K. E.; Salinas, P. C.; Wu, Y. Z.; Biernat, J.; Mandelkow, E. M.; Kim, S. H.; Pettit, G. R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-63</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Over 2000 protein kinases regulate cellular functions.  Screening for inhibitors of some of these kinases has already yielded some potent and selective compds. with promising potential for the treatment of human diseases.  Here, the marine sponge constituent, hymenialdisine (I), was found to be a potent inhibitor of cyclin-dependent kinases (CDKs), glycogen synthase kinase-3β (GSK-3β), and casein kinase 1 (CK1).  I was found to compete with ATP for binding to these kinases.  A CDK2-I complex crystal structure showed that 3 H-bonds linked I to the Glu-81 and Leu-83 residues of CDK2, as obsd. with other inhibitors.  I inhibited CDK5/p35 in vivo as demonstrated by the lack of phosphorylation/down-regulation of Pak1 kinase in E18 rat cortical neurons, and also inhibited GSK-3 in vivo as shown by the inhibition of microtubule-assocd. protein-1B phosphorylation.  I also blocked the in vivo phosphorylation of the microtubule-binding protein, tau, at sites that were hyperphosphorylated by GSK-3 and CDK5/p35 in Alzheimer's disease (cross-reacting with Alzheimer's-specific AT100 antibodies) and blocked presenilin-2 phosphorylation in vitro.  Thus, the natural product, I, is a new kinase inhibitor with promising potential applications for treating neurodegenerative disorders such as Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp80sKXSk6kF7Vg90H21EOLACvtfcHk0liJlIxidPvZVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotFertA%253D%253D&md5=62a4e11bc0d13980751cadd2d1ec723a</span></div><a href="/servlet/linkout?suffix=cit267&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2800%2900063-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252800%252900063-6%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DThunnissen%26aufirst%3DA.%2BM.%2BW.%2BH.%26aulast%3DWhite%26aufirst%3DA.%2BW.%26aulast%3DGarnier%26aufirst%3DM.%26aulast%3DNikolic%26aufirst%3DM.%26aulast%3DTsai%26aufirst%3DL.%2BH.%26aulast%3DWalter%26aufirst%3DJ.%26aulast%3DCleverley%26aufirst%3DK.%2BE.%26aulast%3DSalinas%26aufirst%3DP.%2BC.%26aulast%3DWu%26aufirst%3DY.%2BZ.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26atitle%3DInhibition%2520of%2520cyclin-dependent%2520kinases%252C%2520GSK-3beta%2520and%2520CK1%2520by%2520hymenialdisine%252C%2520a%2520marine%2520sponge%2520constituent%26jtitle%3DChem.%2520Biol.%26date%3D2000%26volume%3D7%26spage%3D51%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref268"><div class="reference"><strong class="refLabel"><a href="#ref268" class="rightTabRefNumLink">268</a></strong><div class="NLM_citation" id="rightTab-cit268"><span><span class="NLM_contrib-group">Palomo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span> </span><span class="NLM_article-title">The potential role of glycogen synthase kinase 3 inhibitors as amyotrophic lateral sclerosis pharmacological therapy</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3028</span><span class="NLM_x">–</span> <span class="NLM_lpage">3034</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.2174%2F092986711796391697" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=21651477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsl2ru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=3028-3034&author=V.+Palomoauthor=D.+I.+Perezauthor=C.+Gilauthor=A.+Martinez&title=The+potential+role+of+glycogen+synthase+kinase+3+inhibitors+as+amyotrophic+lateral+sclerosis+pharmacological+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit268R"><div class="casContent"><span class="casTitleNuber">268</span><div class="casTitle"><span class="NLM_cas:atitle">The potential role of glycogen synthase kinase 3 inhibitors as amyotrophic lateral sclerosis pharmacological therapy</span></div><div class="casAuthors">Palomo, V.; Perez, D. I.; Gil, C.; Martinez, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3028-3034</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects motor neurons.  Lately, this disease has often been related to the protein kinase called glycogen synthase kinase 3 (GSK-3), through the exptl. evidence of alterations of this enzyme on ALS patients.  Therefore, there have been several exptl. studies using GSK-3 inhibitors, in cellular and animal models and also in clin. studies that showed the potential of the therapeutic role of these mols.  GSK-3 inhibitors might play a pivotal role in the pharmacol. of ALS disease with no curative treatment nowadays.  In this review we give an overview of the current research in the area, showing all the evidences of the implication of dysfunctional GSK-3 in this disease on one hand, and on the other presenting the potential role of the GSK-3 inhibitors as a future pharmacol. ALS therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO18DQpfwsk7Vg90H21EOLACvtfcHk0liJlIxidPvZVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsl2ru7g%253D&md5=0082dde65a2d81fbcafe5d6d43cc1374</span></div><a href="/servlet/linkout?suffix=cit268&amp;dbid=16384&amp;doi=10.2174%2F092986711796391697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711796391697%26sid%3Dliteratum%253Aachs%26aulast%3DPalomo%26aufirst%3DV.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DThe%2520potential%2520role%2520of%2520glycogen%2520synthase%2520kinase%25203%2520inhibitors%2520as%2520amyotrophic%2520lateral%2520sclerosis%2520pharmacological%2520therapy%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D3028%26epage%3D3034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref269"><div class="reference"><strong class="refLabel"><a href="#ref269" class="rightTabRefNumLink">269</a></strong><div class="NLM_citation" id="rightTab-cit269"><span><span class="NLM_contrib-group">Chen, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaisina, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Khodor, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramboz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makhortova, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Identification of a maleimide-based glycogen synthase kinase-3 (GSK-3) inhibitor, BIP-135, that prolongs the median survival time of Delta 7 SMA KO mouse model of spinal muscular atrophy</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200085z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlaqsLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=5-11&author=P.+C.+Chenauthor=I.+N.+Gaisinaauthor=B.+F.+El-Khodorauthor=S.+Rambozauthor=N.+R.+Makhortovaauthor=L.+L.+Rubinauthor=A.+P.+Kozikowski&title=Identification+of+a+maleimide-based+glycogen+synthase+kinase-3+%28GSK-3%29+inhibitor%2C+BIP-135%2C+that+prolongs+the+median+survival+time+of+Delta+7+SMA+KO+mouse+model+of+spinal+muscular+atrophy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit269R"><div class="casContent"><span class="casTitleNuber">269</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitor, BIP-135, That Prolongs the Median Survival Time of Δ7 SMA KO Mouse Model of Spinal Muscular Atrophy</span></div><div class="casAuthors">Chen, Po C.; Gaisina, Irina N.; El-Khodor, Bassem F.; Ramboz, Sylvie; Makhortova, Nina R.; Rubin, Lee L.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-11</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of upregulated glycogen synthase kinase-3 (GSK-3) in various pathol. conditions has led to the development of a host of chem. diverse small mol. GSK-3 inhibitors, such as BIP-135 (I).  GSK-3 inhibition emerged as an alternative therapeutic target for treating spinal muscular atrophy (SMA) when a no. of GSK-3 inhibitors were shown to elevate survival motor neuron (SMN) levels in vitro and to rescue motor neurons when their intrinsic SMN level was diminished by SMN-specific short hairpin RNA (shRNA).  Despite their cellular potency, the in vivo efficacy of GSK-3 inhibitors has yet to be evaluated in an animal model of SMA.  Herein, we disclose that a potent and reasonably selective GSK-3 inhibitor, namely BIP-135, was tested in a transgenic Δ7 SMA KO mouse model of SMA and found to prolong the median survival of these animals.  In addn., this compd. was shown to elevate the SMN protein level in SMA patient-derived fibroblast cells as detd. by Western blot, and was neuroprotective in a cell-based, SMA-related model of oxidative stress-induced neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcySOXJLoZx7Vg90H21EOLACvtfcHk0liJlIxidPvZVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlaqsLfL&md5=728c77967169f3fa99263b1a2622d084</span></div><a href="/servlet/linkout?suffix=cit269&amp;dbid=16384&amp;doi=10.1021%2Fcn200085z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200085z%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%2BC.%26aulast%3DGaisina%26aufirst%3DI.%2BN.%26aulast%3DEl-Khodor%26aufirst%3DB.%2BF.%26aulast%3DRamboz%26aufirst%3DS.%26aulast%3DMakhortova%26aufirst%3DN.%2BR.%26aulast%3DRubin%26aufirst%3DL.%2BL.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DIdentification%2520of%2520a%2520maleimide-based%2520glycogen%2520synthase%2520kinase-3%2520%2528GSK-3%2529%2520inhibitor%252C%2520BIP-135%252C%2520that%2520prolongs%2520the%2520median%2520survival%2520time%2520of%2520Delta%25207%2520SMA%2520KO%2520mouse%2520model%2520of%2520spinal%2520muscular%2520atrophy%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D5%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref270"><div class="reference"><strong class="refLabel"><a href="#ref270" class="rightTabRefNumLink">270</a></strong><div class="NLM_citation" id="rightTab-cit270"><span><span class="NLM_contrib-group">Koh, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span> </span><span class="NLM_article-title">Inhibition of glycogen synthase kinase-3 suppresses the onset of symptoms and disease progression of G93A-SOD1 mouse model of ALS</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">205</span><span class="NLM_x">, </span> <span class="NLM_fpage">336</span><span class="NLM_x">–</span> <span class="NLM_lpage">346</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.expneurol.2007.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=17433298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2sXls1aisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=2007&pages=336-346&author=S.+H.+Kohauthor=Y.+Kimauthor=H.+Y.+Kimauthor=S.+Hwangauthor=C.+H.+Leeauthor=S.+H.+Kim&title=Inhibition+of+glycogen+synthase+kinase-3+suppresses+the+onset+of+symptoms+and+disease+progression+of+G93A-SOD1+mouse+model+of+ALS"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit270R"><div class="casContent"><span class="casTitleNuber">270</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of glycogen synthase kinase-3 suppresses the onset of symptoms and disease progression of G93A-SOD1 mouse model of ALS</span></div><div class="casAuthors">Koh, Seong-Ho; Kim, Youngchul; Kim, Hyun Y.; Hwang, Sejin; Lee, Chang Ho; Kim, Seung H.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">336-346</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Glycogen synthase kinase (GSK)-3 has recently been implicated in the pathogenesis of neurodegenerative diseases.  Although the neuroprotective effects of GSK-3 inhibitors in Alzheimer's disease have been established, their effects on amyotrophic lateral sclerosis (ALS) have not been well defined.  This study was undertaken to evaluate the effects of GSK-3 inhibition in the G93A-SOD1 mouse model of ALS.  Groups of G93A-SOD1 mice were treated with varying concns. of GSK-3 inhibitor VIII, a specific GSK-3 inhibitor that crosses the BBB, i.p. 5 days a week after 60 days of age.  The GSK-3 inhibitor VIII treatment significantly delayed the onset of symptoms and prolonged the life span of the animals, and inhibited the activity of GSK-3 in a concn.-dependent manner.  Furthermore, this treatment preserved survival signals and attenuated death and inflammatory signals.  These data suggest that GSK-3 plays an important role in the pathogenic mechanisms of ALS and that inhibition of GSK-3 could be a potential therapeutic candidate for ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgAkuwj5gV4bVg90H21EOLACvtfcHk0lhjvrYGavj2PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXls1aisLY%253D&md5=09429c1fbeb544eef6cb75d4da00b179</span></div><a href="/servlet/linkout?suffix=cit270&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2007.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2007.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DKoh%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DH.%2BY.%26aulast%3DHwang%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BH.%26atitle%3DInhibition%2520of%2520glycogen%2520synthase%2520kinase-3%2520suppresses%2520the%2520onset%2520of%2520symptoms%2520and%2520disease%2520progression%2520of%2520G93A-SOD1%2520mouse%2520model%2520of%2520ALS%26jtitle%3DExp.%2520Neurol.%26date%3D2007%26volume%3D205%26spage%3D336%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref271"><div class="reference"><strong class="refLabel"><a href="#ref271" class="rightTabRefNumLink">271</a></strong><div class="NLM_citation" id="rightTab-cit271"><span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parisiadou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, X. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao-Cheng, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudow, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troncoso, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, H.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson’s-disease-related mutant alpha-synuclein</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">807</span><span class="NLM_x">–</span> <span class="NLM_lpage">827</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2009&pages=807-827&author=X.+Linauthor=L.+Parisiadouauthor=X.+L.+Guauthor=L.+Wangauthor=H.+Shimauthor=L.+Sunauthor=C.+Xieauthor=C.+X.+Longauthor=W.+J.+Yangauthor=J.+Dingauthor=Z.+Z.+Chenauthor=P.+E.+Gallantauthor=J.+H.+Tao-Chengauthor=G.+Rudowauthor=J.+C.+Troncosoauthor=Z.+Liuauthor=Z.+Liauthor=H.+Cai&title=Leucine-rich+repeat+kinase+2+regulates+the+progression+of+neuropathology+induced+by+Parkinson%E2%80%99s-disease-related+mutant+alpha-synuclein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit271&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DX.%26aulast%3DParisiadou%26aufirst%3DL.%26aulast%3DGu%26aufirst%3DX.%2BL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DShim%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DXie%26aufirst%3DC.%26aulast%3DLong%26aufirst%3DC.%2BX.%26aulast%3DYang%26aufirst%3DW.%2BJ.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%2BZ.%26aulast%3DGallant%26aufirst%3DP.%2BE.%26aulast%3DTao-Cheng%26aufirst%3DJ.%2BH.%26aulast%3DRudow%26aufirst%3DG.%26aulast%3DTroncoso%26aufirst%3DJ.%2BC.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DCai%26aufirst%3DH.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520regulates%2520the%2520progression%2520of%2520neuropathology%2520induced%2520by%2520Parkinson%25E2%2580%2599s-disease-related%2520mutant%2520alpha-synuclein%26jtitle%3DNeuron%26date%3D2009%26volume%3D64%26spage%3D807%26epage%3D827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref272"><div class="reference"><strong class="refLabel"><a href="#ref272" class="rightTabRefNumLink">272</a></strong><div class="NLM_citation" id="rightTab-cit272"><span><span class="NLM_contrib-group">Ballatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huryn, D. M.</span><span> </span><span class="NLM_article-title">Modulation of protein–protein interactions as a therapeutic strategy for the treatment of neurodegenerative tauopathies</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.2174%2F156802611794072605" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=21320060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslahsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=317-330&author=C.+Ballatoreauthor=K.+R.+Brundenauthor=J.+Q.+Trojanowskiauthor=V.+M.+Leeauthor=A.+B.+Smithauthor=D.+M.+Huryn&title=Modulation+of+protein%E2%80%93protein+interactions+as+a+therapeutic+strategy+for+the+treatment+of+neurodegenerative+tauopathies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit272R"><div class="casContent"><span class="casTitleNuber">272</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of protein-protein interactions as a therapeutic strategy for the treatment of neurodegenerative tauopathies</span></div><div class="casAuthors">Ballatore, C.; Brunden, K. R.; Trojanowski, J. Q.; Lee, V. M.-Y.; Smith, A. B., III; Huryn, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">317-330</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The recognition that malfunction of the microtubule (MT) assocd. protein tau is likely to play a defining role in the onset and/or progression of a no. of neurodegenerative diseases, including Alzheimer's disease, has resulted in the initiation of drug discovery programs that target this protein.  Tau is an endogenous MT-stabilizing agent that is highly expressed in the axons of neurons.  The MT-stabilizing function of tau is essential for the axonal transport of proteins, neurotransmitters and other cellular constituents.  Under pathol. conditions, tau misfolding and aggregation results in axonal transport deficits that appear to have deleterious consequences for the affected neurons, leading to synapse dysfunction and, ultimately, neuronal loss.  This review focuses on both progress and unresolved issues surrounding the development of novel therapeutics for the treatment of neurodegenerative tauopathies, which are based on (A) MT-stabilizing agents to compensate for the loss of normal tau function and (B) small mol. inhibitors of tau aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRv3v9WR9uIrVg90H21EOLACvtfcHk0lhjvrYGavj2PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslahsLk%253D&md5=b35d6ff9dac27b56e59f1e2fd5b8fafd</span></div><a href="/servlet/linkout?suffix=cit272&amp;dbid=16384&amp;doi=10.2174%2F156802611794072605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611794072605%26sid%3Dliteratum%253Aachs%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DHuryn%26aufirst%3DD.%2BM.%26atitle%3DModulation%2520of%2520protein%25E2%2580%2593protein%2520interactions%2520as%2520a%2520therapeutic%2520strategy%2520for%2520the%2520treatment%2520of%2520neurodegenerative%2520tauopathies%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D317%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref273"><div class="reference"><strong class="refLabel"><a href="#ref273" class="rightTabRefNumLink">273</a></strong><div class="NLM_citation" id="rightTab-cit273"><span><span class="NLM_contrib-group">Wischik, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, C. R.</span><span> </span><span class="NLM_article-title">Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">11213</span><span class="NLM_x">–</span> <span class="NLM_lpage">11218</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref273/cit273&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1073%2Fpnas.93.20.11213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref273/cit273&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=8855335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref273/cit273&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADyaK28XmtVOqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=11213-11218&author=C.+M.+Wischikauthor=P.+C.+Edwardsauthor=R.+Y.+Laiauthor=M.+Rothauthor=C.+R.+Harrington&title=Selective+inhibition+of+Alzheimer+disease-like+tau+aggregation+by+phenothiazines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit273R"><div class="casContent"><span class="casTitleNuber">273</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines</span></div><div class="casAuthors">Wischik, C. M.; Edwards, P. C.; Lai, R. Y.; Roth, M.; Harrington, C. R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">11213-11218</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">In Alzheimer disease (AD) the microtubule-assocd. protein tau is redistributed exponentially into paired helical filaments (PHFs) forming neurofibrillary tangles, which correlate with pyramidal cell destruction and dementia.  Amorphous neuronal deposits and PHFs in AD are characterized by aggregation through the repeat domain and C-terminal truncation at Glu-391 by endogenous proteases.  We show that a similar proteolytically stable complex can be generated in vitro following the self-aggregation of tau protein through a high-affinity binding site in the repeat domain.  Once started, tau capture can be propagated by seeding the further accumulation of truncated tau in the presence of proteases.  We have identified a non-neuroleptic phenothiazine previously used in man (methylene blue, MB), which reverses the proteolytic stability of protease-resistant PHFs by blocking the tau-tau binding interaction through the repeat domain.  Although MB is inhibitory at a higher concn. than may be achieved clin., the tau-tau binding assay was used to identify desmethyl derivs. of MB that have Ki values in the nanomolar range.  Neuroleptic phenothiazines are inactive.  Tau aggregation inhibitors do not affect the tau-tubulin interaction, which also occurs through the repeat domain.  Our findings demonstrate that biol. selective pharmaceutical agents could be developed to facilitate the proteolytic degrdn. of tau aggregates and prevent the further propagation of tau capture in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogZyJ57Clqp7Vg90H21EOLACvtfcHk0lguZGleK6jRow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmtVOqsLg%253D&md5=d586f688ffc47cc4129ed6407bd15720</span></div><a href="/servlet/linkout?suffix=cit273&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.20.11213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.20.11213%26sid%3Dliteratum%253Aachs%26aulast%3DWischik%26aufirst%3DC.%2BM.%26aulast%3DEdwards%26aufirst%3DP.%2BC.%26aulast%3DLai%26aufirst%3DR.%2BY.%26aulast%3DRoth%26aufirst%3DM.%26aulast%3DHarrington%26aufirst%3DC.%2BR.%26atitle%3DSelective%2520inhibition%2520of%2520Alzheimer%2520disease-like%2520tau%2520aggregation%2520by%2520phenothiazines%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1996%26volume%3D93%26spage%3D11213%26epage%3D11218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref274"><div class="reference"><strong class="refLabel"><a href="#ref274" class="rightTabRefNumLink">274</a></strong><div class="NLM_citation" id="rightTab-cit274"><span><span class="NLM_contrib-group">Ballatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossidivito, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.,  3rd.</span><span> </span><span class="NLM_article-title">Aminothienopyridazine inhibitors of tau aggregation: evaluation of structure–activity relationship leads to selection of candidates with desirable in vivo properties</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4451</span><span class="NLM_x">–</span> <span class="NLM_lpage">4461</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=4451-4461&author=C.+Ballatoreauthor=A.+Croweauthor=F.+Piscitelliauthor=M.+Jamesauthor=K.+Louauthor=G.+Rossidivitoauthor=Y.+Yaoauthor=J.+Q.+Trojanowskiauthor=V.+M.+Leeauthor=K.+R.+Brundenauthor=A.+B.+Smith&title=Aminothienopyridazine+inhibitors+of+tau+aggregation%3A+evaluation+of+structure%E2%80%93activity+relationship+leads+to+selection+of+candidates+with+desirable+in+vivo+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit274&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DCrowe%26aufirst%3DA.%26aulast%3DPiscitelli%26aufirst%3DF.%26aulast%3DJames%26aufirst%3DM.%26aulast%3DLou%26aufirst%3DK.%26aulast%3DRossidivito%26aufirst%3DG.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26atitle%3DAminothienopyridazine%2520inhibitors%2520of%2520tau%2520aggregation%253A%2520evaluation%2520of%2520structure%25E2%2580%2593activity%2520relationship%2520leads%2520to%2520selection%2520of%2520candidates%2520with%2520desirable%2520in%2520vivo%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D4451%26epage%3D4461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref275"><div class="reference"><strong class="refLabel"><a href="#ref275" class="rightTabRefNumLink">275</a></strong><div class="NLM_citation" id="rightTab-cit275"><span><span class="NLM_contrib-group">Messing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span> </span><span class="NLM_article-title">Cascade of tau toxicity in inducible hippocampal brain slices and prevention by aggregation inhibitors</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1343</span><span class="NLM_x">–</span> <span class="NLM_lpage">1354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.neurobiolaging.2012.10.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=23158765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslSmu7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1343-1354&author=L.+Messingauthor=J.+M.+Deckerauthor=M.+Josephauthor=E.+Mandelkowauthor=E.+M.+Mandelkow&title=Cascade+of+tau+toxicity+in+inducible+hippocampal+brain+slices+and+prevention+by+aggregation+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit275R"><div class="casContent"><span class="casTitleNuber">275</span><div class="casTitle"><span class="NLM_cas:atitle">Cascade of tau toxicity in inducible hippocampal brain slices and prevention by aggregation inhibitors</span></div><div class="casAuthors">Messing, Lars; Decker, Jochen Martin; Joseph, Maria; Mandelkow, Eckhard; Mandelkow, Eva-Maria</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1343-1354</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Mislocalization and aggregation of the axonal protein tau are hallmarks of Alzheimer's disease and other tauopathies.  Here, we studied the relationship between tau aggregation, loss of spines and neurons, and reversibility by aggregation inhibitors.  To this end we established an in vitro model of tauopathy based on regulatable transgenic hippocampal organotypic slice cultures prepd. from mice expressing proaggregant Tau repeat domain with mutation ΔK280 (TauRDΔK).  Transgene expression was monitored by a bioluminescence reporter assay.  We obsd. abnormal tau phosphorylation and mislocalization of exogenous and endogenous tau into the somatodendritic compartment.  This was paralleled by a redn. of dendritic spines, altered dendritic spine morphol., dysregulation of Ca++ dynamics and elevated activation of microglia.  Neurotoxicity was mediated by Caspase-3 activation and correlated with the expression level of proaggregant TauRDΔK.  Finally, tau aggregates appeared in areas CA1 and CA3 after three weeks in vitro.  Neurodegeneration was relieved by aggregation inhibitors or by switching off transgene expression.  Thus the slice culture model is suitable for monitoring the development of tauopathy and the therapeutic benefit of antiaggregation drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC_PnWs0hCu7Vg90H21EOLACvtfcHk0lguZGleK6jRow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslSmu7rO&md5=795880e4fc8b1dd1f21f4d5fd0c09d59</span></div><a href="/servlet/linkout?suffix=cit275&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2012.10.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2012.10.024%26sid%3Dliteratum%253Aachs%26aulast%3DMessing%26aufirst%3DL.%26aulast%3DDecker%26aufirst%3DJ.%2BM.%26aulast%3DJoseph%26aufirst%3DM.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26atitle%3DCascade%2520of%2520tau%2520toxicity%2520in%2520inducible%2520hippocampal%2520brain%2520slices%2520and%2520prevention%2520by%2520aggregation%2520inhibitors%26jtitle%3DNeurobiol.%2520Aging%26date%3D2013%26volume%3D34%26spage%3D1343%26epage%3D1354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref276"><div class="reference"><strong class="refLabel"><a href="#ref276" class="rightTabRefNumLink">276</a></strong><div class="NLM_citation" id="rightTab-cit276"><span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brindisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Developing beta-secretase inhibitors for treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref276/cit276&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1111%2Fj.1471-4159.2011.07476.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref276/cit276&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=22122681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref276/cit276&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFyns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=71-83&author=A.+K.+Ghoshauthor=M.+Brindisiauthor=J.+Tang&title=Developing+beta-secretase+inhibitors+for+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit276R"><div class="casContent"><span class="casTitleNuber">276</span><div class="casTitle"><span class="NLM_cas:atitle">Developing β-secretase inhibitors for treatment of Alzheimer's disease</span></div><div class="casAuthors">Ghosh, Arun K.; Brindisi, Margherita; Tang, Jordan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">71-83</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  β-Secretase (memapsin 2; BACE-1) is the first protease in the processing of amyloid precursor protein leading to the prodn. of amyloid-β (Aβ) in the brain.  It is believed that high levels of brain Aβ are responsible for the pathogenesis of Alzheimer's disease (AD).  Therefore, β-secretase is a major therapeutic target for the development of inhibitor drugs.  During the past decade, steady progress has been made in the evolution of β-secretase inhibitors toward better drug properties.  Recent inhibitors are potent, selective and have been shown to penetrate the blood-brain barrier to inhibit Aβ levels in the brains of exptl. animals.  Moreover, continuous administration of a β-secretase inhibitor was shown to rescue age-related cognitive decline in transgenic AD mice.  A small no. of β-secretase inhibitors have also entered early phase clin. trials.  These developments offer some optimism for the clin. development of a disease-modifying drug for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvY0fxn2hBubVg90H21EOLACvtfcHk0lguZGleK6jRow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFyns78%253D&md5=186d6ccadd1c207ecd7aaa9cb7584684</span></div><a href="/servlet/linkout?suffix=cit276&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07476.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07476.x%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DDeveloping%2520beta-secretase%2520inhibitors%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2012%26volume%3D120%26spage%3D71%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref277"><div class="reference"><strong class="refLabel"><a href="#ref277" class="rightTabRefNumLink">277</a></strong><div class="NLM_citation" id="rightTab-cit277"><span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith Labell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greg Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Robust central reduction of amyloid-beta in humans with an orally available, non-peptidic beta-secretase inhibitor</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">16507</span><span class="NLM_x">–</span> <span class="NLM_lpage">16516</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+Smith+Labellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+Greg+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-beta+in+humans+with+an+orally+available%2C+non-peptidic+beta-secretase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit277R"><div class="casContent"><span class="casTitleNuber">277</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0ljo2qQJ6OAguQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit277&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DSmith%2BLabell%26aufirst%3DE.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DGreg%2BHall%26aufirst%3DD.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-beta%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520beta-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref278"><div class="reference"><strong class="refLabel"><a href="#ref278" class="rightTabRefNumLink">278</a></strong><div class="NLM_citation" id="rightTab-cit278"><span><span class="NLM_contrib-group">D’Onofrio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panza, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frisardi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solfrizzi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paroni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascavilla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seripa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilotto, A.</span><span> </span><span class="NLM_article-title">Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=19-37&author=G.+D%E2%80%99Onofrioauthor=F.+Panzaauthor=V.+Frisardiauthor=V.+Solfrizziauthor=B.+P.+Imbimboauthor=G.+Paroniauthor=L.+Cascavillaauthor=D.+Seripaauthor=A.+Pilotto&title=Advances+in+the+identification+of+%CE%B3-secretase+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit278&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Onofrio%26aufirst%3DG.%26aulast%3DPanza%26aufirst%3DF.%26aulast%3DFrisardi%26aufirst%3DV.%26aulast%3DSolfrizzi%26aufirst%3DV.%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26aulast%3DParoni%26aufirst%3DG.%26aulast%3DCascavilla%26aufirst%3DL.%26aulast%3DSeripa%26aufirst%3DD.%26aulast%3DPilotto%26aufirst%3DA.%26atitle%3DAdvances%2520in%2520the%2520identification%2520of%2520%25CE%25B3-secretase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2012%26volume%3D7%26spage%3D19%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref279"><div class="reference"><strong class="refLabel"><a href="#ref279" class="rightTabRefNumLink">279</a></strong><div class="NLM_citation" id="rightTab-cit279"><span><span class="NLM_contrib-group">Gillman, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starrett, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcin, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElhone, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mate, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barten, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaczek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decicco, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. E.</span><span> </span><span class="NLM_article-title">Discovery and evaluation of BMS-708163, a potent, selective and orally bioavailable gamma-secretase inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml1000239" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=120-124&author=K.+W.+Gillmanauthor=J.+E.+Starrettauthor=M.+F.+Parkerauthor=K.+Xieauthor=J.+J.+Bronsonauthor=L.+R.+Marcinauthor=K.+E.+McElhoneauthor=C.+P.+Bergstromauthor=R.+A.+Mateauthor=R.+Williamsauthor=J.+E.+Meredithauthor=C.+R.+Burtonauthor=D.+M.+Bartenauthor=J.+H.+Toynauthor=S.+B.+Robertsauthor=K.+A.+Lentzauthor=J.+G.+Houstonauthor=R.+Zaczekauthor=C.+F.+Albrightauthor=C.+P.+Deciccoauthor=J.+E.+Macorauthor=R.+E.+Olson&title=Discovery+and+evaluation+of+BMS-708163%2C+a+potent%2C+selective+and+orally+bioavailable+gamma-secretase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit279&amp;dbid=16384&amp;doi=10.1021%2Fml1000239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1000239%26sid%3Dliteratum%253Aachs%26aulast%3DGillman%26aufirst%3DK.%2BW.%26aulast%3DStarrett%26aufirst%3DJ.%2BE.%26aulast%3DParker%26aufirst%3DM.%2BF.%26aulast%3DXie%26aufirst%3DK.%26aulast%3DBronson%26aufirst%3DJ.%2BJ.%26aulast%3DMarcin%26aufirst%3DL.%2BR.%26aulast%3DMcElhone%26aufirst%3DK.%2BE.%26aulast%3DBergstrom%26aufirst%3DC.%2BP.%26aulast%3DMate%26aufirst%3DR.%2BA.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DMeredith%26aufirst%3DJ.%2BE.%26aulast%3DBurton%26aufirst%3DC.%2BR.%26aulast%3DBarten%26aufirst%3DD.%2BM.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DRoberts%26aufirst%3DS.%2BB.%26aulast%3DLentz%26aufirst%3DK.%2BA.%26aulast%3DHouston%26aufirst%3DJ.%2BG.%26aulast%3DZaczek%26aufirst%3DR.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DDecicco%26aufirst%3DC.%2BP.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26atitle%3DDiscovery%2520and%2520evaluation%2520of%2520BMS-708163%252C%2520a%2520potent%252C%2520selective%2520and%2520orally%2520bioavailable%2520gamma-secretase%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D120%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref280"><div class="reference"><strong class="refLabel"><a href="#ref280" class="rightTabRefNumLink">280</a></strong><div class="NLM_citation" id="rightTab-cit280"><span><span class="NLM_contrib-group">Panza, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solfrizzi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frisardi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capurso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Introno, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colacicco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vendemiale, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capurso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span> </span><span class="NLM_article-title">Disease-modifying approach to the treatment of Alzheimer’s disease: from alpha-secretase activators to gamma-secretase inhibitors and modulators</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref280/cit280&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.2165%2F11315770-000000000-00000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref280/cit280&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=19655822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref280/cit280&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOju7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2009&pages=537-555&author=F.+Panzaauthor=V.+Solfrizziauthor=V.+Frisardiauthor=C.+Capursoauthor=A.+D%E2%80%99Intronoauthor=A.+M.+Colaciccoauthor=G.+Vendemialeauthor=A.+Capursoauthor=B.+P.+Imbimbo&title=Disease-modifying+approach+to+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+from+alpha-secretase+activators+to+gamma-secretase+inhibitors+and+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit280R"><div class="casContent"><span class="casTitleNuber">280</span><div class="casTitle"><span class="NLM_cas:atitle">Disease-modifying approach to the treatment of Alzheimer's disease: from α-secretase activators to γ-secretase inhibitors and modulators</span></div><div class="casAuthors">Panza, Francesco; Solfrizzi, Vincenzo; Frisardi, Vincenza; Capurso, Cristiano; D'Introno, Alessia; Colacicco, Anna M.; Vendemiale, Gianluigi; Capurso, Antonio; Imbimbo, Bruno P.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">537-555</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Wolters Kluwer Health</span>)
        </div><div class="casAbstract">A review.  In the last decade, advances in understanding the neurobiol. of Alzheimer's disease (AD) have translated into an increase in clin. trials assessing various potential AD treatments.  At present, drugs used for the treatment of AD only slightly delay the inevitable symptomatic progression of the disease and do not affect the main neuropathol. hallmarks of the disease, i.e. senile plaques and neurofibrillary tangles.  Brain accumulation of oligomeric species of β-amyloid (Aβ) peptides, the principal components of senile plaques, is believed to play a crucial role in the development of AD.  Based on this hypothesis, huge efforts are being made to identify drugs able to interfere with proteases regulating Aβ formation from amyloid precursor protein (APP).  Compds. that stimulate α-secretase, the enzyme responsible for non-amyloidogenic metab. of APP, are being developed and one of these, EHT-0202, has recently commenced evaluation in a phase II study.  The discovery of inhibitors of β-secretase (memapsin-2, β-amyloid cleaving enzyme-1 [BACE-1]), the enzyme that regulates the first step of amyloidogenic APP metab., has proved to be particularly difficult because of inherent medicinal chem. issues and only one compd. (CTS-21166) has proceeded to clin. testing.  Conversely, several compds. that inhibit γ-secretase, the pivotal enzyme that generates Aβ, have been identified, the most advanced being LY-450139 (semagacestat), presently in phase III clin. development.  There has been considerable disappointment over the failure of a phase III study of tarenflurbil, a compd. believed to modulate the activity of y-secretase, after encouraging phase II findings.  Nevertheless, other promising y-secretase modulators are being developed and are approaching clin. testing.  All these therapeutic approaches increase the hope of slowing the rate of decline in patients with AD and modifying the natural history of this devastating disease within the next 5 years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzAE5mGxaRkLVg90H21EOLACvtfcHk0ljo2qQJ6OAguQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOju7rE&md5=4c311efa2d1d777d67eba5ef68285e6e</span></div><a href="/servlet/linkout?suffix=cit280&amp;dbid=16384&amp;doi=10.2165%2F11315770-000000000-00000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F11315770-000000000-00000%26sid%3Dliteratum%253Aachs%26aulast%3DPanza%26aufirst%3DF.%26aulast%3DSolfrizzi%26aufirst%3DV.%26aulast%3DFrisardi%26aufirst%3DV.%26aulast%3DCapurso%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Introno%26aufirst%3DA.%26aulast%3DColacicco%26aufirst%3DA.%2BM.%26aulast%3DVendemiale%26aufirst%3DG.%26aulast%3DCapurso%26aufirst%3DA.%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26atitle%3DDisease-modifying%2520approach%2520to%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520from%2520alpha-secretase%2520activators%2520to%2520gamma-secretase%2520inhibitors%2520and%2520modulators%26jtitle%3DDrugs%2520Aging%26date%3D2009%26volume%3D26%26spage%3D537%26epage%3D555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref281"><div class="reference"><strong class="refLabel"><a href="#ref281" class="rightTabRefNumLink">281</a></strong><div class="NLM_citation" id="rightTab-cit281"><span><span class="NLM_contrib-group">Khan, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wender, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alkon, D. L.</span><span> </span><span class="NLM_article-title">A cellular model of Alzheimer’s disease therapeutic efficacy: PKC activation reverses Abeta-induced biomarker abnormality on cultured fibroblasts</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span><span class="NLM_x">–</span> <span class="NLM_lpage">339</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref281/cit281&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.nbd.2009.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref281/cit281&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=19233276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref281/cit281&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkslKrsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=332-339&author=T.+K.+Khanauthor=T.+J.+Nelsonauthor=V.+A.+Vermaauthor=P.+A.+Wenderauthor=D.+L.+Alkon&title=A+cellular+model+of+Alzheimer%E2%80%99s+disease+therapeutic+efficacy%3A+PKC+activation+reverses+Abeta-induced+biomarker+abnormality+on+cultured+fibroblasts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit281R"><div class="casContent"><span class="casTitleNuber">281</span><div class="casTitle"><span class="NLM_cas:atitle">A cellular model of Alzheimer's disease therapeutic efficacy: PKC activation reverses Aβ-induced biomarker abnormality on cultured fibroblasts</span></div><div class="casAuthors">Khan, Tapan K.; Nelson, Thomas J.; Verma, Vishal A.; Wender, Paul A.; Alkon, Daniel L.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">332-339</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">PKC signaling is crit. for the non-toxic degrdn. of amyloid precursor protein (APP) and inhibition of GSK3β, which controls phosphorylation of tau protein in Alzheimer's disease (AD).  Thus the misregulation of PKC signaling could contribute to the origins of AD.  Bryostatin, a potent PKC modulator, has the potential to ameliorate both the neurodegeneration and the recent memory loss assocd. with AD.  As reported herein bryostatin and a potent synthetic analog (picolog) are found to cause stimulation of non-amyloidogenic pathways by increasing α-secretase activity and thus lowering the amt. of toxic Aβ produced.  Both bryostatin and picolog increased the secretion of the α-secretase product (s-APP-α) of APP at sub-nanomolar to nanomolar concns.  A peripheral AD-Biomarker has previously been autopsy-validated.  This Biomarker, based on bradykinin-induced differential phosphorylation of Erk1 and Erk2, has been used here to test the therapeutic efficacy both for bryostatin and picolog.  Both of these PKC activators are then shown to convert the AD Erk1/2 phenotype of fibroblasts into the phenotype of "normal" control skin fibroblasts.  This conversion occurred for both the abnormal Erk1/2 phenotype induced by application of Aβ1-42 to the fibroblasts or the phenotype obsd. for fibroblasts of AD patients.  The Aβ1-42-induction, and PKC modulator reversal of the AD Erk1/2 biomarker phenotype demonstrate the AD-Biomarker's potential to monitor both disease progression and treatment response.  Addnl., this first demonstration of the therapeutic potential in AD of a synthetically accessible bryostatin analog warrants further preclin. advancement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH-nc7eUhdP7Vg90H21EOLACvtfcHk0lgvHwMwFjzRlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkslKrsrc%253D&md5=646689af5b2d94bbcfec3a92f8c26320</span></div><a href="/servlet/linkout?suffix=cit281&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2009.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2009.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DT.%2BK.%26aulast%3DNelson%26aufirst%3DT.%2BJ.%26aulast%3DVerma%26aufirst%3DV.%2BA.%26aulast%3DWender%26aufirst%3DP.%2BA.%26aulast%3DAlkon%26aufirst%3DD.%2BL.%26atitle%3DA%2520cellular%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapeutic%2520efficacy%253A%2520PKC%2520activation%2520reverses%2520Abeta-induced%2520biomarker%2520abnormality%2520on%2520cultured%2520fibroblasts%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2009%26volume%3D34%26spage%3D332%26epage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref282"><div class="reference"><strong class="refLabel"><a href="#ref282" class="rightTabRefNumLink">282</a></strong><div class="NLM_citation" id="rightTab-cit282"><span><span class="NLM_contrib-group">Wender, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baryza, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeChristopher, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loy, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, V. A.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of potent bryostatin analogs that modulate PKC translocation selectivity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">6721</span><span class="NLM_x">–</span> <span class="NLM_lpage">6726</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref282/cit282&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1073%2Fpnas.1015270108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref282/cit282&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=21415363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref282/cit282&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlslyrurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=6721-6726&author=P.+A.+Wenderauthor=J.+L.+Baryzaauthor=S.+E.+Brennerauthor=B.+A.+DeChristopherauthor=B.+A.+Loyauthor=A.+J.+Schrierauthor=V.+A.+Verma&title=Design%2C+synthesis%2C+and+evaluation+of+potent+bryostatin+analogs+that+modulate+PKC+translocation+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit282R"><div class="casContent"><span class="casTitleNuber">282</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and evaluation of potent bryostatin analogs that modulate PKC translocation selectivity</span></div><div class="casAuthors">Wender, Paul A.; Baryza, Jeremy L.; Brenner, Stacey E.; DeChristopher, Brian A.; Loy, Brian A.; Schrier, Adam J.; Verma, Vishal A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6721-6726, S6721/1-S6721/29</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Modern methods for the identification of therapeutic leads include chem. or virtual screening of compd. libraries.  Nature's library represents a vast and diverse source of leads, often exhibiting exquisite biol. activities.  However, the advancement of natural product leads into the clinic is often impeded by their scarcity, complexity, and nonoptimal properties or efficacy as well as the challenges assocd. with their synthesis or modification.  Function-oriented synthesis represents a strategy to address these issues through the design of simpler and therefore synthetically more accessible analogs that incorporate the activity-detg. features of the natural product leads.  This study illustrates the application of this strategy to the design and synthesis of functional analogs of the bryostatin marine natural products.  It is specifically directed at exploring the activity-detg. role of bryostatin A-ring functionality on PKC affinity and selectivity.  The resultant functional analogs, which were prepd. by a flexible, modular synthetic strategy, exhibit excellent affinity to PKC and differential isoform selectivity.  These and related studies provide the basic information needed for the design of simplified and thus synthetically more accessible functional analogs that target PKC isoforms, major targets of therapeutic interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQmWfq9UqT9LVg90H21EOLACvtfcHk0lgvHwMwFjzRlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlslyrurg%253D&md5=2d45927ddd5dab065ae42578fe288ca4</span></div><a href="/servlet/linkout?suffix=cit282&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1015270108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1015270108%26sid%3Dliteratum%253Aachs%26aulast%3DWender%26aufirst%3DP.%2BA.%26aulast%3DBaryza%26aufirst%3DJ.%2BL.%26aulast%3DBrenner%26aufirst%3DS.%2BE.%26aulast%3DDeChristopher%26aufirst%3DB.%2BA.%26aulast%3DLoy%26aufirst%3DB.%2BA.%26aulast%3DSchrier%26aufirst%3DA.%2BJ.%26aulast%3DVerma%26aufirst%3DV.%2BA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520potent%2520bryostatin%2520analogs%2520that%2520modulate%2520PKC%2520translocation%2520selectivity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D6721%26epage%3D6726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref283"><div class="reference"><strong class="refLabel"><a href="#ref283" class="rightTabRefNumLink">283</a></strong><div class="NLM_citation" id="rightTab-cit283"><span><span class="NLM_contrib-group">Simons, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dichgans, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, J. B.</span><span> </span><span class="NLM_article-title">Cholesterol and Alzheimer’s disease: Is there a link?</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1089</span><span class="NLM_x">–</span> <span class="NLM_lpage">1093</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2001&pages=1089-1093&author=M.+Simonsauthor=P.+Kellerauthor=J.+Dichgansauthor=J.+B.+Schulz&title=Cholesterol+and+Alzheimer%E2%80%99s+disease%3A+Is+there+a+link%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit283&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSimons%26aufirst%3DM.%26aulast%3DKeller%26aufirst%3DP.%26aulast%3DDichgans%26aufirst%3DJ.%26aulast%3DSchulz%26aufirst%3DJ.%2BB.%26atitle%3DCholesterol%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Is%2520there%2520a%2520link%253F%26jtitle%3DNeurology%26date%3D2001%26volume%3D57%26spage%3D1089%26epage%3D1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref284"><div class="reference"><strong class="refLabel"><a href="#ref284" class="rightTabRefNumLink">284</a></strong><div class="NLM_citation" id="rightTab-cit284"><span><span class="NLM_contrib-group">Simons, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutjohann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Bergmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyreuther, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dichgans, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wormstall, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, J. B.</span><span> </span><span class="NLM_article-title">Treatment with simvastatin in normocholesterolemic patients with Alzheimer’s disease: a 26-week randomized, placebo-controlled, double-blind trial</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">350</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref284/cit284&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1002%2Fana.10292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref284/cit284&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12205648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref284/cit284&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD38Xns1amtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2002&pages=346-350&author=M.+Simonsauthor=F.+Schwarzlerauthor=D.+Lutjohannauthor=K.+von+Bergmannauthor=K.+Beyreutherauthor=J.+Dichgansauthor=H.+Wormstallauthor=T.+Hartmannauthor=J.+B.+Schulz&title=Treatment+with+simvastatin+in+normocholesterolemic+patients+with+Alzheimer%E2%80%99s+disease%3A+a+26-week+randomized%2C+placebo-controlled%2C+double-blind+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit284R"><div class="casContent"><span class="casTitleNuber">284</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial</span></div><div class="casAuthors">Simons, Mikael; Schwaerzler, Frank; Luetjohann, Dieter; von Bergmann, Klaus; Beyreuther, Konrad; Dichgans, Johannes; Wormstall, Henning; Hartmann, Tobias; Schulz, Joerg B.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">346-350</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">In a randomized, placebo-controlled, double-blind study, we investigated whether statins alter cholesterol metabolites and reduce Aβ levels in the cerebrospinal fluid of 44 patients with Alzheimer's disease.  Individuals were given up to 80mg simvastatin daily or placebo for 26 wk.  Overall, simvastatin did not significantly alter cerebrospinal fluid levels of Aβ40 and Aβ42.  In post hoc anal., simvastatin significantly decreased Aβ40 levels in the cerebrospinal fluid of patients with mild Alzheimer's disease.  The redn. of Aβ40 correlated with the redn. of 24S-hydroxycholesterol.  These changes were not obsd. in more severely affected patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgNs2i4vKKW7Vg90H21EOLACvtfcHk0lgvHwMwFjzRlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xns1amtr4%253D&md5=763034bf80e2d706392118bce7093024</span></div><a href="/servlet/linkout?suffix=cit284&amp;dbid=16384&amp;doi=10.1002%2Fana.10292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.10292%26sid%3Dliteratum%253Aachs%26aulast%3DSimons%26aufirst%3DM.%26aulast%3DSchwarzler%26aufirst%3DF.%26aulast%3DLutjohann%26aufirst%3DD.%26aulast%3Dvon%2BBergmann%26aufirst%3DK.%26aulast%3DBeyreuther%26aufirst%3DK.%26aulast%3DDichgans%26aufirst%3DJ.%26aulast%3DWormstall%26aufirst%3DH.%26aulast%3DHartmann%26aufirst%3DT.%26aulast%3DSchulz%26aufirst%3DJ.%2BB.%26atitle%3DTreatment%2520with%2520simvastatin%2520in%2520normocholesterolemic%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%252026-week%2520randomized%252C%2520placebo-controlled%252C%2520double-blind%2520trial%26jtitle%3DAnn.%2520Neurol.%26date%3D2002%26volume%3D52%26spage%3D346%26epage%3D350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref285"><div class="reference"><strong class="refLabel"><a href="#ref285" class="rightTabRefNumLink">285</a></strong><div class="NLM_citation" id="rightTab-cit285"><span><span class="NLM_contrib-group">Puglielli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovacs, D. M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: the cholesterol connection</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">351</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref285/cit285&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnn0403-345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref285/cit285&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=12658281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref285/cit285&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlequrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2003&pages=345-351&author=L.+Puglielliauthor=R.+E.+Tanziauthor=D.+M.+Kovacs&title=Alzheimer%E2%80%99s+disease%3A+the+cholesterol+connection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit285R"><div class="casContent"><span class="casTitleNuber">285</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: the cholesterol connection</span></div><div class="casAuthors">Puglielli, Luigi; Tanzi, Rudolph E.; Kovacs, Dora M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">345-351</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A hallmark of all forms of Alzheimer's disease (AD) is an abnormal accumulation of the β-amyloid protein (Aβ) in specific brain regions.  Both the generation and clearance of Aβ are regulated by cholesterol.  Elevated cholesterol levels increase Aβ in cellular and most animals models of AD, and drugs that inhibit cholesterol synthesis lower Aβ in these models.  Recent studies show that not only the total amt., but also the distribution of cholesterol within neurons, impacts Aβ biogenesis.  The identification of a variant of the apolipoprotein E (APOE) gene as a major genetic risk factor for AD is also consistent with a role for cholesterol in the pathogenesis of AD.  Clin. trials have recently been initiated to test whether lowering plasma and/or neuronal cholesterol levels is a viable strategy for treating and preventing AD.  In this review, we describe recent findings concerning the mol. mechanisms underlying the cholesterol-AD connection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjyel5PRPC67Vg90H21EOLACvtfcHk0lieXY_y_u1lfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlequrY%253D&md5=cd4d7f72ad850c6601b80f77eced97d4</span></div><a href="/servlet/linkout?suffix=cit285&amp;dbid=16384&amp;doi=10.1038%2Fnn0403-345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn0403-345%26sid%3Dliteratum%253Aachs%26aulast%3DPuglielli%26aufirst%3DL.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DKovacs%26aufirst%3DD.%2BM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520cholesterol%2520connection%26jtitle%3DNat.%2520Neurosci.%26date%3D2003%26volume%3D6%26spage%3D345%26epage%3D351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref286"><div class="reference"><strong class="refLabel"><a href="#ref286" class="rightTabRefNumLink">286</a></strong><div class="NLM_citation" id="rightTab-cit286"><span><span class="NLM_contrib-group">Roy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pahan, K.</span><span> </span><span class="NLM_article-title">Prospects of statins in Parkinson disease</span> <span class="citation_source-journal">Neuroscientist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">244</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=244-255&author=A.+Royauthor=K.+Pahan&title=Prospects+of+statins+in+Parkinson+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit286&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DA.%26aulast%3DPahan%26aufirst%3DK.%26atitle%3DProspects%2520of%2520statins%2520in%2520Parkinson%2520disease%26jtitle%3DNeuroscientist%26date%3D2011%26volume%3D17%26spage%3D244%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref287"><div class="reference"><strong class="refLabel"><a href="#ref287" class="rightTabRefNumLink">287</a></strong><div class="NLM_citation" id="rightTab-cit287"><span><span class="NLM_contrib-group">Valenza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattaneo, E.</span><span> </span><span class="NLM_article-title">Emerging roles for cholesterol in Huntington’s disease</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">474</span><span class="NLM_x">–</span> <span class="NLM_lpage">486</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2011&pages=474-486&author=M.+Valenzaauthor=E.+Cattaneo&title=Emerging+roles+for+cholesterol+in+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit287&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DValenza%26aufirst%3DM.%26aulast%3DCattaneo%26aufirst%3DE.%26atitle%3DEmerging%2520roles%2520for%2520cholesterol%2520in%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Neurosci.%26date%3D2011%26volume%3D34%26spage%3D474%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref288"><div class="reference"><strong class="refLabel"><a href="#ref288" class="rightTabRefNumLink">288</a></strong><div class="NLM_citation" id="rightTab-cit288"><span><span class="NLM_contrib-group">Bate, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tayebi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, A.</span><span> </span><span class="NLM_article-title">Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation</span> <span class="citation_source-journal">BMC Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref288/cit288&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1186%2F1741-7007-6-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref288/cit288&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=18269734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref288/cit288&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD1c3gslKjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=8&author=C.+Bateauthor=M.+Tayebiauthor=A.+Williams&title=Sequestration+of+free+cholesterol+in+cell+membranes+by+prions+correlates+with+cytoplasmic+phospholipase+A2+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit288R"><div class="casContent"><span class="casTitleNuber">288</span><div class="casTitle"><span class="NLM_cas:atitle">Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation</span></div><div class="casAuthors">Bate Clive; Tayebi Mourad; Williams Alun</div><div class="citationInfo"><span class="NLM_cas:title">BMC biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The transmissible spongiform encephalopathies (TSEs), otherwise known as the prion diseases, occur following the conversion of the normal cellular prion protein (PrPC) to an alternatively folded isoform (PrPSc).  The accumulation of PrPSc within the brain leads to neurodegeneration through an unidentified mechanism.  Since many neurodegenerative disorders including prion, Parkinson's and Alzheimer's diseases may be modified by cholesterol synthesis inhibitors, the effects of prion infection on the cholesterol balance within neuronal cells were examined.  RESULTS:  We report the novel observation that prion infection altered the membrane composition and significantly increased total cholesterol levels in two neuronal cell lines (ScGT1 and ScN2a cells).  There was a significant correlation between the concentration of free cholesterol in ScGT1 cells and the amounts of PrPSc.  This increase was entirely a result of increased amounts of free cholesterol, as prion infection reduced the amounts of cholesterol esters in cells.  These effects were reproduced in primary cortical neurons by the addition of partially purified PrPSc, but not by PrPC.  Crucially, the effects of prion infection were not a result of increased cholesterol synthesis.  Stimulating cholesterol synthesis via the addition of mevalonate, or adding exogenous cholesterol, had the opposite effect to prion infection on the cholesterol balance.  It did not affect the amounts of free cholesterol within neurons; rather, it significantly increased the amounts of cholesterol esters.  Immunoprecipitation studies have shown that cytoplasmic phospholipase A2 (cPLA2) co-precipitated with PrPSc in ScGT1 cells.  Furthermore, prion infection greatly increased both the phosphorylation of cPLA2 and prostaglandin E2 production.  CONCLUSION:  Prion infection, or the addition of PrPSc, increased the free cholesterol content of cells, a process that could not be replicated by the stimulation of cholesterol synthesis.  The presence of PrPSc increased solubilisation of free cholesterol in cell membranes and affected their function.  It increased activation of the PLA2 pathway, previously implicated in PrPSc formation and in PrPSc-mediated neurotoxicity.  These observations suggest that the neuropathogenesis of prion diseases results from PrPSc altering cholesterol-sensitive processes.  Furthermore, they raise the possibility that disturbances in membrane cholesterol are major triggering events in neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRCrVkxYmEnhMyail4HZd-ifW6udTcc2eaw073ZglWu37ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3gslKjsQ%253D%253D&md5=35f6a86cd96f0f5a35dabdfe370c37cb</span></div><a href="/servlet/linkout?suffix=cit288&amp;dbid=16384&amp;doi=10.1186%2F1741-7007-6-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1741-7007-6-8%26sid%3Dliteratum%253Aachs%26aulast%3DBate%26aufirst%3DC.%26aulast%3DTayebi%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DA.%26atitle%3DSequestration%2520of%2520free%2520cholesterol%2520in%2520cell%2520membranes%2520by%2520prions%2520correlates%2520with%2520cytoplasmic%2520phospholipase%2520A2%2520activation%26jtitle%3DBMC%2520Biol.%26date%3D2008%26volume%3D6%26spage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref289"><div class="reference"><strong class="refLabel"><a href="#ref289" class="rightTabRefNumLink">289</a></strong><div class="NLM_citation" id="rightTab-cit289"><span><span class="NLM_contrib-group">Tobert, J. A.</span><span> </span><span class="NLM_article-title">Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">526</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=517-526&author=J.+A.+Tobert&title=Lovastatin+and+beyond%3A+the+history+of+the+HMG-CoA+reductase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit289&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTobert%26aufirst%3DJ.%2BA.%26atitle%3DLovastatin%2520and%2520beyond%253A%2520the%2520history%2520of%2520the%2520HMG-CoA%2520reductase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D517%26epage%3D526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref290"><div class="reference"><strong class="refLabel"><a href="#ref290" class="rightTabRefNumLink">290</a></strong><div class="NLM_citation" id="rightTab-cit290"><span><span class="NLM_contrib-group">Arawaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machiya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, T.</span><span> </span><span class="NLM_article-title">Heat shock proteins as suppressors of accumulation of toxic prefibrillar intermediates and misfolded proteins in neurodegenerative diseases</span> <span class="citation_source-journal">Curr. Pharm. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref290/cit290&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.2174%2F138920110790909713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref290/cit290&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20170473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref290/cit290&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFeitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=158-166&author=S.+Arawakaauthor=Y.+Machiyaauthor=T.+Kato&title=Heat+shock+proteins+as+suppressors+of+accumulation+of+toxic+prefibrillar+intermediates+and+misfolded+proteins+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit290R"><div class="casContent"><span class="casTitleNuber">290</span><div class="casTitle"><span class="NLM_cas:atitle">Heat shock proteins as suppressors of accumulation of toxic prefibrillar intermediates and misfolded proteins in neurodegenerative diseases</span></div><div class="casAuthors">Arawaka, Shigeki; Machiya, Youhei; Kato, Takeo</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Biotechnology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">158-166</span>CODEN:
                <span class="NLM_cas:coden">CPBUBP</span>;
        ISSN:<span class="NLM_cas:issn">1389-2010</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The most characteristic feature of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and Huntington's disease, is the occurrence of extra- or intracellular fibrillar aggregates contg. misfolded proteins with beta-sheet conformation.  These aggregates are composed of distinct proteins in each neurodegenerative disease.  However, mutations in genes encoding major constituents of aggregates, such as Abeta, tau, α-synuclein, SOD1 and huntingtin, were identified to causally assoc. with familial forms of the diseases.  Biochem. studies demonstrate that these mutant and some wild-type proteins tend to be misfolded or form aggregates.  It was proposed that these diseases are caused by a common mechanism involving misfolded proteins that trigger a toxic cascade leading to neuronal degeneration.  This hypothesis is the basis of the therapeutic potential of heat shock proteins (HSPs), which prevent protein misfolding and aggregation.  Transgenic animal models of the diseases have demonstrated that induction or overexpression of HSPs can suppress neuronal dysfunction and degeneration.  Do the results promise clin. success for HSP-based therapy in neurodegenerative diseases.  Recent findings regarding the pathogenic species generated during fibril formation have highlighted some of the beneficial and problematic aspects of HSP-based therapy.  In this review, we focus on the pathogenic role of prefibrillar intermediates, including sol. oligomers and protofibrils, on neurodegeneration, and the relationship between prefibrillar intermediates and the proteins targeted by HSPs.  We discuss in vitro and in vivo exptl. data showing that HSPs counteract disease progression by acting as suppressors of toxic prefibrillar intermediates and toxic misfolded proteins in neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr30J1Nolw8-7Vg90H21EOLACvtfcHk0lh4h4INbJP9iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFeitbk%253D&md5=c12affb12d00d0b106dafd4d33495dd8</span></div><a href="/servlet/linkout?suffix=cit290&amp;dbid=16384&amp;doi=10.2174%2F138920110790909713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920110790909713%26sid%3Dliteratum%253Aachs%26aulast%3DArawaka%26aufirst%3DS.%26aulast%3DMachiya%26aufirst%3DY.%26aulast%3DKato%26aufirst%3DT.%26atitle%3DHeat%2520shock%2520proteins%2520as%2520suppressors%2520of%2520accumulation%2520of%2520toxic%2520prefibrillar%2520intermediates%2520and%2520misfolded%2520proteins%2520in%2520neurodegenerative%2520diseases%26jtitle%3DCurr.%2520Pharm.%2520Biotechnol.%26date%3D2010%26volume%3D11%26spage%3D158%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref291"><div class="reference"><strong class="refLabel"><a href="#ref291" class="rightTabRefNumLink">291</a></strong><div class="NLM_citation" id="rightTab-cit291"><span><span class="NLM_contrib-group">Wyttenbach, A.; Arrigo, A. P.</span><span> </span><span class="NLM_article-title">The Role of Heat Shock Proteins during Neurodegeneration in Alzheimer’s, Parkinson’s and Huntington’s Disease</span>. In  <span class="citation_source-book">Heat Shock Proteins in Neural Cells</span>; <span class="NLM_contrib-group">Richter-Landsberg, C.</span>, Ed.; <span class="NLM_publisher-name">Springer and R. G. Landes</span>: <span class="NLM_publisher-loc">Georgetown, TX, U.S.</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">125</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=125&author=A.+Wyttenbach&author=A.+P.+Arrigoauthor=C.+Richter-Landsberg&title=Heat+Shock+Proteins+in+Neural+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit291&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWyttenbach%26aufirst%3DA.%26atitle%3DThe%2520Role%2520of%2520Heat%2520Shock%2520Proteins%2520during%2520Neurodegeneration%2520in%2520Alzheimer%25E2%2580%2599s%252C%2520Parkinson%25E2%2580%2599s%2520and%2520Huntington%25E2%2580%2599s%2520Disease%26btitle%3DHeat%2520Shock%2520Proteins%2520in%2520Neural%2520Cells%26aulast%3DRichter-Landsberg%26aufirst%3DC.%26pub%3DSpringer%2520and%2520R.%2520G.%2520Landes%26date%3D2009%26spage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref292"><div class="reference"><strong class="refLabel"><a href="#ref292" class="rightTabRefNumLink">292</a></strong><div class="NLM_citation" id="rightTab-cit292"><span><span class="NLM_contrib-group">Neef, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeger, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiele, D. J.</span><span> </span><span class="NLM_article-title">Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">944</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=930-944&author=D.+W.+Neefauthor=A.+M.+Jaegerauthor=D.+J.+Thiele&title=Heat+shock+transcription+factor+1+as+a+therapeutic+target+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit292&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeef%26aufirst%3DD.%2BW.%26aulast%3DJaeger%26aufirst%3DA.%2BM.%26aulast%3DThiele%26aufirst%3DD.%2BJ.%26atitle%3DHeat%2520shock%2520transcription%2520factor%25201%2520as%2520a%2520therapeutic%2520target%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D930%26epage%3D944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref293"><div class="reference"><strong class="refLabel"><a href="#ref293" class="rightTabRefNumLink">293</a></strong><div class="NLM_citation" id="rightTab-cit293"><span><span class="NLM_contrib-group">Luo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Heat shock protein 90 in neurodegenerative diseases</span> <span class="citation_source-journal">Mol. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref293/cit293&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1186%2F1750-1326-5-24" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref293/cit293&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=20525284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref293/cit293&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BC3cnkslCruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=24&author=W.+Luoauthor=W.+Sunauthor=T.+Tadoneauthor=A.+Rodinaauthor=G.+Chiosis&title=Heat+shock+protein+90+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit293R"><div class="casContent"><span class="casTitleNuber">293</span><div class="casTitle"><span class="NLM_cas:atitle">Heat shock protein 90 in neurodegenerative diseases</span></div><div class="casAuthors">Luo Wenjie; Sun Weilin; Taldone Tony; Rodina Anna; Chiosis Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Molecular neurodegeneration</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Hsp90 is a molecular chaperone with important roles in regulating pathogenic transformation.  In addition to its well-characterized functions in malignancy, recent evidence from several laboratories suggests a role for Hsp90 in maintaining the functional stability of neuronal proteins of aberrant capacity, whether mutated or over-activated, allowing and sustaining the accumulation of toxic aggregates.  In addition, Hsp90 regulates the activity of the transcription factor heat shock factor-1 (HSF-1), the master regulator of the heat shock response, mechanism that cells use for protection when exposed to conditions of stress.  These biological functions therefore propose Hsp90 inhibition as a dual therapeutic modality in neurodegenerative diseases.  First, by suppressing aberrant neuronal activity, Hsp90 inhibitors may ameliorate protein aggregation and its associated toxicity.  Second, by activation of HSF-1 and the subsequent induction of heat shock proteins, such as Hsp70, Hsp90 inhibitors may redirect neuronal aggregate formation, and protect against protein toxicity.  This mini-review will summarize our current knowledge on Hsp90 in neurodegeneration and will focus on the potential beneficial application of Hsp90 inhibitors in neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSYuS3z9s_ui5dYoSR9eyvsfW6udTcc2eb98pIRpxpS77ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cnkslCruw%253D%253D&md5=dd686137ecbf1860adf2d5607eb9b229</span></div><a href="/servlet/linkout?suffix=cit293&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-5-24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-5-24%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DTadone%26aufirst%3DT.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DHeat%2520shock%2520protein%252090%2520in%2520neurodegenerative%2520diseases%26jtitle%3DMol.%2520Neurodegener.%26date%3D2010%26volume%3D5%26spage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref294"><div class="reference"><strong class="refLabel"><a href="#ref294" class="rightTabRefNumLink">294</a></strong><div class="NLM_citation" id="rightTab-cit294"><span><span class="NLM_contrib-group">Trott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westerheide, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morimoto, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morano, K. A.</span><span> </span><span class="NLM_article-title">Activation of heat shock and antioxidant responses by the natural product celastrol: transcriptional signatures of a thiol-targeted molecule</span> <span class="citation_source-journal">Mol. Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1104</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref294/cit294&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1091%2Fmbc.e07-10-1004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref294/cit294&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=18199679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref294/cit294&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslemsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=1104-1112&author=A.+Trottauthor=J.+D.+Westauthor=L.+Klaicauthor=S.+D.+Westerheideauthor=R.+B.+Silvermanauthor=R.+I.+Morimotoauthor=K.+A.+Morano&title=Activation+of+heat+shock+and+antioxidant+responses+by+the+natural+product+celastrol%3A+transcriptional+signatures+of+a+thiol-targeted+molecule"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit294R"><div class="casContent"><span class="casTitleNuber">294</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of heat shock and antioxidant responses by the natural product celastrol: transcriptional signatures of a thiol-targeted molecule</span></div><div class="casAuthors">Trott, Amy; West, James D.; Klaic, Lada; Westerheide, Sandy D.; Silverman, Richard B.; Morimoto, Richard I.; Morano, Kevin A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1104-1112</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1939-4586</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Stress response pathways allow cells to sense and respond to environmental changes and adverse pathophysiol. states.  Pharmacol. modulation of cellular stress pathways has implications in the treatment of human diseases, including neurodegenerative disorders, cardiovascular disease, and cancer.  The quinone methide triterpene celastrol, derived from a traditional Chinese medicinal herb, has numerous pharmacol. properties, and it is a potent activator of the mammalian heat shock transcription factor HSF1.  However, its mode of action and spectrum of cellular targets are poorly understood.  We show here that celastrol activates Hsf1 in Saccharomyces cerevisiae at a similar effective concn. seen in mammalian cells.  Transcriptional profiling revealed that celastrol treatment induces a battery of oxidant defense genes in addn. to heat shock genes.  Celastrol activated the yeast Yap1 oxidant defense transcription factor via the carboxy-terminal redox center that responds to electrophilic compds.  Antioxidant response genes were likewise induced in mammalian cells, demonstrating that the activation of two major cell stress pathways by celastrol is conserved.  We report that celastrol's biol. effects, including inhibition of glucocorticoid receptor activity, can be blocked by the addn. of excess free thiol, suggesting a chem. mechanism for biol. activity based on modification of key reactive thiols by this natural product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUo9eonQNoz7Vg90H21EOLACvtfcHk0lh4h4INbJP9iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslemsLg%253D&md5=3ed78a4b64b8c5471803a07b84a72e26</span></div><a href="/servlet/linkout?suffix=cit294&amp;dbid=16384&amp;doi=10.1091%2Fmbc.e07-10-1004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.e07-10-1004%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DA.%26aulast%3DWest%26aufirst%3DJ.%2BD.%26aulast%3DKlaic%26aufirst%3DL.%26aulast%3DWesterheide%26aufirst%3DS.%2BD.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26aulast%3DMorimoto%26aufirst%3DR.%2BI.%26aulast%3DMorano%26aufirst%3DK.%2BA.%26atitle%3DActivation%2520of%2520heat%2520shock%2520and%2520antioxidant%2520responses%2520by%2520the%2520natural%2520product%2520celastrol%253A%2520transcriptional%2520signatures%2520of%2520a%2520thiol-targeted%2520molecule%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2008%26volume%3D19%26spage%3D1104%26epage%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref295"><div class="reference"><strong class="refLabel"><a href="#ref295" class="rightTabRefNumLink">295</a></strong><div class="NLM_citation" id="rightTab-cit295"><span><span class="NLM_contrib-group">Klaic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trippier, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morimoto, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Remarkable stereospecific conjugate additions to the Hsp90 inhibitor celastrol</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">19634</span><span class="NLM_x">–</span> <span class="NLM_lpage">19637</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja208359a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=19634-19637&author=L.+Klaicauthor=P.+C.+Trippierauthor=R.+K.+Mishraauthor=R.+I.+Morimotoauthor=R.+B.+Silverman&title=Remarkable+stereospecific+conjugate+additions+to+the+Hsp90+inhibitor+celastrol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit295&amp;dbid=16384&amp;doi=10.1021%2Fja208359a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja208359a%26sid%3Dliteratum%253Aachs%26aulast%3DKlaic%26aufirst%3DL.%26aulast%3DTrippier%26aufirst%3DP.%2BC.%26aulast%3DMishra%26aufirst%3DR.%2BK.%26aulast%3DMorimoto%26aufirst%3DR.%2BI.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DRemarkable%2520stereospecific%2520conjugate%2520additions%2520to%2520the%2520Hsp90%2520inhibitor%2520celastrol%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D19634%26epage%3D19637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref296"><div class="reference"><strong class="refLabel"><a href="#ref296" class="rightTabRefNumLink">296</a></strong><div class="NLM_citation" id="rightTab-cit296"><span><span class="NLM_contrib-group">Kieran, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalmar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddoch-Contreras, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnstock, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greensmith, L.</span><span> </span><span class="NLM_article-title">Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">402</span><span class="NLM_x">–</span> <span class="NLM_lpage">405</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref296/cit296&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnm1021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref296/cit296&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=15034571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref296/cit296&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1ektL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=402-405&author=D.+Kieranauthor=B.+Kalmarauthor=J.+R.+Dickauthor=J.+Riddoch-Contrerasauthor=G.+Burnstockauthor=L.+Greensmith&title=Treatment+with+arimoclomol%2C+a+coinducer+of+heat+shock+proteins%2C+delays+disease+progression+in+ALS+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit296R"><div class="casContent"><span class="casTitleNuber">296</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice</span></div><div class="casAuthors">Kieran, Dairin; Kalmar, Bernadett; Dick, James R. T.; Riddoch-Contreras, Joanna; Burnstock, Geoffrey; Greensmith, Linda</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">402-405</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative condition in which motoneurons of the spinal cord and motor cortex die, resulting in progressive paralysis.  This condition has no cure and results in eventual death, usually within 1-5 yr of diagnosis.  Although the specific etiol. of ALS is unknown, 20% of familial cases of the disease carry mutations in the gene encoding Cu/Zn superoxide dismutase-1 (SOD1).  Transgenic mice overexpressing human mutant SOD1 have a phenotype and pathol. that are very similar to that seen in human ALS patients.  Here we show that treatment with arimoclomol, a coinducer of heat shock proteins (HSPs), significantly delays disease progression in mice expressing a SOD1 mutant in which glycine is substituted with alanine at position 93 (SOD1G93A).  Arimoclomol-treated SOD1G93A mice show marked improvement in hind limb muscle function and motoneuron survival in the later stages of the disease, resulting in a 22% increase in lifespan.  Pharmacol. activation of the heat shock response may therefore be a successful therapeutic approach to treating ALS, and possibly other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBaaFjZGbFG7Vg90H21EOLACvtfcHk0ljzhjq-1zBX-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1ektL0%253D&md5=9bed550d76bcc6a34f71f404aa378392</span></div><a href="/servlet/linkout?suffix=cit296&amp;dbid=16384&amp;doi=10.1038%2Fnm1021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1021%26sid%3Dliteratum%253Aachs%26aulast%3DKieran%26aufirst%3DD.%26aulast%3DKalmar%26aufirst%3DB.%26aulast%3DDick%26aufirst%3DJ.%2BR.%26aulast%3DRiddoch-Contreras%26aufirst%3DJ.%26aulast%3DBurnstock%26aufirst%3DG.%26aulast%3DGreensmith%26aufirst%3DL.%26atitle%3DTreatment%2520with%2520arimoclomol%252C%2520a%2520coinducer%2520of%2520heat%2520shock%2520proteins%252C%2520delays%2520disease%2520progression%2520in%2520ALS%2520mice%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D402%26epage%3D405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref297"><div class="reference"><strong class="refLabel"><a href="#ref297" class="rightTabRefNumLink">297</a></strong><div class="NLM_citation" id="rightTab-cit297"><span><span class="NLM_contrib-group">Evans, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gestwicki, J. E.</span><span> </span><span class="NLM_article-title">Heat shock protein 70 (Hsp70) as an emerging drug target</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4585</span><span class="NLM_x">–</span> <span class="NLM_lpage">4602</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100054f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref297/cit297&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4585-4602&author=C.+G.+Evansauthor=L.+Changauthor=J.+E.+Gestwicki&title=Heat+shock+protein+70+%28Hsp70%29+as+an+emerging+drug+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit297R"><div class="casContent"><span class="casTitleNuber">297</span><div class="casTitle"><span class="NLM_cas:atitle">Heat Shock Protein 70 (Hsp70) as an Emerging Drug Target</span></div><div class="casAuthors">Evans, Christopher G.; Chang, Lyra; Gestwicki, Jason E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4585-4602</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5hrQMA77XsrVg90H21EOLACvtfcHk0ljzhjq-1zBX-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejsLc%253D&md5=b87bdc9b76e66d62c130a162037387b5</span></div><a href="/servlet/linkout?suffix=cit297&amp;dbid=16384&amp;doi=10.1021%2Fjm100054f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100054f%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DC.%2BG.%26aulast%3DChang%26aufirst%3DL.%26aulast%3DGestwicki%26aufirst%3DJ.%2BE.%26atitle%3DHeat%2520shock%2520protein%252070%2520%2528Hsp70%2529%2520as%2520an%2520emerging%2520drug%2520target%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4585%26epage%3D4602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref298"><div class="reference"><strong class="refLabel"><a href="#ref298" class="rightTabRefNumLink">298</a></strong><div class="NLM_citation" id="rightTab-cit298"><span><span class="NLM_contrib-group">Fleming, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubinsztein, D. C.</span><span> </span><span class="NLM_article-title">Chemical modulators of autophagy as biological probes and potential therapeutics</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref298/cit298&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnchembio.500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref298/cit298&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=21164513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref298/cit298&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFOjtrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=9-17&author=A.+Flemingauthor=T.+Nodaauthor=T.+Yoshimoriauthor=D.+C.+Rubinsztein&title=Chemical+modulators+of+autophagy+as+biological+probes+and+potential+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit298R"><div class="casContent"><span class="casTitleNuber">298</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical modulators of autophagy as biological probes and potential therapeutics</span></div><div class="casAuthors">Fleming, Angeleen; Noda, Takeshi; Yoshimori, Tamotsu; Rubinsztein, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-17</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Autophagy is an evolutionarily conserved mechanism for protein degrdn. that is crit. for the maintenance of homeostasis in man.  Autophagy has unexpected pleiotropic functions that favor survival of the cell, including nutrient supply under starvation, cleaning of the cellular interior, defense against infection and antigen presentation.  Moreover, defective autophagy is assocd. with a diverse range of disease states, including neurodegeneration, cancer and Crohn's disease.  Here we discuss the roles of mammalian autophagy in health and disease and highlight recent advances in pharmacol. manipulation of autophagic pathways as a therapeutic strategy for a variety of pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhtwNQMxbsPbVg90H21EOLACvtfcHk0ljzhjq-1zBX-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFOjtrrP&md5=5b4a84766cb3bb3d5a095254b4b36d04</span></div><a href="/servlet/linkout?suffix=cit298&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.500%26sid%3Dliteratum%253Aachs%26aulast%3DFleming%26aufirst%3DA.%26aulast%3DNoda%26aufirst%3DT.%26aulast%3DYoshimori%26aufirst%3DT.%26aulast%3DRubinsztein%26aufirst%3DD.%2BC.%26atitle%3DChemical%2520modulators%2520of%2520autophagy%2520as%2520biological%2520probes%2520and%2520potential%2520therapeutics%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D9%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref299"><div class="reference"><strong class="refLabel"><a href="#ref299" class="rightTabRefNumLink">299</a></strong><div class="NLM_citation" id="rightTab-cit299"><span><span class="NLM_contrib-group">Bove, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Vicente, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vila, M.</span><span> </span><span class="NLM_article-title">Fighting neurodegeneration with rapamycin: mechanistic insights</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref299/cit299&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1038%2Fnrn3068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref299/cit299&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=21772323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref299/cit299&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptV2isbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=437-452&author=J.+Boveauthor=M.+Martinez-Vicenteauthor=M.+Vila&title=Fighting+neurodegeneration+with+rapamycin%3A+mechanistic+insights"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit299R"><div class="casContent"><span class="casTitleNuber">299</span><div class="casTitle"><span class="NLM_cas:atitle">Fighting neurodegeneration with rapamycin: mechanistic insights</span></div><div class="casAuthors">Bove, Jordi; Martinez-Vicente, Marta; Vila, Miquel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">437-452</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A growing no. of studies point to rapamycin as a pharmacol. compd. that is able to provide neuroprotection in several exptl. models of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, Huntington's disease and spinocerebellar ataxia type 3.  In addn., rapamycin exerts strong anti-ageing effects in several species, including mammals.  By inhibiting the activity of mammalian target of rapamycin (mTOR), rapamycin influences a variety of essential cellular processes, such as cell growth and proliferation, protein synthesis and autophagy.  Here, we review the mol. mechanisms underlying the neuroprotective effects of rapamycin and discuss the therapeutic potential of this compd. for neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlSMJw9qqEE7Vg90H21EOLACvtfcHk0lgN4RyyGMHPjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptV2isbs%253D&md5=9877fdf5ed611a5454e95153f086b7d9</span></div><a href="/servlet/linkout?suffix=cit299&amp;dbid=16384&amp;doi=10.1038%2Fnrn3068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3068%26sid%3Dliteratum%253Aachs%26aulast%3DBove%26aufirst%3DJ.%26aulast%3DMartinez-Vicente%26aufirst%3DM.%26aulast%3DVila%26aufirst%3DM.%26atitle%3DFighting%2520neurodegeneration%2520with%2520rapamycin%253A%2520mechanistic%2520insights%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2011%26volume%3D12%26spage%3D437%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref300"><div class="reference"><strong class="refLabel"><a href="#ref300" class="rightTabRefNumLink">300</a></strong><div class="NLM_citation" id="rightTab-cit300"><span><span class="NLM_contrib-group">Casarejos, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solano, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perucho, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Yebenes, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mena, M. A.</span><span> </span><span class="NLM_article-title">The accumulation of neurotoxic proteins, induced by proteasome inhibition, is reverted by trehalose, an enhancer of autophagy, in human neuroblastoma cells</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">512</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref300/cit300&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.neuint.2011.01.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref300/cit300&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=21232572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref300/cit300&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFGnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2011&pages=512-520&author=M.+J.+Casarejosauthor=R.+M.+Solanoauthor=A.+Gomezauthor=J.+Peruchoauthor=J.+G.+de+Yebenesauthor=M.+A.+Mena&title=The+accumulation+of+neurotoxic+proteins%2C+induced+by+proteasome+inhibition%2C+is+reverted+by+trehalose%2C+an+enhancer+of+autophagy%2C+in+human+neuroblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit300R"><div class="casContent"><span class="casTitleNuber">300</span><div class="casTitle"><span class="NLM_cas:atitle">The accumulation of neurotoxic proteins, induced by proteasome inhibition, is reverted by trehalose, an enhancer of autophagy, in human neuroblastoma cells</span></div><div class="casAuthors">Casarejos, M. J.; Solano, R. M.; Gomez, A.; Perucho, J.; de Yebenes, J. G.; Mena, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">512-520</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Neurodegenerative diseases like Parkinson's disease, Alzheimer's disease, Huntington's disease and others are due to accumulation of abnormal proteins which fold improperly and impair neuronal function.  Accumulation of these proteins could be achieved by several mechanisms including mutation, overprodn. or impairment of its degrdn.  Inhibition of the normal protein degrdn. is produced by blockade of the ubiquitin proteasome system.  We have shown that epoxomicin, a proteasome inhibitor, increases the levels of proteins involved in neurodegenerative disorders such as α-synuclein and hyper phosphorylated tau in NB69 human neuroblastoma cells and that such increase correlates with an enhanced rate of cell death.  We then investigated whether the stimulation of autophagy, an alternative mechanism for elimination of abnormal proteins, by treatment with trehalose, counteracts the effects of proteasomal blockade.  Trehalose, a disaccharide present in many non-mammalian species, known to enhance autophagy, protects cells against various environmental stresses.  Treatment with trehalose produced a dose and time-dependent increase in the no. of autophagosomes and markers of autophagy in NB69 cells.  Trehalose did not change the no. of total neither the no. of dividing cells in the culture but it completely prevented the necrosis of NB69 induced by epoxomicin.  In addn., the treatment with trehalose reverted the accumulation, induced by epoxomicin, of polyubiquitinated proteins, total and phosphorylated tau, p-GSK-3, and α-synuclein, as well as the α-synuclein intracellular aggregates.  The effects of trehalose were not mediated through activation of free radical scavenging compds., like GSH, or mitochondrial proteins, like DJ1, but trehalose reduced the activation of ERK and chaperone HSP-70 induced by epoxomicin.  Inhibition of ERK phosphorylation prevented the epoxomicin-induced cell death.  Inhibition of autophagy reverted the neuroprotective effects of trehalose in epoxomicin-induced cell death.  These results suggest that trehalose is a powerful modifier of abnormal protein accumulation in neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqm4ZwgOMkH7Vg90H21EOLACvtfcHk0lgN4RyyGMHPjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFGnsb8%253D&md5=1d8884f23645d4324b7834cd2ed6d00c</span></div><a href="/servlet/linkout?suffix=cit300&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2011.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2011.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DCasarejos%26aufirst%3DM.%2BJ.%26aulast%3DSolano%26aufirst%3DR.%2BM.%26aulast%3DGomez%26aufirst%3DA.%26aulast%3DPerucho%26aufirst%3DJ.%26aulast%3Dde%2BYebenes%26aufirst%3DJ.%2BG.%26aulast%3DMena%26aufirst%3DM.%2BA.%26atitle%3DThe%2520accumulation%2520of%2520neurotoxic%2520proteins%252C%2520induced%2520by%2520proteasome%2520inhibition%252C%2520is%2520reverted%2520by%2520trehalose%252C%2520an%2520enhancer%2520of%2520autophagy%252C%2520in%2520human%2520neuroblastoma%2520cells%26jtitle%3DNeurochem.%2520Int.%26date%3D2011%26volume%3D58%26spage%3D512%26epage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref301"><div class="reference"><strong class="refLabel"><a href="#ref301" class="rightTabRefNumLink">301</a></strong><div class="NLM_citation" id="rightTab-cit301"><span><span class="NLM_contrib-group">Dennissen, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kholod, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Leeuwen, F. W.</span><span> </span><span class="NLM_article-title">The ubiquitin proteasome system in neurodegenerative diseases: Culprit, accomplice or victim?</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref301/cit301&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1016%2Fj.pneurobio.2012.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref301/cit301&amp;dbid=8&amp;doi=10.1021%2Fjm3015926&amp;key=22270043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref301/cit301&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFGgt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2012&pages=190-207&author=F.+J.+Dennissenauthor=N.+Kholodauthor=F.+W.+van+Leeuwen&title=The+ubiquitin+proteasome+system+in+neurodegenerative+diseases%3A+Culprit%2C+accomplice+or+victim%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit301R"><div class="casContent"><span class="casTitleNuber">301</span><div class="casTitle"><span class="NLM_cas:atitle">The ubiquitin proteasome system in neurodegenerative diseases: Culprit, accomplice or victim?</span></div><div class="casAuthors">Dennissen, F. J. A.; Kholod, N.; van Leeuwen, F. W.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">190-207</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A shared hallmark for many neurodegenerative disorders is the accumulation of toxic protein species which is assumed to be the cause for these diseases.  Since the ubiquitin proteasome system (UPS) is the most important pathway for selective protein degrdn. it is likely that it is involved in the etiol. neurodegenerative disorders.  Indeed, impairment of the UPS has been reported to occur during neurodegeneration.  Although accumulation of toxic protein species (amyloid β) are in turn known to impair the UPS the relationship is not necessarily causal.  We provide an overview of the most recent insights in the roles the UPS plays in protein degrdn. and other processes.  Addnl., we discuss the role of the UPS in clearance of the toxic proteins known to accumulate in the hallmarks of neurodegenerative diseases.  The present paper will focus on critically reviewing the involvement of the UPS in specific neurodegenerative diseases and will discuss if UPS impairment is a cause, a consequence or both of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvnTK0w6-dVLVg90H21EOLACvtfcHk0lgN4RyyGMHPjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFGgt7w%253D&md5=3d88d59d10a89458bb7cc89553194f39</span></div><a href="/servlet/linkout?suffix=cit301&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2012.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2012.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DDennissen%26aufirst%3DF.%2BJ.%26aulast%3DKholod%26aufirst%3DN.%26aulast%3Dvan%2BLeeuwen%26aufirst%3DF.%2BW.%26atitle%3DThe%2520ubiquitin%2520proteasome%2520system%2520in%2520neurodegenerative%2520diseases%253A%2520Culprit%252C%2520accomplice%2520or%2520victim%253F%26jtitle%3DProg.%2520Neurobiol.%26date%3D2012%26volume%3D96%26spage%3D190%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref302"><div class="reference"><strong class="refLabel"><a href="#ref302" class="rightTabRefNumLink">302</a></strong><div class="NLM_citation" id="rightTab-cit302"><span><span class="NLM_contrib-group">Luo, G.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, W.-D.</span><span> </span><span class="NLM_article-title">Are heat shock proteins therapeutic target for Parkinson’s disease?</span> <span class="citation_source-journal">Int. J. Biol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref302/cit302&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.7150%2Fijbs.3.20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref302/cit302&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCmtr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=20-26&author=G.-R.+Luoauthor=S.+Chenauthor=W.-D.+Le&title=Are+heat+shock+proteins+therapeutic+target+for+Parkinson%E2%80%99s+disease%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit302R"><div class="casContent"><span class="casTitleNuber">302</span><div class="casTitle"><span class="NLM_cas:atitle">Are heat shock proteins therapeutic target for Parkinson's disease?</span></div><div class="casAuthors">Luo, Guang-Rui; Chen, Sheng; Le, Wei-Dong</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biological Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-26</span>CODEN:
                <span class="NLM_cas:coden">IJBSB9</span>;
        ISSN:<span class="NLM_cas:issn">1449-2288</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">A review.  Heat shock proteins (HSPs), known as mol. chaperone to assist protein folding, have recently become a research focus in Parkinson's disease (PD) because the pathogenesis of this disease is highlighted by the intracellular protein misfolding and inclusion body formation.  The present review will focus on the functions of different HSPs and their protective roles in PD.  It is postulated that HSPs may serve as protein folding machinery and work together with ubiquitin-proteasome system (UPS) to assist in decompg. aberrant proteins.  Failure of UPS is thought to play a key role in the pathogenesis of PD.  In addn., HSPs may possess anti-apoptotic effects and keep the homeostasis of dopaminergic neurons against stress conditions.  The crit. role of HSPs and recent discovery of some novel HSPs inducers suggest that HSPs may be potential therapeutic targets for PD and other neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3IzDIptaAiLVg90H21EOLACvtfcHk0lgN4RyyGMHPjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCmtr%252FP&md5=9f0df828092b3be4d825d6234d8dba38</span></div><a href="/servlet/linkout?suffix=cit302&amp;dbid=16384&amp;doi=10.7150%2Fijbs.3.20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fijbs.3.20%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DG.-R.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DLe%26aufirst%3DW.-D.%26atitle%3DAre%2520heat%2520shock%2520proteins%2520therapeutic%2520target%2520for%2520Parkinson%25E2%2580%2599s%2520disease%253F%26jtitle%3DInt.%2520J.%2520Biol.%2520Sci.%26date%3D2007%26volume%3D3%26spage%3D20%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref303"><div class="reference"><strong class="refLabel"><a href="#ref303" class="rightTabRefNumLink">303</a></strong><div class="NLM_citation" id="rightTab-cit303"><span><span class="NLM_contrib-group">Zhao, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. Y.</span><span> </span><span class="NLM_article-title">Chemical chaperone and inhibitor discovery: potential treatments for protein conformational diseases</span> <span class="citation_source-journal">Perspect. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref303/cit303&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A280%3ADC%252BD1MnnslSgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2008&pages=39-48&author=J.+H.+Zhaoauthor=H.+L.+Liuauthor=H.+Y.+Linauthor=C.+H.+Huangauthor=H.+W.+Fangauthor=S.+S.+Chenauthor=Y.+Hoauthor=W.+B.+Tsaiauthor=W.+Y.+Chen&title=Chemical+chaperone+and+inhibitor+discovery%3A+potential+treatments+for+protein+conformational+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit303R"><div class="casContent"><span class="casTitleNuber">303</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical chaperone and inhibitor discovery: potential treatments for protein conformational diseases</span></div><div class="casAuthors">Zhao Jian-Hua; Liu Hsuan-Liang; Lin Hsin-Yi; Huang Chih-Hung; Fang Hsu-Wei; Chen Shiao-Shing; Ho Yih; Tsai Wei-Bor; Chen Wen-Yih</div><div class="citationInfo"><span class="NLM_cas:title">Perspectives in medicinal chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">39-48</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Protein misfolding and aggregation cause a large number of neurodegenerative diseases in humans due to (i) gain of function as observed in Alzheimer's disease, Huntington's disease, Parkinson's disease, and Prion's disease or (ii) loss of function as observed in cystic fibrosis and alpha1-antitrypsin deficiency.  These misfolded proteins could either lead to the formation of harmful amyloids that become toxic for the cells or to be recognized and prematurely degraded by the protein quality control system.  An increasing number of studies has indicated that some low-molecular-weight compounds named as chemical chaperones can reverse the mislocalization and/or aggregation of proteins associated with human conformational diseases.  These small molecules are thought to non-selectively stabilize proteins and facilitate their folding.  In this review, we summarize the probable mechanisms of protein conformational diseases in humans and the use of chemical chaperones and inhibitors as potential therapeutic agents against these diseases.  Furthermore, recent advanced experimental and theoretical approaches underlying the detailed mechanisms of protein conformational changes and current structure-based drug designs towards protein conformational diseases are also discussed.  It is believed that a better understanding of the mechanisms of conformational changes as well as the biological functions of these proteins will lead to the development and design of potential interfering compounds against amyloid formation associated with protein conformational diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTXM2ChGVrbaP6BottYdIAWfW6udTcc2eb6csd3KdvK27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MnnslSgtw%253D%253D&md5=d1fd333b602c2c25a35f369e24507fe9</span></div><a href="/servlet/linkout?suffix=cit303&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%2BH.%26aulast%3DLiu%26aufirst%3DH.%2BL.%26aulast%3DLin%26aufirst%3DH.%2BY.%26aulast%3DHuang%26aufirst%3DC.%2BH.%26aulast%3DFang%26aufirst%3DH.%2BW.%26aulast%3DChen%26aufirst%3DS.%2BS.%26aulast%3DHo%26aufirst%3DY.%26aulast%3DTsai%26aufirst%3DW.%2BB.%26aulast%3DChen%26aufirst%3DW.%2BY.%26atitle%3DChemical%2520chaperone%2520and%2520inhibitor%2520discovery%253A%2520potential%2520treatments%2520for%2520protein%2520conformational%2520diseases%26jtitle%3DPerspect.%2520Med.%2520Chem.%26date%3D2008%26volume%3D1%26spage%3D39%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref304"><div class="reference"><strong class="refLabel"><a href="#ref304" class="rightTabRefNumLink">304</a></strong><div class="NLM_citation" id="rightTab-cit304"><span><span class="NLM_contrib-group">Ali, Y. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitay, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, R. G.</span><span> </span><span class="NLM_article-title">Dealing with misfolded proteins: examining the neuroprotective role of molecular chaperones in neurodegeneration</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">6859</span><span class="NLM_x">–</span> <span class="NLM_lpage">6887</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=6859-6887&author=Y.+O.+Aliauthor=B.+M.+Kitayauthor=R.+G.+Zhai&title=Dealing+with+misfolded+proteins%3A+examining+the+neuroprotective+role+of+molecular+chaperones+in+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit304&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DY.%2BO.%26aulast%3DKitay%26aufirst%3DB.%2BM.%26aulast%3DZhai%26aufirst%3DR.%2BG.%26atitle%3DDealing%2520with%2520misfolded%2520proteins%253A%2520examining%2520the%2520neuroprotective%2520role%2520of%2520molecular%2520chaperones%2520in%2520neurodegeneration%26jtitle%3DMolecules%26date%3D2010%26volume%3D15%26spage%3D6859%26epage%3D6887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref305"><div class="reference"><strong class="refLabel"><a href="#ref305" class="rightTabRefNumLink">305</a></strong><div class="NLM_citation" id="rightTab-cit305"><span><span class="NLM_contrib-group">Cuajungco, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faget, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, A. I.</span><span> </span><span class="NLM_article-title">Metal chelation as a potential therapy for Alzheimer’s disease</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">920</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=920&publication_year=2000&pages=292-304&author=M.+P.+Cuajungcoauthor=K.+Y.+Fagetauthor=X.+Huangauthor=R.+E.+Tanziauthor=A.+I.+Bush&title=Metal+chelation+as+a+potential+therapy+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit305&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCuajungco%26aufirst%3DM.%2BP.%26aulast%3DFaget%26aufirst%3DK.%2BY.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DMetal%2520chelation%2520as%2520a%2520potential%2520therapy%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2000%26volume%3D920%26spage%3D292%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref306"><div class="reference"><strong class="refLabel"><a href="#ref306" class="rightTabRefNumLink">306</a></strong><div class="NLM_citation" id="rightTab-cit306"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span> </span><span class="NLM_article-title">Inhibitory action of macrocyclic platiniferous chelators on metal-induced Ab aggregation</span> <span class="citation_source-journal">Chem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1304</span><span class="NLM_x">–</span> <span class="NLM_lpage">1312</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref306/cit306&amp;dbid=16&amp;doi=10.1021%2Fjm3015926&amp;key=10.1039%2Fc2sc01100j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref306/cit306&amp;dbid=32&amp;doi=10.1021%2Fjm3015926&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1Onu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1304-1312&author=X.+Wangauthor=X.+Wangauthor=C.+Zhangauthor=Y.+Jiaoauthor=Z.+Guo&title=Inhibitory+action+of+macrocyclic+platiniferous+chelators+on+metal-induced+Ab+aggregation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit306R"><div class="casContent"><span class="casTitleNuber">306</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory action of macrocyclic platiniferous chelators on metal-induced Aβ aggregation</span></div><div class="casAuthors">Wang, Xiaohui; Wang, Xiaoyong; Zhang, Changli; Jiao, Yang; Guo, Zijian</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1304-1312</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative illness assocd. with amyloid β-peptide (Aβ) aggregation in the brain.  Aβ shows high affinity for metal ions such as Zn2+ and Cu2+, which constitutes the major reason for the Aβ aggregation and related neurotoxicity.  Metal chelators are potential therapeutic agents for AD because they could sequester metal ions from the Aβ aggregates and reverse the aggregation.  In this study, two macrocyclic platiniferous chelators (PC1, PC2) with cyclen as the metal-chelating unit and Pt(bipyridine)Cl2 as the Aβ-binding unit have been designed as novel bifunctional inhibitors of the metal-induced Aβ aggregation.  The interactions between the chelators and Aβ40 aggregates are studied by tandem mass spectrometry and 1H NMR.  The platinum centers in PC1 and PC2 are shown to coordinate with histidine residues (His-14 or -13) of Aβ40.  The inhibitory effect of the chelators on Aβ40 aggregation induced by Zn2+ and Cu2+ ions is investigated using turbidimetry, a BCA protein assay, and transmission electron microscopy.  PC1 and PC2 show significant inhibition against the Aβ aggregation and the action is more effective than that exerted by cyclen.  By contrast, the corresponding anticancer drug cisplatin exhibits no inhibition against the Aβ aggregation.  PC1 and PC2 can also suppress the Cu-Aβ40 mediated generation of reactive oxygen species and their corresponding neurotoxicity in cortical neuronal cells of mice, and reduce the extent of Aβ aggregation in the brain homogenates of transgenic mice.  These chelators may work through simultaneous metal chelation and peptide modification to interfere with the Aβ aggregation.  Such an intramol. synergism distinguishes PC1 and PC2 from other chelators as potential anti-AD agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9O3gp9Njxh7Vg90H21EOLACvtfcHk0liX24uHdJb_hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1Onu7Y%253D&md5=c2ef80922e9e352ae003a33a41f2e48e</span></div><a href="/servlet/linkout?suffix=cit306&amp;dbid=16384&amp;doi=10.1039%2Fc2sc01100j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2sc01100j%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DJiao%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DZ.%26atitle%3DInhibitory%2520action%2520of%2520macrocyclic%2520platiniferous%2520chelators%2520on%2520metal-induced%2520Ab%2520aggregation%26jtitle%3DChem.%2520Sci.%26date%3D2012%26volume%3D3%26spage%3D1304%26epage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref307"><div class="reference"><strong class="refLabel"><a href="#ref307" class="rightTabRefNumLink">307</a></strong><div class="NLM_citation" id="rightTab-cit307"><span><span class="NLM_contrib-group">Wisniewski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadowski, M.</span><span> </span><span class="NLM_article-title">Preventing beta-amyloid fibrillization and deposition: beta-sheet breakers and pathological chaperone inhibitors</span> <span class="citation_source-journal">BMC Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S5</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=S5&issue=Suppl.+2&author=T.+Wisniewskiauthor=M.+Sadowski&title=Preventing+beta-amyloid+fibrillization+and+deposition%3A+beta-sheet+breakers+and+pathological+chaperone+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit307&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWisniewski%26aufirst%3DT.%26aulast%3DSadowski%26aufirst%3DM.%26atitle%3DPreventing%2520beta-amyloid%2520fibrillization%2520and%2520deposition%253A%2520beta-sheet%2520breakers%2520and%2520pathological%2520chaperone%2520inhibitors%26jtitle%3DBMC%2520Neurosci.%26date%3D2008%26volume%3D9%26issue%3DSuppl.%25202%26spage%3DS5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref308"><div class="reference"><strong class="refLabel"><a href="#ref308" class="rightTabRefNumLink">308</a></strong><div class="NLM_citation" id="rightTab-cit308"><span><span class="NLM_contrib-group">Simons, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caprathe, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeVine, H.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipinski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakkab, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augelli-Szafran, C. E.</span><span> </span><span class="NLM_article-title">The synthesis and structure–activity relationship of substituted <i>N</i>-phenyl anthranilic acid analogs as amyloid aggregation inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">654</span><span class="NLM_x">–</span> <span class="NLM_lpage">657</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=654-657&author=L.+J.+Simonsauthor=B.+W.+Capratheauthor=M.+Callahanauthor=J.+M.+Grahamauthor=T.+Kimuraauthor=Y.+Laiauthor=H.+LeVineauthor=W.+Lipinskiauthor=A.+T.+Sakkabauthor=Y.+Tasakiauthor=L.+C.+Walkerauthor=T.+Yasunagaauthor=Y.+Yeauthor=N.+Zhuangauthor=C.+E.+Augelli-Szafran&title=The+synthesis+and+structure%E2%80%93activity+relationship+of+substituted+N-phenyl+anthranilic+acid+analogs+as+amyloid+aggregation+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit308&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSimons%26aufirst%3DL.%2BJ.%26aulast%3DCaprathe%26aufirst%3DB.%2BW.%26aulast%3DCallahan%26aufirst%3DM.%26aulast%3DGraham%26aufirst%3DJ.%2BM.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DLeVine%26aufirst%3DH.%26aulast%3DLipinski%26aufirst%3DW.%26aulast%3DSakkab%26aufirst%3DA.%2BT.%26aulast%3DTasaki%26aufirst%3DY.%26aulast%3DWalker%26aufirst%3DL.%2BC.%26aulast%3DYasunaga%26aufirst%3DT.%26aulast%3DYe%26aufirst%3DY.%26aulast%3DZhuang%26aufirst%3DN.%26aulast%3DAugelli-Szafran%26aufirst%3DC.%2BE.%26atitle%3DThe%2520synthesis%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520substituted%2520N-phenyl%2520anthranilic%2520acid%2520analogs%2520as%2520amyloid%2520aggregation%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D654%26epage%3D657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref309"><div class="reference"><strong class="refLabel"><a href="#ref309" class="rightTabRefNumLink">309</a></strong><div class="NLM_citation" id="rightTab-cit309"><span><span class="NLM_contrib-group">Heiser, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engernann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunkel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeddrich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waelter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordhoff, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lurz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schugardt, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rautenberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herhaus, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnickel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottcher, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehrach, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanker, E. E.</span><span> </span><span class="NLM_article-title">Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington’s disease by using an automated filter retardation assay</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">16400</span><span class="NLM_x">–</span> <span class="NLM_lpage">16406</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=16400-16406&author=V.+Heiserauthor=S.+Engernannauthor=W.+Brockerauthor=I.+Dunkelauthor=A.+Boeddrichauthor=S.+Waelterauthor=E.+Nordhoffauthor=R.+Lurzauthor=N.+Schugardtauthor=S.+Rautenbergauthor=C.+Herhausauthor=G.+Barnickelauthor=H.+Bottcherauthor=H.+Lehrachauthor=E.+E.+Wanker&title=Identification+of+benzothiazoles+as+potential+polyglutamine+aggregation+inhibitors+of+Huntington%E2%80%99s+disease+by+using+an+automated+filter+retardation+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit309&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeiser%26aufirst%3DV.%26aulast%3DEngernann%26aufirst%3DS.%26aulast%3DBrocker%26aufirst%3DW.%26aulast%3DDunkel%26aufirst%3DI.%26aulast%3DBoeddrich%26aufirst%3DA.%26aulast%3DWaelter%26aufirst%3DS.%26aulast%3DNordhoff%26aufirst%3DE.%26aulast%3DLurz%26aufirst%3DR.%26aulast%3DSchugardt%26aufirst%3DN.%26aulast%3DRautenberg%26aufirst%3DS.%26aulast%3DHerhaus%26aufirst%3DC.%26aulast%3DBarnickel%26aufirst%3DG.%26aulast%3DBottcher%26aufirst%3DH.%26aulast%3DLehrach%26aufirst%3DH.%26aulast%3DWanker%26aufirst%3DE.%2BE.%26atitle%3DIdentification%2520of%2520benzothiazoles%2520as%2520potential%2520polyglutamine%2520aggregation%2520inhibitors%2520of%2520Huntington%25E2%2580%2599s%2520disease%2520by%2520using%2520an%2520automated%2520filter%2520retardation%2520assay%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D16400%26epage%3D16406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref310"><div class="reference"><strong class="refLabel"><a href="#ref310" class="rightTabRefNumLink">310</a></strong><div class="NLM_citation" id="rightTab-cit310"><span><span class="NLM_contrib-group">Geldenhuys, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Schyf, C. J.</span><span> </span><span class="NLM_article-title">Designing drugs with multi-target activity: the next step in the treatment of neurodegenerative disorders</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=115-129&author=W.+J.+Geldenhuysauthor=C.+J.+Van+der+Schyf&title=Designing+drugs+with+multi-target+activity%3A+the+next+step+in+the+treatment+of+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit310&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeldenhuys%26aufirst%3DW.%2BJ.%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26atitle%3DDesigning%2520drugs%2520with%2520multi-target%2520activity%253A%2520the%2520next%2520step%2520in%2520the%2520treatment%2520of%2520neurodegenerative%2520disorders%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2013%26volume%3D8%26spage%3D115%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref311"><div class="reference"><strong class="refLabel"><a href="#ref311" class="rightTabRefNumLink">311</a></strong><div class="NLM_citation" id="rightTab-cit311"><span><span class="NLM_contrib-group">Rizzo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Costa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligresti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrelia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span> </span><span class="NLM_article-title">2-Arylbenzofuran-based molecules as multipotent Alzheimer’s disease modifying agents</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2012&pages=519-532&author=S.+Rizzoauthor=A.+Tarozziauthor=M.+Bartoliniauthor=G.+Da+Costaauthor=A.+Bisiauthor=S.+Gobbiauthor=F.+Bellutiauthor=A.+Ligrestiauthor=M.+Allaraauthor=J.+P.+Montiauthor=V.+Andrisanoauthor=V.+Di+Marzoauthor=P.+Hreliaauthor=A.+Rampa&title=2-Arylbenzofuran-based+molecules+as+multipotent+Alzheimer%E2%80%99s+disease+modifying+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit311&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRizzo%26aufirst%3DS.%26aulast%3DTarozzi%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DDa%2BCosta%26aufirst%3DG.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DAllara%26aufirst%3DM.%26aulast%3DMonti%26aufirst%3DJ.%2BP.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DHrelia%26aufirst%3DP.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3D2-Arylbenzofuran-based%2520molecules%2520as%2520multipotent%2520Alzheimer%25E2%2580%2599s%2520disease%2520modifying%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D58%26spage%3D519%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref312"><div class="reference"><strong class="refLabel"><a href="#ref312" class="rightTabRefNumLink">312</a></strong><div class="NLM_citation" id="rightTab-cit312"><span><span class="NLM_contrib-group">Sorrenti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salerno, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Giacomo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acquaviva, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siracusa, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanella, A.</span><span> </span><span class="NLM_article-title">Imidazole derivatives as antioxidants and selective inhibitors of nNOS</span> <span class="citation_source-journal">Nitric Oxide</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=45-50&author=V.+Sorrentiauthor=L.+Salernoauthor=C.+Di+Giacomoauthor=R.+Acquavivaauthor=M.+A.+Siracusaauthor=A.+Vanella&title=Imidazole+derivatives+as+antioxidants+and+selective+inhibitors+of+nNOS"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit312&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSorrenti%26aufirst%3DV.%26aulast%3DSalerno%26aufirst%3DL.%26aulast%3DDi%2BGiacomo%26aufirst%3DC.%26aulast%3DAcquaviva%26aufirst%3DR.%26aulast%3DSiracusa%26aufirst%3DM.%2BA.%26aulast%3DVanella%26aufirst%3DA.%26atitle%3DImidazole%2520derivatives%2520as%2520antioxidants%2520and%2520selective%2520inhibitors%2520of%2520nNOS%26jtitle%3DNitric%2520Oxide%26date%3D2006%26volume%3D14%26spage%3D45%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref313"><div class="reference"><strong class="refLabel"><a href="#ref313" class="rightTabRefNumLink">313</a></strong><div class="NLM_citation" id="rightTab-cit313"><span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formosa, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Relat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmona, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minguillon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Munoz, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bidon-Chanal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Huprine–tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer’s and prion diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">669</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200840c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=661-669&author=C.+Galdeanoauthor=E.+Viaynaauthor=I.+Solaauthor=X.+Formosaauthor=P.+Campsauthor=A.+Badiaauthor=M.+V.+Closauthor=J.+Relatauthor=M.+Ratiaauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=M.+Salmonaauthor=C.+Minguillonauthor=G.+C.+Gonzalez-Munozauthor=M.+I.+Rodriguez-Francoauthor=A.+Bidon-Chanalauthor=F.+J.+Luqueauthor=D.+Munoz-Torrero&title=Huprine%E2%80%93tacrine+heterodimers+as+anti-amyloidogenic+compounds+of+potential+interest+against+Alzheimer%E2%80%99s+and+prion+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit313&amp;dbid=16384&amp;doi=10.1021%2Fjm200840c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200840c%26sid%3Dliteratum%253Aachs%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DFormosa%26aufirst%3DX.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DRelat%26aufirst%3DJ.%26aulast%3DRatia%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DMinguillon%26aufirst%3DC.%26aulast%3DGonzalez-Munoz%26aufirst%3DG.%2BC.%26aulast%3DRodriguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMunoz-Torrero%26aufirst%3DD.%26atitle%3DHuprine%25E2%2580%2593tacrine%2520heterodimers%2520as%2520anti-amyloidogenic%2520compounds%2520of%2520potential%2520interest%2520against%2520Alzheimer%25E2%2580%2599s%2520and%2520prion%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D661%26epage%3D669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm3015926&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-8%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm3015926%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm3015926" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799ea678e783c28","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
